MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HallAIRA^TownAIRA^^^^^L|MTH^Mother^HL70063|1733 Vverbetuwe Ln^^Cascade^MI^49546^USA^P|^PRN^PH^^^616^3726986ORC|RE||BS49J19846.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS49J19846.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||||CoryellAIRA^SteffiAIRA^Antionette^^^^L|TuscarawasAIRA^TealAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1626 Vennep St^^Brighton^MI^48116^USA^P||^PRN^PH^^^810^3838640|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoryellAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1626 Vennep St^^Brighton^MI^48116^USA^P|^PRN^PH^^^810^3838640ORC|RE||BP05E19854.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP05E19854.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S82B19862^^^AIRA-TEST^MR|||Saint JosephAIRA^OreaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1203 Gewoon Ln^^Saint Clr Shores^MI^48080^USA^P||^PRN^PH^^^586^4983576|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NacogdochesAIRA^Saint JosephAIRA^^^^^L|MTH^Mother^HL70063|1203 Gewoon Ln^^Saint Clr Shores^MI^48080^USA^P|^PRN^PH^^^586^4983576ORC|RE||BS82B19862.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS82B19862.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N79J19870^^^AIRA-TEST^MR||HindsAIRA^FranAIRA^Zuza^^^^L|TrinityAIRA^IngridAIRA^^^^^M||F||2106-3^White^CDCREC|1355 Kijkerk Cir^^Lapeer^MI^48446^USA^P||^PRN^PH^^^810^4317519|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HindsAIRA^TrinityAIRA^^^^^L|MTH^Mother^HL70063|1355 Kijkerk Cir^^Lapeer^MI^48446^USA^P|^PRN^PH^^^810^4317519ORC|RE||BN79J19870.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN79J19870.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A93V19878^^^AIRA-TEST^MR||OakAIRA^HannahAIRA^Maye^^^^L|LawrenceAIRA^CaledoniaAIRA^^^^^M|DOB|F||2106-3^White^CDCREC|1083 Sheden Cir^^Detroit River Station^MI^48222^USA^P||^PRN^PH^^^313^6716416|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OakAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1083 Sheden Cir^^Detroit River Station^MI^48222^USA^P|^PRN^PH^^^313^6716416ORC|RE||BA93V19878.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA93V19878.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D20T19886^^^AIRA-TEST^MR||MadisonAIRA^JourneyAIRA^Deborah^^^^L|PickawayAIRA^DianeAIRA^^^^^M|20230612|F||2106-3^White^CDCREC|1753 Ra en Hunze St^^Wyoming^MI^49509^USA^P||^PRN^PH^^^616^4753013|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^PickawayAIRA^^^^^L|MTH^Mother^HL70063|1753 Ra en Hunze St^^Wyoming^MI^49509^USA^P|^PRN^PH^^^616^4753013ORC|RE||BD20T19886.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD20T19886.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J09X19894^^^AIRA-TEST^MR||TarrantAIRA^PadmaAIRA^Damita^^^^L|MidlandAIRA^JettaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1214 Zeghel Pl^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^7620924|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TarrantAIRA^MidlandAIRA^^^^^L|MTH^Mother^HL70063|1214 Zeghel Pl^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^7620924ORC|RE||BJ09X19894.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K02H19902^^^AIRA-TEST^MR||DeweyAIRA^BridgetAIRA^Rata^^^^L|MartinsonAIRA^BraelynAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1074 Ootterdam Cir^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^3705868|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeweyAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1074 Ootterdam Cir^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^3705868ORC|RE||BK02H19902.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N65Q19910^^^AIRA-TEST^MR||MonoAIRA^LanayaAIRA^Nadia^^^^L|GraysonAIRA^EvaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1637 Ging Ave^^North Branch^MI^48461^USA^P||^PRN^PH^^^810^7084551|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MonoAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1637 Ging Ave^^North Branch^MI^48461^USA^P|^PRN^PH^^^810^7084551ORC|RE||BN65Q19910.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|SHOT DATE||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z53E19918^^^AIRA-TEST^MR||GuadalupeAIRA^HerschellAIRA^Tayce^^^^L|SnyderAIRA^AmayaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1006 Gulpen-Wittem Ln^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^5064846|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuadalupeAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1006 Gulpen-Wittem Ln^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^5064846ORC|RE||BZ53E19918.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20230612||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z26U19926^^^AIRA-TEST^MR||McClainAIRA^ShriAIRA^Cyrena^^^^L|AllenAIRA^MutsukoAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1601 Zmmen St^^Harsens Island^MI^48028^USA^P||^PRN^PH^^^810^6388440|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McClainAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1601 Zmmen St^^Harsens Island^MI^48028^USA^P|^PRN^PH^^^810^6388440ORC|RE||BZ26U19926.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cTA-K.01.12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E47O19934^^^AIRA-TEST^MR||CedarAIRA^SharayAIRA^Erena^^^^L|Olsen LeeAIRA^DulceAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1836 Zaarlem Ave^^Memphis^MI^48041^USA^P||^PRN^PH^^^810^4013546|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CedarAIRA^Olsen LeeAIRA^^^^^L|MTH^Mother^HL70063|1836 Zaarlem Ave^^Memphis^MI^48041^USA^P|^PRN^PH^^^810^4013546ORC|RE||BE47O19934.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14000BADVALUE^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N83D20947^^^AIRA-TEST^MR||GanesAIRA^KajalAIRA^Kendra^^^^L|ClayAIRA^MichikoAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1056 Beel en Maas Cir^^Grandville^MI^49418^USA^P~1056 Beel en Maas Cir^^Grandville^MI^49418^USA^B||^PRN^PH^^^616^7106514|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanesAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1056 Beel en Maas Cir^^Grandville^MI^49418^USA^P|^PRN^PH^^^616^7106514ORC|RE||BN83D20947.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN83D20947.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V41Y20955^^^AIRA-TEST^MR||DouglasAIRA^RuellaAIRA^Bacia^^^^L|CavilAIRA^KaraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1779 Oosten Cir^^Mooreville^MI^48160^USA^P~1779 Oosten Cir^^Mooreville^MI^48160^USA^BA||^PRN^PH^^^734^2420976|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DouglasAIRA^CavilAIRA^^^^^L|MTH^Mother^HL70063|1779 Oosten Cir^^Mooreville^MI^48160^USA^P|^PRN^PH^^^734^2420976ORC|RE||BV41Y20955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV41Y20955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-BDL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P90Y20963^^^AIRA-TEST^MR||LeknesAIRA^MahaliaAIRA^Graeae^^^^L|SheridanAIRA^ErynAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1231 Buth Cir^^Kincheloe^MI^49784^USA^P~1231 Buth Cir^^Kincheloe^MI^49784^USA^BDL||^PRN^PH^^^906^5463530|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeknesAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1231 Buth Cir^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^5463530ORC|RE||BP90Y20963.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP90Y20963.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T64W20971^^^AIRA-TEST^MR||OceanaAIRA^KarlyAIRA^Opal^^^^L|WettilandAIRA^MiliAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1334 Nlkmaar Ave^^Tecumseh^MI^49286^USA^P~1334 Nlkmaar Ave^^Tecumseh^MI^49286^USA^BR||^PRN^PH^^^517^9541235|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OceanaAIRA^WettilandAIRA^^^^^L|MTH^Mother^HL70063|1334 Nlkmaar Ave^^Tecumseh^MI^49286^USA^P|^PRN^PH^^^517^9541235ORC|RE||BT64W20971.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT64W20971.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-C|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E46M20979^^^AIRA-TEST^MR||ByrneAIRA^AnnelieseAIRA^Alexis^^^^L|LlanoAIRA^DierdreAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1438 Meel en Maas Ln^^Silverwood^MI^48760^USA^P~1438 Meel en Maas Ln^^Silverwood^MI^48760^USA^C||^PRN^PH^^^989^6521609|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ByrneAIRA^LlanoAIRA^^^^^L|MTH^Mother^HL70063|1438 Meel en Maas Ln^^Silverwood^MI^48760^USA^P|^PRN^PH^^^989^6521609ORC|RE||BE46M20979.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE46M20979.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-F|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N45J20984^^^AIRA-TEST^MR||HillAIRA^MyriamAIRA^Jaslene^^^^L|MeadeAIRA^PhryniaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1513 Slechte Pl^^Trenton^MI^48183^USA^P~1513 Slechte Pl^^Trenton^MI^48183^USA^F||^PRN^PH^^^734^2789510|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillAIRA^MeadeAIRA^^^^^L|MTH^Mother^HL70063|1513 Slechte Pl^^Trenton^MI^48183^USA^P|^PRN^PH^^^734^2789510ORC|RE||BN45J20984.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN45J20984.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-H|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X14Z20992^^^AIRA-TEST^MR||McCarthyAIRA^BeckyAIRA^Cecia^^^^L|HindsAIRA^LorraeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1501 Komen Ln^^Lansing^MI^48951^USA^P~1501 Komen Ln^^Lansing^MI^48951^USA^H||^PRN^PH^^^517^3131675|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCarthyAIRA^HindsAIRA^^^^^L|MTH^Mother^HL70063|1501 Komen Ln^^Lansing^MI^48951^USA^P|^PRN^PH^^^517^3131675ORC|RE||BX14Z20992.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX14Z20992.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-L|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S90T21003^^^AIRA-TEST^MR||BolgenAIRA^ElleAIRA^Shavonne^^^^L|KjerulfAIRA^JeanneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1643 Verzamelen Pl^^Brownstwn Township^MI^48174^USA^P~1643 Verzamelen Pl^^Brownstwn Township^MI^48174^USA^L||^PRN^PH^^^734^7894431|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BolgenAIRA^KjerulfAIRA^^^^^L|MTH^Mother^HL70063|1643 Verzamelen Pl^^Brownstwn Township^MI^48174^USA^P|^PRN^PH^^^734^7894431ORC|RE||BS90T21003.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS90T21003.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X22F21011^^^AIRA-TEST^MR||HartAIRA^JohannaAIRA^Cadence^^^^L|MeeAIRA^KevinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1321 Bardinxveld-Giessendam Ave^^Bridgewater^MI^48115^USA^P~1321 Bardinxveld-Giessendam Ave^^Bridgewater^MI^48115^USA^M||^PRN^PH^^^734^9681654|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HartAIRA^MeeAIRA^^^^^L|MTH^Mother^HL70063|1321 Bardinxveld-Giessendam Ave^^Bridgewater^MI^48115^USA^P|^PRN^PH^^^734^9681654ORC|RE||BX22F21011.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX22F21011.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F17X21019^^^AIRA-TEST^MR||HamiltonAIRA^IlanaAIRA^Galya^^^^L|ShermanAIRA^SunAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1585 Zrielle Cir^^Garden City^MI^48135^USA^P~1585 Zrielle Cir^^Garden City^MI^48135^USA^N||^PRN^PH^^^734^6213860|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1585 Zrielle Cir^^Garden City^MI^48135^USA^P|^PRN^PH^^^734^6213860ORC|RE||BF17X21019.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF17X21019.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L92S21027^^^AIRA-TEST^MR||PlacerAIRA^HanaAIRA^Mara^^^^L|BellAIRA^BrittaniaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1208 Noorst Pl^^New Hudson^MI^48165^USA^P~1208 Noorst Pl^^New Hudson^MI^48165^USA^O||^PRN^PH^^^248^7788670|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlacerAIRA^BellAIRA^^^^^L|MTH^Mother^HL70063|1208 Noorst Pl^^New Hudson^MI^48165^USA^P|^PRN^PH^^^248^7788670ORC|RE||BL92S21027.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL92S21027.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-P|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M31Z21032^^^AIRA-TEST^MR||InghamAIRA^RoxanaAIRA^Hope^^^^L|CliveAIRA^MagentaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1867 Beere St^^Napoleon^MI^49261^USA^P~1867 Beere St^^Napoleon^MI^49261^USA^P||^PRN^PH^^^517^3582383|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|InghamAIRA^CliveAIRA^^^^^L|MTH^Mother^HL70063|1867 Beere St^^Napoleon^MI^49261^USA^P|^PRN^PH^^^517^3582383ORC|RE||BM31Z21032.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM31Z21032.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE2-RH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K60V21040^^^AIRA-TEST^MR||AdsonAIRA^MeadowAIRA^Katie^^^^L|MonroeAIRA^BerthaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1543 Vuijk Ln^^Fairview^MI^48621^USA^P~1543 Vuijk Ln^^Fairview^MI^48621^USA^RH||^PRN^PH^^^989^9942423|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdsonAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1543 Vuijk Ln^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^9942423ORC|RE||BK60V21040.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK60V21040.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-BIRTH-ORDER-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C24Q21051^^^AIRA-TEST^MR||LyonAIRA^ArezouAIRA^Edythe^^^^L|LackawannaAIRA^IndiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1224 Cuijk Ave^^Hudson^MI^49247^USA^P||^PRN^PH^^^517^6788513|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LyonAIRA^LackawannaAIRA^^^^^L|MTH^Mother^HL70063|1224 Cuijk Ave^^Hudson^MI^49247^USA^P|^PRN^PH^^^517^6788513ORC|RE||BC24Q21051.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC24Q21051.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-BIRTH-ORDER-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M40N21059^^^AIRA-TEST^MR||AdamsAIRA^CathieAIRA^Pierrette^^^^L|Pend OreilleAIRA^OlyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1388 Genray Pl^^Forest Hills^MI^49506^USA^P||^PRN^PH^^^616^4925327|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|2|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^Pend OreilleAIRA^^^^^L|MTH^Mother^HL70063|1388 Genray Pl^^Forest Hills^MI^49506^USA^P|^PRN^PH^^^616^4925327ORC|RE||BM40N21059.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM40N21059.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-BIRTH-ORDER-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z30A21067^^^AIRA-TEST^MR||BolotadAIRA^EttaAIRA^Shannon^^^^L|MontereyAIRA^VandanaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1166 Lijmegen Ln^^Detroit^MI^48220^USA^P||^PRN^PH^^^248^7576845|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|3|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BolotadAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1166 Lijmegen Ln^^Detroit^MI^48220^USA^P|^PRN^PH^^^248^7576845ORC|RE||BZ30A21067.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ30A21067.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-BIRTH-ORDER-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U03U21072^^^AIRA-TEST^MR||NordholmAIRA^CaryAIRA^Kaia^^^^L|AdamsAIRA^SophroniaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1645 Blmelo St^^Samaria^MI^48177^USA^P||^PRN^PH^^^734^7527114|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|4|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NordholmAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1645 Blmelo St^^Samaria^MI^48177^USA^P|^PRN^PH^^^734^7527114ORC|RE||BU03U21072.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU03U21072.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-BIRTH-ORDER-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F69N21080^^^AIRA-TEST^MR||MurrayAIRA^BedeliaAIRA^Rosine^^^^L|MadisonAIRA^UminaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1038 Oardenberg Ave^^Munger^MI^48747^USA^P||^PRN^PH^^^989^2906746|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|5|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurrayAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1038 Oardenberg Ave^^Munger^MI^48747^USA^P|^PRN^PH^^^989^2906746ORC|RE||BF69N21080.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF69N21080.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ETH-2135-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V87R21091^^^AIRA-TEST^MR||PlatteAIRA^DulcieAIRA^Ortensia^^^^L|SpokaneAIRA^SheltonAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1640 Alleen Ave^^Sterling Heights^MI^48310^USA^P||^PRN^PH^^^586^8815102|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlatteAIRA^SpokaneAIRA^^^^^L|MTH^Mother^HL70063|1640 Alleen Ave^^Sterling Heights^MI^48310^USA^P|^PRN^PH^^^586^8815102ORC|RE||BV87R21091.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV87R21091.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ETH-2186-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N40F21099^^^AIRA-TEST^MR||KnoxAIRA^AlexiaAIRA^Parnika^^^^L|MaloneAIRA^RhodaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1669 Geluidsoverlast Cir^^Harrietta^MI^49638^USA^P||^PRN^PH^^^231^9132373|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^MaloneAIRA^^^^^L|MTH^Mother^HL70063|1669 Geluidsoverlast Cir^^Harrietta^MI^49638^USA^P|^PRN^PH^^^231^9132373ORC|RE||BN40F21099.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN40F21099.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ETH-H|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M40P21107^^^AIRA-TEST^MR||MitchellAIRA^VimalaAIRA^Kira^^^^L|ChoctawAIRA^GloraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1855 Noerdijk St^^Perkins^MI^49872^USA^P||^PRN^PH^^^906^7452916|||||||||H^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MitchellAIRA^ChoctawAIRA^^^^^L|MTH^Mother^HL70063|1855 Noerdijk St^^Perkins^MI^49872^USA^P|^PRN^PH^^^906^7452916ORC|RE||BM40P21107.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM40P21107.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ETH-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X69R21112^^^AIRA-TEST^MR||HudspethAIRA^AddisonAIRA^Shavonne^^^^L|ColusaAIRA^ElspethAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1991 Buth St^^Alger^MI^48610^USA^P||^PRN^PH^^^989^7345427|||||||||N^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HudspethAIRA^ColusaAIRA^^^^^L|MTH^Mother^HL70063|1991 Buth St^^Alger^MI^48610^USA^P|^PRN^PH^^^989^7345427ORC|RE||BX69R21112.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX69R21112.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ETH-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H60L21120^^^AIRA-TEST^MR||ParkAIRA^HengAIRA^Prue^^^^L|WilliamsonAIRA^AyelinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1075 Soogeveen Cir^^Lansing^MI^48916^USA^P||^PRN^PH^^^517^2323112|||||||||U^Unknown^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParkAIRA^WilliamsonAIRA^^^^^L|MTH^Mother^HL70063|1075 Soogeveen Cir^^Lansing^MI^48916^USA^P|^PRN^PH^^^517^2323112ORC|RE||BH60L21120.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH60L21120.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-AN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K83W21131^^^AIRA-TEST^MR~493341222^^^AIRA-TEST^AN||McErlaineAIRA^HediaAIRA^Melwyn^^^^L|ClackamasAIRA^IrihapetiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1574 Mof van Twente Ln^^Farmington Hls^MI^48331^USA^P||^PRN^PH^^^248^6875347|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McErlaineAIRA^ClackamasAIRA^^^^^L|MTH^Mother^HL70063|1574 Mof van Twente Ln^^Farmington Hls^MI^48331^USA^P|^PRN^PH^^^248^6875347ORC|RE||BK83W21131.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK83W21131.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-ANC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W68O21139^^^AIRA-TEST^MR~325602259^^^AIRA-TEST^ANC||RodriguezAIRA^TasmineAIRA^Clymene^^^^L|PikeAIRA^ZenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1895 Larneveld Ln^^Clarklake^MI^49234^USA^P||^PRN^PH^^^517^8666801|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RodriguezAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1895 Larneveld Ln^^Clarklake^MI^49234^USA^P|^PRN^PH^^^517^8666801ORC|RE||BW68O21139.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW68O21139.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-AND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I25P21147^^^AIRA-TEST^MR~095048173^^^AIRA-TEST^AND||PerryAIRA^ReidunAIRA^Lizzy^^^^L|MetcalfeAIRA^CailinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1704 Ruimte Pl^^Grand Rapids^MI^49508^USA^P||^PRN^PH^^^616^4534397|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^MetcalfeAIRA^^^^^L|MTH^Mother^HL70063|1704 Ruimte Pl^^Grand Rapids^MI^49508^USA^P|^PRN^PH^^^616^4534397ORC|RE||BI25P21147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI25P21147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-ANON|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C75W21155^^^AIRA-TEST^MR~541342761^^^AIRA-TEST^ANON||LuzerneAIRA^MingmeiAIRA^Manuelle^^^^L|TobinAIRA^DesmaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1444 Belmond St^^Rothbury^MI^49452^USA^P||^PRN^PH^^^231^5766826|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LuzerneAIRA^TobinAIRA^^^^^L|MTH^Mother^HL70063|1444 Belmond St^^Rothbury^MI^49452^USA^P|^PRN^PH^^^231^5766826ORC|RE||BC75W21155.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC75W21155.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-ANT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H15H21160^^^AIRA-TEST^MR~989394414^^^AIRA-TEST^ANT||San SabaAIRA^VesnaAIRA^Antionette^^^^L|BranchAIRA^SorchaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1481 Turen Ln^^Warren^MI^48089^USA^P||^PRN^PH^^^586^4022133|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San SabaAIRA^BranchAIRA^^^^^L|MTH^Mother^HL70063|1481 Turen Ln^^Warren^MI^48089^USA^P|^PRN^PH^^^586^4022133ORC|RE||BH15H21160.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH15H21160.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-APRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T75J21168^^^AIRA-TEST^MR~590545868^^^AIRA-TEST^APRN||PainterAIRA^JacquiAIRA^Darra^^^^L|LlanoAIRA^PriscillaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1427 Meervoud Ave^^Hastings^MI^49058^USA^P||^PRN^PH^^^269^3995647|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PainterAIRA^LlanoAIRA^^^^^L|MTH^Mother^HL70063|1427 Meervoud Ave^^Hastings^MI^49058^USA^P|^PRN^PH^^^269^3995647ORC|RE||BT75J21168.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT75J21168.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N05Y21179^^^AIRA-TEST^MR~403849297^^^AIRA-TEST^BA||FremontAIRA^KensingtonAIRA^Patia^^^^L|GradyAIRA^TessAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1663 Ge Marne Pl^^Caledonia^MI^49316^USA^P||^PRN^PH^^^616^9859759|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremontAIRA^GradyAIRA^^^^^L|MTH^Mother^HL70063|1663 Ge Marne Pl^^Caledonia^MI^49316^USA^P|^PRN^PH^^^616^9859759ORC|RE||BN05Y21179.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN05Y21179.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-BC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B85G21187^^^AIRA-TEST^MR~908616520^^^AIRA-TEST^BC||KarlssonAIRA^CinderellaAIRA^Aylin^^^^L|EmmetAIRA^SirikitAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1812 Farderwijk Pl^^Farmington Hls^MI^48332^USA^P||^PRN^PH^^^248^8343541|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KarlssonAIRA^EmmetAIRA^^^^^L|MTH^Mother^HL70063|1812 Farderwijk Pl^^Farmington Hls^MI^48332^USA^P|^PRN^PH^^^248^8343541ORC|RE||BB85G21187.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB85G21187.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H45I21195^^^AIRA-TEST^MR~278359386^^^AIRA-TEST^BR||GraysAIRA^PatriciaAIRA^Jewell^^^^L|HumboldtAIRA^CeciaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1545 Kchouwen-Duiveland St^^Orchard Lake^MI^48323^USA^P||^PRN^PH^^^248^4378705|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GraysAIRA^HumboldtAIRA^^^^^L|MTH^Mother^HL70063|1545 Kchouwen-Duiveland St^^Orchard Lake^MI^48323^USA^P|^PRN^PH^^^248^4378705ORC|RE||BH45I21195.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH45I21195.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-CC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S78N21203^^^AIRA-TEST^MR~827277402^^^AIRA-TEST^CC||AlamedaAIRA^JamalAIRA^Shawna^^^^L|LancasterAIRA^CaylaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1135 Foogezand-Sappemeer Ln^^Chippewa Temp Correction Fac^MI^49785^USA^P||^PRN^PH^^^906^8641349|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlamedaAIRA^LancasterAIRA^^^^^L|MTH^Mother^HL70063|1135 Foogezand-Sappemeer Ln^^Chippewa Temp Correction Fac^MI^49785^USA^P|^PRN^PH^^^906^8641349ORC|RE||BS78N21203.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS78N21203.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-CY|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H66G21208^^^AIRA-TEST^MR~361241910^^^AIRA-TEST^CY||StonewallAIRA^AlvinaAIRA^Senta^^^^L|WalcottAIRA^AvenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1031 Stromen Cir^^Buchanan^MI^49107^USA^P||^PRN^PH^^^269^6789650|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StonewallAIRA^WalcottAIRA^^^^^L|MTH^Mother^HL70063|1031 Stromen Cir^^Buchanan^MI^49107^USA^P|^PRN^PH^^^269^6789650ORC|RE||BH66G21208.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH66G21208.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DDS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S31J21216^^^AIRA-TEST^MR~250553106^^^AIRA-TEST^DDS||KingfisherAIRA^MakikoAIRA^Rebecca^^^^L|NowataAIRA^MattieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1525 Nwenterand St^^Charlevoix^MI^49720^USA^P||^PRN^PH^^^231^2427612|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KingfisherAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1525 Nwenterand St^^Charlevoix^MI^49720^USA^P|^PRN^PH^^^231^2427612ORC|RE||BS31J21216.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS31J21216.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DEA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I23K21227^^^AIRA-TEST^MR~028072008^^^AIRA-TEST^DEA||IoscoAIRA^KailiAIRA^Kirsten^^^^L|O'BrienAIRA^ClaudiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1744 Meurne Ave^^Monroe^MI^48161^USA^P||^PRN^PH^^^734^8057280|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IoscoAIRA^O'BrienAIRA^^^^^L|MTH^Mother^HL70063|1744 Meurne Ave^^Monroe^MI^48161^USA^P|^PRN^PH^^^734^8057280ORC|RE||BI23K21227.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI23K21227.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DFN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G62L21235^^^AIRA-TEST^MR~958500398^^^AIRA-TEST^DFN||WheelerAIRA^RawnieAIRA^Jaunie^^^^L|AdamsAIRA^AlexiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1493 Waadhoeke Pl^^GM Tech Center^MI^48557^USA^P||^PRN^PH^^^810^4786460|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1493 Waadhoeke Pl^^GM Tech Center^MI^48557^USA^P|^PRN^PH^^^810^4786460ORC|RE||BG62L21235.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG62L21235.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S45O21243^^^AIRA-TEST^MR~205550867^^^AIRA-TEST^DL||TravisAIRA^LinneaAIRA^Marjorie^^^^L|GarrardAIRA^KarenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1320 Piessenlanden Cir^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^8958439|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TravisAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1320 Piessenlanden Cir^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^8958439ORC|RE||BS45O21243.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS45O21243.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M21O21248^^^AIRA-TEST^MR~877997991^^^AIRA-TEST^DN||CastroAIRA^FabiaAIRA^Cyprien^^^^L|BucksAIRA^TammyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1907 Anders Ln^^Tecumseh^MI^49286^USA^P||^PRN^PH^^^517^8322034|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CastroAIRA^BucksAIRA^^^^^L|MTH^Mother^HL70063|1907 Anders Ln^^Tecumseh^MI^49286^USA^P|^PRN^PH^^^517^8322034ORC|RE||BM21O21248.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM21O21248.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D08W21256^^^AIRA-TEST^MR~851777070^^^AIRA-TEST^DO||SiskiyouAIRA^SylviaAIRA^Leanna^^^^L|RichlandAIRA^AndromedaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1146 Butten Cir^^Harbor Point^MI^49740^USA^P||^PRN^PH^^^616^5852789|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SiskiyouAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1146 Butten Cir^^Harbor Point^MI^49740^USA^P|^PRN^PH^^^616^5852789ORC|RE||BD08W21256.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD08W21256.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DPM|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D69Y21267^^^AIRA-TEST^MR~497033914^^^AIRA-TEST^DPM||OsceolaAIRA^GiaAIRA^Silvia^^^^L|FairfieldAIRA^JoellianeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1042 Vet Pl^^Bark River^MI^49807^USA^P||^PRN^PH^^^906^9697071|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OsceolaAIRA^FairfieldAIRA^^^^^L|MTH^Mother^HL70063|1042 Vet Pl^^Bark River^MI^49807^USA^P|^PRN^PH^^^906^9697071ORC|RE||BD69Y21267.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD69Y21267.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-DR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90Z21272^^^AIRA-TEST^MR~299565500^^^AIRA-TEST^DR||CedarAIRA^ManjushaAIRA^Pippa^^^^L|JohnstonAIRA^LaraineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1763 Mint-Oedenrode Ave^^Portage^MI^49081^USA^P||^PRN^PH^^^269^8150256|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CedarAIRA^JohnstonAIRA^^^^^L|MTH^Mother^HL70063|1763 Mint-Oedenrode Ave^^Portage^MI^49081^USA^P|^PRN^PH^^^269^8150256ORC|RE||BF90Z21272.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF90Z21272.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-EI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U27B21280^^^AIRA-TEST^MR~019263907^^^AIRA-TEST^EI||ColumbianaAIRA^LyndaAIRA^Mikayla^^^^L|KlickitatAIRA^DaylaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1025 Dat Ave^^Detroit^MI^48238^USA^P||^PRN^PH^^^313^9589257|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColumbianaAIRA^KlickitatAIRA^^^^^L|MTH^Mother^HL70063|1025 Dat Ave^^Detroit^MI^48238^USA^P|^PRN^PH^^^313^9589257ORC|RE||BU27B21280.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU27B21280.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-EN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M08E21288^^^AIRA-TEST^MR~660213321^^^AIRA-TEST^EN||MontourAIRA^DanikaAIRA^Manasi^^^^L|GillespieAIRA^ErlineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1537 Eoevorden St^^Wilson^MI^49896^USA^P||^PRN^PH^^^906^4704473|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontourAIRA^GillespieAIRA^^^^^L|MTH^Mother^HL70063|1537 Eoevorden St^^Wilson^MI^49896^USA^P|^PRN^PH^^^906^4704473ORC|RE||BM08E21288.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM08E21288.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-FI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X81C21299^^^AIRA-TEST^MR~648483832^^^AIRA-TEST^FI||ShackelfordAIRA^RenAIRA^Tolena^^^^L|StonewallAIRA^YarallaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1458 Lastricum Ave^^Gaylord^MI^49734^USA^P||^PRN^PH^^^989^5992730|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShackelfordAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1458 Lastricum Ave^^Gaylord^MI^49734^USA^P|^PRN^PH^^^989^5992730ORC|RE||BX81C21299.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX81C21299.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-GI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M86C21307^^^AIRA-TEST^MR~842084416^^^AIRA-TEST^GI||HamiltonAIRA^EmilieAIRA^Aliya^^^^L|RockAIRA^NamaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1473 Roep Ave^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^5904154|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^RockAIRA^^^^^L|MTH^Mother^HL70063|1473 Roep Ave^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^5904154ORC|RE||BM86C21307.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM86C21307.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-GL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G63J21315^^^AIRA-TEST^MR~625271351^^^AIRA-TEST^GL||PsconenAIRA^DelythAIRA^Zarifa^^^^L|ShelbyAIRA^NellekeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1412 Vaarle-Nassau Ave^^Allendale^MI^49401^USA^P||^PRN^PH^^^616^2182165|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PsconenAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1412 Vaarle-Nassau Ave^^Allendale^MI^49401^USA^P|^PRN^PH^^^616^2182165ORC|RE||BG63J21315.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG63J21315.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-GN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T65W21320^^^AIRA-TEST^MR~574006033^^^AIRA-TEST^GN||AlleghenyAIRA^CeanaAIRA^Rajni^^^^L|LuceAIRA^KaliAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1229 Symbool Ln^^Sumpter Township^MI^48111^USA^P||^PRN^PH^^^734^9919357|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlleghenyAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1229 Symbool Ln^^Sumpter Township^MI^48111^USA^P|^PRN^PH^^^734^9919357ORC|RE||BT65W21320.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT65W21320.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-HC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N08S21328^^^AIRA-TEST^MR~063195855^^^AIRA-TEST^HC||KeokukAIRA^LaraAIRA^Vevila^^^^L|CumingAIRA^HeidiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1056 Vertelde Cir^^Hghtn Lk Heights^MI^48630^USA^P||^PRN^PH^^^989^8095882|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KeokukAIRA^CumingAIRA^^^^^L|MTH^Mother^HL70063|1056 Vertelde Cir^^Hghtn Lk Heights^MI^48630^USA^P|^PRN^PH^^^989^8095882ORC|RE||BN08S21328.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN08S21328.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-IND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H57P21339^^^AIRA-TEST^MR~448043610^^^AIRA-TEST^IND||PowellAIRA^UsagiAIRA^Carol^^^^L|LoganAIRA^DeviAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1088 Iozendaal Ave^^Beaverton^MI^48612^USA^P||^PRN^PH^^^989^6823520|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PowellAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1088 Iozendaal Ave^^Beaverton^MI^48612^USA^P|^PRN^PH^^^989^6823520ORC|RE||BH57P21339.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH57P21339.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-JHN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z13Q21347^^^AIRA-TEST^MR~763462869^^^AIRA-TEST^JHN||CoconinoAIRA^MeryleAIRA^Maresa^^^^L|AdairAIRA^GitaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1596 Ochinnen Pl^^GR^MI^49503^USA^P||^PRN^PH^^^616^3516665|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoconinoAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1596 Ochinnen Pl^^GR^MI^49503^USA^P|^PRN^PH^^^616^3516665ORC|RE||BZ13Q21347.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ13Q21347.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-LI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D39I21355^^^AIRA-TEST^MR~339136803^^^AIRA-TEST^LI||VargasAIRA^KenyattaAIRA^Sarmistha^^^^L|EvansAIRA^YrsaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1380 Peststellingwerf Cir^^Borculo^MI^49464^USA^P||^PRN^PH^^^616^9906047|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VargasAIRA^EvansAIRA^^^^^L|MTH^Mother^HL70063|1380 Peststellingwerf Cir^^Borculo^MI^49464^USA^P|^PRN^PH^^^616^9906047ORC|RE||BD39I21355.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD39I21355.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-LN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H58O21363^^^AIRA-TEST^MR~985846593^^^AIRA-TEST^LN||ParmerAIRA^JetAIRA^Rae^^^^L|HockingAIRA^NimueAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1576 Bittard-Geleen St^^Vulcan^MI^49892^USA^P||^PRN^PH^^^906^6012763|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParmerAIRA^HockingAIRA^^^^^L|MTH^Mother^HL70063|1576 Bittard-Geleen St^^Vulcan^MI^49892^USA^P|^PRN^PH^^^906^6012763ORC|RE||BH58O21363.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH58O21363.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-LR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L94S21368^^^AIRA-TEST^MR~782391077^^^AIRA-TEST^LR||WayneAIRA^ToraAIRA^Avoca^^^^L|TarrantAIRA^QamraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1981 Llissingen Pl^^New Baltimore^MI^48047^USA^P||^PRN^PH^^^586^4016863|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^TarrantAIRA^^^^^L|MTH^Mother^HL70063|1981 Llissingen Pl^^New Baltimore^MI^48047^USA^P|^PRN^PH^^^586^4016863ORC|RE||BL94S21368.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL94S21368.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U04C21376^^^AIRA-TEST^MR~096431619^^^AIRA-TEST^MA||WashtenawAIRA^ShonaAIRA^Ashley^^^^L|MitchellAIRA^CossetteAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1819 Aalsmeer Cir^^Wyoming^MI^49509^USA^P||^PRN^PH^^^616^2262827|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashtenawAIRA^MitchellAIRA^^^^^L|MTH^Mother^HL70063|1819 Aalsmeer Cir^^Wyoming^MI^49509^USA^P|^PRN^PH^^^616^2262827ORC|RE||BU04C21376.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU04C21376.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MB|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C45M21387^^^AIRA-TEST^MR~255567605^^^AIRA-TEST^MB||BrennanAIRA^PolomaAIRA^Ananda^^^^L|MuscatineAIRA^JenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1276 Laarle-Nassau Ln^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^9365992|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrennanAIRA^MuscatineAIRA^^^^^L|MTH^Mother^HL70063|1276 Laarle-Nassau Ln^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^9365992ORC|RE||BC45M21387.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC45M21387.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D56H21395^^^AIRA-TEST^MR~282629437^^^AIRA-TEST^MC||CampbellAIRA^SubhangiAIRA^Gabby^^^^L|MercerAIRA^JazmynAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1480 Lmallingerland Ln^^Empire^MI^49630^USA^P||^PRN^PH^^^231^9501609|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CampbellAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1480 Lmallingerland Ln^^Empire^MI^49630^USA^P|^PRN^PH^^^231^9501609ORC|RE||BD56H21395.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD56H21395.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MCD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P21V21403^^^AIRA-TEST^MR~434186420^^^AIRA-TEST^MCD||BooneAIRA^AryaAIRA^Annabel^^^^L|WebbAIRA^RashidaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1800 Veghel Ave^^Highland Township^MI^48357^USA^P||^PRN^PH^^^248^4851579|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^WebbAIRA^^^^^L|MTH^Mother^HL70063|1800 Veghel Ave^^Highland Township^MI^48357^USA^P|^PRN^PH^^^248^4851579ORC|RE||BP21V21403.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP21V21403.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U62C21408^^^AIRA-TEST^MR~871022082^^^AIRA-TEST^MCN||GartenlaubAIRA^PomonaAIRA^Terri^^^^L|JuniataAIRA^DesdemonaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1007 Heel Ave^^Central Michigan University^MI^48859^USA^P||^PRN^PH^^^989^6062084|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GartenlaubAIRA^JuniataAIRA^^^^^L|MTH^Mother^HL70063|1007 Heel Ave^^Central Michigan University^MI^48859^USA^P|^PRN^PH^^^989^6062084ORC|RE||BU62C21408.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU62C21408.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MCR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y60F21416^^^AIRA-TEST^MR~609343470^^^AIRA-TEST^MCR||BlaineAIRA^ClaudiaAIRA^Vita^^^^L|SciotoAIRA^EmmylouAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1128 Waar Ave^^Tower^MI^49792^USA^P||^PRN^PH^^^989^5485179|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlaineAIRA^SciotoAIRA^^^^^L|MTH^Mother^HL70063|1128 Waar Ave^^Tower^MI^49792^USA^P|^PRN^PH^^^989^5485179ORC|RE||BY60F21416.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY60F21416.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z36N21427^^^AIRA-TEST^MR~549587156^^^AIRA-TEST^MD||ClarkeAIRA^TristessaAIRA^Yejide^^^^L|LatahAIRA^PierinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1803 Vinden Pl^^Brunswick^MI^49425^USA^P||^PRN^PH^^^231^9442280|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkeAIRA^LatahAIRA^^^^^L|MTH^Mother^HL70063|1803 Vinden Pl^^Brunswick^MI^49425^USA^P|^PRN^PH^^^231^9442280ORC|RE||BZ36N21427.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ36N21427.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J58P21435^^^AIRA-TEST^MR~751903808^^^AIRA-TEST^MI||ErathAIRA^HaleighaAIRA^Jayla^^^^L|MasonAIRA^NiveditaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1750 Odam-Volendam St^^Clarksville^MI^48815^USA^P||^PRN^PH^^^616^3400057|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErathAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1750 Odam-Volendam St^^Clarksville^MI^48815^USA^P|^PRN^PH^^^616^3400057ORC|RE||BJ58P21435.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ58P21435.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G11O21443^^^AIRA-TEST^MR~445885068^^^AIRA-TEST^MR||SonomaAIRA^TempestAIRA^Kasey^^^^L|PatricioAIRA^UlrikeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1848 Voxtel St^^Oakley^MI^48649^USA^P||^PRN^PH^^^989^2389482|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SonomaAIRA^PatricioAIRA^^^^^L|MTH^Mother^HL70063|1848 Voxtel St^^Oakley^MI^48649^USA^P|^PRN^PH^^^989^2389482ORC|RE||BG11O21443.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG11O21443.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-MRT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L90S21448^^^AIRA-TEST^MR~965858045^^^AIRA-TEST^MRT||HarmonAIRA^ErwinaAIRA^Belle^^^^L|YuurAIRA^AdaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1477 Lestland Pl^^Flint^MI^48532^USA^P||^PRN^PH^^^810^4714369|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarmonAIRA^YuurAIRA^^^^^L|MTH^Mother^HL70063|1477 Lestland Pl^^Flint^MI^48532^USA^P|^PRN^PH^^^810^4714369ORC|RE||BL90S21448.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL90S21448.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z79I21456^^^AIRA-TEST^MR~311989367^^^AIRA-TEST^NE||HammarAIRA^NadineAIRA^Karenza^^^^L|MillsAIRA^ShantinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1928 Had Ln^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^6247604|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HammarAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1928 Had Ln^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^6247604ORC|RE||BZ79I21456.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ79I21456.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X68R21467^^^AIRA-TEST^MR~599152903^^^AIRA-TEST^NH||CarrollAIRA^ChyouAIRA^Karly^^^^L|MahoodAIRA^EndoraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1526 Thuis Ln^^Lanse^MI^49946^USA^P||^PRN^PH^^^906^7312610|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^MahoodAIRA^^^^^L|MTH^Mother^HL70063|1526 Thuis Ln^^Lanse^MI^49946^USA^P|^PRN^PH^^^906^7312610ORC|RE||BX68R21467.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX68R21467.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O21L21475^^^AIRA-TEST^MR~908744965^^^AIRA-TEST^NI||KarlssonAIRA^HaleyAIRA^Jade^^^^L|CanadianAIRA^ChodenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1890 Schelp Ln^^Westland^MI^48185^USA^P||^PRN^PH^^^734^6256771|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KarlssonAIRA^CanadianAIRA^^^^^L|MTH^Mother^HL70063|1890 Schelp Ln^^Westland^MI^48185^USA^P|^PRN^PH^^^734^6256771ORC|RE||BO21L21475.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO21L21475.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NII|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G98P21483^^^AIRA-TEST^MR~136457292^^^AIRA-TEST^NII||NormanAIRA^TeminaAIRA^Kyra^^^^L|LevyAIRA^MandieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1628 Zemert-Bakel Pl^^Dundee^MI^48131^USA^P||^PRN^PH^^^734^4250531|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NormanAIRA^LevyAIRA^^^^^L|MTH^Mother^HL70063|1628 Zemert-Bakel Pl^^Dundee^MI^48131^USA^P|^PRN^PH^^^734^4250531ORC|RE||BG98P21483.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG98P21483.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NIIP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y60X21488^^^AIRA-TEST^MR~889859116^^^AIRA-TEST^NIIP||O DayAIRA^UrsellAIRA^Mary^^^^L|ShermanAIRA^MarinelAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1788 Rranekeradeel Pl^^Harrison Township^MI^48045^USA^P||^PRN^PH^^^586^2122415|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O DayAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1788 Rranekeradeel Pl^^Harrison Township^MI^48045^USA^P|^PRN^PH^^^586^2122415ORC|RE||BY60X21488.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY60X21488.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X25F21496^^^AIRA-TEST^MR~520064832^^^AIRA-TEST^NP||AtascosaAIRA^MirabelleAIRA^Pallas^^^^L|SkamaniaAIRA^HadleyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1583 Square Cir^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^5224629|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtascosaAIRA^SkamaniaAIRA^^^^^L|MTH^Mother^HL70063|1583 Square Cir^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^5224629ORC|RE||BX25F21496.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX25F21496.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-NPI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R68V21507^^^AIRA-TEST^MR~506916129^^^AIRA-TEST^NPI||OmssundAIRA^JenellAIRA^Justice^^^^L|HolmesAIRA^ArtemisAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1641 Geweest St^^Bad Axe^MI^48413^USA^P||^PRN^PH^^^989^3982515|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OmssundAIRA^HolmesAIRA^^^^^L|MTH^Mother^HL70063|1641 Geweest St^^Bad Axe^MI^48413^USA^P|^PRN^PH^^^989^3982515ORC|RE||BR68V21507.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR68V21507.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-OD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P27E21515^^^AIRA-TEST^MR~438130189^^^AIRA-TEST^OD||UmatillaAIRA^KanushiAIRA^Nawal^^^^L|PotterAIRA^ArabellaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1628 Sinkelland Ln^^Grand Rapids^MI^49550^USA^P||^PRN^PH^^^616^2027679|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UmatillaAIRA^PotterAIRA^^^^^L|MTH^Mother^HL70063|1628 Sinkelland Ln^^Grand Rapids^MI^49550^USA^P|^PRN^PH^^^616^2027679ORC|RE||BP27E21515.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP27E21515.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E20R21523^^^AIRA-TEST^MR~172001765^^^AIRA-TEST^PA||BrownfieldAIRA^IsaAIRA^Meris^^^^L|Hood RiverAIRA^EmmetAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1829 Zeewolde Pl^^Carleton^MI^48117^USA^P||^PRN^PH^^^734^9655300|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrownfieldAIRA^Hood RiverAIRA^^^^^L|MTH^Mother^HL70063|1829 Zeewolde Pl^^Carleton^MI^48117^USA^P|^PRN^PH^^^734^9655300ORC|RE||BE20R21523.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE20R21523.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N44O21531^^^AIRA-TEST^MR~276618394^^^AIRA-TEST^PCN||StephensAIRA^GuinevereAIRA^Edmonda^^^^L|BelmontAIRA^EmmyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1847 Daadhoeke Cir^^GR^MI^49548^USA^P||^PRN^PH^^^616^9695332|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StephensAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1847 Daadhoeke Cir^^GR^MI^49548^USA^P|^PRN^PH^^^616^9695332ORC|RE||BN44O21531.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN44O21531.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q54I21536^^^AIRA-TEST^MR~178186721^^^AIRA-TEST^PE||BanbergAIRA^FujitaAIRA^Elodia^^^^L|PedersenAIRA^DelphineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1510 Belsen Cir^^Otter Lake^MI^48464^USA^P||^PRN^PH^^^810^2043017|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BanbergAIRA^PedersenAIRA^^^^^L|MTH^Mother^HL70063|1510 Belsen Cir^^Otter Lake^MI^48464^USA^P|^PRN^PH^^^810^2043017ORC|RE||BQ54I21536.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ54I21536.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PEN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E29U21544^^^AIRA-TEST^MR~611924697^^^AIRA-TEST^PEN||ShelbyAIRA^EdenAIRA^Columbia^^^^L|MajorAIRA^LilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1016 Drechterland St^^Trenary^MI^49891^USA^P||^PRN^PH^^^906^2413848|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^MajorAIRA^^^^^L|MTH^Mother^HL70063|1016 Drechterland St^^Trenary^MI^49891^USA^P|^PRN^PH^^^906^2413848ORC|RE||BE29U21544.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE29U21544.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W18U21555^^^AIRA-TEST^MR~715123992^^^AIRA-TEST^PI||DickinsonAIRA^HoshiAIRA^Charlie^^^^L|WestmorelandAIRA^BevinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1166 Roxtel Ln^^Treetops^MI^49735^USA^P||^PRN^PH^^^989^4192864|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DickinsonAIRA^WestmorelandAIRA^^^^^L|MTH^Mother^HL70063|1166 Roxtel Ln^^Treetops^MI^49735^USA^P|^PRN^PH^^^989^4192864ORC|RE||BW18U21555.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW18U21555.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G71G21563^^^AIRA-TEST^MR~765850283^^^AIRA-TEST^PN||CliveAIRA^MaleahAIRA^Melody^^^^L|GlorinnAIRA^MelodyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1832 Loirle Cir^^Canton^MI^48188^USA^P||^PRN^PH^^^734^9260295|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CliveAIRA^GlorinnAIRA^^^^^L|MTH^Mother^HL70063|1832 Loirle Cir^^Canton^MI^48188^USA^P|^PRN^PH^^^734^9260295ORC|RE||BG71G21563.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG71G21563.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PNT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25D21571^^^AIRA-TEST^MR~479132547^^^AIRA-TEST^PNT||MontcalmAIRA^JaylahAIRA^Noelle^^^^L|CannavinAIRA^WalburgaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1530 Soordenveld Cir^^Gm Truck and Bus^MI^48553^USA^P||^PRN^PH^^^810^4526696|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontcalmAIRA^CannavinAIRA^^^^^L|MTH^Mother^HL70063|1530 Soordenveld Cir^^Gm Truck and Bus^MI^48553^USA^P|^PRN^PH^^^810^4526696ORC|RE||BZ25D21571.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25D21571.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PPN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M93T21576^^^AIRA-TEST^MR~776306234^^^AIRA-TEST^PPN||JacksonAIRA^SabahAIRA^Evanthe^^^^L|LivingstonAIRA^NuAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1191 Dernheze Pl^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^3424249|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1191 Dernheze Pl^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^3424249ORC|RE||BM93T21576.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM93T21576.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PRC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O28B21584^^^AIRA-TEST^MR~224208360^^^AIRA-TEST^PRC||ScottAIRA^Zsa-ZsaAIRA^Gaia^^^^L|ThurstonAIRA^UtahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1170 Deghel Cir^^Oakland^MI^48363^USA^P||^PRN^PH^^^248^5652327|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ScottAIRA^ThurstonAIRA^^^^^L|MTH^Mother^HL70063|1170 Deghel Cir^^Oakland^MI^48363^USA^P|^PRN^PH^^^248^5652327ORC|RE||BO28B21584.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO28B21584.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I45L21595^^^AIRA-TEST^MR~612627055^^^AIRA-TEST^PRN||LoweAIRA^PurvaAIRA^Avril^^^^L|ScottAIRA^JerardaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1084 Sense Ave^^Saginaw^MI^48607^USA^P||^PRN^PH^^^989^9259351|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoweAIRA^ScottAIRA^^^^^L|MTH^Mother^HL70063|1084 Sense Ave^^Saginaw^MI^48607^USA^P|^PRN^PH^^^989^9259351ORC|RE||BI45L21595.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI45L21595.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-PT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G00N21603^^^AIRA-TEST^MR~187101179^^^AIRA-TEST^PT||ShawAIRA^GabbyAIRA^Shahnaz^^^^L|RaumaAIRA^EktaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1849 Nwenterand Cir^^Bloomfield Township^MI^48304^USA^P||^PRN^PH^^^248^7912603|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShawAIRA^RaumaAIRA^^^^^L|MTH^Mother^HL70063|1849 Nwenterand Cir^^Bloomfield Township^MI^48304^USA^P|^PRN^PH^^^248^7912603ORC|RE||BG00N21603.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG00N21603.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-QA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q86G21611^^^AIRA-TEST^MR~329935559^^^AIRA-TEST^QA||PottawatomieAIRA^TamathaAIRA^Rakel^^^^L|AlexandersonAIRA^KinetaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1665 Bapelle St^^Good Hart^MI^49737^USA^P||^PRN^PH^^^616^9754993|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PottawatomieAIRA^AlexandersonAIRA^^^^^L|MTH^Mother^HL70063|1665 Bapelle St^^Good Hart^MI^49737^USA^P|^PRN^PH^^^616^9754993ORC|RE||BQ86G21611.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ86G21611.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-RI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R63K21619^^^AIRA-TEST^MR~554430110^^^AIRA-TEST^RI||JeffersonAIRA^MayuriAIRA^Corinne^^^^L|OtsegoAIRA^AnkeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1355 Kteenwijkerland Cir^^Monroe^MI^48161^USA^P||^PRN^PH^^^734^8602044|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^OtsegoAIRA^^^^^L|MTH^Mother^HL70063|1355 Kteenwijkerland Cir^^Monroe^MI^48161^USA^P|^PRN^PH^^^734^8602044ORC|RE||BR63K21619.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR63K21619.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-RN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M73H21627^^^AIRA-TEST^MR~135417625^^^AIRA-TEST^RN||FinkAIRA^HayleyAIRA^Myuna^^^^L|SchuylkillAIRA^GenniferAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1520 Zoeree-Overflakkee Pl^^Grosse Pointe Park^MI^48224^USA^P||^PRN^PH^^^313^6015101|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FinkAIRA^SchuylkillAIRA^^^^^L|MTH^Mother^HL70063|1520 Zoeree-Overflakkee Pl^^Grosse Pointe Park^MI^48224^USA^P|^PRN^PH^^^313^6015101ORC|RE||BM73H21627.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM73H21627.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-RPH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P03V21635^^^AIRA-TEST^MR~832711770^^^AIRA-TEST^RPH||LincolnAIRA^ChandiAIRA^Unnati^^^^L|MadisonAIRA^YemenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1929 Sunschoten St^^Blanchard^MI^49310^USA^P||^PRN^PH^^^989^4665407|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LincolnAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1929 Sunschoten St^^Blanchard^MI^49310^USA^P|^PRN^PH^^^989^4665407ORC|RE||BP03V21635.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP03V21635.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-RR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V91M21643^^^AIRA-TEST^MR~637669055^^^AIRA-TEST^RR||WilliamsAIRA^MahaliaAIRA^Orea^^^^L|BolotadAIRA^YamuraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1663 Afdekking Cir^^Southfield^MI^48033^USA^P||^PRN^PH^^^248^8308170|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsAIRA^BolotadAIRA^^^^^L|MTH^Mother^HL70063|1663 Afdekking Cir^^Southfield^MI^48033^USA^P|^PRN^PH^^^248^8308170ORC|RE||BV91M21643.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV91M21643.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-RRI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C00D21651^^^AIRA-TEST^MR~552650587^^^AIRA-TEST^RRI||JeffersonAIRA^DaphneAIRA^Nashwa^^^^L|Van WertAIRA^WaltraudAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1303 Bchouwen-Duiveland St^^Walkerville^MI^49459^USA^P||^PRN^PH^^^231^3772342|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^Van WertAIRA^^^^^L|MTH^Mother^HL70063|1303 Bchouwen-Duiveland St^^Walkerville^MI^49459^USA^P|^PRN^PH^^^231^3772342ORC|RE||BC00D21651.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC00D21651.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-SL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F56U21659^^^AIRA-TEST^MR~491469680^^^AIRA-TEST^SL||KrogAIRA^AvaniAIRA^Alani^^^^L|ToaleAIRA^LilacAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1170 Verkopen Pl^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^9165961|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KrogAIRA^ToaleAIRA^^^^^L|MTH^Mother^HL70063|1170 Verkopen Pl^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^9165961ORC|RE||BF56U21659.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF56U21659.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-SN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T94X21664^^^AIRA-TEST^MR~914291670^^^AIRA-TEST^SN||HabberstadAIRA^CeresAIRA^Muna^^^^L|TerrellAIRA^MarionAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1744 Will en Sint Hubert Ave^^Southeast^MI^48519^USA^P||^PRN^PH^^^810^4181617|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HabberstadAIRA^TerrellAIRA^^^^^L|MTH^Mother^HL70063|1744 Will en Sint Hubert Ave^^Southeast^MI^48519^USA^P|^PRN^PH^^^810^4181617ORC|RE||BT94X21664.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT94X21664.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-SR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M97G21672^^^AIRA-TEST^MR~353091908^^^AIRA-TEST^SR||TrumbullAIRA^MellissaAIRA^Wendy^^^^L|GeaugaAIRA^SherryAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1087 Heuningen Pl^^Hardwood^MI^49807^USA^P||^PRN^PH^^^906^4372547|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TrumbullAIRA^GeaugaAIRA^^^^^L|MTH^Mother^HL70063|1087 Heuningen Pl^^Hardwood^MI^49807^USA^P|^PRN^PH^^^906^4372547ORC|RE||BM97G21672.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM97G21672.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-SS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J87G21683^^^AIRA-TEST^MR~894707900^^^AIRA-TEST^SS||JonsonAIRA^HaydenAIRA^Galina^^^^L|MerwikAIRA^AlannaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1968 Poekel Cir^^Lansing^MI^48915^USA^P||^PRN^PH^^^517^8901660|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JonsonAIRA^MerwikAIRA^^^^^L|MTH^Mother^HL70063|1968 Poekel Cir^^Lansing^MI^48915^USA^P|^PRN^PH^^^517^8901660ORC|RE||BJ87G21683.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ87G21683.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-TAX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M81X21691^^^AIRA-TEST^MR~527533620^^^AIRA-TEST^TAX||MurrayAIRA^HaleyAIRA^Verena^^^^L|ToddAIRA^WaratahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1238 Nldebroek St^^Grandville^MI^49468^USA^P||^PRN^PH^^^616^9373725|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurrayAIRA^ToddAIRA^^^^^L|MTH^Mother^HL70063|1238 Nldebroek St^^Grandville^MI^49468^USA^P|^PRN^PH^^^616^9373725ORC|RE||BM81X21691.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM81X21691.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L76B21699^^^AIRA-TEST^MR~516688435^^^AIRA-TEST^U||EastlandAIRA^BrankaAIRA^Lauryn^^^^L|LundgrenAIRA^SophieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1757 Klinken Cir^^Brethren^MI^49619^USA^P||^PRN^PH^^^231^2502776|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EastlandAIRA^LundgrenAIRA^^^^^L|MTH^Mother^HL70063|1757 Klinken Cir^^Brethren^MI^49619^USA^P|^PRN^PH^^^231^2502776ORC|RE||BL76B21699.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL76B21699.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-UPIN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y44O21704^^^AIRA-TEST^MR~929856464^^^AIRA-TEST^UPIN||PageAIRA^KaylynAIRA^Louella^^^^L|BrazosAIRA^AdilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1089 Hoststellingwerf Pl^^Levering^MI^49755^USA^P||^PRN^PH^^^616^5011896|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PageAIRA^BrazosAIRA^^^^^L|MTH^Mother^HL70063|1089 Hoststellingwerf Pl^^Levering^MI^49755^USA^P|^PRN^PH^^^616^5011896ORC|RE||BY44O21704.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY44O21704.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-VN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L39C21712^^^AIRA-TEST^MR~027542538^^^AIRA-TEST^VN||MarionAIRA^SamicahAIRA^Casta^^^^L|HellicoskiAIRA^AraceliAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1469 Slechte Ln^^Brockway Township^MI^48097^USA^P||^PRN^PH^^^810^7489398|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^HellicoskiAIRA^^^^^L|MTH^Mother^HL70063|1469 Slechte Ln^^Brockway Township^MI^48097^USA^P|^PRN^PH^^^810^7489398ORC|RE||BL39C21712.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL39C21712.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-WC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P95W21723^^^AIRA-TEST^MR~862490607^^^AIRA-TEST^WC||CrumbakerAIRA^EmileeAIRA^Danuta^^^^L|SharplesAIRA^JendayiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1863 Feerhugowaard Ln^^Manistique^MI^49854^USA^P||^PRN^PH^^^906^6762820|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrumbakerAIRA^SharplesAIRA^^^^^L|MTH^Mother^HL70063|1863 Feerhugowaard Ln^^Manistique^MI^49854^USA^P|^PRN^PH^^^906^6762820ORC|RE||BP95W21723.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP95W21723.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-WCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F85H21731^^^AIRA-TEST^MR~208569124^^^AIRA-TEST^WCN||KearneyAIRA^JaelAIRA^Ainhoa^^^^L|GrantAIRA^AlissaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1749 Meststellingwerf Ave^^Ontonagon^MI^49953^USA^P||^PRN^PH^^^906^2104508|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KearneyAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1749 Meststellingwerf Ave^^Ontonagon^MI^49953^USA^P|^PRN^PH^^^906^2104508ORC|RE||BF85H21731.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF85H21731.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE-XX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C79E21739^^^AIRA-TEST^MR~348965900^^^AIRA-TEST^XX||WashingtonAIRA^NixieAIRA^Jenica^^^^L|NowataAIRA^KynthiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1379 Piessenlanden Ln^^Lamont^MI^49430^USA^P||^PRN^PH^^^616^9254867|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1379 Piessenlanden Ln^^Lamont^MI^49430^USA^P|^PRN^PH^^^616^9254867ORC|RE||BC79E21739.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC79E21739.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E69C21747^^^AIRA-TEST^MR||ParmerAIRA^ShannaAIRA^Arora^^^^L|TuscarawasAIRA^GenieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1121 Passen St^^Troy^MI^48099^USA^P||^PRN^PH^^^248^8544812|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParmerAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1121 Passen St^^Troy^MI^48099^USA^P|^PRN^PH^^^248^8544812ORC|RE||BE69C21747.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||00^New immunization record^NIP001|||||||||||CP|AORC|RE||BE69C21747.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V36B21752^^^AIRA-TEST^MR||MackeyAIRA^NardaAIRA^Gazelle^^^^L|CarrollAIRA^ShamitaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1907 Katerland Ln^^Southfield^MI^48034^USA^P||^PRN^PH^^^248^8838968|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MackeyAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1907 Katerland Ln^^Southfield^MI^48034^USA^P|^PRN^PH^^^248^8838968ORC|RE||BV36B21752.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV36B21752.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G70X21760^^^AIRA-TEST^MR||OwsleyAIRA^RafaelaAIRA^Konstanze^^^^L|MadisonAIRA^KellyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1449 Paragraaf Cir^^Farmington Hls^MI^48333^USA^P||^PRN^PH^^^248^6832293|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwsleyAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1449 Paragraaf Cir^^Farmington Hls^MI^48333^USA^P|^PRN^PH^^^248^6832293ORC|RE||BG70X21760.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||02^Historical information - from other provider^NIP001|||||||||||CP|AORC|RE||BG70X21760.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H03H21771^^^AIRA-TEST^MR||LetcherAIRA^MikaylaAIRA^Sharseia^^^^L|MarionAIRA^LyndseyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1790 Korger-Odoorn Pl^^Flint^MI^48509^USA^P||^PRN^PH^^^810^3435817|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LetcherAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1790 Korger-Odoorn Pl^^Flint^MI^48509^USA^P|^PRN^PH^^^810^3435817ORC|RE||BH03H21771.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||03^Historical information - from parents written record^NIP001|||||||||||CP|AORC|RE||BH03H21771.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B57K21779^^^AIRA-TEST^MR||WoldAIRA^DadeAIRA^Robalyn^^^^L|ButlerAIRA^ChantelAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1747 Huidhorn Pl^^Detroit^MI^48203^USA^P||^PRN^PH^^^313^6402734|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoldAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1747 Huidhorn Pl^^Detroit^MI^48203^USA^P|^PRN^PH^^^313^6402734ORC|RE||BB57K21779.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||04^Historical information - from parents recall^NIP001|||||||||||CP|AORC|RE||BB57K21779.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T08L21787^^^AIRA-TEST^MR||MestaAIRA^MaiaAIRA^Ekala^^^^L|KimballAIRA^AkilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1771 Poes Ave^^Rochester^MI^48309^USA^P||^PRN^PH^^^248^8954100|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MestaAIRA^KimballAIRA^^^^^L|MTH^Mother^HL70063|1771 Poes Ave^^Rochester^MI^48309^USA^P|^PRN^PH^^^248^8954100ORC|RE||BT08L21787.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||05^Historical information - from other registry^NIP001|||||||||||CP|AORC|RE||BT08L21787.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M25Z21792^^^AIRA-TEST^MR||GemAIRA^MarcyAIRA^Zama^^^^L|BoyleAIRA^DesdemonaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1013 Mittenseradiel Cir^^New Haven^MI^48050^USA^P||^PRN^PH^^^586^7035516|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GemAIRA^BoyleAIRA^^^^^L|MTH^Mother^HL70063|1013 Mittenseradiel Cir^^New Haven^MI^48050^USA^P|^PRN^PH^^^586^7035516ORC|RE||BM25Z21792.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||06^Historical information - from birth certificate^NIP001|||||||||||CP|AORC|RE||BM25Z21792.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T63G21800^^^AIRA-TEST^MR||IoscoAIRA^AnnaliseAIRA^Beta^^^^L|GreenAIRA^TerzaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1074 Kulpen-Wittem Ln^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^7343172|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IoscoAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1074 Kulpen-Wittem Ln^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^7343172ORC|RE||BT63G21800.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||07^Historical information - from school record^NIP001|||||||||||CP|AORC|RE||BT63G21800.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-IS-08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U11V21811^^^AIRA-TEST^MR||HarrisonAIRA^ShokoAIRA^Kirra^^^^L|LyonAIRA^MeggieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1509 Vergelijken Pl^^DTE^MI^48260^USA^P||^PRN^PH^^^313^9453634|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1509 Vergelijken Pl^^DTE^MI^48260^USA^P|^PRN^PH^^^313^9453634ORC|RE||BU11V21811.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||08^Historical information - from public agency^NIP001|||||||||||CP|AORC|RE||BU11V21811.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-A|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z81P21819^^^AIRA-TEST^MR||PurolaAIRA^ShawnaAIRA^Lucy^^^^L~PID-5.1^PID-5.2^^^^^A|AdsgaardAIRA^TourmalineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1616 Noerdijk Ave^^Bridgewater^MI^48115^USA^P||^PRN^PH^^^734^9928735|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PurolaAIRA^AdsgaardAIRA^^^^^L|MTH^Mother^HL70063|1616 Noerdijk Ave^^Bridgewater^MI^48115^USA^P|^PRN^PH^^^734^9928735ORC|RE||BZ81P21819.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ81P21819.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I31X21827^^^AIRA-TEST^MR||LenaweeAIRA^LovedayAIRA^Dannell^^^^L~PID-5.1^PID-5.2^^^^^B|WheelerAIRA^KileyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1283 Koxtel Ave^^Omena^MI^49674^USA^P||^PRN^PH^^^231^7426246|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LenaweeAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1283 Koxtel Ave^^Omena^MI^49674^USA^P|^PRN^PH^^^231^7426246ORC|RE||BI31X21827.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI31X21827.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-C|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G05E21832^^^AIRA-TEST^MR||ThompsenAIRA^CytheriaAIRA^Malika^^^^L~PID-5.1^PID-5.2^^^^^C|WhitmanAIRA^ThanhAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1211 Irimpenerwaard Pl^^Powers^MI^49874^USA^P||^PRN^PH^^^906^5841828|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThompsenAIRA^WhitmanAIRA^^^^^L|MTH^Mother^HL70063|1211 Irimpenerwaard Pl^^Powers^MI^49874^USA^P|^PRN^PH^^^906^5841828ORC|RE||BG05E21832.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG05E21832.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O78R21840^^^AIRA-TEST^MR||WilsonAIRA^HadassaAIRA^Rachel^^^^L~PID-5.1^PID-5.2^^^^^D|MercerAIRA^RishbhaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1988 Vantumadiel Ln^^Kentwood^MI^49548^USA^P||^PRN^PH^^^616^5946196|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilsonAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1988 Vantumadiel Ln^^Kentwood^MI^49548^USA^P|^PRN^PH^^^616^5946196ORC|RE||BO78R21840.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO78R21840.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-L|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X84J21851^^^AIRA-TEST^MR||EmmetAIRA^AraceliAIRA^Ela^^^^L~PID-5.1^PID-5.2^^^^^L|BrackenAIRA^LisetteAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1706 Se Marne Ave^^Amway Corp^MI^49355^USA^P||^PRN^PH^^^616^9417975|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EmmetAIRA^BrackenAIRA^^^^^L|MTH^Mother^HL70063|1706 Se Marne Ave^^Amway Corp^MI^49355^USA^P|^PRN^PH^^^616^9417975ORC|RE||BX84J21851.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX84J21851.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M49A21859^^^AIRA-TEST^MR||KimbleAIRA^AyleenAIRA^Modestus^^^^L~PID-5.1^PID-5.2^^^^^M|RobertsAIRA^DristiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1471 Rorsele Cir^^Suttons Bay^MI^49682^USA^P||^PRN^PH^^^231^5185368|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KimbleAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1471 Rorsele Cir^^Suttons Bay^MI^49682^USA^P|^PRN^PH^^^231^5185368ORC|RE||BM49A21859.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM49A21859.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-P|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U06S21867^^^AIRA-TEST^MR||WettilandAIRA^NormaAIRA^Scarlet^^^^L~PID-5.1^PID-5.2^^^^^P|FranklinAIRA^KarlotteAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1029 Preda Ave^^Detroit^MI^48230^USA^P||^PRN^PH^^^313^5170993|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WettilandAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1029 Preda Ave^^Detroit^MI^48230^USA^P|^PRN^PH^^^313^5170993ORC|RE||BU06S21867.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU06S21867.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NAME-TYPE-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C35Z21875^^^AIRA-TEST^MR||CreaserAIRA^AdelindaAIRA^Primrose^^^^L~PID-5.1^PID-5.2^^^^^U|AdamsAIRA^AnahiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1614 Die Ave^^Gm Truck and Bus^MI^48551^USA^P||^PRN^PH^^^810^5579233|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CreaserAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1614 Die Ave^^Gm Truck and Bus^MI^48551^USA^P|^PRN^PH^^^810^5579233ORC|RE||BC35Z21875.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC35Z21875.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-0100-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X14X21880^^^AIRA-TEST^MR||JacksonAIRA^SunnivaAIRA^Astera^^^^L|JeffersonAIRA^MarisaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1028 Arm Cir^^Saint Clr Shrs^MI^48082^USA^P||^PRN^PH^^^586^8191164|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1028 Arm Cir^^Saint Clr Shrs^MI^48082^USA^P|^PRN^PH^^^586^8191164ORC|RE||BX14X21880.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX14X21880.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-0100-01^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-0100-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F91E21888^^^AIRA-TEST^MR||GuernseyAIRA^LeshAIRA^Camira^^^^L|LapeerAIRA^ShyanneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1759 Seeuwarden Ave^^Farmington^MI^48332^USA^P||^PRN^PH^^^248^9382447|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuernseyAIRA^LapeerAIRA^^^^^L|MTH^Mother^HL70063|1759 Seeuwarden Ave^^Farmington^MI^48332^USA^P|^PRN^PH^^^248^9382447ORC|RE||BF91E21888.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF91E21888.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-0100-02^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-0100-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I77Q21899^^^AIRA-TEST^MR||LowndesAIRA^YrsaAIRA^Jonesy^^^^L|AlfalfaAIRA^LurleenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1348 Restvoorne St^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^6686942|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LowndesAIRA^AlfalfaAIRA^^^^^L|MTH^Mother^HL70063|1348 Restvoorne St^^Belleville^MI^48112^USA^P|^PRN^PH^^^734^6686942ORC|RE||BI77Q21899.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI77Q21899.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-0100-05^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-0100-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X78E21907^^^AIRA-TEST^MR||ConnorAIRA^JodiAIRA^Filipina^^^^L|VanceAIRA^VeronaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1354 Bollands Kroon Ave^^Glendora^MI^49107^USA^P||^PRN^PH^^^269^9833218|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ConnorAIRA^VanceAIRA^^^^^L|MTH^Mother^HL70063|1354 Bollands Kroon Ave^^Glendora^MI^49107^USA^P|^PRN^PH^^^269^9833218ORC|RE||BX78E21907.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX78E21907.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-0100-10^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-1970-49|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E09S21915^^^AIRA-TEST^MR||MahoodAIRA^VestaAIRA^Alike^^^^L|WoodburyAIRA^RulaAIRA^^^^^M|20110830|F||2106-3^White^CDCREC|1848 Oeylingen Ave^^Coopersville^MI^49404^USA^P||^PRN^PH^^^616^4272985|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahoodAIRA^WoodburyAIRA^^^^^L|MTH^Mother^HL70063|1848 Oeylingen Ave^^Coopersville^MI^49404^USA^P|^PRN^PH^^^616^4272985ORC|RE||BE09S21915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE09S21915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111230||00005-1970-49^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||WAL^Wyeth^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-1970-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E54Q21920^^^AIRA-TEST^MR||SheridanAIRA^PhoenixAIRA^Amaya^^^^L|HallAIRA^PranatiAIRA^^^^^M|20110830|F||2106-3^White^CDCREC|1236 Hit Ave^^Lansing^MI^48951^USA^P||^PRN^PH^^^517^5253880|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SheridanAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1236 Hit Ave^^Lansing^MI^48951^USA^P|^PRN^PH^^^517^5253880ORC|RE||BE54Q21920.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE54Q21920.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111230||00005-1970-50^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||WAL^Wyeth^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-1971-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X06B21928^^^AIRA-TEST^MR||OakAIRA^DamarisAIRA^Adelaide^^^^L|HowardAIRA^NathalieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1556 Pose Ln^^Concord^MI^49237^USA^P||^PRN^PH^^^517^7341203|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OakAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1556 Pose Ln^^Concord^MI^49237^USA^P|^PRN^PH^^^517^7341203ORC|RE||BX06B21928.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX06B21928.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-1971-01^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-1971-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F57E21939^^^AIRA-TEST^MR||ThrockmortonAIRA^MelaAIRA^Mallory^^^^L|ButteAIRA^AlidaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1471 Keiderland Ln^^Dowagiac^MI^49047^USA^P||^PRN^PH^^^269^8307888|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThrockmortonAIRA^ButteAIRA^^^^^L|MTH^Mother^HL70063|1471 Keiderland Ln^^Dowagiac^MI^49047^USA^P|^PRN^PH^^^269^8307888ORC|RE||BF57E21939.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF57E21939.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-1971-02^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-1971-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N33O21947^^^AIRA-TEST^MR||CannavinAIRA^AddisonAIRA^Lalo^^^^L|LoganAIRA^YejideAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1269 Ieeuwarden Pl^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^9246538|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CannavinAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1269 Ieeuwarden Pl^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^9246538ORC|RE||BN33O21947.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN33O21947.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-1971-04^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005-1971-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I75Z21955^^^AIRA-TEST^MR||HitchcockAIRA^PheliaAIRA^Arika^^^^L|RaumaAIRA^JazlynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1271 Hof van Twente St^^Detroit^MI^48226^USA^P||^PRN^PH^^^313^4603295|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HitchcockAIRA^RaumaAIRA^^^^^L|MTH^Mother^HL70063|1271 Hof van Twente St^^Detroit^MI^48226^USA^P|^PRN^PH^^^313^4603295ORC|RE||BI75Z21955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI75Z21955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005-1971-05^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PFR^Pfizer, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|133^Pneumococcal conjugate PCV 13^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4045-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R96I21960^^^AIRA-TEST^MR||GrahamAIRA^GhitaAIRA^Tean^^^^L|BooneAIRA^AtlantaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1034 Loxmeer Ave^^New Era^MI^49446^USA^P||^PRN^PH^^^231^4059277|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrahamAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1034 Loxmeer Ave^^New Era^MI^49446^USA^P|^PRN^PH^^^231^4059277ORC|RE||BR96I21960.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR96I21960.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4045-00^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4045-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K49V21968^^^AIRA-TEST^MR||RuskAIRA^SadbAIRA^Boa^^^^L|McEntegartAIRA^SondraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1575 Meusden Pl^^Stambaugh^MI^49964^USA^P||^PRN^PH^^^906^2262059|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RuskAIRA^McEntegartAIRA^^^^^L|MTH^Mother^HL70063|1575 Meusden Pl^^Stambaugh^MI^49964^USA^P|^PRN^PH^^^906^2262059ORC|RE||BK49V21968.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK49V21968.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4045-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4045-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L46T21979^^^AIRA-TEST^MR||TansbergAIRA^RaelynAIRA^Jewell^^^^L|Red WillowAIRA^GularaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1223 Rundert Cir^^Gr Blanc^MI^48439^USA^P||^PRN^PH^^^810^6642198|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TansbergAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1223 Rundert Cir^^Gr Blanc^MI^48439^USA^P|^PRN^PH^^^810^6642198ORC|RE||BL46T21979.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL46T21979.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4045-41^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4047-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U36M21987^^^AIRA-TEST^MR||MuskogeeAIRA^LitsaAIRA^Karel^^^^L|BoyleAIRA^KaveriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1550 Excite Ln^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^3463910|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MuskogeeAIRA^BoyleAIRA^^^^^L|MTH^Mother^HL70063|1550 Excite Ln^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^3463910ORC|RE||BU36M21987.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU36M21987.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4047-01^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4047-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D05P21995^^^AIRA-TEST^MR||KnowlesAIRA^SaffronAIRA^Aeryn^^^^L|AndersenAIRA^TyanneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1585 Nerkendam Cir^^Beaver Island^MI^49782^USA^P||^PRN^PH^^^906^7197388|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnowlesAIRA^AndersenAIRA^^^^^L|MTH^Mother^HL70063|1585 Nerkendam Cir^^Beaver Island^MI^49782^USA^P|^PRN^PH^^^906^7197388ORC|RE||BD05P21995.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD05P21995.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4047-20^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4047-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z61J22003^^^AIRA-TEST^MR||CopelandAIRA^WynfledAIRA^Rupa^^^^L|AnderssonAIRA^EldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1839 Dienen St^^GM Tech Center^MI^48557^USA^P||^PRN^PH^^^810^8437827|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CopelandAIRA^AnderssonAIRA^^^^^L|MTH^Mother^HL70063|1839 Dienen St^^GM Tech Center^MI^48557^USA^P|^PRN^PH^^^810^8437827ORC|RE||BZ61J22003.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ61J22003.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4047-41^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4093-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N46Z22008^^^AIRA-TEST^MR||BrikkeAIRA^KarmelAIRA^Niverta^^^^L|JohnssonAIRA^TuhinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1109 Ridderkerk Ln^^Grayling^MI^49739^USA^P||^PRN^PH^^^989^4862006|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrikkeAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1109 Ridderkerk Ln^^Grayling^MI^49739^USA^P|^PRN^PH^^^989^4862006ORC|RE||BN46Z22008.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN46Z22008.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4093-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4093-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C85R22016^^^AIRA-TEST^MR||ThomasAIRA^LowanAIRA^Okelani^^^^L|ArcherAIRA^PaolaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1047 Reststellingwerf St^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^8976827|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThomasAIRA^ArcherAIRA^^^^^L|MTH^Mother^HL70063|1047 Reststellingwerf St^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^8976827ORC|RE||BC85R22016.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC85R22016.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4093-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4093-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I70H22027^^^AIRA-TEST^MR||LyonAIRA^MirrinAIRA^Elexus^^^^L|WardleAIRA^StephenieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1570 Ialten Ave^^Stockbridge^MI^49285^USA^P||^PRN^PH^^^517^4970425|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LyonAIRA^WardleAIRA^^^^^L|MTH^Mother^HL70063|1570 Ialten Ave^^Stockbridge^MI^49285^USA^P|^PRN^PH^^^517^4970425ORC|RE||BI70H22027.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI70H22027.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4093-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4094-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N75L22035^^^AIRA-TEST^MR||ButlerAIRA^AlexaAIRA^Amadis^^^^L|PerkinsAIRA^OdeaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1732 Wietjerksteradeel Ln^^Hawks^MI^49743^USA^P||^PRN^PH^^^989^2722981|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^PerkinsAIRA^^^^^L|MTH^Mother^HL70063|1732 Wietjerksteradeel Ln^^Hawks^MI^49743^USA^P|^PRN^PH^^^989^2722981ORC|RE||BN75L22035.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN75L22035.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4094-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4094-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X87M22043^^^AIRA-TEST^MR||PlacerAIRA^HollyAIRA^Almira^^^^L|WrightAIRA^TerrylynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1070 Dag Cir^^Willow^MI^48164^USA^P||^PRN^PH^^^734^5630252|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlacerAIRA^WrightAIRA^^^^^L|MTH^Mother^HL70063|1070 Dag Cir^^Willow^MI^48164^USA^P|^PRN^PH^^^734^5630252ORC|RE||BX87M22043.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX87M22043.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4094-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4094-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S97U22048^^^AIRA-TEST^MR||HenryAIRA^LuellaAIRA^Katelynn^^^^L|CarrollAIRA^TerzaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1220 Kuiken St^^Jeddo^MI^48032^USA^P||^PRN^PH^^^810^2040539|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HenryAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1220 Kuiken St^^Jeddo^MI^48032^USA^P|^PRN^PH^^^810^2040539ORC|RE||BS97U22048.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS97U22048.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4094-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4095-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R35T22056^^^AIRA-TEST^MR||MontgomeryAIRA^PreciousAIRA^Sofie^^^^L|BeecherAIRA^ZiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1754 Wlkmaar Cir^^Hanover^MI^49241^USA^P||^PRN^PH^^^517^6509987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^BeecherAIRA^^^^^L|MTH^Mother^HL70063|1754 Wlkmaar Cir^^Hanover^MI^49241^USA^P|^PRN^PH^^^517^6509987ORC|RE||BR35T22056.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR35T22056.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4095-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4095-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G17R22067^^^AIRA-TEST^MR||MaverickAIRA^PheliaAIRA^Charleigh^^^^L|JohnssonAIRA^MarnieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1918 Geeze-Leende Ave^^Grand Rapids^MI^49560^USA^P||^PRN^PH^^^616^9984422|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MaverickAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1918 Geeze-Leende Ave^^Grand Rapids^MI^49560^USA^P|^PRN^PH^^^616^9984422ORC|RE||BG17R22067.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG17R22067.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4095-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4095-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q15D22075^^^AIRA-TEST^MR||WorleyAIRA^MiraAIRA^Lucian^^^^L|WashtenawAIRA^JuliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1400 Wilvarenbeek Cir^^Harbor Springs^MI^49737^USA^P||^PRN^PH^^^616^5358806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WorleyAIRA^WashtenawAIRA^^^^^L|MTH^Mother^HL70063|1400 Wilvarenbeek Cir^^Harbor Springs^MI^49737^USA^P|^PRN^PH^^^616^5358806ORC|RE||BQ15D22075.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ15D22075.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4095-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4096-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U61V22083^^^AIRA-TEST^MR||SagadahocAIRA^CarenAIRA^Axelia^^^^L|LickingAIRA^ValedaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1982 Hss Pl^^Bham^MI^48009^USA^P||^PRN^PH^^^248^8537199|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SagadahocAIRA^LickingAIRA^^^^^L|MTH^Mother^HL70063|1982 Hss Pl^^Bham^MI^48009^USA^P|^PRN^PH^^^248^8537199ORC|RE||BU61V22083.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU61V22083.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4096-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4096-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L41H22088^^^AIRA-TEST^MR||CrumbakerAIRA^CorabelleAIRA^Blanche^^^^L|GreeneAIRA^SammyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1515 Ra en Hunze Ave^^Brown City^MI^48416^USA^P||^PRN^PH^^^810^9290948|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrumbakerAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1515 Ra en Hunze Ave^^Brown City^MI^48416^USA^P|^PRN^PH^^^810^9290948ORC|RE||BL41H22088.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL41H22088.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4096-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4096-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V28W22096^^^AIRA-TEST^MR||CartonAIRA^JanaAIRA^Brie^^^^L|HamiltonAIRA^MeritAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1514 Uandgraaf Pl^^White Pigeon^MI^49099^USA^P||^PRN^PH^^^269^3130830|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CartonAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1514 Uandgraaf Pl^^White Pigeon^MI^49099^USA^P|^PRN^PH^^^269^3130830ORC|RE||BV28W22096.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV28W22096.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4096-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E49R22107^^^AIRA-TEST^MR||CroweAIRA^IvannaAIRA^Neveah^^^^L|AinslieAIRA^PameliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1146 Horne St^^Lyndon Township^MI^48118^USA^P||^PRN^PH^^^734^7738015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CroweAIRA^AinslieAIRA^^^^^L|MTH^Mother^HL70063|1146 Horne St^^Lyndon Township^MI^48118^USA^P|^PRN^PH^^^734^7738015ORC|RE||BE49R22107.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE49R22107.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4109-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4109-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C13R22115^^^AIRA-TEST^MR||SulitAIRA^KarminaAIRA^Andy^^^^L|HenryAIRA^AyitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1111 Serkrade Ave^^Redford Township^MI^48239^USA^P||^PRN^PH^^^734^8772733|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SulitAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1111 Serkrade Ave^^Redford Township^MI^48239^USA^P|^PRN^PH^^^734^8772733ORC|RE||BC13R22115.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC13R22115.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4109-02^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4109-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N94E22123^^^AIRA-TEST^MR||LucasAIRA^MagaraAIRA^Olena^^^^L|MedinaAIRA^NashaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1259 Naarle-Nassau Cir^^Forest Hills^MI^49506^USA^P||^PRN^PH^^^616^8757053|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1259 Naarle-Nassau Cir^^Forest Hills^MI^49506^USA^P|^PRN^PH^^^616^8757053ORC|RE||BN94E22123.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN94E22123.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4109-09^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4119-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q31L22128^^^AIRA-TEST^MR||LakeAIRA^KalleAIRA^Skye^^^^L|GranholmAIRA^JakindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1960 Seek Ln^^Columbus Township^MI^48063^USA^P||^PRN^PH^^^810^7215122|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^GranholmAIRA^^^^^L|MTH^Mother^HL70063|1960 Seek Ln^^Columbus Township^MI^48063^USA^P|^PRN^PH^^^810^7215122ORC|RE||BQ31L22128.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ31L22128.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4119-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R43P22136^^^AIRA-TEST^MR||RichardsonAIRA^MandaraAIRA^Zenobia^^^^L|OntonagonAIRA^EllenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1789 Lpmeer Pl^^Edenville^MI^48620^USA^P||^PRN^PH^^^989^4569932|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RichardsonAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1789 Lpmeer Pl^^Edenville^MI^48620^USA^P|^PRN^PH^^^989^4569932ORC|RE||BR43P22136.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR43P22136.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4119-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4119-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X46I22147^^^AIRA-TEST^MR||EliasonAIRA^ElennaAIRA^Karli^^^^L|SnyderAIRA^MadeliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1401 Laaren Pl^^Georgetown Township^MI^49428^USA^P||^PRN^PH^^^616^9935243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EliasonAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1401 Laaren Pl^^Georgetown Township^MI^49428^USA^P|^PRN^PH^^^616^9935243ORC|RE||BX46I22147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX46I22147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4119-03^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4121-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K50T22155^^^AIRA-TEST^MR||PerryAIRA^TanuAIRA^Madura^^^^L|NuckollsAIRA^SteshaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1610 Grand Ln^^Chesterfield Township^MI^48047^USA^P||^PRN^PH^^^586^4236433|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^NuckollsAIRA^^^^^L|MTH^Mother^HL70063|1610 Grand Ln^^Chesterfield Township^MI^48047^USA^P|^PRN^PH^^^586^4236433ORC|RE||BK50T22155.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK50T22155.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4121-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4121-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F73E22163^^^AIRA-TEST^MR||ManisteeAIRA^ZerlindaAIRA^Alanna^^^^L|GlennAIRA^FinvarraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1941 Orummen Ln^^Detroit^MI^48288^USA^P||^PRN^PH^^^313^2650019|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ManisteeAIRA^GlennAIRA^^^^^L|MTH^Mother^HL70063|1941 Orummen Ln^^Detroit^MI^48288^USA^P|^PRN^PH^^^313^2650019ORC|RE||BF73E22163.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF73E22163.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4121-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4133-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D07M22171^^^AIRA-TEST^MR||ShelbyAIRA^AldoraAIRA^Hildegard^^^^L|AnderssonAIRA^MarinaAIRA^^^^^M|20140201|F||2106-3^White^CDCREC|1075 Moerdijk St^^Tipton^MI^49287^USA^P||^PRN^PH^^^517^9915869|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^AnderssonAIRA^^^^^L|MTH^Mother^HL70063|1075 Moerdijk St^^Tipton^MI^49287^USA^P|^PRN^PH^^^517^9915869ORC|RE||BD07M22171.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140401||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD07M22171.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140601||00006-4133-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140601||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4133-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M12Y22176^^^AIRA-TEST^MR||CumberlandAIRA^BonitaAIRA^Nimmi^^^^L|AndroscogginAIRA^LindseyAIRA^^^^^M|20140201|F||2106-3^White^CDCREC|1601 Passen Cir^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^5435088|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CumberlandAIRA^AndroscogginAIRA^^^^^L|MTH^Mother^HL70063|1601 Passen Cir^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^5435088ORC|RE||BM12Y22176.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140401||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM12Y22176.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140601||00006-4133-41^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140601||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4171-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F80Q22184^^^AIRA-TEST^MR||Pend OreilleAIRA^AntionetteAIRA^Zofia^^^^L|DomoAIRA^AspenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1924 Bint-Oedenrode Pl^^Detroit^MI^48239^USA^P||^PRN^PH^^^734^8478275|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Pend OreilleAIRA^DomoAIRA^^^^^L|MTH^Mother^HL70063|1924 Bint-Oedenrode Pl^^Detroit^MI^48239^USA^P|^PRN^PH^^^734^8478275ORC|RE||BF80Q22184.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF80Q22184.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4171-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4171-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P46C22195^^^AIRA-TEST^MR||RussellAIRA^KatyaAIRA^Mily^^^^L|KernAIRA^KarlaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1931 Hoogeveen Ave^^Manistique^MI^49854^USA^P||^PRN^PH^^^906^7502100|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RussellAIRA^KernAIRA^^^^^L|MTH^Mother^HL70063|1931 Hoogeveen Ave^^Manistique^MI^49854^USA^P|^PRN^PH^^^906^7502100ORC|RE||BP46C22195.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP46C22195.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4171-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4681-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M05U22203^^^AIRA-TEST^MR||WilssonAIRA^OraAIRA^Tahnia^^^^L|MuhlenbergAIRA^RosalindAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1426 Dorinchem Cir^^Custer^MI^49405^USA^P||^PRN^PH^^^231^8446712|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilssonAIRA^MuhlenbergAIRA^^^^^L|MTH^Mother^HL70063|1426 Dorinchem Cir^^Custer^MI^49405^USA^P|^PRN^PH^^^231^8446712ORC|RE||BM05U22203.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM05U22203.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4681-00^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4681-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T31R22211^^^AIRA-TEST^MR||Box ButteAIRA^TigerlilyAIRA^Damosel^^^^L|RandallAIRA^AnoushAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1631 Nijssen Pl^^Le Roy^MI^49655^USA^P||^PRN^PH^^^231^5897090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Box ButteAIRA^RandallAIRA^^^^^L|MTH^Mother^HL70063|1631 Nijssen Pl^^Le Roy^MI^49655^USA^P|^PRN^PH^^^231^5897090ORC|RE||BT31R22211.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT31R22211.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4681-01^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4739-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94O22216^^^AIRA-TEST^MR||OsceolaAIRA^SeannaAIRA^Marny^^^^L|DixonAIRA^GayAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1518 Twintig Ln^^Rhodes^MI^48652^USA^P||^PRN^PH^^^989^5987830|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OsceolaAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1518 Twintig Ln^^Rhodes^MI^48652^USA^P|^PRN^PH^^^989^5987830ORC|RE||BC94O22216.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94O22216.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4739-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4739-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C22E22224^^^AIRA-TEST^MR||JosephineAIRA^GitaAIRA^Narcissa^^^^L|ShackelfordAIRA^CarlingAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1332 Soon op Zand St^^Lakeland^MI^48143^USA^P||^PRN^PH^^^810^6423962|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JosephineAIRA^ShackelfordAIRA^^^^^L|MTH^Mother^HL70063|1332 Soon op Zand St^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^6423962ORC|RE||BC22E22224.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC22E22224.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||00006-4739-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4826-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I95M22235^^^AIRA-TEST^MR||TaylorAIRA^AylaAIRA^Sundeep^^^^L|MickelAIRA^RyokoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1347 Rood Ave^^Flint^MI^48550^USA^P||^PRN^PH^^^810^9785378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^MickelAIRA^^^^^L|MTH^Mother^HL70063|1347 Rood Ave^^Flint^MI^48550^USA^P|^PRN^PH^^^810^9785378ORC|RE||BI95M22235.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI95M22235.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4826-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T72Q22243^^^AIRA-TEST^MR||RockcastleAIRA^EmersonAIRA^Cliantha^^^^L|HardinAIRA^VivienAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1170 Gilze en Rijen Pl^^Southfield^MI^48034^USA^P||^PRN^PH^^^248^9221210|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RockcastleAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1170 Gilze en Rijen Pl^^Southfield^MI^48034^USA^P|^PRN^PH^^^248^9221210ORC|RE||BT72Q22243.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT72Q22243.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4826-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4827-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B07X22251^^^AIRA-TEST^MR||ButteAIRA^GretelAIRA^Cindy^^^^L|HarmonAIRA^SibylAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1782 Ge Marne St^^Dowling^MI^49050^USA^P||^PRN^PH^^^269^4054250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButteAIRA^HarmonAIRA^^^^^L|MTH^Mother^HL70063|1782 Ge Marne St^^Dowling^MI^49050^USA^P|^PRN^PH^^^269^4054250ORC|RE||BB07X22251.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB07X22251.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4827-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4827-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H44O22256^^^AIRA-TEST^MR||McKeanAIRA^ScarlettAIRA^Susy^^^^L|OscodaAIRA^HajaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1632 Noerdijk Ave^^Grand Rapids^MI^49560^USA^P||^PRN^PH^^^616^3445669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKeanAIRA^OscodaAIRA^^^^^L|MTH^Mother^HL70063|1632 Noerdijk Ave^^Grand Rapids^MI^49560^USA^P|^PRN^PH^^^616^3445669ORC|RE||BH44O22256.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH44O22256.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4827-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4831-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F03Y22264^^^AIRA-TEST^MR||San BernardinoAIRA^RinzenAIRA^Lyndey^^^^L|MaricopaAIRA^CrystalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1134 Slip Cir^^Merriweather^MI^49947^USA^P||^PRN^PH^^^906^4424586|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San BernardinoAIRA^MaricopaAIRA^^^^^L|MTH^Mother^HL70063|1134 Slip Cir^^Merriweather^MI^49947^USA^P|^PRN^PH^^^906^4424586ORC|RE||BF03Y22264.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF03Y22264.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4831-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4831-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A36Y22275^^^AIRA-TEST^MR||O'ConnellAIRA^ThomasaAIRA^Serenity^^^^L|PatariAIRA^EverildaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1099 Gevangen Pl^^L Anse^MI^49946^USA^P||^PRN^PH^^^906^3512448|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'ConnellAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1099 Gevangen Pl^^L Anse^MI^49946^USA^P|^PRN^PH^^^906^3512448ORC|RE||BA36Y22275.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA36Y22275.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4831-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4837-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X93L22283^^^AIRA-TEST^MR||WhartonAIRA^RagnhildAIRA^Madeline^^^^L|HoltAIRA^TinkaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1026 Zwolle St^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^3476813|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhartonAIRA^HoltAIRA^^^^^L|MTH^Mother^HL70063|1026 Zwolle St^^Lake Linden^MI^49945^USA^P|^PRN^PH^^^906^3476813ORC|RE||BX93L22283.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX93L22283.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4837-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4837-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L95Y22291^^^AIRA-TEST^MR||AlleganAIRA^MagdaleneAIRA^Zehava^^^^L|CassAIRA^MarsalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1899 Sarneveld Cir^^Wyoming^MI^49548^USA^P||^PRN^PH^^^616^9257153|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlleganAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1899 Sarneveld Cir^^Wyoming^MI^49548^USA^P|^PRN^PH^^^616^9257153ORC|RE||BL95Y22291.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL95Y22291.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4837-02^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4837-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C87F22296^^^AIRA-TEST^MR||KrogAIRA^TheclaAIRA^Gale^^^^L|CraneAIRA^PalomiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1770 Teldhoven St^^Alba^MI^49611^USA^P||^PRN^PH^^^231^2249155|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KrogAIRA^CraneAIRA^^^^^L|MTH^Mother^HL70063|1770 Teldhoven St^^Alba^MI^49611^USA^P|^PRN^PH^^^231^2249155ORC|RE||BC87F22296.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC87F22296.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4837-03^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4841-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U74V22304^^^AIRA-TEST^MR||CalaverasAIRA^AdaAIRA^Naomi^^^^L|RichlandAIRA^SandiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1603 Eunschoten Pl^^Carsonville^MI^48419^USA^P||^PRN^PH^^^810^3720417|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CalaverasAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1603 Eunschoten Pl^^Carsonville^MI^48419^USA^P|^PRN^PH^^^810^3720417ORC|RE||BU74V22304.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU74V22304.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4841-00^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4841-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C26I22315^^^AIRA-TEST^MR||TaylorAIRA^LorindaAIRA^Akriti^^^^L|ButteAIRA^LoreneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1604 Nederweert St^^Cottrellville^MI^48039^USA^P||^PRN^PH^^^810^8560923|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^ButteAIRA^^^^^L|MTH^Mother^HL70063|1604 Nederweert St^^Cottrellville^MI^48039^USA^P|^PRN^PH^^^810^8560923ORC|RE||BC26I22315.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC26I22315.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4841-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4841-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T78F22323^^^AIRA-TEST^MR||ColusaAIRA^SawsanAIRA^Moya^^^^L|KnoxAIRA^TutiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1251 Bittard-Geleen Cir^^Clinton Township^MI^48038^USA^P||^PRN^PH^^^586^3264527|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColusaAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1251 Bittard-Geleen Cir^^Clinton Township^MI^48038^USA^P|^PRN^PH^^^586^3264527ORC|RE||BT78F22323.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT78F22323.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4841-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4897-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T03X22331^^^AIRA-TEST^MR||StarkAIRA^FallonAIRA^Aquamarine^^^^L|GarzaAIRA^OreaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1453 Aissewaard Cir^^Comerica Incorporated^MI^48275^USA^P||^PRN^PH^^^313^9543435|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StarkAIRA^GarzaAIRA^^^^^L|MTH^Mother^HL70063|1453 Aissewaard Cir^^Comerica Incorporated^MI^48275^USA^P|^PRN^PH^^^313^9543435ORC|RE||BT03X22331.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT03X22331.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4897-00^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4897-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76A22339^^^AIRA-TEST^MR||KartwoldAIRA^ZelenkaAIRA^Marlene^^^^L|HughesAIRA^JamyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1319 Rardenberg Pl^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^8391380|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KartwoldAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1319 Rardenberg Pl^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^8391380ORC|RE||BG76A22339.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG76A22339.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4897-01^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4898-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B97E22347^^^AIRA-TEST^MR||KentonAIRA^MajestaAIRA^Melissa^^^^L|MercerAIRA^KaelynAIRA^^^^^M|20140830|F||2106-3^White^CDCREC|1074 Merkelland Cir^^Grand Junction^MI^49056^USA^P||^PRN^PH^^^269^7397353|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentonAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1074 Merkelland Cir^^Grand Junction^MI^49056^USA^P|^PRN^PH^^^269^7397353ORC|RE||BB97E22347.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20141030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB97E22347.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20141230||00006-4898-00^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B81R22352^^^AIRA-TEST^MR||HeffordAIRA^KlarissaAIRA^Keelin^^^^L|NightingaleAIRA^AlfredaAIRA^^^^^M|20140830|F||2106-3^White^CDCREC|1129 De winter Ave^^Haslett^MI^48840^USA^P||^PRN^PH^^^517^9627371|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffordAIRA^NightingaleAIRA^^^^^L|MTH^Mother^HL70063|1129 De winter Ave^^Haslett^MI^48840^USA^P|^PRN^PH^^^517^9627371ORC|RE||BB81R22352.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20141030||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB81R22352.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20141230||00006-4898-01^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4943-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X01A22360^^^AIRA-TEST^MR||BredbergAIRA^ShilohAIRA^Eliane^^^^L|ChambersAIRA^ChilaliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1896 Hwartewaterland Pl^^Bloomfield Hills^MI^48301^USA^P||^PRN^PH^^^248^6761403|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BredbergAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1896 Hwartewaterland Pl^^Bloomfield Hills^MI^48301^USA^P|^PRN^PH^^^248^6761403ORC|RE||BX01A22360.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX01A22360.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4943-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4943-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y25J22371^^^AIRA-TEST^MR||Hood RiverAIRA^GiaAIRA^Senta^^^^L|CochranAIRA^EmiliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1067 Wdam-Volendam Cir^^Sang^MI^48045^USA^P||^PRN^PH^^^586^2314385|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Hood RiverAIRA^CochranAIRA^^^^^L|MTH^Mother^HL70063|1067 Wdam-Volendam Cir^^Sang^MI^48045^USA^P|^PRN^PH^^^586^2314385ORC|RE||BY25J22371.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY25J22371.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4943-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4963-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y92S22379^^^AIRA-TEST^MR||GreenAIRA^TammieAIRA^Yumako^^^^L|BranchAIRA^SylviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1659 Ochagen Ln^^Athens^MI^49011^USA^P||^PRN^PH^^^269^9067848|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreenAIRA^BranchAIRA^^^^^L|MTH^Mother^HL70063|1659 Ochagen Ln^^Athens^MI^49011^USA^P|^PRN^PH^^^269^9067848ORC|RE||BY92S22379.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY92S22379.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4963-00^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4963-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D62D22387^^^AIRA-TEST^MR||BorthroydAIRA^YoothaAIRA^Nurhan^^^^L|EstillAIRA^GraniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1142 Upsterland Pl^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^9613596|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BorthroydAIRA^EstillAIRA^^^^^L|MTH^Mother^HL70063|1142 Upsterland Pl^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^9613596ORC|RE||BD62D22387.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD62D22387.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4963-01^ZOSTAVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4963-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C18G22392^^^AIRA-TEST^MR||LatahAIRA^RosemaryAIRA^Emery^^^^L|BordenAIRA^NeeljaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1530 Ealfsen Ln^^Reese^MI^48757^USA^P||^PRN^PH^^^989^2691201|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LatahAIRA^BordenAIRA^^^^^L|MTH^Mother^HL70063|1530 Ealfsen Ln^^Reese^MI^48757^USA^P|^PRN^PH^^^989^2691201ORC|RE||BC18G22392.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC18G22392.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4963-41^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4980-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O72R22400^^^AIRA-TEST^MR||BordenAIRA^LeewanaAIRA^Shaili^^^^L|TylerAIRA^SumehraAIRA^^^^^M|20080518|F||2106-3^White^CDCREC|1829 Zrechterland St^^Sodus^MI^49126^USA^P||^PRN^PH^^^269^2824603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BordenAIRA^TylerAIRA^^^^^L|MTH^Mother^HL70063|1829 Zrechterland St^^Sodus^MI^49126^USA^P|^PRN^PH^^^269^2824603ORC|RE||BO72R22400.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20080718||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO72R22400.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20080918||00006-4980-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20080918||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4981-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J33G22411^^^AIRA-TEST^MR||HemphillAIRA^UrsalaAIRA^Quinn^^^^L|LatahAIRA^NessaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1030 Oeemster Ave^^Genoa Township^MI^48114^USA^P||^PRN^PH^^^810^7479090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HemphillAIRA^LatahAIRA^^^^^L|MTH^Mother^HL70063|1030 Oeemster Ave^^Genoa Township^MI^48114^USA^P|^PRN^PH^^^810^7479090ORC|RE||BJ33G22411.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ33G22411.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4981-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4981-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P06E22419^^^AIRA-TEST^MR||OlssonAIRA^AkakoAIRA^Clio^^^^L|MadisonAIRA^AkasmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1931 Gemert-Bakel St^^Thompson^MI^49854^USA^P||^PRN^PH^^^906^3599660|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OlssonAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1931 Gemert-Bakel St^^Thompson^MI^49854^USA^P|^PRN^PH^^^906^3599660ORC|RE||BP06E22419.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP06E22419.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4981-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4992-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O04F22427^^^AIRA-TEST^MR||LevyAIRA^RodericaAIRA^Dulcinea^^^^L|ThomasAIRA^VasaviAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1555 Rijmegen Pl^^Southfield^MI^48086^USA^P||^PRN^PH^^^248^3003492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LevyAIRA^ThomasAIRA^^^^^L|MTH^Mother^HL70063|1555 Rijmegen Pl^^Southfield^MI^48086^USA^P|^PRN^PH^^^248^3003492ORC|RE||BO04F22427.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO04F22427.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4992-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4992-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O41S22432^^^AIRA-TEST^MR||CarrollAIRA^LakotaAIRA^Reshma^^^^L|LoganAIRA^MalkaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1015 Kuijk Pl^^Onsted^MI^49265^USA^P||^PRN^PH^^^517^3496143|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1015 Kuijk Pl^^Onsted^MI^49265^USA^P|^PRN^PH^^^517^3496143ORC|RE||BO41S22432.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO41S22432.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4992-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4995-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C38H22440^^^AIRA-TEST^MR||JeffersonAIRA^GeneAIRA^Ilene^^^^L|CottleAIRA^HildegardAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1361 Beusel-De Mierden Ave^^Kincheloe^MI^49784^USA^P||^PRN^PH^^^906^4017822|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^CottleAIRA^^^^^L|MTH^Mother^HL70063|1361 Beusel-De Mierden Ave^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^4017822ORC|RE||BC38H22440.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC38H22440.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4995-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4995-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V98I22451^^^AIRA-TEST^MR||KentAIRA^DimityAIRA^Guinevere^^^^L|BrikkeAIRA^PhotiniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1793 Sorst aan de Maas Pl^^Shelby Township^MI^48315^USA^P||^PRN^PH^^^586^5323746|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentAIRA^BrikkeAIRA^^^^^L|MTH^Mother^HL70063|1793 Sorst aan de Maas Pl^^Shelby Township^MI^48315^USA^P|^PRN^PH^^^586^5323746ORC|RE||BV98I22451.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV98I22451.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4995-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4995-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V32S22459^^^AIRA-TEST^MR||SonomaAIRA^LynnAIRA^Delaney^^^^L|MinidokaAIRA^CorinneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1049 Rss St^^Grosse Ile^MI^48138^USA^P||^PRN^PH^^^734^3708032|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SonomaAIRA^MinidokaAIRA^^^^^L|MTH^Mother^HL70063|1049 Rss St^^Grosse Ile^MI^48138^USA^P|^PRN^PH^^^734^3708032ORC|RE||BV32S22459.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV32S22459.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006-4995-41^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4999-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B75O22467^^^AIRA-TEST^MR||WashingtonAIRA^MadisonAIRA^Preeti^^^^L|TobiassenAIRA^AdelynAIRA^^^^^M|20150330|F||2106-3^White^CDCREC|1029 Rulst Cir^^Barbeau^MI^49710^USA^P||^PRN^PH^^^906^4131528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^TobiassenAIRA^^^^^L|MTH^Mother^HL70063|1029 Rulst Cir^^Barbeau^MI^49710^USA^P|^PRN^PH^^^906^4131528ORC|RE||BB75O22467.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150530||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB75O22467.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150730||00006-4999-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150730||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006-4999-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q79P22475^^^AIRA-TEST^MR||Scotts BluffAIRA^JesalAIRA^Zinaida^^^^L|TulsaAIRA^TrilbyAIRA^^^^^M|20150330|F||2106-3^White^CDCREC|1467 Aontferland Ave^^Pleasant Lake^MI^49272^USA^P||^PRN^PH^^^517^3082651|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Scotts BluffAIRA^TulsaAIRA^^^^^L|MTH^Mother^HL70063|1467 Aontferland Ave^^Pleasant Lake^MI^49272^USA^P|^PRN^PH^^^517^3082651ORC|RE||BQ79P22475.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150530||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ79P22475.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150730||00006-4999-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150730||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00052-0603-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G78N22480^^^AIRA-TEST^MR||HendersonAIRA^JulietteAIRA^Dale^^^^L|PlatteAIRA^NardaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1557 Dal Cir^^Warren^MI^48088^USA^P||^PRN^PH^^^586^4589369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HendersonAIRA^PlatteAIRA^^^^^L|MTH^Mother^HL70063|1557 Dal Cir^^Warren^MI^48088^USA^P|^PRN^PH^^^586^4589369ORC|RE||BG78N22480.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG78N22480.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00052-0603-01^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||OTC^Organon Teknika Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00052-0603-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W11R22488^^^AIRA-TEST^MR||TuolumneAIRA^EverildaAIRA^Amiyah^^^^L|LarsenAIRA^MelosaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1265 Eorst aan de Maas Pl^^Parchment^MI^49004^USA^P||^PRN^PH^^^269^2464382|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuolumneAIRA^LarsenAIRA^^^^^L|MTH^Mother^HL70063|1265 Eorst aan de Maas Pl^^Parchment^MI^49004^USA^P|^PRN^PH^^^269^2464382ORC|RE||BW11R22488.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW11R22488.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00052-0603-02^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||OTC^Organon Teknika Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-13533-0131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D11Q22499^^^AIRA-TEST^MR||WahkiakumAIRA^ZiganaAIRA^Sudevi^^^^L|ToddAIRA^NanineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1787 Kaasdriel Ln^^Troy^MI^48098^USA^P||^PRN^PH^^^248^9645476|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WahkiakumAIRA^ToddAIRA^^^^^L|MTH^Mother^HL70063|1787 Kaasdriel Ln^^Troy^MI^48098^USA^P|^PRN^PH^^^248^9645476ORC|RE||BD11Q22499.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD11Q22499.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||13533-0131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-13533-0131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R90Z22507^^^AIRA-TEST^MR||WarrenAIRA^NydiaAIRA^Sevilla^^^^L|LlanoAIRA^RamyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1001 Wuth St^^Glen Arbor^MI^49636^USA^P||^PRN^PH^^^231^7551483|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WarrenAIRA^LlanoAIRA^^^^^L|MTH^Mother^HL70063|1001 Wuth St^^Glen Arbor^MI^49636^USA^P|^PRN^PH^^^231^7551483ORC|RE||BR90Z22507.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR90Z22507.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||13533-0131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-14362-0111-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C21H22515^^^AIRA-TEST^MR||WarrenAIRA^SammaAIRA^Helena^^^^L|JeffersonAIRA^RafaellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1815 Naarle-Nassau Pl^^Elwell^MI^48832^USA^P||^PRN^PH^^^989^5438113|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WarrenAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1815 Naarle-Nassau Pl^^Elwell^MI^48832^USA^P|^PRN^PH^^^989^5438113ORC|RE||BC21H22515.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC21H22515.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14362-0111-03^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-14362-0111-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U42K22520^^^AIRA-TEST^MR||La PazAIRA^MattieAIRA^Kynlee^^^^L|DimmitAIRA^MichelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1520 Wergeijk Cir^^Niles^MI^49120^USA^P||^PRN^PH^^^269^9039689|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|La PazAIRA^DimmitAIRA^^^^^L|MTH^Mother^HL70063|1520 Wergeijk Cir^^Niles^MI^49120^USA^P|^PRN^PH^^^269^9039689ORC|RE||BU42K22520.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU42K22520.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14362-0111-04^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-17478-0131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L35G22528^^^AIRA-TEST^MR||ToaleAIRA^MarjorieAIRA^Idylla^^^^L|ArthurAIRA^TutiAIRA^^^^^M|20161226|F||2106-3^White^CDCREC|1794 Seidschendam-Voorburg St^^Barton Hills^MI^48105^USA^P||^PRN^PH^^^734^8317061|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ToaleAIRA^ArthurAIRA^^^^^L|MTH^Mother^HL70063|1794 Seidschendam-Voorburg St^^Barton Hills^MI^48105^USA^P|^PRN^PH^^^734^8317061ORC|RE||BL35G22528.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170226||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL35G22528.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170426||17478-0131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170426||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-17478-0131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W25S22539^^^AIRA-TEST^MR||DeweyAIRA^GelasiaAIRA^Jacinda^^^^L|MagriAIRA^SuzetteAIRA^^^^^M|20161226|F||2106-3^White^CDCREC|1120 Touten Cir^^Delhi^MI^48103^USA^P||^PRN^PH^^^734^8714371|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeweyAIRA^MagriAIRA^^^^^L|MTH^Mother^HL70063|1120 Touten Cir^^Delhi^MI^48103^USA^P|^PRN^PH^^^734^8714371ORC|RE||BW25S22539.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170226||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW25S22539.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170426||17478-0131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170426||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0845-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P33S22547^^^AIRA-TEST^MR||DickinsonAIRA^WillowAIRA^Niti^^^^L|ReaganAIRA^SaraiAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1354 Dosterhout Cir^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^3916995|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DickinsonAIRA^ReaganAIRA^^^^^L|MTH^Mother^HL70063|1354 Dosterhout Cir^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^3916995ORC|RE||BP33S22547.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP33S22547.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0845-01^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0845-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T91L22555^^^AIRA-TEST^MR||Grand TraverseAIRA^AvahAIRA^Valentina^^^^L|SummresgillAIRA^IkuAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1661 Darlingen Ave^^GR^MI^49546^USA^P||^PRN^PH^^^616^5365683|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Grand TraverseAIRA^SummresgillAIRA^^^^^L|MTH^Mother^HL70063|1661 Darlingen Ave^^GR^MI^49546^USA^P|^PRN^PH^^^616^5365683ORC|RE||BT91L22555.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT91L22555.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0845-11^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0850-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q68U22560^^^AIRA-TEST^MR||LoganAIRA^KlavdiaAIRA^Ariza^^^^L|CusterAIRA^PaygeAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1761 Hucphen Ave^^Houghton Lake Heights^MI^48630^USA^P||^PRN^PH^^^989^5233842|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoganAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1761 Hucphen Ave^^Houghton Lake Heights^MI^48630^USA^P|^PRN^PH^^^989^5233842ORC|RE||BQ68U22560.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ68U22560.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0850-41^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0850-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W88W22568^^^AIRA-TEST^MR||Nez PerceAIRA^GlenAIRA^Jacinda^^^^L|KnottAIRA^NeriaAIRA^^^^^M|20150630|F||2106-3^White^CDCREC|1510 Experiment Cir^^Independence^MI^48348^USA^P||^PRN^PH^^^248^5312300|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Nez PerceAIRA^KnottAIRA^^^^^L|MTH^Mother^HL70063|1510 Experiment Cir^^Independence^MI^48348^USA^P|^PRN^PH^^^248^5312300ORC|RE||BW88W22568.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW88W22568.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151030||19515-0850-52^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0889-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q04X22579^^^AIRA-TEST^MR||WorleyAIRA^ReneeAIRA^Zariah^^^^L|JacksonAIRA^AmariAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1770 Vaarle-Nassau Cir^^Jeddo^MI^48032^USA^P||^PRN^PH^^^810^2045585|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WorleyAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1770 Vaarle-Nassau Cir^^Jeddo^MI^48032^USA^P|^PRN^PH^^^810^2045585ORC|RE||BQ04X22579.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130430||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ04X22579.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130630||19515-0889-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130630||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0889-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G53H22587^^^AIRA-TEST^MR||GreenlandAIRA^CaitAIRA^Bharati^^^^L|SomersetAIRA^ToriAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1873 Zint-Oedenrode St^^Painesdale^MI^49955^USA^P||^PRN^PH^^^906^4460053|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreenlandAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1873 Zint-Oedenrode St^^Painesdale^MI^49955^USA^P|^PRN^PH^^^906^4460053ORC|RE||BG53H22587.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130430||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG53H22587.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130630||19515-0889-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130630||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0890-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W58O22595^^^AIRA-TEST^MR||PushmatahaAIRA^TerentiaAIRA^Siv^^^^L|DawsonAIRA^CariAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1390 Kint-Oedenrode Ln^^Bergland^MI^49910^USA^P||^PRN^PH^^^906^9406319|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PushmatahaAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1390 Kint-Oedenrode Ln^^Bergland^MI^49910^USA^P|^PRN^PH^^^906^9406319ORC|RE||BW58O22595.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW58O22595.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0890-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0890-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K53A22600^^^AIRA-TEST^MR||ClayAIRA^LunaAIRA^Nani^^^^L|WilliamsonAIRA^CrystalAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1291 Beetje Ln^^Lansing^MI^48980^USA^P||^PRN^PH^^^517^9363139|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClayAIRA^WilliamsonAIRA^^^^^L|MTH^Mother^HL70063|1291 Beetje Ln^^Lansing^MI^48980^USA^P|^PRN^PH^^^517^9363139ORC|RE||BK53A22600.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK53A22600.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0890-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0891-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N21F22608^^^AIRA-TEST^MR||CharlevoixAIRA^ApolloniaAIRA^Sarah^^^^L|FranklinAIRA^SidonieAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1024 Nooit St^^Independence^MI^48346^USA^P||^PRN^PH^^^248^5380021|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CharlevoixAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1024 Nooit St^^Independence^MI^48346^USA^P|^PRN^PH^^^248^5380021ORC|RE||BN21F22608.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN21F22608.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0891-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0891-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P18S22619^^^AIRA-TEST^MR||ColoradoAIRA^TrevaAIRA^Gerda^^^^L|LeonAIRA^AnjaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1534 Deal Pl^^Oxford^MI^48371^USA^P||^PRN^PH^^^248^3541637|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColoradoAIRA^LeonAIRA^^^^^L|MTH^Mother^HL70063|1534 Deal Pl^^Oxford^MI^48371^USA^P|^PRN^PH^^^248^3541637ORC|RE||BP18S22619.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP18S22619.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0891-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0893-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y43G22627^^^AIRA-TEST^MR||ValleyAIRA^TerenciaAIRA^Zebina^^^^L|NobleAIRA^ValarieAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1317 Straight St^^Holland^MI^49424^USA^P||^PRN^PH^^^616^5562273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ValleyAIRA^NobleAIRA^^^^^L|MTH^Mother^HL70063|1317 Straight St^^Holland^MI^49424^USA^P|^PRN^PH^^^616^5562273ORC|RE||BY43G22627.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY43G22627.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0893-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0893-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X37V22635^^^AIRA-TEST^MR||CarlisleAIRA^EgeriaAIRA^Lizzy^^^^L|DixonAIRA^NeerjaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1509 Pagina Ln^^Imlay City^MI^48444^USA^P||^PRN^PH^^^810^8389860|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarlisleAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1509 Pagina Ln^^Imlay City^MI^48444^USA^P|^PRN^PH^^^810^8389860ORC|RE||BX37V22635.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX37V22635.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0893-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0894-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K80K22640^^^AIRA-TEST^MR||CottleAIRA^AdelineAIRA^Semra^^^^L|JuniataAIRA^TainnAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1420 Srimpen aan den IJssel Pl^^Southgate^MI^48195^USA^P||^PRN^PH^^^734^4275846|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CottleAIRA^JuniataAIRA^^^^^L|MTH^Mother^HL70063|1420 Srimpen aan den IJssel Pl^^Southgate^MI^48195^USA^P|^PRN^PH^^^734^4275846ORC|RE||BK80K22640.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK80K22640.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0894-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0894-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y45L22648^^^AIRA-TEST^MR||WardleAIRA^SonyaAIRA^Engelberta^^^^L|BonnerAIRA^VilhelminaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1125 Asten St^^Maple City^MI^49664^USA^P||^PRN^PH^^^231^2609259|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WardleAIRA^BonnerAIRA^^^^^L|MTH^Mother^HL70063|1125 Asten St^^Maple City^MI^49664^USA^P|^PRN^PH^^^231^2609259ORC|RE||BY45L22648.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY45L22648.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||19515-0894-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0895-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z08C22659^^^AIRA-TEST^MR||MarionAIRA^RosyAIRA^Ilaria^^^^L|McCarthyAIRA^PragatiAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1677 Huijk Pl^^Eben Junction^MI^49825^USA^P||^PRN^PH^^^906^8766255|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^McCarthyAIRA^^^^^L|MTH^Mother^HL70063|1677 Huijk Pl^^Eben Junction^MI^49825^USA^P|^PRN^PH^^^906^8766255ORC|RE||BZ08C22659.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ08C22659.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0895-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0895-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N91U22667^^^AIRA-TEST^MR||HoggAIRA^HeliAIRA^Crystal^^^^L|DouglasAIRA^DeidraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1007 Noirle Pl^^Highland^MI^48357^USA^P||^PRN^PH^^^248^3396659|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoggAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1007 Noirle Pl^^Highland^MI^48357^USA^P|^PRN^PH^^^248^3396659ORC|RE||BN91U22667.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN91U22667.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||19515-0895-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0896-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q35I22675^^^AIRA-TEST^MR||MontagueAIRA^EdaAIRA^Adishree^^^^L|PikeAIRA^NettieAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1144 Loststellingwerf Ln^^Moscow^MI^49257^USA^P||^PRN^PH^^^517^8596028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontagueAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1144 Loststellingwerf Ln^^Moscow^MI^49257^USA^P|^PRN^PH^^^517^8596028ORC|RE||BQ35I22675.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ35I22675.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0896-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0896-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W43D22680^^^AIRA-TEST^MR||OlsonAIRA^SofieAIRA^Mavis^^^^L|GarfieldAIRA^VaisakhiAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1782 Lppingedam St^^Fountain^MI^49410^USA^P||^PRN^PH^^^231^5641290|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OlsonAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1782 Lppingedam St^^Fountain^MI^49410^USA^P|^PRN^PH^^^231^5641290ORC|RE||BW43D22680.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW43D22680.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0896-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D92Z22688^^^AIRA-TEST^MR||TurvoAIRA^GlendaAIRA^Solace^^^^L|LevyAIRA^AugustaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1643 Weesp Ave^^Sterling Heights^MI^48313^USA^P||^PRN^PH^^^586^9723740|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TurvoAIRA^LevyAIRA^^^^^L|MTH^Mother^HL70063|1643 Weesp Ave^^Sterling Heights^MI^48313^USA^P|^PRN^PH^^^586^9723740ORC|RE||BD92Z22688.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD92Z22688.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0898-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0898-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y99U22699^^^AIRA-TEST^MR||SweeneyAIRA^ItiAIRA^Tuesday^^^^L|ParkAIRA^AerynAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1886 Waasgouw Ln^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^7801242|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SweeneyAIRA^ParkAIRA^^^^^L|MTH^Mother^HL70063|1886 Waasgouw Ln^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^7801242ORC|RE||BY99U22699.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY99U22699.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0898-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0900-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O29L22707^^^AIRA-TEST^MR||MarionAIRA^KarolAIRA^Gelsey^^^^L|CharlevoixAIRA^ZiahonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1691 Koon op Zand St^^Rollin^MI^49247^USA^P||^PRN^PH^^^517^5088935|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^CharlevoixAIRA^^^^^L|MTH^Mother^HL70063|1691 Koon op Zand St^^Rollin^MI^49247^USA^P|^PRN^PH^^^517^5088935ORC|RE||BO29L22707.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO29L22707.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-0900-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0900-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D18J22715^^^AIRA-TEST^MR||FloydAIRA^FrumaAIRA^Beverley^^^^L|MasonAIRA^MardiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1956 Vldebroek Ave^^Peshawbestown^MI^49682^USA^P||^PRN^PH^^^231^8695622|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1956 Vldebroek Ave^^Peshawbestown^MI^49682^USA^P|^PRN^PH^^^231^8695622ORC|RE||BD18J22715.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD18J22715.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-0900-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G06A22720^^^AIRA-TEST^MR||WhatcomAIRA^DaffodilAIRA^Veena^^^^L|HillsdaleAIRA^GundaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1144 Mronckhorst Ave^^Westland^MI^48186^USA^P||^PRN^PH^^^734^7400339|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhatcomAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1144 Mronckhorst Ave^^Westland^MI^48186^USA^P|^PRN^PH^^^734^7400339ORC|RE||BG06A22720.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG06A22720.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0901-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J34H22728^^^AIRA-TEST^MR||OlssenAIRA^CathleenAIRA^Audlin^^^^L|ReevesAIRA^EmaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1847 Deist St^^Maybee^MI^48159^USA^P||^PRN^PH^^^734^7965294|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OlssenAIRA^ReevesAIRA^^^^^L|MTH^Mother^HL70063|1847 Deist St^^Maybee^MI^48159^USA^P|^PRN^PH^^^734^7965294ORC|RE||BJ34H22728.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ34H22728.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||19515-0901-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0903-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D93Y22739^^^AIRA-TEST^MR||RoscommonAIRA^CarolenaAIRA^Aluma^^^^L|RonningAIRA^BryannaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1693 Eardenberg Pl^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^8562783|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RoscommonAIRA^RonningAIRA^^^^^L|MTH^Mother^HL70063|1693 Eardenberg Pl^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^8562783ORC|RE||BD93Y22739.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD93Y22739.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0903-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0903-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F74O22747^^^AIRA-TEST^MR||WellsAIRA^SuzetteAIRA^Liese^^^^L|ColonAIRA^HaldisAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1311 Slkmaar Pl^^Bloomfield Township^MI^48303^USA^P||^PRN^PH^^^248^9970872|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WellsAIRA^ColonAIRA^^^^^L|MTH^Mother^HL70063|1311 Slkmaar Pl^^Bloomfield Township^MI^48303^USA^P|^PRN^PH^^^248^9970872ORC|RE||BF74O22747.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF74O22747.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0903-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0908-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L00M22755^^^AIRA-TEST^MR||OaklandAIRA^SeonaidAIRA^Jodie^^^^L|JeffersonAIRA^SalihahAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1864 Eeghel Ln^^Ann Arbor^MI^48104^USA^P||^PRN^PH^^^734^9909403|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OaklandAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1864 Eeghel Ln^^Ann Arbor^MI^48104^USA^P|^PRN^PH^^^734^9909403ORC|RE||BL00M22755.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL00M22755.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0908-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0908-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M18X22760^^^AIRA-TEST^MR||HancockAIRA^EllenAIRA^Laney^^^^L|LaenAIRA^HengAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1650 Koeree-Overflakkee Ln^^Kimball^MI^48074^USA^P||^PRN^PH^^^810^2781554|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HancockAIRA^LaenAIRA^^^^^L|MTH^Mother^HL70063|1650 Koeree-Overflakkee Ln^^Kimball^MI^48074^USA^P|^PRN^PH^^^810^2781554ORC|RE||BM18X22760.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM18X22760.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||19515-0908-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0909-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R47A22768^^^AIRA-TEST^MR||OrangeAIRA^LitaAIRA^Hermelinda^^^^L|GranholmAIRA^JoselynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1227 Eeudal Ln^^Carland^MI^48831^USA^P||^PRN^PH^^^989^3133620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OrangeAIRA^GranholmAIRA^^^^^L|MTH^Mother^HL70063|1227 Eeudal Ln^^Carland^MI^48831^USA^P|^PRN^PH^^^989^3133620ORC|RE||BR47A22768.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR47A22768.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-0909-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0909-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P71V22779^^^AIRA-TEST^MR||MayesAIRA^RitaAIRA^Gwendolen^^^^L|GanesAIRA^MiraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1418 Dans St^^Benton Harbor^MI^49023^USA^P||^PRN^PH^^^269^3959102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MayesAIRA^GanesAIRA^^^^^L|MTH^Mother^HL70063|1418 Dans St^^Benton Harbor^MI^49023^USA^P|^PRN^PH^^^269^3959102ORC|RE||BP71V22779.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP71V22779.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-0909-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0912-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B30M22787^^^AIRA-TEST^MR||GanronAIRA^ClaiborneAIRA^Nina^^^^L|OsageAIRA^AnnaliseAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1066 Hollands Kroon Pl^^GR^MI^49501^USA^P||^PRN^PH^^^616^7830061|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanronAIRA^OsageAIRA^^^^^L|MTH^Mother^HL70063|1066 Hollands Kroon Pl^^GR^MI^49501^USA^P|^PRN^PH^^^616^7830061ORC|RE||BB30M22787.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB30M22787.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0912-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-0912-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M50V22795^^^AIRA-TEST^MR||BannockAIRA^VaisakhiAIRA^Lizzy^^^^L|CulpAIRA^ErenaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1364 Aoermond Cir^^Shelby Township^MI^48317^USA^P||^PRN^PH^^^586^9721179|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BannockAIRA^CulpAIRA^^^^^L|MTH^Mother^HL70063|1364 Aoermond Cir^^Shelby Township^MI^48317^USA^P|^PRN^PH^^^586^9721179ORC|RE||BM50V22795.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM50V22795.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||19515-0912-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||IDB^ID Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-21695-0413-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O38E22800^^^AIRA-TEST^MR||WayneAIRA^NicoleAIRA^Ciar^^^^L|JohnsonAIRA^SeverinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1236 Sleutel Ave^^Bay City^MI^48706^USA^P||^PRN^PH^^^989^4840898|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1236 Sleutel Ave^^Bay City^MI^48706^USA^P|^PRN^PH^^^989^4840898ORC|RE||BO38E22800.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO38E22800.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21695-0413-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MBL^Massachusetts Biologic Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0010-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A05D22808^^^AIRA-TEST^MR||PerryAIRA^SujataAIRA^Phyllida^^^^L|PauldingAIRA^VelikaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1554 Seerijnen Cir^^Sand Creek^MI^49279^USA^P||^PRN^PH^^^517^9927624|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^PauldingAIRA^^^^^L|MTH^Mother^HL70063|1554 Seerijnen Cir^^Sand Creek^MI^49279^USA^P|^PRN^PH^^^517^9927624ORC|RE||BA05D22808.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA05D22808.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||33332-0010-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H94I22819^^^AIRA-TEST^MR||EstillAIRA^MinaAIRA^Nancy^^^^L|CusterAIRA^ShilohAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1917 Seert Pl^^Richmond Township^MI^48062^USA^P||^PRN^PH^^^586^9613518|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EstillAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1917 Seert Pl^^Richmond Township^MI^48062^USA^P|^PRN^PH^^^586^9613518ORC|RE||BH94I22819.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH94I22819.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0013-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0013-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S87E22827^^^AIRA-TEST^MR||HoltAIRA^LexieAIRA^Onora^^^^L|WellsAIRA^BarbaraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1906 Larum Pl^^Waterford Township^MI^48327^USA^P||^PRN^PH^^^248^7371892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoltAIRA^WellsAIRA^^^^^L|MTH^Mother^HL70063|1906 Larum Pl^^Waterford Township^MI^48327^USA^P|^PRN^PH^^^248^7371892ORC|RE||BS87E22827.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS87E22827.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0013-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U05S22835^^^AIRA-TEST^MR||MorrisAIRA^BatesAIRA^Mirrin^^^^L|NicholasAIRA^EfiaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1507 Ge Ronde Venen Ave^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^7011558|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrisAIRA^NicholasAIRA^^^^^L|MTH^Mother^HL70063|1507 Ge Ronde Venen Ave^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^7011558ORC|RE||BU05S22835.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU05S22835.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0014-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0014-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D21O22840^^^AIRA-TEST^MR||AllenAIRA^AletaAIRA^Safia^^^^L|BexarAIRA^NiciaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1984 Oppingedam Cir^^Grand Rapids^MI^49505^USA^P||^PRN^PH^^^616^4430417|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^BexarAIRA^^^^^L|MTH^Mother^HL70063|1984 Oppingedam Cir^^Grand Rapids^MI^49505^USA^P|^PRN^PH^^^616^4430417ORC|RE||BD21O22840.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD21O22840.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0014-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O96A22848^^^AIRA-TEST^MR||CowlitzAIRA^KarliAIRA^Jala^^^^L|GartenlaubAIRA^FaizahAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1641 Oosterhout Ave^^Midland^MI^48641^USA^P||^PRN^PH^^^989^3831933|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CowlitzAIRA^GartenlaubAIRA^^^^^L|MTH^Mother^HL70063|1641 Oosterhout Ave^^Midland^MI^48641^USA^P|^PRN^PH^^^989^3831933ORC|RE||BO96A22848.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO96A22848.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0015-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0015-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N33M22859^^^AIRA-TEST^MR||GlennAIRA^EmanueleAIRA^Catrin^^^^L|GreenupAIRA^TristessaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1230 Gpeldoorn Ave^^Lake Ann^MI^49650^USA^P||^PRN^PH^^^231^4425892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GlennAIRA^GreenupAIRA^^^^^L|MTH^Mother^HL70063|1230 Gpeldoorn Ave^^Lake Ann^MI^49650^USA^P|^PRN^PH^^^231^4425892ORC|RE||BN33M22859.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN33M22859.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0015-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C95C22867^^^AIRA-TEST^MR||JeffersonAIRA^JuneAIRA^Altheda^^^^L|WebsterAIRA^FrancesAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1474 Veerhugowaard Cir^^National Mine^MI^49865^USA^P||^PRN^PH^^^906^2812056|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1474 Veerhugowaard Cir^^National Mine^MI^49865^USA^P|^PRN^PH^^^906^2812056ORC|RE||BC95C22867.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC95C22867.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0016-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0016-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y09U22875^^^AIRA-TEST^MR||AdamsAIRA^AdaminaAIRA^Eleri^^^^L|Box ButteAIRA^EngelbertaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1154 Pellendoorn Cir^^Superior Township^MI^48198^USA^P||^PRN^PH^^^734^7926245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^Box ButteAIRA^^^^^L|MTH^Mother^HL70063|1154 Pellendoorn Cir^^Superior Township^MI^48198^USA^P|^PRN^PH^^^734^7926245ORC|RE||BY09U22875.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY09U22875.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0016-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y74E22880^^^AIRA-TEST^MR||McKeanAIRA^IzanamiAIRA^Paige^^^^L|BannockAIRA^RoisAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1048 Kijsden-Margraten Pl^^Watton^MI^49970^USA^P||^PRN^PH^^^906^4478090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKeanAIRA^BannockAIRA^^^^^L|MTH^Mother^HL70063|1048 Kijsden-Margraten Pl^^Watton^MI^49970^USA^P|^PRN^PH^^^906^4478090ORC|RE||BY74E22880.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY74E22880.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0017-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0017-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W19V22888^^^AIRA-TEST^MR||SummitAIRA^SevillaAIRA^Grace^^^^L|MidlandAIRA^MansiAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1592 Llochteren St^^Pellston^MI^49769^USA^P||^PRN^PH^^^616^3132626|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SummitAIRA^MidlandAIRA^^^^^L|MTH^Mother^HL70063|1592 Llochteren St^^Pellston^MI^49769^USA^P|^PRN^PH^^^616^3132626ORC|RE||BW19V22888.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW19V22888.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0017-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0018-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J80P22899^^^AIRA-TEST^MR||JohnsonAIRA^BambalinaAIRA^Aldabella^^^^L|AslsenAIRA^MerlinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1552 Solenwaard St^^Fremont^MI^49413^USA^P||^PRN^PH^^^231^9102315|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^AslsenAIRA^^^^^L|MTH^Mother^HL70063|1552 Solenwaard St^^Fremont^MI^49413^USA^P|^PRN^PH^^^231^9102315ORC|RE||BJ80P22899.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ80P22899.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0018-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0018-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V98X22907^^^AIRA-TEST^MR||MahoodAIRA^TrixiAIRA^Uschi^^^^L|LilleyAIRA^OnawaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1867 Simpelveld Ln^^Prattville^MI^49271^USA^P||^PRN^PH^^^517^8140491|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahoodAIRA^LilleyAIRA^^^^^L|MTH^Mother^HL70063|1867 Simpelveld Ln^^Prattville^MI^49271^USA^P|^PRN^PH^^^517^8140491ORC|RE||BV98X22907.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV98X22907.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0018-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y94D22915^^^AIRA-TEST^MR||CanadianAIRA^ElenaAIRA^Allyson^^^^L|HillsdaleAIRA^FayneAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1557 Prootegast St^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^3103265|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CanadianAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1557 Prootegast St^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^3103265ORC|RE||BY94D22915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY94D22915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||33332-0110-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R16S22920^^^AIRA-TEST^MR||MiamiAIRA^BatesAIRA^Teagan^^^^L|MarshallAIRA^GabiAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1507 Geheel Ave^^Douglas^MI^49406^USA^P||^PRN^PH^^^269^8276810|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MiamiAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1507 Geheel Ave^^Douglas^MI^49406^USA^P|^PRN^PH^^^269^8276810ORC|RE||BR16S22920.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR16S22920.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0113-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0113-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z74Q22928^^^AIRA-TEST^MR||KootenaiAIRA^PrimaAIRA^Minna^^^^L|LaenAIRA^ReneeAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1060 Nlkmaar Ln^^Utica^MI^48315^USA^P||^PRN^PH^^^586^7236525|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KootenaiAIRA^LaenAIRA^^^^^L|MTH^Mother^HL70063|1060 Nlkmaar Ln^^Utica^MI^48315^USA^P|^PRN^PH^^^586^7236525ORC|RE||BZ74Q22928.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ74Q22928.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||33332-0113-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C91B22939^^^AIRA-TEST^MR||OtoeAIRA^JennaAIRA^Isabelle^^^^L|WettilandAIRA^SchmetterlingAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1850 Aholen St^^Saginaw^MI^48608^USA^P||^PRN^PH^^^989^2588260|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OtoeAIRA^WettilandAIRA^^^^^L|MTH^Mother^HL70063|1850 Aholen St^^Saginaw^MI^48608^USA^P|^PRN^PH^^^989^2588260ORC|RE||BC91B22939.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC91B22939.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0114-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A34L22947^^^AIRA-TEST^MR||HolingsonAIRA^HeroAIRA^Lara^^^^L|SwanwickAIRA^SaffronAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1580 Katerland St^^Athens^MI^49011^USA^P||^PRN^PH^^^269^3220197|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolingsonAIRA^SwanwickAIRA^^^^^L|MTH^Mother^HL70063|1580 Katerland St^^Athens^MI^49011^USA^P|^PRN^PH^^^269^3220197ORC|RE||BA34L22947.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA34L22947.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||33332-0114-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y53Y22955^^^AIRA-TEST^MR||KendallAIRA^ArianeAIRA^Idola^^^^L|WallowaAIRA^AlysaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1098 Vloemendaal Pl^^Kincheloe^MI^49784^USA^P||^PRN^PH^^^906^9232618|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KendallAIRA^WallowaAIRA^^^^^L|MTH^Mother^HL70063|1098 Vloemendaal Pl^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^9232618ORC|RE||BY53Y22955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY53Y22955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0115-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0115-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E74L22960^^^AIRA-TEST^MR||JacintoAIRA^VevinaAIRA^Filomene^^^^L|FranklinAIRA^DarriAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1406 Wint-Michielsgestel St^^Palms^MI^48465^USA^P||^PRN^PH^^^989^5935659|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacintoAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1406 Wint-Michielsgestel St^^Palms^MI^48465^USA^P|^PRN^PH^^^989^5935659ORC|RE||BE74L22960.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE74L22960.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||33332-0115-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O89T22968^^^AIRA-TEST^MR||YoungAIRA^GalaAIRA^Azaria^^^^L|O'ConnellAIRA^ArdenAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1200 Kleden Pl^^Ann Arbor^MI^48104^USA^P||^PRN^PH^^^734^6339245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoungAIRA^O'ConnellAIRA^^^^^L|MTH^Mother^HL70063|1200 Kleden Pl^^Ann Arbor^MI^48104^USA^P|^PRN^PH^^^734^6339245ORC|RE||BO89T22968.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO89T22968.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0116-10^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z04S22979^^^AIRA-TEST^MR||BanderaAIRA^CaitAIRA^Aiyanna^^^^L|RunnelsAIRA^MaineAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1014 Bontfoort Cir^^Alger^MI^48610^USA^P||^PRN^PH^^^989^7215383|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BanderaAIRA^RunnelsAIRA^^^^^L|MTH^Mother^HL70063|1014 Bontfoort Cir^^Alger^MI^48610^USA^P|^PRN^PH^^^989^7215383ORC|RE||BZ04S22979.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ04S22979.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0116-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I20D22987^^^AIRA-TEST^MR||HutchinsonAIRA^ArabellaAIRA^Patsy^^^^L|OlssonAIRA^EmiliaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1845 Hof van Twente St^^Millington^MI^48746^USA^P||^PRN^PH^^^989^3598910|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HutchinsonAIRA^OlssonAIRA^^^^^L|MTH^Mother^HL70063|1845 Hof van Twente St^^Millington^MI^48746^USA^P|^PRN^PH^^^989^3598910ORC|RE||BI20D22987.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI20D22987.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0117-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N47S22995^^^AIRA-TEST^MR||BagleyAIRA^LianAIRA^Gryffyn^^^^L|FitzpatrickAIRA^WeemaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1858 Bcht-Susteren Cir^^Waters^MI^49797^USA^P||^PRN^PH^^^989^8068088|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BagleyAIRA^FitzpatrickAIRA^^^^^L|MTH^Mother^HL70063|1858 Bcht-Susteren Cir^^Waters^MI^49797^USA^P|^PRN^PH^^^989^8068088ORC|RE||BN47S22995.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN47S22995.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0117-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y91E23000^^^AIRA-TEST^MR||MadisonAIRA^VonnyAIRA^Nita^^^^L|CusackAIRA^JuliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1817 Ruimte Ln^^Grand Marais^MI^49839^USA^P||^PRN^PH^^^906^2694138|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^CusackAIRA^^^^^L|MTH^Mother^HL70063|1817 Ruimte Ln^^Grand Marais^MI^49839^USA^P|^PRN^PH^^^906^2694138ORC|RE||BY91E23000.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY91E23000.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0118-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W37P23008^^^AIRA-TEST^MR||MarionAIRA^UnityAIRA^Noleta^^^^L|YumaAIRA^VirginiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1714 Rinsum Cir^^Palmer^MI^49871^USA^P||^PRN^PH^^^906^7108684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^YumaAIRA^^^^^L|MTH^Mother^HL70063|1714 Rinsum Cir^^Palmer^MI^49871^USA^P|^PRN^PH^^^906^7108684ORC|RE||BW37P23008.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW37P23008.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0118-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0316-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S12U23019^^^AIRA-TEST^MR||GanronAIRA^CataloniaAIRA^Zhalore^^^^L|PersonAIRA^LeiaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1881 Terwerderadeel Ln^^Flushing^MI^48433^USA^P||^PRN^PH^^^810^8941236|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanronAIRA^PersonAIRA^^^^^L|MTH^Mother^HL70063|1881 Terwerderadeel Ln^^Flushing^MI^48433^USA^P|^PRN^PH^^^810^8941236ORC|RE||BS12U23019.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS12U23019.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0316-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0316-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q08Y23027^^^AIRA-TEST^MR||HamiltonAIRA^AxelleAIRA^Else^^^^L|PageAIRA^KetikaAIRA^^^^^M|20161228|F||2106-3^White^CDCREC|1121 Schilderen St^^Gobles^MI^49055^USA^P||^PRN^PH^^^269^6784559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^PageAIRA^^^^^L|MTH^Mother^HL70063|1121 Schilderen St^^Gobles^MI^49055^USA^P|^PRN^PH^^^269^6784559ORC|RE||BQ08Y23027.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ08Y23027.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170428||33332-0316-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170428||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0317-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L89L23035^^^AIRA-TEST^MR||DouglasAIRA^BoroniaAIRA^Lareine^^^^L|FitzpatrickAIRA^DawaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1432 Bexel Ln^^Bloomingdale^MI^49026^USA^P||^PRN^PH^^^269^6530127|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DouglasAIRA^FitzpatrickAIRA^^^^^L|MTH^Mother^HL70063|1432 Bexel Ln^^Bloomingdale^MI^49026^USA^P|^PRN^PH^^^269^6530127ORC|RE||BL89L23035.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL89L23035.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0317-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0317-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V78R23040^^^AIRA-TEST^MR||BonnevilleAIRA^MandieAIRA^Arachne^^^^L|HolmesAIRA^MachikoAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1466 Eroningen Cir^^Stevensville^MI^49127^USA^P||^PRN^PH^^^269^4897765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BonnevilleAIRA^HolmesAIRA^^^^^L|MTH^Mother^HL70063|1466 Eroningen Cir^^Stevensville^MI^49127^USA^P|^PRN^PH^^^269^4897765ORC|RE||BV78R23040.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV78R23040.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0317-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0318-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I98U23048^^^AIRA-TEST^MR||MarlinAIRA^JoleneAIRA^Shobha^^^^L|ModocAIRA^RonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1094 Kchouwen-Duiveland St^^Sault Sainte Marie^MI^49784^USA^P||^PRN^PH^^^906^6146941|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarlinAIRA^ModocAIRA^^^^^L|MTH^Mother^HL70063|1094 Kchouwen-Duiveland St^^Sault Sainte Marie^MI^49784^USA^P|^PRN^PH^^^906^6146941ORC|RE||BI98U23048.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI98U23048.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0318-01^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0318-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C24A23059^^^AIRA-TEST^MR||OlsonAIRA^TainnAIRA^Christina^^^^L|LowndesAIRA^YejideAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1298 Koggenland St^^Redford^MI^48239^USA^P||^PRN^PH^^^734^4104064|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OlsonAIRA^LowndesAIRA^^^^^L|MTH^Mother^HL70063|1298 Koggenland St^^Redford^MI^48239^USA^P|^PRN^PH^^^734^4104064ORC|RE||BC24A23059.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC24A23059.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0318-02^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C73X23067^^^AIRA-TEST^MR||TuscolaAIRA^MichaelaAIRA^Arachne^^^^L|ArenacAIRA^RaynaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1026 Zoorn Pl^^Detroit^MI^48267^USA^P||^PRN^PH^^^313^2288951|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuscolaAIRA^ArenacAIRA^^^^^L|MTH^Mother^HL70063|1026 Zoorn Pl^^Detroit^MI^48267^USA^P|^PRN^PH^^^313^2288951ORC|RE||BC73X23067.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC73X23067.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0416-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0416-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A99V23075^^^AIRA-TEST^MR||PolkAIRA^AdrianaAIRA^Lauren^^^^L|EnaAIRA^YehuditAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1179 Waanstad Cir^^Standale^MI^49504^USA^P||^PRN^PH^^^616^6806272|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^EnaAIRA^^^^^L|MTH^Mother^HL70063|1179 Waanstad Cir^^Standale^MI^49504^USA^P|^PRN^PH^^^616^6806272ORC|RE||BA99V23075.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA99V23075.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||33332-0416-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L45Y23080^^^AIRA-TEST^MR||OntonagonAIRA^RupertaAIRA^Henka^^^^L|CanadianAIRA^NoorAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1941 Klimmen St^^Detroit^MI^48288^USA^P||^PRN^PH^^^313^7632396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OntonagonAIRA^CanadianAIRA^^^^^L|MTH^Mother^HL70063|1941 Klimmen St^^Detroit^MI^48288^USA^P|^PRN^PH^^^313^7632396ORC|RE||BL45Y23080.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL45Y23080.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0417-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0417-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74G23088^^^AIRA-TEST^MR||HallAIRA^ZoeAIRA^Blaine^^^^L|KootenaiAIRA^GypsyAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1779 Goed Ave^^Grand Rapids^MI^49501^USA^P||^PRN^PH^^^616^7233269|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HallAIRA^KootenaiAIRA^^^^^L|MTH^Mother^HL70063|1779 Goed Ave^^Grand Rapids^MI^49501^USA^P|^PRN^PH^^^616^7233269ORC|RE||BB74G23088.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74G23088.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||33332-0417-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R89R23099^^^AIRA-TEST^MR||SewardAIRA^KaritaAIRA^Acadia^^^^L|LakeAIRA^RakelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1372 Elk Pl^^Saginaw^MI^48607^USA^P||^PRN^PH^^^989^3544386|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SewardAIRA^LakeAIRA^^^^^L|MTH^Mother^HL70063|1372 Elk Pl^^Saginaw^MI^48607^USA^P|^PRN^PH^^^989^3544386ORC|RE||BR89R23099.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR89R23099.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0418-10^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O19T23107^^^AIRA-TEST^MR||LeknesAIRA^Guan-yinAIRA^Cecia^^^^L|CentreAIRA^MadisynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1405 Mardenberg Cir^^Rodney^MI^49342^USA^P||^PRN^PH^^^231^2263839|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeknesAIRA^CentreAIRA^^^^^L|MTH^Mother^HL70063|1405 Mardenberg Cir^^Rodney^MI^49342^USA^P|^PRN^PH^^^231^2263839ORC|RE||BO19T23107.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO19T23107.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-0418-11^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0519-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E65I23115^^^AIRA-TEST^MR||ShelbyAIRA^KerstinAIRA^Gedala^^^^L|LevyAIRA^VidoniaAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1364 Vunspeet St^^Owosso^MI^48867^USA^P||^PRN^PH^^^989^2843747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^LevyAIRA^^^^^L|MTH^Mother^HL70063|1364 Vunspeet St^^Owosso^MI^48867^USA^P|^PRN^PH^^^989^2843747ORC|RE||BE65I23115.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE65I23115.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||33332-0519-01^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0519-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H79A23120^^^AIRA-TEST^MR||LapeerAIRA^TooraAIRA^Priya^^^^L|NelsonAIRA^SiennaAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1354 Hinsum Cir^^Sandusky^MI^48471^USA^P||^PRN^PH^^^810^4993951|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LapeerAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1354 Hinsum Cir^^Sandusky^MI^48471^USA^P|^PRN^PH^^^810^4993951ORC|RE||BH79A23120.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH79A23120.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||33332-0519-25^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-0629-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V18J23128^^^AIRA-TEST^MR||AdamsAIRA^RaphaellaAIRA^Carlen^^^^L|ColumbiaAIRA^MalikaAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1712 Brede Pl^^Saint Clair Shrs^MI^48082^USA^P||^PRN^PH^^^586^7203811|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1712 Brede Pl^^Saint Clair Shrs^MI^48082^USA^P|^PRN^PH^^^586^7203811ORC|RE||BV18J23128.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV18J23128.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||33332-0629-10^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||CSL^CSL Behring, Inc^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515-0001-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G64H23139^^^AIRA-TEST^MR||AllamakeeAIRA^LurneaAIRA^Gemma^^^^L|RockcastleAIRA^IlannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1209 Otadskanaal Ave^^Flint^MI^48503^USA^P||^PRN^PH^^^810^4004911|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllamakeeAIRA^RockcastleAIRA^^^^^L|MTH^Mother^HL70063|1209 Otadskanaal Ave^^Flint^MI^48503^USA^P|^PRN^PH^^^810^4004911ORC|RE||BG64H23139.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG64H23139.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515-0001-00^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||INT^Intercell Biomedical^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515-0001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N74X23147^^^AIRA-TEST^MR||WoodburyAIRA^ZenithAIRA^Dianthe^^^^L|BoydAIRA^LunaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1707 Schoonheid St^^Grand Rapids^MI^49501^USA^P||^PRN^PH^^^616^3973375|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodburyAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1707 Schoonheid St^^Grand Rapids^MI^49501^USA^P|^PRN^PH^^^616^3973375ORC|RE||BN74X23147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN74X23147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515-0001-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U27C23155^^^AIRA-TEST^MR||UmatillaAIRA^RihanaAIRA^Madilynn^^^^L|WarrenAIRA^DaniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1721 Nelfzijl Ave^^Orion^MI^48362^USA^P||^PRN^PH^^^248^6510691|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UmatillaAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1721 Nelfzijl Ave^^Orion^MI^48362^USA^P|^PRN^PH^^^248^6510691ORC|RE||BU27C23155.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU27C23155.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515-0002-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0012-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R57A23163^^^AIRA-TEST^MR||GreggAIRA^LakotaAIRA^India^^^^L|SimpsonAIRA^EbonyAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1006 Kijkerk Pl^^Rose City^MI^48654^USA^P||^PRN^PH^^^989^7767241|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreggAIRA^SimpsonAIRA^^^^^L|MTH^Mother^HL70063|1006 Kijkerk Pl^^Rose City^MI^48654^USA^P|^PRN^PH^^^989^7767241ORC|RE||BR57A23163.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR57A23163.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||42874-0012-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L26K23171^^^AIRA-TEST^MR||JansonAIRA^DerrythAIRA^Vonnie^^^^L|OkfuskeeAIRA^PilttiAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1946 Zmsterdam Pl^^Jonesville^MI^49250^USA^P||^PRN^PH^^^517^4693102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JansonAIRA^OkfuskeeAIRA^^^^^L|MTH^Mother^HL70063|1946 Zmsterdam Pl^^Jonesville^MI^49250^USA^P|^PRN^PH^^^517^4693102ORC|RE||BL26K23171.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL26K23171.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||42874-0012-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I39A23179^^^AIRA-TEST^MR||TaylorAIRA^KamakshiAIRA^Nabelung^^^^L|CassiaAIRA^LemuelaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1425 Eapelle Pl^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^5263173|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^CassiaAIRA^^^^^L|MTH^Mother^HL70063|1425 Eapelle Pl^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^5263173ORC|RE||BI39A23179.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI39A23179.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||42874-0013-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R02X23187^^^AIRA-TEST^MR||JofrayAIRA^MeiAIRA^Iona^^^^L|SiouxAIRA^MayuriAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1500 Loerdijk Ln^^Michigan Bankard^MI^48950^USA^P||^PRN^PH^^^517^4726721|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JofrayAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1500 Loerdijk Ln^^Michigan Bankard^MI^48950^USA^P|^PRN^PH^^^517^4726721ORC|RE||BR02X23187.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR02X23187.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||42874-0013-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V25M23195^^^AIRA-TEST^MR||ChristianAIRA^ZerlindaAIRA^Renata^^^^L|EnnisAIRA^KorneliaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1232 Eergen Pl^^Kentwood^MI^49546^USA^P||^PRN^PH^^^616^4514244|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChristianAIRA^EnnisAIRA^^^^^L|MTH^Mother^HL70063|1232 Eergen Pl^^Kentwood^MI^49546^USA^P|^PRN^PH^^^616^4514244ORC|RE||BV25M23195.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV25M23195.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||42874-0014-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0014-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W12F23203^^^AIRA-TEST^MR||ForestAIRA^NevaAIRA^Jolanta^^^^L|PecosAIRA^SavitriAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1284 Spreiding Ave^^Pierport^MI^49614^USA^P||^PRN^PH^^^231^4362206|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ForestAIRA^PecosAIRA^^^^^L|MTH^Mother^HL70063|1284 Spreiding Ave^^Pierport^MI^49614^USA^P|^PRN^PH^^^231^4362206ORC|RE||BW12F23203.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW12F23203.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||42874-0014-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q39W23208^^^AIRA-TEST^MR||ChaseAIRA^LeeaAIRA^Zion^^^^L|ShiawasseeAIRA^AlynaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1332 Teert St^^Weidman^MI^48893^USA^P||^PRN^PH^^^989^3374928|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChaseAIRA^ShiawasseeAIRA^^^^^L|MTH^Mother^HL70063|1332 Teert St^^Weidman^MI^48893^USA^P|^PRN^PH^^^989^3374928ORC|RE||BQ39W23208.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ39W23208.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||42874-0015-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0015-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P63J23216^^^AIRA-TEST^MR||LehighAIRA^CybillAIRA^Birgitte^^^^L|ThurstonAIRA^SibongileAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1252 Pruten Cir^^Frontier^MI^49239^USA^P||^PRN^PH^^^517^9414934|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LehighAIRA^ThurstonAIRA^^^^^L|MTH^Mother^HL70063|1252 Pruten Cir^^Frontier^MI^49239^USA^P|^PRN^PH^^^517^9414934ORC|RE||BP63J23216.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP63J23216.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||42874-0015-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S76A23227^^^AIRA-TEST^MR||BoiseAIRA^GayleneAIRA^Sula^^^^L|YorkAIRA^CharleighAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1540 Cladel Ln^^Bloomfield^MI^48304^USA^P||^PRN^PH^^^248^2933541|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BoiseAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1540 Cladel Ln^^Bloomfield^MI^48304^USA^P|^PRN^PH^^^248^2933541ORC|RE||BS76A23227.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS76A23227.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||42874-0016-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0016-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M10H23235^^^AIRA-TEST^MR||McCrearyAIRA^FinvarraAIRA^Sabirah^^^^L|BoydAIRA^KaliyahAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1745 Sloemendaal Cir^^Gaylord^MI^49734^USA^P||^PRN^PH^^^989^6827487|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCrearyAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1745 Sloemendaal Cir^^Gaylord^MI^49734^USA^P|^PRN^PH^^^989^6827487ORC|RE||BM10H23235.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM10H23235.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||42874-0016-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J03D23243^^^AIRA-TEST^MR||MenomineeAIRA^ThyrrniAIRA^Micah^^^^L|YorkAIRA^MadonnaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1395 Cranendonck Cir^^Four Mile Lake^MI^48130^USA^P||^PRN^PH^^^734^3614997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenomineeAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1395 Cranendonck Cir^^Four Mile Lake^MI^48130^USA^P|^PRN^PH^^^734^3614997ORC|RE||BJ03D23243.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ03D23243.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0017-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0017-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H17Y23248^^^AIRA-TEST^MR||WoodAIRA^CarinAIRA^Tanya^^^^L|GogebicAIRA^IsabellAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1892 Hond Ln^^Walkerville^MI^49459^USA^P||^PRN^PH^^^231^2964828|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodAIRA^GogebicAIRA^^^^^L|MTH^Mother^HL70063|1892 Hond Ln^^Walkerville^MI^49459^USA^P|^PRN^PH^^^231^2964828ORC|RE||BH17Y23248.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH17Y23248.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0017-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0116-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H89Y23256^^^AIRA-TEST^MR||PikeAIRA^RobbinAIRA^Trista^^^^L|OsceolaAIRA^LurlineAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1303 Swolle Ln^^Detroit^MI^48203^USA^P||^PRN^PH^^^313^4243106|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1303 Swolle Ln^^Detroit^MI^48203^USA^P|^PRN^PH^^^313^4243106ORC|RE||BH89Y23256.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH89Y23256.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||42874-0116-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0117-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O60M23267^^^AIRA-TEST^MR||LambAIRA^SamaraAIRA^Iris^^^^L|AldridgeAIRA^MeaginAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1241 Guiven Ln^^Ameritech^MI^48663^USA^P||^PRN^PH^^^989^5274067|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LambAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1241 Guiven Ln^^Ameritech^MI^48663^USA^P|^PRN^PH^^^989^5274067ORC|RE||BO60M23267.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO60M23267.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0117-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-0117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q21Y23275^^^AIRA-TEST^MR||MartinAIRA^KlarissaAIRA^Alodia^^^^L|CochranAIRA^DelcineAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1959 Drimpenerwaard Ln^^Vassar^MI^48768^USA^P||^PRN^PH^^^989^9831625|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MartinAIRA^CochranAIRA^^^^^L|MTH^Mother^HL70063|1959 Drimpenerwaard Ln^^Vassar^MI^48768^USA^P|^PRN^PH^^^989^9831625ORC|RE||BQ21Y23275.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ21Y23275.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||42874-0117-10^FLUBLOK, QUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S99G23283^^^AIRA-TEST^MR||HarmonAIRA^CaimileAIRA^Joselyn^^^^L|LoganAIRA^ErenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1764 Hlphen aan den Rijn Ln^^Burt^MI^48417^USA^P||^PRN^PH^^^989^7155756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarmonAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1764 Hlphen aan den Rijn Ln^^Burt^MI^48417^USA^P|^PRN^PH^^^989^7155756ORC|RE||BS99G23283.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS99G23283.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-0002-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-0002-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E28M23288^^^AIRA-TEST^MR||HoodAIRA^HedyAIRA^Andrea^^^^L|BurlesonAIRA^JaydenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1706 Hoermond St^^Roosevelt Park^MI^49441^USA^P||^PRN^PH^^^231^4601649|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoodAIRA^BurlesonAIRA^^^^^L|MTH^Mother^HL70063|1706 Hoermond St^^Roosevelt Park^MI^49441^USA^P|^PRN^PH^^^231^4601649ORC|RE||BE28M23288.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE28M23288.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-0002-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-0003-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E68O23296^^^AIRA-TEST^MR||CummingsAIRA^NishaAIRA^Kaliyah^^^^L|JasperAIRA^SelaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1129 Nlkmaar St^^Baraga^MI^49908^USA^P||^PRN^PH^^^906^5461014|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CummingsAIRA^JasperAIRA^^^^^L|MTH^Mother^HL70063|1129 Nlkmaar St^^Baraga^MI^49908^USA^P|^PRN^PH^^^906^5461014ORC|RE||BE68O23296.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE68O23296.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-0003-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-0003-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F61W23307^^^AIRA-TEST^MR||IndianaAIRA^KazannaAIRA^Abbie^^^^L|HolmesAIRA^GloraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1780 Leiden St^^Comerica Incorporated^MI^48275^USA^P||^PRN^PH^^^313^7840915|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IndianaAIRA^HolmesAIRA^^^^^L|MTH^Mother^HL70063|1780 Leiden St^^Comerica Incorporated^MI^48275^USA^P|^PRN^PH^^^313^7840915ORC|RE||BF61W23307.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF61W23307.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-0003-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-0114-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X24N23315^^^AIRA-TEST^MR||KnoxAIRA^DevakiAIRA^Oma^^^^L|LewisAIRA^DaleAIRA^^^^^M|20170630|F||2106-3^White^CDCREC|1151 Seeuwarderadeel Cir^^Huntingtn Wds^MI^48070^USA^P||^PRN^PH^^^248^2211970|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1151 Seeuwarderadeel Cir^^Huntingtn Wds^MI^48070^USA^P|^PRN^PH^^^248^2211970ORC|RE||BX24N23315.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX24N23315.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171030||46028-0114-01^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-0114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q89Y23323^^^AIRA-TEST^MR||CreghanAIRA^AbaAIRA^Nea^^^^L|MarinAIRA^CarlottaAIRA^^^^^M|20170630|F||2106-3^White^CDCREC|1880 Kust Cir^^Ceresco^MI^49033^USA^P||^PRN^PH^^^269^2349351|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CreghanAIRA^MarinAIRA^^^^^L|MTH^Mother^HL70063|1880 Kust Cir^^Ceresco^MI^49033^USA^P|^PRN^PH^^^269^2349351ORC|RE||BQ89Y23323.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ89Y23323.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171030||46028-0114-02^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-0114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E69J23328^^^AIRA-TEST^MR||ThompsenAIRA^ZuriaaAIRA^Amaris^^^^L|MacombAIRA^AnnieAIRA^^^^^M|20170630|F||2106-3^White^CDCREC|1712 Ztichtse Vecht Pl^^Farmington Hls^MI^48331^USA^P||^PRN^PH^^^248^9477014|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThompsenAIRA^MacombAIRA^^^^^L|MTH^Mother^HL70063|1712 Ztichtse Vecht Pl^^Farmington Hls^MI^48331^USA^P|^PRN^PH^^^248^9477014ORC|RE||BE69J23328.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170830||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE69J23328.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171030||46028-0114-11^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171030||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-0208-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N51W23336^^^AIRA-TEST^MR||BooneAIRA^StefanieAIRA^Michele^^^^L|TobiassenAIRA^LeylaAIRA^^^^^M|20171228|F||2106-3^White^CDCREC|1360 Tholen Cir^^Carney^MI^49812^USA^P||^PRN^PH^^^906^9700329|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^TobiassenAIRA^^^^^L|MTH^Mother^HL70063|1360 Tholen Cir^^Carney^MI^49812^USA^P|^PRN^PH^^^906^9700329ORC|RE||BN51W23336.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN51W23336.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180429||46028-0208-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-0218-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J94N23347^^^AIRA-TEST^MR||LeeAIRA^GarlandAIRA^Lemuela^^^^L|ColumbiaAIRA^NessanAIRA^^^^^M|20171228|F||2106-3^White^CDCREC|1905 Moeten Ln^^Lakeland^MI^48143^USA^P||^PRN^PH^^^810^5883802|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1905 Moeten Ln^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^5883802ORC|RE||BJ94N23347.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ94N23347.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180429||46028-0218-11^Meningococcal (Groups A) CRM197 Oligosaccharide Co^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-0219-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F33D23355^^^AIRA-TEST^MR||FranklinAIRA^CarmelAIRA^Gajendra^^^^L|KiowaAIRA^GaeAIRA^^^^^M|20171228|F||2106-3^White^CDCREC|1354 Kookplaten Cir^^Omer^MI^48749^USA^P||^PRN^PH^^^989^5731852|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^KiowaAIRA^^^^^L|MTH^Mother^HL70063|1354 Kookplaten Cir^^Omer^MI^48749^USA^P|^PRN^PH^^^989^5731852ORC|RE||BF33D23355.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF33D23355.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180429||46028-0219-11^Meningococcal (Groups C, Y, W-135) CRM197 Oligosac^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0010-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D50I23363^^^AIRA-TEST^MR||RobertsAIRA^NadiaAIRA^Theodosia^^^^L|VintonAIRA^KaydenceAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1468 Llphen-Chaam Ln^^Gwinn^MI^49841^USA^P||^PRN^PH^^^906^9570429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobertsAIRA^VintonAIRA^^^^^L|MTH^Mother^HL70063|1468 Llphen-Chaam Ln^^Gwinn^MI^49841^USA^P|^PRN^PH^^^906^9570429ORC|RE||BD50I23363.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD50I23363.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0010-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0010-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z58Z23368^^^AIRA-TEST^MR||ClayAIRA^HippolytaAIRA^Cynthia^^^^L|HutchinsonAIRA^BronaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1769 Sardenberg St^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^8580245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClayAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1769 Sardenberg St^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^8580245ORC|RE||BZ58Z23368.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ58Z23368.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0010-25^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0010-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V69G23376^^^AIRA-TEST^MR||AlconaAIRA^ShereeAIRA^Nirvelli^^^^L|FreestoneAIRA^SammieAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1112 Poerdalen Cir^^Detroit^MI^48203^USA^P||^PRN^PH^^^313^7649643|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlconaAIRA^FreestoneAIRA^^^^^L|MTH^Mother^HL70063|1112 Poerdalen Cir^^Detroit^MI^48203^USA^P|^PRN^PH^^^313^7649643ORC|RE||BV69G23376.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV69G23376.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0010-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0011-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B30N23387^^^AIRA-TEST^MR||DouglasAIRA^OletheaAIRA^Piper^^^^L|LinnAIRA^DrisanaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1971 Hittenseradeel St^^Caro^MI^48723^USA^P||^PRN^PH^^^989^3151669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DouglasAIRA^LinnAIRA^^^^^L|MTH^Mother^HL70063|1971 Hittenseradeel St^^Caro^MI^48723^USA^P|^PRN^PH^^^989^3151669ORC|RE||BB30N23387.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB30N23387.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0011-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0011-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U85S23395^^^AIRA-TEST^MR||AudubonAIRA^SophiaAIRA^Lizbeth^^^^L|WashingtonAIRA^MildredAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1127 Kchtkarspelen Cir^^Saint Clair Shores^MI^48080^USA^P||^PRN^PH^^^586^5267784|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AudubonAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1127 Kchtkarspelen Cir^^Saint Clair Shores^MI^48080^USA^P|^PRN^PH^^^586^5267784ORC|RE||BU85S23395.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU85S23395.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0011-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94A23403^^^AIRA-TEST^MR||StephensAIRA^OmegaAIRA^Elinor^^^^L|HitchcockAIRA^KerenAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1987 Dmersfoort Ln^^Kalamazoo^MI^49007^USA^P||^PRN^PH^^^269^7332932|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StephensAIRA^HitchcockAIRA^^^^^L|MTH^Mother^HL70063|1987 Dmersfoort Ln^^Kalamazoo^MI^49007^USA^P|^PRN^PH^^^269^7332932ORC|RE||BC94A23403.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94A23403.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0012-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0012-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X19J23408^^^AIRA-TEST^MR||WhatcomAIRA^AlouettaAIRA^Azul^^^^L|El DoradoAIRA^ThordisAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1473 Gijnwaarden St^^Cedarville^MI^49719^USA^P||^PRN^PH^^^906^6433539|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhatcomAIRA^El DoradoAIRA^^^^^L|MTH^Mother^HL70063|1473 Gijnwaarden St^^Cedarville^MI^49719^USA^P|^PRN^PH^^^906^6433539ORC|RE||BX19J23408.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX19J23408.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0012-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B96I23416^^^AIRA-TEST^MR||KnowlesAIRA^BarbAIRA^Nichelle^^^^L|PendletonAIRA^XaquelinaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1246 Aundert Ave^^Springfield Township^MI^48350^USA^P||^PRN^PH^^^248^5619991|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnowlesAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1246 Aundert Ave^^Springfield Township^MI^48350^USA^P|^PRN^PH^^^248^5619991ORC|RE||BB96I23416.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB96I23416.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0013-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V65X23427^^^AIRA-TEST^MR||FremontAIRA^ShakuntalaAIRA^Joscelin^^^^L|MorrosAIRA^AdibaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1245 Will en Sint Hubert Cir^^Canton^MI^48184^USA^P||^PRN^PH^^^734^2511648|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremontAIRA^MorrosAIRA^^^^^L|MTH^Mother^HL70063|1245 Will en Sint Hubert Cir^^Canton^MI^48184^USA^P|^PRN^PH^^^734^2511648ORC|RE||BV65X23427.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV65X23427.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0013-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J79K23435^^^AIRA-TEST^MR||ClearfieldAIRA^SindyAIRA^Eireen^^^^L|BexarAIRA^YasminaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1566 Bcheemda Ave^^Baraga^MI^49908^USA^P||^PRN^PH^^^906^3699999|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClearfieldAIRA^BexarAIRA^^^^^L|MTH^Mother^HL70063|1566 Bcheemda Ave^^Baraga^MI^49908^USA^P|^PRN^PH^^^906^3699999ORC|RE||BJ79K23435.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ79K23435.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-58^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0013-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T06I23443^^^AIRA-TEST^MR||MorganAIRA^MercedesAIRA^Aquaria^^^^L|TuscarawasAIRA^PhutikaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1011 Meudal St^^Galesburg^MI^49053^USA^P||^PRN^PH^^^269^3807317|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1011 Meudal St^^Galesburg^MI^49053^USA^P|^PRN^PH^^^269^3807317ORC|RE||BT06I23443.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT06I23443.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0013-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0014-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T87I23448^^^AIRA-TEST^MR||FillmoreAIRA^ColletteAIRA^Ultima^^^^L|GreenAIRA^AvaraAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1895 Kexel Pl^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^6769577|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FillmoreAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1895 Kexel Pl^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^6769577ORC|RE||BT87I23448.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT87I23448.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0014-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0014-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q47O23456^^^AIRA-TEST^MR||Pend OreilleAIRA^ElinoreAIRA^Acedia^^^^L|LandbergAIRA^AzarniAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1613 Hijmegen Ln^^Grosse Pointe Shores^MI^48236^USA^P||^PRN^PH^^^313^5840399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Pend OreilleAIRA^LandbergAIRA^^^^^L|MTH^Mother^HL70063|1613 Hijmegen Ln^^Grosse Pointe Shores^MI^48236^USA^P|^PRN^PH^^^313^5840399ORC|RE||BQ47O23456.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ47O23456.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0014-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0111-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G22H23467^^^AIRA-TEST^MR||SolanoAIRA^JacquelineAIRA^Nilini^^^^L|JonesAIRA^AnyaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1498 Foppersum Ave^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^4520430|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SolanoAIRA^JonesAIRA^^^^^L|MTH^Mother^HL70063|1498 Foppersum Ave^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^4520430ORC|RE||BG22H23467.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG22H23467.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0111-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0112-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W55V23475^^^AIRA-TEST^MR||MadisonAIRA^TatyaAIRA^Cailin^^^^L|BrooksAIRA^KaitlynnAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1427 Ee Wolden Pl^^Kingston^MI^48741^USA^P||^PRN^PH^^^989^7236765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1427 Ee Wolden Pl^^Kingston^MI^48741^USA^P|^PRN^PH^^^989^7236765ORC|RE||BW55V23475.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW55V23475.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0112-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0113-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M64U23483^^^AIRA-TEST^MR||WallerAIRA^FaineAIRA^Shina^^^^L|RainsAIRA^HalfridaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1741 Aeventer Ave^^Canton^MI^48184^USA^P||^PRN^PH^^^734^7796656|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WallerAIRA^RainsAIRA^^^^^L|MTH^Mother^HL70063|1741 Aeventer Ave^^Canton^MI^48184^USA^P|^PRN^PH^^^734^7796656ORC|RE||BM64U23483.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM64U23483.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0113-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0113-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F39B23488^^^AIRA-TEST^MR||PlymouthAIRA^MandieAIRA^Sarah^^^^L|RichlandAIRA^UlfhildrAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1552 Eeerijnen Ave^^West Bloomfield^MI^48325^USA^P||^PRN^PH^^^248^2269022|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlymouthAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1552 Eeerijnen Ave^^West Bloomfield^MI^48325^USA^P|^PRN^PH^^^248^2269022ORC|RE||BF39B23488.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF39B23488.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0113-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0215-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y12D23496^^^AIRA-TEST^MR||GelfryAIRA^AileenAIRA^Kisa^^^^L|O'NeillAIRA^CelesteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1494 Sucphen Ave^^South Branch^MI^48761^USA^P||^PRN^PH^^^989^4128592|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GelfryAIRA^O'NeillAIRA^^^^^L|MTH^Mother^HL70063|1494 Sucphen Ave^^South Branch^MI^48761^USA^P|^PRN^PH^^^989^4128592ORC|RE||BY12D23496.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY12D23496.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0215-10^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0215-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A46C23507^^^AIRA-TEST^MR||SantiagoAIRA^KaloniceAIRA^Mitzi^^^^L|LewisAIRA^KenyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1066 Wtaphorst Ave^^Bloomfld Township^MI^48303^USA^P||^PRN^PH^^^248^9959768|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SantiagoAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1066 Wtaphorst Ave^^Bloomfld Township^MI^48303^USA^P|^PRN^PH^^^248^9959768ORC|RE||BA46C23507.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA46C23507.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0215-15^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0215-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F50U23515^^^AIRA-TEST^MR||GallatinAIRA^AlbaAIRA^Tokiko^^^^L|WahkiakumAIRA^BarbieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1027 Cirkel Pl^^Midland^MI^48640^USA^P||^PRN^PH^^^989^4824997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GallatinAIRA^WahkiakumAIRA^^^^^L|MTH^Mother^HL70063|1027 Cirkel Pl^^Midland^MI^48640^USA^P|^PRN^PH^^^989^4824997ORC|RE||BF50U23515.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF50U23515.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0215-58^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0215-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y55T23523^^^AIRA-TEST^MR||OrangeAIRA^MerisaAIRA^Perri^^^^L|ClarkAIRA^OolaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1439 Hiessenlanden St^^Beaver Island^MI^49782^USA^P||^PRN^PH^^^906^6254532|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OrangeAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1439 Hiessenlanden St^^Beaver Island^MI^49782^USA^P|^PRN^PH^^^906^6254532ORC|RE||BY55T23523.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY55T23523.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0215-88^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0225-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z47G23528^^^AIRA-TEST^MR||MononaAIRA^LinnetAIRA^Gracelynn^^^^L|LeonAIRA^TainnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1933 Diemen Ln^^Gulliver^MI^49840^USA^P||^PRN^PH^^^906^8892675|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MononaAIRA^LeonAIRA^^^^^L|MTH^Mother^HL70063|1933 Diemen Ln^^Gulliver^MI^49840^USA^P|^PRN^PH^^^906^8892675ORC|RE||BZ47G23528.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ47G23528.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0225-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0225-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L04A23536^^^AIRA-TEST^MR||TitusAIRA^CalistaAIRA^Maitryi^^^^L|KrogAIRA^KaiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1447 Peventer Pl^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^7853642|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TitusAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1447 Peventer Pl^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^7853642ORC|RE||BL04A23536.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL04A23536.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0225-58^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0248-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R04M23547^^^AIRA-TEST^MR||ClarksonAIRA^ViriniAIRA^Spring^^^^L|CaseyAIRA^MutsukoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1603 Nrootegast St^^Berkley^MI^48072^USA^P||^PRN^PH^^^248^2840002|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarksonAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1603 Nrootegast St^^Berkley^MI^48072^USA^P|^PRN^PH^^^248^2840002ORC|RE||BR04M23547.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR04M23547.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0248-58^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0250-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O49E23555^^^AIRA-TEST^MR||CarsonAIRA^RosaleenAIRA^Alula^^^^L|ButteAIRA^RonniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1305 Column Cir^^Willow^MI^48164^USA^P||^PRN^PH^^^734^9872289|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarsonAIRA^ButteAIRA^^^^^L|MTH^Mother^HL70063|1305 Column Cir^^Willow^MI^48164^USA^P|^PRN^PH^^^734^9872289ORC|RE||BO49E23555.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO49E23555.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0250-51^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0278-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D95D23563^^^AIRA-TEST^MR||PenobscotAIRA^SirikitAIRA^Rosalie^^^^L|LaneAIRA^CarewAIRA^^^^^M|20121117|F||2106-3^White^CDCREC|1774 Trootegast Ave^^Leland^MI^49654^USA^P||^PRN^PH^^^231^2536243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PenobscotAIRA^LaneAIRA^^^^^L|MTH^Mother^HL70063|1774 Trootegast Ave^^Leland^MI^49654^USA^P|^PRN^PH^^^231^2536243ORC|RE||BD95D23563.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD95D23563.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130317||49281-0278-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130317||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0286-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D80G23568^^^AIRA-TEST^MR||CoosAIRA^AlleneAIRA^Lucy^^^^L|BooneAIRA^PalilaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1630 Dilburg Ave^^Covert^MI^49043^USA^P||^PRN^PH^^^269^3496994|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoosAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1630 Dilburg Ave^^Covert^MI^49043^USA^P|^PRN^PH^^^269^3496994ORC|RE||BD80G23568.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD80G23568.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0286-01^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0286-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R03G23576^^^AIRA-TEST^MR||NightingaleAIRA^LariAIRA^Carlie^^^^L|SeminoleAIRA^ShaunnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1966 Werneuzen Cir^^Free Soil^MI^49411^USA^P||^PRN^PH^^^231^4550649|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NightingaleAIRA^SeminoleAIRA^^^^^L|MTH^Mother^HL70063|1966 Werneuzen Cir^^Free Soil^MI^49411^USA^P|^PRN^PH^^^231^4550649ORC|RE||BR03G23576.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR03G23576.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0286-05^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0286-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U82K23587^^^AIRA-TEST^MR||LaenAIRA^GudaAIRA^Sibel^^^^L|AlconaAIRA^ErnestineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1521 Noststellingwerf Ln^^Brownstown Township^MI^48173^USA^P||^PRN^PH^^^734^9605462|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaenAIRA^AlconaAIRA^^^^^L|MTH^Mother^HL70063|1521 Noststellingwerf Ln^^Brownstown Township^MI^48173^USA^P|^PRN^PH^^^734^9605462ORC|RE||BU82K23587.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU82K23587.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0286-10^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0286-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S30H23595^^^AIRA-TEST^MR||UmatillaAIRA^SamulariaAIRA^Quincy^^^^L|BinghamAIRA^CadeeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1267 Qytsjerksteradiel Ave^^Lake Angelus^MI^48326^USA^P||^PRN^PH^^^248^5605712|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UmatillaAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1267 Qytsjerksteradiel Ave^^Lake Angelus^MI^48326^USA^P|^PRN^PH^^^248^5605712ORC|RE||BS30H23595.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS30H23595.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0286-58^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0291-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L12T23603^^^AIRA-TEST^MR||LeonAIRA^SilkeAIRA^Minka^^^^L|BlaineAIRA^PhilomelaAIRA^^^^^M|20160815|F||2106-3^White^CDCREC|1888 Baadhoeke Ave^^Ramsay^MI^49959^USA^P||^PRN^PH^^^906^7844289|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeonAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1888 Baadhoeke Ave^^Ramsay^MI^49959^USA^P|^PRN^PH^^^906^7844289ORC|RE||BL12T23603.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161015||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL12T23603.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161215||49281-0291-10^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161215||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0291-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B30B23608^^^AIRA-TEST^MR||MilamAIRA^ChloeAIRA^Kamea^^^^L|AdsonAIRA^SurotamaAIRA^^^^^M|20111229|F||2106-3^White^CDCREC|1477 Tlphen-Chaam Ln^^Owendale^MI^48754^USA^P||^PRN^PH^^^989^8682620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MilamAIRA^AdsonAIRA^^^^^L|MTH^Mother^HL70063|1477 Tlphen-Chaam Ln^^Owendale^MI^48754^USA^P|^PRN^PH^^^989^8682620ORC|RE||BB30B23608.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120229||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB30B23608.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120430||49281-0291-83^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120430||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0298-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T70Q23616^^^AIRA-TEST^MR||OrangeAIRA^RiekoAIRA^Giacinta^^^^L|FremmingAIRA^IonaAIRA^^^^^M|20121112|F||2106-3^White^CDCREC|1377 Taadhoeke Ave^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^9191805|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OrangeAIRA^FremmingAIRA^^^^^L|MTH^Mother^HL70063|1377 Taadhoeke Ave^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^9191805ORC|RE||BT70Q23616.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT70Q23616.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130312||49281-0298-10^TRIPEDIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130312||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0386-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W88U23627^^^AIRA-TEST^MR||TerrellAIRA^HilzarieAIRA^Birgit^^^^L|MontgomeryAIRA^YdelAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1017 Souda Ln^^Freeport^MI^49325^USA^P||^PRN^PH^^^616^7267762|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TerrellAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1017 Souda Ln^^Freeport^MI^49325^USA^P|^PRN^PH^^^616^7267762ORC|RE||BW88U23627.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW88U23627.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0386-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0387-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C03T23635^^^AIRA-TEST^MR||LimestoneAIRA^OrlanAIRA^Kerzi^^^^L|ImperialAIRA^FaincheAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1918 Einsum Cir^^Oakley^MI^48649^USA^P||^PRN^PH^^^989^6535233|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LimestoneAIRA^ImperialAIRA^^^^^L|MTH^Mother^HL70063|1918 Einsum Cir^^Oakley^MI^48649^USA^P|^PRN^PH^^^989^6535233ORC|RE||BC03T23635.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC03T23635.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0387-65^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0388-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S95T23643^^^AIRA-TEST^MR||MarshallAIRA^AvelAIRA^Dristi^^^^L|LegresleyAIRA^CynthiaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1997 Geschiedenis Cir^^Dowling^MI^49050^USA^P||^PRN^PH^^^269^2705459|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarshallAIRA^LegresleyAIRA^^^^^L|MTH^Mother^HL70063|1997 Geschiedenis Cir^^Dowling^MI^49050^USA^P|^PRN^PH^^^269^2705459ORC|RE||BS95T23643.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS95T23643.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0388-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0389-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U56W23648^^^AIRA-TEST^MR||NewberryAIRA^ChrysanthaAIRA^Rhona^^^^L|DefianceAIRA^TejiAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1509 Meumen Cir^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^4285312|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewberryAIRA^DefianceAIRA^^^^^L|MTH^Mother^HL70063|1509 Meumen Cir^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^4285312ORC|RE||BU56W23648.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU56W23648.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||49281-0389-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0390-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q75P23656^^^AIRA-TEST^MR||IsdalAIRA^MaggieAIRA^Evie^^^^L|DentonAIRA^DelythAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1980 Hem Pl^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^2728285|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IsdalAIRA^DentonAIRA^^^^^L|MTH^Mother^HL70063|1980 Hem Pl^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^2728285ORC|RE||BQ75P23656.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ75P23656.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0390-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0391-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O01G23667^^^AIRA-TEST^MR||AtwellAIRA^BrierAIRA^Ulalia^^^^L|KingAIRA^DeionAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1493 Doordwijk Ave^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^2991253|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtwellAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1493 Doordwijk Ave^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^2991253ORC|RE||BO01G23667.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO01G23667.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0391-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0392-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C90R23675^^^AIRA-TEST^MR||CookeAIRA^EurwenAIRA^Marisol^^^^L|RussellAIRA^EkalaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1698 Sundert St^^Chase Bank^MI^48278^USA^P||^PRN^PH^^^313^3114899|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CookeAIRA^RussellAIRA^^^^^L|MTH^Mother^HL70063|1698 Sundert St^^Chase Bank^MI^48278^USA^P|^PRN^PH^^^313^3114899ORC|RE||BC90R23675.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC90R23675.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0392-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0392-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O66B23683^^^AIRA-TEST^MR||WahkiakumAIRA^PanyaAIRA^Lizzy^^^^L|InghamAIRA^PiperAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1988 Aapelle St^^Oakville^MI^48160^USA^P||^PRN^PH^^^734^6587465|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WahkiakumAIRA^InghamAIRA^^^^^L|MTH^Mother^HL70063|1988 Aapelle St^^Oakville^MI^48160^USA^P|^PRN^PH^^^734^6587465ORC|RE||BO66B23683.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO66B23683.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0392-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0393-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L67B23688^^^AIRA-TEST^MR||HuronAIRA^MarmaraAIRA^Zula^^^^L|AndersonAIRA^DarcieAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1097 Voosendaal Pl^^Sterling Heights^MI^48314^USA^P||^PRN^PH^^^586^5843003|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuronAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1097 Voosendaal Pl^^Sterling Heights^MI^48314^USA^P|^PRN^PH^^^586^5843003ORC|RE||BL67B23688.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL67B23688.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0393-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0393-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C46C23696^^^AIRA-TEST^MR||LivingstonAIRA^KaynaAIRA^Imogen^^^^L|MuskogeeAIRA^XyliaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1008 Lettergreep Cir^^Saint Heights^MI^48311^USA^P||^PRN^PH^^^586^9574529|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LivingstonAIRA^MuskogeeAIRA^^^^^L|MTH^Mother^HL70063|1008 Lettergreep Cir^^Saint Heights^MI^48311^USA^P|^PRN^PH^^^586^9574529ORC|RE||BC46C23696.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC46C23696.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0393-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0394-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S06A23707^^^AIRA-TEST^MR||AtokaAIRA^KristyAIRA^Michel^^^^L|GanronAIRA^RosAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1020 Pijchen Ave^^Allouez^MI^49805^USA^P||^PRN^PH^^^906^7169388|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtokaAIRA^GanronAIRA^^^^^L|MTH^Mother^HL70063|1020 Pijchen Ave^^Allouez^MI^49805^USA^P|^PRN^PH^^^906^7169388ORC|RE||BS06A23707.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS06A23707.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0394-15^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0394-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T01C23715^^^AIRA-TEST^MR||DanielsonAIRA^YaretziAIRA^Bakarne^^^^L|RogersAIRA^NilganAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1626 Beuningen Cir^^Flint^MI^48551^USA^P||^PRN^PH^^^810^3342761|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DanielsonAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1626 Beuningen Cir^^Flint^MI^48551^USA^P|^PRN^PH^^^810^3342761ORC|RE||BT01C23715.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT01C23715.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0394-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0395-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R96U23723^^^AIRA-TEST^MR||GrahamAIRA^CosetteAIRA^Aziza^^^^L|AransasAIRA^ShielaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1460 Dchijndel Ln^^Kentwood^MI^49506^USA^P||^PRN^PH^^^616^3988342|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrahamAIRA^AransasAIRA^^^^^L|MTH^Mother^HL70063|1460 Dchijndel Ln^^Kentwood^MI^49506^USA^P|^PRN^PH^^^616^3988342ORC|RE||BR96U23723.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR96U23723.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0395-65^FLUZONE HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0395-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L25K23728^^^AIRA-TEST^MR||WardleAIRA^LeewanaAIRA^Pivari^^^^L|MerrickAIRA^Mary-JaneAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1923 Tpsterland Ln^^Sandusky^MI^48471^USA^P||^PRN^PH^^^810^9725128|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WardleAIRA^MerrickAIRA^^^^^L|MTH^Mother^HL70063|1923 Tpsterland Ln^^Sandusky^MI^48471^USA^P|^PRN^PH^^^810^9725128ORC|RE||BL25K23728.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL25K23728.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0395-88^Fluzone HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0396-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W30K23736^^^AIRA-TEST^MR||AndersonAIRA^PeniAIRA^Sarea^^^^L|SusasAIRA^DevakiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1389 Zunspeet Pl^^Tekonsha^MI^49092^USA^P||^PRN^PH^^^517^9585988|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndersonAIRA^SusasAIRA^^^^^L|MTH^Mother^HL70063|1389 Zunspeet Pl^^Tekonsha^MI^49092^USA^P|^PRN^PH^^^517^9585988ORC|RE||BW30K23736.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW30K23736.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0396-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0396-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K18T23747^^^AIRA-TEST^MR||AdaAIRA^ElvinaAIRA^Karli^^^^L|McCuskerAIRA^SnigdhaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1376 Boxtel Ln^^Leslie^MI^49251^USA^P||^PRN^PH^^^517^5590671|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdaAIRA^McCuskerAIRA^^^^^L|MTH^Mother^HL70063|1376 Boxtel Ln^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^5590671ORC|RE||BK18T23747.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK18T23747.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0396-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0397-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J69G23755^^^AIRA-TEST^MR||LlanoAIRA^GitanaAIRA^Marisa^^^^L|PersonAIRA^AnayaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1247 Hout St^^Millington^MI^48746^USA^P||^PRN^PH^^^989^9850765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LlanoAIRA^PersonAIRA^^^^^L|MTH^Mother^HL70063|1247 Hout St^^Millington^MI^48746^USA^P|^PRN^PH^^^989^9850765ORC|RE||BJ69G23755.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ69G23755.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0397-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0397-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H91M23763^^^AIRA-TEST^MR||ShiawasseeAIRA^ElysaAIRA^Belda^^^^L|MartinsonAIRA^ZaylinAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1334 Mijfheerenlanden Ln^^Casnovia^MI^49318^USA^P||^PRN^PH^^^231^8380880|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShiawasseeAIRA^MartinsonAIRA^^^^^L|MTH^Mother^HL70063|1334 Mijfheerenlanden Ln^^Casnovia^MI^49318^USA^P|^PRN^PH^^^231^8380880ORC|RE||BH91M23763.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH91M23763.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0397-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0399-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V86L23768^^^AIRA-TEST^MR||BinghamAIRA^ZeanesAIRA^Marilyn^^^^L|PenobscotAIRA^KaliskaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1486 Coensdrecht Cir^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^4040968|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BinghamAIRA^PenobscotAIRA^^^^^L|MTH^Mother^HL70063|1486 Coensdrecht Cir^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^4040968ORC|RE||BV86L23768.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV86L23768.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0399-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0399-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y85Q23776^^^AIRA-TEST^MR||LincolnAIRA^SevillaAIRA^Evania^^^^L|JauppiAIRA^KeilanaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1468 He Bilt Ln^^Union Pier^MI^49129^USA^P||^PRN^PH^^^269^7525744|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LincolnAIRA^JauppiAIRA^^^^^L|MTH^Mother^HL70063|1468 He Bilt Ln^^Union Pier^MI^49129^USA^P|^PRN^PH^^^269^7525744ORC|RE||BY85Q23776.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY85Q23776.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0399-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P51W23787^^^AIRA-TEST^MR||KentAIRA^XiomaraAIRA^Anteia^^^^L|SnohomishAIRA^SahibaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1803 Drave Ln^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^8447759|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentAIRA^SnohomishAIRA^^^^^L|MTH^Mother^HL70063|1803 Drave Ln^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^8447759ORC|RE||BP51W23787.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP51W23787.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-05^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J15W23795^^^AIRA-TEST^MR||MahaskaAIRA^NayokoAIRA^Tathra^^^^L|BergenAIRA^MckinleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1938 Happy Ave^^Dover^MI^48130^USA^P||^PRN^PH^^^734^3934511|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahaskaAIRA^BergenAIRA^^^^^L|MTH^Mother^HL70063|1938 Happy Ave^^Dover^MI^48130^USA^P|^PRN^PH^^^734^3934511ORC|RE||BJ15W23795.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ15W23795.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-10^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02Y23803^^^AIRA-TEST^MR||YoungAIRA^RoshanAIRA^Marilyn^^^^L|MedinaAIRA^MarthaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1883 Woerendaal Pl^^Farmingtn Hls^MI^48332^USA^P||^PRN^PH^^^248^6786792|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoungAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1883 Woerendaal Pl^^Farmingtn Hls^MI^48332^USA^P|^PRN^PH^^^248^6786792ORC|RE||BD02Y23803.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02Y23803.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-15^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q86Q23811^^^AIRA-TEST^MR||RogersAIRA^CharityAIRA^Orlanda^^^^L|AdairAIRA^ZeraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1684 Oss Cir^^Merritt^MI^49667^USA^P||^PRN^PH^^^231^3193890|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RogersAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1684 Oss Cir^^Merritt^MI^49667^USA^P|^PRN^PH^^^231^3193890ORC|RE||BQ86Q23811.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ86Q23811.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-20^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X36H23819^^^AIRA-TEST^MR||WrightAIRA^QueridaAIRA^Laetitia^^^^L|DallasAIRA^EurwenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1428 Lerwerderadeel Ave^^GR^MI^49515^USA^P||^PRN^PH^^^616^4450760|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WrightAIRA^DallasAIRA^^^^^L|MTH^Mother^HL70063|1428 Lerwerderadeel Ave^^GR^MI^49515^USA^P|^PRN^PH^^^616^4450760ORC|RE||BX36H23819.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX36H23819.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-58^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V45J23827^^^AIRA-TEST^MR||JansonAIRA^FaincheAIRA^Winda^^^^L|HowardAIRA^DaniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1461 Vijnacker-Nootdorp Pl^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^6525419|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JansonAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1461 Vijnacker-Nootdorp Pl^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^6525419ORC|RE||BV45J23827.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV45J23827.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-88^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0400-89|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M90K23835^^^AIRA-TEST^MR||ColusaAIRA^MalkahAIRA^Divya^^^^L|MackeyAIRA^RebeccaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1660 Deerenveen Ave^^Ann Arbor^MI^48108^USA^P||^PRN^PH^^^734^4179839|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColusaAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1660 Deerenveen Ave^^Ann Arbor^MI^48108^USA^P|^PRN^PH^^^734^4179839ORC|RE||BM90K23835.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM90K23835.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0400-89^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0401-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D19Q23843^^^AIRA-TEST^MR||PresidioAIRA^SelaAIRA^Linnea^^^^L|ParkAIRA^EchoAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1596 Laals Cir^^Britton^MI^49229^USA^P||^PRN^PH^^^517^7838602|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PresidioAIRA^ParkAIRA^^^^^L|MTH^Mother^HL70063|1596 Laals Cir^^Britton^MI^49229^USA^P|^PRN^PH^^^517^7838602ORC|RE||BD19Q23843.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD19Q23843.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0401-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0401-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N71Z23851^^^AIRA-TEST^MR||BooneAIRA^KirraAIRA^Lissa^^^^L|SiouxAIRA^StarAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1821 Otrijen Ln^^Leonidas^MI^49066^USA^P||^PRN^PH^^^269^8007068|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1821 Otrijen Ln^^Leonidas^MI^49066^USA^P|^PRN^PH^^^269^8007068ORC|RE||BN71Z23851.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN71Z23851.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0401-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0403-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O95I23856^^^AIRA-TEST^MR||DanuelsonAIRA^IvyAIRA^Kala^^^^L|SykesAIRA^PriscillaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1962 Beuningen Ave^^South Rockwood^MI^48179^USA^P||^PRN^PH^^^734^3789163|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DanuelsonAIRA^SykesAIRA^^^^^L|MTH^Mother^HL70063|1962 Beuningen Ave^^South Rockwood^MI^48179^USA^P|^PRN^PH^^^734^3789163ORC|RE||BO95I23856.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO95I23856.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0403-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0403-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K31S23864^^^AIRA-TEST^MR||DeuelAIRA^WendiAIRA^Fabiana^^^^L|McKeanAIRA^NeenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1847 Oeeuwarderadeel Cir^^Engadine^MI^49827^USA^P||^PRN^PH^^^906^8507961|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeuelAIRA^McKeanAIRA^^^^^L|MTH^Mother^HL70063|1847 Oeeuwarderadeel Cir^^Engadine^MI^49827^USA^P|^PRN^PH^^^906^8507961ORC|RE||BK31S23864.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK31S23864.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0403-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0413-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A62R23875^^^AIRA-TEST^MR||CowleyAIRA^KaileyAIRA^Sharleen^^^^L|LindstromAIRA^NgaioAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1682 Eaadhoeke Cir^^GR^MI^49528^USA^P||^PRN^PH^^^616^6381315|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CowleyAIRA^LindstromAIRA^^^^^L|MTH^Mother^HL70063|1682 Eaadhoeke Cir^^GR^MI^49528^USA^P|^PRN^PH^^^616^6381315ORC|RE||BA62R23875.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA62R23875.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0413-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R02W23883^^^AIRA-TEST^MR||Santa CruzAIRA^HazelleAIRA^Madhulika^^^^L|CoryellAIRA^IdraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1125 Sastricum Pl^^Oxford^MI^48371^USA^P||^PRN^PH^^^248^3165220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa CruzAIRA^CoryellAIRA^^^^^L|MTH^Mother^HL70063|1125 Sastricum Pl^^Oxford^MI^48371^USA^P|^PRN^PH^^^248^3165220ORC|RE||BR02W23883.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR02W23883.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0413-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M11I23891^^^AIRA-TEST^MR||StonewallAIRA^ValentinaAIRA^Opal^^^^L|HoreAIRA^LyndaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1138 Zudwest-Fryslan Ave^^Shaftsburg^MI^48882^USA^P||^PRN^PH^^^517^9744150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StonewallAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1138 Zudwest-Fryslan Ave^^Shaftsburg^MI^48882^USA^P|^PRN^PH^^^517^9744150ORC|RE||BM11I23891.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM11I23891.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0413-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D44H23896^^^AIRA-TEST^MR||RuskAIRA^EminaAIRA^Carly^^^^L|HofflundAIRA^SanaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1420 Laals Ave^^Presque Isle^MI^49777^USA^P||^PRN^PH^^^989^6548202|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RuskAIRA^HofflundAIRA^^^^^L|MTH^Mother^HL70063|1420 Laals Ave^^Presque Isle^MI^49777^USA^P|^PRN^PH^^^989^6548202ORC|RE||BD44H23896.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD44H23896.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0413-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0414-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B24R23904^^^AIRA-TEST^MR||ConnorAIRA^LaylaAIRA^Ronni^^^^L|KananenAIRA^JoraAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1365 Aalkenswaard Ln^^Tipton^MI^49287^USA^P||^PRN^PH^^^517^2468814|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ConnorAIRA^KananenAIRA^^^^^L|MTH^Mother^HL70063|1365 Aalkenswaard Ln^^Tipton^MI^49287^USA^P|^PRN^PH^^^517^2468814ORC|RE||BB24R23904.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB24R23904.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0414-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E35P23915^^^AIRA-TEST^MR||GrendalAIRA^SonalAIRA^Signe^^^^L|TobiassenAIRA^YakshaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1865 Temperatuur St^^Charlotte^MI^48813^USA^P||^PRN^PH^^^517^7685923|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrendalAIRA^TobiassenAIRA^^^^^L|MTH^Mother^HL70063|1865 Temperatuur St^^Charlotte^MI^48813^USA^P|^PRN^PH^^^517^7685923ORC|RE||BE35P23915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE35P23915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-50^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0414-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M74E23923^^^AIRA-TEST^MR||WoodAIRA^SatyavatiAIRA^Trifine^^^^L|InyoAIRA^RiniAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1644 Nladel Ln^^Warren^MI^48088^USA^P||^PRN^PH^^^586^4225244|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodAIRA^InyoAIRA^^^^^L|MTH^Mother^HL70063|1644 Nladel Ln^^Warren^MI^48088^USA^P|^PRN^PH^^^586^4225244ORC|RE||BM74E23923.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM74E23923.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0414-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F27U23931^^^AIRA-TEST^MR||HolingsonAIRA^NijuAIRA^Tonie^^^^L|EatonAIRA^JaylenAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1279 Aaarbeek St^^Harbor Beach^MI^48441^USA^P||^PRN^PH^^^989^5440991|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolingsonAIRA^EatonAIRA^^^^^L|MTH^Mother^HL70063|1279 Aaarbeek St^^Harbor Beach^MI^48441^USA^P|^PRN^PH^^^989^5440991ORC|RE||BF27U23931.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF27U23931.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0414-88^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0415-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K71N23936^^^AIRA-TEST^MR||EriksonAIRA^KellsieAIRA^Arachne^^^^L|PikeAIRA^JoslynAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1607 Werwerderadeel St^^Lenox^MI^48048^USA^P||^PRN^PH^^^586^7847880|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EriksonAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1607 Werwerderadeel St^^Lenox^MI^48048^USA^P|^PRN^PH^^^586^7847880ORC|RE||BK71N23936.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK71N23936.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0415-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0415-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R32Z23944^^^AIRA-TEST^MR||WintermanAIRA^AureAIRA^Mariah^^^^L|KnoxAIRA^AdenaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1453 Alleen Cir^^Lanse^MI^49946^USA^P||^PRN^PH^^^906^9341757|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WintermanAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1453 Alleen Cir^^Lanse^MI^49946^USA^P|^PRN^PH^^^906^9341757ORC|RE||BR32Z23944.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR32Z23944.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0415-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0415-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I69I23955^^^AIRA-TEST^MR||LebanonAIRA^AnshuAIRA^Jaylynn^^^^L|DarkeAIRA^AyameAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1101 Wuth Cir^^Washington Township^MI^48095^USA^P||^PRN^PH^^^586^4949431|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LebanonAIRA^DarkeAIRA^^^^^L|MTH^Mother^HL70063|1101 Wuth Cir^^Washington Township^MI^48095^USA^P|^PRN^PH^^^586^4949431ORC|RE||BI69I23955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI69I23955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||49281-0415-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P82T23963^^^AIRA-TEST^MR||DixonAIRA^BlindaAIRA^Delcine^^^^L|WoodfordAIRA^ParnitaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1838 Koon op Zand St^^Mount Pleasant^MI^48858^USA^P||^PRN^PH^^^989^8965681|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DixonAIRA^WoodfordAIRA^^^^^L|MTH^Mother^HL70063|1838 Koon op Zand St^^Mount Pleasant^MI^48858^USA^P|^PRN^PH^^^989^8965681ORC|RE||BP82T23963.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP82T23963.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0416-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N80K23971^^^AIRA-TEST^MR||WoodburyAIRA^JonieAIRA^Lizette^^^^L|WashitaAIRA^DelilaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1539 Laag en Braassem St^^Frenchtown^MI^48161^USA^P||^PRN^PH^^^734^9413991|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodburyAIRA^WashitaAIRA^^^^^L|MTH^Mother^HL70063|1539 Laag en Braassem St^^Frenchtown^MI^48161^USA^P|^PRN^PH^^^734^9413991ORC|RE||BN80K23971.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN80K23971.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0416-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y16G23976^^^AIRA-TEST^MR||NewaygoAIRA^GilbertaAIRA^Hoku^^^^L|FremontAIRA^MegaraAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1990 Tppingedam St^^Lansing^MI^48924^USA^P||^PRN^PH^^^517^5503740|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewaygoAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1990 Tppingedam St^^Lansing^MI^48924^USA^P|^PRN^PH^^^517^5503740ORC|RE||BY16G23976.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY16G23976.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0416-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y70D23984^^^AIRA-TEST^MR||KnoxAIRA^MalayaAIRA^Shaunna^^^^L|IronAIRA^MorganceAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1226 Rmsterdam Ave^^Detroit^MI^48231^USA^P||^PRN^PH^^^313^5044756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^IronAIRA^^^^^L|MTH^Mother^HL70063|1226 Rmsterdam Ave^^Detroit^MI^48231^USA^P|^PRN^PH^^^313^5044756ORC|RE||BY70D23984.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY70D23984.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0416-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y02E23995^^^AIRA-TEST^MR||LueatosAIRA^AnnataAIRA^Adelpha^^^^L|BerrienAIRA^HelimaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1476 Rchouwen-Duiveland Cir^^Brighton Township^MI^48116^USA^P||^PRN^PH^^^810^2139559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LueatosAIRA^BerrienAIRA^^^^^L|MTH^Mother^HL70063|1476 Rchouwen-Duiveland Cir^^Brighton Township^MI^48116^USA^P|^PRN^PH^^^810^2139559ORC|RE||BY02E23995.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY02E23995.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0417-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V51O24003^^^AIRA-TEST^MR||CoalAIRA^RayAIRA^Cleo^^^^L|CarterAIRA^VasantaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1738 Koe Ave^^Comerica^MI^48267^USA^P||^PRN^PH^^^313^2912764|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoalAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1738 Koe Ave^^Comerica^MI^48267^USA^P|^PRN^PH^^^313^2912764ORC|RE||BV51O24003.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV51O24003.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0417-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E00Z24011^^^AIRA-TEST^MR||BradfordAIRA^SalwaAIRA^Nisha^^^^L|DunnAIRA^FilbertaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1118 Herschelling Ave^^Kalamazoo^MI^49002^USA^P||^PRN^PH^^^269^5008772|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BradfordAIRA^DunnAIRA^^^^^L|MTH^Mother^HL70063|1118 Herschelling Ave^^Kalamazoo^MI^49002^USA^P|^PRN^PH^^^269^5008772ORC|RE||BE00Z24011.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE00Z24011.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0417-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G85S24016^^^AIRA-TEST^MR||BoyleAIRA^KairiAIRA^Arnisha^^^^L|CallowayAIRA^GayatriAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1761 Zoerdijk Pl^^Scottville^MI^49454^USA^P||^PRN^PH^^^231^5882256|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BoyleAIRA^CallowayAIRA^^^^^L|MTH^Mother^HL70063|1761 Zoerdijk Pl^^Scottville^MI^49454^USA^P|^PRN^PH^^^231^5882256ORC|RE||BG85S24016.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG85S24016.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0417-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R70B24024^^^AIRA-TEST^MR||LaRueAIRA^MadhulikaAIRA^Anupama^^^^L|DickinsonAIRA^KadenceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1643 Roes St^^Orion Township^MI^48359^USA^P||^PRN^PH^^^248^9651461|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaRueAIRA^DickinsonAIRA^^^^^L|MTH^Mother^HL70063|1643 Roes St^^Orion Township^MI^48359^USA^P|^PRN^PH^^^248^9651461ORC|RE||BR70B24024.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR70B24024.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0418-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0418-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G09A24035^^^AIRA-TEST^MR||SullivanAIRA^NerinaAIRA^Ranee^^^^L|OldhamAIRA^MaritzaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1365 Reventer Cir^^Palms^MI^48465^USA^P||^PRN^PH^^^989^3723986|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SullivanAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1365 Reventer Cir^^Palms^MI^48465^USA^P|^PRN^PH^^^989^3723986ORC|RE||BG09A24035.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG09A24035.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0418-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0418-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W62K24043^^^AIRA-TEST^MR||MercerAIRA^WendiAIRA^Parker^^^^L|LewisAIRA^IkuAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1389 Oor Ln^^Vehicle License Plates^MI^48980^USA^P||^PRN^PH^^^517^3366420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercerAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1389 Oor Ln^^Vehicle License Plates^MI^48980^USA^P|^PRN^PH^^^517^3366420ORC|RE||BW62K24043.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW62K24043.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0418-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0418-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O08T24051^^^AIRA-TEST^MR||BeckhamAIRA^KaliAIRA^Raquelle^^^^L|ClarkeAIRA^EmmalynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1577 Hoevorden Ln^^Detroit^MI^48243^USA^P||^PRN^PH^^^313^8954039|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeckhamAIRA^ClarkeAIRA^^^^^L|MTH^Mother^HL70063|1577 Hoevorden Ln^^Detroit^MI^48243^USA^P|^PRN^PH^^^313^8954039ORC|RE||BO08T24051.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO08T24051.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0418-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0487-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A64D24056^^^AIRA-TEST^MR||SacAIRA^ClotildaAIRA^Frances^^^^L|HoltAIRA^AbigailAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1741 Nacht Ave^^Oakland^MI^48306^USA^P||^PRN^PH^^^248^2793456|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SacAIRA^HoltAIRA^^^^^L|MTH^Mother^HL70063|1741 Nacht Ave^^Oakland^MI^48306^USA^P|^PRN^PH^^^248^2793456ORC|RE||BA64D24056.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA64D24056.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||49281-0487-58^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0488-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S48O24064^^^AIRA-TEST^MR||ClintonAIRA^SheelaAIRA^Shreya^^^^L|SantiagoAIRA^PreetiAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1856 Weert Pl^^Moran^MI^49760^USA^P||^PRN^PH^^^906^2452022|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^SantiagoAIRA^^^^^L|MTH^Mother^HL70063|1856 Weert Pl^^Moran^MI^49760^USA^P|^PRN^PH^^^906^2452022ORC|RE||BS48O24064.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS48O24064.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||49281-0488-78^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0489-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M01I24075^^^AIRA-TEST^MR||LakeAIRA^CatalinAIRA^Kamali^^^^L|PurolaAIRA^PriscillaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1181 Dinnenmaas Ave^^Cedar^MI^49621^USA^P||^PRN^PH^^^231^3389858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^PurolaAIRA^^^^^L|MTH^Mother^HL70063|1181 Dinnenmaas Ave^^Cedar^MI^49621^USA^P|^PRN^PH^^^231^3389858ORC|RE||BM01I24075.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM01I24075.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0489-01^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0489-91|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B76C24083^^^AIRA-TEST^MR||ShelbyAIRA^LeslyAIRA^Aniyah^^^^L|BarkerAIRA^ArmelleAIRA^^^^^M|20170529|F||2106-3^White^CDCREC|1982 Gosser Cir^^La Salle^MI^48145^USA^P||^PRN^PH^^^734^6191087|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^BarkerAIRA^^^^^L|MTH^Mother^HL70063|1982 Gosser Cir^^La Salle^MI^48145^USA^P|^PRN^PH^^^734^6191087ORC|RE||BB76C24083.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170729||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB76C24083.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170929||49281-0489-91^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0510-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H98P24091^^^AIRA-TEST^MR||HutchinsonAIRA^AnzuAIRA^Clove^^^^L|GarfieldAIRA^KatyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1521 Vader Pl^^Flint^MI^48509^USA^P||^PRN^PH^^^810^5640422|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HutchinsonAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1521 Vader Pl^^Flint^MI^48509^USA^P|^PRN^PH^^^810^5640422ORC|RE||BH98P24091.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH98P24091.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0510-05^PENTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0513-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E88E24096^^^AIRA-TEST^MR||IsdalAIRA^PaziaAIRA^Gilen^^^^L|DeuelAIRA^DeliaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1208 Seeuwarden Cir^^Detroit^MI^48236^USA^P||^PRN^PH^^^313^7241907|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IsdalAIRA^DeuelAIRA^^^^^L|MTH^Mother^HL70063|1208 Seeuwarden Cir^^Detroit^MI^48236^USA^P|^PRN^PH^^^313^7241907ORC|RE||BE88E24096.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE88E24096.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0513-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0513-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W23B24104^^^AIRA-TEST^MR||AdairAIRA^AryaAIRA^Myah^^^^L|SiskiyouAIRA^PaulomiAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1099 Berkendam Ave^^Azalia^MI^48110^USA^P||^PRN^PH^^^734^6050901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^SiskiyouAIRA^^^^^L|MTH^Mother^HL70063|1099 Berkendam Ave^^Azalia^MI^48110^USA^P|^PRN^PH^^^734^6050901ORC|RE||BW23B24104.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW23B24104.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0513-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0514-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H13O24115^^^AIRA-TEST^MR||JacksonAIRA^AmaraAIRA^Chanel^^^^L|JacksonAIRA^NirvelliAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1675 Huren St^^Eastport^MI^49627^USA^P||^PRN^PH^^^231^6699495|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1675 Huren St^^Eastport^MI^49627^USA^P|^PRN^PH^^^231^6699495ORC|RE||BH13O24115.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH13O24115.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0514-00^Fluzone Quadrivalent, Peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0514-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S46R24126^^^AIRA-TEST^MR||HobellAIRA^AquamarineAIRA^Georgia^^^^L|JonsonAIRA^TreasaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1766 Oden Cir^^Rochester Hls^MI^48307^USA^P||^PRN^PH^^^248^8649698|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HobellAIRA^JonsonAIRA^^^^^L|MTH^Mother^HL70063|1766 Oden Cir^^Rochester Hls^MI^48307^USA^P|^PRN^PH^^^248^8649698ORC|RE||BS46R24126.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS46R24126.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0514-25^Fluzone Quadrivalent, peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0516-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W93F24134^^^AIRA-TEST^MR||WexfordAIRA^AdielAIRA^Zora^^^^L|WilsonAIRA^KendraAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1977 Hedemblik Ave^^Cadillac^MI^49601^USA^P||^PRN^PH^^^231^2339263|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WexfordAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1977 Hedemblik Ave^^Cadillac^MI^49601^USA^P|^PRN^PH^^^231^2339263ORC|RE||BW93F24134.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW93F24134.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0516-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0516-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K99F24139^^^AIRA-TEST^MR||ComalAIRA^PankitaAIRA^Linley^^^^L|MuskogeeAIRA^AnselmaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1407 Dexel Ave^^Jackson^MI^49203^USA^P||^PRN^PH^^^517^2367333|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComalAIRA^MuskogeeAIRA^^^^^L|MTH^Mother^HL70063|1407 Dexel Ave^^Jackson^MI^49203^USA^P|^PRN^PH^^^517^2367333ORC|RE||BK99F24139.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK99F24139.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0516-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0517-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E86N24147^^^AIRA-TEST^MR||Van WertAIRA^ElyshiaAIRA^Horatia^^^^L|YorkAIRA^KiskaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1111 Eesterveld Ave^^Springport^MI^49284^USA^P||^PRN^PH^^^517^4146602|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Van WertAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1111 Eesterveld Ave^^Springport^MI^49284^USA^P|^PRN^PH^^^517^4146602ORC|RE||BE86N24147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE86N24147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0517-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0517-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U03J24158^^^AIRA-TEST^MR||PolkAIRA^AmbriaAIRA^Tianna^^^^L|CookeAIRA^NayeliAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1832 Gopik St^^Caro^MI^48723^USA^P||^PRN^PH^^^989^9749373|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^CookeAIRA^^^^^L|MTH^Mother^HL70063|1832 Gopik St^^Caro^MI^48723^USA^P|^PRN^PH^^^989^9749373ORC|RE||BU03J24158.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU03J24158.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0517-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0518-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H13S24166^^^AIRA-TEST^MR||LenbergAIRA^MimosaAIRA^Ahimsa^^^^L|AdamsAIRA^VanessaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1480 Gouda Ln^^Webberville^MI^48892^USA^P||^PRN^PH^^^517^4753389|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LenbergAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1480 Gouda Ln^^Webberville^MI^48892^USA^P|^PRN^PH^^^517^4753389ORC|RE||BH13S24166.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH13S24166.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0518-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0518-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y14H24174^^^AIRA-TEST^MR||MontourAIRA^RosalynAIRA^Kaia^^^^L|MarshallAIRA^TrixiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1839 Derg en Dal Ave^^Keweenaw Bay^MI^49908^USA^P||^PRN^PH^^^906^7084820|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontourAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1839 Derg en Dal Ave^^Keweenaw Bay^MI^49908^USA^P|^PRN^PH^^^906^7084820ORC|RE||BY14H24174.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY14H24174.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0518-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0545-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I92J24179^^^AIRA-TEST^MR||HendersonAIRA^HoneyAIRA^Paulomi^^^^L|JofrayAIRA^KitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1509 Baastricht Cir^^Hartland^MI^48353^USA^P||^PRN^PH^^^810^4356119|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HendersonAIRA^JofrayAIRA^^^^^L|MTH^Mother^HL70063|1509 Baastricht Cir^^Hartland^MI^48353^USA^P|^PRN^PH^^^810^4356119ORC|RE||BI92J24179.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI92J24179.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0545-03^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0545-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q64Y24187^^^AIRA-TEST^MR||BooneAIRA^NorahAIRA^Brysen^^^^L|BristolAIRA^SaryuAIRA^^^^^M|20160727|F||2106-3^White^CDCREC|1197 Hest Maas en Waal Cir^^Clinton Township^MI^48036^USA^P||^PRN^PH^^^586^6268284|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^BristolAIRA^^^^^L|MTH^Mother^HL70063|1197 Hest Maas en Waal Cir^^Clinton Township^MI^48036^USA^P|^PRN^PH^^^586^6268284ORC|RE||BQ64Y24187.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160927||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ64Y24187.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161127||49281-0545-05^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161127||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0545-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X77L24198^^^AIRA-TEST^MR||San Luis ObispoAIRA^SafiaAIRA^Paula^^^^L|WayneAIRA^ErlineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1454 Leeze-Leende Ln^^Wyoming^MI^49503^USA^P||^PRN^PH^^^616^8759619|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San Luis ObispoAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1454 Leeze-Leende Ln^^Wyoming^MI^49503^USA^P|^PRN^PH^^^616^8759619ORC|RE||BX77L24198.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX77L24198.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0545-15^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0547-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D19R24206^^^AIRA-TEST^MR||HamiltonAIRA^ZuriaaAIRA^Prisha^^^^L|MonroeAIRA^IndaliaiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1229 Aldebroek Cir^^Winn^MI^48896^USA^P||^PRN^PH^^^989^6394705|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1229 Aldebroek Cir^^Winn^MI^48896^USA^P|^PRN^PH^^^989^6394705ORC|RE||BD19R24206.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD19R24206.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0547-58^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0560-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N66K24214^^^AIRA-TEST^MR||ErathAIRA^HuldaAIRA^Dale^^^^L|PayetteAIRA^BlossomAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1367 Zill en Sint Hubert Ave^^New Baltimore^MI^48051^USA^P||^PRN^PH^^^586^4901284|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErathAIRA^PayetteAIRA^^^^^L|MTH^Mother^HL70063|1367 Zill en Sint Hubert Ave^^New Baltimore^MI^48051^USA^P|^PRN^PH^^^586^4901284ORC|RE||BN66K24214.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN66K24214.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0560-05^DTAP-IPV^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0562-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z18Y24219^^^AIRA-TEST^MR||SonomaAIRA^BentaAIRA^Rohana^^^^L|LucasAIRA^BonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1990 Sontferland St^^Grand Rapids^MI^49507^USA^P||^PRN^PH^^^616^9183429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SonomaAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1990 Sontferland St^^Grand Rapids^MI^49507^USA^P|^PRN^PH^^^616^9183429ORC|RE||BZ18Y24219.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ18Y24219.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0562-10^Quadracel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0562-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X23D24227^^^AIRA-TEST^MR||BooneAIRA^CharlaAIRA^Kennedi^^^^L|JeffersonAIRA^GabrielaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1258 Horne Ln^^Lake Nepessing^MI^48446^USA^P||^PRN^PH^^^810^9838131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1258 Horne Ln^^Lake Nepessing^MI^48446^USA^P|^PRN^PH^^^810^9838131ORC|RE||BX23D24227.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX23D24227.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0562-58^QUADRACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0589-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E25M24238^^^AIRA-TEST^MR||SheridanAIRA^LeahAIRA^Camille^^^^L|FranklinAIRA^NealaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1676 Keerhugowaard St^^Gladwin^MI^48624^USA^P||^PRN^PH^^^989^2645061|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SheridanAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1676 Keerhugowaard St^^Gladwin^MI^48624^USA^P|^PRN^PH^^^989^2645061ORC|RE||BE25M24238.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE25M24238.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0589-05^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0589-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G92P24246^^^AIRA-TEST^MR||FrioAIRA^MadhaviAIRA^Analia^^^^L|ImperialAIRA^ClariceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1309 Dulst St^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^5323435|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FrioAIRA^ImperialAIRA^^^^^L|MTH^Mother^HL70063|1309 Dulst St^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^5323435ORC|RE||BG92P24246.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG92P24246.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0589-58^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0621-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z94P24254^^^AIRA-TEST^MR||PinalAIRA^AemiliaAIRA^Vikki^^^^L|GraysonAIRA^CindyAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1001 Tirschot Ln^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^6321671|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PinalAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1001 Tirschot Ln^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^6321671ORC|RE||BZ94P24254.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ94P24254.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0621-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0621-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I58U24259^^^AIRA-TEST^MR||NightingaleAIRA^AmayaAIRA^Lina^^^^L|CarrollAIRA^CorindaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1597 Daanstad Ave^^Luce Township^MI^48118^USA^P||^PRN^PH^^^734^7769213|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NightingaleAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1597 Daanstad Ave^^Luce Township^MI^48118^USA^P|^PRN^PH^^^734^7769213ORC|RE||BI58U24259.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI58U24259.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0621-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0625-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B82A24267^^^AIRA-TEST^MR||LaurelAIRA^KallieAIRA^Emily^^^^L|AroostookAIRA^MckennaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1052 Wandgraaf Cir^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^7318582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaurelAIRA^AroostookAIRA^^^^^L|MTH^Mother^HL70063|1052 Wandgraaf Cir^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^7318582ORC|RE||BB82A24267.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB82A24267.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0625-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0625-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N14G24278^^^AIRA-TEST^MR||LlanoAIRA^AveriAIRA^Ali^^^^L|LeknesAIRA^TertiaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1588 Sundert Ave^^Southfield^MI^48075^USA^P||^PRN^PH^^^248^7281028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LlanoAIRA^LeknesAIRA^^^^^L|MTH^Mother^HL70063|1588 Sundert Ave^^Southfield^MI^48075^USA^P|^PRN^PH^^^248^7281028ORC|RE||BN14G24278.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN14G24278.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0625-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0627-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O65J24286^^^AIRA-TEST^MR||ArthurAIRA^WillaAIRA^Octavia^^^^L|AthensAIRA^ManushiAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1362 Wubbergen Ave^^Emmett^MI^48022^USA^P||^PRN^PH^^^810^6676753|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArthurAIRA^AthensAIRA^^^^^L|MTH^Mother^HL70063|1362 Wubbergen Ave^^Emmett^MI^48022^USA^P|^PRN^PH^^^810^6676753ORC|RE||BO65J24286.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO65J24286.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0627-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0627-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I06K24294^^^AIRA-TEST^MR||McKiernanAIRA^AvantiAIRA^Marmara^^^^L|JeffersonAIRA^EktaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1218 Gint-Michielsgestel Ave^^Lapeer^MI^48446^USA^P||^PRN^PH^^^810^3300420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKiernanAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1218 Gint-Michielsgestel Ave^^Lapeer^MI^48446^USA^P|^PRN^PH^^^810^3300420ORC|RE||BI06K24294.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI06K24294.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0627-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0629-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N30K24299^^^AIRA-TEST^MR||AdsonAIRA^StephenieAIRA^Eloise^^^^L|SierraAIRA^GraniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1679 Mss Cir^^Warren^MI^48091^USA^P||^PRN^PH^^^586^3625632|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdsonAIRA^SierraAIRA^^^^^L|MTH^Mother^HL70063|1679 Mss Cir^^Warren^MI^48091^USA^P|^PRN^PH^^^586^3625632ORC|RE||BN30K24299.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN30K24299.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0629-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0629-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A55F24307^^^AIRA-TEST^MR||SilowAIRA^SavitaAIRA^Yaravi^^^^L|BaylorAIRA^LaxmiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1720 Dpe St^^Willow^MI^48164^USA^P||^PRN^PH^^^734^3226939|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SilowAIRA^BaylorAIRA^^^^^L|MTH^Mother^HL70063|1720 Dpe St^^Willow^MI^48164^USA^P|^PRN^PH^^^734^3226939ORC|RE||BA55F24307.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA55F24307.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0629-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0640-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U54Q24318^^^AIRA-TEST^MR||LoveAIRA^DinaAIRA^Kunti^^^^L|MajorAIRA^CaylaAIRA^^^^^M|20100831|F||2106-3^White^CDCREC|1567 Srechterland St^^Hermansville^MI^49847^USA^P||^PRN^PH^^^906^2042542|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoveAIRA^MajorAIRA^^^^^L|MTH^Mother^HL70063|1567 Srechterland St^^Hermansville^MI^49847^USA^P|^PRN^PH^^^906^2042542ORC|RE||BU54Q24318.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101031||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU54Q24318.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20101231||49281-0640-15^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101231||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0650-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I35B24326^^^AIRA-TEST^MR||SchoolcraftAIRA^MarinkaAIRA^Pramada^^^^L|WoodsAIRA^SubhangiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1489 Toxtel Ln^^Mount Clemens^MI^48043^USA^P||^PRN^PH^^^586^5383752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SchoolcraftAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1489 Toxtel Ln^^Mount Clemens^MI^48043^USA^P|^PRN^PH^^^586^5383752ORC|RE||BI35B24326.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI35B24326.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0650-10^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0650-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F39O24334^^^AIRA-TEST^MR||LeonardAIRA^ZarifaAIRA^Katy^^^^L|SummitAIRA^NiciaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1039 Gnschede St^^Lansing^MI^48924^USA^P||^PRN^PH^^^517^3031028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeonardAIRA^SummitAIRA^^^^^L|MTH^Mother^HL70063|1039 Gnschede St^^Lansing^MI^48924^USA^P|^PRN^PH^^^517^3031028ORC|RE||BF39O24334.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF39O24334.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0650-25^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0650-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P99I24339^^^AIRA-TEST^MR||TansbergAIRA^ImaniAIRA^Ames^^^^L|AdairAIRA^BeauAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1870 Blst-Wijhe Ln^^Holland^MI^49422^USA^P||^PRN^PH^^^616^4463612|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TansbergAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1870 Blst-Wijhe Ln^^Holland^MI^49422^USA^P|^PRN^PH^^^616^4463612ORC|RE||BP99I24339.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP99I24339.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0650-50^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0650-70|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E04E24347^^^AIRA-TEST^MR||UnionAIRA^AnataAIRA^Wilhelmina^^^^L|CooperAIRA^BegoniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1359 Lilburg Cir^^Farmingtn Hls^MI^48334^USA^P||^PRN^PH^^^248^7001356|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^CooperAIRA^^^^^L|MTH^Mother^HL70063|1359 Lilburg Cir^^Farmingtn Hls^MI^48334^USA^P|^PRN^PH^^^248^7001356ORC|RE||BE04E24347.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE04E24347.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0650-70^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0650-90|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R96K24358^^^AIRA-TEST^MR||RiverAIRA^UsoaAIRA^Uda^^^^L|ButlerAIRA^SaekoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1787 Mytsjerksteradiel Ave^^Belleville^MI^48111^USA^P||^PRN^PH^^^734^4614437|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RiverAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1787 Mytsjerksteradiel Ave^^Belleville^MI^48111^USA^P|^PRN^PH^^^734^4614437ORC|RE||BR96K24358.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR96K24358.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0650-90^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0703-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y39V24366^^^AIRA-TEST^MR||GalvestonAIRA^MinkaAIRA^Kavindra^^^^L|McCrackenAIRA^VelmaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1307 Oisterwijk Cir^^Laurium^MI^49913^USA^P||^PRN^PH^^^906^9317011|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GalvestonAIRA^McCrackenAIRA^^^^^L|MTH^Mother^HL70063|1307 Oisterwijk Cir^^Laurium^MI^49913^USA^P|^PRN^PH^^^906^9317011ORC|RE||BY39V24366.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY39V24366.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||49281-0703-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0705-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E09K24374^^^AIRA-TEST^MR||OaklandAIRA^ThanhAIRA^Katrina^^^^L|CrittendenAIRA^ElspethAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1442 Eeudal Ln^^Chesterfield Township^MI^48047^USA^P||^PRN^PH^^^586^3780982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OaklandAIRA^CrittendenAIRA^^^^^L|MTH^Mother^HL70063|1442 Eeudal Ln^^Chesterfield Township^MI^48047^USA^P|^PRN^PH^^^586^3780982ORC|RE||BE09K24374.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE09K24374.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||49281-0705-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0707-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R31Y24379^^^AIRA-TEST^MR||San BernardinoAIRA^HiriwaAIRA^Zillah^^^^L|LimestoneAIRA^PrabhaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1209 Wlphen aan den Rijn Pl^^Coppersville^MI^49404^USA^P||^PRN^PH^^^616^4483316|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San BernardinoAIRA^LimestoneAIRA^^^^^L|MTH^Mother^HL70063|1209 Wlphen aan den Rijn Pl^^Coppersville^MI^49404^USA^P|^PRN^PH^^^616^4483316ORC|RE||BR31Y24379.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR31Y24379.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0707-48^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0707-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G77U24387^^^AIRA-TEST^MR||ApacheAIRA^TobitAIRA^Alessandra^^^^L|ViergesAIRA^OrielAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1516 Norendijk Ave^^Greenville^MI^48838^USA^P||^PRN^PH^^^231^2170566|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ApacheAIRA^ViergesAIRA^^^^^L|MTH^Mother^HL70063|1516 Norendijk Ave^^Greenville^MI^48838^USA^P|^PRN^PH^^^231^2170566ORC|RE||BG77U24387.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG77U24387.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||49281-0707-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0708-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T81E24398^^^AIRA-TEST^MR||BaragaAIRA^MandaAIRA^Shayla^^^^L|SagadahocAIRA^DevikaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1421 Ontvangen Cir^^Shepherd^MI^48883^USA^P||^PRN^PH^^^989^8474792|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BaragaAIRA^SagadahocAIRA^^^^^L|MTH^Mother^HL70063|1421 Ontvangen Cir^^Shepherd^MI^48883^USA^P|^PRN^PH^^^989^8474792ORC|RE||BT81E24398.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT81E24398.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0708-40^Fluzone Intradermal Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0708-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A80S24406^^^AIRA-TEST^MR||BeaverAIRA^AdoraAIRA^Alyvia^^^^L|MonoAIRA^IrihapetiAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1238 Met St^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^8431878|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^MonoAIRA^^^^^L|MTH^Mother^HL70063|1238 Met St^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^8431878ORC|RE||BA80S24406.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA80S24406.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0708-48^FLUZONE INTRADERMAL QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0709-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J23V24414^^^AIRA-TEST^MR||HaleAIRA^CorinAIRA^Marea^^^^L|GreenAIRA^MarionAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1086 Merkelland Ln^^Croton^MI^49337^USA^P||^PRN^PH^^^231^8895134|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaleAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1086 Merkelland Ln^^Croton^MI^49337^USA^P|^PRN^PH^^^231^8895134ORC|RE||BJ23V24414.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ23V24414.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0709-48^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0709-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W00T24419^^^AIRA-TEST^MR||DuvalAIRA^KyonAIRA^Ruth^^^^L|MorreyAIRA^AntheaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1388 Zaag Cir^^Wolverine^MI^49799^USA^P||^PRN^PH^^^231^6281581|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DuvalAIRA^MorreyAIRA^^^^^L|MTH^Mother^HL70063|1388 Zaag Cir^^Wolverine^MI^49799^USA^P|^PRN^PH^^^231^6281581ORC|RE||BW00T24419.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW00T24419.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||49281-0709-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0710-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M67D24427^^^AIRA-TEST^MR||Presque IsleAIRA^JanetAIRA^Viola^^^^L|RossAIRA^SanciaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1794 Oerschelling Ave^^Canton^MI^48184^USA^P||^PRN^PH^^^734^9403580|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Presque IsleAIRA^RossAIRA^^^^^L|MTH^Mother^HL70063|1794 Oerschelling Ave^^Canton^MI^48184^USA^P|^PRN^PH^^^734^9403580ORC|RE||BM67D24427.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM67D24427.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0710-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0710-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S88A24438^^^AIRA-TEST^MR||MercerAIRA^KellyAIRA^Cindy^^^^L|AtascosaAIRA^AnataAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1404 Terug Cir^^Ida^MI^48140^USA^P||^PRN^PH^^^734^9477525|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercerAIRA^AtascosaAIRA^^^^^L|MTH^Mother^HL70063|1404 Terug Cir^^Ida^MI^48140^USA^P|^PRN^PH^^^734^9477525ORC|RE||BS88A24438.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS88A24438.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||49281-0710-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0712-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E46I24446^^^AIRA-TEST^MR||HawkeAIRA^MaduraAIRA^Aspen^^^^L|YubaAIRA^CadenceAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1632 Appel St^^Wetmore^MI^49895^USA^P||^PRN^PH^^^906^2009255|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HawkeAIRA^YubaAIRA^^^^^L|MTH^Mother^HL70063|1632 Appel St^^Wetmore^MI^49895^USA^P|^PRN^PH^^^906^2009255ORC|RE||BE46I24446.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE46I24446.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0712-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0712-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z22P24454^^^AIRA-TEST^MR||KennebecAIRA^GuinevereAIRA^Theodora^^^^L|StarrAIRA^KinleyAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1347 Vithoorn Pl^^Portland^MI^48875^USA^P||^PRN^PH^^^517^4855745|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KennebecAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1347 Vithoorn Pl^^Portland^MI^48875^USA^P|^PRN^PH^^^517^4855745ORC|RE||BZ22P24454.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ22P24454.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||49281-0712-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0718-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R21I24459^^^AIRA-TEST^MR||PimaAIRA^AkakoAIRA^Lyris^^^^L|FranklinAIRA^EkaterinaAIRA^^^^^M|20190228|F||2106-3^White^CDCREC|1291 Rudwest-Fryslan Pl^^London Township^MI^48160^USA^P||^PRN^PH^^^734^3453756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PimaAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1291 Rudwest-Fryslan Pl^^London Township^MI^48160^USA^P|^PRN^PH^^^734^3453756ORC|RE||BR21I24459.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR21I24459.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190629||49281-0718-10^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0718-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U83U24467^^^AIRA-TEST^MR||RileyAIRA^HaliaAIRA^Miranda^^^^L|Van BurenAIRA^JonesyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1804 Gen Boer Pl^^Loch Alpine^MI^48103^USA^P||^PRN^PH^^^734^9563668|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RileyAIRA^Van BurenAIRA^^^^^L|MTH^Mother^HL70063|1804 Gen Boer Pl^^Loch Alpine^MI^48103^USA^P|^PRN^PH^^^734^9563668ORC|RE||BU83U24467.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU83U24467.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0718-88^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PSC^Protein Sciences^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0790-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O69C24478^^^AIRA-TEST^MR||ElliottAIRA^LizbethAIRA^Rhodanthe^^^^L|ScottAIRA^RanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1909 Benray Ln^^Williamsburg^MI^49690^USA^P||^PRN^PH^^^231^6472652|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ElliottAIRA^ScottAIRA^^^^^L|MTH^Mother^HL70063|1909 Benray Ln^^Williamsburg^MI^49690^USA^P|^PRN^PH^^^231^6472652ORC|RE||BO69C24478.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO69C24478.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0790-20^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0790-38|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q55B24486^^^AIRA-TEST^MR||BrownAIRA^AlejandraAIRA^Haliey^^^^L|EdmonsonAIRA^SuzetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1444 Loerdijk Ln^^Spruce^MI^48762^USA^P||^PRN^PH^^^989^2694617|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrownAIRA^EdmonsonAIRA^^^^^L|MTH^Mother^HL70063|1444 Loerdijk Ln^^Spruce^MI^48762^USA^P|^PRN^PH^^^989^2694617ORC|RE||BQ55B24486.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ55B24486.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0790-38^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0790-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D99T24494^^^AIRA-TEST^MR||LyonAIRA^AzadehAIRA^Emalia^^^^L|HodgeAIRA^AndeaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1848 Mlphen-Chaam Cir^^Belmont^MI^49306^USA^P||^PRN^PH^^^616^4471607|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LyonAIRA^HodgeAIRA^^^^^L|MTH^Mother^HL70063|1848 Mlphen-Chaam Cir^^Belmont^MI^49306^USA^P|^PRN^PH^^^616^4471607ORC|RE||BD99T24494.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD99T24494.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0790-51^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0790-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F29L24499^^^AIRA-TEST^MR||SulitAIRA^YukakoAIRA^Tatum^^^^L|CherryAIRA^RevaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1656 Moerdijk Cir^^Lennon^MI^48449^USA^P||^PRN^PH^^^989^5101670|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SulitAIRA^CherryAIRA^^^^^L|MTH^Mother^HL70063|1656 Moerdijk Cir^^Lennon^MI^48449^USA^P|^PRN^PH^^^989^5101670ORC|RE||BF29L24499.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF29L24499.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0790-88^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0800-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U76G24507^^^AIRA-TEST^MR||SnohomishAIRA^OpalAIRA^Sabia^^^^L|AlgerAIRA^TulasiAIRA^^^^^M|20170104|F||2106-3^White^CDCREC|1025 Neusden Ave^^Greenbush^MI^48738^USA^P||^PRN^PH^^^989^5457720|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SnohomishAIRA^AlgerAIRA^^^^^L|MTH^Mother^HL70063|1025 Neusden Ave^^Greenbush^MI^48738^USA^P|^PRN^PH^^^989^5457720ORC|RE||BU76G24507.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170304||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU76G24507.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170504||49281-0800-83^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170504||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0820-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V19K24518^^^AIRA-TEST^MR||BohneAIRA^FreyaAIRA^Filbertha^^^^L|PhelpsAIRA^DorotaAIRA^^^^^M|20170104|F||2106-3^White^CDCREC|1536 Weumen Pl^^Cascade Township^MI^49506^USA^P||^PRN^PH^^^616^6016390|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BohneAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1536 Weumen Pl^^Cascade Township^MI^49506^USA^P|^PRN^PH^^^616^6016390ORC|RE||BV19K24518.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170304||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV19K24518.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170504||49281-0820-10^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170504||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0860-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W21C24526^^^AIRA-TEST^MR||LeeAIRA^PeridotAIRA^Kalare^^^^L|SanilacAIRA^GwynethAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1996 Vreemd Pl^^Vernon^MI^48476^USA^P||^PRN^PH^^^989^3808531|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^SanilacAIRA^^^^^L|MTH^Mother^HL70063|1996 Vreemd Pl^^Vernon^MI^48476^USA^P|^PRN^PH^^^989^3808531ORC|RE||BW21C24526.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW21C24526.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0860-10^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0860-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H33Q24534^^^AIRA-TEST^MR||JensenAIRA^ErzsebetAIRA^Guadalupe^^^^L|UnionAIRA^GitaAIRA^^^^^M|20110215|F||2106-3^White^CDCREC|1120 Kan Cir^^Willow^MI^48164^USA^P||^PRN^PH^^^734^2758921|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JensenAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1120 Kan Cir^^Willow^MI^48164^USA^P|^PRN^PH^^^734^2758921ORC|RE||BH33Q24534.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110415||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH33Q24534.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110615||49281-0860-55^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110615||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0860-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W23Y24539^^^AIRA-TEST^MR||LeeAIRA^SuneeAIRA^Louella^^^^L|HendersonAIRA^LysAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1709 Zoeken Ln^^Lincoln^MI^48742^USA^P||^PRN^PH^^^989^5015396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1709 Zoeken Ln^^Lincoln^MI^48742^USA^P|^PRN^PH^^^989^5015396ORC|RE||BW23Y24539.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW23Y24539.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0860-78^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0860-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R85U24547^^^AIRA-TEST^MR||FranklinAIRA^PalomaAIRA^Alyssa^^^^L|LindblomAIRA^LeshAIRA^^^^^M|20110215|F||2106-3^White^CDCREC|1209 Porendijk Cir^^Huntingtn Wds^MI^48070^USA^P||^PRN^PH^^^248^2424063|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^LindblomAIRA^^^^^L|MTH^Mother^HL70063|1209 Porendijk Cir^^Huntingtn Wds^MI^48070^USA^P|^PRN^PH^^^248^2424063ORC|RE||BR85U24547.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110415||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR85U24547.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110615||49281-0860-88^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110615||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0913-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W46R24558^^^AIRA-TEST^MR||GarfieldAIRA^ZaltanaAIRA^Virginia^^^^L|BenewahAIRA^PoppyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1750 Moeree-Overflakkee Cir^^Brandon^MI^48462^USA^P||^PRN^PH^^^248^3577231|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarfieldAIRA^BenewahAIRA^^^^^L|MTH^Mother^HL70063|1750 Moeree-Overflakkee Cir^^Brandon^MI^48462^USA^P|^PRN^PH^^^248^3577231ORC|RE||BW46R24558.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW46R24558.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0913-01^STAMARIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0915-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O26X24566^^^AIRA-TEST^MR||MadisonAIRA^IseultAIRA^Rosalba^^^^L|CaseyAIRA^MarkettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1727 Mmallingerland Cir^^Mooreville^MI^48160^USA^P||^PRN^PH^^^734^9016083|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1727 Mmallingerland Cir^^Mooreville^MI^48160^USA^P|^PRN^PH^^^734^9016083ORC|RE||BO26X24566.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO26X24566.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0915-01^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0915-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H81T24574^^^AIRA-TEST^MR||LeelanauAIRA^LaineAIRA^Corinna^^^^L|HoggAIRA^ChruseAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1763 Doudenberg Pl^^Lum^MI^48412^USA^P||^PRN^PH^^^810^6279959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeelanauAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1763 Doudenberg Pl^^Lum^MI^48412^USA^P|^PRN^PH^^^810^6279959ORC|RE||BH81T24574.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH81T24574.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0915-05^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0915-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F56W24579^^^AIRA-TEST^MR||DouglasAIRA^TessaAIRA^Prachi^^^^L|AdaAIRA^MyleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1139 Stoel Cir^^Lansing^MI^48913^USA^P||^PRN^PH^^^517^2355679|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DouglasAIRA^AdaAIRA^^^^^L|MTH^Mother^HL70063|1139 Stoel Cir^^Lansing^MI^48913^USA^P|^PRN^PH^^^517^2355679ORC|RE||BF56W24579.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF56W24579.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0915-58^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-0915-68|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T28K24587^^^AIRA-TEST^MR||DeltaAIRA^HedeaAIRA^Anabelle^^^^L|CottleAIRA^CorentineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1801 Pongeradeel Cir^^Lansing^MI^48921^USA^P||^PRN^PH^^^517^3110913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeltaAIRA^CottleAIRA^^^^^L|MTH^Mother^HL70063|1801 Pongeradeel Cir^^Lansing^MI^48921^USA^P|^PRN^PH^^^517^3110913ORC|RE||BT28K24587.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT28K24587.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-0915-68^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|37^Yellow Fever VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110330||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-1693-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z12E24598^^^AIRA-TEST^MR||HopkinsAIRA^FidelimaAIRA^Neala^^^^L|RunnelsAIRA^LinleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1212 Saarlemmerliede en Spaarnwoude Ln^^Grand Rapids^MI^49503^USA^P||^PRN^PH^^^616^6883340|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HopkinsAIRA^RunnelsAIRA^^^^^L|MTH^Mother^HL70063|1212 Saarlemmerliede en Spaarnwoude Ln^^Grand Rapids^MI^49503^USA^P|^PRN^PH^^^616^6883340ORC|RE||BZ12E24598.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ12E24598.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-1693-00^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-1693-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J11T24606^^^AIRA-TEST^MR||MuskingumAIRA^MeghanaAIRA^Whitney^^^^L|ClackamasAIRA^QuintessaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1945 Kssen Cir^^North Adams^MI^49262^USA^P||^PRN^PH^^^517^4812605|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MuskingumAIRA^ClackamasAIRA^^^^^L|MTH^Mother^HL70063|1945 Kssen Cir^^North Adams^MI^49262^USA^P|^PRN^PH^^^517^4812605ORC|RE||BJ11T24606.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ11T24606.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-1693-09^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-2883-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N11W24614^^^AIRA-TEST^MR||SewardAIRA^AileenAIRA^Ronda^^^^L|SpokaneAIRA^JayleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1256 Kuidplas St^^Kendall^MI^49062^USA^P||^PRN^PH^^^269^5862465|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SewardAIRA^SpokaneAIRA^^^^^L|MTH^Mother^HL70063|1256 Kuidplas St^^Kendall^MI^49062^USA^P|^PRN^PH^^^269^5862465ORC|RE||BN11W24614.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN11W24614.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-2883-00^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-2883-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y18K24619^^^AIRA-TEST^MR||LenbergAIRA^AlissonAIRA^Akana^^^^L|NorthamptonAIRA^DonataAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1788 Markt Cir^^Lincoln^MI^48742^USA^P||^PRN^PH^^^989^6429044|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LenbergAIRA^NorthamptonAIRA^^^^^L|MTH^Mother^HL70063|1788 Markt Cir^^Lincoln^MI^48742^USA^P|^PRN^PH^^^989^6429044ORC|RE||BY18K24619.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY18K24619.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-2883-09^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-3096-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R91N24627^^^AIRA-TEST^MR||GannonAIRA^ReginaAIRA^Hide^^^^L|FayetteAIRA^KynleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1885 Tppingedam Pl^^Pittsfield Township^MI^48104^USA^P||^PRN^PH^^^734^4465905|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GannonAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1885 Tppingedam Pl^^Pittsfield Township^MI^48104^USA^P|^PRN^PH^^^734^4465905ORC|RE||BR91N24627.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR91N24627.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-3096-00^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-3469-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D60D24638^^^AIRA-TEST^MR||LucasAIRA^MaraAIRA^Llv^^^^L|IsabellaAIRA^TrudeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1510 Uude IJsselstreek Pl^^Muskegon Heights^MI^49444^USA^P||^PRN^PH^^^231^7737993|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^IsabellaAIRA^^^^^L|MTH^Mother^HL70063|1510 Uude IJsselstreek Pl^^Muskegon Heights^MI^49444^USA^P|^PRN^PH^^^231^7737993ORC|RE||BD60D24638.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD60D24638.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-3469-00^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-3469-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R75H24646^^^AIRA-TEST^MR||OhioAIRA^ElexusAIRA^Olalla^^^^L|McClungAIRA^GiacintaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1231 Sutten St^^Rhodes^MI^48652^USA^P||^PRN^PH^^^989^5710860|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OhioAIRA^McClungAIRA^^^^^L|MTH^Mother^HL70063|1231 Sutten St^^Rhodes^MI^48652^USA^P|^PRN^PH^^^989^5710860ORC|RE||BR75H24646.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR75H24646.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-3469-09^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||DVX^Dynavax, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285-0138-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q64H24654^^^AIRA-TEST^MR||JeffersonAIRA^GodivaAIRA^Shakti^^^^L|MarionAIRA^CyrenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1123 Mude IJsselstreek Pl^^Caledonia^MI^49316^USA^P||^PRN^PH^^^616^8092857|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1123 Mude IJsselstreek Pl^^Caledonia^MI^49316^USA^P|^PRN^PH^^^616^8092857ORC|RE||BQ64H24654.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ64H24654.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285-0138-50^Adenovirus Type 4 and Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||BRR^Barr Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|143^Adenovirus VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140611||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285-0174-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y35R24659^^^AIRA-TEST^MR||WashingtonAIRA^HuonAIRA^Chantal^^^^L|BeckhamAIRA^GitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1655 Lde Ave^^Baraga^MI^49908^USA^P||^PRN^PH^^^906^6956028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1655 Lde Ave^^Baraga^MI^49908^USA^P|^PRN^PH^^^906^6956028ORC|RE||BY35R24659.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY35R24659.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285-0174-02^Adenovirus Type 4 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||BRR^Barr Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|143^Adenovirus VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140611||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285-0175-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R37A24667^^^AIRA-TEST^MR||LewisAIRA^AparajitaAIRA^Donna^^^^L|BremerAIRA^AbeliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1606 Aluis Ln^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^6241175|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LewisAIRA^BremerAIRA^^^^^L|MTH^Mother^HL70063|1606 Aluis Ln^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^6241175ORC|RE||BR37A24667.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR37A24667.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285-0175-02^Adenovirus Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||BRR^Barr Laboratories^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|143^Adenovirus VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140611||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-0734-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S21H24678^^^AIRA-TEST^MR||BexarAIRA^EmeldaAIRA^Verona^^^^L|San JuanAIRA^AlexandriaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1375 Meeze-Leende Cir^^Houghton Lake Heights^MI^48630^USA^P||^PRN^PH^^^989^8848367|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BexarAIRA^San JuanAIRA^^^^^L|MTH^Mother^HL70063|1375 Meeze-Leende Cir^^Houghton Lake Heights^MI^48630^USA^P|^PRN^PH^^^989^8848367ORC|RE||BS21H24678.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS21H24678.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-0734-00^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-0980-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A98E24686^^^AIRA-TEST^MR||BellAIRA^PomonaAIRA^Journee^^^^L|CrumbakerAIRA^KaieAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1588 Ae Fryske Marren Pl^^Royal Oak^MI^48073^USA^P||^PRN^PH^^^248^7743689|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BellAIRA^CrumbakerAIRA^^^^^L|MTH^Mother^HL70063|1588 Ae Fryske Marren Pl^^Royal Oak^MI^48073^USA^P|^PRN^PH^^^248^7743689ORC|RE||BA98E24686.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA98E24686.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-0980-00^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-2219-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B39U24694^^^AIRA-TEST^MR||CusackAIRA^ChlorisAIRA^Guda^^^^L|CrawfordAIRA^AdhiraAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1137 Mpe Pl^^Ironwood^MI^49938^USA^P||^PRN^PH^^^906^7385811|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusackAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1137 Mpe Pl^^Ironwood^MI^49938^USA^P|^PRN^PH^^^906^7385811ORC|RE||BB39U24694.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB39U24694.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-2219-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-2219-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U79V24699^^^AIRA-TEST^MR||ThurstonAIRA^AponiAIRA^Sakiko^^^^L|LuceAIRA^KerziAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1208 Wof van Twente Ave^^Lake Nepessing^MI^48446^USA^P||^PRN^PH^^^810^4382406|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThurstonAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1208 Wof van Twente Ave^^Lake Nepessing^MI^48446^USA^P|^PRN^PH^^^810^4382406ORC|RE||BU79V24699.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU79V24699.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||54868-2219-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-3339-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q01U24707^^^AIRA-TEST^MR||KyleAIRA^AishaAIRA^Adar^^^^L|SusquehannaAIRA^JayaniAIRA^^^^^M|20090228|F||2106-3^White^CDCREC|1431 Rersel Ave^^Ishpeming^MI^49865^USA^P||^PRN^PH^^^906^5387167|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KyleAIRA^SusquehannaAIRA^^^^^L|MTH^Mother^HL70063|1431 Rersel Ave^^Ishpeming^MI^49865^USA^P|^PRN^PH^^^906^5387167ORC|RE||BQ01U24707.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20090429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ01U24707.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20090629||54868-3339-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20090629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-3339-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M12R24718^^^AIRA-TEST^MR||AlbrechtsonAIRA^SavitriAIRA^Sienna^^^^L|PhelpsAIRA^BetaAIRA^^^^^M|20090228|F||2106-3^White^CDCREC|1378 Deldermalsen Ave^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^4289448|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlbrechtsonAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1378 Deldermalsen Ave^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^4289448ORC|RE||BM12R24718.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20090429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM12R24718.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20090629||54868-3339-09^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20090629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-4320-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A42M24726^^^AIRA-TEST^MR||YorkAIRA^AmyAIRA^Lowenna^^^^L|GlennAIRA^KarliAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1512 Berneuzen Ave^^Center Line^MI^48015^USA^P||^PRN^PH^^^586^3407157|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YorkAIRA^GlennAIRA^^^^^L|MTH^Mother^HL70063|1512 Berneuzen Ave^^Center Line^MI^48015^USA^P|^PRN^PH^^^586^3407157ORC|RE||BA42M24726.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA42M24726.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-4320-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-4320-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I84S24734^^^AIRA-TEST^MR||GranholmAIRA^YurikoAIRA^Lucie^^^^L|GreenAIRA^MarshaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1670 Veerde Pl^^Lennon^MI^48449^USA^P||^PRN^PH^^^989^8444243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GranholmAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1670 Veerde Pl^^Lennon^MI^48449^USA^P|^PRN^PH^^^989^8444243ORC|RE||BI84S24734.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI84S24734.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-4320-09^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|33^Pneumococcal Polysaccharide VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150424||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-6177-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N74V24739^^^AIRA-TEST^MR||DurbinAIRA^GeraniumAIRA^Rylan^^^^L|LewisAIRA^MistyAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1251 Wude IJsselstreek St^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^2041628|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DurbinAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1251 Wude IJsselstreek St^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^2041628ORC|RE||BN74V24739.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN74V24739.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-6177-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-6180-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z09U24747^^^AIRA-TEST^MR||WaschingAIRA^AvantiAIRA^Karolina^^^^L|BonnevilleAIRA^PearlAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1915 Nierden Ln^^Bentley^MI^48613^USA^P||^PRN^PH^^^989^7215379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WaschingAIRA^BonnevilleAIRA^^^^^L|MTH^Mother^HL70063|1915 Nierden Ln^^Bentley^MI^48613^USA^P|^PRN^PH^^^989^7215379ORC|RE||BZ09U24747.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ09U24747.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||54868-6180-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-55045-3841-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D90J24758^^^AIRA-TEST^MR||EllisAIRA^JosieAIRA^Vivian^^^^L|RussellAIRA^RosaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1889 Sen Boer Pl^^Saint Heights^MI^48314^USA^P||^PRN^PH^^^586^5548907|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EllisAIRA^RussellAIRA^^^^^L|MTH^Mother^HL70063|1889 Sen Boer Pl^^Saint Heights^MI^48314^USA^P|^PRN^PH^^^586^5548907ORC|RE||BD90J24758.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD90J24758.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||55045-3841-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0801-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K78U24766^^^AIRA-TEST^MR||WashingtonAIRA^LykaiosAIRA^Mitsuko^^^^L|StarrAIRA^EvitaAIRA^^^^^M|20170516|F||2106-3^White^CDCREC|1044 Gaasdriel Ln^^Oakland Township^MI^48306^USA^P||^PRN^PH^^^248^9549405|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1044 Gaasdriel Ln^^Oakland Township^MI^48306^USA^P|^PRN^PH^^^248^9549405ORC|RE||BK78U24766.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170716||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK78U24766.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170916||58160-0801-11^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170916||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0802-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R67P24774^^^AIRA-TEST^MR||HowardAIRA^LailaAIRA^Jan^^^^L|OlssonAIRA^ArohaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1719 Lieve Ave^^Minden City^MI^48465^USA^P||^PRN^PH^^^989^8825240|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowardAIRA^OlssonAIRA^^^^^L|MTH^Mother^HL70063|1719 Lieve Ave^^Minden City^MI^48465^USA^P|^PRN^PH^^^989^8825240ORC|RE||BR67P24774.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR67P24774.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0802-02^AS03 Adjuvant^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0804-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P74B24779^^^AIRA-TEST^MR||LemhiAIRA^ChizuAIRA^Jagrati^^^^L|IslandAIRA^BettieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1511 Mitgeest Ave^^Canton^MI^48184^USA^P||^PRN^PH^^^734^9014353|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LemhiAIRA^IslandAIRA^^^^^L|MTH^Mother^HL70063|1511 Mitgeest Ave^^Canton^MI^48184^USA^P|^PRN^PH^^^734^9014353ORC|RE||BP74B24779.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP74B24779.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0804-01^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0806-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90Q24787^^^AIRA-TEST^MR||TillamookAIRA^JolieAIRA^Veena^^^^L|OldhamAIRA^RaphaelaAIRA^^^^^M|20110814|F||2106-3^White^CDCREC|1812 Zachte Ln^^New Era^MI^49446^USA^P||^PRN^PH^^^231^9078950|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TillamookAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1812 Zachte Ln^^New Era^MI^49446^USA^P|^PRN^PH^^^231^9078950ORC|RE||BF90Q24787.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111014||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF90Q24787.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111214||58160-0806-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111214||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0806-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X28U24798^^^AIRA-TEST^MR||ComalAIRA^RosAIRA^Donelle^^^^L|RandallAIRA^BansariAIRA^^^^^M|20110814|F||2106-3^White^CDCREC|1347 Hubbergen Ave^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^2962030|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComalAIRA^RandallAIRA^^^^^L|MTH^Mother^HL70063|1347 Hubbergen Ave^^Ash Township^MI^48117^USA^P|^PRN^PH^^^734^2962030ORC|RE||BX28U24798.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111014||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX28U24798.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111214||58160-0806-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111214||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0808-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W32B24806^^^AIRA-TEST^MR||GrayAIRA^DonnaAIRA^Adelaide^^^^L|GreenupAIRA^AgathaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1463 Rchouwen-Duiveland St^^Bay City^MI^48707^USA^P||^PRN^PH^^^989^9253908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrayAIRA^GreenupAIRA^^^^^L|MTH^Mother^HL70063|1463 Rchouwen-Duiveland St^^Bay City^MI^48707^USA^P|^PRN^PH^^^989^9253908ORC|RE||BW32B24806.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW32B24806.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0808-15^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0809-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N28P24814^^^AIRA-TEST^MR||ClintonAIRA^ArmelleAIRA^Amari^^^^L|ParkesAIRA^EllenAIRA^^^^^M|20170528|F||2106-3^White^CDCREC|1412 Lost Gelre St^^GR^MI^49507^USA^P||^PRN^PH^^^616^4819867|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^ParkesAIRA^^^^^L|MTH^Mother^HL70063|1412 Lost Gelre St^^GR^MI^49507^USA^P|^PRN^PH^^^616^4819867ORC|RE||BN28P24814.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170728||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN28P24814.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170928||58160-0809-01^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170928||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0809-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W32V24819^^^AIRA-TEST^MR||ChickasawAIRA^SecundaAIRA^Colenso^^^^L|KeithAIRA^NyreeAIRA^^^^^M|20170528|F||2106-3^White^CDCREC|1177 Deventer Ave^^Metamora^MI^48455^USA^P||^PRN^PH^^^810^9411703|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChickasawAIRA^KeithAIRA^^^^^L|MTH^Mother^HL70063|1177 Deventer Ave^^Metamora^MI^48455^USA^P|^PRN^PH^^^810^9411703ORC|RE||BW32V24819.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170728||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW32V24819.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170928||58160-0809-05^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170928||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0810-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W90P24827^^^AIRA-TEST^MR||ComancheAIRA^AletaAIRA^Olathe^^^^L|LassenAIRA^BegoniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1054 King Pl^^Vulcan^MI^49852^USA^P||^PRN^PH^^^906^2846745|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComancheAIRA^LassenAIRA^^^^^L|MTH^Mother^HL70063|1054 King Pl^^Vulcan^MI^49852^USA^P|^PRN^PH^^^906^2846745ORC|RE||BW90P24827.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW90P24827.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0810-01^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0810-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L77J24838^^^AIRA-TEST^MR||HowarthAIRA^OlgaAIRA^Rayma^^^^L|MorrowAIRA^AvaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1838 Vomeren St^^Bloomfield^MI^48302^USA^P||^PRN^PH^^^248^5661218|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowarthAIRA^MorrowAIRA^^^^^L|MTH^Mother^HL70063|1838 Vomeren St^^Bloomfield^MI^48302^USA^P|^PRN^PH^^^248^5661218ORC|RE||BL77J24838.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL77J24838.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0810-11^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0810-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J47D24846^^^AIRA-TEST^MR||MagoffinAIRA^LastriAIRA^Jessie^^^^L|BranchAIRA^PebblesAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1406 Noogeveen Ln^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^6944975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagoffinAIRA^BranchAIRA^^^^^L|MTH^Mother^HL70063|1406 Noogeveen Ln^^Hesperia^MI^49421^USA^P|^PRN^PH^^^231^6944975ORC|RE||BJ47D24846.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ47D24846.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0810-43^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0810-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K59I24854^^^AIRA-TEST^MR||KayAIRA^MerrillAIRA^Alexis^^^^L|YorkAIRA^AfraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1599 Soogeveen Cir^^Ridgeway^MI^49229^USA^P||^PRN^PH^^^517^2994324|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KayAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1599 Soogeveen Cir^^Ridgeway^MI^49229^USA^P|^PRN^PH^^^517^2994324ORC|RE||BK59I24854.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK59I24854.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0810-52^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|20^Diphtheria/Tetanus/Pertussis (DTaP) VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0811-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F46C24859^^^AIRA-TEST^MR||WettilandAIRA^NikeAIRA^Kendall^^^^L|NormanAIRA^NarethaAIRA^^^^^M|20101023|F||2106-3^White^CDCREC|1482 Hon en Breugel Ave^^Dexter Township^MI^48169^USA^P||^PRN^PH^^^734^4256934|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WettilandAIRA^NormanAIRA^^^^^L|MTH^Mother^HL70063|1482 Hon en Breugel Ave^^Dexter Township^MI^48169^USA^P|^PRN^PH^^^734^4256934ORC|RE||BF46C24859.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101223||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF46C24859.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110223||58160-0811-41^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110223||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0811-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L96U24867^^^AIRA-TEST^MR||OfvermarkAIRA^JaninaAIRA^Haylie^^^^L|BeaverAIRA^DavanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1277 Rest St^^Moorestown^MI^49651^USA^P||^PRN^PH^^^231^6116718|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OfvermarkAIRA^BeaverAIRA^^^^^L|MTH^Mother^HL70063|1277 Rest St^^Moorestown^MI^49651^USA^P|^PRN^PH^^^231^6116718ORC|RE||BL96U24867.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL96U24867.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0811-43^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0811-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G47P24878^^^AIRA-TEST^MR||RunnelsAIRA^OrindaAIRA^Shrijani^^^^L|HutchinsonAIRA^MichelineAIRA^^^^^M|20101023|F||2106-3^White^CDCREC|1883 Remsmond Pl^^Mooreville^MI^48160^USA^P||^PRN^PH^^^734^9244449|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RunnelsAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1883 Remsmond Pl^^Mooreville^MI^48160^USA^P|^PRN^PH^^^734^9244449ORC|RE||BG47P24878.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101223||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG47P24878.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110223||58160-0811-51^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110223||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0811-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y95P24886^^^AIRA-TEST^MR||SweeneyAIRA^GelasiaAIRA^Onenn^^^^L|HusseyAIRA^SmritiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1435 He Fryske Marren Ave^^Jonesville^MI^49250^USA^P||^PRN^PH^^^517^4299693|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SweeneyAIRA^HusseyAIRA^^^^^L|MTH^Mother^HL70063|1435 He Fryske Marren Ave^^Jonesville^MI^49250^USA^P|^PRN^PH^^^517^4299693ORC|RE||BY95P24886.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY95P24886.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0811-52^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0812-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I91J24894^^^AIRA-TEST^MR||ErieAIRA^HildeAIRA^Zuzana^^^^L|UpshurAIRA^ApanieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1501 Lirschot Pl^^East Detroit^MI^48021^USA^P||^PRN^PH^^^586^3789965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErieAIRA^UpshurAIRA^^^^^L|MTH^Mother^HL70063|1501 Lirschot Pl^^East Detroit^MI^48021^USA^P|^PRN^PH^^^586^3789965ORC|RE||BI91J24894.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI91J24894.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0812-01^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0812-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R96R24899^^^AIRA-TEST^MR||Keya PahaAIRA^ChyouAIRA^Kynthia^^^^L|KentAIRA^DevikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1596 Earneveld St^^Kenockee Township^MI^48006^USA^P||^PRN^PH^^^810^2390545|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Keya PahaAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1596 Earneveld St^^Kenockee Township^MI^48006^USA^P|^PRN^PH^^^810^2390545ORC|RE||BR96R24899.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR96R24899.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0812-11^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0812-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L97J24907^^^AIRA-TEST^MR||MillsAIRA^EmersonAIRA^Ranjana^^^^L|El DoradoAIRA^KarsynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1614 Deldermalsen St^^Ameritech^MI^48663^USA^P||^PRN^PH^^^989^7091918|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MillsAIRA^El DoradoAIRA^^^^^L|MTH^Mother^HL70063|1614 Deldermalsen St^^Ameritech^MI^48663^USA^P|^PRN^PH^^^989^7091918ORC|RE||BL97J24907.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL97J24907.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0812-43^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0812-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F12N24918^^^AIRA-TEST^MR||DelawareAIRA^MagnaAIRA^Ancika^^^^L|HoggAIRA^AnisaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1951 Station Pl^^Watervliet^MI^49098^USA^P||^PRN^PH^^^269^9312242|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DelawareAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1951 Station Pl^^Watervliet^MI^49098^USA^P|^PRN^PH^^^269^9312242ORC|RE||BF12N24918.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF12N24918.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0812-52^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G16V24926^^^AIRA-TEST^MR||ClintonAIRA^CalistaAIRA^Alaysia^^^^L|PetersAIRA^AlestiAIRA^^^^^M|20170406|F||2106-3^White^CDCREC|1388 Meppel Ln^^Bruce Township^MI^48065^USA^P||^PRN^PH^^^586^2437822|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^PetersAIRA^^^^^L|MTH^Mother^HL70063|1388 Meppel Ln^^Bruce Township^MI^48065^USA^P|^PRN^PH^^^586^2437822ORC|RE||BG16V24926.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170606||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG16V24926.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170806||58160-0815-01^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170806||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W46W24934^^^AIRA-TEST^MR||GonzalesAIRA^UnnatiAIRA^Ida^^^^L|ButlerAIRA^CharleenAIRA^^^^^M|20170917|F||2106-3^White^CDCREC|1658 Manier Pl^^Eau Claire^MI^49111^USA^P||^PRN^PH^^^269^5606082|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GonzalesAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1658 Manier Pl^^Eau Claire^MI^49111^USA^P|^PRN^PH^^^269^5606082ORC|RE||BW46W24934.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20171117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW46W24934.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180117||58160-0815-05^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180117||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q09K24939^^^AIRA-TEST^MR||GanesAIRA^ConstanceAIRA^Zagros^^^^L|PowellAIRA^CarrylAIRA^^^^^M|20170917|F||2106-3^White^CDCREC|1677 Vermenigvuldigen Ave^^Lawton^MI^49065^USA^P||^PRN^PH^^^269^5732593|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanesAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1677 Vermenigvuldigen Ave^^Lawton^MI^49065^USA^P|^PRN^PH^^^269^5732593ORC|RE||BQ09K24939.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20171117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ09K24939.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180117||58160-0815-11^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180117||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I51H24947^^^AIRA-TEST^MR||NicholasAIRA^RinzenAIRA^Savarna^^^^L|CourtAIRA^KirimaAIRA^^^^^M|20170917|F||2106-3^White^CDCREC|1079 Nldebroek Pl^^Independence Township^MI^48346^USA^P||^PRN^PH^^^248^6274780|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NicholasAIRA^CourtAIRA^^^^^L|MTH^Mother^HL70063|1079 Nldebroek Pl^^Independence Township^MI^48346^USA^P|^PRN^PH^^^248^6274780ORC|RE||BI51H24947.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20171117||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI51H24947.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180117||58160-0815-34^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180117||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T16O24958^^^AIRA-TEST^MR||GelfryAIRA^BoaAIRA^Bo-Bae^^^^L|UnionAIRA^AmandineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1385 Oor Pl^^Saint Clr Shrs^MI^48080^USA^P||^PRN^PH^^^586^3950849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GelfryAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1385 Oor Pl^^Saint Clr Shrs^MI^48080^USA^P|^PRN^PH^^^586^3950849ORC|RE||BT16O24958.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT16O24958.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0815-41^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U91Z24966^^^AIRA-TEST^MR||PutnamAIRA^DeannaAIRA^Piper^^^^L|MorrisAIRA^KateAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1769 Aergen St^^Richville^MI^48758^USA^P||^PRN^PH^^^989^2782097|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PutnamAIRA^MorrisAIRA^^^^^L|MTH^Mother^HL70063|1769 Aergen St^^Richville^MI^48758^USA^P|^PRN^PH^^^989^2782097ORC|RE||BU91Z24966.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU91Z24966.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0815-43^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-46|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O93W24974^^^AIRA-TEST^MR||PortageAIRA^SeirianAIRA^Honey^^^^L|RiverAIRA^TakiyahAIRA^^^^^M|20101002|F||2106-3^White^CDCREC|1534 Hunspeet Cir^^Richmond^MI^48062^USA^P||^PRN^PH^^^586^3868929|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PortageAIRA^RiverAIRA^^^^^L|MTH^Mother^HL70063|1534 Hunspeet Cir^^Richmond^MI^48062^USA^P|^PRN^PH^^^586^3868929ORC|RE||BO93W24974.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20101202||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO93W24974.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110202||58160-0815-46^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110202||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H99G24979^^^AIRA-TEST^MR||FerryAIRA^BabetteAIRA^Urvasi^^^^L|MedinaAIRA^SexburthAIRA^^^^^M|20101226|F||2106-3^White^CDCREC|1163 Dicht Pl^^Conklin^MI^49403^USA^P||^PRN^PH^^^616^2536599|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FerryAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1163 Dicht Pl^^Conklin^MI^49403^USA^P|^PRN^PH^^^616^2536599ORC|RE||BH99G24979.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110226||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH99G24979.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110426||58160-0815-48^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110426||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0815-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P26U24987^^^AIRA-TEST^MR||WashingtonAIRA^DollyAIRA^Jean^^^^L|UnionAIRA^HabikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1468 Zernheze Pl^^Saint Johns^MI^48879^USA^P||^PRN^PH^^^989^5625052|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1468 Zernheze Pl^^Saint Johns^MI^48879^USA^P|^PRN^PH^^^989^5625052ORC|RE||BP26U24987.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP26U24987.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0815-52^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0816-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J00J24998^^^AIRA-TEST^MR||YorkAIRA^MaureenAIRA^Jolie^^^^L|CanadianAIRA^PiperAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1253 Handerd Ave^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^8540856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YorkAIRA^CanadianAIRA^^^^^L|MTH^Mother^HL70063|1253 Handerd Ave^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^8540856ORC|RE||BJ00J24998.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ00J24998.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0816-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0816-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F10Y25006^^^AIRA-TEST^MR||FayetteAIRA^DylanAIRA^Paloma^^^^L|GrundyAIRA^GinevraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1042 Lwenterand Ln^^Tustin^MI^49688^USA^P||^PRN^PH^^^231^3982815|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FayetteAIRA^GrundyAIRA^^^^^L|MTH^Mother^HL70063|1042 Lwenterand Ln^^Tustin^MI^49688^USA^P|^PRN^PH^^^231^3982815ORC|RE||BF10Y25006.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF10Y25006.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0816-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0818-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L20B25014^^^AIRA-TEST^MR||LewisAIRA^BlondelleAIRA^Belva^^^^L|WinneshiekAIRA^KailynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1874 Sorendijk St^^Spring Lake^MI^49456^USA^P||^PRN^PH^^^616^3305879|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LewisAIRA^WinneshiekAIRA^^^^^L|MTH^Mother^HL70063|1874 Sorendijk St^^Spring Lake^MI^49456^USA^P|^PRN^PH^^^616^3305879ORC|RE||BL20B25014.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL20B25014.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0818-11^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|IM^Intramuscular^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0819-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P03R25019^^^AIRA-TEST^MR||MalaAIRA^NabilaAIRA^Valerie^^^^L|MeadeAIRA^KaieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1729 Halderberge Cir^^Arnold^MI^49819^USA^P||^PRN^PH^^^906^7992110|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MalaAIRA^MeadeAIRA^^^^^L|MTH^Mother^HL70063|1729 Halderberge Cir^^Arnold^MI^49819^USA^P|^PRN^PH^^^906^7992110ORC|RE||BP03R25019.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP03R25019.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0819-12^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0820-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H84G25027^^^AIRA-TEST^MR||ParkAIRA^BridgetAIRA^Delphine^^^^L|FloydAIRA^KarmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1980 Ve Ronde Venen St^^Orion Township^MI^48359^USA^P||^PRN^PH^^^248^4028796|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParkAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1980 Ve Ronde Venen St^^Orion Township^MI^48359^USA^P|^PRN^PH^^^248^4028796ORC|RE||BH84G25027.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH84G25027.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0820-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0820-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74Q25038^^^AIRA-TEST^MR||GanesAIRA^RulaAIRA^Rosanne^^^^L|OkmulgeeAIRA^HineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1617 Hsten Cir^^Brownstown Township^MI^48193^USA^P||^PRN^PH^^^734^2498206|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanesAIRA^OkmulgeeAIRA^^^^^L|MTH^Mother^HL70063|1617 Hsten Cir^^Brownstown Township^MI^48193^USA^P|^PRN^PH^^^734^2498206ORC|RE||BB74Q25038.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74Q25038.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0820-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0820-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E19T25046^^^AIRA-TEST^MR||BentonAIRA^GenesisAIRA^Tanushi^^^^L|TuscolaAIRA^OctaviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1190 Drie St^^Crooked Lake^MI^48116^USA^P||^PRN^PH^^^810^3785904|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BentonAIRA^TuscolaAIRA^^^^^L|MTH^Mother^HL70063|1190 Drie St^^Crooked Lake^MI^48116^USA^P|^PRN^PH^^^810^3785904ORC|RE||BE19T25046.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE19T25046.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0820-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0820-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H81A25054^^^AIRA-TEST^MR||FanninAIRA^ShayleeAIRA^Sampriti^^^^L|SowdenAIRA^PaolinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1830 Ttrecht Pl^^Sault S Marie^MI^49783^USA^P||^PRN^PH^^^906^9222698|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FanninAIRA^SowdenAIRA^^^^^L|MTH^Mother^HL70063|1830 Ttrecht Pl^^Sault S Marie^MI^49783^USA^P|^PRN^PH^^^906^9222698ORC|RE||BH81A25054.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH81A25054.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0820-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0821-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y96A25059^^^AIRA-TEST^MR||WilliamsAIRA^BodilAIRA^Mily^^^^L|BrazosAIRA^VivianAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1606 Natuurlijke St^^Gay^MI^49945^USA^P||^PRN^PH^^^906^9488765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsAIRA^BrazosAIRA^^^^^L|MTH^Mother^HL70063|1606 Natuurlijke St^^Gay^MI^49945^USA^P|^PRN^PH^^^906^9488765ORC|RE||BY96A25059.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY96A25059.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0821-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0821-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H21J25067^^^AIRA-TEST^MR||JohnsonAIRA^AzaleaAIRA^Anika^^^^L|KananenAIRA^IngaborgAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1518 Mijsden-Margraten Pl^^Oakland Township^MI^48306^USA^P||^PRN^PH^^^248^9735650|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^KananenAIRA^^^^^L|MTH^Mother^HL70063|1518 Mijsden-Margraten Pl^^Oakland Township^MI^48306^USA^P|^PRN^PH^^^248^9735650ORC|RE||BH21J25067.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH21J25067.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0821-05^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0821-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z44E25078^^^AIRA-TEST^MR||KossuthAIRA^CadenceAIRA^Viera^^^^L|BellAIRA^MaizahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1560 Elementaire Ln^^Goodrich^MI^48438^USA^P||^PRN^PH^^^810^9043403|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KossuthAIRA^BellAIRA^^^^^L|MTH^Mother^HL70063|1560 Elementaire Ln^^Goodrich^MI^48438^USA^P|^PRN^PH^^^810^9043403ORC|RE||BZ44E25078.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ44E25078.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0821-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0821-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O62S25086^^^AIRA-TEST^MR||MaloneAIRA^AngeliqueAIRA^Messina^^^^L|ClintonAIRA^KehindeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1819 Toordenveld St^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^4236304|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MaloneAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1819 Toordenveld St^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^4236304ORC|RE||BO62S25086.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO62S25086.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0821-34^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0821-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G57G25094^^^AIRA-TEST^MR||IowaAIRA^BrendaAIRA^Nanna^^^^L|IoscoAIRA^TasmineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1404 Sapelle Pl^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^4430538|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IowaAIRA^IoscoAIRA^^^^^L|MTH^Mother^HL70063|1404 Sapelle Pl^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^4430538ORC|RE||BG57G25094.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG57G25094.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0821-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0821-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V71U25099^^^AIRA-TEST^MR||La SalleAIRA^MalkahAIRA^Manuela^^^^L|ButlerAIRA^EmmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1909 Jopik Ave^^Redford^MI^48240^USA^P||^PRN^PH^^^313^5298882|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|La SalleAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1909 Jopik Ave^^Redford^MI^48240^USA^P|^PRN^PH^^^313^5298882ORC|RE||BV71U25099.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV71U25099.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0821-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|146^DTaP, IPV, Hib, HepB^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20151105||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0823-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W87C25107^^^AIRA-TEST^MR||ReillyAIRA^AijahAIRA^Hadria^^^^L|DalyAIRA^ViolentaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1435 Pe Friese Meren Ln^^Avoca^MI^48006^USA^P||^PRN^PH^^^810^2806932|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReillyAIRA^DalyAIRA^^^^^L|MTH^Mother^HL70063|1435 Pe Friese Meren Ln^^Avoca^MI^48006^USA^P|^PRN^PH^^^810^2806932ORC|RE||BW87C25107.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW87C25107.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0823-11^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0825-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U55V25118^^^AIRA-TEST^MR||BuchananAIRA^DillianAIRA^Willow^^^^L|BristolAIRA^GajendraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1395 Veidschendam-Voorburg Pl^^Montague^MI^49437^USA^P||^PRN^PH^^^231^6436400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BuchananAIRA^BristolAIRA^^^^^L|MTH^Mother^HL70063|1395 Veidschendam-Voorburg Pl^^Montague^MI^49437^USA^P|^PRN^PH^^^231^6436400ORC|RE||BU55V25118.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU55V25118.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0825-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0825-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G77U25126^^^AIRA-TEST^MR||MontgomeryAIRA^UjjwalaAIRA^Alumit^^^^L|FranklinAIRA^SapphireAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1791 Zollumerland Ln^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^8993708|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1791 Zollumerland Ln^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^8993708ORC|RE||BG77U25126.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG77U25126.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0825-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0825-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R80D25134^^^AIRA-TEST^MR||MurphyAIRA^KaridaAIRA^Lesh^^^^L|MahoningAIRA^VivienAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1244 Dint-Michielsgestel Cir^^Scio Township^MI^48103^USA^P||^PRN^PH^^^734^2318913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurphyAIRA^MahoningAIRA^^^^^L|MTH^Mother^HL70063|1244 Dint-Michielsgestel Cir^^Scio Township^MI^48103^USA^P|^PRN^PH^^^734^2318913ORC|RE||BR80D25134.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR80D25134.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0825-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0825-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D82C25139^^^AIRA-TEST^MR||CuyahogaAIRA^CharliAIRA^Paola^^^^L|CassAIRA^PoppyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1374 Oeder-Betuwe Ave^^Clinton Township^MI^48038^USA^P||^PRN^PH^^^586^5046108|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CuyahogaAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1374 Oeder-Betuwe Ave^^Clinton Township^MI^48038^USA^P|^PRN^PH^^^586^5046108ORC|RE||BD82C25139.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD82C25139.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0825-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B05H25147^^^AIRA-TEST^MR||WolfeAIRA^AkinaAIRA^Lucy^^^^L|ClarkAIRA^BrennaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1234 Dochem Pl^^Berrien Sprgs^MI^49103^USA^P||^PRN^PH^^^269^8270497|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WolfeAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1234 Dochem Pl^^Berrien Sprgs^MI^49103^USA^P|^PRN^PH^^^269^8270497ORC|RE||BB05H25147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB05H25147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0826-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0826-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W76Q25158^^^AIRA-TEST^MR||Keya PahaAIRA^ElisabethAIRA^Electra^^^^L|DelawareAIRA^SubhagaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1453 Earneveld Pl^^Carson City^MI^48811^USA^P||^PRN^PH^^^989^7856547|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Keya PahaAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1453 Earneveld Pl^^Carson City^MI^48811^USA^P|^PRN^PH^^^989^7856547ORC|RE||BW76Q25158.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW76Q25158.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0826-05^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0826-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y29U25166^^^AIRA-TEST^MR||HoltAIRA^GenesiaAIRA^Donna^^^^L|CarterAIRA^QuintaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1032 Ztten-Leur Cir^^Limestone^MI^49816^USA^P||^PRN^PH^^^906^9336104|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoltAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1032 Ztten-Leur Cir^^Limestone^MI^49816^USA^P|^PRN^PH^^^906^9336104ORC|RE||BY29U25166.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY29U25166.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0826-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0826-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U75W25174^^^AIRA-TEST^MR||BonnevilleAIRA^NiradharaAIRA^Fosetta^^^^L|San JuanAIRA^TitianAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1212 Btede Broec St^^Ann Arbor^MI^48108^USA^P||^PRN^PH^^^734^8511226|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BonnevilleAIRA^San JuanAIRA^^^^^L|MTH^Mother^HL70063|1212 Btede Broec St^^Ann Arbor^MI^48108^USA^P|^PRN^PH^^^734^8511226ORC|RE||BU75W25174.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU75W25174.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0826-34^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0826-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M26G25179^^^AIRA-TEST^MR||LeeAIRA^FreyaAIRA^Lucetta^^^^L|PauldingAIRA^LeilaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1757 Longeradeel St^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^4425485|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^PauldingAIRA^^^^^L|MTH^Mother^HL70063|1757 Longeradeel St^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^4425485ORC|RE||BM26G25179.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM26G25179.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0826-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0826-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y21S25187^^^AIRA-TEST^MR||SmithAIRA^TaviaAIRA^Aleah^^^^L|LakeAIRA^ArushiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1079 Vordering Ln^^Curran^MI^48728^USA^P||^PRN^PH^^^989^3152301|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SmithAIRA^LakeAIRA^^^^^L|MTH^Mother^HL70063|1079 Vordering Ln^^Curran^MI^48728^USA^P|^PRN^PH^^^989^3152301ORC|RE||BY21S25187.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY21S25187.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0826-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|52^Hep A, adult^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160720||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0828-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T03L25198^^^AIRA-TEST^MR||GosperAIRA^KatelinAIRA^Cloris^^^^L|BergenAIRA^LiliannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1719 Set Pl^^Fargo^MI^48006^USA^P||^PRN^PH^^^810^7161837|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GosperAIRA^BergenAIRA^^^^^L|MTH^Mother^HL70063|1719 Set Pl^^Fargo^MI^48006^USA^P|^PRN^PH^^^810^7161837ORC|RE||BT03L25198.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT03L25198.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0828-01^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0828-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M03N25206^^^AIRA-TEST^MR||WinnebagoAIRA^CaseyAIRA^Valentina^^^^L|SciotoAIRA^ZenaideAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1619 Besterveld Ln^^Albion^MI^49224^USA^P||^PRN^PH^^^517^2070575|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WinnebagoAIRA^SciotoAIRA^^^^^L|MTH^Mother^HL70063|1619 Besterveld Ln^^Albion^MI^49224^USA^P|^PRN^PH^^^517^2070575ORC|RE||BM03N25206.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM03N25206.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0828-03^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|121^Shingles VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180212||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0830-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I13A25214^^^AIRA-TEST^MR||LatimerAIRA^DorindaAIRA^Guinevere^^^^L|MajorAIRA^BernadineAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1019 We Marne Pl^^Marine City^MI^48039^USA^P||^PRN^PH^^^810^2957300|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LatimerAIRA^MajorAIRA^^^^^L|MTH^Mother^HL70063|1019 We Marne Pl^^Marine City^MI^48039^USA^P|^PRN^PH^^^810^2957300ORC|RE||BI13A25214.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI13A25214.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-05^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0830-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S90F25219^^^AIRA-TEST^MR||AllenAIRA^UtaAIRA^Bridgit^^^^L|BallardAIRA^FanchonAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1605 Koevorden Ln^^Selfridge Air National Guard^MI^48045^USA^P||^PRN^PH^^^586^7015283|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^BallardAIRA^^^^^L|MTH^Mother^HL70063|1605 Koevorden Ln^^Selfridge Air National Guard^MI^48045^USA^P|^PRN^PH^^^586^7015283ORC|RE||BS90F25219.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS90F25219.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-34^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0830-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W00Z25227^^^AIRA-TEST^MR||HancockAIRA^SharniAIRA^Saffi^^^^L|HickmanAIRA^JaylinAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1929 Rlissingen Cir^^Gaylord^MI^49734^USA^P||^PRN^PH^^^989^8824160|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HancockAIRA^HickmanAIRA^^^^^L|MTH^Mother^HL70063|1929 Rlissingen Cir^^Gaylord^MI^49734^USA^P|^PRN^PH^^^989^8824160ORC|RE||BW00Z25227.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW00Z25227.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-43^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0830-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G41K25238^^^AIRA-TEST^MR||WorthAIRA^CybeleAIRA^Anar^^^^L|WyandotAIRA^SunitiAIRA^^^^^M|20160728|F||2106-3^White^CDCREC|1161 Normerland Ave^^Martin^MI^49070^USA^P||^PRN^PH^^^269^8443428|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WorthAIRA^WyandotAIRA^^^^^L|MTH^Mother^HL70063|1161 Normerland Ave^^Martin^MI^49070^USA^P|^PRN^PH^^^269^8443428ORC|RE||BG41K25238.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160928||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG41K25238.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161128||58160-0830-52^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|118^HPV, bivalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20110503||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161128||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M45A25246^^^AIRA-TEST^MR||AndroscogginAIRA^AiAIRA^Clare^^^^L|KnoxAIRA^IngabergAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1350 Veilig Ln^^Grand Rapids^MI^49530^USA^P||^PRN^PH^^^616^3650192|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndroscogginAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1350 Veilig Ln^^Grand Rapids^MI^49530^USA^P|^PRN^PH^^^616^3650192ORC|RE||BM45A25246.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM45A25246.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0842-01^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y14E25254^^^AIRA-TEST^MR||CassiaAIRA^ChaneAIRA^Iniga^^^^L|ShelbyAIRA^CorineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1150 Klein Ln^^Mikado^MI^48745^USA^P||^PRN^PH^^^989^2717029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassiaAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1150 Klein Ln^^Mikado^MI^48745^USA^P|^PRN^PH^^^989^2717029ORC|RE||BY14E25254.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY14E25254.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0842-05^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M16C25259^^^AIRA-TEST^MR||LaceyAIRA^CornelianAIRA^Karen^^^^L|OntonagonAIRA^HayleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1718 Nladel St^^Reese^MI^48757^USA^P||^PRN^PH^^^989^2418311|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaceyAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1718 Nladel St^^Reese^MI^48757^USA^P|^PRN^PH^^^989^2418311ORC|RE||BM16C25259.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM16C25259.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0842-11^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W13P25267^^^AIRA-TEST^MR||LucasAIRA^HadleyAIRA^Leura^^^^L|VenangoAIRA^HestiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1885 Oroningen Pl^^Ecorse^MI^48229^USA^P||^PRN^PH^^^313^6878527|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^VenangoAIRA^^^^^L|MTH^Mother^HL70063|1885 Oroningen Pl^^Ecorse^MI^48229^USA^P|^PRN^PH^^^313^6878527ORC|RE||BW13P25267.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW13P25267.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0842-34^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E05S25278^^^AIRA-TEST^MR||LimestoneAIRA^SumiAIRA^Neala^^^^L|GardenAIRA^HeaAIRA^^^^^M|20110214|F||2106-3^White^CDCREC|1939 Beeze-Leende Pl^^Cassopolis^MI^49031^USA^P||^PRN^PH^^^269^3276651|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LimestoneAIRA^GardenAIRA^^^^^L|MTH^Mother^HL70063|1939 Beeze-Leende Pl^^Cassopolis^MI^49031^USA^P|^PRN^PH^^^269^3276651ORC|RE||BE05S25278.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110414||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE05S25278.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110614||58160-0842-41^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110614||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X66H25286^^^AIRA-TEST^MR||IarrestadAIRA^ArleneAIRA^Raghnailt^^^^L|MurrayAIRA^HeidiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1472 Wachten St^^Blaney Park^MI^49836^USA^P||^PRN^PH^^^906^4589806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IarrestadAIRA^MurrayAIRA^^^^^L|MTH^Mother^HL70063|1472 Wachten St^^Blaney Park^MI^49836^USA^P|^PRN^PH^^^906^4589806ORC|RE||BX66H25286.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX66H25286.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0842-43^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P91A25294^^^AIRA-TEST^MR||JauppiAIRA^SkylarAIRA^Edalene^^^^L|ConnorAIRA^GoldieAIRA^^^^^M|20110214|F||2106-3^White^CDCREC|1777 Meest Ave^^Capac^MI^48014^USA^P||^PRN^PH^^^810^6594284|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JauppiAIRA^ConnorAIRA^^^^^L|MTH^Mother^HL70063|1777 Meest Ave^^Capac^MI^48014^USA^P|^PRN^PH^^^810^6594284ORC|RE||BP91A25294.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110414||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP91A25294.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110614||58160-0842-51^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110614||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0842-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K68E25299^^^AIRA-TEST^MR||AndersonAIRA^TamahAIRA^Lakeisha^^^^L|HoggAIRA^TeresaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1065 Voppersum Ave^^Midland^MI^48641^USA^P||^PRN^PH^^^989^2782966|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndersonAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1065 Voppersum Ave^^Midland^MI^48641^USA^P|^PRN^PH^^^989^2782966ORC|RE||BK68E25299.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK68E25299.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0842-52^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|138^Td (adult)^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170411||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0851-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X65J25307^^^AIRA-TEST^MR||BinghamAIRA^LindsayAIRA^Gaynor^^^^L|LoganAIRA^StephanyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1421 Betalen St^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^8512652|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BinghamAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1421 Betalen St^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^8512652ORC|RE||BX65J25307.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX65J25307.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0851-01^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0854-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N40W25318^^^AIRA-TEST^MR||UvaldeAIRA^FarikaAIRA^Huon^^^^L|WayrynenAIRA^PaulineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1515 Taadhoeke Ave^^Hemlock^MI^48626^USA^P||^PRN^PH^^^989^4258680|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UvaldeAIRA^WayrynenAIRA^^^^^L|MTH^Mother^HL70063|1515 Taadhoeke Ave^^Hemlock^MI^48626^USA^P|^PRN^PH^^^989^4258680ORC|RE||BN40W25318.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN40W25318.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0854-52^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|119^rotavirus, monovalent^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20141022||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0879-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q92K25326^^^AIRA-TEST^MR||MontereyAIRA^ValAIRA^Annata^^^^L|LewisAIRA^ChandiAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1196 Boekel Ave^^Powers^MI^49874^USA^P||^PRN^PH^^^906^7650083|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontereyAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1196 Boekel Ave^^Powers^MI^49874^USA^P|^PRN^PH^^^906^7650083ORC|RE||BQ92K25326.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ92K25326.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||58160-0879-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0879-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q97L25334^^^AIRA-TEST^MR||AdaAIRA^MercyAIRA^Jessica^^^^L|ChampaignAIRA^VonnieAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1531 Reimerswaal Cir^^Kingston^MI^48741^USA^P||^PRN^PH^^^989^8366917|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdaAIRA^ChampaignAIRA^^^^^L|MTH^Mother^HL70063|1531 Reimerswaal Cir^^Kingston^MI^48741^USA^P|^PRN^PH^^^989^8366917ORC|RE||BQ97L25334.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ97L25334.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||58160-0879-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0880-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A49N25342^^^AIRA-TEST^MR||ChippewaAIRA^EstrellaAIRA^Nataly^^^^L|ElmoreAIRA^SaharAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1260 Meurne Ave^^Wyoming^MI^49519^USA^P||^PRN^PH^^^616^8654368|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChippewaAIRA^ElmoreAIRA^^^^^L|MTH^Mother^HL70063|1260 Meurne Ave^^Wyoming^MI^49519^USA^P|^PRN^PH^^^616^8654368ORC|RE||BA49N25342.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA49N25342.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0880-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0880-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V87W25350^^^AIRA-TEST^MR||BeaverAIRA^YayoiAIRA^Lenis^^^^L|PotterAIRA^SandiaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1898 Tenlo St^^White Pigeon^MI^49099^USA^P||^PRN^PH^^^269^3148561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^PotterAIRA^^^^^L|MTH^Mother^HL70063|1898 Tenlo St^^White Pigeon^MI^49099^USA^P|^PRN^PH^^^269^3148561ORC|RE||BV87W25350.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV87W25350.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0880-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0881-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B30N25355^^^AIRA-TEST^MR||HeffordAIRA^BenitaAIRA^Karen^^^^L|LoveAIRA^AvelineAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1717 Teeuwarden St^^Southfield^MI^48075^USA^P||^PRN^PH^^^248^7659687|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffordAIRA^LoveAIRA^^^^^L|MTH^Mother^HL70063|1717 Teeuwarden St^^Southfield^MI^48075^USA^P|^PRN^PH^^^248^7659687ORC|RE||BB30N25355.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB30N25355.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0881-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0881-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O16X25363^^^AIRA-TEST^MR||VargasAIRA^AlvitaAIRA^Teresa^^^^L|WatersAIRA^ErasmaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1455 Ztten-Leur Ave^^Livonia^MI^48153^USA^P||^PRN^PH^^^734^6811582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VargasAIRA^WatersAIRA^^^^^L|MTH^Mother^HL70063|1455 Ztten-Leur Ave^^Livonia^MI^48153^USA^P|^PRN^PH^^^734^6811582ORC|RE||BO16X25363.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO16X25363.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0881-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0883-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R57M25374^^^AIRA-TEST^MR||Van BurenAIRA^TarraAIRA^Suzy^^^^L|HamiltonAIRA^LynseyAIRA^^^^^M|20150403|F||2106-3^White^CDCREC|1268 Reststellingwerf Ave^^Canton^MI^48184^USA^P||^PRN^PH^^^734^7194742|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Van BurenAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1268 Reststellingwerf Ave^^Canton^MI^48184^USA^P|^PRN^PH^^^734^7194742ORC|RE||BR57M25374.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150603||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR57M25374.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150803||58160-0883-41^Fluarix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150803||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0883-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X44F25382^^^AIRA-TEST^MR||OchiltreeAIRA^PaulinaAIRA^Christal^^^^L|BenzieAIRA^BelinaAIRA^^^^^M|20150403|F||2106-3^White^CDCREC|1344 Zollumerland en Nieuwkruisland Pl^^Grand Rapids^MI^49519^USA^P||^PRN^PH^^^616^3757354|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OchiltreeAIRA^BenzieAIRA^^^^^L|MTH^Mother^HL70063|1344 Zollumerland en Nieuwkruisland Pl^^Grand Rapids^MI^49519^USA^P|^PRN^PH^^^616^3757354ORC|RE||BX44F25382.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150603||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX44F25382.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150803||58160-0883-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150803||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0898-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T81O25390^^^AIRA-TEST^MR||HenryAIRA^AroraAIRA^Tessa^^^^L|AdairAIRA^DesireeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1313 Wemsmond Ave^^Orion Township^MI^48359^USA^P||^PRN^PH^^^248^6622636|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HenryAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1313 Wemsmond Ave^^Orion Township^MI^48359^USA^P|^PRN^PH^^^248^6622636ORC|RE||BT81O25390.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT81O25390.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0898-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0898-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D75K25395^^^AIRA-TEST^MR||SierraAIRA^JazlynnAIRA^Gryffyn^^^^L|MarlinAIRA^SophieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1297 Grave St^^Rives Jct^MI^49277^USA^P||^PRN^PH^^^517^3481471|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SierraAIRA^MarlinAIRA^^^^^L|MTH^Mother^HL70063|1297 Grave St^^Rives Jct^MI^49277^USA^P|^PRN^PH^^^517^3481471ORC|RE||BD75K25395.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD75K25395.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0898-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0900-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G84U25403^^^AIRA-TEST^MR||McKinnonAIRA^SavannaAIRA^Odetta^^^^L|IrvingAIRA^PhiladelphiaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1971 Ze Marne Cir^^Lansing^MI^48918^USA^P||^PRN^PH^^^517^5233200|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKinnonAIRA^IrvingAIRA^^^^^L|MTH^Mother^HL70063|1971 Ze Marne Cir^^Lansing^MI^48918^USA^P|^PRN^PH^^^517^5233200ORC|RE||BG84U25403.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG84U25403.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0900-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0900-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G80H25414^^^AIRA-TEST^MR||ElmoreAIRA^ScarletAIRA^Pier^^^^L|KingAIRA^CynthiaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1711 Veek Ln^^Detroit^MI^48223^USA^P||^PRN^PH^^^313^6489714|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ElmoreAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1711 Veek Ln^^Detroit^MI^48223^USA^P|^PRN^PH^^^313^6489714ORC|RE||BG80H25414.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG80H25414.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||58160-0900-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A17N25422^^^AIRA-TEST^MR||ButlerAIRA^MerlinAIRA^Amitola^^^^L|LeonardAIRA^FayneAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1103 Cuijk Pl^^GR^MI^49508^USA^P||^PRN^PH^^^616^3480983|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^LeonardAIRA^^^^^L|MTH^Mother^HL70063|1103 Cuijk Pl^^GR^MI^49508^USA^P|^PRN^PH^^^616^3480983ORC|RE||BA17N25422.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA17N25422.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0901-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H13R25430^^^AIRA-TEST^MR||KlamathAIRA^CarmelAIRA^Hedasaa^^^^L|AlofsonAIRA^MikkiAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1211 Muur Pl^^Glennie^MI^48737^USA^P||^PRN^PH^^^989^2783062|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlamathAIRA^AlofsonAIRA^^^^^L|MTH^Mother^HL70063|1211 Muur Pl^^Glennie^MI^48737^USA^P|^PRN^PH^^^989^2783062ORC|RE||BH13R25430.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH13R25430.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||58160-0901-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0903-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I98S25435^^^AIRA-TEST^MR||EllisAIRA^LucyAIRA^Ahava^^^^L|SolanoAIRA^FelciaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1728 Wdam-Volendam St^^Sawyer^MI^49125^USA^P||^PRN^PH^^^269^2842430|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EllisAIRA^SolanoAIRA^^^^^L|MTH^Mother^HL70063|1728 Wdam-Volendam St^^Sawyer^MI^49125^USA^P|^PRN^PH^^^269^2842430ORC|RE||BI98S25435.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI98S25435.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||58160-0903-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0903-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K95R25443^^^AIRA-TEST^MR||BeaverAIRA^GretteAIRA^Cyrene^^^^L|WayneAIRA^MadelineAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1974 Rietjerksteradeel Pl^^Ray^MI^48096^USA^P||^PRN^PH^^^586^3473906|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1974 Rietjerksteradeel Pl^^Ray^MI^48096^USA^P|^PRN^PH^^^586^3473906ORC|RE||BK95R25443.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK95R25443.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||58160-0903-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0905-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O04G25454^^^AIRA-TEST^MR||CampbellAIRA^PortiaAIRA^Galya^^^^L|PontotocAIRA^MareaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1402 Oldebroek St^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^7636167|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CampbellAIRA^PontotocAIRA^^^^^L|MTH^Mother^HL70063|1402 Oldebroek St^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^7636167ORC|RE||BO04G25454.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO04G25454.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||58160-0905-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0905-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A25D25462^^^AIRA-TEST^MR||WoldAIRA^ArtemisiaAIRA^Madelia^^^^L|LarsonAIRA^SeleneAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1412 Spsterland Ln^^White Pigeon^MI^49099^USA^P||^PRN^PH^^^269^4429442|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoldAIRA^LarsonAIRA^^^^^L|MTH^Mother^HL70063|1412 Spsterland Ln^^White Pigeon^MI^49099^USA^P|^PRN^PH^^^269^4429442ORC|RE||BA25D25462.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA25D25462.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||58160-0905-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0907-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N61B25470^^^AIRA-TEST^MR||GillespieAIRA^JordynAIRA^Stella^^^^L|KananenAIRA^GargiAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1360 Kmsterdam St^^Grand Rapids^MI^49510^USA^P||^PRN^PH^^^616^3018552|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GillespieAIRA^KananenAIRA^^^^^L|MTH^Mother^HL70063|1360 Kmsterdam St^^Grand Rapids^MI^49510^USA^P|^PRN^PH^^^616^3018552ORC|RE||BN61B25470.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN61B25470.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||58160-0907-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0907-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S95F25475^^^AIRA-TEST^MR||LapeerAIRA^JusticeAIRA^Orana^^^^L|TrumbullAIRA^MasaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1136 Rozendaal Ave^^South Lyon^MI^48178^USA^P||^PRN^PH^^^248^2691912|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LapeerAIRA^TrumbullAIRA^^^^^L|MTH^Mother^HL70063|1136 Rozendaal Ave^^South Lyon^MI^48178^USA^P|^PRN^PH^^^248^2691912ORC|RE||BS95F25475.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS95F25475.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||58160-0907-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0955-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R91S25483^^^AIRA-TEST^MR||WayrynenAIRA^AskiniAIRA^Harley^^^^L|NanceAIRA^LatriceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1552 Keeze-Leende Ln^^Grand Rapids^MI^49534^USA^P||^PRN^PH^^^616^2305692|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayrynenAIRA^NanceAIRA^^^^^L|MTH^Mother^HL70063|1552 Keeze-Leende Ln^^Grand Rapids^MI^49534^USA^P|^PRN^PH^^^616^2305692ORC|RE||BR91S25483.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR91S25483.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0955-09^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0958-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A18W25494^^^AIRA-TEST^MR||HarrisAIRA^CynaraAIRA^Aliyah^^^^L|OtterstromAIRA^GenjiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1235 Muidplas Cir^^Hopkins^MI^49328^USA^P||^PRN^PH^^^269^9543728|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisAIRA^OtterstromAIRA^^^^^L|MTH^Mother^HL70063|1235 Muidplas Cir^^Hopkins^MI^49328^USA^P|^PRN^PH^^^269^9543728ORC|RE||BA18W25494.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA18W25494.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0958-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0959-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T71C25502^^^AIRA-TEST^MR||GeneseeAIRA^JarviaAIRA^Decima^^^^L|KjerulfAIRA^SheelaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1614 Bill en Sint Hubert Cir^^Charlevoix^MI^49711^USA^P||^PRN^PH^^^231^7323506|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeneseeAIRA^KjerulfAIRA^^^^^L|MTH^Mother^HL70063|1614 Bill en Sint Hubert Cir^^Charlevoix^MI^49711^USA^P|^PRN^PH^^^231^7323506ORC|RE||BT71C25502.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT71C25502.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0959-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|148^Meningococcal C/Y-Hib PRP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|19981216||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0964-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O86I25510^^^AIRA-TEST^MR||AshlandAIRA^LeilaniAIRA^Tourmaline^^^^L|Le FloreAIRA^MaliyahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1415 Waarnemen Cir^^Macomb^MI^48044^USA^P||^PRN^PH^^^586^7390856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AshlandAIRA^Le FloreAIRA^^^^^L|MTH^Mother^HL70063|1415 Waarnemen Cir^^Macomb^MI^48044^USA^P|^PRN^PH^^^586^7390856ORC|RE||BO86I25510.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO86I25510.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0964-12^RABAVERT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0966-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P80M25515^^^AIRA-TEST^MR||MorrosAIRA^CauveryAIRA^Jocosa^^^^L|ClackamasAIRA^IdoniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1971 Zat St^^Mott Park^MI^48504^USA^P||^PRN^PH^^^810^5055338|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrosAIRA^ClackamasAIRA^^^^^L|MTH^Mother^HL70063|1971 Zat St^^Mott Park^MI^48504^USA^P|^PRN^PH^^^810^5055338ORC|RE||BP80M25515.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP80M25515.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0966-01^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0966-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A37B25523^^^AIRA-TEST^MR||GlasscockAIRA^AbeoAIRA^Rinzen^^^^L|DallamAIRA^HazelAIRA^^^^^M|20160819|F||2106-3^White^CDCREC|1816 Bcheemda St^^Fort Gratiot Township^MI^48059^USA^P||^PRN^PH^^^810^9101318|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GlasscockAIRA^DallamAIRA^^^^^L|MTH^Mother^HL70063|1816 Bcheemda St^^Fort Gratiot Township^MI^48059^USA^P|^PRN^PH^^^810^9101318ORC|RE||BA37B25523.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161019||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA37B25523.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161219||58160-0966-12^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161219||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0976-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V69L25534^^^AIRA-TEST^MR||LueatosAIRA^LyndaAIRA^Bree^^^^L|HarrisonAIRA^AzraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1028 Mpe Ln^^GR^MI^49514^USA^P||^PRN^PH^^^616^3829904|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LueatosAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1028 Mpe Ln^^GR^MI^49514^USA^P|^PRN^PH^^^616^3829904ORC|RE||BV69L25534.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV69L25534.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0976-02^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0976-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C33M25542^^^AIRA-TEST^MR||CamasAIRA^ChristieAIRA^Sevati^^^^L|LouisaAIRA^SitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1740 Butten Pl^^Saginaw^MI^48608^USA^P||^PRN^PH^^^989^3761639|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CamasAIRA^LouisaAIRA^^^^^L|MTH^Mother^HL70063|1740 Butten Pl^^Saginaw^MI^48608^USA^P|^PRN^PH^^^989^3761639ORC|RE||BC33M25542.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC33M25542.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0976-06^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-0976-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K71L25550^^^AIRA-TEST^MR||FairfieldAIRA^KylieAIRA^Namiko^^^^L|SaundersAIRA^NoniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1820 Bchagen Pl^^Turner^MI^48765^USA^P||^PRN^PH^^^989^8074185|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FairfieldAIRA^SaundersAIRA^^^^^L|MTH^Mother^HL70063|1820 Bchagen Pl^^Turner^MI^48765^USA^P|^PRN^PH^^^989^8074185ORC|RE||BK71L25550.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK71L25550.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-0976-20^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SKB^GlaxoSmithKline^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|163^Meningococcal B VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20160809||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62195-0051-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H60A25555^^^AIRA-TEST^MR||CochiseAIRA^IrvetteAIRA^Nancy^^^^L|KartwoldAIRA^DianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1112 Nint-Michielsgestel Ave^^Lansing^MI^48956^USA^P||^PRN^PH^^^517^2284254|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CochiseAIRA^KartwoldAIRA^^^^^L|MTH^Mother^HL70063|1112 Nint-Michielsgestel Ave^^Lansing^MI^48956^USA^P|^PRN^PH^^^517^2284254ORC|RE||BH60A25555.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH60A25555.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62195-0051-01^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62195-0051-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B75J25563^^^AIRA-TEST^MR||OttawaAIRA^JaydaAIRA^Shannah^^^^L|HockingAIRA^KordeliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1295 Heimerswaal Ln^^Saginaw^MI^48603^USA^P||^PRN^PH^^^989^8844621|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OttawaAIRA^HockingAIRA^^^^^L|MTH^Mother^HL70063|1295 Heimerswaal Ln^^Saginaw^MI^48603^USA^P|^PRN^PH^^^989^8844621ORC|RE||BB75J25563.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB75J25563.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62195-0051-10^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||VAL^Valneva^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|134^Japanese Encephalitis VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20140124||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-0613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H51T25574^^^AIRA-TEST^MR||GrundyAIRA^LanaiAIRA^Sonam^^^^L|ShiawasseeAIRA^KaridaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1944 King St^^Detroit^MI^48216^USA^P||^PRN^PH^^^313^4401179|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrundyAIRA^ShiawasseeAIRA^^^^^L|MTH^Mother^HL70063|1944 King St^^Detroit^MI^48216^USA^P|^PRN^PH^^^313^4401179ORC|RE||BH51T25574.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH51T25574.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||62577-0613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-0613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y43O25582^^^AIRA-TEST^MR||KittitasAIRA^AmdisAIRA^Easter^^^^L|EllisAIRA^NessaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1704 Touw Ln^^Cascade Township^MI^49546^USA^P||^PRN^PH^^^616^9905004|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KittitasAIRA^EllisAIRA^^^^^L|MTH^Mother^HL70063|1704 Touw Ln^^Cascade Township^MI^49546^USA^P|^PRN^PH^^^616^9905004ORC|RE||BY43O25582.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY43O25582.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||62577-0613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-0614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E48H25590^^^AIRA-TEST^MR||McMullenAIRA^UlrikeAIRA^Shannelle^^^^L|WashingtonAIRA^LeelaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1261 Bieden Ave^^Filion^MI^48432^USA^P||^PRN^PH^^^989^7776579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McMullenAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1261 Bieden Ave^^Filion^MI^48432^USA^P|^PRN^PH^^^989^7776579ORC|RE||BE48H25590.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE48H25590.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||62577-0614-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-0614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A87M25595^^^AIRA-TEST^MR||RobinsonAIRA^LynseyAIRA^Dulcinea^^^^L|BordenAIRA^AngelineAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1837 Kijkerk Cir^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^5377085|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobinsonAIRA^BordenAIRA^^^^^L|MTH^Mother^HL70063|1837 Kijkerk Cir^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^5377085ORC|RE||BA87M25595.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA87M25595.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||62577-0614-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63361-0245-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I56L25603^^^AIRA-TEST^MR||UvaldeAIRA^FloriaAIRA^Aria^^^^L|RogersAIRA^DayleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1841 Deist Cir^^Tawas City^MI^48764^USA^P||^PRN^PH^^^989^3649488|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UvaldeAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1841 Deist Cir^^Tawas City^MI^48764^USA^P|^PRN^PH^^^989^3649488ORC|RE||BI56L25603.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI56L25603.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63361-0245-10^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63361-0245-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A06V25614^^^AIRA-TEST^MR||UnionAIRA^MichelAIRA^Urania^^^^L|AdsonAIRA^DaralisAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1286 Dmallingerland Pl^^Cascade Township^MI^49546^USA^P||^PRN^PH^^^616^9777788|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^AdsonAIRA^^^^^L|MTH^Mother^HL70063|1286 Dmallingerland Pl^^Cascade Township^MI^49546^USA^P|^PRN^PH^^^616^9777788ORC|RE||BA06V25614.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA06V25614.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63361-0245-58^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|28^DTaP (Diphtheria, Tetanus, Pertussis) Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180824||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0501-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z56X25622^^^AIRA-TEST^MR||RiversideAIRA^JuliannaAIRA^Raphaella^^^^L|BrownAIRA^GalateaAIRA^^^^^M|20160918|F||2106-3^White^CDCREC|1626 Kunseradiel Pl^^Detroit^MI^48202^USA^P||^PRN^PH^^^313^4546313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RiversideAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1626 Kunseradiel Pl^^Detroit^MI^48202^USA^P|^PRN^PH^^^313^4546313ORC|RE||BZ56X25622.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161118||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ56X25622.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170118||63851-0501-01^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170118||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0501-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z83D25630^^^AIRA-TEST^MR||EastlandAIRA^SeverinaAIRA^Narmada^^^^L|MetcalfeAIRA^RadhikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1754 Noorden Cir^^Olivet^MI^49076^USA^P||^PRN^PH^^^269^7078327|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EastlandAIRA^MetcalfeAIRA^^^^^L|MTH^Mother^HL70063|1754 Noorden Cir^^Olivet^MI^49076^USA^P|^PRN^PH^^^269^7078327ORC|RE||BZ83D25630.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ83D25630.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-0501-02^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0511-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M96X25635^^^AIRA-TEST^MR||AdamsAIRA^TiannaAIRA^Jade^^^^L|ColumbiaAIRA^SamulariaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1952 Tegengesteld Ln^^Sylvan Township^MI^48118^USA^P||^PRN^PH^^^734^5460273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1952 Tegengesteld Ln^^Sylvan Township^MI^48118^USA^P|^PRN^PH^^^734^5460273ORC|RE||BM96X25635.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM96X25635.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-0511-11^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|175^Rabies VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20091006||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0612-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L49N25643^^^AIRA-TEST^MR||BooneAIRA^TaniAIRA^Alison^^^^L|LarsenAIRA^ModestusAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1590 Buis Pl^^Buckley^MI^49620^USA^P||^PRN^PH^^^231^2615916|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^LarsenAIRA^^^^^L|MTH^Mother^HL70063|1590 Buis Pl^^Buckley^MI^49620^USA^P|^PRN^PH^^^231^2615916ORC|RE||BL49N25643.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL49N25643.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||63851-0612-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0612-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K26R25654^^^AIRA-TEST^MR||AlfalfaAIRA^GretelAIRA^Ruchika^^^^L|IversenAIRA^OpheliaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1270 Buurman Pl^^Custer^MI^49405^USA^P||^PRN^PH^^^231^2915741|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlfalfaAIRA^IversenAIRA^^^^^L|MTH^Mother^HL70063|1270 Buurman Pl^^Custer^MI^49405^USA^P|^PRN^PH^^^231^2915741ORC|RE||BK26R25654.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK26R25654.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||63851-0612-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H03T25662^^^AIRA-TEST^MR||GreenAIRA^KeilantraAIRA^Liora^^^^L|YubaAIRA^SalimaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1811 Moeder Ave^^Jackson^MI^49201^USA^P||^PRN^PH^^^517^3017866|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreenAIRA^YubaAIRA^^^^^L|MTH^Mother^HL70063|1811 Moeder Ave^^Jackson^MI^49201^USA^P|^PRN^PH^^^517^3017866ORC|RE||BH03T25662.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH03T25662.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||63851-0613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-0613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I39J25670^^^AIRA-TEST^MR||AllamakeeAIRA^ElziraAIRA^Anca^^^^L|GarfieldAIRA^LeighAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1274 Dicht St^^Detroit^MI^48217^USA^P||^PRN^PH^^^313^2462028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllamakeeAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1274 Dicht St^^Detroit^MI^48217^USA^P|^PRN^PH^^^313^2462028ORC|RE||BI39J25670.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI39J25670.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||63851-0613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-64678-0211-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W10G25675^^^AIRA-TEST^MR||GeaugaAIRA^ErisAIRA^Kelda^^^^L|ColonAIRA^OmakaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1575 Sudwest Fryslan St^^Pontiac^MI^48343^USA^P||^PRN^PH^^^248^9451806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeaugaAIRA^ColonAIRA^^^^^L|MTH^Mother^HL70063|1575 Sudwest Fryslan St^^Pontiac^MI^48343^USA^P|^PRN^PH^^^248^9451806ORC|RE||BW10G25675.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW10G25675.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||64678-0211-01^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MIP^Emergent BioDefense Operations Lansing^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|24^Anthrax VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180321||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-64678-0211-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W19R25683^^^AIRA-TEST^MR||PsconenAIRA^LizAIRA^Rati^^^^L|ScottAIRA^IsabellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1908 Groen St^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^9616821|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PsconenAIRA^ScottAIRA^^^^^L|MTH^Mother^HL70063|1908 Groen St^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^9616821ORC|RE||BW19R25683.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW19R25683.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||64678-0211-05^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MIP^Emergent BioDefense Operations Lansing^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|24^Anthrax VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20180321||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0107-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I42B25694^^^AIRA-TEST^MR||FresnoAIRA^KhalidaAIRA^Cinderella^^^^L|NightingaleAIRA^RakelAIRA^^^^^M|20091218|F||2106-3^White^CDCREC|1055 Lontferland St^^Brownstwn Township^MI^48134^USA^P||^PRN^PH^^^734^9424420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FresnoAIRA^NightingaleAIRA^^^^^L|MTH^Mother^HL70063|1055 Lontferland St^^Brownstwn Township^MI^48134^USA^P|^PRN^PH^^^734^9424420ORC|RE||BI42B25694.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100218||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI42B25694.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100418||66019-0107-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100418||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0108-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J87V25702^^^AIRA-TEST^MR||BathAIRA^ZandraAIRA^Kesi^^^^L|BrennanAIRA^AkiliAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1067 Mouten Pl^^Baraga^MI^49908^USA^P||^PRN^PH^^^906^7307843|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BathAIRA^BrennanAIRA^^^^^L|MTH^Mother^HL70063|1067 Mouten Pl^^Baraga^MI^49908^USA^P|^PRN^PH^^^906^7307843ORC|RE||BJ87V25702.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ87V25702.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66019-0108-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0108-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P96X25710^^^AIRA-TEST^MR||FremontAIRA^BreannaAIRA^Zuri^^^^L|MickelAIRA^HelinaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1934 Hsten Ln^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^6831885|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremontAIRA^MickelAIRA^^^^^L|MTH^Mother^HL70063|1934 Hsten Ln^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^6831885ORC|RE||BP96X25710.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP96X25710.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66019-0108-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C45J25715^^^AIRA-TEST^MR||GarfieldAIRA^CarleeAIRA^Yejide^^^^L|HancockAIRA^ChalsieAIRA^^^^^M|20120318|F||2106-3^White^CDCREC|1082 Daarle-Nassau Cir^^Detroit^MI^48212^USA^P||^PRN^PH^^^313^9109549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarfieldAIRA^HancockAIRA^^^^^L|MTH^Mother^HL70063|1082 Daarle-Nassau Cir^^Detroit^MI^48212^USA^P|^PRN^PH^^^313^9109549ORC|RE||BC45J25715.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120518||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC45J25715.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120718||66019-0109-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120718||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0109-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I92L25723^^^AIRA-TEST^MR||AdamsAIRA^SanyogitaAIRA^Jolan^^^^L|IronAIRA^CheyanneAIRA^^^^^M|20120318|F||2106-3^White^CDCREC|1352 Vloeistof Cir^^Remus^MI^49340^USA^P||^PRN^PH^^^989^9954574|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^IronAIRA^^^^^L|MTH^Mother^HL70063|1352 Vloeistof Cir^^Remus^MI^49340^USA^P|^PRN^PH^^^989^9954574ORC|RE||BI92L25723.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120518||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI92L25723.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120718||66019-0109-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120718||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0110-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T53E25734^^^AIRA-TEST^MR||HoltAIRA^LitaAIRA^Sachi^^^^L|ManisteeAIRA^ElysiaAIRA^^^^^M|20130317|F||2106-3^White^CDCREC|1627 Dubbel Cir^^Jackson^MI^49201^USA^P||^PRN^PH^^^517^2504847|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoltAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1627 Dubbel Cir^^Jackson^MI^49201^USA^P|^PRN^PH^^^517^2504847ORC|RE||BT53E25734.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130517||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT53E25734.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130717||66019-0110-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130717||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T02G25742^^^AIRA-TEST^MR||CallowayAIRA^AnnunziataAIRA^Emmett^^^^L|PenobscotAIRA^SamuelaAIRA^^^^^M|20130317|F||2106-3^White^CDCREC|1058 Ware Pl^^West Bloomfield^MI^48324^USA^P||^PRN^PH^^^248^7647043|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CallowayAIRA^PenobscotAIRA^^^^^L|MTH^Mother^HL70063|1058 Ware Pl^^West Bloomfield^MI^48324^USA^P|^PRN^PH^^^248^7647043ORC|RE||BT02G25742.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130517||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT02G25742.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130717||66019-0110-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130717||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B62Q25750^^^AIRA-TEST^MR||Santa CruzAIRA^HansineAIRA^Clodia^^^^L|OxfordAIRA^ZoeyAIRA^^^^^M|20091212|F||2106-3^White^CDCREC|1162 Sidden-Delfland Cir^^Hghtn Lk Heights^MI^48630^USA^P||^PRN^PH^^^989^7233499|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa CruzAIRA^OxfordAIRA^^^^^L|MTH^Mother^HL70063|1162 Sidden-Delfland Cir^^Hghtn Lk Heights^MI^48630^USA^P|^PRN^PH^^^989^7233499ORC|RE||BB62Q25750.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100212||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB62Q25750.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100412||66019-0200-01^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100412||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A33M25755^^^AIRA-TEST^MR||BellAIRA^KisaAIRA^Michel^^^^L|ClarkAIRA^NapeaAIRA^^^^^M|20091212|F||2106-3^White^CDCREC|1737 Barendrecht St^^New Baltimore^MI^48051^USA^P||^PRN^PH^^^586^6482756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BellAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1737 Barendrecht St^^New Baltimore^MI^48051^USA^P|^PRN^PH^^^586^6482756ORC|RE||BA33M25755.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100212||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA33M25755.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100412||66019-0200-10^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100412||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0300-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I86S25763^^^AIRA-TEST^MR||SenecaAIRA^LunaAIRA^Columba^^^^L|WagonerAIRA^InezAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1487 Zpmeer Pl^^Brownstown Township^MI^48183^USA^P||^PRN^PH^^^734^7035172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SenecaAIRA^WagonerAIRA^^^^^L|MTH^Mother^HL70063|1487 Zpmeer Pl^^Brownstown Township^MI^48183^USA^P|^PRN^PH^^^734^7035172ORC|RE||BI86S25763.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI86S25763.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66019-0300-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0300-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S16U25774^^^AIRA-TEST^MR||RiversideAIRA^ZaraAIRA^Guddu^^^^L|OmssundAIRA^JoanneAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1812 Sersel Ave^^Grand Jct^MI^49056^USA^P||^PRN^PH^^^269^6582031|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RiversideAIRA^OmssundAIRA^^^^^L|MTH^Mother^HL70063|1812 Sersel Ave^^Grand Jct^MI^49056^USA^P|^PRN^PH^^^269^6582031ORC|RE||BS16U25774.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS16U25774.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66019-0300-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0301-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H24U25782^^^AIRA-TEST^MR||MercerAIRA^CarnaAIRA^Haimi^^^^L|BolgenAIRA^AbaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1709 Synaarlo Ln^^Amway Corp^MI^49355^USA^P||^PRN^PH^^^616^9589157|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercerAIRA^BolgenAIRA^^^^^L|MTH^Mother^HL70063|1709 Synaarlo Ln^^Amway Corp^MI^49355^USA^P|^PRN^PH^^^616^9589157ORC|RE||BH24U25782.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH24U25782.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66019-0301-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U77S25790^^^AIRA-TEST^MR||McCarthyAIRA^SajniAIRA^Ronalda^^^^L|CalaverasAIRA^EmmanuelleAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1866 Neemskerk St^^Dowling^MI^49050^USA^P||^PRN^PH^^^269^3773390|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCarthyAIRA^CalaverasAIRA^^^^^L|MTH^Mother^HL70063|1866 Neemskerk St^^Dowling^MI^49050^USA^P|^PRN^PH^^^269^3773390ORC|RE||BU77S25790.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU77S25790.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66019-0301-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0302-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P35Q25795^^^AIRA-TEST^MR||MadisonAIRA^PalomaAIRA^Raeka^^^^L|BaileyAIRA^GabbyAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1375 Gratis Ave^^Farmington Hills^MI^48333^USA^P||^PRN^PH^^^248^2674037|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^BaileyAIRA^^^^^L|MTH^Mother^HL70063|1375 Gratis Ave^^Farmington Hills^MI^48333^USA^P|^PRN^PH^^^248^2674037ORC|RE||BP35Q25795.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP35Q25795.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66019-0302-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0302-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V93Q25803^^^AIRA-TEST^MR||LucasAIRA^VaruniAIRA^Rere^^^^L|BlairAIRA^BeccalynnAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1057 Lundert Ave^^North Branch^MI^48461^USA^P||^PRN^PH^^^810^8670675|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^BlairAIRA^^^^^L|MTH^Mother^HL70063|1057 Lundert Ave^^North Branch^MI^48461^USA^P|^PRN^PH^^^810^8670675ORC|RE||BV93Q25803.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV93Q25803.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66019-0302-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0303-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G42W25814^^^AIRA-TEST^MR||ProtheroeAIRA^CarleighAIRA^Bobbi^^^^L|WilsonAIRA^HanneAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1955 Nierden St^^Whittemore^MI^48770^USA^P||^PRN^PH^^^989^6812389|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ProtheroeAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1955 Nierden St^^Whittemore^MI^48770^USA^P|^PRN^PH^^^989^6812389ORC|RE||BG42W25814.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG42W25814.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||66019-0303-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0303-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K96E25822^^^AIRA-TEST^MR||JacksonAIRA^KorraAIRA^Coral^^^^L|WoodsAIRA^AishaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1877 Toerdijk St^^Troy^MI^48098^USA^P||^PRN^PH^^^248^6000397|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1877 Toerdijk St^^Troy^MI^48098^USA^P|^PRN^PH^^^248^6000397ORC|RE||BK96E25822.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK96E25822.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||66019-0303-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0304-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U71P25830^^^AIRA-TEST^MR||HallAIRA^GabriellaAIRA^Onida^^^^L|McDonaldAIRA^HemangiAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1213 Lisse Pl^^Moorestown^MI^49651^USA^P||^PRN^PH^^^231^9012017|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HallAIRA^McDonaldAIRA^^^^^L|MTH^Mother^HL70063|1213 Lisse Pl^^Moorestown^MI^49651^USA^P|^PRN^PH^^^231^9012017ORC|RE||BU71P25830.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU71P25830.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||66019-0304-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0304-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N81N25835^^^AIRA-TEST^MR||DavisAIRA^ThanhAIRA^Mardi^^^^L|CowleAIRA^AlyviaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1383 Gewas Ln^^Lansing^MI^48909^USA^P||^PRN^PH^^^517^8084945|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DavisAIRA^CowleAIRA^^^^^L|MTH^Mother^HL70063|1383 Gewas Ln^^Lansing^MI^48909^USA^P|^PRN^PH^^^517^8084945ORC|RE||BN81N25835.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN81N25835.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||66019-0304-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0305-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I94U25843^^^AIRA-TEST^MR||RaumaAIRA^HansineAIRA^Diarria^^^^L|SwindellsAIRA^KeylaAIRA^^^^^M|20181228|F||2106-3^White^CDCREC|1108 Ehenen St^^Freedom Township^MI^48118^USA^P||^PRN^PH^^^734^6155575|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RaumaAIRA^SwindellsAIRA^^^^^L|MTH^Mother^HL70063|1108 Ehenen St^^Freedom Township^MI^48118^USA^P|^PRN^PH^^^734^6155575ORC|RE||BI94U25843.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20190228||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI94U25843.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190429||66019-0305-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190429||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-0305-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W84F25854^^^AIRA-TEST^MR||Contra CostaAIRA^MinelliAIRA^Zara^^^^L|LassenAIRA^YesminaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1039 Dal Ave^^Lake Odessa^MI^48849^USA^P||^PRN^PH^^^616^8015569|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Contra CostaAIRA^LassenAIRA^^^^^L|MTH^Mother^HL70063|1039 Dal Ave^^Lake Odessa^MI^48849^USA^P|^PRN^PH^^^616^8015569ORC|RE||BW84F25854.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW84F25854.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-0305-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MED^MedImmune, Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q63W25862^^^AIRA-TEST^MR||JacintoAIRA^GilbertaAIRA^Doreen^^^^L|BaragaAIRA^EfterpiAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1374 Selsen Cir^^Grand Blanc^MI^48480^USA^P||^PRN^PH^^^810^9313300|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacintoAIRA^BaragaAIRA^^^^^L|MTH^Mother^HL70063|1374 Selsen Cir^^Grand Blanc^MI^48480^USA^P|^PRN^PH^^^810^9313300ORC|RE||BQ63W25862.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ63W25862.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0000-01^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0000-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C89C25870^^^AIRA-TEST^MR||SacramentoAIRA^AkasmaAIRA^Daksha^^^^L|O NeillAIRA^ShylaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1577 Girschot Pl^^Beulah^MI^49617^USA^P||^PRN^PH^^^231^8429309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SacramentoAIRA^O NeillAIRA^^^^^L|MTH^Mother^HL70063|1577 Girschot Pl^^Beulah^MI^49617^USA^P|^PRN^PH^^^231^8429309ORC|RE||BC89C25870.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC89C25870.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0000-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0112-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B29M25875^^^AIRA-TEST^MR||HoeyAIRA^GeorginaAIRA^Caley^^^^L|SilowAIRA^MorenwynAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1231 Pemert-Bakel Ave^^Point Aux Pin^MI^49775^USA^P||^PRN^PH^^^231^2643108|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoeyAIRA^SilowAIRA^^^^^L|MTH^Mother^HL70063|1231 Pemert-Bakel Ave^^Point Aux Pin^MI^49775^USA^P|^PRN^PH^^^231^2643108ORC|RE||BB29M25875.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB29M25875.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||66521-0112-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0112-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N54B25883^^^AIRA-TEST^MR||BordenAIRA^NatashaAIRA^Reman^^^^L|AndroscogginAIRA^FionaAIRA^^^^^M|20100228|F||2106-3^White^CDCREC|1230 Kopen Ave^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^5408771|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BordenAIRA^AndroscogginAIRA^^^^^L|MTH^Mother^HL70063|1230 Kopen Ave^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^5408771ORC|RE||BN54B25883.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN54B25883.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100629||66521-0112-10^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0113-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M19U25894^^^AIRA-TEST^MR||JonesAIRA^SophroniaAIRA^Albinka^^^^L|RoachAIRA^ScarlettAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1016 Daadhoeke Ln^^Indian River^MI^49749^USA^P||^PRN^PH^^^231^6550675|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JonesAIRA^RoachAIRA^^^^^L|MTH^Mother^HL70063|1016 Daadhoeke Ln^^Indian River^MI^49749^USA^P|^PRN^PH^^^231^6550675ORC|RE||BM19U25894.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM19U25894.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66521-0113-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R51Y25902^^^AIRA-TEST^MR||SulitAIRA^AkanaAIRA^Leena^^^^L|SylteAIRA^ElkeAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1130 Dollands Kroon Cir^^Alba^MI^49611^USA^P||^PRN^PH^^^231^2487182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SulitAIRA^SylteAIRA^^^^^L|MTH^Mother^HL70063|1130 Dollands Kroon Cir^^Alba^MI^49611^USA^P|^PRN^PH^^^231^2487182ORC|RE||BR51Y25902.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR51Y25902.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66521-0113-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A49V25910^^^AIRA-TEST^MR||GrahamAIRA^LindaAIRA^Umina^^^^L|LorainAIRA^AbbeyAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1106 Oapendrecht Ln^^Grand Rapids^MI^49502^USA^P||^PRN^PH^^^616^5099003|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrahamAIRA^LorainAIRA^^^^^L|MTH^Mother^HL70063|1106 Oapendrecht Ln^^Grand Rapids^MI^49502^USA^P|^PRN^PH^^^616^5099003ORC|RE||BA49V25910.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA49V25910.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||66521-0114-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W98M25915^^^AIRA-TEST^MR||MickelAIRA^MirrinAIRA^Bohdana^^^^L|OxfordAIRA^IvannaAIRA^^^^^M|20120229|F||2106-3^White^CDCREC|1229 Waddinxveen Ln^^Ann Arbor^MI^48109^USA^P||^PRN^PH^^^734^4549219|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MickelAIRA^OxfordAIRA^^^^^L|MTH^Mother^HL70063|1229 Waddinxveen Ln^^Ann Arbor^MI^48109^USA^P|^PRN^PH^^^734^4549219ORC|RE||BW98M25915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20120429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW98M25915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20120629||66521-0114-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0115-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D56Y25923^^^AIRA-TEST^MR||CowlitzAIRA^CynereAIRA^Connie^^^^L|ClermontAIRA^NetanyaAIRA^^^^^M|20110228|F||2106-3^White^CDCREC|1797 Mde St^^Chippewa Lake^MI^49320^USA^P||^PRN^PH^^^231^6051716|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CowlitzAIRA^ClermontAIRA^^^^^L|MTH^Mother^HL70063|1797 Mde St^^Chippewa Lake^MI^49320^USA^P|^PRN^PH^^^231^6051716ORC|RE||BD56Y25923.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD56Y25923.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110629||66521-0115-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D40K25934^^^AIRA-TEST^MR||GeneseeAIRA^HadassahAIRA^Meckenzie^^^^L|CrosbyAIRA^FawneAIRA^^^^^M|20130228|F||2106-3^White^CDCREC|1068 Vilburg Ln^^Watervliet^MI^49098^USA^P||^PRN^PH^^^269^7572451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeneseeAIRA^CrosbyAIRA^^^^^L|MTH^Mother^HL70063|1068 Vilburg Ln^^Watervliet^MI^49098^USA^P|^PRN^PH^^^269^7572451ORC|RE||BD40K25934.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD40K25934.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130629||66521-0115-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0116-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L72B25942^^^AIRA-TEST^MR||LucasAIRA^VictoriaAIRA^Alysa^^^^L|PoweshiekAIRA^RosemaryAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1896 Bardinxveld-Giessendam Ave^^Grand Rapids^MI^49523^USA^P||^PRN^PH^^^616^3818523|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^PoweshiekAIRA^^^^^L|MTH^Mother^HL70063|1896 Bardinxveld-Giessendam Ave^^Grand Rapids^MI^49523^USA^P|^PRN^PH^^^616^3818523ORC|RE||BL72B25942.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL72B25942.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A61A25950^^^AIRA-TEST^MR||GibbonsAIRA^EdenAIRA^Ginette^^^^L|OrangeAIRA^YamiletAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1944 Kampen St^^Fair Haven^MI^48023^USA^P||^PRN^PH^^^810^4302334|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GibbonsAIRA^OrangeAIRA^^^^^L|MTH^Mother^HL70063|1944 Kampen St^^Fair Haven^MI^48023^USA^P|^PRN^PH^^^810^4302334ORC|RE||BA61A25950.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA61A25950.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B37I25955^^^AIRA-TEST^MR||IsdalAIRA^JulianaAIRA^Maribeth^^^^L|OldhamAIRA^AmiraAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1207 Aansluiten Cir^^Pierson^MI^49339^USA^P||^PRN^PH^^^231^6088678|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IsdalAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1207 Aansluiten Cir^^Pierson^MI^49339^USA^P|^PRN^PH^^^231^6088678ORC|RE||BB37I25955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB37I25955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0116-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W74L25963^^^AIRA-TEST^MR||ParkerAIRA^UttaraAIRA^Ginger^^^^L|RomsvigAIRA^AngelicaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1989 Coord-Beveland Ave^^Novi^MI^48374^USA^P||^PRN^PH^^^248^9030561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParkerAIRA^RomsvigAIRA^^^^^L|MTH^Mother^HL70063|1989 Coord-Beveland Ave^^Novi^MI^48374^USA^P|^PRN^PH^^^248^9030561ORC|RE||BW74L25963.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW74L25963.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||66521-0116-12^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0117-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C92H25974^^^AIRA-TEST^MR||MickelAIRA^MerriAIRA^Caragh^^^^L|WashingtonAIRA^MalilaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1480 Ceeuwarden Ln^^Coloma^MI^49038^USA^P||^PRN^PH^^^269^8223975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MickelAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1480 Ceeuwarden Ln^^Coloma^MI^49038^USA^P|^PRN^PH^^^269^8223975ORC|RE||BC92H25974.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC92H25974.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X23C25982^^^AIRA-TEST^MR||GraysonAIRA^HenriettaAIRA^Hippolyta^^^^L|DawsonAIRA^ZariyahAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1881 Buizen Cir^^Clay Township^MI^48001^USA^P||^PRN^PH^^^810^5480416|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GraysonAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1881 Buizen Cir^^Clay Township^MI^48001^USA^P|^PRN^PH^^^810^5480416ORC|RE||BX23C25982.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX23C25982.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A87K25990^^^AIRA-TEST^MR||PierceAIRA^ThistleAIRA^Hidi^^^^L|CastroAIRA^BrennaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1112 Vergelijken Ln^^Iron Mountain^MI^49801^USA^P||^PRN^PH^^^906^2995773|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PierceAIRA^CastroAIRA^^^^^L|MTH^Mother^HL70063|1112 Vergelijken Ln^^Iron Mountain^MI^49801^USA^P|^PRN^PH^^^906^2995773ORC|RE||BA87K25990.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA87K25990.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0117-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W54P25995^^^AIRA-TEST^MR||LycomingAIRA^LillianaAIRA^Rianne^^^^L|BedfordAIRA^DanaAIRA^^^^^M|20150228|F||2106-3^White^CDCREC|1565 Uilburg Pl^^Van Buren Township^MI^48111^USA^P||^PRN^PH^^^734^9588889|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LycomingAIRA^BedfordAIRA^^^^^L|MTH^Mother^HL70063|1565 Uilburg Pl^^Van Buren Township^MI^48111^USA^P|^PRN^PH^^^734^9588889ORC|RE||BW54P25995.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW54P25995.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150629||66521-0117-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0118-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X32R26003^^^AIRA-TEST^MR||SandstromAIRA^DoraAIRA^Mandeep^^^^L|AransasAIRA^CharlotteAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1480 Ofwel Ave^^Nisula^MI^49952^USA^P||^PRN^PH^^^906^9576359|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SandstromAIRA^AransasAIRA^^^^^L|MTH^Mother^HL70063|1480 Ofwel Ave^^Nisula^MI^49952^USA^P|^PRN^PH^^^906^9576359ORC|RE||BX32R26003.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX32R26003.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T13Q26014^^^AIRA-TEST^MR||JohnsonAIRA^AkilaAIRA^Emilee^^^^L|BanbergAIRA^AgathaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1927 Emmen St^^Detroit^MI^48230^USA^P||^PRN^PH^^^313^7779953|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^BanbergAIRA^^^^^L|MTH^Mother^HL70063|1927 Emmen St^^Detroit^MI^48230^USA^P|^PRN^PH^^^313^7779953ORC|RE||BT13Q26014.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT13Q26014.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D76D26022^^^AIRA-TEST^MR||DillAIRA^JazminAIRA^Prachi^^^^L|Van WertAIRA^AriahAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1369 Ierneuzen Pl^^Kentwood^MI^49548^USA^P||^PRN^PH^^^616^5384089|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DillAIRA^Van WertAIRA^^^^^L|MTH^Mother^HL70063|1369 Ierneuzen Pl^^Kentwood^MI^49548^USA^P|^PRN^PH^^^616^5384089ORC|RE||BD76D26022.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD76D26022.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0118-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y43I26030^^^AIRA-TEST^MR||BurlesonAIRA^ZeldaAIRA^Ankita^^^^L|OlsenAIRA^BrisaAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1934 Helmond Ln^^Champion^MI^49814^USA^P||^PRN^PH^^^906^6111398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurlesonAIRA^OlsenAIRA^^^^^L|MTH^Mother^HL70063|1934 Helmond Ln^^Champion^MI^49814^USA^P|^PRN^PH^^^906^6111398ORC|RE||BY43I26030.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY43I26030.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160629||66521-0118-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M39B26035^^^AIRA-TEST^MR||UnionAIRA^EstefaniaAIRA^Sydney^^^^L|TitusAIRA^BrittanyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1067 Gat Cir^^Worth Township^MI^48032^USA^P||^PRN^PH^^^810^5862838|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^TitusAIRA^^^^^L|MTH^Mother^HL70063|1067 Gat Cir^^Worth Township^MI^48032^USA^P|^PRN^PH^^^810^5862838ORC|RE||BM39B26035.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM39B26035.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-0200-02^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-0200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S53V26043^^^AIRA-TEST^MR||SykesAIRA^BiddyAIRA^Vittoria^^^^L|DickinsonAIRA^ParveenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1950 Hladel Ln^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^5091191|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SykesAIRA^DickinsonAIRA^^^^^L|MTH^Mother^HL70063|1950 Hladel Ln^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^5091191ORC|RE||BS53V26043.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS53V26043.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-0200-10^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-69401-0000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q08K26054^^^AIRA-TEST^MR||BohneAIRA^PrashantiAIRA^Brook^^^^L|AllenAIRA^MargotAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1440 Weerenveen Ave^^Auburn Hills^MI^48326^USA^P||^PRN^PH^^^248^9432697|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BohneAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1440 Weerenveen Ave^^Auburn Hills^MI^48326^USA^P|^PRN^PH^^^248^9432697ORC|RE||BQ08K26054.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ08K26054.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||69401-0000-01^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-69401-0000-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B82V26062^^^AIRA-TEST^MR||DawsonAIRA^NikitaAIRA^Juliana^^^^L|WilliamsAIRA^KasaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1966 Maken Ln^^Pontiac^MI^48343^USA^P||^PRN^PH^^^248^3370025|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DawsonAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1966 Maken Ln^^Pontiac^MI^48343^USA^P|^PRN^PH^^^248^3370025ORC|RE||BB82V26062.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB82V26062.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||69401-0000-02^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|25^Typhoid VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120529||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460-0001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E24M26070^^^AIRA-TEST^MR||KyleAIRA^BaakoAIRA^Salima^^^^L|EigumAIRA^AmarisAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1948 Aelft St^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^4565596|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KyleAIRA^EigumAIRA^^^^^L|MTH^Mother^HL70063|1948 Aelft St^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^4565596ORC|RE||BE24M26070.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE24M26070.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460-0001-01^Vaxchora^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|174^Cholera Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170706||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J40D26075^^^AIRA-TEST^MR||HuronAIRA^FawnAIRA^Rasine^^^^L|MontgomeryAIRA^AngelicaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1932 Kalsmeer Ln^^Lowell^MI^49331^USA^P||^PRN^PH^^^616^2304084|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuronAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1932 Kalsmeer Ln^^Lowell^MI^49331^USA^P|^PRN^PH^^^616^2304084ORC|RE||BJ40D26075.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ40D26075.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70460-0002-01^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|174^Cholera Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170706||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460-0002-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C69U26083^^^AIRA-TEST^MR||PsconenAIRA^LucilleAIRA^Zenda^^^^L|GilaAIRA^ValisaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1194 Ve Marne Pl^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^9825945|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PsconenAIRA^GilaAIRA^^^^^L|MTH^Mother^HL70063|1194 Ve Marne Pl^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^9825945ORC|RE||BC69U26083.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC69U26083.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460-0002-02^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PAX^PaxVax^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|174^Cholera Vaccine VIS^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20170706||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D31P26094^^^AIRA-TEST^MR||ShelbyAIRA^SylviaAIRA^Jules^^^^L|BucklesAIRA^ReginaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1945 Dlphen-Chaam Cir^^Jasper^MI^49248^USA^P||^PRN^PH^^^517^3882210|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^BucklesAIRA^^^^^L|MTH^Mother^HL70063|1945 Dlphen-Chaam Cir^^Jasper^MI^49248^USA^P|^PRN^PH^^^517^3882210ORC|RE||BD31P26094.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD31P26094.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0001-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0001-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W25X26102^^^AIRA-TEST^MR||SkagAIRA^ThereseAIRA^Isis^^^^L|UptonAIRA^ZambdaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1329 Dest Maas en Waal St^^Detroit^MI^48230^USA^P||^PRN^PH^^^313^9158570|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkagAIRA^UptonAIRA^^^^^L|MTH^Mother^HL70063|1329 Dest Maas en Waal St^^Detroit^MI^48230^USA^P|^PRN^PH^^^313^9158570ORC|RE||BW25X26102.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW25X26102.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0001-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z36I26110^^^AIRA-TEST^MR||ModocAIRA^KamekoAIRA^Clarissa^^^^L|CusackAIRA^ChristelAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1413 Beppel Ave^^Negaunee^MI^49866^USA^P||^PRN^PH^^^906^4441544|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ModocAIRA^CusackAIRA^^^^^L|MTH^Mother^HL70063|1413 Beppel Ave^^Negaunee^MI^49866^USA^P|^PRN^PH^^^906^4441544ORC|RE||BZ36I26110.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ36I26110.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0002-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0002-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K29S26115^^^AIRA-TEST^MR||HamiltonAIRA^GudduAIRA^Petunia^^^^L|DakotaAIRA^LorisAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1743 Paard Ln^^Saint Johns^MI^48879^USA^P||^PRN^PH^^^989^8961425|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^DakotaAIRA^^^^^L|MTH^Mother^HL70063|1743 Paard Ln^^Saint Johns^MI^48879^USA^P|^PRN^PH^^^989^8961425ORC|RE||BK29S26115.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK29S26115.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0002-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0018-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F42Q26123^^^AIRA-TEST^MR||ColusaAIRA^MeggieAIRA^Afric^^^^L|BlaineAIRA^KlavdiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1355 Schreeuw Ln^^Bronson^MI^49028^USA^P||^PRN^PH^^^517^2213805|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColusaAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1355 Schreeuw Ln^^Bronson^MI^49028^USA^P|^PRN^PH^^^517^2213805ORC|RE||BF42Q26123.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF42Q26123.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-0018-03^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0018-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J26U26134^^^AIRA-TEST^MR||YoloAIRA^RadmillaAIRA^Allie^^^^L|KnoxAIRA^ChilaliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1407 Plotseling Ln^^Crystal Falls^MI^49920^USA^P||^PRN^PH^^^906^5792676|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoloAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1407 Plotseling Ln^^Crystal Falls^MI^49920^USA^P|^PRN^PH^^^906^5792676ORC|RE||BJ26U26134.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ26U26134.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-0018-04^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X13Z26142^^^AIRA-TEST^MR||DouglasAIRA^BarbAIRA^Amani^^^^L|AlpineAIRA^RamlaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1630 Porendijk Cir^^Ira^MI^48023^USA^P||^PRN^PH^^^810^9157091|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DouglasAIRA^AlpineAIRA^^^^^L|MTH^Mother^HL70063|1630 Porendijk Cir^^Ira^MI^48023^USA^P|^PRN^PH^^^810^9157091ORC|RE||BX13Z26142.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX13Z26142.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0119-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0119-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q84B26150^^^AIRA-TEST^MR||ShermanAIRA^JoelleAIRA^Llv^^^^L|TaylorAIRA^LailahAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1692 Zin Pl^^Barlow Branch^MI^49686^USA^P||^PRN^PH^^^231^3005222|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShermanAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1692 Zin Pl^^Barlow Branch^MI^49686^USA^P|^PRN^PH^^^231^3005222ORC|RE||BQ84B26150.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ84B26150.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0119-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0119-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W14U26155^^^AIRA-TEST^MR||O DayAIRA^ErlineAIRA^Niral^^^^L|BinghamAIRA^LukinaAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1779 Aansluiten Ave^^Imlay City^MI^48444^USA^P||^PRN^PH^^^810^9270926|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O DayAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1779 Aansluiten Ave^^Imlay City^MI^48444^USA^P|^PRN^PH^^^810^9270926ORC|RE||BW14U26155.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW14U26155.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0119-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0119-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S09F26163^^^AIRA-TEST^MR||ClayAIRA^LexieAIRA^Clove^^^^L|ChampaignAIRA^ClareAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1274 Woerden Cir^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^2917842|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClayAIRA^ChampaignAIRA^^^^^L|MTH^Mother^HL70063|1274 Woerden Cir^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^2917842ORC|RE||BS09F26163.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS09F26163.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0119-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0120-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W60Q26174^^^AIRA-TEST^MR||HockingAIRA^EverildaAIRA^Jenell^^^^L|HolmesAIRA^LariaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1936 Pmersfoort St^^Flint^MI^48551^USA^P||^PRN^PH^^^810^9338736|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HockingAIRA^HolmesAIRA^^^^^L|MTH^Mother^HL70063|1936 Pmersfoort St^^Flint^MI^48551^USA^P|^PRN^PH^^^810^9338736ORC|RE||BW60Q26174.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW60Q26174.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0120-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A24K26182^^^AIRA-TEST^MR||BeaverAIRA^JutteAIRA^Bambi^^^^L|CameronAIRA^CheyenneAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1164 Oorlog Ave^^Lakewood Club^MI^49457^USA^P||^PRN^PH^^^231^7234755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1164 Oorlog Ave^^Lakewood Club^MI^49457^USA^P|^PRN^PH^^^231^7234755ORC|RE||BA24K26182.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA24K26182.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0120-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y99O26190^^^AIRA-TEST^MR||SpoonerAIRA^MacyAIRA^Charla^^^^L|LoganAIRA^MaritzaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1127 Nooise Meren Ln^^New Lothrop^MI^48460^USA^P||^PRN^PH^^^810^6674687|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SpoonerAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1127 Nooise Meren Ln^^New Lothrop^MI^48460^USA^P|^PRN^PH^^^810^6674687ORC|RE||BY99O26190.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY99O26190.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0120-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F52P26195^^^AIRA-TEST^MR||GregoryAIRA^LuanaAIRA^Marguerite^^^^L|MontgomeryAIRA^WillowAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1658 Bronten St^^Fennville^MI^49408^USA^P||^PRN^PH^^^269^4004085|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GregoryAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1658 Bronten St^^Fennville^MI^49408^USA^P|^PRN^PH^^^269^4004085ORC|RE||BF52P26195.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF52P26195.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0120-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C11X26203^^^AIRA-TEST^MR||WrigleyAIRA^ObeliaAIRA^Sakiko^^^^L|OlssenAIRA^BerniceAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1569 Ns-Hertogenbosch Pl^^Holton^MI^49425^USA^P||^PRN^PH^^^231^9479824|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WrigleyAIRA^OlssenAIRA^^^^^L|MTH^Mother^HL70063|1569 Ns-Hertogenbosch Pl^^Holton^MI^49425^USA^P|^PRN^PH^^^231^9479824ORC|RE||BC11X26203.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC11X26203.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0200-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q16Y26214^^^AIRA-TEST^MR||OwyheeAIRA^LizethAIRA^Dara^^^^L|Cerro GordoAIRA^SabiraAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1342 Upeldoorn Ave^^Quincy^MI^49082^USA^P||^PRN^PH^^^517^7156619|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwyheeAIRA^Cerro GordoAIRA^^^^^L|MTH^Mother^HL70063|1342 Upeldoorn Ave^^Quincy^MI^49082^USA^P|^PRN^PH^^^517^7156619ORC|RE||BQ16Y26214.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ16Y26214.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0200-02^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0200-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R14T26222^^^AIRA-TEST^MR||SaginawAIRA^ShavonneAIRA^Yehudi^^^^L|CornelinsonAIRA^EmersonAIRA^^^^^M|20170228|F||2106-3^White^CDCREC|1012 Gulst Ave^^Kewadin^MI^49648^USA^P||^PRN^PH^^^231^2156582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SaginawAIRA^CornelinsonAIRA^^^^^L|MTH^Mother^HL70063|1012 Gulst Ave^^Kewadin^MI^49648^USA^P|^PRN^PH^^^231^2156582ORC|RE||BR14T26222.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR14T26222.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170629||70461-0200-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0200-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V32Y26230^^^AIRA-TEST^MR||LeeAIRA^GotzoneAIRA^Vinita^^^^L|WebbAIRA^FelicityAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1995 Wcheemda St^^Brighton Township^MI^48116^USA^P||^PRN^PH^^^810^2028235|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^WebbAIRA^^^^^L|MTH^Mother^HL70063|1995 Wcheemda St^^Brighton Township^MI^48116^USA^P|^PRN^PH^^^810^2028235ORC|RE||BV32Y26230.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV32Y26230.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0200-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0201-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N44W26235^^^AIRA-TEST^MR||Roger MillsAIRA^DanaAIRA^Wasima^^^^L|FremontAIRA^BerwynAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1391 Waterland Pl^^Richmond^MI^48062^USA^P||^PRN^PH^^^586^5856484|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Roger MillsAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1391 Waterland Pl^^Richmond^MI^48062^USA^P|^PRN^PH^^^586^5856484ORC|RE||BN44W26235.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN44W26235.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0201-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0201-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D89V26243^^^AIRA-TEST^MR||SkagAIRA^IolantheAIRA^Kitu^^^^L|KlamathAIRA^CecilyAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1622 Dollands Kroon Pl^^Samaria^MI^48177^USA^P||^PRN^PH^^^734^3688134|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkagAIRA^KlamathAIRA^^^^^L|MTH^Mother^HL70063|1622 Dollands Kroon Pl^^Samaria^MI^48177^USA^P|^PRN^PH^^^734^3688134ORC|RE||BD89V26243.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD89V26243.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0201-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P68J26254^^^AIRA-TEST^MR||GarzaAIRA^JyotsnaAIRA^Eloise^^^^L|DuncanAIRA^AvasaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1818 Geweest Ln^^Brunswick^MI^49425^USA^P||^PRN^PH^^^231^9733785|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarzaAIRA^DuncanAIRA^^^^^L|MTH^Mother^HL70063|1818 Geweest Ln^^Brunswick^MI^49425^USA^P|^PRN^PH^^^231^9733785ORC|RE||BP68J26254.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP68J26254.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0301-10^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0301-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L91Y26262^^^AIRA-TEST^MR||WheelerAIRA^AliyaAIRA^Kenna^^^^L|HindsAIRA^NaiaAIRA^^^^^M|20180228|F||2106-3^White^CDCREC|1506 Kerkrade Cir^^Georgetown Township^MI^49428^USA^P||^PRN^PH^^^616^9439747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^HindsAIRA^^^^^L|MTH^Mother^HL70063|1506 Kerkrade Cir^^Georgetown Township^MI^49428^USA^P|^PRN^PH^^^616^9439747ORC|RE||BL91Y26262.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL91Y26262.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180629||70461-0301-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0318-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z97F26270^^^AIRA-TEST^MR||MorganAIRA^SabellaAIRA^Iona^^^^L|GrantAIRA^JoanneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1696 Neerenveen Ln^^Wolverine World Wide^MI^49351^USA^P||^PRN^PH^^^616^2188658|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1696 Neerenveen Ln^^Wolverine World Wide^MI^49351^USA^P|^PRN^PH^^^616^2188658ORC|RE||BZ97F26270.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ97F26270.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-0318-03^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0318-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U08N26275^^^AIRA-TEST^MR||NewberryAIRA^CorazonAIRA^Cheryl^^^^L|HarrisonAIRA^BethanyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1940 Barum Cir^^Monroe^MI^48161^USA^P||^PRN^PH^^^734^3400595|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewberryAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1940 Barum Cir^^Monroe^MI^48161^USA^P|^PRN^PH^^^734^3400595ORC|RE||BU08N26275.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU08N26275.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-0318-04^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R04C26283^^^AIRA-TEST^MR||WoodburyAIRA^MerrynAIRA^Charu^^^^L|HallAIRA^ThorborgAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1391 Hutten Cir^^Fraser^MI^48026^USA^P||^PRN^PH^^^586^2003654|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodburyAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1391 Hutten Cir^^Fraser^MI^48026^USA^P|^PRN^PH^^^586^2003654ORC|RE||BR04C26283.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR04C26283.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-0418-10^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R92J26294^^^AIRA-TEST^MR||NewtonAIRA^YachiAIRA^Katyayani^^^^L|McPhersonAIRA^BrandeeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1011 Neststellingwerf Cir^^Lansing^MI^48929^USA^P||^PRN^PH^^^517^5780824|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewtonAIRA^McPhersonAIRA^^^^^L|MTH^Mother^HL70063|1011 Neststellingwerf Cir^^Lansing^MI^48929^USA^P|^PRN^PH^^^517^5780824ORC|RE||BR92J26294.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR92J26294.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-0418-11^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M94N26302^^^AIRA-TEST^MR||GreggAIRA^ShianAIRA^Melissa^^^^L|TereAIRA^AnarAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1848 Rrimpenerwaard Ln^^Sault S Marie^MI^49786^USA^P||^PRN^PH^^^906^4758217|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreggAIRA^TereAIRA^^^^^L|MTH^Mother^HL70063|1848 Rrimpenerwaard Ln^^Sault S Marie^MI^49786^USA^P|^PRN^PH^^^906^4758217ORC|RE||BM94N26302.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM94N26302.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0614-01^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-0614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G12O26310^^^AIRA-TEST^MR||MenomineeAIRA^KatrenAIRA^Lotta^^^^L|LohmannAIRA^AzizaAIRA^^^^^M|20180912|F||2106-3^White^CDCREC|1066 Besterveld Ave^^Greenville^MI^48838^USA^P||^PRN^PH^^^231^2998674|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenomineeAIRA^LohmannAIRA^^^^^L|MTH^Mother^HL70063|1066 Besterveld Ave^^Greenville^MI^48838^USA^P|^PRN^PH^^^231^2998674ORC|RE||BG12O26310.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20181112||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG12O26310.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20190112||70461-0614-11^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||SEQ^Seqirus^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20190112||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-0470-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K97P26315^^^AIRA-TEST^MR||WilliamsonAIRA^RaquelleAIRA^Tala^^^^L|PecosAIRA^AlishaAIRA^^^^^M|20140228|F||2106-3^White^CDCREC|1484 Gulpen-Wittem Ave^^Detroit^MI^48227^USA^P||^PRN^PH^^^313^8961632|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsonAIRA^PecosAIRA^^^^^L|MTH^Mother^HL70063|1484 Gulpen-Wittem Ave^^Detroit^MI^48227^USA^P|^PRN^PH^^^313^8961632ORC|RE||BK97P26315.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140429||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK97P26315.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140629||76420-0470-10^Physicians EZ Use Flu Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140629||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-0471-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R92O26323^^^AIRA-TEST^MR||CliveAIRA^AdenaAIRA^Ofra^^^^L|MedinaAIRA^SkylerAIRA^^^^^M|20160911|F||2106-3^White^CDCREC|1045 Ware St^^Hadley^MI^48440^USA^P||^PRN^PH^^^810^4612456|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CliveAIRA^MedinaAIRA^^^^^L|MTH^Mother^HL70063|1045 Ware St^^Hadley^MI^48440^USA^P|^PRN^PH^^^810^4612456ORC|RE||BR92O26323.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161111||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR92O26323.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170111||76420-0471-01^Medical Provider Single Use EZ Flu Shot Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170111||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-0482-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O41H26334^^^AIRA-TEST^MR||McPhersonAIRA^ChelsiaAIRA^Kaliska^^^^L|SarpyAIRA^DarleneAIRA^^^^^M|20160911|F||2106-3^White^CDCREC|1653 Nladel Ave^^Chatham^MI^49816^USA^P||^PRN^PH^^^906^8110053|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McPhersonAIRA^SarpyAIRA^^^^^L|MTH^Mother^HL70063|1653 Nladel Ave^^Chatham^MI^49816^USA^P|^PRN^PH^^^906^8110053ORC|RE||BO41H26334.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161111||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO41H26334.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170111||76420-0482-01^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||NOV^Novartis Pharmaceutical Corporation^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170111||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-0483-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E17E26342^^^AIRA-TEST^MR||KaufmanAIRA^PalomiAIRA^Meta^^^^L|ElliottAIRA^MarissaAIRA^^^^^M|20160911|F||2106-3^White^CDCREC|1885 Links St^^Port Sheldon^MI^49460^USA^P||^PRN^PH^^^616^2364189|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KaufmanAIRA^ElliottAIRA^^^^^L|MTH^Mother^HL70063|1885 Links St^^Port Sheldon^MI^49460^USA^P|^PRN^PH^^^616^2364189ORC|RE||BE17E26342.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161111||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE17E26342.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170111||76420-0483-01^Medical Provider Single Use EZ Flu Shot 2013-2014^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||PMC^sanofi pasteur^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|135^Influenza, high dose seasonal^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20150807||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170111||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-OBS-METHOD-VXC40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D41X26350^^^AIRA-TEST^MR||SiegasAIRA^JoselynAIRA^Destry^^^^L|KrogAIRA^SamyeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1176 Kantoor Ln^^Loretto^MI^49852^USA^P||^PRN^PH^^^906^3035935|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SiegasAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1176 Kantoor Ln^^Loretto^MI^49852^USA^P|^PRN^PH^^^906^3035935ORC|RE||BD41X26350.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD41X26350.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-OBS-METHOD-VXC41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B29Z26355^^^AIRA-TEST^MR||MathiesenAIRA^TrilochanaAIRA^Barbara^^^^L|HancockAIRA^HarshaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1129 Betekende Cir^^Argyle^MI^48410^USA^P||^PRN^PH^^^989^3152726|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MathiesenAIRA^HancockAIRA^^^^^L|MTH^Mother^HL70063|1129 Betekende Cir^^Argyle^MI^48410^USA^P|^PRN^PH^^^989^3152726ORC|RE||BB29Z26355.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB29Z26355.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC41^per visit^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PROTECT-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C11R26363^^^AIRA-TEST^MR||HoughtonAIRA^CassiaAIRA^Riane^^^^L|HernandezAIRA^KiskaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1661 Ncht-Susteren Ave^^Alto^MI^49302^USA^P||^PRN^PH^^^616^6379859|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|N||||A|20200308|20200308NK1|1|HoughtonAIRA^HernandezAIRA^^^^^L|MTH^Mother^HL70063|1661 Ncht-Susteren Ave^^Alto^MI^49302^USA^P|^PRN^PH^^^616^6379859ORC|RE||BC11R26363.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC11R26363.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PROTECT-Y|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S49T26374^^^AIRA-TEST^MR||DomoAIRA^ToraAIRA^Greta^^^^L|HindsAIRA^AlejandraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1953 Lift Ave^^Howell^MI^48863^USA^P||^PRN^PH^^^517^6269785|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|Y||||A|20200308|20200308NK1|1|DomoAIRA^HindsAIRA^^^^^L|MTH^Mother^HL70063|1953 Lift Ave^^Howell^MI^48863^USA^P|^PRN^PH^^^517^6269785ORC|RE||BS49T26374.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS49T26374.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S58U26382^^^AIRA-TEST^MR||ChambersAIRA^MyrtleAIRA^Shantah^^^^L|BoyleAIRA^MorganAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1954 Krimpenerwaard St^^Four Mile Lake^MI^48130^USA^P||^PRN^PH^^^734^5361127|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||01^No reminder/recall^HL70215|||||A|20200308|20200308NK1|1|ChambersAIRA^BoyleAIRA^^^^^L|MTH^Mother^HL70063|1954 Krimpenerwaard St^^Four Mile Lake^MI^48130^USA^P|^PRN^PH^^^734^5361127ORC|RE||BS58U26382.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS58U26382.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76A26390^^^AIRA-TEST^MR||EricksonAIRA^MelissaAIRA^Catava^^^^L|FerryAIRA^MinetteAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1881 Beeuwarden Ave^^Kawkawlin^MI^48631^USA^P||^PRN^PH^^^989^9346607|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/recall - any method^HL70215|||||A|20200308|20200308NK1|1|EricksonAIRA^FerryAIRA^^^^^L|MTH^Mother^HL70063|1881 Beeuwarden Ave^^Kawkawlin^MI^48631^USA^P|^PRN^PH^^^989^9346607ORC|RE||BG76A26390.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG76A26390.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H27D26395^^^AIRA-TEST^MR||MontgomeryAIRA^NeroliAIRA^Ciannait^^^^L|DunnAIRA^LeticiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1017 Wedum St^^North Manitou^MI^49654^USA^P||^PRN^PH^^^231^2825201|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||03^Reminder/recall - no calls^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^DunnAIRA^^^^^L|MTH^Mother^HL70063|1017 Wedum St^^North Manitou^MI^49654^USA^P|^PRN^PH^^^231^2825201ORC|RE||BH27D26395.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH27D26395.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R24W26403^^^AIRA-TEST^MR||LyonAIRA^AnaliaAIRA^Ilaria^^^^L|EricksonAIRA^ZennorAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1919 Dordrecht Ln^^Atlanta^MI^49709^USA^P||^PRN^PH^^^989^9800272|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||04^Reminder only - any method^HL70215|||||A|20200308|20200308NK1|1|LyonAIRA^EricksonAIRA^^^^^L|MTH^Mother^HL70063|1919 Dordrecht Ln^^Atlanta^MI^49709^USA^P|^PRN^PH^^^989^9800272ORC|RE||BR24W26403.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR24W26403.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N82C26414^^^AIRA-TEST^MR||BrownfieldAIRA^TrixyAIRA^Joelliane^^^^L|WotherspoonAIRA^KaneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1759 Schiedam Ave^^Pelkie^MI^49958^USA^P||^PRN^PH^^^906^6772528|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||05^Reminder only - no calls^HL70215|||||A|20200308|20200308NK1|1|BrownfieldAIRA^WotherspoonAIRA^^^^^L|MTH^Mother^HL70063|1759 Schiedam Ave^^Pelkie^MI^49958^USA^P|^PRN^PH^^^906^6772528ORC|RE||BN82C26414.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN82C26414.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T03D26422^^^AIRA-TEST^MR||LawrenceAIRA^TitianAIRA^Tenzing^^^^L|WheelerAIRA^NydiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1500 Sterven St^^Baraga^MI^49908^USA^P||^PRN^PH^^^906^9081971|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||06^Recall only - any method^HL70215|||||A|20200308|20200308NK1|1|LawrenceAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1500 Sterven St^^Baraga^MI^49908^USA^P|^PRN^PH^^^906^9081971ORC|RE||BT03D26422.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT03D26422.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M66H26430^^^AIRA-TEST^MR||ClintonAIRA^LisabetAIRA^Lizette^^^^L|McCleanAIRA^CarissaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1645 Hudewater St^^Laingsburg^MI^48848^USA^P||^PRN^PH^^^517^2743908|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||07^Recall only - no calls^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^McCleanAIRA^^^^^L|MTH^Mother^HL70063|1645 Hudewater St^^Laingsburg^MI^48848^USA^P|^PRN^PH^^^517^2743908ORC|RE||BM66H26430.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM66H26430.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T59Y26435^^^AIRA-TEST^MR||DauphinAIRA^MirandaAIRA^Nitu^^^^L|ManningAIRA^KenyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1576 Dchtkarspelen Ln^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^8618838|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||08^Reminder/recall - to provider^HL70215|||||A|20200308|20200308NK1|1|DauphinAIRA^ManningAIRA^^^^^L|MTH^Mother^HL70063|1576 Dchtkarspelen Ln^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^8618838ORC|RE||BT59Y26435.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT59Y26435.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F10Y26443^^^AIRA-TEST^MR||JeffersonAIRA^FarahAIRA^Prudence^^^^L|SonomaAIRA^CollettaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1668 Delmond Cir^^GR^MI^49501^USA^P||^PRN^PH^^^616^8019295|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||09^Reminder to provider^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^SonomaAIRA^^^^^L|MTH^Mother^HL70063|1668 Delmond Cir^^GR^MI^49501^USA^P|^PRN^PH^^^616^8019295ORC|RE||BF10Y26443.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF10Y26443.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A65S26454^^^AIRA-TEST^MR||BarrettAIRA^LourdesAIRA^Bertha^^^^L|GoodingAIRA^MachiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1530 Vliegtuig Ave^^Flint^MI^48502^USA^P||^PRN^PH^^^810^8951409|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||10^Only reminder to provider, no recall^HL70215|||||A|20200308|20200308NK1|1|BarrettAIRA^GoodingAIRA^^^^^L|MTH^Mother^HL70063|1530 Vliegtuig Ave^^Flint^MI^48502^USA^P|^PRN^PH^^^810^8951409ORC|RE||BA65S26454.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA65S26454.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y93D26462^^^AIRA-TEST^MR||GraysonAIRA^HayleeAIRA^Candie^^^^L|IversenAIRA^VerrinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1759 Win Ave^^Copper Harbor^MI^49918^USA^P||^PRN^PH^^^906^9591053|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||11^Recall to provider^HL70215|||||A|20200308|20200308NK1|1|GraysonAIRA^IversenAIRA^^^^^L|MTH^Mother^HL70063|1759 Win Ave^^Copper Harbor^MI^49918^USA^P|^PRN^PH^^^906^9591053ORC|RE||BY93D26462.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY93D26462.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-PUBLICITY-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H51T26470^^^AIRA-TEST^MR||AshtabulaAIRA^SummerAIRA^Alexia^^^^L|BlancoAIRA^MorenwynAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1471 Rs-Hertogenbosch Ln^^Ypsilanti^MI^48197^USA^P||^PRN^PH^^^734^7934258|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||12^Only recall to provider, no reminder^HL70215|||||A|20200308|20200308NK1|1|AshtabulaAIRA^BlancoAIRA^^^^^L|MTH^Mother^HL70063|1471 Rs-Hertogenbosch Ln^^Ypsilanti^MI^48197^USA^P|^PRN^PH^^^734^7934258ORC|RE||BH51T26470.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH51T26470.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-1002-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M92O26475^^^AIRA-TEST^MR||HickmanAIRA^SiranAIRA^Dulce^^^^L|WaschingAIRA^NataliaAIRA^^^^^M|20160107|F||1002-5^American Indian or Alaska Native^HL70005|1757 Nutten St^^Ann Arbor^MI^48113^USA^P||^PRN^PH^^^734^2897939|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HickmanAIRA^WaschingAIRA^^^^^L|MTH^Mother^HL70063|1757 Nutten St^^Ann Arbor^MI^48113^USA^P|^PRN^PH^^^734^2897939ORC|RE||BM92O26475.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM92O26475.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2028-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A31V26483^^^AIRA-TEST^MR||ErieAIRA^AldercyAIRA^Sharni^^^^L|RunnelsAIRA^AmiceAIRA^^^^^M|20160107|F||2028-9^Asian^HL70005|1714 Mint-Oedenrode Ave^^Stanwood^MI^49346^USA^P||^PRN^PH^^^231^8191436|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErieAIRA^RunnelsAIRA^^^^^L|MTH^Mother^HL70063|1714 Mint-Oedenrode Ave^^Stanwood^MI^49346^USA^P|^PRN^PH^^^231^8191436ORC|RE||BA31V26483.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA31V26483.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2034-7|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V95T26494^^^AIRA-TEST^MR||MontgomeryAIRA^AtmajaAIRA^Clarice^^^^L|CumingAIRA^TressaAIRA^^^^^M|20160107|F||2034-7^Chinese^HL70005|1316 Minnenmaas Ln^^Columbus^MI^48063^USA^P||^PRN^PH^^^810^5153581|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^CumingAIRA^^^^^L|MTH^Mother^HL70063|1316 Minnenmaas Ln^^Columbus^MI^48063^USA^P|^PRN^PH^^^810^5153581ORC|RE||BV95T26494.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV95T26494.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2036-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H40B26502^^^AIRA-TEST^MR||TuscolaAIRA^BetseyAIRA^Jennifer^^^^L|SabineAIRA^BlaineAIRA^^^^^M|20160107|F||2036-2^Filipino^HL70005|1317 Mchagen St^^Eben Junction^MI^49826^USA^P||^PRN^PH^^^906^7442485|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuscolaAIRA^SabineAIRA^^^^^L|MTH^Mother^HL70063|1317 Mchagen St^^Eben Junction^MI^49826^USA^P|^PRN^PH^^^906^7442485ORC|RE||BH40B26502.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH40B26502.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2039-6|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z11Y26510^^^AIRA-TEST^MR||ProvidenceAIRA^MorillaAIRA^Angelina^^^^L|UvaldeAIRA^MurphyAIRA^^^^^M|20160107|F||2039-6^Japanese^HL70005|1290 Diepe Ave^^Troy^MI^48098^USA^P||^PRN^PH^^^248^4396735|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ProvidenceAIRA^UvaldeAIRA^^^^^L|MTH^Mother^HL70063|1290 Diepe Ave^^Troy^MI^48098^USA^P|^PRN^PH^^^248^4396735ORC|RE||BZ11Y26510.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ11Y26510.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2054-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K00K26515^^^AIRA-TEST^MR||ColoradoAIRA^MirrinAIRA^Rosy^^^^L|IrvingAIRA^ShereeAIRA^^^^^M|20160107|F||2054-5^Black or African-American^HL70005|1654 Earen Pl^^Tipton^MI^49287^USA^P||^PRN^PH^^^517^9976494|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColoradoAIRA^IrvingAIRA^^^^^L|MTH^Mother^HL70063|1654 Earen Pl^^Tipton^MI^49287^USA^P|^PRN^PH^^^517^9976494ORC|RE||BK00K26515.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK00K26515.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2076-8|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F29H26523^^^AIRA-TEST^MR||CusackAIRA^DreamaAIRA^Penny^^^^L|PasoAIRA^AletheaAIRA^^^^^M|20160107|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|1630 Oeek Ln^^Chrysler Corporation^MI^48288^USA^P||^PRN^PH^^^313^4083350|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusackAIRA^PasoAIRA^^^^^L|MTH^Mother^HL70063|1630 Oeek Ln^^Chrysler Corporation^MI^48288^USA^P|^PRN^PH^^^313^4083350ORC|RE||BF29H26523.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF29H26523.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2106-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X73M26534^^^AIRA-TEST^MR||KingAIRA^BashaAIRA^Lilah^^^^L|MononaAIRA^ThaisAIRA^^^^^M|20160107|F||2106-3^White^HL70005|1537 Wint Anthonis Ave^^Rochester Hills^MI^48306^USA^P||^PRN^PH^^^248^5566801|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KingAIRA^MononaAIRA^^^^^L|MTH^Mother^HL70063|1537 Wint Anthonis Ave^^Rochester Hills^MI^48306^USA^P|^PRN^PH^^^248^5566801ORC|RE||BX73M26534.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX73M26534.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2131-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L63R26542^^^AIRA-TEST^MR||EliasonAIRA^MaizahAIRA^Nitika^^^^L|BrownAIRA^NatalieAIRA^^^^^M|20160107|F||2131-1^Other Race^HL70005|1872 Eemert-Bakel Ln^^Barton City^MI^48705^USA^P||^PRN^PH^^^989^3022516|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EliasonAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1872 Eemert-Bakel Ln^^Barton City^MI^48705^USA^P|^PRN^PH^^^989^3022516ORC|RE||BL63R26542.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL63R26542.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2135-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U43O26550^^^AIRA-TEST^MR||StevensAIRA^NarellaAIRA^Fiona^^^^L|McDonaldAIRA^CantaraAIRA^^^^^M|20160107|F||2135-2^Hispanic or Latino^HL70005|1024 Ooxmeer Pl^^Detroit^MI^48220^USA^P||^PRN^PH^^^248^7749984|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StevensAIRA^McDonaldAIRA^^^^^L|MTH^Mother^HL70063|1024 Ooxmeer Pl^^Detroit^MI^48220^USA^P|^PRN^PH^^^248^7749984ORC|RE||BU43O26550.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU43O26550.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-2186-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D39N26555^^^AIRA-TEST^MR||YavapaiAIRA^MyieshaAIRA^Mona^^^^L|FillmoreAIRA^KorraAIRA^^^^^M|20160107|F||2186-5^not Hispanic or Latino^HL70005|1062 Poorst Ave^^Farmington Hls^MI^48334^USA^P||^PRN^PH^^^248^9234435|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YavapaiAIRA^FillmoreAIRA^^^^^L|MTH^Mother^HL70063|1062 Poorst Ave^^Farmington Hls^MI^48334^USA^P|^PRN^PH^^^248^9234435ORC|RE||BD39N26555.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD39N26555.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-A|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P35Q26563^^^AIRA-TEST^MR||PotterAIRA^PhotiniAIRA^Caitrin^^^^L|DelawareAIRA^MakaylaAIRA^^^^^M|20160107|F||A^Asian or Pacific Islander^HL70005|1471 Nden Ave^^Flint^MI^48557^USA^P||^PRN^PH^^^810^8961887|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PotterAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1471 Nden Ave^^Flint^MI^48557^USA^P|^PRN^PH^^^810^8961887ORC|RE||BP35Q26563.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP35Q26563.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q05M26574^^^AIRA-TEST^MR||ShelbyAIRA^LizaAIRA^Ginevra^^^^L|GladwinAIRA^SindyAIRA^^^^^M|20160107|F||B^Black or African-American^HL70005|1821 Leventer Pl^^Dixboro^MI^48105^USA^P||^PRN^PH^^^734^8025585|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^GladwinAIRA^^^^^L|MTH^Mother^HL70063|1821 Leventer Pl^^Dixboro^MI^48105^USA^P|^PRN^PH^^^734^8025585ORC|RE||BQ05M26574.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ05M26574.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-I|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H58R26582^^^AIRA-TEST^MR||FultonAIRA^MahuruAIRA^Miakoda^^^^L|MercerAIRA^HarshitaAIRA^^^^^M|20160107|F||I^American Indian or Alaska Native^HL70005|1168 Hontfoort St^^Clarkston^MI^48346^USA^P||^PRN^PH^^^248^8411015|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FultonAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1168 Hontfoort St^^Clarkston^MI^48346^USA^P|^PRN^PH^^^248^8411015ORC|RE||BH58R26582.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH58R26582.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R66O26590^^^AIRA-TEST^MR||JanttiAIRA^AngevinAIRA^Haylee^^^^L|CaribouAIRA^DonnaAIRA^^^^^M|20160107|F||O^Other Race^HL70005|1115 Sinkelland Cir^^Rochester Hills^MI^48306^USA^P||^PRN^PH^^^248^3479047|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JanttiAIRA^CaribouAIRA^^^^^L|MTH^Mother^HL70063|1115 Sinkelland Cir^^Rochester Hills^MI^48306^USA^P|^PRN^PH^^^248^3479047ORC|RE||BR66O26590.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR66O26590.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S82T26595^^^AIRA-TEST^MR||McEntegartAIRA^ClareAIRA^Thea^^^^L|WheelerAIRA^NeerjaAIRA^^^^^M|20160107|F||U^Unknown^HL70005|1729 Ne Fryske Marren Pl^^Willow^MI^48164^USA^P||^PRN^PH^^^734^4431317|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McEntegartAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1729 Ne Fryske Marren Pl^^Willow^MI^48164^USA^P|^PRN^PH^^^734^4431317ORC|RE||BS82T26595.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS82T26595.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RACE-W|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E09E26603^^^AIRA-TEST^MR||EastlandAIRA^PolomaAIRA^Lynnea^^^^L|MarquetteAIRA^ShelleyAIRA^^^^^M|20160107|F||W^White^HL70005|1075 Edge Ln^^North Star^MI^48862^USA^P||^PRN^PH^^^989^5633373|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EastlandAIRA^MarquetteAIRA^^^^^L|MTH^Mother^HL70063|1075 Edge Ln^^North Star^MI^48862^USA^P|^PRN^PH^^^989^5633373ORC|RE||BE09E26603.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE09E26603.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-REG-STATUS-R|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V58C26614^^^AIRA-TEST^MR||BowieAIRA^LyraAIRA^Roselyn^^^^L|BallAIRA^BarbaraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1341 Ceventer Ln^^Iron Mountain^MI^49801^USA^P||^PRN^PH^^^906^6187694|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||R|20200308|20200308NK1|1|BowieAIRA^BallAIRA^^^^^L|MTH^Mother^HL70063|1341 Ceventer Ln^^Iron Mountain^MI^49801^USA^P|^PRN^PH^^^906^6187694ORC|RE||BV58C26614.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV58C26614.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-ASC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J17Q26622^^^AIRA-TEST^MR||AshtabulaAIRA^RaeleneAIRA^Cecania^^^^L|KlickitatAIRA^AngevinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1316 Team Cir^^Wequetonsing^MI^49740^USA^P||^PRN^PH^^^616^3359451|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AshtabulaAIRA^KlickitatAIRA^^^^^L|ASC^Associate^HL70063|1316 Team Cir^^Wequetonsing^MI^49740^USA^P|^PRN^PH^^^616^3359451ORC|RE||BJ17Q26622.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ17Q26622.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-BRO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B81X26630^^^AIRA-TEST^MR||MeeAIRA^JerushaAIRA^Karida^^^^L|SiouxAIRA^KayleeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1060 Oijdemeren St^^Newaygo^MI^49337^USA^P||^PRN^PH^^^231^9194523|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MeeAIRA^SiouxAIRA^^^^^L|BRO^Brother^HL70063|1060 Oijdemeren St^^Newaygo^MI^49337^USA^P|^PRN^PH^^^231^9194523ORC|RE||BB81X26630.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB81X26630.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-CGV|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J98E26635^^^AIRA-TEST^MR||FultonAIRA^LucilleAIRA^Akuti^^^^L|AlleghenyAIRA^NellekeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1481 Controle St^^Harrison Township^MI^48045^USA^P||^PRN^PH^^^586^6585472|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FultonAIRA^AlleghenyAIRA^^^^^L|CGV^Care Giver^HL70063|1481 Controle St^^Harrison Township^MI^48045^USA^P|^PRN^PH^^^586^6585472ORC|RE||BJ98E26635.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ98E26635.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-CHD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L91W26643^^^AIRA-TEST^MR||BlaineAIRA^ArabellaAIRA^Ryoko^^^^L|CameronAIRA^PriscillaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1331 Leugen Cir^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^5852294|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlaineAIRA^CameronAIRA^^^^^L|CHD^Child^HL70063|1331 Leugen Cir^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^5852294ORC|RE||BL91W26643.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL91W26643.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-DEP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X30A26654^^^AIRA-TEST^MR||MedinaAIRA^EunaAIRA^Bohdana^^^^L|JeromeAIRA^MargaritaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1300 Hontfoort Pl^^Lansing^MI^48922^USA^P||^PRN^PH^^^517^9474162|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MedinaAIRA^JeromeAIRA^^^^^L|DEP^Handicapped dependent^HL70063|1300 Hontfoort Pl^^Lansing^MI^48922^USA^P|^PRN^PH^^^517^9474162ORC|RE||BX30A26654.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX30A26654.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-DOM|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M76S26662^^^AIRA-TEST^MR||HaleAIRA^VaruniAIRA^Liadan^^^^L|GreenupAIRA^HemangiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1624 Lerg en Dal Cir^^Bloomfield Village^MI^48301^USA^P||^PRN^PH^^^248^3093993|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaleAIRA^GreenupAIRA^^^^^L|DOM^Life partner^HL70063|1624 Lerg en Dal Cir^^Bloomfield Village^MI^48301^USA^P|^PRN^PH^^^248^3093993ORC|RE||BM76S26662.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM76S26662.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-EMC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R54K26670^^^AIRA-TEST^MR||JeffersonAIRA^EleanorAIRA^Simoni^^^^L|VintonAIRA^KelilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1139 Dnderbanken St^^Jackson National Life Ins Co^MI^48951^USA^P||^PRN^PH^^^517^9373892|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^VintonAIRA^^^^^L|EMC^Emergency contact^HL70063|1139 Dnderbanken St^^Jackson National Life Ins Co^MI^48951^USA^P|^PRN^PH^^^517^9373892ORC|RE||BR54K26670.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR54K26670.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-EME|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F66I26675^^^AIRA-TEST^MR||SimpsonAIRA^BibiAIRA^Olba^^^^L|CedarAIRA^MorgandyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1807 Manderd Cir^^Midland^MI^48640^USA^P||^PRN^PH^^^989^6613209|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimpsonAIRA^CedarAIRA^^^^^L|EME^Employee^HL70063|1807 Manderd Cir^^Midland^MI^48640^USA^P|^PRN^PH^^^989^6613209ORC|RE||BF66I26675.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF66I26675.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-EMR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D43L26683^^^AIRA-TEST^MR||JohnsonAIRA^SabinaAIRA^Jordan^^^^L|PushmatahaAIRA^WinterAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1443 Sliedrecht Pl^^Traunik^MI^49891^USA^P||^PRN^PH^^^906^8800929|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^PushmatahaAIRA^^^^^L|EMR^Employer^HL70063|1443 Sliedrecht Pl^^Traunik^MI^49891^USA^P|^PRN^PH^^^906^8800929ORC|RE||BD43L26683.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD43L26683.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-EXF|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q01X26694^^^AIRA-TEST^MR||AlamedaAIRA^EliseAIRA^Agneta^^^^L|HellicoskiAIRA^AthaliaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1268 Vollands Kroon Ln^^Clarksville^MI^48815^USA^P||^PRN^PH^^^616^2736125|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlamedaAIRA^HellicoskiAIRA^^^^^L|EXF^Extended family^HL70063|1268 Vollands Kroon Ln^^Clarksville^MI^48815^USA^P|^PRN^PH^^^616^2736125ORC|RE||BQ01X26694.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ01X26694.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-FCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L29J26702^^^AIRA-TEST^MR||BarrenAIRA^EleoraAIRA^Ryann^^^^L|GreenupAIRA^ArtiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1042 Weer Pl^^Hale^MI^48739^USA^P||^PRN^PH^^^989^8566810|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BarrenAIRA^GreenupAIRA^^^^^L|FCH^Foster Child^HL70063|1042 Weer Pl^^Hale^MI^48739^USA^P|^PRN^PH^^^989^8566810ORC|RE||BL29J26702.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL29J26702.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-FND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H80I26710^^^AIRA-TEST^MR||LaRueAIRA^GenevieveAIRA^Celena^^^^L|CannavinAIRA^SagaraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1483 Tytsjerksteradiel Cir^^Palmyra^MI^49268^USA^P||^PRN^PH^^^517^4883021|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaRueAIRA^CannavinAIRA^^^^^L|FND^Friend^HL70063|1483 Tytsjerksteradiel Cir^^Palmyra^MI^49268^USA^P|^PRN^PH^^^517^4883021ORC|RE||BH80I26710.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH80I26710.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-FTH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R39A26715^^^AIRA-TEST^MR||ScottAIRA^ZeeAIRA^Topaz^^^^L|GraysonAIRA^MelanyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1328 Hodegraven-Reeuwijk St^^Huntington Wd^MI^48070^USA^P||^PRN^PH^^^248^4722078|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ScottAIRA^GraysonAIRA^^^^^L|FTH^Father^HL70063|1328 Hodegraven-Reeuwijk St^^Huntington Wd^MI^48070^USA^P|^PRN^PH^^^248^4722078ORC|RE||BR39A26715.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR39A26715.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-GCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X84P26723^^^AIRA-TEST^MR||DalyAIRA^KristabelAIRA^Ytha^^^^L|HughesAIRA^AverilAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1002 Zuurstof Ln^^Perkins^MI^49872^USA^P||^PRN^PH^^^906^6558192|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DalyAIRA^HughesAIRA^^^^^L|GCH^Grandchild^HL70063|1002 Zuurstof Ln^^Perkins^MI^49872^USA^P|^PRN^PH^^^906^6558192ORC|RE||BX84P26723.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX84P26723.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-GRD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I93I26734^^^AIRA-TEST^MR||WashingtonAIRA^EnoraAIRA^Louisa^^^^L|BreathittAIRA^TiffanyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1112 Cuijk Ave^^Leland^MI^49654^USA^P||^PRN^PH^^^231^9796526|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^BreathittAIRA^^^^^L|GRD^Guardian^HL70063|1112 Cuijk Ave^^Leland^MI^49654^USA^P|^PRN^PH^^^231^9796526ORC|RE||BI93I26734.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI93I26734.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-GRP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C86P26742^^^AIRA-TEST^MR||PintoAIRA^AureAIRA^Shika^^^^L|EllisAIRA^TessAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1276 Geerenveen Ln^^Tuscola^MI^48769^USA^P||^PRN^PH^^^989^3166488|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PintoAIRA^EllisAIRA^^^^^L|GRP^Grand Parent^HL70063|1276 Geerenveen Ln^^Tuscola^MI^48769^USA^P|^PRN^PH^^^989^3166488ORC|RE||BC86P26742.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC86P26742.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-MGR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R25V26750^^^AIRA-TEST^MR||GrayAIRA^AchaziaAIRA^Tansy^^^^L|ReevesAIRA^MenuhaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1808 Eon en Breugel St^^Hanover^MI^49241^USA^P||^PRN^PH^^^517^8994480|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrayAIRA^ReevesAIRA^^^^^L|MGR^Manager^HL70063|1808 Eon en Breugel St^^Hanover^MI^49241^USA^P|^PRN^PH^^^517^8994480ORC|RE||BR25V26750.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR25V26750.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-MTH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K11A26755^^^AIRA-TEST^MR||McLennanAIRA^KyonAIRA^Sydney^^^^L|RandallAIRA^AnkaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1392 Oldebroek St^^Allendale^MI^49401^USA^P||^PRN^PH^^^616^2367399|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McLennanAIRA^RandallAIRA^^^^^L|MTH^Mother^HL70063|1392 Oldebroek St^^Allendale^MI^49401^USA^P|^PRN^PH^^^616^2367399ORC|RE||BK11A26755.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK11A26755.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-NCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q87I26763^^^AIRA-TEST^MR||NewtonAIRA^EdenaAIRA^Isis^^^^L|KananenAIRA^TuruaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1434 Heerijnen St^^Grosse Pointe Woods^MI^48236^USA^P||^PRN^PH^^^313^3598238|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewtonAIRA^KananenAIRA^^^^^L|NCH^Natural child^HL70063|1434 Heerijnen St^^Grosse Pointe Woods^MI^48236^USA^P|^PRN^PH^^^313^3598238ORC|RE||BQ87I26763.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ87I26763.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-NON|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G45S26774^^^AIRA-TEST^MR||WarrenAIRA^ShailiAIRA^Philena^^^^L|GrahamAIRA^EdaleneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1093 Kss Pl^^Linwood^MI^48634^USA^P||^PRN^PH^^^989^3966991|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WarrenAIRA^GrahamAIRA^^^^^L|NON^None^HL70063|1093 Kss Pl^^Linwood^MI^48634^USA^P|^PRN^PH^^^989^3966991ORC|RE||BG45S26774.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG45S26774.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-OAD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L53Z26782^^^AIRA-TEST^MR||MillsAIRA^RowenaAIRA^Dharmista^^^^L|CaseyAIRA^ShriAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1832 Suidhorn Pl^^Karlin^MI^49643^USA^P||^PRN^PH^^^231^7396635|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MillsAIRA^CaseyAIRA^^^^^L|OAD^Other adult^HL70063|1832 Suidhorn Pl^^Karlin^MI^49643^USA^P|^PRN^PH^^^231^7396635ORC|RE||BL53Z26782.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL53Z26782.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-OTH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B50M26790^^^AIRA-TEST^MR||ErathAIRA^BrinaAIRA^Sawyer^^^^L|PacificAIRA^AlissaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1418 Renkum Pl^^Gilford^MI^48736^USA^P||^PRN^PH^^^989^7329572|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErathAIRA^PacificAIRA^^^^^L|OTH^Other^HL70063|1418 Renkum Pl^^Gilford^MI^48736^USA^P|^PRN^PH^^^989^7329572ORC|RE||BB50M26790.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB50M26790.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-OWN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O15I26795^^^AIRA-TEST^MR||DimmitAIRA^NadiaAIRA^Marlene^^^^L|KennebecAIRA^DamarisAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1627 Doordwijkerhout Cir^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^8010934|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DimmitAIRA^KennebecAIRA^^^^^L|OWN^Owner^HL70063|1627 Doordwijkerhout Cir^^Belleville^MI^48112^USA^P|^PRN^PH^^^734^8010934ORC|RE||BO15I26795.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO15I26795.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-PAR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B03Z26803^^^AIRA-TEST^MR||AlgerAIRA^CarinaAIRA^Addi^^^^L|WilsonAIRA^LaetitiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1414 Douten Cir^^Ocqueoc^MI^49759^USA^P||^PRN^PH^^^989^8906861|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlgerAIRA^WilsonAIRA^^^^^L|PAR^Parent^HL70063|1414 Douten Cir^^Ocqueoc^MI^49759^USA^P|^PRN^PH^^^989^8906861ORC|RE||BB03Z26803.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB03Z26803.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-SCH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F93W26814^^^AIRA-TEST^MR||MonroeAIRA^BerangerAIRA^Meera^^^^L|MononAIRA^PalomaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1177 Morst aan de Maas Pl^^Muskegon^MI^49444^USA^P||^PRN^PH^^^231^9618497|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MonroeAIRA^MononAIRA^^^^^L|SCH^Step Child^HL70063|1177 Morst aan de Maas Pl^^Muskegon^MI^49444^USA^P|^PRN^PH^^^231^9618497ORC|RE||BF93W26814.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF93W26814.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-SEL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M75A26822^^^AIRA-TEST^MR||WilbargerAIRA^NolaAIRA^Lemuela^^^^L|JensenAIRA^RupalAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1311 Arm Ln^^Ishpeming^MI^49849^USA^P||^PRN^PH^^^906^6955333|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilbargerAIRA^JensenAIRA^^^^^L|SEL^Self^HL70063|1311 Arm Ln^^Ishpeming^MI^49849^USA^P|^PRN^PH^^^906^6955333ORC|RE||BM75A26822.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM75A26822.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-SIB|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I04Q26830^^^AIRA-TEST^MR||AuglaizeAIRA^IsabelAIRA^Ariella^^^^L|ReaganAIRA^DaeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1510 Onmiddellijke St^^Painesdale^MI^49955^USA^P||^PRN^PH^^^906^5720598|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AuglaizeAIRA^ReaganAIRA^^^^^L|SIB^Sibling^HL70063|1510 Onmiddellijke St^^Painesdale^MI^49955^USA^P|^PRN^PH^^^906^5720598ORC|RE||BI04Q26830.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI04Q26830.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-SIS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W56E26835^^^AIRA-TEST^MR||San BernardinoAIRA^OrsolaAIRA^Patience^^^^L|LoupAIRA^GilanaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1824 Kchijndel St^^West Bloomfield^MI^48322^USA^P||^PRN^PH^^^248^5209228|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San BernardinoAIRA^LoupAIRA^^^^^L|SIS^Sister^HL70063|1824 Kchijndel St^^West Bloomfield^MI^48322^USA^P|^PRN^PH^^^248^5209228ORC|RE||BW56E26835.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW56E26835.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-SPO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K66K26843^^^AIRA-TEST^MR||TaylorAIRA^IndaliaiAIRA^Antje^^^^L|McQuadeAIRA^AmaniAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1031 Gergen Cir^^Lake Angelus^MI^48326^USA^P||^PRN^PH^^^248^5118055|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^McQuadeAIRA^^^^^L|SPO^Spouse^HL70063|1031 Gergen Cir^^Lake Angelus^MI^48326^USA^P|^PRN^PH^^^248^5118055ORC|RE||BK66K26843.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK66K26843.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-TRA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y38Q26854^^^AIRA-TEST^MR||YoloAIRA^MenuhaAIRA^Hafwen^^^^L|HarlanAIRA^EvaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1741 Zelfs Ave^^Rochester Hls^MI^48306^USA^P||^PRN^PH^^^248^5276592|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoloAIRA^HarlanAIRA^^^^^L|TRA^Trainer^HL70063|1741 Zelfs Ave^^Rochester Hls^MI^48306^USA^P|^PRN^PH^^^248^5276592ORC|RE||BY38Q26854.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY38Q26854.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-UNK|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M14P26862^^^AIRA-TEST^MR||KinneyAIRA^PeninaAIRA^Ngaire^^^^L|PerryAIRA^ArabellaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1478 Claricum Ave^^Troy^MI^48083^USA^P||^PRN^PH^^^248^8890992|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KinneyAIRA^PerryAIRA^^^^^L|UNK^Unknown^HL70063|1478 Claricum Ave^^Troy^MI^48083^USA^P|^PRN^PH^^^248^8890992ORC|RE||BM14P26862.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM14P26862.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-RELATE-WRD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S03X26870^^^AIRA-TEST^MR||KinnearAIRA^TatyanaAIRA^Fiorella^^^^L|MickelAIRA^PritikaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1514 Hestervoort Pl^^Harrison^MI^48625^USA^P||^PRN^PH^^^989^8311966|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KinnearAIRA^MickelAIRA^^^^^L|WRD^Ward of court^HL70063|1514 Hestervoort Pl^^Harrison^MI^48625^USA^P|^PRN^PH^^^989^8311966ORC|RE||BS03X26870.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS03X26870.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-SEX-F|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O70M26875^^^AIRA-TEST^MR||GreerAIRA^ErikaAIRA^Olivia^^^^L|StarrAIRA^ElmiraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1200 Rerwerderadiel Cir^^Eben Jct^MI^49825^USA^P||^PRN^PH^^^906^5083857|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreerAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1200 Rerwerderadiel Cir^^Eben Jct^MI^49825^USA^P|^PRN^PH^^^906^5083857ORC|RE||BO70M26875.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO70M26875.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-SEX-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U61Q26883^^^AIRA-TEST^MR||YakimaAIRA^RevelationAIRA^Kanushi^^^^L|MissaukeeAIRA^MindyAIRA^^^^^M|20160107|M||2106-3^White^CDCREC|1518 Winkelland St^^Huntingtn Wds^MI^48070^USA^P||^PRN^PH^^^248^8535761|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YakimaAIRA^MissaukeeAIRA^^^^^L|MTH^Mother^HL70063|1518 Winkelland St^^Huntingtn Wds^MI^48070^USA^P|^PRN^PH^^^248^8535761ORC|RE||BU61Q26883.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU61Q26883.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-SEX-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K63R26894^^^AIRA-TEST^MR||WoldAIRA^SuvrataAIRA^Morgen^^^^L|CowlitzAIRA^DrinaAIRA^^^^^M|20160107|O||2106-3^White^CDCREC|1891 Handel Ln^^Gay^MI^49945^USA^P||^PRN^PH^^^906^4032315|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoldAIRA^CowlitzAIRA^^^^^L|MTH^Mother^HL70063|1891 Handel Ln^^Gay^MI^49945^USA^P|^PRN^PH^^^906^4032315ORC|RE||BK63R26894.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK63R26894.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-SEX-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I36G26902^^^AIRA-TEST^MR||PlatteAIRA^KaieAIRA^Sibel^^^^L|OmssundAIRA^ManishaAIRA^^^^^M|20160107|U||2106-3^White^CDCREC|1248 Aidden-Drenthe Ln^^Bloomfield Township^MI^48301^USA^P||^PRN^PH^^^248^2630547|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlatteAIRA^OmssundAIRA^^^^^L|MTH^Mother^HL70063|1248 Aidden-Drenthe Ln^^Bloomfield Township^MI^48301^USA^P|^PRN^PH^^^248^2630547ORC|RE||BI36G26902.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI36G26902.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I65A26910^^^AIRA-TEST^MR||VintonAIRA^UrvasiAIRA^Ciara^^^^L|OakAIRA^TotieAIRA^^^^^M|19960831|F||2106-3^White^CDCREC|1280 Uoggenland Ave^^Barbeau^MI^49710^USA^P||^PRN^PH^^^906^7856266|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VintonAIRA^OakAIRA^^^^^L|MTH^Mother^HL70063|1280 Uoggenland Ave^^Barbeau^MI^49710^USA^P|^PRN^PH^^^906^7856266ORC|RE||BI65A26910.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19961031||01^DTP^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI65A26910.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19961231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19961231||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S07T26915^^^AIRA-TEST^MR||ReevesAIRA^NikkiAIRA^Ryesen^^^^L|DelawareAIRA^JordynAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1212 Moderne Pl^^Port Huron^MI^48061^USA^P||^PRN^PH^^^810^9945309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReevesAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1212 Moderne Pl^^Port Huron^MI^48061^USA^P|^PRN^PH^^^810^9945309ORC|RE||BS07T26915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||02^OPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS07T26915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J64Z26923^^^AIRA-TEST^MR||DeWittAIRA^DianeAIRA^Isabel^^^^L|JasperAIRA^AgnetaAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1543 Kutten Ln^^Meskegon^MI^49445^USA^P||^PRN^PH^^^231^8635057|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeWittAIRA^JasperAIRA^^^^^L|MTH^Mother^HL70063|1543 Kutten Ln^^Meskegon^MI^49445^USA^P|^PRN^PH^^^231^8635057ORC|RE||BJ64Z26923.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||03^MMR^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ64Z26923.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T69L26934^^^AIRA-TEST^MR||LieAIRA^JayleeAIRA^Logan^^^^L|KildahlAIRA^AraceliAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1015 Fijne Ln^^Cornell^MI^49818^USA^P||^PRN^PH^^^906^7936987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LieAIRA^KildahlAIRA^^^^^L|MTH^Mother^HL70063|1015 Fijne Ln^^Cornell^MI^49818^USA^P|^PRN^PH^^^906^7936987ORC|RE||BT69L26934.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||04^Measles and Rubella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT69L26934.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E14O26942^^^AIRA-TEST^MR||SykesAIRA^AndreaAIRA^Ela^^^^L|HardinAIRA^PartheniaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1202 Krechterland Pl^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^5727836|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SykesAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1202 Krechterland Pl^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^5727836ORC|RE||BE14O26942.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||05^measles^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE14O26942.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I95X26950^^^AIRA-TEST^MR||SundeAIRA^VerenaAIRA^Hestia^^^^L|HalsallAIRA^PhaedraAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1519 Poensdrecht St^^Grand Rapids^MI^49504^USA^P||^PRN^PH^^^616^7945828|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SundeAIRA^HalsallAIRA^^^^^L|MTH^Mother^HL70063|1519 Poensdrecht St^^Grand Rapids^MI^49504^USA^P|^PRN^PH^^^616^7945828ORC|RE||BI95X26950.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||06^rubella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI95X26950.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O34V26955^^^AIRA-TEST^MR||FanninAIRA^CailynAIRA^Lizbeth^^^^L|CochranAIRA^DeenaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1396 Gluis Ave^^Garden^MI^49835^USA^P||^PRN^PH^^^906^4568540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FanninAIRA^CochranAIRA^^^^^L|MTH^Mother^HL70063|1396 Gluis Ave^^Garden^MI^49835^USA^P|^PRN^PH^^^906^4568540ORC|RE||BO34V26955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||07^mumps^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO34V26955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C24R26963^^^AIRA-TEST^MR||BayAIRA^BronwenAIRA^Jilli^^^^L|CarterAIRA^LucianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1172 Oalkenburg aan de Geul Pl^^Jeddo^MI^48032^USA^P||^PRN^PH^^^810^2742172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BayAIRA^CarterAIRA^^^^^L|MTH^Mother^HL70063|1172 Oalkenburg aan de Geul Pl^^Jeddo^MI^48032^USA^P|^PRN^PH^^^810^2742172ORC|RE||BC24R26963.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||08^Hep B, adolescent or pediatric^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC24R26963.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F76K26974^^^AIRA-TEST^MR||KennebecAIRA^SigrunAIRA^Karyan^^^^L|McCarthyAIRA^AnahidAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1693 Eytsjerksteradiel Ave^^Deerfield^MI^49238^USA^P||^PRN^PH^^^517^2267876|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KennebecAIRA^McCarthyAIRA^^^^^L|MTH^Mother^HL70063|1693 Eytsjerksteradiel Ave^^Deerfield^MI^49238^USA^P|^PRN^PH^^^517^2267876ORC|RE||BF76K26974.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||09^Td (adult), adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF76K26974.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J81Y26982^^^AIRA-TEST^MR||BurkeAIRA^AkshitaAIRA^Jetta^^^^L|ManisteeAIRA^OliviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1661 Eof van Twente Pl^^Kingsley^MI^49649^USA^P||^PRN^PH^^^231^6370509|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1661 Eof van Twente Pl^^Kingsley^MI^49649^USA^P|^PRN^PH^^^231^6370509ORC|RE||BJ81Y26982.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||10^IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ81Y26982.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F91I26990^^^AIRA-TEST^MR||DomoAIRA^MarisaAIRA^Raphaela^^^^L|SullivanAIRA^ElisabethAIRA^^^^^M|20091023|F||2106-3^White^CDCREC|1361 Cuijk Pl^^Southeast^MI^48529^USA^P||^PRN^PH^^^810^5928112|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DomoAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1361 Cuijk Pl^^Southeast^MI^48529^USA^P|^PRN^PH^^^810^5928112ORC|RE||BF91I26990.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20091223||100^pneumococcal conjugate PCV 7^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF91I26990.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100223||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100223||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G55S26995^^^AIRA-TEST^MR||SowdenAIRA^AzlandAIRA^Geraldine^^^^L|TerrellAIRA^WasemeAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1311 Zud-Beijerland St^^Saint Clair Shores^MI^48080^USA^P||^PRN^PH^^^586^5293251|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SowdenAIRA^TerrellAIRA^^^^^L|MTH^Mother^HL70063|1311 Zud-Beijerland St^^Saint Clair Shores^MI^48080^USA^P|^PRN^PH^^^586^5293251ORC|RE||BG55S26995.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||101^typhoid, ViCPs^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG55S26995.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A63M27003^^^AIRA-TEST^MR||BurkeAIRA^PhoebeAIRA^Dikranouhi^^^^L|BentonAIRA^MollyAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1676 Naar beneden Ave^^Almont^MI^48003^USA^P||^PRN^PH^^^810^9069431|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^BentonAIRA^^^^^L|MTH^Mother^HL70063|1676 Naar beneden Ave^^Almont^MI^48003^USA^P|^PRN^PH^^^810^9069431ORC|RE||BA63M27003.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||102^DTP-Hib-Hep B^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA63M27003.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-103|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S19S27014^^^AIRA-TEST^MR||AllenAIRA^IngerAIRA^Edythe^^^^L|HoreAIRA^TanyaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1709 Nerwerderadeel Cir^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^3590165|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1709 Nerwerderadeel Cir^^Ash Township^MI^48117^USA^P|^PRN^PH^^^734^3590165ORC|RE||BS19S27014.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||103^meningococcal C conjugate^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS19S27014.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L58D27022^^^AIRA-TEST^MR||BrotAIRA^AjaAIRA^Piper^^^^L|KnoxAIRA^SharleenAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1286 Oith Pl^^Grand Rapids^MI^49504^USA^P||^PRN^PH^^^616^2280959|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrotAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1286 Oith Pl^^Grand Rapids^MI^49504^USA^P|^PRN^PH^^^616^2280959ORC|RE||BL58D27022.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||104^Hep A-Hep B^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL58D27022.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X09V27030^^^AIRA-TEST^MR||JeffersonAIRA^SevatiAIRA^Lorelei^^^^L|MontereyAIRA^HonoraAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1209 Ken Boer St^^GR^MI^49512^USA^P||^PRN^PH^^^616^8217375|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1209 Ken Boer St^^GR^MI^49512^USA^P|^PRN^PH^^^616^8217375ORC|RE||BX09V27030.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||105^vaccinia (smallpox) diluted^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX09V27030.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-106|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I84B27035^^^AIRA-TEST^MR||PhiladelphiaAIRA^SageAIRA^Phuong^^^^L|MartinAIRA^TanakaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1587 Ooes St^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^5640497|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PhiladelphiaAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1587 Ooes St^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^5640497ORC|RE||BI84B27035.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||106^DTaP, 5 pertussis antigens^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI84B27035.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-107|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25R27043^^^AIRA-TEST^MR||SterlingAIRA^HermiaAIRA^Panthea^^^^L|SchoolcraftAIRA^OlaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1601 Loon op Zand Ave^^East Grand Rapids^MI^49506^USA^P||^PRN^PH^^^616^5410778|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SterlingAIRA^SchoolcraftAIRA^^^^^L|MTH^Mother^HL70063|1601 Loon op Zand Ave^^East Grand Rapids^MI^49506^USA^P|^PRN^PH^^^616^5410778ORC|RE||BZ25R27043.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||107^DTaP, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25R27043.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-108|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J14L27054^^^AIRA-TEST^MR||RaumaAIRA^JessieAIRA^Melanctha^^^^L|Buena VistaAIRA^TaciAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1134 Kilvarenbeek Ln^^Raisinvl Township^MI^48161^USA^P||^PRN^PH^^^734^3384481|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RaumaAIRA^Buena VistaAIRA^^^^^L|MTH^Mother^HL70063|1134 Kilvarenbeek Ln^^Raisinvl Township^MI^48161^USA^P|^PRN^PH^^^734^3384481ORC|RE||BJ14L27054.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||108^meningococcal, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ14L27054.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-109|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X33J27062^^^AIRA-TEST^MR||WoodsAIRA^SebastianaAIRA^Engracia^^^^L|LakeAIRA^BakarneAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1781 Eon en Breugel Pl^^Barton City^MI^48705^USA^P||^PRN^PH^^^989^4243153|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodsAIRA^LakeAIRA^^^^^L|MTH^Mother^HL70063|1781 Eon en Breugel Pl^^Barton City^MI^48705^USA^P|^PRN^PH^^^989^4243153ORC|RE||BX33J27062.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||109^pneumococcal, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX33J27062.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D31C27070^^^AIRA-TEST^MR||SykesAIRA^AraxieAIRA^Corazon^^^^L|LancasterAIRA^JamalAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1274 Kerg en Dal Pl^^Greenbush^MI^48738^USA^P||^PRN^PH^^^989^8532752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SykesAIRA^LancasterAIRA^^^^^L|MTH^Mother^HL70063|1274 Kerg en Dal Pl^^Greenbush^MI^48738^USA^P|^PRN^PH^^^989^8532752ORC|RE||BD31C27070.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||11^pertussis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD31C27070.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H49B27078^^^AIRA-TEST^MR||StoryAIRA^BrinleyAIRA^Orsa^^^^L|McIntoshAIRA^IndaliaiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1548 Gedemblik Pl^^Saint Clr Shores^MI^48080^USA^P||^PRN^PH^^^586^6321302|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StoryAIRA^McIntoshAIRA^^^^^L|MTH^Mother^HL70063|1548 Gedemblik Pl^^Saint Clr Shores^MI^48080^USA^P|^PRN^PH^^^586^6321302ORC|RE||BH49B27078.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||110^DTaP-Hep B-IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH49B27078.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C76C27086^^^AIRA-TEST^MR||BarkerAIRA^EvadneAIRA^Amitola^^^^L|SalzeberAIRA^CarineAIRA^^^^^M|20140521|F||2106-3^White^CDCREC|1439 Zpe Ave^^GR^MI^49509^USA^P||^PRN^PH^^^616^9468292|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BarkerAIRA^SalzeberAIRA^^^^^L|MTH^Mother^HL70063|1439 Zpe Ave^^GR^MI^49509^USA^P|^PRN^PH^^^616^9468292ORC|RE||BC76C27086.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140721||111^Influenza, live, intranasal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC76C27086.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20140921||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20140921||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N54N27091^^^AIRA-TEST^MR||SkagAIRA^Guan-yinAIRA^Ylwa^^^^L|LeonardAIRA^BurildaAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1863 Lachen Ln^^Wyandotte^MI^48193^USA^P||^PRN^PH^^^734^8829405|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkagAIRA^LeonardAIRA^^^^^L|MTH^Mother^HL70063|1863 Lachen Ln^^Wyandotte^MI^48193^USA^P|^PRN^PH^^^734^8829405ORC|RE||BN54N27091.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||112^tetanus toxoid, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN54N27091.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-113|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K43Z27099^^^AIRA-TEST^MR||ClarionAIRA^JoleneAIRA^Nurhan^^^^L|LarssenAIRA^LeikoAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1730 Dad Ave^^Cass City^MI^48726^USA^P||^PRN^PH^^^989^7157535|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarionAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1730 Dad Ave^^Cass City^MI^48726^USA^P|^PRN^PH^^^989^7157535ORC|RE||BK43Z27099.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||113^Td (adult) preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK43Z27099.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-114|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L78T27110^^^AIRA-TEST^MR||EdwardsAIRA^TalonAIRA^Rolanda^^^^L|SwindellsAIRA^StacyAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1800 Sleutel Ave^^Grand Junction^MI^49056^USA^P||^PRN^PH^^^269^3208759|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EdwardsAIRA^SwindellsAIRA^^^^^L|MTH^Mother^HL70063|1800 Sleutel Ave^^Grand Junction^MI^49056^USA^P|^PRN^PH^^^269^3208759ORC|RE||BL78T27110.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||114^meningococcal MCV4P^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL78T27110.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B96V27118^^^AIRA-TEST^MR||OkmulgeeAIRA^AnkaAIRA^Maree^^^^L|ChopeAIRA^SissyAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1146 Wiel Cir^^Grand Rapids^MI^49509^USA^P||^PRN^PH^^^616^3223550|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OkmulgeeAIRA^ChopeAIRA^^^^^L|MTH^Mother^HL70063|1146 Wiel Cir^^Grand Rapids^MI^49509^USA^P|^PRN^PH^^^616^3223550ORC|RE||BB96V27118.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||115^Tdap^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB96V27118.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-116|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y03A27126^^^AIRA-TEST^MR||MillsAIRA^NiraAIRA^Val^^^^L|FranklinAIRA^YusraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1703 Lang Ln^^GR^MI^49519^USA^P||^PRN^PH^^^616^3947763|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MillsAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1703 Lang Ln^^GR^MI^49519^USA^P|^PRN^PH^^^616^3947763ORC|RE||BY03A27126.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||116^rotavirus, pentavalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY03A27126.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-118|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V04K27134^^^AIRA-TEST^MR||PayneAIRA^AcediaAIRA^Dulce^^^^L|LivingstonAIRA^PaygeAIRA^^^^^M|20090327|F||2106-3^White^CDCREC|1641 Bantumadiel Cir^^Athens^MI^49011^USA^P||^PRN^PH^^^269^6143049|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PayneAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1641 Bantumadiel Cir^^Athens^MI^49011^USA^P|^PRN^PH^^^269^6143049ORC|RE||BV04K27134.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||118^HPV, bivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV04K27134.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-119|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V04Z27142^^^AIRA-TEST^MR||LynchAIRA^LinaAIRA^Ethelda^^^^L|AndersonAIRA^MikiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1912 Gotterdam Pl^^Detroit^MI^48223^USA^P||^PRN^PH^^^313^3322508|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LynchAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1912 Gotterdam Pl^^Detroit^MI^48223^USA^P|^PRN^PH^^^313^3322508ORC|RE||BV04Z27142.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||119^rotavirus, monovalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV04Z27142.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-120|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N47M27147^^^AIRA-TEST^MR||PierceAIRA^SaumyaAIRA^Marion^^^^L|ChambersAIRA^ArdaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1925 Zunschoten Cir^^Curtis^MI^49820^USA^P||^PRN^PH^^^906^7035076|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PierceAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1925 Zunschoten Cir^^Curtis^MI^49820^USA^P|^PRN^PH^^^906^7035076ORC|RE||BN47M27147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||120^DTaP-Hib-IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN47M27147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-121|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I76M27155^^^AIRA-TEST^MR||MarshAIRA^KirileeAIRA^Bambalina^^^^L|HopkinsAIRA^ClevaAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1707 Nmmen Cir^^Litchfield^MI^49252^USA^P||^PRN^PH^^^517^6013597|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarshAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1707 Nmmen Cir^^Litchfield^MI^49252^USA^P|^PRN^PH^^^517^6013597ORC|RE||BI76M27155.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||121^zoster^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI76M27155.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-122|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q76I27166^^^AIRA-TEST^MR||HoodAIRA^GudduAIRA^Siran^^^^L|McCleanAIRA^LurneaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1197 Dlagtwedde Ave^^Dutton^MI^49316^USA^P||^PRN^PH^^^616^7069971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoodAIRA^McCleanAIRA^^^^^L|MTH^Mother^HL70063|1197 Dlagtwedde Ave^^Dutton^MI^49316^USA^P|^PRN^PH^^^616^7069971ORC|RE||BQ76I27166.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||122^rotavirus, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ76I27166.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-125|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q97Y27174^^^AIRA-TEST^MR||OsageAIRA^XenobiaAIRA^Paisley^^^^L|StephensAIRA^VevinaAIRA^^^^^M|20100427|F||2106-3^White^CDCREC|1916 Sucphen Pl^^Fair Haven^MI^48023^USA^P||^PRN^PH^^^810^4748841|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OsageAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1916 Sucphen Pl^^Fair Haven^MI^48023^USA^P|^PRN^PH^^^810^4748841ORC|RE||BQ97Y27174.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100627||125^Novel Influenza-H1N1-09, nasal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ97Y27174.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100827||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100827||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-126|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T64Y27182^^^AIRA-TEST^MR||MononAIRA^ColleenAIRA^Jennifer^^^^L|LilleyAIRA^MihokoAIRA^^^^^M|20100427|F||2106-3^White^CDCREC|1887 Verre Cir^^Wyoming^MI^49418^USA^P||^PRN^PH^^^616^2136830|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MononAIRA^LilleyAIRA^^^^^L|MTH^Mother^HL70063|1887 Verre Cir^^Wyoming^MI^49418^USA^P|^PRN^PH^^^616^2136830ORC|RE||BT64Y27182.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100627||126^Novel influenza-H1N1-09, preservative-free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT64Y27182.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100827||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100827||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-127|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S37N27187^^^AIRA-TEST^MR||LivingstonAIRA^AyannaAIRA^Lida^^^^L|LubbockAIRA^AmelindaAIRA^^^^^M|20100427|F||2106-3^White^CDCREC|1289 Voerdalen St^^Colon^MI^49040^USA^P||^PRN^PH^^^269^4507925|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LivingstonAIRA^LubbockAIRA^^^^^L|MTH^Mother^HL70063|1289 Voerdalen St^^Colon^MI^49040^USA^P|^PRN^PH^^^269^4507925ORC|RE||BS37N27187.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100627||127^Novel influenza-H1N1-09^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS37N27187.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100827||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100827||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-128|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G40Z27195^^^AIRA-TEST^MR||MonoAIRA^StephanyAIRA^Vivienne^^^^L|LamarAIRA^CarlyAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1278 Gteenwijkerland St^^Avoca^MI^48006^USA^P||^PRN^PH^^^810^3686872|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MonoAIRA^LamarAIRA^^^^^L|MTH^Mother^HL70063|1278 Gteenwijkerland St^^Avoca^MI^48006^USA^P|^PRN^PH^^^810^3686872ORC|RE||BG40Z27195.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||128^Novel Influenza-H1N1-09, all formulations^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG40Z27195.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-129|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O94J27206^^^AIRA-TEST^MR||BastropAIRA^JumokeAIRA^Sabia^^^^L|HopkinsAIRA^TamaraAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1172 Dolenwaard St^^Fostoria^MI^48435^USA^P||^PRN^PH^^^989^9749363|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BastropAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1172 Dolenwaard St^^Fostoria^MI^48435^USA^P|^PRN^PH^^^989^9749363ORC|RE||BO94J27206.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||129^Japanese Encephalitis, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO94J27206.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-130|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X51L27214^^^AIRA-TEST^MR||BrownAIRA^JanetAIRA^Mavis^^^^L|DillAIRA^ArinyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1311 Waterland Ave^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^7968485|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrownAIRA^DillAIRA^^^^^L|MTH^Mother^HL70063|1311 Waterland Ave^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^7968485ORC|RE||BX51L27214.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||130^DTaP-IPV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX51L27214.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-131|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S66Q27222^^^AIRA-TEST^MR||WashingtonAIRA^LaynaAIRA^Alma^^^^L|OtoeAIRA^AngelicaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1927 Naag en Braassem St^^Forest Hills^MI^49506^USA^P||^PRN^PH^^^616^8168050|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^OtoeAIRA^^^^^L|MTH^Mother^HL70063|1927 Naag en Braassem St^^Forest Hills^MI^49506^USA^P|^PRN^PH^^^616^8168050ORC|RE||BS66Q27222.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||131^typhus, historical^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS66Q27222.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-132|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E22M27227^^^AIRA-TEST^MR||AllenAIRA^Ha-NeulAIRA^Michiko^^^^L|HillAIRA^HarlowAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1654 Nollumerland en Nieuwkruisland Ave^^Comerica Incorporated^MI^48275^USA^P||^PRN^PH^^^313^3712184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^HillAIRA^^^^^L|MTH^Mother^HL70063|1654 Nollumerland en Nieuwkruisland Ave^^Comerica Incorporated^MI^48275^USA^P|^PRN^PH^^^313^3712184ORC|RE||BE22M27227.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||132^DTaP-IPV-HIB-HEP B, historical^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE22M27227.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-133|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P25M27235^^^AIRA-TEST^MR||HeffernanAIRA^PriscillaAIRA^Agape^^^^L|BanderaAIRA^EnricaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1529 Momeren Ln^^Oakville^MI^48160^USA^P||^PRN^PH^^^734^2571519|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^BanderaAIRA^^^^^L|MTH^Mother^HL70063|1529 Momeren Ln^^Oakville^MI^48160^USA^P|^PRN^PH^^^734^2571519ORC|RE||BP25M27235.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||133^Pneumococcal conjugate PCV 13^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP25M27235.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-134|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q44I27246^^^AIRA-TEST^MR||OkfuskeeAIRA^RebekahAIRA^Kaveri^^^^L|WayneAIRA^AlyssaAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1727 Wdam-Volendam Pl^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^9982153|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OkfuskeeAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1727 Wdam-Volendam Pl^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^9982153ORC|RE||BQ44I27246.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||134^Japanese Encephalitis IM^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ44I27246.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-135|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J83C27254^^^AIRA-TEST^MR||FayetteAIRA^XaquelinaAIRA^Julia^^^^L|KnoxAIRA^ApirkaAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1624 Wensen Cir^^Kingsford Retail^MI^49801^USA^P||^PRN^PH^^^906^6196764|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FayetteAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1624 Wensen Cir^^Kingsford Retail^MI^49801^USA^P|^PRN^PH^^^906^6196764ORC|RE||BJ83C27254.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||135^Influenza, high dose seasonal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ83C27254.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-136|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K09K27262^^^AIRA-TEST^MR||TravisAIRA^GeraldineAIRA^Terri^^^^L|BaylorAIRA^NatsukoAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1234 Aof van Twente Pl^^Lansing^MI^48951^USA^P||^PRN^PH^^^517^9677343|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TravisAIRA^BaylorAIRA^^^^^L|MTH^Mother^HL70063|1234 Aof van Twente Pl^^Lansing^MI^48951^USA^P|^PRN^PH^^^517^9677343ORC|RE||BK09K27262.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||136^Meningococcal MCV4O^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK09K27262.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-137|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X89E27270^^^AIRA-TEST^MR||AlfalfaAIRA^LystraAIRA^Cybill^^^^L|BerntsenAIRA^JuanaAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1700 Koe Cir^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^8084148|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlfalfaAIRA^BerntsenAIRA^^^^^L|MTH^Mother^HL70063|1700 Koe Cir^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^8084148ORC|RE||BX89E27270.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||137^HPV, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX89E27270.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-138|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z94M27278^^^AIRA-TEST^MR||WarrenAIRA^HaleyAIRA^Buttercup^^^^L|PendletonAIRA^RaeAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1301 Dordrecht Cir^^Crooked Lake^MI^48116^USA^P||^PRN^PH^^^810^5185777|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WarrenAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1301 Dordrecht Cir^^Crooked Lake^MI^48116^USA^P|^PRN^PH^^^810^5185777ORC|RE||BZ94M27278.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||138^Td (adult)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ94M27278.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-139|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z76W27283^^^AIRA-TEST^MR||WallowaAIRA^SengaAIRA^Nashwa^^^^L|SalzeberAIRA^MauraAIRA^^^^^M|20090729|F||2106-3^White^CDCREC|1990 Oijnwaarden Cir^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^7151255|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WallowaAIRA^SalzeberAIRA^^^^^L|MTH^Mother^HL70063|1990 Oijnwaarden Cir^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^7151255ORC|RE||BZ76W27283.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||139^Td(adult) unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ76W27283.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-14|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N17O27291^^^AIRA-TEST^MR||AllenAIRA^KessieAIRA^Edrea^^^^L|GreenlandAIRA^LanaiAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1814 Zitje Ln^^Westwood^MI^49006^USA^P||^PRN^PH^^^269^2405773|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^GreenlandAIRA^^^^^L|MTH^Mother^HL70063|1814 Zitje Ln^^Westwood^MI^49006^USA^P|^PRN^PH^^^269^2405773ORC|RE||BN17O27291.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||14^IG, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN17O27291.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-140|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N68M27302^^^AIRA-TEST^MR||McClungAIRA^QamraAIRA^Karida^^^^L|JuniataAIRA^MikkiAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1676 Overleg Ln^^Center Line^MI^48015^USA^P||^PRN^PH^^^586^6424148|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McClungAIRA^JuniataAIRA^^^^^L|MTH^Mother^HL70063|1676 Overleg Ln^^Center Line^MI^48015^USA^P|^PRN^PH^^^586^6424148ORC|RE||BN68M27302.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||140^Influenza, seasonal, injectable, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN68M27302.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L37Q27310^^^AIRA-TEST^MR||BreckinridgeAIRA^JonieAIRA^Alyson^^^^L|LucasAIRA^AderesAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1092 Indien St^^Sterling Heights^MI^48310^USA^P||^PRN^PH^^^586^3959620|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BreckinridgeAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1092 Indien St^^Sterling Heights^MI^48310^USA^P|^PRN^PH^^^586^3959620ORC|RE||BL37Q27310.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||141^Influenza, seasonal, injectable^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL37Q27310.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-142|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X55M27318^^^AIRA-TEST^MR||WayneAIRA^HelimaAIRA^Kirra^^^^L|PutnamAIRA^ElvanAIRA^^^^^M|20140613|F||2106-3^White^CDCREC|1922 Hout St^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^8680438|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^PutnamAIRA^^^^^L|MTH^Mother^HL70063|1922 Hout St^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^8680438ORC|RE||BX55M27318.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150613||142^tetanus toxoid, not adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX55M27318.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150813||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150813||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-143|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S28S27323^^^AIRA-TEST^MR||SkamaniaAIRA^TerentiaAIRA^Carnelian^^^^L|Presque IsleAIRA^RajaAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1897 Ueesp St^^Maple City^MI^49664^USA^P||^PRN^PH^^^231^5602817|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkamaniaAIRA^Presque IsleAIRA^^^^^L|MTH^Mother^HL70063|1897 Ueesp St^^Maple City^MI^49664^USA^P|^PRN^PH^^^231^5602817ORC|RE||BS28S27323.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||143^Adenovirus types 4 and 7^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS28S27323.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-144|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I30K27331^^^AIRA-TEST^MR||PedersenAIRA^LalasaAIRA^Vinata^^^^L|UvaldeAIRA^PandoraAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1451 Doordenveld St^^Auburn^MI^48611^USA^P||^PRN^PH^^^989^9455851|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PedersenAIRA^UvaldeAIRA^^^^^L|MTH^Mother^HL70063|1451 Doordenveld St^^Auburn^MI^48611^USA^P|^PRN^PH^^^989^9455851ORC|RE||BI30K27331.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||144^Influenza, seasonal, intradermal, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI30K27331.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-147|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O05B27342^^^AIRA-TEST^MR||CambriaAIRA^CastaAIRA^Rangi^^^^L|WhitleyAIRA^AkasmaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1285 Mronckhorst Ln^^Central Michigan University^MI^48859^USA^P||^PRN^PH^^^989^2873054|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CambriaAIRA^WhitleyAIRA^^^^^L|MTH^Mother^HL70063|1285 Mronckhorst Ln^^Central Michigan University^MI^48859^USA^P|^PRN^PH^^^989^2873054ORC|RE||BO05B27342.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||147^meningococcal MCV4, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO05B27342.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-148|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S26J27350^^^AIRA-TEST^MR||IoniaAIRA^ChalsieAIRA^Diane^^^^L|WahkiakumAIRA^TamsinAIRA^^^^^M|20180110|F||2106-3^White^CDCREC|1859 Lachen Ln^^Bridgewater^MI^48115^USA^P||^PRN^PH^^^734^8839936|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IoniaAIRA^WahkiakumAIRA^^^^^L|MTH^Mother^HL70063|1859 Lachen Ln^^Bridgewater^MI^48115^USA^P|^PRN^PH^^^734^8839936ORC|RE||BS26J27350.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180310||148^Meningococcal C/Y-HIB PRP^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS26J27350.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180510||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180510||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-149|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M13A27358^^^AIRA-TEST^MR||DickinsonAIRA^AmberAIRA^Erin^^^^L|ClayAIRA^KittyAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1130 Ooerden Cir^^Benzonia^MI^49616^USA^P||^PRN^PH^^^231^2069943|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DickinsonAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1130 Ooerden Cir^^Benzonia^MI^49616^USA^P|^PRN^PH^^^231^2069943ORC|RE||BM13A27358.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||149^influenza, live, intranasal, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM13A27358.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K98R27363^^^AIRA-TEST^MR||WarrenAIRA^AaliyahAIRA^Shirin^^^^L|ThomasAIRA^RobynAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1257 Hoermond Pl^^Port Austin^MI^48467^USA^P||^PRN^PH^^^989^5259377|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WarrenAIRA^ThomasAIRA^^^^^L|MTH^Mother^HL70063|1257 Hoermond Pl^^Port Austin^MI^48467^USA^P|^PRN^PH^^^989^5259377ORC|RE||BK98R27363.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||15^Influenza, split (incl. purified surface antigen)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK98R27363.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-150|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V10N27371^^^AIRA-TEST^MR||FloydAIRA^MaitaneAIRA^Cayla^^^^L|Des MoinesAIRA^DikranouhiAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1292 Tundert St^^Oscoda^MI^48750^USA^P||^PRN^PH^^^989^3689413|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^Des MoinesAIRA^^^^^L|MTH^Mother^HL70063|1292 Tundert St^^Oscoda^MI^48750^USA^P|^PRN^PH^^^989^3689413ORC|RE||BV10N27371.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||150^Influenza, injectable, quadrivalent, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV10N27371.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-151|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O99U27382^^^AIRA-TEST^MR||ClatsopAIRA^AkiraAIRA^Payge^^^^L|Red WillowAIRA^AhnadaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1794 Laat Ln^^Grand Rapids^MI^49509^USA^P||^PRN^PH^^^616^9326274|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClatsopAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1794 Laat Ln^^Grand Rapids^MI^49509^USA^P|^PRN^PH^^^616^9326274ORC|RE||BO99U27382.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||151^Influenza nasal, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO99U27382.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J82B27390^^^AIRA-TEST^MR||FrontierAIRA^HeaterAIRA^Simran^^^^L|BelmontAIRA^ProsperaAIRA^^^^^M|20120927|F||2106-3^White^CDCREC|1208 Lettergreep St^^Amway Corp^MI^49356^USA^P||^PRN^PH^^^616^3102799|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FrontierAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1208 Lettergreep St^^Amway Corp^MI^49356^USA^P|^PRN^PH^^^616^3102799ORC|RE||BJ82B27390.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20121127||152^Pneumococcal Conjugate, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ82B27390.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130127||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130127||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-153|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K51R27398^^^AIRA-TEST^MR||LakeAIRA^JolieAIRA^Julianna^^^^L|TetonAIRA^ZeeAIRA^^^^^M|20150423|F||2106-3^White^CDCREC|1838 Huidplas St^^Brownstown Township^MI^48183^USA^P||^PRN^PH^^^734^7068068|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^TetonAIRA^^^^^L|MTH^Mother^HL70063|1838 Huidplas St^^Brownstown Township^MI^48183^USA^P|^PRN^PH^^^734^7068068ORC|RE||BK51R27398.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160423||153^Influenza, injectable, MDCK, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK51R27398.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160623||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160623||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-155|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X96R27403^^^AIRA-TEST^MR||ArmstrongAIRA^ManuellaAIRA^Dillian^^^^L|HamiltonAIRA^ArleneAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1743 Grimmelen Ave^^Eagle^MI^48822^USA^P||^PRN^PH^^^517^5373876|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArmstrongAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1743 Grimmelen Ave^^Eagle^MI^48822^USA^P|^PRN^PH^^^517^5373876ORC|RE||BX96R27403.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||155^Influenza, recombinant, injectable, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX96R27403.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-158|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N90W27411^^^AIRA-TEST^MR||GreerAIRA^SteffiAIRA^Elsie^^^^L|BourbonAIRA^SummerAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1936 Overbetuwe Ave^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^4655644|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreerAIRA^BourbonAIRA^^^^^L|MTH^Mother^HL70063|1936 Overbetuwe Ave^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^4655644ORC|RE||BN90W27411.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||158^Influenza, injectable, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN90W27411.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-16|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V89M27422^^^AIRA-TEST^MR||ThornleyAIRA^MareaAIRA^Wyanet^^^^L|Des MoinesAIRA^HeaterAIRA^^^^^M|20030830|F||2106-3^White^CDCREC|1090 Meervoud St^^Midland^MI^48686^USA^P||^PRN^PH^^^989^8106065|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThornleyAIRA^Des MoinesAIRA^^^^^L|MTH^Mother^HL70063|1090 Meervoud St^^Midland^MI^48686^USA^P|^PRN^PH^^^989^8106065ORC|RE||BV89M27422.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20031030||16^Influenza, whole^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV89M27422.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20031230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20031230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-160|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S39X27430^^^AIRA-TEST^MR||WheelerAIRA^BernadineAIRA^Latifa^^^^L|DuvalAIRA^AzlandAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1667 Hint Anthonis St^^Clifford^MI^48727^USA^P||^PRN^PH^^^989^8368034|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^DuvalAIRA^^^^^L|MTH^Mother^HL70063|1667 Hint Anthonis St^^Clifford^MI^48727^USA^P|^PRN^PH^^^989^8368034ORC|RE||BS39X27430.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||160^Influenza A monovalent (H5N1), ADJUVANTED-2013^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS39X27430.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-161|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I31A27438^^^AIRA-TEST^MR||WalcottAIRA^SylviaAIRA^Hyacinth^^^^L|UptonAIRA^LuluAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1987 Natuurlijke St^^Ceresco^MI^49033^USA^P||^PRN^PH^^^269^2396653|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WalcottAIRA^UptonAIRA^^^^^L|MTH^Mother^HL70063|1987 Natuurlijke St^^Ceresco^MI^49033^USA^P|^PRN^PH^^^269^2396653ORC|RE||BI31A27438.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||161^Influenza, injectable,quadrivalent, preservative free,^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI31A27438.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-162|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W37Y27443^^^AIRA-TEST^MR||DuvalAIRA^SitaraAIRA^Salina^^^^L|PinalAIRA^MarianneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1539 Oeerijnen Ln^^Hubbard Lake^MI^49747^USA^P||^PRN^PH^^^989^8594936|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DuvalAIRA^PinalAIRA^^^^^L|MTH^Mother^HL70063|1539 Oeerijnen Ln^^Hubbard Lake^MI^49747^USA^P|^PRN^PH^^^989^8594936ORC|RE||BW37Y27443.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||162^meningococcal B, recombinant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW37Y27443.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-163|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P22M27451^^^AIRA-TEST^MR||AtokaAIRA^TionneAIRA^Coorah^^^^L|AdamsAIRA^LeslieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1813 Halfsen Ln^^Mc Bain^MI^49657^USA^P||^PRN^PH^^^231^2781326|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtokaAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1813 Halfsen Ln^^Mc Bain^MI^49657^USA^P|^PRN^PH^^^231^2781326ORC|RE||BP22M27451.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||163^meningococcal B, OMV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP22M27451.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-164|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I07S27462^^^AIRA-TEST^MR||JeromeAIRA^LavaniAIRA^Eloise^^^^L|LubbockAIRA^ShanaAIRA^^^^^M|20140702|F||2106-3^White^CDCREC|1810 Wtadskanaal Cir^^Dearborn^MI^48126^USA^P||^PRN^PH^^^313^9349429|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeromeAIRA^LubbockAIRA^^^^^L|MTH^Mother^HL70063|1810 Wtadskanaal Cir^^Dearborn^MI^48126^USA^P|^PRN^PH^^^313^9349429ORC|RE||BI07S27462.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20140902||164^meningococcal B, unspecified^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI07S27462.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20141102||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141102||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T85Q27470^^^AIRA-TEST^MR||KaneAIRA^ChristineAIRA^Prioska^^^^L|LouisaAIRA^TaylorAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1061 Euidhorn Ln^^Detroit^MI^48201^USA^P||^PRN^PH^^^313^9691584|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KaneAIRA^LouisaAIRA^^^^^L|MTH^Mother^HL70063|1061 Euidhorn Ln^^Detroit^MI^48201^USA^P|^PRN^PH^^^313^9691584ORC|RE||BT85Q27470.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||165^HPV9^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT85Q27470.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-166|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P41C27478^^^AIRA-TEST^MR||NelsonAIRA^BlaiseAIRA^Hadassah^^^^L|LaurelAIRA^ZiganaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1665 Vrave St^^Tipton^MI^49287^USA^P||^PRN^PH^^^517^5325713|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NelsonAIRA^LaurelAIRA^^^^^L|MTH^Mother^HL70063|1665 Vrave St^^Tipton^MI^49287^USA^P|^PRN^PH^^^517^5325713ORC|RE||BP41C27478.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||166^influenza, intradermal, quadrivalent, preservative free^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP41C27478.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-167|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J00U27483^^^AIRA-TEST^MR||BrennanAIRA^TheophaniaAIRA^Fawn^^^^L|McErlaineAIRA^MaitaneAIRA^^^^^M|20150730|F||2106-3^White^CDCREC|1830 Hoog Pl^^Pentwater^MI^49449^USA^P||^PRN^PH^^^231^4106161|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrennanAIRA^McErlaineAIRA^^^^^L|MTH^Mother^HL70063|1830 Hoog Pl^^Pentwater^MI^49449^USA^P|^PRN^PH^^^231^4106161ORC|RE||BJ00U27483.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150930||167^meningococcal, unknown serogroups^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ00U27483.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20151130||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20151130||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-168|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X74M27491^^^AIRA-TEST^MR||WyomingAIRA^KimbaAIRA^Dade^^^^L|ProvidenceAIRA^LizzieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1265 Ceeuwarden Cir^^Ada^MI^49301^USA^P||^PRN^PH^^^616^6818684|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WyomingAIRA^ProvidenceAIRA^^^^^L|MTH^Mother^HL70063|1265 Ceeuwarden Cir^^Ada^MI^49301^USA^P|^PRN^PH^^^616^6818684ORC|RE||BX74M27491.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||168^influenza, trivalent, adjuvanted^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX74M27491.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-169|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N59K27502^^^AIRA-TEST^MR||ParmerAIRA^JuliannaAIRA^Rory^^^^L|DixonAIRA^JadenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1479 Serkrade St^^Homer^MI^49245^USA^P||^PRN^PH^^^517^3856827|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParmerAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1479 Serkrade St^^Homer^MI^49245^USA^P|^PRN^PH^^^517^3856827ORC|RE||BN59K27502.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||169^Hep A, live attenuated^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN59K27502.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-17|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X41G27510^^^AIRA-TEST^MR||LakeAIRA^JosephineAIRA^Felda^^^^L|BernstrainAIRA^AmandlaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1030 Oe Wolden Cir^^Nazareth^MI^49074^USA^P||^PRN^PH^^^269^5928291|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^BernstrainAIRA^^^^^L|MTH^Mother^HL70063|1030 Oe Wolden Cir^^Nazareth^MI^49074^USA^P|^PRN^PH^^^269^5928291ORC|RE||BX41G27510.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||17^Hib, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX41G27510.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-170|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K50R27518^^^AIRA-TEST^MR||BarrettAIRA^MarielAIRA^Katy^^^^L|HoodAIRA^AmiyahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1722 Oengelo Ave^^GR^MI^49512^USA^P||^PRN^PH^^^616^6752757|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BarrettAIRA^HoodAIRA^^^^^L|MTH^Mother^HL70063|1722 Oengelo Ave^^GR^MI^49512^USA^P|^PRN^PH^^^616^6752757ORC|RE||BK50R27518.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||170^DTAP/IPV/HIB - non-US^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK50R27518.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-171|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09W27526^^^AIRA-TEST^MR||CusterAIRA^KensingtonAIRA^Adeola^^^^L|PickawayAIRA^AletaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1681 Leggen Cir^^Waldron^MI^49288^USA^P||^PRN^PH^^^517^3914445|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusterAIRA^PickawayAIRA^^^^^L|MTH^Mother^HL70063|1681 Leggen Cir^^Waldron^MI^49288^USA^P|^PRN^PH^^^517^3914445ORC|RE||BU09W27526.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||171^Influenza, injectable, MDCK, preservative free, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09W27526.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-172|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N88Y27534^^^AIRA-TEST^MR||YoakumAIRA^KirraAIRA^Gin^^^^L|ShastaAIRA^AlissaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1631 Maasdonk Cir^^Twining^MI^48766^USA^P||^PRN^PH^^^989^5247300|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoakumAIRA^ShastaAIRA^^^^^L|MTH^Mother^HL70063|1631 Maasdonk Cir^^Twining^MI^48766^USA^P|^PRN^PH^^^989^5247300ORC|RE||BN88Y27534.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||172^cholera, WC-rBS^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN88Y27534.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-173|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J84W27539^^^AIRA-TEST^MR||WoodfordAIRA^LemanaAIRA^Matty^^^^L|IowaAIRA^ErmineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1667 Been St^^Macomb Township^MI^48044^USA^P||^PRN^PH^^^586^9626909|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodfordAIRA^IowaAIRA^^^^^L|MTH^Mother^HL70063|1667 Been St^^Macomb Township^MI^48044^USA^P|^PRN^PH^^^586^9626909ORC|RE||BJ84W27539.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||173^cholera, BivWC^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ84W27539.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-174|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J25C27547^^^AIRA-TEST^MR||MakinAIRA^AylwenAIRA^Kaya^^^^L|WilbargerAIRA^ShaliniAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1458 Suidhorn Pl^^Genoa Township^MI^48114^USA^P||^PRN^PH^^^810^5872329|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MakinAIRA^WilbargerAIRA^^^^^L|MTH^Mother^HL70063|1458 Suidhorn Pl^^Genoa Township^MI^48114^USA^P|^PRN^PH^^^810^5872329ORC|RE||BJ25C27547.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||174^cholera, live attenuated^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ25C27547.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-175|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H94I27558^^^AIRA-TEST^MR||CaldwellAIRA^KavitaAIRA^Astrid^^^^L|ClintonAIRA^VikkiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1256 Rsten Pl^^Afton^MI^49705^USA^P||^PRN^PH^^^231^6643531|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaldwellAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1256 Rsten Pl^^Afton^MI^49705^USA^P|^PRN^PH^^^231^6643531ORC|RE||BH94I27558.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||175^Rabies - IM Diploid cell culture^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH94I27558.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-176|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K48Z27566^^^AIRA-TEST^MR||KossuthAIRA^MineAIRA^Wendy^^^^L|McGannAIRA^KirraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1834 Zoensdrecht Pl^^Superior Township^MI^48105^USA^P||^PRN^PH^^^734^6509157|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KossuthAIRA^McGannAIRA^^^^^L|MTH^Mother^HL70063|1834 Zoensdrecht Pl^^Superior Township^MI^48105^USA^P|^PRN^PH^^^734^6509157ORC|RE||BK48Z27566.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||176^Rabies - IM fibroblast culture^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK48Z27566.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-177|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R57A27574^^^AIRA-TEST^MR||PedersenAIRA^DianeAIRA^Sonnenschein^^^^L|McErlaneAIRA^AlishaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1114 Bangedijk Ln^^Kimball Township^MI^48074^USA^P||^PRN^PH^^^810^2691657|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PedersenAIRA^McErlaneAIRA^^^^^L|MTH^Mother^HL70063|1114 Bangedijk Ln^^Kimball Township^MI^48074^USA^P|^PRN^PH^^^810^2691657ORC|RE||BR57A27574.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||177^PCV10^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR57A27574.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-178|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E48X27579^^^AIRA-TEST^MR||ErathAIRA^AlodieAIRA^Roshan^^^^L|KeanyAIRA^LeikoAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1951 Barneveld St^^Barlow Branch^MI^49686^USA^P||^PRN^PH^^^231^5465620|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErathAIRA^KeanyAIRA^^^^^L|MTH^Mother^HL70063|1951 Barneveld St^^Barlow Branch^MI^49686^USA^P|^PRN^PH^^^231^5465620ORC|RE||BE48X27579.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||178^OPV bivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE48X27579.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-179|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q49T27587^^^AIRA-TEST^MR||DauphinAIRA^RayleneAIRA^Ava^^^^L|ShappeAIRA^AnchoretAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1845 Mesterveld Cir^^Harbor Springs^MI^49737^USA^P||^PRN^PH^^^616^7123672|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DauphinAIRA^ShappeAIRA^^^^^L|MTH^Mother^HL70063|1845 Mesterveld Cir^^Harbor Springs^MI^49737^USA^P|^PRN^PH^^^616^7123672ORC|RE||BQ49T27587.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||179^OPV ,monovalent, unspecified^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ49T27587.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-18|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C60V27598^^^AIRA-TEST^MR||SnyderAIRA^KairosAIRA^Sneha^^^^L|GreeleyAIRA^DakotaAIRA^^^^^M|20160617|F||2106-3^White^CDCREC|1350 Beerenveen Ln^^Wales Township^MI^48027^USA^P||^PRN^PH^^^810^5801151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SnyderAIRA^GreeleyAIRA^^^^^L|MTH^Mother^HL70063|1350 Beerenveen Ln^^Wales Township^MI^48027^USA^P|^PRN^PH^^^810^5801151ORC|RE||BC60V27598.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160817||18^rabies, intramuscular injection^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC60V27598.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20161017||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20161017||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-180|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y74X27606^^^AIRA-TEST^MR||HamiltonAIRA^SefikaAIRA^Alexa^^^^L|MajorAIRA^KesiaAIRA^^^^^M|20161005|F||2106-3^White^CDCREC|1713 Ooes Ln^^State of Michigan^MI^48913^USA^P||^PRN^PH^^^517^2969360|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^MajorAIRA^^^^^L|MTH^Mother^HL70063|1713 Ooes Ln^^State of Michigan^MI^48913^USA^P|^PRN^PH^^^517^2969360ORC|RE||BY74X27606.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161205||180^tetanus immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY74X27606.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170205||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170205||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-181|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F29I27614^^^AIRA-TEST^MR||RobinsonAIRA^KuhukAIRA^Naomi^^^^L|TemplemanAIRA^ValentinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1541 Waren Cir^^Detroit^MI^48229^USA^P||^PRN^PH^^^313^7794865|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobinsonAIRA^TemplemanAIRA^^^^^L|MTH^Mother^HL70063|1541 Waren Cir^^Detroit^MI^48229^USA^P|^PRN^PH^^^313^7794865ORC|RE||BF29I27614.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||181^anthrax immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF29I27614.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-182|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F64O27619^^^AIRA-TEST^MR||FranklinAIRA^AmalieAIRA^Uttara^^^^L|MaderaAIRA^SaktiAIRA^^^^^M|20160916|F||2106-3^White^CDCREC|1841 Woerdijk Ln^^Midland^MI^48667^USA^P||^PRN^PH^^^989^6699607|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1841 Woerdijk Ln^^Midland^MI^48667^USA^P|^PRN^PH^^^989^6699607ORC|RE||BF64O27619.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20161116||182^OPV, Unspecified^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF64O27619.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170116||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170116||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-183|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N43E27627^^^AIRA-TEST^MR||HuntingdonAIRA^MelwynAIRA^Morgandy^^^^L|LeknesAIRA^SibongileAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1009 Kittenseradeel Ave^^Springfield Township^MI^48350^USA^P||^PRN^PH^^^248^7483631|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuntingdonAIRA^LeknesAIRA^^^^^L|MTH^Mother^HL70063|1009 Kittenseradeel Ave^^Springfield Township^MI^48350^USA^P|^PRN^PH^^^248^7483631ORC|RE||BN43E27627.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||183^Yellow fever vaccine - alt^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN43E27627.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-184|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K38Q27638^^^AIRA-TEST^MR||BurtAIRA^CleopatraAIRA^Hildemar^^^^L|BanderaAIRA^MridulAIRA^^^^^M|20161101|F||2106-3^White^CDCREC|1380 Lijfheerenlanden Ave^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^6090777|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurtAIRA^BanderaAIRA^^^^^L|MTH^Mother^HL70063|1380 Lijfheerenlanden Ave^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^6090777ORC|RE||BK38Q27638.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170101||184^Yellow fever, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK38Q27638.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20170301||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20170301||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-185|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q80S27646^^^AIRA-TEST^MR||GeaugaAIRA^EndaAIRA^Fay^^^^L|AlgerAIRA^TaliaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1103 Hulst Ln^^Detroit^MI^48229^USA^P||^PRN^PH^^^313^6836963|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeaugaAIRA^AlgerAIRA^^^^^L|MTH^Mother^HL70063|1103 Hulst Ln^^Detroit^MI^48229^USA^P|^PRN^PH^^^313^6836963ORC|RE||BQ80S27646.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||185^influenza, recombinant, quadrivalent,injectable, preservative^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ80S27646.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-186|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L88D27654^^^AIRA-TEST^MR||BredbergAIRA^DagmarAIRA^Meagin^^^^L|PawneeAIRA^GretchenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1629 Wild St^^Lansing^MI^48911^USA^P||^PRN^PH^^^517^2410484|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BredbergAIRA^PawneeAIRA^^^^^L|MTH^Mother^HL70063|1629 Wild St^^Lansing^MI^48911^USA^P|^PRN^PH^^^517^2410484ORC|RE||BL88D27654.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||186^Influenza, injectable, MDCK, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL88D27654.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-187|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M40Y27659^^^AIRA-TEST^MR||MercerAIRA^VaIdaAIRA^Saida^^^^L|MackeyAIRA^DabaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1963 Teerijnen Ln^^Flint^MI^48552^USA^P||^PRN^PH^^^810^5521068|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercerAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1963 Teerijnen Ln^^Flint^MI^48552^USA^P|^PRN^PH^^^810^5521068ORC|RE||BM40Y27659.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||187^zoster recombinant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM40Y27659.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-188|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K23Q27667^^^AIRA-TEST^MR||BraceyAIRA^MikkiAIRA^Anusia^^^^L|PatariAIRA^PresleyAIRA^^^^^M|20170626|F||2106-3^White^CDCREC|1804 Sturen St^^Edenville^MI^48620^USA^P||^PRN^PH^^^989^4538272|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BraceyAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1804 Sturen St^^Edenville^MI^48620^USA^P|^PRN^PH^^^989^4538272ORC|RE||BK23Q27667.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170826||188^zoster, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK23Q27667.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171026||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171026||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-189|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M02J27678^^^AIRA-TEST^MR||CrawfordAIRA^ArinyaAIRA^Lynnette^^^^L|PintoAIRA^LucianaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1112 Dlochteren Ave^^Livonia^MI^48154^USA^P||^PRN^PH^^^734^8079069|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^PintoAIRA^^^^^L|MTH^Mother^HL70063|1112 Dlochteren Ave^^Livonia^MI^48154^USA^P|^PRN^PH^^^734^8079069ORC|RE||BM02J27678.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||189^HepB-CpG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM02J27678.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-19|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G09K27686^^^AIRA-TEST^MR||CherokeeAIRA^ImogenAIRA^Daniela^^^^L|InyoAIRA^TanashaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1083 Kennisgeving Ln^^Saint Clr Shrs^MI^48080^USA^P||^PRN^PH^^^586^2729020|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CherokeeAIRA^InyoAIRA^^^^^L|MTH^Mother^HL70063|1083 Kennisgeving Ln^^Saint Clr Shrs^MI^48080^USA^P|^PRN^PH^^^586^2729020ORC|RE||BG09K27686.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||19^BCG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG09K27686.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-190|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S85D27694^^^AIRA-TEST^MR||FranklinAIRA^AliviaAIRA^Drusilla^^^^L|ChesterAIRA^MaataAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1246 Ootterdam Ln^^Willis^MI^48191^USA^P||^PRN^PH^^^734^2535314|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^ChesterAIRA^^^^^L|MTH^Mother^HL70063|1246 Ootterdam Ln^^Willis^MI^48191^USA^P|^PRN^PH^^^734^2535314ORC|RE||BS85D27694.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||190^Typhoid conjugate vaccine (TCV)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS85D27694.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-191|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C87T27699^^^AIRA-TEST^MR||Santa ClaraAIRA^JourneyAIRA^Brisa^^^^L|MarshallAIRA^EllieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1186 Prnhem St^^Southgate^MI^48195^USA^P||^PRN^PH^^^734^3785803|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa ClaraAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1186 Prnhem St^^Southgate^MI^48195^USA^P|^PRN^PH^^^734^3785803ORC|RE||BC87T27699.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||191^meningococcal A polysaccharide (non-US)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC87T27699.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-192|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I82Y27710^^^AIRA-TEST^MR||LarsenAIRA^XyliaAIRA^Thistle^^^^L|TravisAIRA^AlodieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1235 Hinkelland Ln^^Orchard Lake^MI^48323^USA^P||^PRN^PH^^^248^5863964|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LarsenAIRA^TravisAIRA^^^^^L|MTH^Mother^HL70063|1235 Hinkelland Ln^^Orchard Lake^MI^48323^USA^P|^PRN^PH^^^248^5863964ORC|RE||BI82Y27710.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||192^meningococcal AC polysaccharide (non-US)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI82Y27710.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-193|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U47Y27718^^^AIRA-TEST^MR||WhitakerAIRA^AnemoneAIRA^Harper^^^^L|MontcalmAIRA^SanrevelleAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1764 Cijsden-Margraten Ave^^Lake Orion^MI^48359^USA^P||^PRN^PH^^^248^5256719|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitakerAIRA^MontcalmAIRA^^^^^L|MTH^Mother^HL70063|1764 Cijsden-Margraten Ave^^Lake Orion^MI^48359^USA^P|^PRN^PH^^^248^5256719ORC|RE||BU47Y27718.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||193^Hep A-Hep B, pediatric/adolescent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU47Y27718.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-194|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O41G27726^^^AIRA-TEST^MR||WellsAIRA^PeaceAIRA^Eir^^^^L|BrazosAIRA^AlizaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1176 Sutten Ln^^Brampton^MI^49837^USA^P||^PRN^PH^^^906^9507897|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WellsAIRA^BrazosAIRA^^^^^L|MTH^Mother^HL70063|1176 Sutten Ln^^Brampton^MI^49837^USA^P|^PRN^PH^^^906^9507897ORC|RE||BO41G27726.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||194^Influenza, Southern Hemisphere^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO41G27726.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-195|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R40K27734^^^AIRA-TEST^MR||DundyAIRA^AndreanaAIRA^Loretta^^^^L|HockingAIRA^KatyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1621 Wapelle St^^Kingsley^MI^49649^USA^P||^PRN^PH^^^231^2669241|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DundyAIRA^HockingAIRA^^^^^L|MTH^Mother^HL70063|1621 Wapelle St^^Kingsley^MI^49649^USA^P|^PRN^PH^^^231^2669241ORC|RE||BR40K27734.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||195^DT, IPV adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR40K27734.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T08S27742^^^AIRA-TEST^MR||CraigAIRA^YonAIRA^Kusum^^^^L|SullivanAIRA^ArtemisiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1659 Alagtwedde Cir^^Coldwater^MI^49036^USA^P||^PRN^PH^^^517^7070421|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CraigAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1659 Alagtwedde Cir^^Coldwater^MI^49036^USA^P|^PRN^PH^^^517^7070421ORC|RE||BT08S27742.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||20^DTaP^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT08S27742.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-21|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P03K27747^^^AIRA-TEST^MR||PetersAIRA^KuntiAIRA^Arda^^^^L|GreenlandAIRA^YasminAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1656 Ooerdijk St^^Dow Chemical USA^MI^48674^USA^P||^PRN^PH^^^989^4627351|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PetersAIRA^GreenlandAIRA^^^^^L|MTH^Mother^HL70063|1656 Ooerdijk St^^Dow Chemical USA^MI^48674^USA^P|^PRN^PH^^^989^4627351ORC|RE||BP03K27747.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP03K27747.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-22|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V01J27755^^^AIRA-TEST^MR||Nez PerceAIRA^KiskaAIRA^Carina^^^^L|WashingtonAIRA^SexburthAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1314 Guenen Cir^^Kalamazoo^MI^49048^USA^P||^PRN^PH^^^269^7590622|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Nez PerceAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1314 Guenen Cir^^Kalamazoo^MI^49048^USA^P|^PRN^PH^^^269^7590622ORC|RE||BV01J27755.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||22^DTP-Hib^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV01J27755.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-24|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R11X27766^^^AIRA-TEST^MR||GartenlaubAIRA^SabirahAIRA^Pratiksha^^^^L|HutchinsonAIRA^FrancescaAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1018 Waarschijnlijk Ave^^Westland^MI^48186^USA^P||^PRN^PH^^^734^7802339|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GartenlaubAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1018 Waarschijnlijk Ave^^Westland^MI^48186^USA^P|^PRN^PH^^^734^7802339ORC|RE||BR11X27766.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||24^anthrax^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR11X27766.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W75J27774^^^AIRA-TEST^MR||KinnearAIRA^OreliaAIRA^Zavanna^^^^L|UlsethAIRA^ShannaAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1157 Helpen Ln^^Decatur^MI^49045^USA^P||^PRN^PH^^^269^5727602|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KinnearAIRA^UlsethAIRA^^^^^L|MTH^Mother^HL70063|1157 Helpen Ln^^Decatur^MI^49045^USA^P|^PRN^PH^^^269^5727602ORC|RE||BW75J27774.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||25^typhoid, oral^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW75J27774.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-26|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T72P27782^^^AIRA-TEST^MR||HickmanAIRA^JadwigaAIRA^Saru^^^^L|Santa CruzAIRA^DoloresAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1751 Valkenswaard Pl^^Palms^MI^48465^USA^P||^PRN^PH^^^989^8782931|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HickmanAIRA^Santa CruzAIRA^^^^^L|MTH^Mother^HL70063|1751 Valkenswaard Pl^^Palms^MI^48465^USA^P|^PRN^PH^^^989^8782931ORC|RE||BT72P27782.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||26^cholera^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT72P27782.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-28|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H01F27787^^^AIRA-TEST^MR||HoreAIRA^DeenaAIRA^Xiomara^^^^L|PageAIRA^TulasiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1704 Nardinxveld-Giessendam Pl^^Grosse Pointe Park^MI^48230^USA^P||^PRN^PH^^^313^9906617|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoreAIRA^PageAIRA^^^^^L|MTH^Mother^HL70063|1704 Nardinxveld-Giessendam Pl^^Grosse Pointe Park^MI^48230^USA^P|^PRN^PH^^^313^9906617ORC|RE||BH01F27787.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||28^DT (pediatric)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH01F27787.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-31|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K41M27795^^^AIRA-TEST^MR||OttawaAIRA^PenelopeAIRA^Kelila^^^^L|Red WillowAIRA^BrankaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1001 Nluis Ave^^Berrien Springs^MI^49104^USA^P||^PRN^PH^^^269^5092201|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OttawaAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1001 Nluis Ave^^Berrien Springs^MI^49104^USA^P|^PRN^PH^^^269^5092201ORC|RE||BK41M27795.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||31^Hep A, pediatric, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK41M27795.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-32|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I07W27806^^^AIRA-TEST^MR||LeeAIRA^OrnellaAIRA^Amira^^^^L|ModocAIRA^ArianaAIRA^^^^^M|20170626|F||2106-3^White^CDCREC|1599 Danderd Cir^^Saugatuck^MI^49453^USA^P||^PRN^PH^^^269^9671340|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^ModocAIRA^^^^^L|MTH^Mother^HL70063|1599 Danderd Cir^^Saugatuck^MI^49453^USA^P|^PRN^PH^^^269^9671340ORC|RE||BI07W27806.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20170826||32^meningococcal MPSV4^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI07W27806.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20171026||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171026||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-33|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J52A27814^^^AIRA-TEST^MR||HopkinsAIRA^SaffiAIRA^Sakari^^^^L|HoreAIRA^MychauAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1571 Vint Anthonis Ln^^Hardwood^MI^49807^USA^P||^PRN^PH^^^906^9518302|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HopkinsAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1571 Vint Anthonis Ln^^Hardwood^MI^49807^USA^P|^PRN^PH^^^906^9518302ORC|RE||BJ52A27814.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||33^pneumococcal polysaccharide PPV23^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ52A27814.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y09S27822^^^AIRA-TEST^MR||CaddoAIRA^DidrikaAIRA^Ohanna^^^^L|KirklandAIRA^LemanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1848 Claricum Pl^^Mio^MI^48647^USA^P||^PRN^PH^^^989^9168368|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaddoAIRA^KirklandAIRA^^^^^L|MTH^Mother^HL70063|1848 Claricum Pl^^Mio^MI^48647^USA^P|^PRN^PH^^^989^9168368ORC|RE||BY09S27822.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||34^RIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY09S27822.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-35|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T38H27827^^^AIRA-TEST^MR||BanbergAIRA^MariamneAIRA^Caresse^^^^L|MonroeAIRA^AriellaAIRA^^^^^M|20140613|F||2106-3^White^CDCREC|1342 Eaaren St^^Almont^MI^48003^USA^P||^PRN^PH^^^810^7690864|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BanbergAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1342 Eaaren St^^Almont^MI^48003^USA^P|^PRN^PH^^^810^7690864ORC|RE||BT38H27827.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150613||35^tetanus toxoid, adsorbed^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT38H27827.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150813||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150813||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-37|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S22W27835^^^AIRA-TEST^MR||ColumbiaAIRA^RylanAIRA^Braelynn^^^^L|PayetteAIRA^ChrysillaAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1088 Scht-Susteren Cir^^Deerton^MI^49822^USA^P||^PRN^PH^^^906^7384985|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColumbiaAIRA^PayetteAIRA^^^^^L|MTH^Mother^HL70063|1088 Scht-Susteren Cir^^Deerton^MI^49822^USA^P|^PRN^PH^^^906^7384985ORC|RE||BS22W27835.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||37^yellow fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS22W27835.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-38|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B80Y27846^^^AIRA-TEST^MR||OldhamAIRA^AllisonAIRA^Mahima^^^^L|ChelanAIRA^HildaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1384 Doogeveen Pl^^Cascade Township^MI^49546^USA^P||^PRN^PH^^^616^8774039|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OldhamAIRA^ChelanAIRA^^^^^L|MTH^Mother^HL70063|1384 Doogeveen Pl^^Cascade Township^MI^49546^USA^P|^PRN^PH^^^616^8774039ORC|RE||BB80Y27846.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||38^rubella/mumps^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB80Y27846.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-39|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H77B27854^^^AIRA-TEST^MR||LucasAIRA^SashaAIRA^Lilia^^^^L|SpencerAIRA^AyushiAIRA^^^^^M|20150523|F||2106-3^White^CDCREC|1219 Wachten Cir^^Quincy^MI^49082^USA^P||^PRN^PH^^^517^4831279|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^SpencerAIRA^^^^^L|MTH^Mother^HL70063|1219 Wachten Cir^^Quincy^MI^49082^USA^P|^PRN^PH^^^517^4831279ORC|RE||BH77B27854.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150723||39^Japanese encephalitis SC^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH77B27854.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150923||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150923||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I16N27862^^^AIRA-TEST^MR||StonewallAIRA^TaborriAIRA^Behira^^^^L|RomsvigAIRA^FlorenceAIRA^^^^^M|20150217|F||2106-3^White^CDCREC|1713 Rundert Ln^^Us Army Tank-Auto Command^MI^48397^USA^P||^PRN^PH^^^586^7641402|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StonewallAIRA^RomsvigAIRA^^^^^L|MTH^Mother^HL70063|1713 Rundert Ln^^Us Army Tank-Auto Command^MI^48397^USA^P|^PRN^PH^^^586^7641402ORC|RE||BI16N27862.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150417||40^rabies, intradermal injection^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI16N27862.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150617||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150617||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H26Z27867^^^AIRA-TEST^MR||CherokeeAIRA^GirijaAIRA^Enye^^^^L|KootenaiAIRA^ZeebaAIRA^^^^^M|20150412|F||2106-3^White^CDCREC|1352 Kuijk St^^Free Soil^MI^49411^USA^P||^PRN^PH^^^231^8126827|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CherokeeAIRA^KootenaiAIRA^^^^^L|MTH^Mother^HL70063|1352 Kuijk St^^Free Soil^MI^49411^USA^P|^PRN^PH^^^231^8126827ORC|RE||BH26Z27867.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150612||41^typhoid, parenteral^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH26Z27867.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150812||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150812||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-42|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N12D27875^^^AIRA-TEST^MR||ClarkAIRA^KiaraAIRA^Keilantra^^^^L|MorganAIRA^HadilAIRA^^^^^M|19980426|F||2106-3^White^CDCREC|1174 Stok Pl^^Bedford^MI^49020^USA^P||^PRN^PH^^^269^3953688|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^MorganAIRA^^^^^L|MTH^Mother^HL70063|1174 Stok Pl^^Bedford^MI^49020^USA^P|^PRN^PH^^^269^3953688ORC|RE||BN12D27875.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19980626||42^Hep B, adolescent/high risk infant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN12D27875.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19980826||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19980826||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S74A27886^^^AIRA-TEST^MR||AllenAIRA^FayAIRA^Saxona^^^^L|BastropAIRA^KaylynAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1506 Peventer St^^Manistee^MI^49660^USA^P||^PRN^PH^^^231^8214397|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^BastropAIRA^^^^^L|MTH^Mother^HL70063|1506 Peventer St^^Manistee^MI^49660^USA^P|^PRN^PH^^^231^8214397ORC|RE||BS74A27886.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||43^Hep B, adult^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS74A27886.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-44|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K34I27894^^^AIRA-TEST^MR||MacombAIRA^LiviaAIRA^Suma^^^^L|AlgerAIRA^DebbyAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1508 Gaarbeek Ln^^Traverse City^MI^49696^USA^P||^PRN^PH^^^231^6493443|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MacombAIRA^AlgerAIRA^^^^^L|MTH^Mother^HL70063|1508 Gaarbeek Ln^^Traverse City^MI^49696^USA^P|^PRN^PH^^^231^6493443ORC|RE||BK34I27894.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||44^Hep B, dialysis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK34I27894.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-45|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O70Y27902^^^AIRA-TEST^MR||ClarkAIRA^LyrisAIRA^Mora^^^^L|GlasscockAIRA^BlossomAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1379 Beide St^^Hillman^MI^49746^USA^P||^PRN^PH^^^989^6541080|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^GlasscockAIRA^^^^^L|MTH^Mother^HL70063|1379 Beide St^^Hillman^MI^49746^USA^P|^PRN^PH^^^989^6541080ORC|RE||BO70Y27902.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||45^Hep B, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO70Y27902.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-46|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D81W27907^^^AIRA-TEST^MR||BanderaAIRA^JillianAIRA^Tammi^^^^L|HougenAIRA^SamirahAIRA^^^^^M|20000830|F||2106-3^White^CDCREC|1346 Host Gelre Ave^^Rapid City^MI^49676^USA^P||^PRN^PH^^^231^4574196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BanderaAIRA^HougenAIRA^^^^^L|MTH^Mother^HL70063|1346 Host Gelre Ave^^Rapid City^MI^49676^USA^P|^PRN^PH^^^231^4574196ORC|RE||BD81W27907.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20001030||46^Hib (PRP-D)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD81W27907.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20001230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20001230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-47|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W97E27915^^^AIRA-TEST^MR||DurbinAIRA^CicelyAIRA^Luciana^^^^L|MaderaAIRA^RebekahAIRA^^^^^M|20070830|F||2106-3^White^CDCREC|1216 Vilburg Ln^^Alba^MI^49611^USA^P||^PRN^PH^^^231^9711660|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DurbinAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1216 Vilburg Ln^^Alba^MI^49611^USA^P|^PRN^PH^^^231^9711660ORC|RE||BW97E27915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20071030||47^Hib (HbOC)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW97E27915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20071230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20071230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z07G27926^^^AIRA-TEST^MR||HeffernanAIRA^LilianAIRA^Anastasia^^^^L|SkamaniaAIRA^SolanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1344 Buth Ln^^Bergland^MI^49910^USA^P||^PRN^PH^^^906^4625824|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^SkamaniaAIRA^^^^^L|MTH^Mother^HL70063|1344 Buth Ln^^Bergland^MI^49910^USA^P|^PRN^PH^^^906^4625824ORC|RE||BZ07G27926.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||48^Hib (PRP-T)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ07G27926.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-49|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U79J27934^^^AIRA-TEST^MR||JohnssonAIRA^EudoraAIRA^Zilia^^^^L|DimmitAIRA^AryannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1665 Ding Cir^^Amasa^MI^49903^USA^P||^PRN^PH^^^906^5150153|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnssonAIRA^DimmitAIRA^^^^^L|MTH^Mother^HL70063|1665 Ding Cir^^Amasa^MI^49903^USA^P|^PRN^PH^^^906^5150153ORC|RE||BU79J27934.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||49^Hib (PRP-OMP)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU79J27934.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q69E27942^^^AIRA-TEST^MR||LorainAIRA^FionnAIRA^Sandia^^^^L|HartAIRA^JoslinAIRA^^^^^M|20101030|F||2106-3^White^CDCREC|1786 Noetinchem Ave^^Lansing^MI^48911^USA^P||^PRN^PH^^^517^6321504|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LorainAIRA^HartAIRA^^^^^L|MTH^Mother^HL70063|1786 Noetinchem Ave^^Lansing^MI^48911^USA^P|^PRN^PH^^^517^6321504ORC|RE||BQ69E27942.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20111030||50^DTaP-Hib^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ69E27942.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20111230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20111230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B19K27947^^^AIRA-TEST^MR||San SabaAIRA^MingmeiAIRA^Maia^^^^L|BrowneAIRA^ChaylenAIRA^^^^^M|20151110|F||2106-3^White^CDCREC|1755 Tlmelo St^^Detroit^MI^48203^USA^P||^PRN^PH^^^313^3455822|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San SabaAIRA^BrowneAIRA^^^^^L|MTH^Mother^HL70063|1755 Tlmelo St^^Detroit^MI^48203^USA^P|^PRN^PH^^^313^3455822ORC|RE||BB19K27947.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20160110||51^Hib-Hep B^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB19K27947.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20160310||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20160310||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N91N27955^^^AIRA-TEST^MR||TurnerAIRA^SunitiAIRA^Sierra^^^^L|CimarronAIRA^DesireeAIRA^^^^^M|20080107|F||2106-3^White^CDCREC|1908 Lladel Ln^^Podunk^MI^48158^USA^P||^PRN^PH^^^734^9160225|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TurnerAIRA^CimarronAIRA^^^^^L|MTH^Mother^HL70063|1908 Lladel Ln^^Podunk^MI^48158^USA^P|^PRN^PH^^^734^9160225ORC|RE||BN91N27955.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||52^Hep A, adult^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN91N27955.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-53|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I93W27966^^^AIRA-TEST^MR||WashingtonAIRA^SeleneAIRA^Lydia^^^^L|BuchananAIRA^MaricelAIRA^^^^^M|20150217|F||2106-3^White^CDCREC|1165 Soorst Ave^^Merritt^MI^49667^USA^P||^PRN^PH^^^231^4286467|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^BuchananAIRA^^^^^L|MTH^Mother^HL70063|1165 Soorst Ave^^Merritt^MI^49667^USA^P|^PRN^PH^^^231^4286467ORC|RE||BI93W27966.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20150417||53^typhoid, parenteral, AKD (U.S. military)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI93W27966.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20150617||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20150617||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-54|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L36T27974^^^AIRA-TEST^MR||HarrisonAIRA^JessicaAIRA^Kayla^^^^L|CrittendenAIRA^ShaniyaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1003 Oith Cir^^Howell^MI^48855^USA^P||^PRN^PH^^^517^2650299|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^CrittendenAIRA^^^^^L|MTH^Mother^HL70063|1003 Oith Cir^^Howell^MI^48855^USA^P|^PRN^PH^^^517^2650299ORC|RE||BL36T27974.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||54^adenovirus, type 4^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL36T27974.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z12P27982^^^AIRA-TEST^MR||PowerAIRA^ChristianAIRA^Shina^^^^L|FremstadAIRA^TooraAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1252 Kldebroek Ave^^Shelby Township^MI^48315^USA^P||^PRN^PH^^^586^2016942|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PowerAIRA^FremstadAIRA^^^^^L|MTH^Mother^HL70063|1252 Kldebroek Ave^^Shelby Township^MI^48315^USA^P|^PRN^PH^^^586^2016942ORC|RE||BZ12P27982.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||55^adenovirus, type 7^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ12P27982.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-62|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F50A27987^^^AIRA-TEST^MR||EdmonsonAIRA^JuneAIRA^Kalie^^^^L|EdmundsAIRA^PhoenixAIRA^^^^^M|20090327|F||2106-3^White^CDCREC|1530 Zwemmen Ln^^Burt Lake^MI^49717^USA^P||^PRN^PH^^^231^8038024|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EdmonsonAIRA^EdmundsAIRA^^^^^L|MTH^Mother^HL70063|1530 Zwemmen Ln^^Burt Lake^MI^49717^USA^P|^PRN^PH^^^231^8038024ORC|RE||BF50A27987.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||62^HPV, quadrivalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF50A27987.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-66|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C12A27995^^^AIRA-TEST^MR||TrumbullAIRA^KierstenAIRA^Brygida^^^^L|CastroAIRA^BreannaAIRA^^^^^M|20020830|F||2106-3^White^CDCREC|1153 Keemster St^^Flint^MI^48502^USA^P||^PRN^PH^^^810^5783810|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TrumbullAIRA^CastroAIRA^^^^^L|MTH^Mother^HL70063|1153 Keemster St^^Flint^MI^48502^USA^P|^PRN^PH^^^810^5783810ORC|RE||BC12A27995.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20021030||66^Lyme disease^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC12A27995.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20021230||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20021230||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-69|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G55O28006^^^AIRA-TEST^MR||Walla WallaAIRA^AltheaAIRA^Stephany^^^^L|CannavinAIRA^AksanaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1921 Oissewaard Pl^^Muskegon^MI^49441^USA^P||^PRN^PH^^^231^7300848|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Walla WallaAIRA^CannavinAIRA^^^^^L|MTH^Mother^HL70063|1921 Oissewaard Pl^^Muskegon^MI^49441^USA^P|^PRN^PH^^^231^7300848ORC|RE||BG55O28006.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||69^parainfluenza-3^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG55O28006.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-74|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S41D28014^^^AIRA-TEST^MR||FloydAIRA^OphrahAIRA^Hylda^^^^L|SullivanAIRA^TainnAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1041 Dapelle St^^Sault S Marie^MI^49786^USA^P||^PRN^PH^^^906^2201392|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1041 Dapelle St^^Sault S Marie^MI^49786^USA^P|^PRN^PH^^^906^2201392ORC|RE||BS41D28014.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||74^rotavirus, tetravalent^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS41D28014.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-75|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O81C28022^^^AIRA-TEST^MR||CharlevoixAIRA^JulieAIRA^Maye^^^^L|RogersAIRA^MilenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1243 Eoppersum Cir^^Lake Odessa^MI^48849^USA^P||^PRN^PH^^^616^3732531|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CharlevoixAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1243 Eoppersum Cir^^Lake Odessa^MI^48849^USA^P|^PRN^PH^^^616^3732531ORC|RE||BO81C28022.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||75^vaccinia (smallpox)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO81C28022.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-76|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q72Y28027^^^AIRA-TEST^MR||ClintonAIRA^BeckyAIRA^Esme^^^^L|ChambersAIRA^SianAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1866 Stof Ln^^Caspian^MI^49915^USA^P||^PRN^PH^^^906^4400378|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^ChambersAIRA^^^^^L|MTH^Mother^HL70063|1866 Stof Ln^^Caspian^MI^49915^USA^P|^PRN^PH^^^906^4400378ORC|RE||BQ72Y28027.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||76^Staphylococcus bacterio lysate^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ72Y28027.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-77|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H00O28035^^^AIRA-TEST^MR||InghamAIRA^YutsukoAIRA^Rahel^^^^L|ButteAIRA^MitziAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1379 Me Bilt Cir^^Lansing^MI^48950^USA^P||^PRN^PH^^^517^8807376|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|InghamAIRA^ButteAIRA^^^^^L|MTH^Mother^HL70063|1379 Me Bilt Cir^^Lansing^MI^48950^USA^P|^PRN^PH^^^517^8807376ORC|RE||BH00O28035.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||77^tick-borne encephalitis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH00O28035.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M34F28046^^^AIRA-TEST^MR||MarrietteAIRA^AmbikaAIRA^Zenaide^^^^L|CrawfordAIRA^JaelynnAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1832 Sijnwaarden Ln^^Vassar^MI^48769^USA^P||^PRN^PH^^^989^4904854|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarrietteAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1832 Sijnwaarden Ln^^Vassar^MI^48769^USA^P|^PRN^PH^^^989^4904854ORC|RE||BM34F28046.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||78^tularemia vaccine^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM34F28046.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-80|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A29D28054^^^AIRA-TEST^MR||IowaAIRA^CeinwenAIRA^Wanda^^^^L|CowleAIRA^NarmadaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1361 Nidden-Drenthe St^^Saint Helen^MI^48656^USA^P||^PRN^PH^^^989^7958428|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IowaAIRA^CowleAIRA^^^^^L|MTH^Mother^HL70063|1361 Nidden-Drenthe St^^Saint Helen^MI^48656^USA^P|^PRN^PH^^^989^7958428ORC|RE||BA29D28054.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||80^VEE, live^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA29D28054.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O72Q28062^^^AIRA-TEST^MR||FremmingAIRA^NashwaAIRA^Shyla^^^^L|CuyahogaAIRA^CarlinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1921 Oiessenlanden St^^Wyoming^MI^49548^USA^P||^PRN^PH^^^616^5679936|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremmingAIRA^CuyahogaAIRA^^^^^L|MTH^Mother^HL70063|1921 Oiessenlanden St^^Wyoming^MI^49548^USA^P|^PRN^PH^^^616^5679936ORC|RE||BO72Q28062.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||801^AS03 Adjuvant^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO72Q28062.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-81|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R72O28067^^^AIRA-TEST^MR||PerryAIRA^KadishaAIRA^Reagan^^^^L|AllamakeeAIRA^SusieAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1281 Ommen Ln^^Hessel^MI^49745^USA^P||^PRN^PH^^^906^2979975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^AllamakeeAIRA^^^^^L|MTH^Mother^HL70063|1281 Ommen Ln^^Hessel^MI^49745^USA^P|^PRN^PH^^^906^2979975ORC|RE||BR72O28067.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||81^VEE, inactivated^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR72O28067.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-82|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A59I28075^^^AIRA-TEST^MR||HaughtonAIRA^AzarniAIRA^Alissa^^^^L|BarkerAIRA^CeliaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1928 Laarn Pl^^Comstock^MI^49041^USA^P||^PRN^PH^^^269^9186528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaughtonAIRA^BarkerAIRA^^^^^L|MTH^Mother^HL70063|1928 Laarn Pl^^Comstock^MI^49041^USA^P|^PRN^PH^^^269^9186528ORC|RE||BA59I28075.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||82^adenovirus, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA59I28075.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E94F28086^^^AIRA-TEST^MR||ClarkAIRA^BlandaAIRA^Maliah^^^^L|KnoxAIRA^AlanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1467 Fudwest-Fryslan Ave^^GR^MI^49504^USA^P||^PRN^PH^^^616^7047372|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1467 Fudwest-Fryslan Ave^^GR^MI^49504^USA^P|^PRN^PH^^^616^7047372ORC|RE||BE94F28086.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||83^Hep A, ped/adol, 2 dose^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE94F28086.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-84|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F22S28094^^^AIRA-TEST^MR||CurryAIRA^GudrunAIRA^Lupe^^^^L|BuschAIRA^ZaliaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1963 Oerneuzen Pl^^Chesterfield^MI^48047^USA^P||^PRN^PH^^^586^7279051|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CurryAIRA^BuschAIRA^^^^^L|MTH^Mother^HL70063|1963 Oerneuzen Pl^^Chesterfield^MI^48047^USA^P|^PRN^PH^^^586^7279051ORC|RE||BF22S28094.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||84^Hep A, ped/adol, 3 dose^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF22S28094.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-85|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X35T28102^^^AIRA-TEST^MR||TarrantAIRA^ZandraAIRA^Romy^^^^L|SnyderAIRA^AnnabelAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1816 Maassluis St^^North Port^MI^49670^USA^P||^PRN^PH^^^231^3473938|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TarrantAIRA^SnyderAIRA^^^^^L|MTH^Mother^HL70063|1816 Maassluis St^^North Port^MI^49670^USA^P|^PRN^PH^^^231^3473938ORC|RE||BX35T28102.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||85^Hep A, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX35T28102.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E38H28107^^^AIRA-TEST^MR||EatonAIRA^EmberAIRA^Marvel^^^^L|LucasAIRA^GalaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1685 Oalderberge Cir^^Detroit^MI^48260^USA^P||^PRN^PH^^^313^6811840|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EatonAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1685 Oalderberge Cir^^Detroit^MI^48260^USA^P|^PRN^PH^^^313^6811840ORC|RE||BE38H28107.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||88^Influenza, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE38H28107.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-89|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q29A28115^^^AIRA-TEST^MR||PowerAIRA^FawnAIRA^Hailey^^^^L|KayAIRA^KatharinaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1200 Oollumerland en Nieuwkruisland St^^Capac^MI^48014^USA^P||^PRN^PH^^^810^5542860|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PowerAIRA^KayAIRA^^^^^L|MTH^Mother^HL70063|1200 Oollumerland en Nieuwkruisland St^^Capac^MI^48014^USA^P|^PRN^PH^^^810^5542860ORC|RE||BQ29A28115.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||89^polio, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ29A28115.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-90|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C69K28126^^^AIRA-TEST^MR||OtterstromAIRA^EfiaAIRA^Nora^^^^L|ProtheroeAIRA^KadeAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1814 Dinsum Ave^^Jones^MI^49061^USA^P||^PRN^PH^^^269^9646317|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OtterstromAIRA^ProtheroeAIRA^^^^^L|MTH^Mother^HL70063|1814 Dinsum Ave^^Jones^MI^49061^USA^P|^PRN^PH^^^269^9646317ORC|RE||BC69K28126.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||90^rabies, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC69K28126.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-91|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F81J28134^^^AIRA-TEST^MR||AdamsAIRA^JanaeAIRA^Irina^^^^L|MiamiAIRA^BaraAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1854 Zingewaard Pl^^Northeast^MI^48506^USA^P||^PRN^PH^^^810^7807434|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^MiamiAIRA^^^^^L|MTH^Mother^HL70063|1854 Zingewaard Pl^^Northeast^MI^48506^USA^P|^PRN^PH^^^810^7807434ORC|RE||BF81J28134.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||91^typhoid, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF81J28134.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-92|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G79W28142^^^AIRA-TEST^MR||FremmingAIRA^ManuelleAIRA^Kessie^^^^L|GormanAIRA^ArmelleAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1255 Woes Ave^^Norway^MI^49870^USA^P||^PRN^PH^^^906^5743447|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremmingAIRA^GormanAIRA^^^^^L|MTH^Mother^HL70063|1255 Woes Ave^^Norway^MI^49870^USA^P|^PRN^PH^^^906^5743447ORC|RE||BG79W28142.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||92^VEE, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG79W28142.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-94|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q22B28147^^^AIRA-TEST^MR||WebsterAIRA^LainaAIRA^Hadria^^^^L|SaloAIRA^TullyAIRA^^^^^M|20180106|F||2106-3^White^CDCREC|1791 Maadhoeke St^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^7642162|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WebsterAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1791 Maadhoeke St^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^7642162ORC|RE||BQ22B28147.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||94^MMRV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ22B28147.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-AN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||381360802^^^AIRA-TEST^AN~O47J28156^^^AIRA-TEST^MR||ThornleyAIRA^YesminaAIRA^Yon^^^^L|GrundyAIRA^RhondaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1589 Schouwen-Duiveland Cir^^Bancroft^MI^48414^USA^P||^PRN^PH^^^989^9532717|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThornleyAIRA^GrundyAIRA^^^^^L|MTH^Mother^HL70063|1589 Schouwen-Duiveland Cir^^Bancroft^MI^48414^USA^P|^PRN^PH^^^989^9532717ORC|RE||BO47J28156.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO47J28156.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-ANC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||134073636^^^AIRA-TEST^ANC~O93A28166^^^AIRA-TEST^MR||FranklinAIRA^GayleAIRA^Yasu^^^^L|KyleAIRA^RodenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1157 Hoest Cir^^Jenison^MI^49428^USA^P||^PRN^PH^^^616^8349724|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^KyleAIRA^^^^^L|MTH^Mother^HL70063|1157 Hoest Cir^^Jenison^MI^49428^USA^P|^PRN^PH^^^616^8349724ORC|RE||BO93A28166.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO93A28166.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-AND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||928969040^^^AIRA-TEST^AND~O79P28174^^^AIRA-TEST^MR||MuskingumAIRA^GeraldineAIRA^Antje^^^^L|DelawareAIRA^JobinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1877 Gopik Cir^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^2301869|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MuskingumAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1877 Gopik Cir^^Hesperia^MI^49421^USA^P|^PRN^PH^^^231^2301869ORC|RE||BO79P28174.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO79P28174.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-ANON|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||427488867^^^AIRA-TEST^ANON~D86V28182^^^AIRA-TEST^MR||MeaghanAIRA^CatalinAIRA^Jobina^^^^L|ParmerAIRA^PortiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1973 Zunschoten Ave^^Marcellus^MI^49067^USA^P||^PRN^PH^^^269^7265212|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MeaghanAIRA^ParmerAIRA^^^^^L|MTH^Mother^HL70063|1973 Zunschoten Ave^^Marcellus^MI^49067^USA^P|^PRN^PH^^^269^7265212ORC|RE||BD86V28182.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD86V28182.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-ANT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||760042931^^^AIRA-TEST^ANT~V35F28187^^^AIRA-TEST^MR||CaldwellAIRA^SelmaAIRA^Erika^^^^L|EriksonAIRA^YovelaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1926 Tosterhout St^^Mecosta^MI^49332^USA^P||^PRN^PH^^^231^2706819|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaldwellAIRA^EriksonAIRA^^^^^L|MTH^Mother^HL70063|1926 Tosterhout St^^Mecosta^MI^49332^USA^P|^PRN^PH^^^231^2706819ORC|RE||BV35F28187.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV35F28187.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-APRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||527194345^^^AIRA-TEST^APRN~N83X28195^^^AIRA-TEST^MR||LarssenAIRA^HadriaAIRA^Adelina^^^^L|NightingaleAIRA^MarianaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1086 Rindhoven Cir^^Leroy^MI^49655^USA^P||^PRN^PH^^^231^8436051|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LarssenAIRA^NightingaleAIRA^^^^^L|MTH^Mother^HL70063|1086 Rindhoven Cir^^Leroy^MI^49655^USA^P|^PRN^PH^^^231^8436051ORC|RE||BN83X28195.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN83X28195.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||085628127^^^AIRA-TEST^BA~H58W28206^^^AIRA-TEST^MR||BellAIRA^BlodwenAIRA^Engracia^^^^L|OscodaAIRA^BrandeeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1248 Bijssen Cir^^Vassar^MI^48768^USA^P||^PRN^PH^^^989^3699113|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BellAIRA^OscodaAIRA^^^^^L|MTH^Mother^HL70063|1248 Bijssen Cir^^Vassar^MI^48768^USA^P|^PRN^PH^^^989^3699113ORC|RE||BH58W28206.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH58W28206.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-BC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||421429054^^^AIRA-TEST^BC~S58L28214^^^AIRA-TEST^MR||GrantAIRA^AquamarineAIRA^Zalia^^^^L|PrebleAIRA^ShariAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1374 Poosendaal Pl^^Daggett^MI^49821^USA^P||^PRN^PH^^^906^9456051|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^PrebleAIRA^^^^^L|MTH^Mother^HL70063|1374 Poosendaal Pl^^Daggett^MI^49821^USA^P|^PRN^PH^^^906^9456051ORC|RE||BS58L28214.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS58L28214.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||007158496^^^AIRA-TEST^BR~D76E28222^^^AIRA-TEST^MR||CreghanAIRA^MorgenAIRA^Tiffany^^^^L|ClintonAIRA^AnonaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1384 Iietjerksteradeel Cir^^Sears^MI^49679^USA^P||^PRN^PH^^^231^7570994|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CreghanAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1384 Iietjerksteradeel Cir^^Sears^MI^49679^USA^P|^PRN^PH^^^231^7570994ORC|RE||BD76E28222.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD76E28222.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-CC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||702817642^^^AIRA-TEST^CC~X09U28227^^^AIRA-TEST^MR||CottonAIRA^ShainaAIRA^Sabrina^^^^L|WashingtonAIRA^WaltraudAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1995 Semert-Bakel Ave^^Midland^MI^48670^USA^P||^PRN^PH^^^989^8146515|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CottonAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1995 Semert-Bakel Ave^^Midland^MI^48670^USA^P|^PRN^PH^^^989^8146515ORC|RE||BX09U28227.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX09U28227.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-CY|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||290601751^^^AIRA-TEST^CY~I96E28238^^^AIRA-TEST^MR||HamiltonAIRA^KoorineAIRA^Shantina^^^^L|CoryellAIRA^NiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1394 Mcheemda Ave^^Flint^MI^48551^USA^P||^PRN^PH^^^810^7504220|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^CoryellAIRA^^^^^L|MTH^Mother^HL70063|1394 Mcheemda Ave^^Flint^MI^48551^USA^P|^PRN^PH^^^810^7504220ORC|RE||BI96E28238.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI96E28238.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DDS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||162377083^^^AIRA-TEST^DDS~B57G28246^^^AIRA-TEST^MR||BoyleAIRA^ManishaAIRA^Girija^^^^L|DouglasAIRA^AzlandAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1706 Sodegraven-Reeuwijk Ln^^Camden^MI^49232^USA^P||^PRN^PH^^^517^3907456|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BoyleAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1706 Sodegraven-Reeuwijk Ln^^Camden^MI^49232^USA^P|^PRN^PH^^^517^3907456ORC|RE||BB57G28246.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB57G28246.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DEA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||805194332^^^AIRA-TEST^DEA~B80Z28254^^^AIRA-TEST^MR||MecostaAIRA^AnusiaAIRA^Davine^^^^L|PayneAIRA^DelcineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1746 Moon op Zand Pl^^Troy^MI^48083^USA^P||^PRN^PH^^^248^2992454|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MecostaAIRA^PayneAIRA^^^^^L|MTH^Mother^HL70063|1746 Moon op Zand Pl^^Troy^MI^48083^USA^P|^PRN^PH^^^248^2992454ORC|RE||BB80Z28254.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB80Z28254.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DFN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||871487514^^^AIRA-TEST^DFN~D35O28262^^^AIRA-TEST^MR||CrittendenAIRA^ZdenkaAIRA^Rossa^^^^L|HaleAIRA^DelilahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1232 Hluis Cir^^Sears^MI^49679^USA^P||^PRN^PH^^^231^2362705|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrittendenAIRA^HaleAIRA^^^^^L|MTH^Mother^HL70063|1232 Hluis Cir^^Sears^MI^49679^USA^P|^PRN^PH^^^231^2362705ORC|RE||BD35O28262.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD35O28262.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||837408994^^^AIRA-TEST^DL~N13Y28267^^^AIRA-TEST^MR||GrendalAIRA^HadassahAIRA^Maiya^^^^L|SacramentoAIRA^NeeljaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1791 Mensen St^^Standish^MI^48658^USA^P||^PRN^PH^^^989^5775407|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrendalAIRA^SacramentoAIRA^^^^^L|MTH^Mother^HL70063|1791 Mensen St^^Standish^MI^48658^USA^P|^PRN^PH^^^989^5775407ORC|RE||BN13Y28267.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN13Y28267.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||611843919^^^AIRA-TEST^DN~S42S28275^^^AIRA-TEST^MR||StoryAIRA^JuliaAIRA^Mariquita^^^^L|OchiltreeAIRA^SelenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1604 Euren Pl^^Quinnesec^MI^49876^USA^P||^PRN^PH^^^906^6488926|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StoryAIRA^OchiltreeAIRA^^^^^L|MTH^Mother^HL70063|1604 Euren Pl^^Quinnesec^MI^49876^USA^P|^PRN^PH^^^906^6488926ORC|RE||BS42S28275.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS42S28275.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DO|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||597312211^^^AIRA-TEST^DO~Z42M28286^^^AIRA-TEST^MR||UnionAIRA^SanyuktaAIRA^Tekla^^^^L|MononAIRA^SangitaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1159 Eunspeet Ave^^Fostoria^MI^48435^USA^P||^PRN^PH^^^989^7178232|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^MononAIRA^^^^^L|MTH^Mother^HL70063|1159 Eunspeet Ave^^Fostoria^MI^48435^USA^P|^PRN^PH^^^989^7178232ORC|RE||BZ42M28286.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ42M28286.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DPM|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||783212417^^^AIRA-TEST^DPM~C47I28294^^^AIRA-TEST^MR||SuthernsAIRA^ThanhAIRA^Peony^^^^L|AllamakeeAIRA^EmberAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1036 Wulpen-Wittem St^^Hillsdale^MI^49242^USA^P||^PRN^PH^^^517^2480467|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SuthernsAIRA^AllamakeeAIRA^^^^^L|MTH^Mother^HL70063|1036 Wulpen-Wittem St^^Hillsdale^MI^49242^USA^P|^PRN^PH^^^517^2480467ORC|RE||BC47I28294.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC47I28294.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-DR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||089416844^^^AIRA-TEST^DR~D76D28302^^^AIRA-TEST^MR||TrumbullAIRA^AshlynnAIRA^Anamika^^^^L|DentonAIRA^LowannaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1658 Zernheze Pl^^Marysville^MI^48040^USA^P||^PRN^PH^^^810^4762280|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TrumbullAIRA^DentonAIRA^^^^^L|MTH^Mother^HL70063|1658 Zernheze Pl^^Marysville^MI^48040^USA^P|^PRN^PH^^^810^4762280ORC|RE||BD76D28302.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD76D28302.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-EI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||119446873^^^AIRA-TEST^EI~Z65L28307^^^AIRA-TEST^MR||DaviessAIRA^PegAIRA^Dominique^^^^L|ClarkAIRA^KatyinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1593 Ee Marne Pl^^Spring Arbor^MI^49283^USA^P||^PRN^PH^^^517^5636325|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DaviessAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1593 Ee Marne Pl^^Spring Arbor^MI^49283^USA^P|^PRN^PH^^^517^5636325ORC|RE||BZ65L28307.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ65L28307.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-EN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||591763155^^^AIRA-TEST^EN~J12U28315^^^AIRA-TEST^MR||WalkerAIRA^HildaAIRA^Kit^^^^L|AlexanderAIRA^ArnaldaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1564 Oefening Cir^^Augusta Township^MI^48160^USA^P||^PRN^PH^^^734^4373755|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WalkerAIRA^AlexanderAIRA^^^^^L|MTH^Mother^HL70063|1564 Oefening Cir^^Augusta Township^MI^48160^USA^P|^PRN^PH^^^734^4373755ORC|RE||BJ12U28315.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ12U28315.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-FI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||496668773^^^AIRA-TEST^FI~N80S28326^^^AIRA-TEST^MR||SimpsonAIRA^AkaishaAIRA^Stephenie^^^^L|PerkinsAIRA^AlamedaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1598 Kronckhorst St^^Kinross^MI^49752^USA^P||^PRN^PH^^^906^9882888|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimpsonAIRA^PerkinsAIRA^^^^^L|MTH^Mother^HL70063|1598 Kronckhorst St^^Kinross^MI^49752^USA^P|^PRN^PH^^^906^9882888ORC|RE||BN80S28326.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN80S28326.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-GI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||123496397^^^AIRA-TEST^GI~O37O28334^^^AIRA-TEST^MR||MarlinAIRA^CandidaAIRA^Chanah^^^^L|NorthumberlandAIRA^ValoraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1079 Vleermuis Pl^^Grand Rapids^MI^49530^USA^P||^PRN^PH^^^616^3640887|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarlinAIRA^NorthumberlandAIRA^^^^^L|MTH^Mother^HL70063|1079 Vleermuis Pl^^Grand Rapids^MI^49530^USA^P|^PRN^PH^^^616^3640887ORC|RE||BO37O28334.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO37O28334.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-GL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||502495972^^^AIRA-TEST^GL~C05E28342^^^AIRA-TEST^MR||LancasterAIRA^RaeganAIRA^Finola^^^^L|ProtheroeAIRA^CornelianAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1527 Lichaam Cir^^Clarkston^MI^48348^USA^P||^PRN^PH^^^248^3947650|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LancasterAIRA^ProtheroeAIRA^^^^^L|MTH^Mother^HL70063|1527 Lichaam Cir^^Clarkston^MI^48348^USA^P|^PRN^PH^^^248^3947650ORC|RE||BC05E28342.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC05E28342.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-GN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||333051132^^^AIRA-TEST^GN~H06O28347^^^AIRA-TEST^MR||MorrowAIRA^AdilaAIRA^Margarita^^^^L|YoungAIRA^TrifineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1054 Eorsele St^^Free Soil^MI^49411^USA^P||^PRN^PH^^^231^9033792|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrowAIRA^YoungAIRA^^^^^L|MTH^Mother^HL70063|1054 Eorsele St^^Free Soil^MI^49411^USA^P|^PRN^PH^^^231^9033792ORC|RE||BH06O28347.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH06O28347.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-HC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||246999090^^^AIRA-TEST^HC~A32D28355^^^AIRA-TEST^MR||BooneAIRA^BarbaraAIRA^Ulrike^^^^L|MenifeeAIRA^PatienceAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1673 Aelft Ave^^West Bloomfield^MI^48322^USA^P||^PRN^PH^^^248^5466543|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BooneAIRA^MenifeeAIRA^^^^^L|MTH^Mother^HL70063|1673 Aelft Ave^^West Bloomfield^MI^48322^USA^P|^PRN^PH^^^248^5466543ORC|RE||BA32D28355.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA32D28355.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-IND|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||104600145^^^AIRA-TEST^IND~U36N28366^^^AIRA-TEST^MR||Los AngelesAIRA^AudrianaAIRA^Karma^^^^L|WagonerAIRA^DavidaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1470 Hmmen Ave^^Detroit^MI^48227^USA^P||^PRN^PH^^^313^4313590|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Los AngelesAIRA^WagonerAIRA^^^^^L|MTH^Mother^HL70063|1470 Hmmen Ave^^Detroit^MI^48227^USA^P|^PRN^PH^^^313^4313590ORC|RE||BU36N28366.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU36N28366.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-JHN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||671171259^^^AIRA-TEST^JHN~B87L28374^^^AIRA-TEST^MR||LieAIRA^AnneAIRA^Ciannait^^^^L|MorrisAIRA^JulyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1596 Materiaal Ln^^Benton Harbor^MI^49023^USA^P||^PRN^PH^^^269^9148225|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LieAIRA^MorrisAIRA^^^^^L|MTH^Mother^HL70063|1596 Materiaal Ln^^Benton Harbor^MI^49023^USA^P|^PRN^PH^^^269^9148225ORC|RE||BB87L28374.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB87L28374.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-LI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||209382934^^^AIRA-TEST^LI~D74M28382^^^AIRA-TEST^MR||SciotoAIRA^LodemaAIRA^Abhilasha^^^^L|KildahlAIRA^RhiannonAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1982 Helmond Ln^^Azalia^MI^48110^USA^P||^PRN^PH^^^734^4531941|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SciotoAIRA^KildahlAIRA^^^^^L|MTH^Mother^HL70063|1982 Helmond Ln^^Azalia^MI^48110^USA^P|^PRN^PH^^^734^4531941ORC|RE||BD74M28382.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD74M28382.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-LN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||755327353^^^AIRA-TEST^LN~L50U28387^^^AIRA-TEST^MR||ParkAIRA^AleighaAIRA^Taliyah^^^^L|AtokaAIRA^KoloraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1343 Sheden St^^Brownstown^MI^48134^USA^P||^PRN^PH^^^734^6445281|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParkAIRA^AtokaAIRA^^^^^L|MTH^Mother^HL70063|1343 Sheden St^^Brownstown^MI^48134^USA^P|^PRN^PH^^^734^6445281ORC|RE||BL50U28387.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL50U28387.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-LR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||858682341^^^AIRA-TEST^LR~X31X28395^^^AIRA-TEST^MR||MagoffinAIRA^AdoraAIRA^Neelam^^^^L|ComanoAIRA^ElgaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1798 Rlphen aan den Rijn Pl^^Meskegon^MI^49441^USA^P||^PRN^PH^^^231^6982763|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagoffinAIRA^ComanoAIRA^^^^^L|MTH^Mother^HL70063|1798 Rlphen aan den Rijn Pl^^Meskegon^MI^49441^USA^P|^PRN^PH^^^231^6982763ORC|RE||BX31X28395.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX31X28395.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||046686140^^^AIRA-TEST^MA~H57I28406^^^AIRA-TEST^MR||Le FloreAIRA^CeceliaAIRA^Sandy^^^^L|EstillAIRA^RubiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1282 Gardinxveld-Giessendam Cir^^Rochester Hls^MI^48309^USA^P||^PRN^PH^^^248^2645661|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Le FloreAIRA^EstillAIRA^^^^^L|MTH^Mother^HL70063|1282 Gardinxveld-Giessendam Cir^^Rochester Hls^MI^48309^USA^P|^PRN^PH^^^248^2645661ORC|RE||BH57I28406.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH57I28406.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MB|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||067405544^^^AIRA-TEST^MB~O63N28414^^^AIRA-TEST^MR||AntrimAIRA^StaceyAIRA^Neha^^^^L|KingAIRA^BronwenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1755 Gteenwijkerland Ave^^Houghton^MI^49931^USA^P||^PRN^PH^^^906^4772863|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AntrimAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1755 Gteenwijkerland Ave^^Houghton^MI^49931^USA^P|^PRN^PH^^^906^4772863ORC|RE||BO63N28414.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO63N28414.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||481690161^^^AIRA-TEST^MC~D99O28422^^^AIRA-TEST^MR||MarlinAIRA^LianaAIRA^Jael^^^^L|GannonAIRA^SeptimaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1291 Vude IJsselstreek St^^Chesterfield^MI^48051^USA^P||^PRN^PH^^^586^8302534|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarlinAIRA^GannonAIRA^^^^^L|MTH^Mother^HL70063|1291 Vude IJsselstreek St^^Chesterfield^MI^48051^USA^P|^PRN^PH^^^586^8302534ORC|RE||BD99O28422.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD99O28422.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MCD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||660674706^^^AIRA-TEST^MCD~Z45S28427^^^AIRA-TEST^MR||EriksonAIRA^LuiseAIRA^Gayatri^^^^L|Mc VeetyAIRA^ZolaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1224 Groeide St^^Six Lakes^MI^48886^USA^P||^PRN^PH^^^989^4049511|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EriksonAIRA^Mc VeetyAIRA^^^^^L|MTH^Mother^HL70063|1224 Groeide St^^Six Lakes^MI^48886^USA^P|^PRN^PH^^^989^4049511ORC|RE||BZ45S28427.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ45S28427.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||586665614^^^AIRA-TEST^MCN~T29Z28435^^^AIRA-TEST^MR||SagadahocAIRA^EnoraAIRA^Bliss^^^^L|RowanAIRA^AkutiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1501 Tittenseradeel Pl^^Northport^MI^49670^USA^P||^PRN^PH^^^231^3876658|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SagadahocAIRA^RowanAIRA^^^^^L|MTH^Mother^HL70063|1501 Tittenseradeel Pl^^Northport^MI^49670^USA^P|^PRN^PH^^^231^3876658ORC|RE||BT29Z28435.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT29Z28435.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MCR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||324899745^^^AIRA-TEST^MCR~W75Z28446^^^AIRA-TEST^MR||MooreAIRA^ZinniaAIRA^Syshe^^^^L|GreeneAIRA^PalilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1823 Geleen Ave^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^2151384|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MooreAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1823 Geleen Ave^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^2151384ORC|RE||BW75Z28446.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW75Z28446.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||041818860^^^AIRA-TEST^MD~S07Q28454^^^AIRA-TEST^MR||SacramentoAIRA^BhoomiAIRA^Jina^^^^L|RogersAIRA^NaddaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1823 Dutten Ave^^Ishpeming^MI^49849^USA^P||^PRN^PH^^^906^7379879|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SacramentoAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1823 Dutten Ave^^Ishpeming^MI^49849^USA^P|^PRN^PH^^^906^7379879ORC|RE||BS07Q28454.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS07Q28454.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||253395886^^^AIRA-TEST^MI~P25C28462^^^AIRA-TEST^MR||BrackenAIRA^BerangerAIRA^Silvie^^^^L|GarrardAIRA^SionedAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1244 Oloemendaal Pl^^East Detroit^MI^48021^USA^P||^PRN^PH^^^586^2175304|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrackenAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1244 Oloemendaal Pl^^East Detroit^MI^48021^USA^P|^PRN^PH^^^586^2175304ORC|RE||BP25C28462.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP25C28462.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||099355459^^^AIRA-TEST^MR~G70I28467^^^AIRA-TEST^MR||GartenlaubAIRA^VyvyanAIRA^Orpah^^^^L|O'NeillAIRA^ElliceAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1088 Wexel St^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^7934621|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GartenlaubAIRA^O'NeillAIRA^^^^^L|MTH^Mother^HL70063|1088 Wexel St^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^7934621ORC|RE||BG70I28467.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG70I28467.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-MRT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||361987660^^^AIRA-TEST^MRT~P61Z28475^^^AIRA-TEST^MR||Scotts BluffAIRA^BirgitteAIRA^Elyshia^^^^L|ShoshoneAIRA^ShaylaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1744 Dijfheerenlanden Ln^^Flint^MI^48505^USA^P||^PRN^PH^^^810^6131948|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Scotts BluffAIRA^ShoshoneAIRA^^^^^L|MTH^Mother^HL70063|1744 Dijfheerenlanden Ln^^Flint^MI^48505^USA^P|^PRN^PH^^^810^6131948ORC|RE||BP61Z28475.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP61Z28475.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||942415397^^^AIRA-TEST^NE~K86O28486^^^AIRA-TEST^MR||LowndesAIRA^CandideAIRA^Alka^^^^L|LarsonAIRA^HelenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1945 Dss St^^Hamburg^MI^48189^USA^P||^PRN^PH^^^734^5999846|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LowndesAIRA^LarsonAIRA^^^^^L|MTH^Mother^HL70063|1945 Dss St^^Hamburg^MI^48189^USA^P|^PRN^PH^^^734^5999846ORC|RE||BK86O28486.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK86O28486.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||974158354^^^AIRA-TEST^NH~A09U28494^^^AIRA-TEST^MR||DauphinAIRA^SaraidAIRA^Gargi^^^^L|HoodAIRA^HeleddAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1996 Sinkelland Cir^^Brownstown Township^MI^48193^USA^P||^PRN^PH^^^734^4144777|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DauphinAIRA^HoodAIRA^^^^^L|MTH^Mother^HL70063|1996 Sinkelland Cir^^Brownstown Township^MI^48193^USA^P|^PRN^PH^^^734^4144777ORC|RE||BA09U28494.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA09U28494.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||975466520^^^AIRA-TEST^NI~I74W28502^^^AIRA-TEST^MR||LevyAIRA^JaylynAIRA^Theresa^^^^L|JeffersonAIRA^CarajeanAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1111 Dldebroek Ln^^Montgomery^MI^49255^USA^P||^PRN^PH^^^517^7113120|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LevyAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1111 Dldebroek Ln^^Montgomery^MI^49255^USA^P|^PRN^PH^^^517^7113120ORC|RE||BI74W28502.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI74W28502.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NII|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||681289456^^^AIRA-TEST^NII~J05T28507^^^AIRA-TEST^MR||MontgomeryAIRA^ZayitAIRA^Alma^^^^L|SanduskyAIRA^TacitaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1949 Mrnhem Ave^^Podunk^MI^48158^USA^P||^PRN^PH^^^734^5064989|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^SanduskyAIRA^^^^^L|MTH^Mother^HL70063|1949 Mrnhem Ave^^Podunk^MI^48158^USA^P|^PRN^PH^^^734^5064989ORC|RE||BJ05T28507.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ05T28507.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NIIP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||580071596^^^AIRA-TEST^NIIP~I43T28518^^^AIRA-TEST^MR||AmadorAIRA^AnanaAIRA^Syna^^^^L|AmmensAIRA^LindsayAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1602 Beweging Cir^^Elberta^MI^49628^USA^P||^PRN^PH^^^231^6575835|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AmadorAIRA^AmmensAIRA^^^^^L|MTH^Mother^HL70063|1602 Beweging Cir^^Elberta^MI^49628^USA^P|^PRN^PH^^^231^6575835ORC|RE||BI43T28518.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI43T28518.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NP|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||722127133^^^AIRA-TEST^NP~L04M28526^^^AIRA-TEST^MR||AlofsonAIRA^LanaAIRA^Mariabella^^^^L|NormanAIRA^ElizabethAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1595 Gorst aan de Maas St^^Lake Orion^MI^48360^USA^P||^PRN^PH^^^248^6904923|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlofsonAIRA^NormanAIRA^^^^^L|MTH^Mother^HL70063|1595 Gorst aan de Maas St^^Lake Orion^MI^48360^USA^P|^PRN^PH^^^248^6904923ORC|RE||BL04M28526.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL04M28526.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-NPI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||993855822^^^AIRA-TEST^NPI~L87I28534^^^AIRA-TEST^MR||SilsethAIRA^CelinaAIRA^Vinvella^^^^L|OchiltreeAIRA^MikaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1054 Als Ln^^Curran^MI^48728^USA^P||^PRN^PH^^^989^6103169|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SilsethAIRA^OchiltreeAIRA^^^^^L|MTH^Mother^HL70063|1054 Als Ln^^Curran^MI^48728^USA^P|^PRN^PH^^^989^6103169ORC|RE||BL87I28534.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL87I28534.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-OD|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||774193370^^^AIRA-TEST^OD~K93O28542^^^AIRA-TEST^MR||CheboyganAIRA^SharonAIRA^Rieko^^^^L|OaklandAIRA^MeghanAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1363 Vlphen-Chaam St^^Borculo^MI^49464^USA^P||^PRN^PH^^^616^4936622|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CheboyganAIRA^OaklandAIRA^^^^^L|MTH^Mother^HL70063|1363 Vlphen-Chaam St^^Borculo^MI^49464^USA^P|^PRN^PH^^^616^4936622ORC|RE||BK93O28542.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK93O28542.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||411404318^^^AIRA-TEST^PA~Y14H28547^^^AIRA-TEST^MR||WhartonAIRA^KerryAIRA^Vinita^^^^L|ModocAIRA^CharlotteAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1780 Denk Pl^^Lansing^MI^48933^USA^P||^PRN^PH^^^517^7992054|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhartonAIRA^ModocAIRA^^^^^L|MTH^Mother^HL70063|1780 Denk Pl^^Lansing^MI^48933^USA^P|^PRN^PH^^^517^7992054ORC|RE||BY14H28547.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY14H28547.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||358086193^^^AIRA-TEST^PCN~R82C28558^^^AIRA-TEST^MR||BerrienAIRA^ArmorelAIRA^Eda^^^^L|HabberstadAIRA^XiomaraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1559 Druten Ave^^Horton^MI^49246^USA^P||^PRN^PH^^^517^8018511|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BerrienAIRA^HabberstadAIRA^^^^^L|MTH^Mother^HL70063|1559 Druten Ave^^Horton^MI^49246^USA^P|^PRN^PH^^^517^8018511ORC|RE||BR82C28558.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR82C28558.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PE|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||665216794^^^AIRA-TEST^PE~V09W28566^^^AIRA-TEST^MR||NilsenAIRA^JoyAIRA^Edlyn^^^^L|VistanstAIRA^ElaineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1776 Tubbergen Cir^^Utica^MI^48316^USA^P||^PRN^PH^^^586^6264793|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NilsenAIRA^VistanstAIRA^^^^^L|MTH^Mother^HL70063|1776 Tubbergen Cir^^Utica^MI^48316^USA^P|^PRN^PH^^^586^6264793ORC|RE||BV09W28566.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV09W28566.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PEN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||378696215^^^AIRA-TEST^PEN~U03Z28574^^^AIRA-TEST^MR||ReillyAIRA^AnoushAIRA^Londyn^^^^L|IsdalAIRA^ChenoaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1781 Dof van Twente Ave^^Oak Grove^MI^48863^USA^P||^PRN^PH^^^517^2717703|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReillyAIRA^IsdalAIRA^^^^^L|MTH^Mother^HL70063|1781 Dof van Twente Ave^^Oak Grove^MI^48863^USA^P|^PRN^PH^^^517^2717703ORC|RE||BU03Z28574.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU03Z28574.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||355286115^^^AIRA-TEST^PI~L55Q28582^^^AIRA-TEST^MR||ButlerAIRA^PritikaAIRA^Soleil^^^^L|DarkeAIRA^DelilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1630 Wantumadiel St^^Plymouth^MI^48170^USA^P||^PRN^PH^^^734^2837521|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^DarkeAIRA^^^^^L|MTH^Mother^HL70063|1630 Wantumadiel St^^Plymouth^MI^48170^USA^P|^PRN^PH^^^734^2837521ORC|RE||BL55Q28582.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL55Q28582.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||159237408^^^AIRA-TEST^PN~O83W28587^^^AIRA-TEST^MR||SilowAIRA^KlaudiaAIRA^Zohra^^^^L|WagonerAIRA^ShanataAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1029 Omallingerland St^^Ravenna^MI^49451^USA^P||^PRN^PH^^^231^5699818|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SilowAIRA^WagonerAIRA^^^^^L|MTH^Mother^HL70063|1029 Omallingerland St^^Ravenna^MI^49451^USA^P|^PRN^PH^^^231^5699818ORC|RE||BO83W28587.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO83W28587.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PNT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||552289228^^^AIRA-TEST^PNT~F39F28595^^^AIRA-TEST^MR||CameronAIRA^RosalindAIRA^Brooklyn^^^^L|LoveAIRA^AvisAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1634 Reststellingwerf Ave^^Coloma^MI^49039^USA^P||^PRN^PH^^^269^7634274|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CameronAIRA^LoveAIRA^^^^^L|MTH^Mother^HL70063|1634 Reststellingwerf Ave^^Coloma^MI^49039^USA^P|^PRN^PH^^^269^7634274ORC|RE||BF39F28595.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF39F28595.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PPN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||462362656^^^AIRA-TEST^PPN~A27P28606^^^AIRA-TEST^MR||La PazAIRA^XylonaAIRA^Bambi^^^^L|CusterAIRA^AmberleyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1220 Bint-Michielsgestel Pl^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^5066110|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|La PazAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1220 Bint-Michielsgestel Pl^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^5066110ORC|RE||BA27P28606.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA27P28606.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PRC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||037758666^^^AIRA-TEST^PRC~R89K28614^^^AIRA-TEST^MR||MahoneyAIRA^AnitaAIRA^Jaida^^^^L|BelmontAIRA^DulcinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1438 Nuidhorn Ave^^Woodland Park^MI^49309^USA^P||^PRN^PH^^^231^4069288|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahoneyAIRA^BelmontAIRA^^^^^L|MTH^Mother^HL70063|1438 Nuidhorn Ave^^Woodland Park^MI^49309^USA^P|^PRN^PH^^^231^4069288ORC|RE||BR89K28614.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR89K28614.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PRN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||277629509^^^AIRA-TEST^PRN~J18F28622^^^AIRA-TEST^MR||GilespieAIRA^JarrahAIRA^Lodema^^^^L|ElmoreAIRA^KellyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1984 Kinsum St^^Milan^MI^48160^USA^P||^PRN^PH^^^734^6246032|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GilespieAIRA^ElmoreAIRA^^^^^L|MTH^Mother^HL70063|1984 Kinsum St^^Milan^MI^48160^USA^P|^PRN^PH^^^734^6246032ORC|RE||BJ18F28622.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ18F28622.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-PT|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||903317796^^^AIRA-TEST^PT~M33G28627^^^AIRA-TEST^MR||Box ButteAIRA^BijalAIRA^Selah^^^^L|MadisonAIRA^BananAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1199 Suth Cir^^Radio Bible Class^MI^49555^USA^P||^PRN^PH^^^616^3823405|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Box ButteAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1199 Suth Cir^^Radio Bible Class^MI^49555^USA^P|^PRN^PH^^^616^3823405ORC|RE||BM33G28627.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM33G28627.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-QA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||175918296^^^AIRA-TEST^QA~N98R28635^^^AIRA-TEST^MR||MontgomeryAIRA^CourtneyAIRA^Idonia^^^^L|KootenaiAIRA^KaylynnAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1951 Eeuw Pl^^Chippewa Reg Correction Fac^MI^49784^USA^P||^PRN^PH^^^906^4187771|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^KootenaiAIRA^^^^^L|MTH^Mother^HL70063|1951 Eeuw Pl^^Chippewa Reg Correction Fac^MI^49784^USA^P|^PRN^PH^^^906^4187771ORC|RE||BN98R28635.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98R28635.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-RI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||046794933^^^AIRA-TEST^RI~C46Y28646^^^AIRA-TEST^MR||AransasAIRA^KuraAIRA^Tamara^^^^L|WoldAIRA^DeidraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1543 Bindhoven Ave^^Sturgis^MI^49091^USA^P||^PRN^PH^^^269^3430321|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AransasAIRA^WoldAIRA^^^^^L|MTH^Mother^HL70063|1543 Bindhoven Ave^^Sturgis^MI^49091^USA^P|^PRN^PH^^^269^3430321ORC|RE||BC46Y28646.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC46Y28646.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-RN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||068645156^^^AIRA-TEST^RN~G86K28654^^^AIRA-TEST^MR||AnningAIRA^CarleighAIRA^Prisha^^^^L|HawkeAIRA^RhiannonAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1158 Buizen Pl^^Four Mile Lake^MI^48130^USA^P||^PRN^PH^^^734^6388364|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AnningAIRA^HawkeAIRA^^^^^L|MTH^Mother^HL70063|1158 Buizen Pl^^Four Mile Lake^MI^48130^USA^P|^PRN^PH^^^734^6388364ORC|RE||BG86K28654.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG86K28654.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-RPH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||648748196^^^AIRA-TEST^RPH~A74Z28662^^^AIRA-TEST^MR||MultnomahAIRA^AvaAIRA^Zelma^^^^L|LaRueAIRA^ToveAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1040 Ztichtse Vecht Pl^^AT&T^MI^48663^USA^P||^PRN^PH^^^989^9138941|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MultnomahAIRA^LaRueAIRA^^^^^L|MTH^Mother^HL70063|1040 Ztichtse Vecht Pl^^AT&T^MI^48663^USA^P|^PRN^PH^^^989^9138941ORC|RE||BA74Z28662.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA74Z28662.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-RR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||602061122^^^AIRA-TEST^RR~K12I28667^^^AIRA-TEST^MR||PettersonAIRA^YevonAIRA^Scota^^^^L|AtokaAIRA^ChizuAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1253 Uemsmond Ave^^Paradise^MI^49768^USA^P||^PRN^PH^^^906^9803023|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PettersonAIRA^AtokaAIRA^^^^^L|MTH^Mother^HL70063|1253 Uemsmond Ave^^Paradise^MI^49768^USA^P|^PRN^PH^^^906^9803023ORC|RE||BK12I28667.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK12I28667.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-RRI|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||071998866^^^AIRA-TEST^RRI~X93W28675^^^AIRA-TEST^MR||HofflundAIRA^KanchanaAIRA^Evelyn^^^^L|DouglasAIRA^MasaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1025 'enterwolde Ln^^Goodrich^MI^48438^USA^P||^PRN^PH^^^810^2646717|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HofflundAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1025 'enterwolde Ln^^Goodrich^MI^48438^USA^P|^PRN^PH^^^810^2646717ORC|RE||BX93W28675.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX93W28675.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-SL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||864416839^^^AIRA-TEST^SL~P00Y28686^^^AIRA-TEST^MR||GormanAIRA^MagdalenAIRA^Orianna^^^^L|MiljkeimAIRA^TheoneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1271 Homeren Ln^^Benton Harbor^MI^49022^USA^P||^PRN^PH^^^269^7946677|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GormanAIRA^MiljkeimAIRA^^^^^L|MTH^Mother^HL70063|1271 Homeren Ln^^Benton Harbor^MI^49022^USA^P|^PRN^PH^^^269^7946677ORC|RE||BP00Y28686.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP00Y28686.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-SN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||695224915^^^AIRA-TEST^SN~M41X28694^^^AIRA-TEST^MR||ScottAIRA^AmberAIRA^Bron^^^^L|AdamsAIRA^EsperanzaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1014 Oennep Ave^^Pittsford^MI^49271^USA^P||^PRN^PH^^^517^5670851|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ScottAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1014 Oennep Ave^^Pittsford^MI^49271^USA^P|^PRN^PH^^^517^5670851ORC|RE||BM41X28694.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM41X28694.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-SR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||661026601^^^AIRA-TEST^SR~T66G28702^^^AIRA-TEST^MR||CrawfordAIRA^ElgaAIRA^Anninka^^^^L|MorrillAIRA^LeodaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1633 Korst aan de Maas Pl^^Commerce Township^MI^48382^USA^P||^PRN^PH^^^248^5257187|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^MorrillAIRA^^^^^L|MTH^Mother^HL70063|1633 Korst aan de Maas Pl^^Commerce Township^MI^48382^USA^P|^PRN^PH^^^248^5257187ORC|RE||BT66G28702.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT66G28702.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-SS|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||345751725^^^AIRA-TEST^SS~I26C28707^^^AIRA-TEST^MR||JasperAIRA^ChastityAIRA^Angel^^^^L|WilliamsonAIRA^OdileAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1179 Laarlemmermeer Ave^^Au Gres^MI^48703^USA^P||^PRN^PH^^^989^6424843|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JasperAIRA^WilliamsonAIRA^^^^^L|MTH^Mother^HL70063|1179 Laarlemmermeer Ave^^Au Gres^MI^48703^USA^P|^PRN^PH^^^989^6424843ORC|RE||BI26C28707.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI26C28707.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-TAX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||205192336^^^AIRA-TEST^TAX~G22L28718^^^AIRA-TEST^MR||Santa CruzAIRA^NixieAIRA^Solace^^^^L|ArmstrongAIRA^TobitAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1186 Dden Pl^^Herron^MI^49744^USA^P||^PRN^PH^^^989^4663807|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa CruzAIRA^ArmstrongAIRA^^^^^L|MTH^Mother^HL70063|1186 Dden Pl^^Herron^MI^49744^USA^P|^PRN^PH^^^989^4663807ORC|RE||BG22L28718.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG22L28718.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-U|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||695809390^^^AIRA-TEST^U~A25K28726^^^AIRA-TEST^MR||WashingtonAIRA^CireaAIRA^Edolie^^^^L|JonsonAIRA^PollyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1325 Serkendam St^^Hessel^MI^49745^USA^P||^PRN^PH^^^906^3873350|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^JonsonAIRA^^^^^L|MTH^Mother^HL70063|1325 Serkendam St^^Hessel^MI^49745^USA^P|^PRN^PH^^^906^3873350ORC|RE||BA25K28726.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA25K28726.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-UPIN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||845338584^^^AIRA-TEST^UPIN~B58A28734^^^AIRA-TEST^MR||HoreAIRA^TrudeAIRA^Shradhdha^^^^L|RaumaAIRA^GonerilAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1660 Poorst Ln^^Walled Lake^MI^48390^USA^P||^PRN^PH^^^248^8082818|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoreAIRA^RaumaAIRA^^^^^L|MTH^Mother^HL70063|1660 Poorst Ln^^Walled Lake^MI^48390^USA^P|^PRN^PH^^^248^8082818ORC|RE||BB58A28734.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB58A28734.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-VN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||510674880^^^AIRA-TEST^VN~F02W28742^^^AIRA-TEST^MR||ToaleAIRA^IngaAIRA^Haldana^^^^L|O DayAIRA^IstasAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1651 Suggereren Ave^^Bath^MI^48808^USA^P||^PRN^PH^^^517^2045819|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ToaleAIRA^O DayAIRA^^^^^L|MTH^Mother^HL70063|1651 Suggereren Ave^^Bath^MI^48808^USA^P|^PRN^PH^^^517^2045819ORC|RE||BF02W28742.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF02W28742.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-WC|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||963280062^^^AIRA-TEST^WC~O65U28747^^^AIRA-TEST^MR||MadisonAIRA^AjaAIRA^Dianne^^^^L|KimbleAIRA^CeinwenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1745 Rongeradeel Ave^^Moscow^MI^49257^USA^P||^PRN^PH^^^517^8157573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^KimbleAIRA^^^^^L|MTH^Mother^HL70063|1745 Rongeradeel Ave^^Moscow^MI^49257^USA^P|^PRN^PH^^^517^8157573ORC|RE||BO65U28747.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO65U28747.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-WCN|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||977809540^^^AIRA-TEST^WCN~F21I28758^^^AIRA-TEST^MR||LemhiAIRA^HelimaAIRA^Lexi^^^^L|FultonAIRA^HengAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1802 Uoudrichem St^^Milford Township^MI^48380^USA^P||^PRN^PH^^^248^7135282|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LemhiAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1802 Uoudrichem St^^Milford Township^MI^48380^USA^P|^PRN^PH^^^248^7135282ORC|RE||BF21I28758.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF21I28758.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ID-TYPE2-XX|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||923318890^^^AIRA-TEST^XX~I12N28766^^^AIRA-TEST^MR||ChopeAIRA^BobbieAIRA^Neha^^^^L|CumberlandAIRA^AgnetaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1141 Bidden-Drenthe Ave^^Saint Clair Shores^MI^48080^USA^P||^PRN^PH^^^586^2442458|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChopeAIRA^CumberlandAIRA^^^^^L|MTH^Mother^HL70063|1141 Bidden-Drenthe Ave^^Saint Clair Shores^MI^48080^USA^P|^PRN^PH^^^586^2442458ORC|RE||BI12N28766.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI12N28766.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005010001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W51K28774^^^AIRA-TEST^MR||JohnstonAIRA^VibhutiAIRA^Karlee^^^^L|TrumbullAIRA^AquaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1539 Zoerdijk St^^Grosse Pointe^MI^48230^USA^P||^PRN^PH^^^313^4133342|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnstonAIRA^TrumbullAIRA^^^^^L|MTH^Mother^HL70063|1539 Zoerdijk St^^Grosse Pointe^MI^48230^USA^P|^PRN^PH^^^313^4133342ORC|RE||BW51K28774.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW51K28774.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005010001^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005010002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R40N28782^^^AIRA-TEST^MR||HoodAIRA^PoonamAIRA^Catriona^^^^L|KildahlAIRA^KayleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1143 Bmsterdam Cir^^Orion^MI^48359^USA^P||^PRN^PH^^^248^8339161|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoodAIRA^KildahlAIRA^^^^^L|MTH^Mother^HL70063|1143 Bmsterdam Cir^^Orion^MI^48359^USA^P|^PRN^PH^^^248^8339161ORC|RE||BR40N28782.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR40N28782.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005010002^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005010005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X16H28787^^^AIRA-TEST^MR||GanronAIRA^CherlinAIRA^Rudrani^^^^L|CentreAIRA^MekiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1598 Laatste Cir^^Roscommon^MI^48653^USA^P||^PRN^PH^^^989^5704736|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanronAIRA^CentreAIRA^^^^^L|MTH^Mother^HL70063|1598 Laatste Cir^^Roscommon^MI^48653^USA^P|^PRN^PH^^^989^5704736ORC|RE||BX16H28787.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX16H28787.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005010005^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005010010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q33E28795^^^AIRA-TEST^MR||MakinAIRA^ChristelAIRA^Somatra^^^^L|KentAIRA^CyzarineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1693 Totaal Cir^^Eben Jct^MI^49825^USA^P||^PRN^PH^^^906^5726174|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MakinAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1693 Totaal Cir^^Eben Jct^MI^49825^USA^P|^PRN^PH^^^906^5726174ORC|RE||BQ33E28795.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ33E28795.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005010010^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005197049|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J19E28806^^^AIRA-TEST^MR||McMullenAIRA^AhimsaAIRA^Musetta^^^^L|JensenAIRA^RandieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1419 Herneuzen Ln^^Southeast^MI^48529^USA^P||^PRN^PH^^^810^5006869|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McMullenAIRA^JensenAIRA^^^^^L|MTH^Mother^HL70063|1419 Herneuzen Ln^^Southeast^MI^48529^USA^P|^PRN^PH^^^810^5006869ORC|RE||BJ19E28806.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ19E28806.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005197049^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005197050|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I22D28814^^^AIRA-TEST^MR||PikeAIRA^JarahAIRA^Lorie^^^^L|WinnebagoAIRA^TulasiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1215 Renswoude Ave^^Laingsburg^MI^48848^USA^P||^PRN^PH^^^517^5305500|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^WinnebagoAIRA^^^^^L|MTH^Mother^HL70063|1215 Renswoude Ave^^Laingsburg^MI^48848^USA^P|^PRN^PH^^^517^5305500ORC|RE||BI22D28814.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI22D28814.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005197050^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005197101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D43I28822^^^AIRA-TEST^MR||AldridgeAIRA^KadeAIRA^Lucy^^^^L|RobertsAIRA^ConcepcionAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1600 Nastricum Ave^^Warren^MI^48089^USA^P||^PRN^PH^^^586^6108136|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AldridgeAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1600 Nastricum Ave^^Warren^MI^48089^USA^P|^PRN^PH^^^586^6108136ORC|RE||BD43I28822.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD43I28822.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005197101^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005197102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S24R28827^^^AIRA-TEST^MR||ButlerAIRA^CalliopeAIRA^Odessa^^^^L|MenomineeAIRA^BetaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1212 Alphen-Chaam Pl^^Decatur^MI^49045^USA^P||^PRN^PH^^^269^3549498|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^MenomineeAIRA^^^^^L|MTH^Mother^HL70063|1212 Alphen-Chaam Pl^^Decatur^MI^49045^USA^P|^PRN^PH^^^269^3549498ORC|RE||BS24R28827.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS24R28827.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005197102^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005197104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F71M28838^^^AIRA-TEST^MR||CarrollAIRA^CarlyAIRA^Helouse^^^^L|DallamAIRA^MadisynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1920 Mynaarlo Pl^^Jackson^MI^49203^USA^P||^PRN^PH^^^517^6687822|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^DallamAIRA^^^^^L|MTH^Mother^HL70063|1920 Mynaarlo Pl^^Jackson^MI^49203^USA^P|^PRN^PH^^^517^6687822ORC|RE||BF71M28838.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF71M28838.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005197104^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00005197105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H67E28846^^^AIRA-TEST^MR||RoscommonAIRA^VikkiAIRA^Miyoko^^^^L|AuglaizeAIRA^RonaldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1788 Hutten Ave^^Canton^MI^48187^USA^P||^PRN^PH^^^734^8365445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RoscommonAIRA^AuglaizeAIRA^^^^^L|MTH^Mother^HL70063|1788 Hutten Ave^^Canton^MI^48187^USA^P|^PRN^PH^^^734^8365445ORC|RE||BH67E28846.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH67E28846.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00005197105^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006404500|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A42T28854^^^AIRA-TEST^MR||AndrewsAIRA^IvanaAIRA^Abella^^^^L|MorrowAIRA^DahliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1932 Smmen St^^Herron^MI^49744^USA^P||^PRN^PH^^^989^2698342|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndrewsAIRA^MorrowAIRA^^^^^L|MTH^Mother^HL70063|1932 Smmen St^^Herron^MI^49744^USA^P|^PRN^PH^^^989^2698342ORC|RE||BA42T28854.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA42T28854.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006404500^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006404501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X62I28862^^^AIRA-TEST^MR||BarrettAIRA^YovelaAIRA^Kate^^^^L|PacificAIRA^PramadaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1249 Iampen Ave^^Brownstown Township^MI^48193^USA^P||^PRN^PH^^^734^7153524|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BarrettAIRA^PacificAIRA^^^^^L|MTH^Mother^HL70063|1249 Iampen Ave^^Brownstown Township^MI^48193^USA^P|^PRN^PH^^^734^7153524ORC|RE||BX62I28862.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX62I28862.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006404501^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006404541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S84M28867^^^AIRA-TEST^MR||PerryAIRA^WillaAIRA^Cristiona^^^^L|WheelerAIRA^ShashiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1978 Htaphorst Cir^^Frenchtown^MI^48161^USA^P||^PRN^PH^^^734^3250984|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1978 Htaphorst Cir^^Frenchtown^MI^48161^USA^P|^PRN^PH^^^734^3250984ORC|RE||BS84M28867.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS84M28867.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006404541^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006404701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N25U28876^^^AIRA-TEST^MR||CassAIRA^MarcieAIRA^Anita^^^^L|SamuelsonAIRA^ImogenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1904 Kteenbergen Ln^^GR^MI^49503^USA^P||^PRN^PH^^^616^3608245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^SamuelsonAIRA^^^^^L|MTH^Mother^HL70063|1904 Kteenbergen Ln^^GR^MI^49503^USA^P|^PRN^PH^^^616^3608245ORC|RE||BN25U28876.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN25U28876.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006404701^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006404720|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P59M28886^^^AIRA-TEST^MR||BenzieAIRA^SirenaAIRA^Gulara^^^^L|SnowAIRA^KellyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1271 Woes Ln^^Brohman^MI^49312^USA^P||^PRN^PH^^^231^9092907|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BenzieAIRA^SnowAIRA^^^^^L|MTH^Mother^HL70063|1271 Woes Ln^^Brohman^MI^49312^USA^P|^PRN^PH^^^231^9092907ORC|RE||BP59M28886.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP59M28886.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006404720^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006404741|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X23A28894^^^AIRA-TEST^MR||CrawfordAIRA^HedeaAIRA^Cynara^^^^L|OkanoganAIRA^MichikoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1684 Hodegraven-Reeuwijk Ln^^Wyoming^MI^49519^USA^P||^PRN^PH^^^616^4134459|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^OkanoganAIRA^^^^^L|MTH^Mother^HL70063|1684 Hodegraven-Reeuwijk Ln^^Wyoming^MI^49519^USA^P|^PRN^PH^^^616^4134459ORC|RE||BX23A28894.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX23A28894.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006404741^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K87R28902^^^AIRA-TEST^MR||GeaugaAIRA^PhyllisAIRA^Candide^^^^L|GlasscockAIRA^GinetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1974 Goppersum Cir^^Selfridge Angb^MI^48045^USA^P||^PRN^PH^^^586^4425968|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeaugaAIRA^GlasscockAIRA^^^^^L|MTH^Mother^HL70063|1974 Goppersum Cir^^Selfridge Angb^MI^48045^USA^P|^PRN^PH^^^586^4425968ORC|RE||BK87R28902.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK87R28902.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409301^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V73Y28907^^^AIRA-TEST^MR||GratiotAIRA^MarthaAIRA^Lenis^^^^L|LohmannAIRA^SierraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1910 Vereisen Ln^^Hartford^MI^49057^USA^P||^PRN^PH^^^269^3965510|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GratiotAIRA^LohmannAIRA^^^^^L|MTH^Mother^HL70063|1910 Vereisen Ln^^Hartford^MI^49057^USA^P|^PRN^PH^^^269^3965510ORC|RE||BV73Y28907.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV73Y28907.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409302^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409309|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O20V28915^^^AIRA-TEST^MR||BradfordAIRA^SibongileAIRA^Ila^^^^L|HallAIRA^LaquettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1851 Vaardigheid Ave^^Capac^MI^48014^USA^P||^PRN^PH^^^810^6767759|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BradfordAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1851 Vaardigheid Ave^^Capac^MI^48014^USA^P|^PRN^PH^^^810^6767759ORC|RE||BO20V28915.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO20V28915.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409309^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F74I28926^^^AIRA-TEST^MR||MenomineeAIRA^DannaAIRA^Saidah^^^^L|OwyheeAIRA^KevinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1475 Rente Ln^^Beaver Island^MI^49782^USA^P||^PRN^PH^^^906^3390467|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenomineeAIRA^OwyheeAIRA^^^^^L|MTH^Mother^HL70063|1475 Rente Ln^^Beaver Island^MI^49782^USA^P|^PRN^PH^^^906^3390467ORC|RE||BF74I28926.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF74I28926.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409401^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D71Y28934^^^AIRA-TEST^MR||PerryAIRA^MyaAIRA^Volumnia^^^^L|Bear LakeAIRA^JordanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1172 Eeuw Ln^^Gregory^MI^48137^USA^P||^PRN^PH^^^734^5482641|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^Bear LakeAIRA^^^^^L|MTH^Mother^HL70063|1172 Eeuw Ln^^Gregory^MI^48137^USA^P|^PRN^PH^^^734^5482641ORC|RE||BD71Y28934.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD71Y28934.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409402^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409409|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T70U28942^^^AIRA-TEST^MR||RoseAIRA^CossetteAIRA^Rainbow^^^^L|MarinAIRA^UshaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1029 Huid Ave^^Tawas City^MI^48764^USA^P||^PRN^PH^^^989^3060352|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RoseAIRA^MarinAIRA^^^^^L|MTH^Mother^HL70063|1029 Huid Ave^^Tawas City^MI^48764^USA^P|^PRN^PH^^^989^3060352ORC|RE||BT70U28942.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT70U28942.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409409^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U82B28947^^^AIRA-TEST^MR||DakotaAIRA^LucilleAIRA^Sashenka^^^^L|CrawfordAIRA^MatildaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1977 Gytsjerksteradiel Ln^^Wheeler^MI^48662^USA^P||^PRN^PH^^^989^3323861|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DakotaAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1977 Gytsjerksteradiel Ln^^Wheeler^MI^48662^USA^P|^PRN^PH^^^989^3323861ORC|RE||BU82B28947.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU82B28947.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409501^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H29Q28957^^^AIRA-TEST^MR||MasonAIRA^XimenaAIRA^Paige^^^^L|CollingsworthAIRA^AmesAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1761 Sinsum St^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^6787051|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^CollingsworthAIRA^^^^^L|MTH^Mother^HL70063|1761 Sinsum St^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^6787051ORC|RE||BH29Q28957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH29Q28957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409502^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409509|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D54D28966^^^AIRA-TEST^MR||FranklinAIRA^LeewanaAIRA^Quorra^^^^L|CliveAIRA^PoppyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1826 Dijkerk Cir^^Parchment^MI^49004^USA^P||^PRN^PH^^^269^4845426|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^CliveAIRA^^^^^L|MTH^Mother^HL70063|1826 Dijkerk Cir^^Parchment^MI^49004^USA^P|^PRN^PH^^^269^4845426ORC|RE||BD54D28966.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD54D28966.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409509^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R77C28974^^^AIRA-TEST^MR||CallowayAIRA^CarlenAIRA^Kayley^^^^L|HoreAIRA^FinleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1684 Rellendoorn Pl^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^6811241|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CallowayAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1684 Rellendoorn Pl^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^6811241ORC|RE||BR77C28974.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR77C28974.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409601^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N98F28982^^^AIRA-TEST^MR||ArenacAIRA^MaryamAIRA^Bron^^^^L|PiscataquisAIRA^LorenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1802 Duder-Amstel St^^Grosse Pointe^MI^48236^USA^P||^PRN^PH^^^313^2569864|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArenacAIRA^PiscataquisAIRA^^^^^L|MTH^Mother^HL70063|1802 Duder-Amstel St^^Grosse Pointe^MI^48236^USA^P|^PRN^PH^^^313^2569864ORC|RE||BN98F28982.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98F28982.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409602^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006409609|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L00F28987^^^AIRA-TEST^MR||PickawayAIRA^ShanaAIRA^Jillie^^^^L|AdaAIRA^DeeptiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1677 Nardinxveld-Giessendam Cir^^Cross Village^MI^49723^USA^P||^PRN^PH^^^616^8815043|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PickawayAIRA^AdaAIRA^^^^^L|MTH^Mother^HL70063|1677 Nardinxveld-Giessendam Cir^^Cross Village^MI^49723^USA^P|^PRN^PH^^^616^8815043ORC|RE||BL00F28987.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL00F28987.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006409609^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006410901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E27H28996^^^AIRA-TEST^MR||McCullochAIRA^ShailiAIRA^Marabel^^^^L|FarrellAIRA^JacintheAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1372 Vinden Ave^^Weston^MI^49289^USA^P||^PRN^PH^^^517^5422992|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCullochAIRA^FarrellAIRA^^^^^L|MTH^Mother^HL70063|1372 Vinden Ave^^Weston^MI^49289^USA^P|^PRN^PH^^^517^5422992ORC|RE||BE27H28996.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE27H28996.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006410901^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006410902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E91E29005^^^AIRA-TEST^MR||AsotinAIRA^FaylinnAIRA^Malati^^^^L|OaklandAIRA^JazmynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1688 Wranendonck Pl^^Johannesburg^MI^49751^USA^P||^PRN^PH^^^989^6591380|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AsotinAIRA^OaklandAIRA^^^^^L|MTH^Mother^HL70063|1688 Wranendonck Pl^^Johannesburg^MI^49751^USA^P|^PRN^PH^^^989^6591380ORC|RE||BE91E29005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE91E29005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006410902^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006410909|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D08R29013^^^AIRA-TEST^MR||McGannAIRA^ChantelAIRA^Nidra^^^^L|San Luis ObispoAIRA^AdelynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1231 Koele Cir^^Casco Township^MI^48064^USA^P||^PRN^PH^^^810^7350412|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McGannAIRA^San Luis ObispoAIRA^^^^^L|MTH^Mother^HL70063|1231 Koele Cir^^Casco Township^MI^48064^USA^P|^PRN^PH^^^810^7350412ORC|RE||BD08R29013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD08R29013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006410909^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006411901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D86T29021^^^AIRA-TEST^MR||TobiassenAIRA^KarenaAIRA^Jayne^^^^L|EliasonAIRA^NainaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1219 Bezoek St^^Akron^MI^48701^USA^P||^PRN^PH^^^989^5227837|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TobiassenAIRA^EliasonAIRA^^^^^L|MTH^Mother^HL70063|1219 Bezoek St^^Akron^MI^48701^USA^P|^PRN^PH^^^989^5227837ORC|RE||BD86T29021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD86T29021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006411901^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006411902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B73U29026^^^AIRA-TEST^MR||VictoriaAIRA^JordanAIRA^Nixie^^^^L|StantonAIRA^ZariaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1215 Geimerswaal St^^Ludington^MI^49431^USA^P||^PRN^PH^^^231^8555620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VictoriaAIRA^StantonAIRA^^^^^L|MTH^Mother^HL70063|1215 Geimerswaal St^^Ludington^MI^49431^USA^P|^PRN^PH^^^231^8555620ORC|RE||BB73U29026.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB73U29026.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006411902^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006411903|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X97N29034^^^AIRA-TEST^MR||SivertsenAIRA^HavanaAIRA^Daray^^^^L|SomersetAIRA^JemimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1939 Roetermeer Ave^^Taylor^MI^48180^USA^P||^PRN^PH^^^313^2192806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SivertsenAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1939 Roetermeer Ave^^Taylor^MI^48180^USA^P|^PRN^PH^^^313^2192806ORC|RE||BX97N29034.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX97N29034.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006411903^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006412101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K58N29045^^^AIRA-TEST^MR||SchuylkillAIRA^RosalieAIRA^Cliantha^^^^L|Santa BarbaraAIRA^RicardaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1821 Pangedijk Pl^^Coldwater^MI^49036^USA^P||^PRN^PH^^^517^6595465|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SchuylkillAIRA^Santa BarbaraAIRA^^^^^L|MTH^Mother^HL70063|1821 Pangedijk Pl^^Coldwater^MI^49036^USA^P|^PRN^PH^^^517^6595465ORC|RE||BK58N29045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK58N29045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006412101^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006412102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W34O29053^^^AIRA-TEST^MR||EricksonAIRA^TaciAIRA^Coral^^^^L|HuronAIRA^DeionAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1775 Lrmelo Cir^^Harbor Springs^MI^49737^USA^P||^PRN^PH^^^616^5275805|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EricksonAIRA^HuronAIRA^^^^^L|MTH^Mother^HL70063|1775 Lrmelo Cir^^Harbor Springs^MI^49737^USA^P|^PRN^PH^^^616^5275805ORC|RE||BW34O29053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW34O29053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006412102^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006413301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S80Z29058^^^AIRA-TEST^MR||MarionAIRA^CaseyAIRA^Ada^^^^L|AldridgeAIRA^NanineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1786 Bosser Ln^^Meskegon^MI^49440^USA^P||^PRN^PH^^^231^9570280|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1786 Bosser Ln^^Meskegon^MI^49440^USA^P|^PRN^PH^^^231^9570280ORC|RE||BS80Z29058.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS80Z29058.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006413301^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006413341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D04W29066^^^AIRA-TEST^MR||OsageAIRA^MorenwynAIRA^Joslin^^^^L|Bear LakeAIRA^VesperaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1725 Dier Ln^^Dryden^MI^48428^USA^P||^PRN^PH^^^810^6266233|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OsageAIRA^Bear LakeAIRA^^^^^L|MTH^Mother^HL70063|1725 Dier Ln^^Dryden^MI^48428^USA^P|^PRN^PH^^^810^6266233ORC|RE||BD04W29066.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD04W29066.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006413341^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006417100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S32G29077^^^AIRA-TEST^MR||KiowaAIRA^ToriAIRA^Sade^^^^L|SummresgillAIRA^BraelynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1733 Symbool Ln^^Pompeii^MI^48874^USA^P||^PRN^PH^^^989^8355783|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KiowaAIRA^SummresgillAIRA^^^^^L|MTH^Mother^HL70063|1733 Symbool Ln^^Pompeii^MI^48874^USA^P|^PRN^PH^^^989^8355783ORC|RE||BS32G29077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS32G29077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006417100^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006417101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J48X29085^^^AIRA-TEST^MR||JonesAIRA^ZondaAIRA^Nanon^^^^L|FultonAIRA^KianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1228 Hilversum St^^Shepherd^MI^48883^USA^P||^PRN^PH^^^989^4277471|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JonesAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1228 Hilversum St^^Shepherd^MI^48883^USA^P|^PRN^PH^^^989^4277471ORC|RE||BJ48X29085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ48X29085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006417101^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006468100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E21H29093^^^AIRA-TEST^MR||AndersonAIRA^ElisaAIRA^Jakayla^^^^L|DonleyAIRA^StinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1832 Station St^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^9852074|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndersonAIRA^DonleyAIRA^^^^^L|MTH^Mother^HL70063|1832 Station St^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^9852074ORC|RE||BE21H29093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE21H29093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006468100^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006468101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y72A29098^^^AIRA-TEST^MR||Red WillowAIRA^PortiaAIRA^Rosemary^^^^L|CherokeeAIRA^KamariaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1989 Werelddeel Ave^^White Cloud^MI^49349^USA^P||^PRN^PH^^^231^4317395|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Red WillowAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1989 Werelddeel Ave^^White Cloud^MI^49349^USA^P|^PRN^PH^^^231^4317395ORC|RE||BY72A29098.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY72A29098.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006468101^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006473900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C50O29106^^^AIRA-TEST^MR||SummitAIRA^HermiaAIRA^Shoshannah^^^^L|Olsen LeeAIRA^AshimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1992 Hijssen St^^Vehicle License Plates^MI^48980^USA^P||^PRN^PH^^^517^8826419|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SummitAIRA^Olsen LeeAIRA^^^^^L|MTH^Mother^HL70063|1992 Hijssen St^^Vehicle License Plates^MI^48980^USA^P|^PRN^PH^^^517^8826419ORC|RE||BC50O29106.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC50O29106.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006473900^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006473901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M79F29117^^^AIRA-TEST^MR||HarmonAIRA^DymphnaAIRA^Crystal^^^^L|DakotaAIRA^GerardaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1418 Spelen St^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^8880001|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarmonAIRA^DakotaAIRA^^^^^L|MTH^Mother^HL70063|1418 Spelen St^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^8880001ORC|RE||BM79F29117.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM79F29117.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006473901^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006482600|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F30B29125^^^AIRA-TEST^MR||NormanAIRA^NazaretAIRA^Emanuela^^^^L|San FranciscoAIRA^ArdelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1828 Pmersfoort Cir^^Lake Orion^MI^48360^USA^P||^PRN^PH^^^248^6499273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NormanAIRA^San FranciscoAIRA^^^^^L|MTH^Mother^HL70063|1828 Pmersfoort Cir^^Lake Orion^MI^48360^USA^P|^PRN^PH^^^248^6499273ORC|RE||BF30B29125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF30B29125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006482600^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006482601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I22Q29133^^^AIRA-TEST^MR||BrennanAIRA^AnoushAIRA^Bianca^^^^L|HawkeAIRA^DamoselAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1915 Ke Marne Cir^^Brimley^MI^49715^USA^P||^PRN^PH^^^906^2515253|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrennanAIRA^HawkeAIRA^^^^^L|MTH^Mother^HL70063|1915 Ke Marne Cir^^Brimley^MI^49715^USA^P|^PRN^PH^^^906^2515253ORC|RE||BI22Q29133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI22Q29133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006482601^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006482700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G19R29138^^^AIRA-TEST^MR||NewportAIRA^PenelopeAIRA^Hana^^^^L|San SabaAIRA^EudociaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1046 Kde Cir^^Afton^MI^49705^USA^P||^PRN^PH^^^231^3717000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewportAIRA^San SabaAIRA^^^^^L|MTH^Mother^HL70063|1046 Kde Cir^^Afton^MI^49705^USA^P|^PRN^PH^^^231^3717000ORC|RE||BG19R29138.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG19R29138.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006482700^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006482701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z91L29146^^^AIRA-TEST^MR||JohnsonAIRA^JinaAIRA^Natasha^^^^L|ScottAIRA^SophiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1749 Verwerderadeel Ln^^Lansing^MI^48950^USA^P||^PRN^PH^^^517^2488750|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^ScottAIRA^^^^^L|MTH^Mother^HL70063|1749 Verwerderadeel Ln^^Lansing^MI^48950^USA^P|^PRN^PH^^^517^2488750ORC|RE||BZ91L29146.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ91L29146.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006482701^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006483101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V36D29157^^^AIRA-TEST^MR||BentonAIRA^AmbrosineAIRA^Radmilla^^^^L|MadisonAIRA^AylinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1456 Henkum Ln^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^5043839|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BentonAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1456 Henkum Ln^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^5043839ORC|RE||BV36D29157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV36D29157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006483101^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006483141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X87K29165^^^AIRA-TEST^MR||ErikssonAIRA^HayleyAIRA^Jaen^^^^L|WayneAIRA^JemimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1937 Lilvarenbeek Cir^^Webster^MI^48130^USA^P||^PRN^PH^^^734^7363920|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErikssonAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1937 Lilvarenbeek Cir^^Webster^MI^48130^USA^P|^PRN^PH^^^734^7363920ORC|RE||BX87K29165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX87K29165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006483141^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006483701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G44F29173^^^AIRA-TEST^MR||WatmoughAIRA^ValerieAIRA^Udaya^^^^L|WilliamsAIRA^CaitAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1991 Bolenwaard St^^Channing^MI^49815^USA^P||^PRN^PH^^^906^9424184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WatmoughAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1991 Bolenwaard St^^Channing^MI^49815^USA^P|^PRN^PH^^^906^9424184ORC|RE||BG44F29173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG44F29173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006483701^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006483702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S55Q29178^^^AIRA-TEST^MR||JeffersonAIRA^LaurynAIRA^Atlanta^^^^L|AndersenAIRA^SigrunAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1476 Claricum Ln^^Grand Rapids^MI^49530^USA^P||^PRN^PH^^^616^5657968|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^AndersenAIRA^^^^^L|MTH^Mother^HL70063|1476 Claricum Ln^^Grand Rapids^MI^49530^USA^P|^PRN^PH^^^616^5657968ORC|RE||BS55Q29178.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS55Q29178.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006483702^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006483703|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X54K29186^^^AIRA-TEST^MR||HolingsonAIRA^SeannaAIRA^Kesi^^^^L|TaylorAIRA^TejalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1602 Eladel Ln^^Vulcan^MI^49892^USA^P||^PRN^PH^^^906^4089930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolingsonAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1602 Eladel Ln^^Vulcan^MI^49892^USA^P|^PRN^PH^^^906^4089930ORC|RE||BX54K29186.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX54K29186.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006483703^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006484100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I59C29197^^^AIRA-TEST^MR||ClintonAIRA^TimandraAIRA^Lien^^^^L|MadisonAIRA^BeatriceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1985 Lilburg Ln^^Ann Arbor^MI^48107^USA^P||^PRN^PH^^^734^3980791|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1985 Lilburg Ln^^Ann Arbor^MI^48107^USA^P|^PRN^PH^^^734^3980791ORC|RE||BI59C29197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI59C29197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006484100^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006484101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M48Z29205^^^AIRA-TEST^MR||HitchcockAIRA^OrnellaAIRA^Kiki^^^^L|ShelbyAIRA^AspenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1750 Hosterhout Ln^^Grosse Pointe Farms^MI^48230^USA^P||^PRN^PH^^^313^2422038|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HitchcockAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1750 Hosterhout Ln^^Grosse Pointe Farms^MI^48230^USA^P|^PRN^PH^^^313^2422038ORC|RE||BM48Z29205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM48Z29205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006484101^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006484141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J33U29213^^^AIRA-TEST^MR||LawrenceAIRA^WeemaAIRA^Marcy^^^^L|ClareAIRA^HallieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1380 Fladel St^^Mi Department of Revenue^MI^48929^USA^P||^PRN^PH^^^517^3733184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LawrenceAIRA^ClareAIRA^^^^^L|MTH^Mother^HL70063|1380 Fladel St^^Mi Department of Revenue^MI^48929^USA^P|^PRN^PH^^^517^3733184ORC|RE||BJ33U29213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ33U29213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006484141^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006489700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K84S29221^^^AIRA-TEST^MR||HendersonAIRA^SophieAIRA^Pepita^^^^L|ClarkAIRA^AlfonsaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1118 Bitgeest St^^Howell^MI^48863^USA^P||^PRN^PH^^^517^3452952|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HendersonAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1118 Bitgeest St^^Howell^MI^48863^USA^P|^PRN^PH^^^517^3452952ORC|RE||BK84S29221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK84S29221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006489700^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006489701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F02C29229^^^AIRA-TEST^MR||SagadahocAIRA^HopeAIRA^Leopolda^^^^L|SaloAIRA^InesAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1968 Venlo Ave^^Glenn^MI^49416^USA^P||^PRN^PH^^^269^4390308|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SagadahocAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1968 Venlo Ave^^Glenn^MI^49416^USA^P|^PRN^PH^^^269^4390308ORC|RE||BF02C29229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF02C29229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006489701^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006489800|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D37G29234^^^AIRA-TEST^MR||MeigsAIRA^SatyavatiAIRA^Alex^^^^L|LincolnAIRA^LeaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1050 Spel Cir^^Harbor Beach^MI^48441^USA^P||^PRN^PH^^^989^9563848|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MeigsAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1050 Spel Cir^^Harbor Beach^MI^48441^USA^P|^PRN^PH^^^989^9563848ORC|RE||BD37G29234.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD37G29234.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006489800^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006489801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L74K29242^^^AIRA-TEST^MR||CowleAIRA^AddiAIRA^Coralia^^^^L|ClintonAIRA^MayakoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1814 Toststellingwerf Cir^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^2110596|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CowleAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1814 Toststellingwerf Cir^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^2110596ORC|RE||BL74K29242.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL74K29242.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006489801^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006494300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G31M29253^^^AIRA-TEST^MR||AdairAIRA^LeuraAIRA^Alondra^^^^L|WayneAIRA^OdaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1068 Beendam St^^Kentwood^MI^49588^USA^P||^PRN^PH^^^616^7585172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1068 Beendam St^^Kentwood^MI^49588^USA^P|^PRN^PH^^^616^7585172ORC|RE||BG31M29253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG31M29253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006494300^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006494301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W76Y29261^^^AIRA-TEST^MR||StarrAIRA^BronnenAIRA^Mariola^^^^L|CumberlandAIRA^HavanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1614 Ook Ln^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^9808536|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StarrAIRA^CumberlandAIRA^^^^^L|MTH^Mother^HL70063|1614 Ook Ln^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^9808536ORC|RE||BW76Y29261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW76Y29261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006494301^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006496300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U09S29269^^^AIRA-TEST^MR||MercedAIRA^TierneyAIRA^Aubrie^^^^L|MarshallAIRA^ShielaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1317 Iteenwijkerland Ln^^Ferndale^MI^48220^USA^P||^PRN^PH^^^248^2290965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercedAIRA^MarshallAIRA^^^^^L|MTH^Mother^HL70063|1317 Iteenwijkerland Ln^^Ferndale^MI^48220^USA^P|^PRN^PH^^^248^2290965ORC|RE||BU09S29269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU09S29269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006496300^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006496301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H72N29274^^^AIRA-TEST^MR||PermanAIRA^AddieAIRA^Whoopi^^^^L|UnionAIRA^ZiziAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1192 Zaaren Ln^^Tecumseh^MI^49286^USA^P||^PRN^PH^^^517^2802422|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PermanAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1192 Zaaren Ln^^Tecumseh^MI^49286^USA^P|^PRN^PH^^^517^2802422ORC|RE||BH72N29274.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH72N29274.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006496301^ZOSTAVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006496341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z03B29285^^^AIRA-TEST^MR||HoggAIRA^AnyaAIRA^Elspeth^^^^L|NevadaAIRA^LeslyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1642 Cardenberg Cir^^Kalamazoo^MI^49003^USA^P||^PRN^PH^^^269^8504343|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoggAIRA^NevadaAIRA^^^^^L|MTH^Mother^HL70063|1642 Cardenberg Cir^^Kalamazoo^MI^49003^USA^P|^PRN^PH^^^269^8504343ORC|RE||BZ03B29285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ03B29285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006496341^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006498000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T32B29293^^^AIRA-TEST^MR||WapelloAIRA^ManuellaAIRA^Mahala^^^^L|TuolumneAIRA^FeldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1359 Olie Ln^^Stanton^MI^48888^USA^P||^PRN^PH^^^989^9167359|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WapelloAIRA^TuolumneAIRA^^^^^L|MTH^Mother^HL70063|1359 Olie Ln^^Stanton^MI^48888^USA^P|^PRN^PH^^^989^9167359ORC|RE||BT32B29293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT32B29293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006498000^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006498100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z37W29301^^^AIRA-TEST^MR||CusterAIRA^GitikaAIRA^Nimmi^^^^L|AlgerAIRA^MariquitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1587 Leidschendam-Voorburg Ln^^Waterford^MI^48327^USA^P||^PRN^PH^^^248^3692965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusterAIRA^AlgerAIRA^^^^^L|MTH^Mother^HL70063|1587 Leidschendam-Voorburg Ln^^Waterford^MI^48327^USA^P|^PRN^PH^^^248^3692965ORC|RE||BZ37W29301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ37W29301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006498100^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006498101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T39F29309^^^AIRA-TEST^MR||FremstadAIRA^TalasiAIRA^Zofia^^^^L|McCurtainAIRA^CallaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1546 Soogezand-Sappemeer Cir^^Shelby Township^MI^48318^USA^P||^PRN^PH^^^586^4659982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremstadAIRA^McCurtainAIRA^^^^^L|MTH^Mother^HL70063|1546 Soogezand-Sappemeer Cir^^Shelby Township^MI^48318^USA^P|^PRN^PH^^^586^4659982ORC|RE||BT39F29309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT39F29309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006498101^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499200|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E51Q29314^^^AIRA-TEST^MR||NorthamptonAIRA^KirbyAIRA^Leontine^^^^L|GrantAIRA^TuruaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1583 Hrmelo Ave^^Lansing^MI^48911^USA^P||^PRN^PH^^^517^5129755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NorthamptonAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1583 Hrmelo Ave^^Lansing^MI^48911^USA^P|^PRN^PH^^^517^5129755ORC|RE||BE51Q29314.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE51Q29314.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499200^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X87B29322^^^AIRA-TEST^MR||MontagueAIRA^SofieAIRA^Ethel^^^^L|TillmanAIRA^CireaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1486 Koordoostpolder Pl^^Alpena^MI^49707^USA^P||^PRN^PH^^^989^7249321|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontagueAIRA^TillmanAIRA^^^^^L|MTH^Mother^HL70063|1486 Koordoostpolder Pl^^Alpena^MI^49707^USA^P|^PRN^PH^^^989^7249321ORC|RE||BX87B29322.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX87B29322.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499201^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499500|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A74P29333^^^AIRA-TEST^MR||YorkAIRA^RupaliAIRA^Maru^^^^L|RichardsonAIRA^EsperanzaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1082 Kiel Ln^^GR^MI^49507^USA^P||^PRN^PH^^^616^5202959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YorkAIRA^RichardsonAIRA^^^^^L|MTH^Mother^HL70063|1082 Kiel Ln^^GR^MI^49507^USA^P|^PRN^PH^^^616^5202959ORC|RE||BA74P29333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA74P29333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499500^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K64F29341^^^AIRA-TEST^MR||LincolnAIRA^ShyanneAIRA^Bijal^^^^L|CaseyAIRA^TaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1085 Rrnhem Ln^^Mount Morris^MI^48458^USA^P||^PRN^PH^^^810^9163656|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LincolnAIRA^CaseyAIRA^^^^^L|MTH^Mother^HL70063|1085 Rrnhem Ln^^Mount Morris^MI^48458^USA^P|^PRN^PH^^^810^9163656ORC|RE||BK64F29341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK64F29341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499501^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E12U29349^^^AIRA-TEST^MR||SilowAIRA^NadezdaAIRA^Lilia^^^^L|CherokeeAIRA^RainbowAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1306 Hopen Pl^^Goodells^MI^48027^USA^P||^PRN^PH^^^810^2298886|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SilowAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1306 Hopen Pl^^Goodells^MI^48027^USA^P|^PRN^PH^^^810^2298886ORC|RE||BE12U29349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE12U29349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499541^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S62J29357^^^AIRA-TEST^MR||HarlanAIRA^TessieAIRA^Yaksha^^^^L|RockcastleAIRA^DianneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1711 Hear Ln^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^6315604|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarlanAIRA^RockcastleAIRA^^^^^L|MTH^Mother^HL70063|1711 Hear Ln^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^6315604ORC|RE||BS62J29357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS62J29357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499900^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00006499901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X76D29365^^^AIRA-TEST^MR||SequoyahAIRA^KaterinaAIRA^Bertana^^^^L|KnowlesAIRA^MiyokoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1324 Judwest-Fryslan Ln^^Burton^MI^48529^USA^P||^PRN^PH^^^810^7387740|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SequoyahAIRA^KnowlesAIRA^^^^^L|MTH^Mother^HL70063|1324 Judwest-Fryslan Ln^^Burton^MI^48529^USA^P|^PRN^PH^^^810^7387740ORC|RE||BX76D29365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX76D29365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00006499901^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-0100-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q86Q29370^^^AIRA-TEST^MR||ShelbyAIRA^NazirahAIRA^Aurora^^^^L|HenryAIRA^AlyssaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1653 Laat Ave^^Keego Harbor^MI^48320^USA^P||^PRN^PH^^^248^5953765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1653 Laat Ave^^Keego Harbor^MI^48320^USA^P|^PRN^PH^^^248^5953765ORC|RE||BQ86Q29370.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ86Q29370.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-0100-01^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-0100-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V92V29380^^^AIRA-TEST^MR||ClarkeAIRA^TeklaAIRA^Gisela^^^^L|BoydAIRA^RaineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1586 Won en Breugel Ave^^Walled Lake^MI^48390^USA^P||^PRN^PH^^^248^8702074|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkeAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1586 Won en Breugel Ave^^Walled Lake^MI^48390^USA^P|^PRN^PH^^^248^8702074ORC|RE||BV92V29380.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV92V29380.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-0100-02^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-0100-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V64D29389^^^AIRA-TEST^MR||SandersAIRA^BonaAIRA^Corina^^^^L|CherokeeAIRA^DawaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1966 Sangedijk St^^Boyne Falls^MI^49713^USA^P||^PRN^PH^^^231^5327969|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SandersAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1966 Sangedijk St^^Boyne Falls^MI^49713^USA^P|^PRN^PH^^^231^5327969ORC|RE||BV64D29389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV64D29389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-0100-05^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-0100-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C03X29397^^^AIRA-TEST^MR||WoodfordAIRA^BarbaraAIRA^Ester^^^^L|CusterAIRA^RossaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1001 Kreeg Ln^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^2834427|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodfordAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1001 Kreeg Ln^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^2834427ORC|RE||BC03X29397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC03X29397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-0100-10^Trumenba^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-1970-49|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V62E29405^^^AIRA-TEST^MR||CulbersonAIRA^ChristelAIRA^Melissa^^^^L|DanielsonAIRA^AlyssaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1686 Zchagen Ave^^Detroit^MI^48264^USA^P||^PRN^PH^^^313^3301996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CulbersonAIRA^DanielsonAIRA^^^^^L|MTH^Mother^HL70063|1686 Zchagen Ave^^Detroit^MI^48264^USA^P|^PRN^PH^^^313^3301996ORC|RE||BV62E29405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV62E29405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-1970-49^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-1970-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N18Y29410^^^AIRA-TEST^MR||HillsdaleAIRA^RowenaAIRA^Chrysilla^^^^L|WolfeAIRA^NealaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1477 Btichtse Vecht Pl^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^2211133|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillsdaleAIRA^WolfeAIRA^^^^^L|MTH^Mother^HL70063|1477 Btichtse Vecht Pl^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^2211133ORC|RE||BN18Y29410.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN18Y29410.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-1970-50^Prevnar^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-1971-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L89H29421^^^AIRA-TEST^MR||CanyonAIRA^ScarlettAIRA^Shyla^^^^L|RossAIRA^AingealAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1465 Yeimerswaal Ln^^North Star^MI^48862^USA^P||^PRN^PH^^^989^9588690|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CanyonAIRA^RossAIRA^^^^^L|MTH^Mother^HL70063|1465 Yeimerswaal Ln^^North Star^MI^48862^USA^P|^PRN^PH^^^989^9588690ORC|RE||BL89H29421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL89H29421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-1971-01^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-1971-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B08P29429^^^AIRA-TEST^MR||RobertsAIRA^DevnetAIRA^Rafaella^^^^L|YamhillAIRA^MajondraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1828 Bepalen Ln^^Bloomfield Township^MI^48302^USA^P||^PRN^PH^^^248^4624900|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobertsAIRA^YamhillAIRA^^^^^L|MTH^Mother^HL70063|1828 Bepalen Ln^^Bloomfield Township^MI^48302^USA^P|^PRN^PH^^^248^4624900ORC|RE||BB08P29429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB08P29429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-1971-02^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-1971-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W08P29437^^^AIRA-TEST^MR||McCarthyAIRA^ZulaAIRA^Rachel^^^^L|BrooksAIRA^CarmitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1041 Wapelle Ave^^Detroit^MI^48237^USA^P||^PRN^PH^^^248^7323675|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCarthyAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1041 Wapelle Ave^^Detroit^MI^48237^USA^P|^PRN^PH^^^248^7323675ORC|RE||BW08P29437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW08P29437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-1971-04^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0005-1971-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y00Z29445^^^AIRA-TEST^MR||HarrisonAIRA^KaylynnAIRA^Lani^^^^L|ReevesAIRA^JanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1619 Boven Pl^^Kalamazoo^MI^49007^USA^P||^PRN^PH^^^269^2861326|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^ReevesAIRA^^^^^L|MTH^Mother^HL70063|1619 Boven Pl^^Kalamazoo^MI^49007^USA^P|^PRN^PH^^^269^2861326ORC|RE||BY00Z29445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY00Z29445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0005-1971-05^PREVNAR 13^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00052060301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G60U29450^^^AIRA-TEST^MR||YoungAIRA^AlexandriaAIRA^Belva^^^^L|TehamaAIRA^RaizelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1453 Zingen Pl^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^4850669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoungAIRA^TehamaAIRA^^^^^L|MTH^Mother^HL70063|1453 Zingen Pl^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^4850669ORC|RE||BG60U29450.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG60U29450.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00052060301^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-00052060302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y55V29458^^^AIRA-TEST^MR||SabineAIRA^DaeAIRA^Hafwen^^^^L|ThorsenAIRA^NedivaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1750 Keppel Ave^^Melvin^MI^48454^USA^P||^PRN^PH^^^810^5904205|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SabineAIRA^ThorsenAIRA^^^^^L|MTH^Mother^HL70063|1750 Keppel Ave^^Melvin^MI^48454^USA^P|^PRN^PH^^^810^5904205ORC|RE||BY55V29458.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY55V29458.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||00052060302^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4045-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X23N29469^^^AIRA-TEST^MR||AntrimAIRA^TessaAIRA^Alonsa^^^^L|ManisteeAIRA^AkutiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1660 Wude IJsselstreek St^^Flint^MI^48552^USA^P||^PRN^PH^^^810^3631365|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AntrimAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1660 Wude IJsselstreek St^^Flint^MI^48552^USA^P|^PRN^PH^^^810^3631365ORC|RE||BX23N29469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX23N29469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4045-00^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4045-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H10B29477^^^AIRA-TEST^MR||CumberlandAIRA^YusraAIRA^Melody^^^^L|BlaineAIRA^AbeoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1191 Mapelle Ln^^Atlanta^MI^49709^USA^P||^PRN^PH^^^989^6682982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CumberlandAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1191 Mapelle Ln^^Atlanta^MI^49709^USA^P|^PRN^PH^^^989^6682982ORC|RE||BH10B29477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH10B29477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4045-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4045-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U37A29485^^^AIRA-TEST^MR||AdairAIRA^RachelAIRA^Ailish^^^^L|StallardAIRA^HeleddAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1030 Piel Pl^^Willow Run^MI^48198^USA^P||^PRN^PH^^^734^8620129|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^StallardAIRA^^^^^L|MTH^Mother^HL70063|1030 Piel Pl^^Willow Run^MI^48198^USA^P|^PRN^PH^^^734^8620129ORC|RE||BU37A29485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU37A29485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4045-41^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4047-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U42K29490^^^AIRA-TEST^MR||LucasAIRA^MaceyAIRA^Malika^^^^L|IoscoAIRA^DellAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1726 Oooise Meren Cir^^Dow Chemical Mi Division^MI^48667^USA^P||^PRN^PH^^^989^7050144|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^IoscoAIRA^^^^^L|MTH^Mother^HL70063|1726 Oooise Meren Cir^^Dow Chemical Mi Division^MI^48667^USA^P|^PRN^PH^^^989^7050144ORC|RE||BU42K29490.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU42K29490.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4047-01^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4047-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M09D29498^^^AIRA-TEST^MR||CassAIRA^MelvinaAIRA^Raphaela^^^^L|EmmetAIRA^SharayAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1413 Ieeuwarden St^^Brooklyn^MI^49230^USA^P||^PRN^PH^^^517^7172075|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^EmmetAIRA^^^^^L|MTH^Mother^HL70063|1413 Ieeuwarden St^^Brooklyn^MI^49230^USA^P|^PRN^PH^^^517^7172075ORC|RE||BM09D29498.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM09D29498.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4047-20^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4047-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V75Y29509^^^AIRA-TEST^MR||BerntsenAIRA^AlloraAIRA^Araminta^^^^L|La SalleAIRA^SusanneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1437 Weemskerk Ave^^Washingtn Township^MI^48095^USA^P||^PRN^PH^^^586^2611264|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BerntsenAIRA^La SalleAIRA^^^^^L|MTH^Mother^HL70063|1437 Weemskerk Ave^^Washingtn Township^MI^48095^USA^P|^PRN^PH^^^586^2611264ORC|RE||BV75Y29509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV75Y29509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4047-41^RotaTeq^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4093-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V61W29517^^^AIRA-TEST^MR||WeilAIRA^KeylaAIRA^Ryba^^^^L|AinslieAIRA^FairleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1981 Pijkerk Ave^^Marine City^MI^48039^USA^P||^PRN^PH^^^810^8152792|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WeilAIRA^AinslieAIRA^^^^^L|MTH^Mother^HL70063|1981 Pijkerk Ave^^Marine City^MI^48039^USA^P|^PRN^PH^^^810^8152792ORC|RE||BV61W29517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV61W29517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4093-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4093-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V83P29525^^^AIRA-TEST^MR||MontgomeryAIRA^ElbertinaAIRA^Aricia^^^^L|MerrickAIRA^ThaliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1164 Ra en Hunze Cir^^Sault S Marie^MI^49786^USA^P||^PRN^PH^^^906^6184278|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^MerrickAIRA^^^^^L|MTH^Mother^HL70063|1164 Ra en Hunze Cir^^Sault S Marie^MI^49786^USA^P|^PRN^PH^^^906^6184278ORC|RE||BV83P29525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV83P29525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4093-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4093-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L78T29530^^^AIRA-TEST^MR||FisherAIRA^AlanaAIRA^Catalonia^^^^L|BoydAIRA^AdalynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1978 Balfsen Ave^^Crystal^MI^48818^USA^P||^PRN^PH^^^989^9712021|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FisherAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1978 Balfsen Ave^^Crystal^MI^48818^USA^P|^PRN^PH^^^989^9712021ORC|RE||BL78T29530.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL78T29530.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4093-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4094-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y79K29538^^^AIRA-TEST^MR||WolfeAIRA^KristinaAIRA^Emelia^^^^L|KyleAIRA^SiennaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1083 Blst-Wijhe St^^Manchester^MI^48158^USA^P||^PRN^PH^^^734^3290381|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WolfeAIRA^KyleAIRA^^^^^L|MTH^Mother^HL70063|1083 Blst-Wijhe St^^Manchester^MI^48158^USA^P|^PRN^PH^^^734^3290381ORC|RE||BY79K29538.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY79K29538.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4094-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4094-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T47M29549^^^AIRA-TEST^MR||MuskogeeAIRA^SylvieAIRA^Pazia^^^^L|EstillAIRA^BridgetAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1935 Doudenberg Cir^^Bay View^MI^49770^USA^P||^PRN^PH^^^231^2901497|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MuskogeeAIRA^EstillAIRA^^^^^L|MTH^Mother^HL70063|1935 Doudenberg Cir^^Bay View^MI^49770^USA^P|^PRN^PH^^^231^2901497ORC|RE||BT47M29549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT47M29549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4094-02^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4094-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I21M29557^^^AIRA-TEST^MR||GrantAIRA^RupalAIRA^Livana^^^^L|FairfieldAIRA^SubhagaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1177 Mrimmelen Ln^^Saint Heights^MI^48312^USA^P||^PRN^PH^^^586^7695248|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^FairfieldAIRA^^^^^L|MTH^Mother^HL70063|1177 Mrimmelen Ln^^Saint Heights^MI^48312^USA^P|^PRN^PH^^^586^7695248ORC|RE||BI21M29557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI21M29557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4094-09^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4095-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y23K29565^^^AIRA-TEST^MR||CanadianAIRA^RosalindAIRA^Ultima^^^^L|ShermanAIRA^SeliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1707 Hchtkarspelen Ln^^Portage^MI^49002^USA^P||^PRN^PH^^^269^8623243|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CanadianAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1707 Hchtkarspelen Ln^^Portage^MI^49002^USA^P|^PRN^PH^^^269^8623243ORC|RE||BY23K29565.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY23K29565.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4095-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4095-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H01B29573^^^AIRA-TEST^MR||LakeAIRA^TillieAIRA^Zoey^^^^L|ShermanAIRA^LedahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1588 Bontfoort St^^Addison^MI^49220^USA^P||^PRN^PH^^^517^8395842|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1588 Bontfoort St^^Addison^MI^49220^USA^P|^PRN^PH^^^517^8395842ORC|RE||BH01B29573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH01B29573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4095-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4095-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K22J29581^^^AIRA-TEST^MR||McLennanAIRA^CarmenAIRA^Avoca^^^^L|GradyAIRA^EricaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1278 Haalte Pl^^Novi^MI^48376^USA^P||^PRN^PH^^^248^5123083|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McLennanAIRA^GradyAIRA^^^^^L|MTH^Mother^HL70063|1278 Haalte Pl^^Novi^MI^48376^USA^P|^PRN^PH^^^248^5123083ORC|RE||BK22J29581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK22J29581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4095-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4096-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D22P29586^^^AIRA-TEST^MR||RockcastleAIRA^KimAIRA^Tory^^^^L|SomersetAIRA^FredaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1966 Gorsele Cir^^Michigan Bankard^MI^48950^USA^P||^PRN^PH^^^517^7831473|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RockcastleAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1966 Gorsele Cir^^Michigan Bankard^MI^48950^USA^P|^PRN^PH^^^517^7831473ORC|RE||BD22P29586.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD22P29586.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4096-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4096-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D95V29594^^^AIRA-TEST^MR||AdamsAIRA^DarinkaAIRA^Donna^^^^L|NormanAIRA^MireyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1743 Nandgraaf Pl^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^2768005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^NormanAIRA^^^^^L|MTH^Mother^HL70063|1743 Nandgraaf Pl^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^2768005ORC|RE||BD95V29594.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD95V29594.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4096-02^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4096-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R74H29605^^^AIRA-TEST^MR||HillAIRA^TelmaAIRA^Shin^^^^L|Mc VeetyAIRA^CarhaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1372 Kookplaten Ln^^Mid Michigan Reg Med Center^MI^48670^USA^P||^PRN^PH^^^989^8139016|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillAIRA^Mc VeetyAIRA^^^^^L|MTH^Mother^HL70063|1372 Kookplaten Ln^^Mid Michigan Reg Med Center^MI^48670^USA^P|^PRN^PH^^^989^8139016ORC|RE||BR74H29605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR74H29605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4096-09^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z83U29613^^^AIRA-TEST^MR||KlebergAIRA^MasaAIRA^Orseline^^^^L|GilespieAIRA^PradeeptaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1407 Oluis Ave^^Auburn^MI^48611^USA^P||^PRN^PH^^^989^8474086|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlebergAIRA^GilespieAIRA^^^^^L|MTH^Mother^HL70063|1407 Oluis Ave^^Auburn^MI^48611^USA^P|^PRN^PH^^^989^8474086ORC|RE||BZ83U29613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ83U29613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4109-01^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4109-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P86C29621^^^AIRA-TEST^MR||BrewsterAIRA^LynnetteAIRA^Jacky^^^^L|ClarkAIRA^YdelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1836 Vertellen St^^Manitou Beach^MI^49253^USA^P||^PRN^PH^^^517^2121980|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrewsterAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1836 Vertellen St^^Manitou Beach^MI^49253^USA^P|^PRN^PH^^^517^2121980ORC|RE||BP86C29621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP86C29621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4109-02^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4109-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A62Y29626^^^AIRA-TEST^MR||BayAIRA^EmeliaAIRA^Sebastianne^^^^L|GraysonAIRA^WinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1201 Nek Ln^^Camden^MI^49232^USA^P||^PRN^PH^^^517^8474982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BayAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1201 Nek Ln^^Camden^MI^49232^USA^P|^PRN^PH^^^517^8474982ORC|RE||BA62Y29626.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA62Y29626.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4109-09^GARDASIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4119-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R98X29634^^^AIRA-TEST^MR||JolsenAIRA^SynaAIRA^Phoena^^^^L|SaginawAIRA^KrystalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1264 Sturen Ln^^Utica^MI^48318^USA^P||^PRN^PH^^^586^5067738|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JolsenAIRA^SaginawAIRA^^^^^L|MTH^Mother^HL70063|1264 Sturen Ln^^Utica^MI^48318^USA^P|^PRN^PH^^^586^5067738ORC|RE||BR98X29634.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR98X29634.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4119-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R55T29645^^^AIRA-TEST^MR||HemphillAIRA^MandyAIRA^Mily^^^^L|PushmatahaAIRA^CaitlinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1960 Zeewolde Cir^^Comerica Incorporated^MI^48275^USA^P||^PRN^PH^^^313^3464979|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HemphillAIRA^PushmatahaAIRA^^^^^L|MTH^Mother^HL70063|1960 Zeewolde Cir^^Comerica Incorporated^MI^48275^USA^P|^PRN^PH^^^313^3464979ORC|RE||BR55T29645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR55T29645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4119-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4119-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F80V29653^^^AIRA-TEST^MR||FinnAIRA^MarissaAIRA^Katherine^^^^L|SalineAIRA^AnnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1589 Otichtse Vecht Pl^^Sterling Heights^MI^48310^USA^P||^PRN^PH^^^586^2745709|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FinnAIRA^SalineAIRA^^^^^L|MTH^Mother^HL70063|1589 Otichtse Vecht Pl^^Sterling Heights^MI^48310^USA^P|^PRN^PH^^^586^2745709ORC|RE||BF80V29653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF80V29653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4119-03^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4121-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z12I29661^^^AIRA-TEST^MR||WayneAIRA^DorotaAIRA^Maya^^^^L|DeltaAIRA^BoaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1729 Foordenveld St^^Chesterfield Township^MI^48051^USA^P||^PRN^PH^^^586^8440614|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^DeltaAIRA^^^^^L|MTH^Mother^HL70063|1729 Foordenveld St^^Chesterfield Township^MI^48051^USA^P|^PRN^PH^^^586^8440614ORC|RE||BZ12I29661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ12I29661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4121-01^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4121-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I71H29666^^^AIRA-TEST^MR||MorganAIRA^TamasineAIRA^Tammi^^^^L|BellAIRA^ClariceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1837 Blst-Wijhe Pl^^Wolverine^MI^49799^USA^P||^PRN^PH^^^231^4493717|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^BellAIRA^^^^^L|MTH^Mother^HL70063|1837 Blst-Wijhe Pl^^Wolverine^MI^49799^USA^P|^PRN^PH^^^231^4493717ORC|RE||BI71H29666.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI71H29666.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4121-02^GARDASIL 9^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4133-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R28D29674^^^AIRA-TEST^MR||DurbinAIRA^NorikoAIRA^Primula^^^^L|GreggAIRA^TiffanyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1364 Gpe Ave^^Business Reply Mail^MI^49502^USA^P||^PRN^PH^^^616^4661659|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DurbinAIRA^GreggAIRA^^^^^L|MTH^Mother^HL70063|1364 Gpe Ave^^Business Reply Mail^MI^49502^USA^P|^PRN^PH^^^616^4661659ORC|RE||BR28D29674.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR28D29674.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4133-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4133-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y04V29685^^^AIRA-TEST^MR||OgemawAIRA^RonaAIRA^Vanja^^^^L|FremontAIRA^NgaioAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1678 Rellendoorn Ave^^Levering^MI^49755^USA^P||^PRN^PH^^^616^7285330|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OgemawAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1678 Rellendoorn Ave^^Levering^MI^49755^USA^P|^PRN^PH^^^616^7285330ORC|RE||BY04V29685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY04V29685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4133-41^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4171-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X21N29693^^^AIRA-TEST^MR||O'BrianAIRA^FondaAIRA^Kerzi^^^^L|AdamsAIRA^ShivaunAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1560 Kapitein Ave^^Berrien Center^MI^49102^USA^P||^PRN^PH^^^269^5844708|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'BrianAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1560 Kapitein Ave^^Berrien Center^MI^49102^USA^P|^PRN^PH^^^269^5844708ORC|RE||BX21N29693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX21N29693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4171-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4171-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X30T29701^^^AIRA-TEST^MR||GranholmAIRA^AnnoraAIRA^Berdine^^^^L|MarionAIRA^MatildaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1949 Kubbergen Ave^^Posen^MI^49776^USA^P||^PRN^PH^^^989^6216605|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GranholmAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1949 Kubbergen Ave^^Posen^MI^49776^USA^P|^PRN^PH^^^989^6216605ORC|RE||BX30T29701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX30T29701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4171-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4681-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z42T29706^^^AIRA-TEST^MR||WheelerAIRA^MereAIRA^Cara^^^^L|RandallAIRA^JoyceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1580 Oerg en Dal Ln^^Skandia^MI^49885^USA^P||^PRN^PH^^^906^6457211|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^RandallAIRA^^^^^L|MTH^Mother^HL70063|1580 Oerg en Dal Ln^^Skandia^MI^49885^USA^P|^PRN^PH^^^906^6457211ORC|RE||BZ42T29706.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ42T29706.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4681-00^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4681-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X98W29717^^^AIRA-TEST^MR||ClarkAIRA^AngwenAIRA^Mayuko^^^^L|RinggoldAIRA^AwstaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1139 Renswoude Ln^^Jackson^MI^49202^USA^P||^PRN^PH^^^517^9772523|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^RinggoldAIRA^^^^^L|MTH^Mother^HL70063|1139 Renswoude Ln^^Jackson^MI^49202^USA^P|^PRN^PH^^^517^9772523ORC|RE||BX98W29717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX98W29717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4681-01^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4739-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O42F29725^^^AIRA-TEST^MR||GreerAIRA^TiberiaAIRA^Cyzarine^^^^L|WestportAIRA^MarielAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1563 Motor Cir^^Greenland^MI^49929^USA^P||^PRN^PH^^^906^7932865|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreerAIRA^WestportAIRA^^^^^L|MTH^Mother^HL70063|1563 Motor Cir^^Greenland^MI^49929^USA^P|^PRN^PH^^^906^7932865ORC|RE||BO42F29725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO42F29725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4739-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4739-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W50C29733^^^AIRA-TEST^MR||GregoryAIRA^GladysAIRA^Columbia^^^^L|BinghamAIRA^AnselmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1031 Waarlemmermeer Pl^^Dexter Township^MI^48169^USA^P||^PRN^PH^^^734^6535528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GregoryAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1031 Waarlemmermeer Pl^^Dexter Township^MI^48169^USA^P|^PRN^PH^^^734^6535528ORC|RE||BW50C29733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW50C29733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4739-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4826-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T23D29741^^^AIRA-TEST^MR||Van WertAIRA^KerriAIRA^Loretta^^^^L|LimestoneAIRA^DaminiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1618 Tchagen St^^Empire^MI^49630^USA^P||^PRN^PH^^^231^5870018|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Van WertAIRA^LimestoneAIRA^^^^^L|MTH^Mother^HL70063|1618 Tchagen St^^Empire^MI^49630^USA^P|^PRN^PH^^^231^5870018ORC|RE||BT23D29741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT23D29741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4826-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C02F29746^^^AIRA-TEST^MR||Los AngelesAIRA^KathieAIRA^Elzira^^^^L|HaysAIRA^AlexAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1255 Dtichtse Vecht Ave^^Montrose^MI^48457^USA^P||^PRN^PH^^^810^9424361|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Los AngelesAIRA^HaysAIRA^^^^^L|MTH^Mother^HL70063|1255 Dtichtse Vecht Ave^^Montrose^MI^48457^USA^P|^PRN^PH^^^810^9424361ORC|RE||BC02F29746.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC02F29746.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4826-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4827-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M21G29757^^^AIRA-TEST^MR||StrubleAIRA^ErantheAIRA^Hyacinth^^^^L|CrumbakerAIRA^AdahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1860 Lteenwijkerland Pl^^Selfridge Air National Guard^MI^48045^USA^P||^PRN^PH^^^586^4682492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StrubleAIRA^CrumbakerAIRA^^^^^L|MTH^Mother^HL70063|1860 Lteenwijkerland Pl^^Selfridge Air National Guard^MI^48045^USA^P|^PRN^PH^^^586^4682492ORC|RE||BM21G29757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM21G29757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4827-00^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4827-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O56R29765^^^AIRA-TEST^MR||CliveAIRA^FernandaAIRA^Neria^^^^L|MontgomeryAIRA^KaritaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1867 Totaal Pl^^North Star^MI^48862^USA^P||^PRN^PH^^^989^6282271|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CliveAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1867 Totaal Pl^^North Star^MI^48862^USA^P|^PRN^PH^^^989^6282271ORC|RE||BO56R29765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO56R29765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4827-01^VARIVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4831-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I84F29773^^^AIRA-TEST^MR||IversenAIRA^LondonAIRA^Glennis^^^^L|MasonAIRA^ChaitraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1491 Nmstelveen Cir^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^5916205|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IversenAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1491 Nmstelveen Cir^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^5916205ORC|RE||BI84F29773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI84F29773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4831-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4831-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K07N29781^^^AIRA-TEST^MR||OatesAIRA^BianAIRA^Holly^^^^L|NordholmAIRA^VeraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1009 Foerendaal Pl^^Selfridge^MI^48045^USA^P||^PRN^PH^^^586^4010388|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OatesAIRA^NordholmAIRA^^^^^L|MTH^Mother^HL70063|1009 Foerendaal Pl^^Selfridge^MI^48045^USA^P|^PRN^PH^^^586^4010388ORC|RE||BK07N29781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK07N29781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4831-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4837-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W02V29786^^^AIRA-TEST^MR||KlickitatAIRA^DianeAIRA^Blaze^^^^L|SheridanAIRA^AaliyahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1543 Oorger-Odoorn St^^Grand Rapids^MI^49525^USA^P||^PRN^PH^^^616^2884900|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlickitatAIRA^SheridanAIRA^^^^^L|MTH^Mother^HL70063|1543 Oorger-Odoorn St^^Grand Rapids^MI^49525^USA^P|^PRN^PH^^^616^2884900ORC|RE||BW02V29786.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW02V29786.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4837-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4837-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S51F29794^^^AIRA-TEST^MR||MartinAIRA^CinnabarAIRA^Kalanit^^^^L|San BenitoAIRA^PennieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1699 Klein St^^Lansing^MI^48922^USA^P||^PRN^PH^^^517^6667681|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MartinAIRA^San BenitoAIRA^^^^^L|MTH^Mother^HL70063|1699 Klein St^^Lansing^MI^48922^USA^P|^PRN^PH^^^517^6667681ORC|RE||BS51F29794.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS51F29794.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4837-02^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4837-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z33N29805^^^AIRA-TEST^MR||MorrisAIRA^TatumAIRA^Leslie^^^^L|McKinnonAIRA^AlissonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1441 Kanderd Ave^^Clawson^MI^48017^USA^P||^PRN^PH^^^248^2775150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrisAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1441 Kanderd Ave^^Clawson^MI^48017^USA^P|^PRN^PH^^^248^2775150ORC|RE||BZ33N29805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ33N29805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4837-03^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4841-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S93W29813^^^AIRA-TEST^MR||KentAIRA^YakshaAIRA^Karen^^^^L|GarvinAIRA^LamornaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1219 Dichtbij Cir^^Auburn Hills^MI^48321^USA^P||^PRN^PH^^^248^5882543|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentAIRA^GarvinAIRA^^^^^L|MTH^Mother^HL70063|1219 Dichtbij Cir^^Auburn Hills^MI^48321^USA^P|^PRN^PH^^^248^5882543ORC|RE||BS93W29813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS93W29813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4841-00^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4841-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B87H29821^^^AIRA-TEST^MR||Scotts BluffAIRA^HarshitaAIRA^Mersadize^^^^L|JacksonAIRA^NaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1042 Meldhoven St^^Rockland^MI^49960^USA^P||^PRN^PH^^^906^2497507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Scotts BluffAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1042 Meldhoven St^^Rockland^MI^49960^USA^P|^PRN^PH^^^906^2497507ORC|RE||BB87H29821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB87H29821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4841-01^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4841-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N21I29826^^^AIRA-TEST^MR||WexfordAIRA^BrigitteAIRA^Scota^^^^L|MontgomeryAIRA^ShaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1475 Scherpenzeel Ave^^Fraser^MI^48026^USA^P||^PRN^PH^^^586^2967605|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WexfordAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1475 Scherpenzeel Ave^^Fraser^MI^48026^USA^P|^PRN^PH^^^586^2967605ORC|RE||BN21I29826.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN21I29826.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4841-41^VAQTA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4897-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W93Q29837^^^AIRA-TEST^MR||PatariAIRA^NanineAIRA^Ginger^^^^L|BrownAIRA^EvelynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1861 Aanbod Ave^^Flint^MI^48552^USA^P||^PRN^PH^^^810^6086264|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PatariAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1861 Aanbod Ave^^Flint^MI^48552^USA^P|^PRN^PH^^^810^6086264ORC|RE||BW93Q29837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW93Q29837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4897-00^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4897-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O16J29845^^^AIRA-TEST^MR||WestportAIRA^WanettaAIRA^Sherry^^^^L|GregoryAIRA^TerentiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1919 Bunnik Cir^^Lansing^MI^48980^USA^P||^PRN^PH^^^517^5986396|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WestportAIRA^GregoryAIRA^^^^^L|MTH^Mother^HL70063|1919 Bunnik Cir^^Lansing^MI^48980^USA^P|^PRN^PH^^^517^5986396ORC|RE||BO16J29845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO16J29845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4897-01^PedvaxHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4898-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W59Y29853^^^AIRA-TEST^MR||PenistonAIRA^CorentineAIRA^Caralee^^^^L|ClintonAIRA^AyleenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1049 Odam-Volendam Ln^^Flint^MI^48531^USA^P||^PRN^PH^^^810^9971442|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PenistonAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1049 Odam-Volendam Ln^^Flint^MI^48531^USA^P|^PRN^PH^^^810^9971442ORC|RE||BW59Y29853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW59Y29853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4898-00^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O74I29861^^^AIRA-TEST^MR||ThorsenAIRA^ShaynaAIRA^Sonya^^^^L|PlacerAIRA^FelipaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1249 Dampen Cir^^Lansing^MI^48906^USA^P||^PRN^PH^^^517^5859908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThorsenAIRA^PlacerAIRA^^^^^L|MTH^Mother^HL70063|1249 Dampen Cir^^Lansing^MI^48906^USA^P|^PRN^PH^^^517^5859908ORC|RE||BO74I29861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO74I29861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4898-01^COMVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4943-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W48K29866^^^AIRA-TEST^MR||HendersonAIRA^AnteiaAIRA^Runa^^^^L|BakeyAIRA^TillyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1014 Kergen op Zoom St^^Onekama^MI^49675^USA^P||^PRN^PH^^^231^9122466|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HendersonAIRA^BakeyAIRA^^^^^L|MTH^Mother^HL70063|1014 Kergen op Zoom St^^Onekama^MI^49675^USA^P|^PRN^PH^^^231^9122466ORC|RE||BW48K29866.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW48K29866.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4943-00^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4943-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C61W29877^^^AIRA-TEST^MR||GraysonAIRA^LucianAIRA^Nazaret^^^^L|AlconaAIRA^TaborriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1662 Ernhem Cir^^Carleton^MI^48117^USA^P||^PRN^PH^^^734^2795532|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GraysonAIRA^AlconaAIRA^^^^^L|MTH^Mother^HL70063|1662 Ernhem Cir^^Carleton^MI^48117^USA^P|^PRN^PH^^^734^2795532ORC|RE||BC61W29877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC61W29877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4943-01^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4963-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T78S29885^^^AIRA-TEST^MR||BlancoAIRA^DenaAIRA^Reagan^^^^L|HabberstadAIRA^KassidyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1585 Haar Ave^^Sault Sainte Marie^MI^49784^USA^P||^PRN^PH^^^906^9965193|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlancoAIRA^HabberstadAIRA^^^^^L|MTH^Mother^HL70063|1585 Haar Ave^^Sault Sainte Marie^MI^49784^USA^P|^PRN^PH^^^906^9965193ORC|RE||BT78S29885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT78S29885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4963-00^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4963-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X43J29893^^^AIRA-TEST^MR||BreathittAIRA^JocelynnAIRA^Gadar^^^^L|ThornleyAIRA^NellwynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1038 Oestland Ln^^Perry^MI^48872^USA^P||^PRN^PH^^^517^6773257|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BreathittAIRA^ThornleyAIRA^^^^^L|MTH^Mother^HL70063|1038 Oestland Ln^^Perry^MI^48872^USA^P|^PRN^PH^^^517^6773257ORC|RE||BX43J29893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX43J29893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4963-01^ZOSTAVAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4963-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J14K29901^^^AIRA-TEST^MR||FranklinAIRA^KestrelAIRA^Rosenwyn^^^^L|MonroeAIRA^MalihaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1518 Daadhoeke Pl^^Ithaca^MI^48847^USA^P||^PRN^PH^^^989^2863255|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1518 Daadhoeke Pl^^Ithaca^MI^48847^USA^P|^PRN^PH^^^989^2863255ORC|RE||BJ14K29901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ14K29901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4963-41^Zostavax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4980-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M34Q29906^^^AIRA-TEST^MR||CowleyAIRA^GenniferAIRA^Lareyne^^^^L|CharlevoixAIRA^LaviniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1063 Saasdonk Ln^^Wequetonsing^MI^49740^USA^P||^PRN^PH^^^616^4638415|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CowleyAIRA^CharlevoixAIRA^^^^^L|MTH^Mother^HL70063|1063 Saasdonk Ln^^Wequetonsing^MI^49740^USA^P|^PRN^PH^^^616^4638415ORC|RE||BM34Q29906.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM34Q29906.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4980-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4981-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H04D29917^^^AIRA-TEST^MR||HardingAIRA^TosiaAIRA^Rylan^^^^L|SowdenAIRA^WinnieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1646 Haaren Cir^^Saint Clr Shores^MI^48082^USA^P||^PRN^PH^^^586^8056445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HardingAIRA^SowdenAIRA^^^^^L|MTH^Mother^HL70063|1646 Haaren Cir^^Saint Clr Shores^MI^48082^USA^P|^PRN^PH^^^586^8056445ORC|RE||BH04D29917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH04D29917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4981-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4981-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C22T29925^^^AIRA-TEST^MR||PolkAIRA^AmarisAIRA^Sammi^^^^L|MaricopaAIRA^PelagiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1064 Sronten St^^Sault S Marie^MI^49784^USA^P||^PRN^PH^^^906^3325462|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^MaricopaAIRA^^^^^L|MTH^Mother^HL70063|1064 Sronten St^^Sault S Marie^MI^49784^USA^P|^PRN^PH^^^906^3325462ORC|RE||BC22T29925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC22T29925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4981-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4992-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B15U29933^^^AIRA-TEST^MR||JensenAIRA^TawnieAIRA^Farika^^^^L|PayneAIRA^LienAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1403 Hekela St^^Wequetonsing^MI^49740^USA^P||^PRN^PH^^^616^9799294|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JensenAIRA^PayneAIRA^^^^^L|MTH^Mother^HL70063|1403 Hekela St^^Wequetonsing^MI^49740^USA^P|^PRN^PH^^^616^9799294ORC|RE||BB15U29933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB15U29933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4992-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4992-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U50J29941^^^AIRA-TEST^MR||MasonAIRA^CourtneyAIRA^Meda^^^^L|AllottAIRA^KaridaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1454 Beerhugowaard Cir^^Detroit^MI^48208^USA^P||^PRN^PH^^^313^4950283|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^AllottAIRA^^^^^L|MTH^Mother^HL70063|1454 Beerhugowaard Cir^^Detroit^MI^48208^USA^P|^PRN^PH^^^313^4950283ORC|RE||BU50J29941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU50J29941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4992-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4995-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q31M29946^^^AIRA-TEST^MR||ShelbyAIRA^PenelopeAIRA^Madeleine^^^^L|Keya PahaAIRA^FulviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1400 Hsten Ln^^Tawas City^MI^48763^USA^P||^PRN^PH^^^989^6570369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^Keya PahaAIRA^^^^^L|MTH^Mother^HL70063|1400 Hsten Ln^^Tawas City^MI^48763^USA^P|^PRN^PH^^^989^6570369ORC|RE||BQ31M29946.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ31M29946.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4995-00^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4995-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P63A29957^^^AIRA-TEST^MR||TaylorAIRA^EloiseAIRA^Guadalupe^^^^L|DelawareAIRA^ThaliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1561 Vlphen aan den Rijn Ave^^Bancroft^MI^48414^USA^P||^PRN^PH^^^989^8503824|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1561 Vlphen aan den Rijn Ave^^Bancroft^MI^48414^USA^P|^PRN^PH^^^989^8503824ORC|RE||BP63A29957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP63A29957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4995-01^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4995-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y52I29965^^^AIRA-TEST^MR||PlatteAIRA^CharleighAIRA^Serenity^^^^L|GrantAIRA^LinetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1557 Mint-Oedenrode Cir^^Kalamazoo^MI^49004^USA^P||^PRN^PH^^^269^3491901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlatteAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1557 Mint-Oedenrode Cir^^Kalamazoo^MI^49004^USA^P|^PRN^PH^^^269^3491901ORC|RE||BY52I29965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY52I29965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4995-41^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4999-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U36N29973^^^AIRA-TEST^MR||BlairAIRA^HuaAIRA^Linnea^^^^L|PenobscotAIRA^GalenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1967 Aingewaard Pl^^Jones^MI^49061^USA^P||^PRN^PH^^^269^8311175|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlairAIRA^PenobscotAIRA^^^^^L|MTH^Mother^HL70063|1967 Aingewaard Pl^^Jones^MI^49061^USA^P|^PRN^PH^^^269^8311175ORC|RE||BU36N29973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU36N29973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4999-00^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0006-4999-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N07W29981^^^AIRA-TEST^MR||ChesterAIRA^NiaAIRA^Glynnis^^^^L|UmatillaAIRA^BryleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1720 Olkmaar St^^Hermansville^MI^49847^USA^P||^PRN^PH^^^906^7875323|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChesterAIRA^UmatillaAIRA^^^^^L|MTH^Mother^HL70063|1720 Olkmaar St^^Hermansville^MI^49847^USA^P|^PRN^PH^^^906^7875323ORC|RE||BN07W29981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN07W29981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0006-4999-01^ProQuad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0052-0603-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D43C29986^^^AIRA-TEST^MR||ShawAIRA^NanineAIRA^Clemence^^^^L|SummresgillAIRA^BirgittaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1766 Rinkelland Pl^^Muir^MI^48860^USA^P||^PRN^PH^^^989^3161108|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShawAIRA^SummresgillAIRA^^^^^L|MTH^Mother^HL70063|1766 Rinkelland Pl^^Muir^MI^48860^USA^P|^PRN^PH^^^989^3161108ORC|RE||BD43C29986.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD43C29986.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0052-0603-01^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-0052-0603-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U82L29997^^^AIRA-TEST^MR||WayneAIRA^EdwinaAIRA^Clarabelle^^^^L|ReaganAIRA^AtalantaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1687 Giessenlanden Ln^^Marine City^MI^48039^USA^P||^PRN^PH^^^810^8204694|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^ReaganAIRA^^^^^L|MTH^Mother^HL70063|1687 Giessenlanden Ln^^Marine City^MI^48039^USA^P|^PRN^PH^^^810^8204694ORC|RE||BU82L29997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU82L29997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||0052-0603-02^BCG VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-13533-131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q79D30005^^^AIRA-TEST^MR||AuglaizeAIRA^KarlaAIRA^Keisha^^^^L|CamasAIRA^CadenceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1991 Mmmen Pl^^Chesterfield^MI^48047^USA^P||^PRN^PH^^^586^7175956|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AuglaizeAIRA^CamasAIRA^^^^^L|MTH^Mother^HL70063|1991 Mmmen Pl^^Chesterfield^MI^48047^USA^P|^PRN^PH^^^586^7175956ORC|RE||BQ79D30005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ79D30005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||13533-131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-13533-131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P89N30013^^^AIRA-TEST^MR||GreeleyAIRA^StaceyAIRA^Sahar^^^^L|Mc VeetyAIRA^TaviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1804 Gemert-Bakel Ave^^Grosse Pointe Woods^MI^48236^USA^P||^PRN^PH^^^313^2142142|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeleyAIRA^Mc VeetyAIRA^^^^^L|MTH^Mother^HL70063|1804 Gemert-Bakel Ave^^Grosse Pointe Woods^MI^48236^USA^P|^PRN^PH^^^313^2142142ORC|RE||BP89N30013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP89N30013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||13533-131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-13533013100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I71R30021^^^AIRA-TEST^MR||HarlanAIRA^ZinaidaAIRA^Leba^^^^L|WinneshiekAIRA^ElseAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1946 Zeist Pl^^Allenton^MI^48002^USA^P||^PRN^PH^^^810^6145608|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarlanAIRA^WinneshiekAIRA^^^^^L|MTH^Mother^HL70063|1946 Zeist Pl^^Allenton^MI^48002^USA^P|^PRN^PH^^^810^6145608ORC|RE||BI71R30021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI71R30021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||13533013100^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-13533013101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z22E30026^^^AIRA-TEST^MR||ParkesAIRA^AlisonAIRA^Hesper^^^^L|JacksonAIRA^AmeliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1172 Loppersum Ave^^Loretto^MI^49852^USA^P||^PRN^PH^^^906^2939395|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParkesAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1172 Loppersum Ave^^Loretto^MI^49852^USA^P|^PRN^PH^^^906^2939395ORC|RE||BZ22E30026.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ22E30026.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||13533013101^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-14362-0111-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U38O30037^^^AIRA-TEST^MR||ButlerAIRA^LiliaAIRA^Alike^^^^L|BernstrainAIRA^ShawnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1104 Afbeelding St^^Cass City^MI^48726^USA^P||^PRN^PH^^^989^2004428|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^BernstrainAIRA^^^^^L|MTH^Mother^HL70063|1104 Afbeelding St^^Cass City^MI^48726^USA^P|^PRN^PH^^^989^2004428ORC|RE||BU38O30037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU38O30037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14362-0111-3^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-14362-0111-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H98D30045^^^AIRA-TEST^MR||HumboldtAIRA^LylaAIRA^Georgia^^^^L|MackinacAIRA^DabriaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1813 Ma en Hunze Ave^^Fife Lake^MI^49633^USA^P||^PRN^PH^^^231^2531538|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HumboldtAIRA^MackinacAIRA^^^^^L|MTH^Mother^HL70063|1813 Ma en Hunze Ave^^Fife Lake^MI^49633^USA^P|^PRN^PH^^^231^2531538ORC|RE||BH98D30045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH98D30045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14362-0111-4^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-14362011103|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X89Y30053^^^AIRA-TEST^MR||BaragaAIRA^PattyAIRA^Diantha^^^^L|EliasonAIRA^RupertaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1395 Schiedam Pl^^Union Lake^MI^48387^USA^P||^PRN^PH^^^248^5333407|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BaragaAIRA^EliasonAIRA^^^^^L|MTH^Mother^HL70063|1395 Schiedam Pl^^Union Lake^MI^48387^USA^P|^PRN^PH^^^248^5333407ORC|RE||BX89Y30053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX89Y30053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14362011103^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-14362011104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X53G30061^^^AIRA-TEST^MR||SantiagoAIRA^NiaAIRA^Ulalia^^^^L|PottawatomieAIRA^WillowAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1821 Pchinnen Pl^^Metamora^MI^48455^USA^P||^PRN^PH^^^810^5639218|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SantiagoAIRA^PottawatomieAIRA^^^^^L|MTH^Mother^HL70063|1821 Pchinnen Pl^^Metamora^MI^48455^USA^P|^PRN^PH^^^810^5639218ORC|RE||BX53G30061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX53G30061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||14362011104^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-17478-131-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R43E30066^^^AIRA-TEST^MR||SykesAIRA^LatifaAIRA^Armynel^^^^L|OhioAIRA^CheriseAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1199 Ceemskerk St^^Gay^MI^49945^USA^P||^PRN^PH^^^906^7071053|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SykesAIRA^OhioAIRA^^^^^L|MTH^Mother^HL70063|1199 Ceemskerk St^^Gay^MI^49945^USA^P|^PRN^PH^^^906^7071053ORC|RE||BR43E30066.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR43E30066.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||17478-131-00^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-17478-131-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X50T30074^^^AIRA-TEST^MR||JeffersonAIRA^HonourAIRA^Mariasha^^^^L|PayneAIRA^KlaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1077 Koerendaal Pl^^Forest Lake^MI^49862^USA^P||^PRN^PH^^^906^4433855|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^PayneAIRA^^^^^L|MTH^Mother^HL70063|1077 Koerendaal Pl^^Forest Lake^MI^49862^USA^P|^PRN^PH^^^906^4433855ORC|RE||BX50T30074.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX50T30074.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||17478-131-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-17478013100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P77P30085^^^AIRA-TEST^MR||BerrienAIRA^AdaliaAIRA^Petra^^^^L|McDonaldAIRA^MerlinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1251 Meeze-Leende St^^Saint Charles^MI^48655^USA^P||^PRN^PH^^^989^6132348|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BerrienAIRA^McDonaldAIRA^^^^^L|MTH^Mother^HL70063|1251 Meeze-Leende St^^Saint Charles^MI^48655^USA^P|^PRN^PH^^^989^6132348ORC|RE||BP77P30085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP77P30085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||17478013100^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-17478013101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P03Z30093^^^AIRA-TEST^MR||GossAIRA^MeldaAIRA^Melissa^^^^L|PushmatahaAIRA^CallieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1398 Bieuwkoop Cir^^Hickory Corners^MI^49060^USA^P||^PRN^PH^^^269^2224503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GossAIRA^PushmatahaAIRA^^^^^L|MTH^Mother^HL70063|1398 Bieuwkoop Cir^^Hickory Corners^MI^49060^USA^P|^PRN^PH^^^269^2224503ORC|RE||BP03Z30093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP03Z30093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||17478013101^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-845-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E56V30101^^^AIRA-TEST^MR||GarrardAIRA^ItaAIRA^Sasha^^^^L|ScottAIRA^JackieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1853 Schinnen Ln^^Clinton Township^MI^48038^USA^P||^PRN^PH^^^586^5392046|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarrardAIRA^ScottAIRA^^^^^L|MTH^Mother^HL70063|1853 Schinnen Ln^^Clinton Township^MI^48038^USA^P|^PRN^PH^^^586^5392046ORC|RE||BE56V30101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE56V30101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-845-01^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-845-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z30J30106^^^AIRA-TEST^MR||WettilandAIRA^LainaAIRA^Calista^^^^L|El DoradoAIRA^FarfallaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1427 Jopik Cir^^Croton^MI^49337^USA^P||^PRN^PH^^^231^5687242|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WettilandAIRA^El DoradoAIRA^^^^^L|MTH^Mother^HL70063|1427 Jopik Cir^^Croton^MI^49337^USA^P|^PRN^PH^^^231^5687242ORC|RE||BZ30J30106.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ30J30106.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-845-11^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-850-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D73Z30114^^^AIRA-TEST^MR||LucasAIRA^EirAIRA^Miriam^^^^L|BagleyAIRA^SalihahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1166 Gaaren Ave^^Comins^MI^48619^USA^P||^PRN^PH^^^989^9224027|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^BagleyAIRA^^^^^L|MTH^Mother^HL70063|1166 Gaaren Ave^^Comins^MI^48619^USA^P|^PRN^PH^^^989^9224027ORC|RE||BD73Z30114.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD73Z30114.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-850-41^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-850-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L43J30122^^^AIRA-TEST^MR||BakerAIRA^RadhikaAIRA^Jumoke^^^^L|TrinityAIRA^AngelaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1136 Feeuwarden Ave^^Pewamo^MI^48873^USA^P||^PRN^PH^^^989^3087857|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BakerAIRA^TrinityAIRA^^^^^L|MTH^Mother^HL70063|1136 Feeuwarden Ave^^Pewamo^MI^48873^USA^P|^PRN^PH^^^989^3087857ORC|RE||BL43J30122.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL43J30122.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-850-52^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-889-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S94W30133^^^AIRA-TEST^MR||MorrowAIRA^ArezouAIRA^Ryann^^^^L|GarrardAIRA^AletaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1606 Neeuwarden St^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^2221082|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrowAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1606 Neeuwarden St^^Lake Linden^MI^49945^USA^P|^PRN^PH^^^906^2221082ORC|RE||BS94W30133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS94W30133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-889-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-889-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F06T30141^^^AIRA-TEST^MR||KentAIRA^CecaniaAIRA^Marieke^^^^L|MahoningAIRA^TheresaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1565 Kalderberge St^^North Muskegon^MI^49445^USA^P||^PRN^PH^^^231^8607756|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentAIRA^MahoningAIRA^^^^^L|MTH^Mother^HL70063|1565 Kalderberge St^^North Muskegon^MI^49445^USA^P|^PRN^PH^^^231^8607756ORC|RE||BF06T30141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF06T30141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-889-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-890-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L07H30149^^^AIRA-TEST^MR||MenardAIRA^RenAIRA^Panthea^^^^L|SundeAIRA^TheodoraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1843 Misterwijk Pl^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^2852000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenardAIRA^SundeAIRA^^^^^L|MTH^Mother^HL70063|1843 Misterwijk Pl^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^2852000ORC|RE||BL07H30149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL07H30149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-890-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-890-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y01K30157^^^AIRA-TEST^MR||GregoryAIRA^OraleeAIRA^Signy^^^^L|TrimbleAIRA^DelythAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1684 Lift Cir^^Weston^MI^49289^USA^P||^PRN^PH^^^517^5767421|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GregoryAIRA^TrimbleAIRA^^^^^L|MTH^Mother^HL70063|1684 Lift Cir^^Weston^MI^49289^USA^P|^PRN^PH^^^517^5767421ORC|RE||BY01K30157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY01K30157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-890-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-891-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P76J30162^^^AIRA-TEST^MR||MonroeAIRA^AphroditeAIRA^Juene^^^^L|TereAIRA^KristalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1775 Kaanstad Pl^^Interlochen^MI^49643^USA^P||^PRN^PH^^^231^8098525|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MonroeAIRA^TereAIRA^^^^^L|MTH^Mother^HL70063|1775 Kaanstad Pl^^Interlochen^MI^49643^USA^P|^PRN^PH^^^231^8098525ORC|RE||BP76J30162.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP76J30162.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-891-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-891-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U61P30173^^^AIRA-TEST^MR||PikeAIRA^ElidaAIRA^Happy^^^^L|BenewahAIRA^ItzelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1157 Auiven Cir^^Cone^MI^48160^USA^P||^PRN^PH^^^734^5876059|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^BenewahAIRA^^^^^L|MTH^Mother^HL70063|1157 Auiven Cir^^Cone^MI^48160^USA^P|^PRN^PH^^^734^5876059ORC|RE||BU61P30173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU61P30173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-891-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-893-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R21J30181^^^AIRA-TEST^MR||TereAIRA^IshanaAIRA^Hetal^^^^L|LeeAIRA^MoyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1254 Da en Hunze Ln^^Comerica^MI^48255^USA^P||^PRN^PH^^^313^8380798|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TereAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1254 Da en Hunze Ln^^Comerica^MI^48255^USA^P|^PRN^PH^^^313^8380798ORC|RE||BR21J30181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR21J30181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-893-02^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-893-07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L01D30189^^^AIRA-TEST^MR||McIntoshAIRA^AntigoneAIRA^Callia^^^^L|LeelanauAIRA^ShianAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1263 Wachten Ave^^Kewadin^MI^49648^USA^P||^PRN^PH^^^231^2751219|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McIntoshAIRA^LeelanauAIRA^^^^^L|MTH^Mother^HL70063|1263 Wachten Ave^^Kewadin^MI^49648^USA^P|^PRN^PH^^^231^2751219ORC|RE||BL01D30189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL01D30189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-893-07^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-894-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X61F30197^^^AIRA-TEST^MR||MariposaAIRA^DestryAIRA^Cheri^^^^L|TuscarawasAIRA^NiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1218 Ochtend Ln^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^2801458|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MariposaAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1218 Ochtend Ln^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^2801458ORC|RE||BX61F30197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX61F30197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-894-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-894-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S42B30202^^^AIRA-TEST^MR||HutchinsonAIRA^MekiaAIRA^Delma^^^^L|GarvinAIRA^AlessandraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1461 Blaricum St^^White Lake^MI^48386^USA^P||^PRN^PH^^^248^6689571|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HutchinsonAIRA^GarvinAIRA^^^^^L|MTH^Mother^HL70063|1461 Blaricum St^^White Lake^MI^48386^USA^P|^PRN^PH^^^248^6689571ORC|RE||BS42B30202.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS42B30202.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-894-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-895-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E91B30213^^^AIRA-TEST^MR||PolkAIRA^NiliniAIRA^Cecia^^^^L|HartAIRA^ZeebaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1374 Dtichtse Vecht Pl^^York Township^MI^48160^USA^P||^PRN^PH^^^734^2319822|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^HartAIRA^^^^^L|MTH^Mother^HL70063|1374 Dtichtse Vecht Pl^^York Township^MI^48160^USA^P|^PRN^PH^^^734^2319822ORC|RE||BE91B30213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE91B30213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-895-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-895-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T83O30221^^^AIRA-TEST^MR||SandstromAIRA^SabiraAIRA^Bronnen^^^^L|OldhamAIRA^MichelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1722 Wittenseradeel Ln^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^7071996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SandstromAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1722 Wittenseradeel Ln^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^7071996ORC|RE||BT83O30221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT83O30221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-895-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-896-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L39W30229^^^AIRA-TEST^MR||CumberlandAIRA^LouellaAIRA^May^^^^L|PowerAIRA^ChayAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1641 Vtadskanaal Ave^^Augusta^MI^49012^USA^P||^PRN^PH^^^269^8560620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CumberlandAIRA^PowerAIRA^^^^^L|MTH^Mother^HL70063|1641 Vtadskanaal Ave^^Augusta^MI^49012^USA^P|^PRN^PH^^^269^8560620ORC|RE||BL39W30229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL39W30229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-896-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-896-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T46Q30237^^^AIRA-TEST^MR||HampsonAIRA^PeggieAIRA^Anya^^^^L|HoltAIRA^ClarineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1500 Kchouwen-Duiveland St^^Cadmus^MI^49221^USA^P||^PRN^PH^^^517^9235995|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HampsonAIRA^HoltAIRA^^^^^L|MTH^Mother^HL70063|1500 Kchouwen-Duiveland St^^Cadmus^MI^49221^USA^P|^PRN^PH^^^517^9235995ORC|RE||BT46Q30237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT46Q30237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-896-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-898-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q17Q30242^^^AIRA-TEST^MR||CusterAIRA^AlexandriaAIRA^Isleen^^^^L|DurbinAIRA^KimatraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1392 Noogeveen Ln^^MI Metro^MI^48340^USA^P||^PRN^PH^^^248^7958075|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusterAIRA^DurbinAIRA^^^^^L|MTH^Mother^HL70063|1392 Noogeveen Ln^^MI Metro^MI^48340^USA^P|^PRN^PH^^^248^7958075ORC|RE||BQ17Q30242.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ17Q30242.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-898-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-898-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E27V30253^^^AIRA-TEST^MR||NewtonAIRA^SpringAIRA^Harper^^^^L|ClayAIRA^TalyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1744 Delfzijl Pl^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^9458609|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewtonAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1744 Delfzijl Pl^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^9458609ORC|RE||BE27V30253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE27V30253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-898-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-900-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F65S30261^^^AIRA-TEST^MR||NeorinAIRA^RowenaAIRA^Fionola^^^^L|AtascosaAIRA^TamsinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1250 Wytsjerksteradiel Ln^^Ravenna^MI^49451^USA^P||^PRN^PH^^^231^3189006|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NeorinAIRA^AtascosaAIRA^^^^^L|MTH^Mother^HL70063|1250 Wytsjerksteradiel Ln^^Ravenna^MI^49451^USA^P|^PRN^PH^^^231^3189006ORC|RE||BF65S30261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF65S30261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-900-01^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-900-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G50M30269^^^AIRA-TEST^MR||ButteAIRA^FiorellaAIRA^Carenza^^^^L|LambAIRA^HaleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1980 Fe Wolden Ave^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^4840630|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButteAIRA^LambAIRA^^^^^L|MTH^Mother^HL70063|1980 Fe Wolden Ave^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^4840630ORC|RE||BG50M30269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG50M30269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-900-11^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z21E30277^^^AIRA-TEST^MR||BayAIRA^LiliaAIRA^Ryan^^^^L|NelsenAIRA^HoneyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1447 Virschot Cir^^Mosherville^MI^49258^USA^P||^PRN^PH^^^517^4989994|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BayAIRA^NelsenAIRA^^^^^L|MTH^Mother^HL70063|1447 Virschot Cir^^Mosherville^MI^49258^USA^P|^PRN^PH^^^517^4989994ORC|RE||BZ21E30277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ21E30277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-901-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z08U30282^^^AIRA-TEST^MR||HarrisonAIRA^TheoraAIRA^Ema^^^^L|MonoAIRA^ColensoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1995 Berkrade Ave^^Shingleton^MI^49884^USA^P||^PRN^PH^^^906^5192600|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^MonoAIRA^^^^^L|MTH^Mother^HL70063|1995 Berkrade Ave^^Shingleton^MI^49884^USA^P|^PRN^PH^^^906^5192600ORC|RE||BZ08U30282.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ08U30282.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-901-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-903-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I26U30293^^^AIRA-TEST^MR||MuscatineAIRA^ChaitraAIRA^Sahar^^^^L|CummingsAIRA^DahliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1281 Break Ave^^Waterford Township^MI^48327^USA^P||^PRN^PH^^^248^7305772|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MuscatineAIRA^CummingsAIRA^^^^^L|MTH^Mother^HL70063|1281 Break Ave^^Waterford Township^MI^48327^USA^P|^PRN^PH^^^248^7305772ORC|RE||BI26U30293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI26U30293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-903-01^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-903-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K09I30301^^^AIRA-TEST^MR||AllamakeeAIRA^SorayaAIRA^Thalia^^^^L|ByrneAIRA^ChlorisAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1553 Iudwest-Fryslan Cir^^Silverwood^MI^48760^USA^P||^PRN^PH^^^989^7027913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllamakeeAIRA^ByrneAIRA^^^^^L|MTH^Mother^HL70063|1553 Iudwest-Fryslan Cir^^Silverwood^MI^48760^USA^P|^PRN^PH^^^989^7027913ORC|RE||BK09I30301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK09I30301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-903-11^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-908-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S52J30309^^^AIRA-TEST^MR||ColemanAIRA^AndreaAIRA^Fifi^^^^L|PerryAIRA^RuchikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1039 Vaanstad Ln^^Lansing^MI^48916^USA^P||^PRN^PH^^^517^7668431|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColemanAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1039 Vaanstad Ln^^Lansing^MI^48916^USA^P|^PRN^PH^^^517^7668431ORC|RE||BS52J30309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS52J30309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-908-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-908-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W36P30317^^^AIRA-TEST^MR||LeslieAIRA^GebrieleAIRA^Erlina^^^^L|LewisAIRA^SienaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1021 Onthouden Ln^^Grand Blanc^MI^48480^USA^P||^PRN^PH^^^810^8464558|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeslieAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1021 Onthouden Ln^^Grand Blanc^MI^48480^USA^P|^PRN^PH^^^810^8464558ORC|RE||BW36P30317.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW36P30317.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-908-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-909-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C77G30322^^^AIRA-TEST^MR||LeeAIRA^HallieAIRA^Rosy^^^^L|AlpenaAIRA^KonstanzeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1792 Uit Ave^^Raco^MI^49715^USA^P||^PRN^PH^^^906^9084269|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^AlpenaAIRA^^^^^L|MTH^Mother^HL70063|1792 Uit Ave^^Raco^MI^49715^USA^P|^PRN^PH^^^906^9084269ORC|RE||BC77G30322.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC77G30322.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-909-41^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-909-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U57T30333^^^AIRA-TEST^MR||MerrickAIRA^AliciaAIRA^Donla^^^^L|FayetteAIRA^AnneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1751 Tozendaal Ave^^Boon^MI^49618^USA^P||^PRN^PH^^^231^9638496|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MerrickAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1751 Tozendaal Ave^^Boon^MI^49618^USA^P|^PRN^PH^^^231^9638496ORC|RE||BU57T30333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU57T30333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-909-52^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-912-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N66X30341^^^AIRA-TEST^MR||StephensAIRA^MarmaraAIRA^Nolene^^^^L|RoachAIRA^RataAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1230 Tellen Pl^^Ray Township^MI^48096^USA^P||^PRN^PH^^^586^7749151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StephensAIRA^RoachAIRA^^^^^L|MTH^Mother^HL70063|1230 Tellen Pl^^Ray Township^MI^48096^USA^P|^PRN^PH^^^586^7749151ORC|RE||BN66X30341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN66X30341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-912-41^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515-912-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M91Z30349^^^AIRA-TEST^MR||BerntsenAIRA^DelaneyAIRA^Filberta^^^^L|StonewallAIRA^KuntiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1777 Voordenveld Ave^^Sharon^MI^48158^USA^P||^PRN^PH^^^734^6067008|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BerntsenAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1777 Voordenveld Ave^^Sharon^MI^48158^USA^P|^PRN^PH^^^734^6067008ORC|RE||BM91Z30349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM91Z30349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515-912-52^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515084501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q06Q30357^^^AIRA-TEST^MR||WebsterAIRA^TrushaAIRA^Karina^^^^L|HarneyAIRA^SuruchiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1887 Reimerswaal Ln^^Stockbridge^MI^49285^USA^P||^PRN^PH^^^517^8736438|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WebsterAIRA^HarneyAIRA^^^^^L|MTH^Mother^HL70063|1887 Reimerswaal Ln^^Stockbridge^MI^49285^USA^P|^PRN^PH^^^517^8736438ORC|RE||BQ06Q30357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ06Q30357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515084501^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515084511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F79O30362^^^AIRA-TEST^MR||MontgomeryAIRA^KamrynAIRA^Trinidad^^^^L|MaverickAIRA^RuchikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1153 Set St^^Lansing^MI^48929^USA^P||^PRN^PH^^^517^3057536|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontgomeryAIRA^MaverickAIRA^^^^^L|MTH^Mother^HL70063|1153 Set St^^Lansing^MI^48929^USA^P|^PRN^PH^^^517^3057536ORC|RE||BF79O30362.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF79O30362.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515084511^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515085041|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I70U30373^^^AIRA-TEST^MR||WeilAIRA^SakuraAIRA^Ultima^^^^L|AsotinAIRA^CoorahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1380 Gaan Cir^^Farmington Hills^MI^48334^USA^P||^PRN^PH^^^248^5017025|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WeilAIRA^AsotinAIRA^^^^^L|MTH^Mother^HL70063|1380 Gaan Cir^^Farmington Hills^MI^48334^USA^P|^PRN^PH^^^248^5017025ORC|RE||BI70U30373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI70U30373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515085041^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515085052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R80S30381^^^AIRA-TEST^MR||GranholmAIRA^RodericaAIRA^Manju^^^^L|PowerAIRA^NeelamAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1421 Synaarlo St^^Harbert^MI^49115^USA^P||^PRN^PH^^^269^6814305|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GranholmAIRA^PowerAIRA^^^^^L|MTH^Mother^HL70063|1421 Synaarlo St^^Harbert^MI^49115^USA^P|^PRN^PH^^^269^6814305ORC|RE||BR80S30381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR80S30381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515085052^Flulaval^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515088902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T66A30389^^^AIRA-TEST^MR||JakobsenAIRA^AlysaAIRA^Prima^^^^L|VintonAIRA^EvieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1302 Oittenseradiel Cir^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^5394268|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JakobsenAIRA^VintonAIRA^^^^^L|MTH^Mother^HL70063|1302 Oittenseradiel Cir^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^5394268ORC|RE||BT66A30389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT66A30389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515088902^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515088907|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U20L30397^^^AIRA-TEST^MR||HallAIRA^SabrinaAIRA^Ainsley^^^^L|SponlandAIRA^CarmelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1670 Werelddeel Ln^^Blanchard^MI^49310^USA^P||^PRN^PH^^^989^4390540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HallAIRA^SponlandAIRA^^^^^L|MTH^Mother^HL70063|1670 Werelddeel Ln^^Blanchard^MI^49310^USA^P|^PRN^PH^^^989^4390540ORC|RE||BU20L30397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU20L30397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515088907^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L21N30402^^^AIRA-TEST^MR||CowleyAIRA^OrianaAIRA^Glenys^^^^L|GlorinnAIRA^GalateaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1899 Lheden Pl^^Copemish^MI^49625^USA^P||^PRN^PH^^^231^6545107|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CowleyAIRA^GlorinnAIRA^^^^^L|MTH^Mother^HL70063|1899 Lheden Pl^^Copemish^MI^49625^USA^P|^PRN^PH^^^231^6545107ORC|RE||BL21N30402.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL21N30402.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089002^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089007|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T22R30413^^^AIRA-TEST^MR||JohnsonAIRA^LuciaAIRA^Kate^^^^L|WolfeAIRA^DionyzaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1801 Beststellingwerf Cir^^Kewadin^MI^49648^USA^P||^PRN^PH^^^231^2295513|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^WolfeAIRA^^^^^L|MTH^Mother^HL70063|1801 Beststellingwerf Cir^^Kewadin^MI^49648^USA^P|^PRN^PH^^^231^2295513ORC|RE||BT22R30413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT22R30413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089007^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S79L30421^^^AIRA-TEST^MR||CorrinAIRA^MyfanwyAIRA^Deidra^^^^L|FillmoreAIRA^MelliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1312 Eardenberg Pl^^Livonia^MI^48151^USA^P||^PRN^PH^^^734^8403918|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CorrinAIRA^FillmoreAIRA^^^^^L|MTH^Mother^HL70063|1312 Eardenberg Pl^^Livonia^MI^48151^USA^P|^PRN^PH^^^734^8403918ORC|RE||BS79L30421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS79L30421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089101^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P51F30429^^^AIRA-TEST^MR||LarsonAIRA^MarinelAIRA^Jarvinia^^^^L|PedersenAIRA^MarileeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1632 Souda Cir^^Sault Sainte Marie^MI^49784^USA^P||^PRN^PH^^^906^7325662|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LarsonAIRA^PedersenAIRA^^^^^L|MTH^Mother^HL70063|1632 Souda Cir^^Sault Sainte Marie^MI^49784^USA^P|^PRN^PH^^^906^7325662ORC|RE||BP51F30429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP51F30429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089111^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J74D30437^^^AIRA-TEST^MR||San Luis ObispoAIRA^RoseanneAIRA^Haylee^^^^L|WellsAIRA^ArohaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1099 Rpeldoorn Ln^^Flint^MI^48506^USA^P||^PRN^PH^^^810^7719238|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San Luis ObispoAIRA^WellsAIRA^^^^^L|MTH^Mother^HL70063|1099 Rpeldoorn Ln^^Flint^MI^48506^USA^P|^PRN^PH^^^810^7719238ORC|RE||BJ74D30437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ74D30437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089302^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089307|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B10B30442^^^AIRA-TEST^MR||CartonAIRA^KirbyAIRA^Crispina^^^^L|CassAIRA^PrachiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1093 Eemsmond Ln^^Lakeside^MI^49116^USA^P||^PRN^PH^^^269^4020878|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CartonAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1093 Eemsmond Ln^^Lakeside^MI^49116^USA^P|^PRN^PH^^^269^4020878ORC|RE||BB10B30442.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB10B30442.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089307^FLULAVAL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089441|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W51M30453^^^AIRA-TEST^MR||NormanAIRA^CallistaAIRA^Maj^^^^L|AntelopeAIRA^JourneyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1489 Toorst Cir^^East Lansing^MI^48825^USA^P||^PRN^PH^^^517^4893195|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NormanAIRA^AntelopeAIRA^^^^^L|MTH^Mother^HL70063|1489 Toorst Cir^^East Lansing^MI^48825^USA^P|^PRN^PH^^^517^4893195ORC|RE||BW51M30453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW51M30453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089441^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089452|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P44T30461^^^AIRA-TEST^MR||WorthAIRA^PhuongAIRA^Zeanes^^^^L|SullivanAIRA^AmbikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1190 Eonseradeel St^^South Lyon^MI^48178^USA^P||^PRN^PH^^^248^3668977|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WorthAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1190 Eonseradeel St^^South Lyon^MI^48178^USA^P|^PRN^PH^^^248^3668977ORC|RE||BP44T30461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP44T30461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089452^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P84T30469^^^AIRA-TEST^MR||MiljkeimAIRA^KristenAIRA^Avel^^^^L|YoakumAIRA^DaliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1073 Meusden St^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^3355482|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MiljkeimAIRA^YoakumAIRA^^^^^L|MTH^Mother^HL70063|1073 Meusden St^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^3355482ORC|RE||BP84T30469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP84T30469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089501^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V98X30477^^^AIRA-TEST^MR||FreestoneAIRA^AbellaAIRA^Elli^^^^L|CooperAIRA^InariAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1690 Zorne Cir^^Interlochen^MI^49643^USA^P||^PRN^PH^^^231^4775151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FreestoneAIRA^CooperAIRA^^^^^L|MTH^Mother^HL70063|1690 Zorne Cir^^Interlochen^MI^49643^USA^P|^PRN^PH^^^231^4775151ORC|RE||BV98X30477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV98X30477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089511^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N45N30482^^^AIRA-TEST^MR||MarionAIRA^YaffaAIRA^Taliyah^^^^L|MadisonAIRA^YungaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1745 Alphen aan den Rijn St^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^5337114|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1745 Alphen aan den Rijn St^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^5337114ORC|RE||BN45N30482.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN45N30482.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089601^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H11W30493^^^AIRA-TEST^MR||OldhamAIRA^IdehAIRA^Odea^^^^L|GibbonsAIRA^OrchidAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1891 Heuningen Pl^^Ada^MI^49301^USA^P||^PRN^PH^^^616^8427528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OldhamAIRA^GibbonsAIRA^^^^^L|MTH^Mother^HL70063|1891 Heuningen Pl^^Ada^MI^49301^USA^P|^PRN^PH^^^616^8427528ORC|RE||BH11W30493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH11W30493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089611^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V98S30501^^^AIRA-TEST^MR||HarneyAIRA^KaleyAIRA^Lychorinda^^^^L|EastlandAIRA^DarrelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1780 Luijk Pl^^Flat Rock^MI^48134^USA^P||^PRN^PH^^^734^4045530|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarneyAIRA^EastlandAIRA^^^^^L|MTH^Mother^HL70063|1780 Luijk Pl^^Flat Rock^MI^48134^USA^P|^PRN^PH^^^734^4045530ORC|RE||BV98S30501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV98S30501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089801^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515089811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O12C30509^^^AIRA-TEST^MR||ErikssonAIRA^VeenaAIRA^Rayelle^^^^L|WerstadAIRA^DivyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1931 Dest Maas en Waal Ave^^Hamburg^MI^48139^USA^P||^PRN^PH^^^810^8146802|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErikssonAIRA^WerstadAIRA^^^^^L|MTH^Mother^HL70063|1931 Dest Maas en Waal Ave^^Hamburg^MI^48139^USA^P|^PRN^PH^^^810^8146802ORC|RE||BO12C30509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO12C30509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515089811^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X37C30517^^^AIRA-TEST^MR||WashtenawAIRA^AnnikaAIRA^Adrianna^^^^L|WilsonAIRA^TuruaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1598 Dholen St^^Lansing^MI^48922^USA^P||^PRN^PH^^^517^5053623|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashtenawAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1598 Dholen St^^Lansing^MI^48922^USA^P|^PRN^PH^^^517^5053623ORC|RE||BX37C30517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX37C30517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090001^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L12C30522^^^AIRA-TEST^MR||StrubleAIRA^AramintaAIRA^Dixie^^^^L|WilliamsAIRA^MarigoldAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1540 Doesburg Pl^^Lansing^MI^48921^USA^P||^PRN^PH^^^517^6275875|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StrubleAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1540 Doesburg Pl^^Lansing^MI^48921^USA^P|^PRN^PH^^^517^6275875ORC|RE||BL12C30522.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL12C30522.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090011^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z91O30533^^^AIRA-TEST^MR||EllisAIRA^KatelynAIRA^Dore^^^^L|AldridgeAIRA^KhalidaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1259 Mronckhorst St^^Ann Arbor^MI^48106^USA^P||^PRN^PH^^^734^6724106|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EllisAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1259 Mronckhorst St^^Ann Arbor^MI^48106^USA^P|^PRN^PH^^^734^6724106ORC|RE||BZ91O30533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ91O30533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090141^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H15J30541^^^AIRA-TEST^MR||O'NeillAIRA^AbileneAIRA^Michelle^^^^L|WotherspoonAIRA^GurleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1613 Htaphorst Pl^^Boyne City^MI^49712^USA^P||^PRN^PH^^^231^8444194|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'NeillAIRA^WotherspoonAIRA^^^^^L|MTH^Mother^HL70063|1613 Htaphorst Pl^^Boyne City^MI^49712^USA^P|^PRN^PH^^^231^8444194ORC|RE||BH15J30541.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH15J30541.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090152^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S92S30549^^^AIRA-TEST^MR||LaneAIRA^AltaAIRA^Yeva^^^^L|ModocAIRA^KenwynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1480 Wuder-Amstel Ln^^Cassopolis^MI^49031^USA^P||^PRN^PH^^^269^2922864|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaneAIRA^ModocAIRA^^^^^L|MTH^Mother^HL70063|1480 Wuder-Amstel Ln^^Cassopolis^MI^49031^USA^P|^PRN^PH^^^269^2922864ORC|RE||BS92S30549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS92S30549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090301^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U44V30557^^^AIRA-TEST^MR||Mc VeetyAIRA^TertiaAIRA^Doria^^^^L|WolfeAIRA^MorganaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1402 Koeree-Overflakkee Ave^^Fraser^MI^48026^USA^P||^PRN^PH^^^586^4407323|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Mc VeetyAIRA^WolfeAIRA^^^^^L|MTH^Mother^HL70063|1402 Koeree-Overflakkee Ave^^Fraser^MI^48026^USA^P|^PRN^PH^^^586^4407323ORC|RE||BU44V30557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU44V30557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090311^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090841|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V60U30562^^^AIRA-TEST^MR||LindstromAIRA^RiannaAIRA^Amanda^^^^L|MorrosAIRA^MarisolAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1305 Siddelburg Cir^^Stephenson^MI^49887^USA^P||^PRN^PH^^^906^5930149|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LindstromAIRA^MorrosAIRA^^^^^L|MTH^Mother^HL70063|1305 Siddelburg Cir^^Stephenson^MI^49887^USA^P|^PRN^PH^^^906^5930149ORC|RE||BV60U30562.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV60U30562.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090841^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090852|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O11A30570^^^AIRA-TEST^MR||PetersenAIRA^CalliaAIRA^Safiya^^^^L|ShermanAIRA^NinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1085 Aardenberg Cir^^Lyons^MI^48851^USA^P||^PRN^PH^^^989^4846374|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PetersenAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1085 Aardenberg Cir^^Lyons^MI^48851^USA^P|^PRN^PH^^^989^4846374ORC|RE||BO11A30570.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO11A30570.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090852^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090941|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S01X30581^^^AIRA-TEST^MR||TaylorAIRA^SentaAIRA^Rosabelle^^^^L|BoundaryAIRA^IdehAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1623 Enschede St^^Warren^MI^48397^USA^P||^PRN^PH^^^586^5943674|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^BoundaryAIRA^^^^^L|MTH^Mother^HL70063|1623 Enschede St^^Warren^MI^48397^USA^P|^PRN^PH^^^586^5943674ORC|RE||BS01X30581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS01X30581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090941^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515090952|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N90O30589^^^AIRA-TEST^MR||BarrenAIRA^LanikaiAIRA^Yasmine^^^^L|GunnersonAIRA^ChaylenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1218 Soirle Ln^^Burr Oak^MI^49030^USA^P||^PRN^PH^^^269^8854838|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BarrenAIRA^GunnersonAIRA^^^^^L|MTH^Mother^HL70063|1218 Soirle Ln^^Burr Oak^MI^49030^USA^P|^PRN^PH^^^269^8854838ORC|RE||BN90O30589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN90O30589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515090952^Flulaval Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515091241|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R41W30597^^^AIRA-TEST^MR||MorganAIRA^RohanaAIRA^Maree^^^^L|BullittAIRA^AnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1191 Vingewaal St^^Kalamazoo^MI^49004^USA^P||^PRN^PH^^^269^4038169|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^BullittAIRA^^^^^L|MTH^Mother^HL70063|1191 Vingewaal St^^Kalamazoo^MI^49004^USA^P|^PRN^PH^^^269^4038169ORC|RE||BR41W30597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR41W30597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515091241^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-19515091252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q75G30605^^^AIRA-TEST^MR||AlleghenyAIRA^BetteAIRA^Toakase^^^^L|GageAIRA^KiraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1664 Geluidsoverlast Pl^^Wyoming^MI^49519^USA^P||^PRN^PH^^^616^2780205|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlleghenyAIRA^GageAIRA^^^^^L|MTH^Mother^HL70063|1664 Geluidsoverlast Pl^^Wyoming^MI^49519^USA^P|^PRN^PH^^^616^2780205ORC|RE||BQ75G30605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ75G30605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||19515091252^Flulaval quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-21695-413-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A93P30613^^^AIRA-TEST^MR||NobleAIRA^DaylaAIRA^Mily^^^^L|WexfordAIRA^MaeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1116 Paadhoeke Ln^^Detroit^MI^48221^USA^P||^PRN^PH^^^313^4002913|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NobleAIRA^WexfordAIRA^^^^^L|MTH^Mother^HL70063|1116 Paadhoeke Ln^^Detroit^MI^48221^USA^P|^PRN^PH^^^313^4002913ORC|RE||BA93P30613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA93P30613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21695-413-01^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-21695041301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P46T30618^^^AIRA-TEST^MR||FairfieldAIRA^ErzsebetAIRA^Willa^^^^L|GuthrieAIRA^NiamhAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1698 Doet Pl^^Edwardsburg^MI^49130^USA^P||^PRN^PH^^^269^9339136|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FairfieldAIRA^GuthrieAIRA^^^^^L|MTH^Mother^HL70063|1698 Doet Pl^^Edwardsburg^MI^49130^USA^P|^PRN^PH^^^269^9339136ORC|RE||BP46T30618.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP46T30618.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21695041301^Tetanus and Diphtheria Toxoids Adsorbed^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-010-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F35L30629^^^AIRA-TEST^MR||DakotaAIRA^FaynaAIRA^Amadi^^^^L|RichlandAIRA^HabikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1422 Zergen Ln^^GR^MI^49505^USA^P||^PRN^PH^^^616^7905387|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DakotaAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1422 Zergen Ln^^GR^MI^49505^USA^P|^PRN^PH^^^616^7905387ORC|RE||BF35L30629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF35L30629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-010-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K97N30637^^^AIRA-TEST^MR||ComancheAIRA^EllaAIRA^Bianca^^^^L|UlsethAIRA^JayleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1280 Jerwerderadeel Cir^^Lansing^MI^48921^USA^P||^PRN^PH^^^517^7903534|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComancheAIRA^UlsethAIRA^^^^^L|MTH^Mother^HL70063|1280 Jerwerderadeel Cir^^Lansing^MI^48921^USA^P|^PRN^PH^^^517^7903534ORC|RE||BK97N30637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK97N30637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-013-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-013-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z26X30645^^^AIRA-TEST^MR||VictoriaAIRA^AdabelleAIRA^Ruchika^^^^L|ThayerAIRA^GuenevereAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1537 Enkelvoudige Ave^^Battle Creek^MI^49017^USA^P||^PRN^PH^^^269^8464946|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VictoriaAIRA^ThayerAIRA^^^^^L|MTH^Mother^HL70063|1537 Enkelvoudige Ave^^Battle Creek^MI^49017^USA^P|^PRN^PH^^^269^8464946ORC|RE||BZ26X30645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ26X30645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-013-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W57T30653^^^AIRA-TEST^MR||MeadeAIRA^HalleAIRA^Malva^^^^L|IowaAIRA^SaxonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1447 Zitje Cir^^Kenockee Township^MI^48006^USA^P||^PRN^PH^^^810^4589779|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MeadeAIRA^IowaAIRA^^^^^L|MTH^Mother^HL70063|1447 Zitje Cir^^Kenockee Township^MI^48006^USA^P|^PRN^PH^^^810^4589779ORC|RE||BW57T30653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW57T30653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-014-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-014-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y74L30658^^^AIRA-TEST^MR||WayneAIRA^MelissaAIRA^Nasrin^^^^L|MontcalmAIRA^SaniyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1787 Mapendrecht St^^Spring Arbor^MI^49283^USA^P||^PRN^PH^^^517^9381314|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^MontcalmAIRA^^^^^L|MTH^Mother^HL70063|1787 Mapendrecht St^^Spring Arbor^MI^49283^USA^P|^PRN^PH^^^517^9381314ORC|RE||BY74L30658.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY74L30658.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-014-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76M30669^^^AIRA-TEST^MR||BradfordAIRA^ArvaAIRA^Blaise^^^^L|ShermanAIRA^RaginiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1441 Helft Ln^^Midland^MI^48641^USA^P||^PRN^PH^^^989^2730291|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BradfordAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1441 Helft Ln^^Midland^MI^48641^USA^P|^PRN^PH^^^989^2730291ORC|RE||BG76M30669.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG76M30669.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-015-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-015-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H26W30677^^^AIRA-TEST^MR||CimarronAIRA^AmberleyAIRA^Nirvana^^^^L|BrowneAIRA^OreaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1145 Soudrichem Ave^^Melvindale^MI^48122^USA^P||^PRN^PH^^^313^5993273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CimarronAIRA^BrowneAIRA^^^^^L|MTH^Mother^HL70063|1145 Soudrichem Ave^^Melvindale^MI^48122^USA^P|^PRN^PH^^^313^5993273ORC|RE||BH26W30677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH26W30677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-015-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X95S30685^^^AIRA-TEST^MR||DixonAIRA^ReenaAIRA^Carmel^^^^L|JacintoAIRA^DarleneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1304 Teldhoven Ln^^Pontiac^MI^48341^USA^P||^PRN^PH^^^248^6516682|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DixonAIRA^JacintoAIRA^^^^^L|MTH^Mother^HL70063|1304 Teldhoven Ln^^Pontiac^MI^48341^USA^P|^PRN^PH^^^248^6516682ORC|RE||BX95S30685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX95S30685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-016-01^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-016-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q10Y30693^^^AIRA-TEST^MR||PersonAIRA^CossetteAIRA^Suravinda^^^^L|CochiseAIRA^MaryamAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1403 Zunschoten Ln^^Rothbury^MI^49452^USA^P||^PRN^PH^^^231^5825473|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PersonAIRA^CochiseAIRA^^^^^L|MTH^Mother^HL70063|1403 Zunschoten Ln^^Rothbury^MI^49452^USA^P|^PRN^PH^^^231^5825473ORC|RE||BQ10Y30693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ10Y30693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-016-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S87Z30698^^^AIRA-TEST^MR||GanronAIRA^ChandaniAIRA^Roslyn^^^^L|MaddocksAIRA^PhoolanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1026 Wutphen Ln^^Breckenridge^MI^48615^USA^P||^PRN^PH^^^989^5797225|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanronAIRA^MaddocksAIRA^^^^^L|MTH^Mother^HL70063|1026 Wutphen Ln^^Breckenridge^MI^48615^USA^P|^PRN^PH^^^989^5797225ORC|RE||BS87Z30698.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS87Z30698.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-017-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-017-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R22P30709^^^AIRA-TEST^MR||FrioAIRA^RowanAIRA^Vasavi^^^^L|PlymouthAIRA^GwenhyvarAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1748 Slkmaar Ave^^Hanover^MI^49241^USA^P||^PRN^PH^^^517^9902199|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FrioAIRA^PlymouthAIRA^^^^^L|MTH^Mother^HL70063|1748 Slkmaar Ave^^Hanover^MI^49241^USA^P|^PRN^PH^^^517^9902199ORC|RE||BR22P30709.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR22P30709.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-017-02^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-018-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C02G30717^^^AIRA-TEST^MR||ParmerAIRA^AlisaAIRA^Matana^^^^L|KlebergAIRA^AdinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1465 Raalte St^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^8721324|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParmerAIRA^KlebergAIRA^^^^^L|MTH^Mother^HL70063|1465 Raalte St^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^8721324ORC|RE||BC02G30717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC02G30717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-018-01^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-018-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G11R30725^^^AIRA-TEST^MR||DixonAIRA^TapiAIRA^Bethany^^^^L|WotherspoonAIRA^NydiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1217 Iaastricht Ave^^Monroe^MI^48161^USA^P||^PRN^PH^^^734^8401131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DixonAIRA^WotherspoonAIRA^^^^^L|MTH^Mother^HL70063|1217 Iaastricht Ave^^Monroe^MI^48161^USA^P|^PRN^PH^^^734^8401131ORC|RE||BG11R30725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG11R30725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-018-02^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I47K30733^^^AIRA-TEST^MR||ColemanAIRA^SebastianaAIRA^Roshan^^^^L|OchiltreeAIRA^ReganAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1743 Oalkenburg aan de Geul Pl^^Hickory Crnrs^MI^49060^USA^P||^PRN^PH^^^269^6428277|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColemanAIRA^OchiltreeAIRA^^^^^L|MTH^Mother^HL70063|1743 Oalkenburg aan de Geul Pl^^Hickory Crnrs^MI^49060^USA^P|^PRN^PH^^^269^6428277ORC|RE||BI47K30733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI47K30733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-110-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J74Y30738^^^AIRA-TEST^MR||SagadahocAIRA^InasAIRA^Mika^^^^L|GormanAIRA^NeerjaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1510 Elagtwedde Ave^^Decatur^MI^49045^USA^P||^PRN^PH^^^269^4805100|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SagadahocAIRA^GormanAIRA^^^^^L|MTH^Mother^HL70063|1510 Elagtwedde Ave^^Decatur^MI^49045^USA^P|^PRN^PH^^^269^4805100ORC|RE||BJ74Y30738.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ74Y30738.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-113-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-113-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T87J30749^^^AIRA-TEST^MR||HobellAIRA^ArieneAIRA^Carling^^^^L|MalheurAIRA^JillianAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1753 Zud-Beijerland Ave^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^3833956|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HobellAIRA^MalheurAIRA^^^^^L|MTH^Mother^HL70063|1753 Zud-Beijerland Ave^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^3833956ORC|RE||BT87J30749.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT87J30749.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-113-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N44L30757^^^AIRA-TEST^MR||HendersonAIRA^ElliAIRA^Edrea^^^^L|KimballAIRA^MintaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1242 Lorsele Ave^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^2289157|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HendersonAIRA^KimballAIRA^^^^^L|MTH^Mother^HL70063|1242 Lorsele Ave^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^2289157ORC|RE||BN44L30757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN44L30757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-114-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z88D30765^^^AIRA-TEST^MR||LenaweeAIRA^KayAIRA^Ashley^^^^L|SiouxAIRA^YukakoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1056 Lilvarenbeek Pl^^Ann Arbor^MI^48109^USA^P||^PRN^PH^^^734^7034892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LenaweeAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1056 Lilvarenbeek Pl^^Ann Arbor^MI^48109^USA^P|^PRN^PH^^^734^7034892ORC|RE||BZ88D30765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ88D30765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-114-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q84A30773^^^AIRA-TEST^MR||WinneshiekAIRA^GabrielAIRA^Olive^^^^L|LatahAIRA^GiselleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1515 Leeuwarden Cir^^Henderson^MI^48841^USA^P||^PRN^PH^^^989^8792702|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WinneshiekAIRA^LatahAIRA^^^^^L|MTH^Mother^HL70063|1515 Leeuwarden Cir^^Henderson^MI^48841^USA^P|^PRN^PH^^^989^8792702ORC|RE||BQ84A30773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ84A30773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-115-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-115-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C15T30778^^^AIRA-TEST^MR||LoganAIRA^RukminiAIRA^Zalia^^^^L|AlpineAIRA^GwennapAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1337 Nint-Michielsgestel Ave^^Ellsworth^MI^49729^USA^P||^PRN^PH^^^231^9556523|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoganAIRA^AlpineAIRA^^^^^L|MTH^Mother^HL70063|1337 Nint-Michielsgestel Ave^^Ellsworth^MI^49729^USA^P|^PRN^PH^^^231^9556523ORC|RE||BC15T30778.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC15T30778.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-115-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C42G30789^^^AIRA-TEST^MR||CruzAIRA^CaitAIRA^Lyla^^^^L|IversenAIRA^MayukoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1651 Dassenaar St^^Middleville^MI^49333^USA^P||^PRN^PH^^^269^3340632|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CruzAIRA^IversenAIRA^^^^^L|MTH^Mother^HL70063|1651 Dassenaar St^^Middleville^MI^49333^USA^P|^PRN^PH^^^269^3340632ORC|RE||BC42G30789.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC42G30789.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-116-10^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R87Q30797^^^AIRA-TEST^MR||CrawfordAIRA^EudocieAIRA^Athanasia^^^^L|BolgenAIRA^ArelyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1099 Reeuwarden Ln^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^6808983|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^BolgenAIRA^^^^^L|MTH^Mother^HL70063|1099 Reeuwarden Ln^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^6808983ORC|RE||BR87Q30797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR87Q30797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-116-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P77U30805^^^AIRA-TEST^MR||StevensAIRA^ApolloniaAIRA^Verrin^^^^L|CookeAIRA^MoselleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1911 Mcheemda Ave^^Caro^MI^48723^USA^P||^PRN^PH^^^989^8380870|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StevensAIRA^CookeAIRA^^^^^L|MTH^Mother^HL70063|1911 Mcheemda Ave^^Caro^MI^48723^USA^P|^PRN^PH^^^989^8380870ORC|RE||BP77U30805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP77U30805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-117-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K32A30813^^^AIRA-TEST^MR||HardinAIRA^ZahraAIRA^Stacy^^^^L|YoakumAIRA^ManuelaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1576 Wolk Ave^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^6221492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HardinAIRA^YoakumAIRA^^^^^L|MTH^Mother^HL70063|1576 Wolk Ave^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^6221492ORC|RE||BK32A30813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK32A30813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-117-11^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A49R30818^^^AIRA-TEST^MR||BraceyAIRA^IzanamiAIRA^Odetta^^^^L|KinneyAIRA^BalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1226 Ztten-Leur Ave^^Washingtn Township^MI^48095^USA^P||^PRN^PH^^^586^3020374|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BraceyAIRA^KinneyAIRA^^^^^L|MTH^Mother^HL70063|1226 Ztten-Leur Ave^^Washingtn Township^MI^48095^USA^P|^PRN^PH^^^586^3020374ORC|RE||BA49R30818.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA49R30818.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-118-10^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F59Y30826^^^AIRA-TEST^MR||HaskellAIRA^VasantiAIRA^Armynel^^^^L|StephensAIRA^DiarriaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1717 Kuth Pl^^Arnold^MI^49819^USA^P||^PRN^PH^^^906^9672175|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaskellAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1717 Kuth Pl^^Arnold^MI^49819^USA^P|^PRN^PH^^^906^9672175ORC|RE||BF59Y30826.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF59Y30826.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-118-11^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-316-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I68C30837^^^AIRA-TEST^MR||GanronAIRA^AveraAIRA^Chanel^^^^L|SimpsonAIRA^IsratAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1604 Bedum Ln^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^6397135|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanronAIRA^SimpsonAIRA^^^^^L|MTH^Mother^HL70063|1604 Bedum Ln^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^6397135ORC|RE||BI68C30837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI68C30837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-316-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-316-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S57M30845^^^AIRA-TEST^MR||HowarthAIRA^TeriAIRA^Kimatra^^^^L|BentonAIRA^AdriannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1774 Links St^^Edwardsburg^MI^49130^USA^P||^PRN^PH^^^269^7120707|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowarthAIRA^BentonAIRA^^^^^L|MTH^Mother^HL70063|1774 Links St^^Edwardsburg^MI^49130^USA^P|^PRN^PH^^^269^7120707ORC|RE||BS57M30845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS57M30845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-316-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-317-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A45B30853^^^AIRA-TEST^MR||HardinAIRA^ZeebaAIRA^Angel^^^^L|ClevelandAIRA^TrishaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1434 Veerde Ave^^GR^MI^49508^USA^P||^PRN^PH^^^616^9035748|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HardinAIRA^ClevelandAIRA^^^^^L|MTH^Mother^HL70063|1434 Veerde Ave^^GR^MI^49508^USA^P|^PRN^PH^^^616^9035748ORC|RE||BA45B30853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA45B30853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-317-01^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-317-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N84N30861^^^AIRA-TEST^MR||AlbrechtsonAIRA^JannaAIRA^Katharina^^^^L|SpieccAIRA^SchuylerAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1050 Eheden Ave^^Lakeville^MI^48366^USA^P||^PRN^PH^^^248^5581255|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlbrechtsonAIRA^SpieccAIRA^^^^^L|MTH^Mother^HL70063|1050 Eheden Ave^^Lakeville^MI^48366^USA^P|^PRN^PH^^^248^5581255ORC|RE||BN84N30861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN84N30861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-317-02^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-318-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V79M30869^^^AIRA-TEST^MR||SamuelsonAIRA^TheanoAIRA^Ghislain^^^^L|TuscarawasAIRA^AtmajaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1954 Keppel Pl^^Genoa Township^MI^48114^USA^P||^PRN^PH^^^810^7844713|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SamuelsonAIRA^TuscarawasAIRA^^^^^L|MTH^Mother^HL70063|1954 Keppel Pl^^Genoa Township^MI^48114^USA^P|^PRN^PH^^^810^7844713ORC|RE||BV79M30869.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV79M30869.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-318-01^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-318-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A08Z30874^^^AIRA-TEST^MR||BerntsenAIRA^MalvaAIRA^Kelly^^^^L|ClallamAIRA^CiaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1544 Renkum Cir^^Riga^MI^49276^USA^P||^PRN^PH^^^517^4929849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BerntsenAIRA^ClallamAIRA^^^^^L|MTH^Mother^HL70063|1544 Renkum Cir^^Riga^MI^49276^USA^P|^PRN^PH^^^517^4929849ORC|RE||BA08Z30874.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA08Z30874.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-318-02^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I33G30885^^^AIRA-TEST^MR||SanduskyAIRA^LystraAIRA^Lareyne^^^^L|MarquetteAIRA^SparrowAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1878 Ma en Hunze Pl^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^7994633|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SanduskyAIRA^MarquetteAIRA^^^^^L|MTH^Mother^HL70063|1878 Ma en Hunze Pl^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^7994633ORC|RE||BI33G30885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI33G30885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-416-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-416-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I56G30893^^^AIRA-TEST^MR||PayneAIRA^ZazaAIRA^Bala^^^^L|RoachAIRA^HannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1107 Noodzakelijk Pl^^Iron River^MI^49935^USA^P||^PRN^PH^^^906^6845800|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PayneAIRA^RoachAIRA^^^^^L|MTH^Mother^HL70063|1107 Noodzakelijk Pl^^Iron River^MI^49935^USA^P|^PRN^PH^^^906^6845800ORC|RE||BI56G30893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI56G30893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-416-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I05D30901^^^AIRA-TEST^MR||McFernanAIRA^EmelyAIRA^Kolora^^^^L|BanbergAIRA^BegaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1875 Exacte Ln^^Delray^MI^48217^USA^P||^PRN^PH^^^313^4267299|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McFernanAIRA^BanbergAIRA^^^^^L|MTH^Mother^HL70063|1875 Exacte Ln^^Delray^MI^48217^USA^P|^PRN^PH^^^313^4267299ORC|RE||BI05D30901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI05D30901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-417-10^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-417-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X18U30909^^^AIRA-TEST^MR||ColusaAIRA^ChanahAIRA^Leilani^^^^L|IowaAIRA^VivianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1257 Positie Pl^^Sagola^MI^49881^USA^P||^PRN^PH^^^906^6167397|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColusaAIRA^IowaAIRA^^^^^L|MTH^Mother^HL70063|1257 Positie Pl^^Sagola^MI^49881^USA^P|^PRN^PH^^^906^6167397ORC|RE||BX18U30909.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX18U30909.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-417-11^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U98K30914^^^AIRA-TEST^MR||AndrewsAIRA^KaitlynAIRA^Apollonia^^^^L|GrantAIRA^SaritaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1721 Midden-Drenthe Cir^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^8271882|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndrewsAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1721 Midden-Drenthe Cir^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^8271882ORC|RE||BU98K30914.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU98K30914.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-418-10^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A51V30924^^^AIRA-TEST^MR||MahoningAIRA^GwendolenAIRA^Gaea^^^^L|MercedAIRA^ChruseAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1032 Vrachtwagen St^^Portage^MI^49002^USA^P||^PRN^PH^^^269^2046617|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahoningAIRA^MercedAIRA^^^^^L|MTH^Mother^HL70063|1032 Vrachtwagen St^^Portage^MI^49002^USA^P|^PRN^PH^^^269^2046617ORC|RE||BA51V30924.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA51V30924.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-418-11^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-519-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F92X30933^^^AIRA-TEST^MR||FreestoneAIRA^LaeAIRA^Neoma^^^^L|McLeanAIRA^RaelynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1315 Sijswijk Cir^^Harris^MI^49845^USA^P||^PRN^PH^^^906^3985135|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FreestoneAIRA^McLeanAIRA^^^^^L|MTH^Mother^HL70063|1315 Sijswijk Cir^^Harris^MI^49845^USA^P|^PRN^PH^^^906^3985135ORC|RE||BF92X30933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF92X30933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-519-01^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-519-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M53R30941^^^AIRA-TEST^MR||KlebergAIRA^DharmistaAIRA^Prapti^^^^L|BastropAIRA^ChalsieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1200 Auiven St^^Bridgman^MI^49106^USA^P||^PRN^PH^^^269^8684315|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlebergAIRA^BastropAIRA^^^^^L|MTH^Mother^HL70063|1200 Auiven St^^Bridgman^MI^49106^USA^P|^PRN^PH^^^269^8684315ORC|RE||BM53R30941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM53R30941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-519-25^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332-629-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P38N30949^^^AIRA-TEST^MR||CedarAIRA^SarahAIRA^Galay^^^^L|NorthamptonAIRA^VerushkaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1275 Aest St^^Middlevle^MI^49333^USA^P||^PRN^PH^^^269^3576965|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CedarAIRA^NorthamptonAIRA^^^^^L|MTH^Mother^HL70063|1275 Aest St^^Middlevle^MI^49333^USA^P|^PRN^PH^^^269^3576965ORC|RE||BP38N30949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP38N30949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332-629-10^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M88T30954^^^AIRA-TEST^MR||LubbockAIRA^ElleAIRA^Zoleen^^^^L|CooperAIRA^OrlandaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1639 Llagtwedde Ave^^Northwest^MI^48532^USA^P||^PRN^PH^^^810^6045366|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LubbockAIRA^CooperAIRA^^^^^L|MTH^Mother^HL70063|1639 Llagtwedde Ave^^Northwest^MI^48532^USA^P|^PRN^PH^^^810^6045366ORC|RE||BM88T30954.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM88T30954.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001001^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P36K30965^^^AIRA-TEST^MR||WashitaAIRA^AmberjillAIRA^Alzena^^^^L|MaderaAIRA^LindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1614 Jeusden St^^Bellevue^MI^49021^USA^P||^PRN^PH^^^269^6740325|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashitaAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1614 Jeusden St^^Bellevue^MI^49021^USA^P|^PRN^PH^^^269^6740325ORC|RE||BP36K30965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP36K30965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001301^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W16M30973^^^AIRA-TEST^MR||MickelAIRA^AlisonAIRA^Amaya^^^^L|KnowlesAIRA^NewlynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1695 Gtichtse Vecht Cir^^Milford Township^MI^48380^USA^P||^PRN^PH^^^248^6931014|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MickelAIRA^KnowlesAIRA^^^^^L|MTH^Mother^HL70063|1695 Gtichtse Vecht Cir^^Milford Township^MI^48380^USA^P|^PRN^PH^^^248^6931014ORC|RE||BW16M30973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW16M30973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001302^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T25M30981^^^AIRA-TEST^MR||LapeerAIRA^KinleyAIRA^Linne^^^^L|OxfordAIRA^RowenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1120 Tissewaard Ln^^Presque Isle^MI^49777^USA^P||^PRN^PH^^^989^3587041|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LapeerAIRA^OxfordAIRA^^^^^L|MTH^Mother^HL70063|1120 Tissewaard Ln^^Presque Isle^MI^49777^USA^P|^PRN^PH^^^989^3587041ORC|RE||BT25M30981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT25M30981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001401^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R88W30989^^^AIRA-TEST^MR||GreeneAIRA^ZinaidaAIRA^Tani^^^^L|HarrisonAIRA^BlandaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1004 Seimerswaal Ln^^Farmington Hills^MI^48331^USA^P||^PRN^PH^^^248^5764639|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeneAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1004 Seimerswaal Ln^^Farmington Hills^MI^48331^USA^P|^PRN^PH^^^248^5764639ORC|RE||BR88W30989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR88W30989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001402^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G55D30994^^^AIRA-TEST^MR||MooreAIRA^JacintheAIRA^Yaralla^^^^L|RogersAIRA^AnsleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1451 Vlphen aan den Rijn Ln^^Kenton^MI^49967^USA^P||^PRN^PH^^^906^9455151|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MooreAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1451 Vlphen aan den Rijn Ln^^Kenton^MI^49967^USA^P|^PRN^PH^^^906^9455151ORC|RE||BG55D30994.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG55D30994.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001501^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X68I31005^^^AIRA-TEST^MR||MiamiAIRA^CharlotteAIRA^Aretina^^^^L|MartinAIRA^AzariaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1104 Touw Pl^^Free Soil^MI^49411^USA^P||^PRN^PH^^^231^6067485|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MiamiAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1104 Touw Pl^^Free Soil^MI^49411^USA^P|^PRN^PH^^^231^6067485ORC|RE||BX68I31005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX68I31005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001502^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T59F31013^^^AIRA-TEST^MR||JansonAIRA^UshmaAIRA^Cora^^^^L|OhioAIRA^EsmeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1809 Wundert Ave^^Casco^MI^48064^USA^P||^PRN^PH^^^810^5336079|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JansonAIRA^OhioAIRA^^^^^L|MTH^Mother^HL70063|1809 Wundert Ave^^Casco^MI^48064^USA^P|^PRN^PH^^^810^5336079ORC|RE||BT59F31013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT59F31013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001601^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X06T31021^^^AIRA-TEST^MR||CokeAIRA^AthenaAIRA^Onenn^^^^L|CrawfordAIRA^KristinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1433 Zaad Ln^^Meskegon^MI^49445^USA^P||^PRN^PH^^^231^7216316|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CokeAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1433 Zaad Ln^^Meskegon^MI^49445^USA^P|^PRN^PH^^^231^7216316ORC|RE||BX06T31021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX06T31021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001602^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y72S31029^^^AIRA-TEST^MR||BowieAIRA^CheriseAIRA^Achal^^^^L|SiouxAIRA^WendyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1982 Noeree-Overflakkee Pl^^Painesdale^MI^49955^USA^P||^PRN^PH^^^906^6705768|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BowieAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1982 Noeree-Overflakkee Pl^^Painesdale^MI^49955^USA^P|^PRN^PH^^^906^6705768ORC|RE||BY72S31029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY72S31029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001701^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L21Z31034^^^AIRA-TEST^MR||TuscarawasAIRA^ApolloniaAIRA^Rosalind^^^^L|FisherAIRA^AvrilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1051 Wrimmelen Ave^^Laingsburg^MI^48848^USA^P||^PRN^PH^^^517^9049849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuscarawasAIRA^FisherAIRA^^^^^L|MTH^Mother^HL70063|1051 Wrimmelen Ave^^Laingsburg^MI^48848^USA^P|^PRN^PH^^^517^9049849ORC|RE||BL21Z31034.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL21Z31034.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001702^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W59X31045^^^AIRA-TEST^MR||EnnisAIRA^LynseyAIRA^Albina^^^^L|ButteAIRA^GhislaineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1986 Huid Ave^^Ashley^MI^48806^USA^P||^PRN^PH^^^989^2713930|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EnnisAIRA^ButteAIRA^^^^^L|MTH^Mother^HL70063|1986 Huid Ave^^Ashley^MI^48806^USA^P|^PRN^PH^^^989^2713930ORC|RE||BW59X31045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW59X31045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001801^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332001802|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F20Z31053^^^AIRA-TEST^MR||ClevelandAIRA^HikaAIRA^Sayoko^^^^L|AntelopeAIRA^PiperAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1316 Dtein St^^Marlette^MI^48453^USA^P||^PRN^PH^^^989^8701041|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClevelandAIRA^AntelopeAIRA^^^^^L|MTH^Mother^HL70063|1316 Dtein St^^Marlette^MI^48453^USA^P|^PRN^PH^^^989^8701041ORC|RE||BF20Z31053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF20Z31053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332001802^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U93M31061^^^AIRA-TEST^MR||JacksonAIRA^AasiaAIRA^Azalia^^^^L|LemhiAIRA^AmandeepAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1315 Vint-Oedenrode Cir^^Saint Helen^MI^48656^USA^P||^PRN^PH^^^989^8935614|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^LemhiAIRA^^^^^L|MTH^Mother^HL70063|1315 Vint-Oedenrode Cir^^Saint Helen^MI^48656^USA^P|^PRN^PH^^^989^8935614ORC|RE||BU93M31061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU93M31061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011010^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B37X31069^^^AIRA-TEST^MR||McKinnonAIRA^ElyshiaAIRA^Mariah^^^^L|StanislausAIRA^AmorinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1735 Vis Pl^^GR^MI^49514^USA^P||^PRN^PH^^^616^3861638|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKinnonAIRA^StanislausAIRA^^^^^L|MTH^Mother^HL70063|1735 Vis Pl^^GR^MI^49514^USA^P|^PRN^PH^^^616^3861638ORC|RE||BB37X31069.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB37X31069.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011310^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y46H31074^^^AIRA-TEST^MR||FerryAIRA^ChanceAIRA^Jarmila^^^^L|RossAIRA^TatyanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1737 Baterland St^^Sidnaw^MI^49961^USA^P||^PRN^PH^^^906^3977722|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FerryAIRA^RossAIRA^^^^^L|MTH^Mother^HL70063|1737 Baterland St^^Sidnaw^MI^49961^USA^P|^PRN^PH^^^906^3977722ORC|RE||BY46H31074.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY46H31074.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011311^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I31B31085^^^AIRA-TEST^MR||DallasAIRA^FredaAIRA^Bernice^^^^L|HindsAIRA^MerriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1138 Antwoord Pl^^Detroit^MI^48216^USA^P||^PRN^PH^^^313^9615382|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DallasAIRA^HindsAIRA^^^^^L|MTH^Mother^HL70063|1138 Antwoord Pl^^Detroit^MI^48216^USA^P|^PRN^PH^^^313^9615382ORC|RE||BI31B31085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI31B31085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011410^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C08Q31093^^^AIRA-TEST^MR||LewisAIRA^AdelindaAIRA^Savanah^^^^L|MillsAIRA^MarlyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1098 Nooit Ln^^Gregory^MI^48137^USA^P||^PRN^PH^^^734^9212894|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LewisAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1098 Nooit Ln^^Gregory^MI^48137^USA^P|^PRN^PH^^^734^9212894ORC|RE||BC08Q31093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC08Q31093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011411^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P39W31101^^^AIRA-TEST^MR||Saint JosephAIRA^KlaraAIRA^Vivian^^^^L|WarrenAIRA^AlaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1463 Begeleiden Ln^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^9794170|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Saint JosephAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1463 Begeleiden Ln^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^9794170ORC|RE||BP39W31101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP39W31101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011510^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S28R31109^^^AIRA-TEST^MR||BrennanAIRA^GuinevereAIRA^Vivienne^^^^L|PolkAIRA^AbbyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1051 Rlphen-Chaam Cir^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^2929383|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrennanAIRA^PolkAIRA^^^^^L|MTH^Mother^HL70063|1051 Rlphen-Chaam Cir^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^2929383ORC|RE||BS28R31109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS28R31109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011511^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A27W31114^^^AIRA-TEST^MR||AtwellAIRA^NeliaAIRA^Kendal^^^^L|AndroscogginAIRA^OderaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1788 Rodegraven-Reeuwijk Ave^^Union Lake^MI^48387^USA^P||^PRN^PH^^^248^8966250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtwellAIRA^AndroscogginAIRA^^^^^L|MTH^Mother^HL70063|1788 Rodegraven-Reeuwijk Ave^^Union Lake^MI^48387^USA^P|^PRN^PH^^^248^8966250ORC|RE||BA27W31114.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA27W31114.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011610^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y35I31125^^^AIRA-TEST^MR||ProvidenceAIRA^RumikoAIRA^Tonia^^^^L|AntrimAIRA^BobbyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1208 Krnhem Ln^^Cone^MI^48160^USA^P||^PRN^PH^^^734^7608229|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ProvidenceAIRA^AntrimAIRA^^^^^L|MTH^Mother^HL70063|1208 Krnhem Ln^^Cone^MI^48160^USA^P|^PRN^PH^^^734^7608229ORC|RE||BY35I31125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY35I31125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011611^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E70U31133^^^AIRA-TEST^MR||HaughtonAIRA^LaurenAIRA^Nabelung^^^^L|HuntAIRA^WhitneyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1658 Vooruit St^^Midland^MI^48670^USA^P||^PRN^PH^^^989^4571610|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaughtonAIRA^HuntAIRA^^^^^L|MTH^Mother^HL70063|1658 Vooruit St^^Midland^MI^48670^USA^P|^PRN^PH^^^989^4571610ORC|RE||BE70U31133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE70U31133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011710^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011711|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H20I31141^^^AIRA-TEST^MR||HaskellAIRA^LucilleAIRA^Lillian^^^^L|DeuelAIRA^GinnyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1638 Roxtel Ave^^Bay View^MI^49770^USA^P||^PRN^PH^^^231^6994019|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaskellAIRA^DeuelAIRA^^^^^L|MTH^Mother^HL70063|1638 Roxtel Ave^^Bay View^MI^49770^USA^P|^PRN^PH^^^231^6994019ORC|RE||BH20I31141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH20I31141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011711^Afluria^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B53A31149^^^AIRA-TEST^MR||WalshAIRA^DeirdreAIRA^Rickena^^^^L|DavisAIRA^BrysenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1823 Kampen St^^Belding^MI^48887^USA^P||^PRN^PH^^^616^3544604|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WalshAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1823 Kampen St^^Belding^MI^48887^USA^P|^PRN^PH^^^616^3544604ORC|RE||BB53A31149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB53A31149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011810^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332011811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S71B31154^^^AIRA-TEST^MR||MontereyAIRA^CherryAIRA^Lien^^^^L|NevadaAIRA^JasminAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1192 Laaksbergen Pl^^Negaunee^MI^49866^USA^P||^PRN^PH^^^906^9709603|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontereyAIRA^NevadaAIRA^^^^^L|MTH^Mother^HL70063|1192 Laaksbergen Pl^^Negaunee^MI^49866^USA^P|^PRN^PH^^^906^9709603ORC|RE||BS71B31154.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS71B31154.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332011811^AFLURIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332031601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P96H31165^^^AIRA-TEST^MR||OwenAIRA^IdolaAIRA^Cadence^^^^L|WardleAIRA^EloueraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1542 Bingewaal Ave^^Macomb Township^MI^48044^USA^P||^PRN^PH^^^586^6049031|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwenAIRA^WardleAIRA^^^^^L|MTH^Mother^HL70063|1542 Bingewaal Ave^^Macomb Township^MI^48044^USA^P|^PRN^PH^^^586^6049031ORC|RE||BP96H31165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP96H31165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332031601^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332031602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F59E31173^^^AIRA-TEST^MR||MacombAIRA^RiannonAIRA^Elinor^^^^L|HuronAIRA^MeghanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1289 Ten Boer Pl^^Quincy^MI^49082^USA^P||^PRN^PH^^^517^3998535|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MacombAIRA^HuronAIRA^^^^^L|MTH^Mother^HL70063|1289 Ten Boer Pl^^Quincy^MI^49082^USA^P|^PRN^PH^^^517^3998535ORC|RE||BF59E31173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF59E31173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332031602^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332031701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X20K31181^^^AIRA-TEST^MR||DouglasAIRA^PhoebeAIRA^Ellema^^^^L|WinnebagoAIRA^BrankaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1446 Sergen op Zoom Ln^^Lake^MI^48632^USA^P||^PRN^PH^^^989^7053302|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DouglasAIRA^WinnebagoAIRA^^^^^L|MTH^Mother^HL70063|1446 Sergen op Zoom Ln^^Lake^MI^48632^USA^P|^PRN^PH^^^989^7053302ORC|RE||BX20K31181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX20K31181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332031701^Afluria Quadrivalent preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332031702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L52U31189^^^AIRA-TEST^MR||MorganAIRA^RaneeAIRA^Obelia^^^^L|LaRueAIRA^NovaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1820 Sulpen-Wittem Ln^^Georgetown Tp^MI^49428^USA^P||^PRN^PH^^^616^3314309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^LaRueAIRA^^^^^L|MTH^Mother^HL70063|1820 Sulpen-Wittem Ln^^Georgetown Tp^MI^49428^USA^P|^PRN^PH^^^616^3314309ORC|RE||BL52U31189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL52U31189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332031702^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332031801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J35R31194^^^AIRA-TEST^MR||BrazosAIRA^VaishaliAIRA^Nadie^^^^L|LeeAIRA^MaritaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1939 Lmmen Cir^^Waterford^MI^48328^USA^P||^PRN^PH^^^248^3916979|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrazosAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1939 Lmmen Cir^^Waterford^MI^48328^USA^P|^PRN^PH^^^248^3916979ORC|RE||BJ35R31194.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ35R31194.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332031801^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332031802|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N11J31205^^^AIRA-TEST^MR||CaldwellAIRA^EmeliaAIRA^Minelli^^^^L|ThurstonAIRA^LitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1680 Ttichtse Vecht Pl^^Macomb^MI^48044^USA^P||^PRN^PH^^^586^3690064|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaldwellAIRA^ThurstonAIRA^^^^^L|MTH^Mother^HL70063|1680 Ttichtse Vecht Pl^^Macomb^MI^48044^USA^P|^PRN^PH^^^586^3690064ORC|RE||BN11J31205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN11J31205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332031802^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332041610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F47L31213^^^AIRA-TEST^MR||LeeAIRA^Ha-NeulAIRA^Delphine^^^^L|PittsburgAIRA^WyanetAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1375 Vpsterland Ave^^Cedar Lake^MI^48812^USA^P||^PRN^PH^^^989^5022670|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^PittsburgAIRA^^^^^L|MTH^Mother^HL70063|1375 Vpsterland Ave^^Cedar Lake^MI^48812^USA^P|^PRN^PH^^^989^5022670ORC|RE||BF47L31213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF47L31213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332041610^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332041611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q09H31221^^^AIRA-TEST^MR||ClarkeAIRA^SudeviAIRA^Erwina^^^^L|SwisherAIRA^PrachiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1086 Acht Pl^^Farmingtn Hls^MI^48336^USA^P||^PRN^PH^^^248^6924035|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkeAIRA^SwisherAIRA^^^^^L|MTH^Mother^HL70063|1086 Acht Pl^^Farmingtn Hls^MI^48336^USA^P|^PRN^PH^^^248^6924035ORC|RE||BQ09H31221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ09H31221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332041611^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332041710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F32D31229^^^AIRA-TEST^MR||ClarionAIRA^EfterpiAIRA^Temina^^^^L|PowellAIRA^HeliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1329 Wenray Cir^^Flint^MI^48550^USA^P||^PRN^PH^^^810^8617846|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarionAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1329 Wenray Cir^^Flint^MI^48550^USA^P|^PRN^PH^^^810^8617846ORC|RE||BF32D31229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF32D31229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332041710^Afluria Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332041711|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G27J31234^^^AIRA-TEST^MR||BucklesAIRA^HollyAIRA^Sandya^^^^L|EliasonAIRA^LanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1060 Toordoostpolder St^^Howell^MI^48843^USA^P||^PRN^PH^^^517^7877842|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BucklesAIRA^EliasonAIRA^^^^^L|MTH^Mother^HL70063|1060 Toordoostpolder St^^Howell^MI^48843^USA^P|^PRN^PH^^^517^7877842ORC|RE||BG27J31234.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG27J31234.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332041711^Afluria quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332041810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B78W31245^^^AIRA-TEST^MR||HillsdaleAIRA^MorganAIRA^Leighton^^^^L|BooneAIRA^MorwennaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1422 Breda St^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^5208097|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillsdaleAIRA^BooneAIRA^^^^^L|MTH^Mother^HL70063|1422 Breda St^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^5208097ORC|RE||BB78W31245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB78W31245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332041810^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332041811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F70C31253^^^AIRA-TEST^MR||MenardAIRA^VevinaAIRA^Casta^^^^L|OsceolaAIRA^GhislaineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1356 Pruten Pl^^Byron^MI^48418^USA^P||^PRN^PH^^^810^4033107|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenardAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1356 Pruten Pl^^Byron^MI^48418^USA^P|^PRN^PH^^^810^4033107ORC|RE||BF70C31253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF70C31253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332041811^AFLURIA QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332051901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V37X31261^^^AIRA-TEST^MR||ChristensonAIRA^KathrynAIRA^Netta^^^^L|CherokeeAIRA^CapriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1470 Geimerswaal Ln^^Hart^MI^49420^USA^P||^PRN^PH^^^231^2985366|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChristensonAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1470 Geimerswaal Ln^^Hart^MI^49420^USA^P|^PRN^PH^^^231^2985366ORC|RE||BV37X31261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV37X31261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332051901^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332051925|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D50I31269^^^AIRA-TEST^MR||Nez PerceAIRA^CelieAIRA^Akanksha^^^^L|PainterAIRA^LivAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1905 Rij Ln^^Westwood^MI^49006^USA^P||^PRN^PH^^^269^9390846|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Nez PerceAIRA^PainterAIRA^^^^^L|MTH^Mother^HL70063|1905 Rij Ln^^Westwood^MI^49006^USA^P|^PRN^PH^^^269^9390846ORC|RE||BD50I31269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD50I31269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332051925^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-33332062910|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L52H31274^^^AIRA-TEST^MR||LincolnAIRA^KaliskaAIRA^Alessa^^^^L|Black HawkAIRA^AshleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1966 Oontferland Ln^^New Baltimore^MI^48047^USA^P||^PRN^PH^^^586^6380919|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LincolnAIRA^Black HawkAIRA^^^^^L|MTH^Mother^HL70063|1966 Oontferland Ln^^New Baltimore^MI^48047^USA^P|^PRN^PH^^^586^6380919ORC|RE||BL52H31274.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL52H31274.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||33332062910^Influenza A^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515-001-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J21Y31285^^^AIRA-TEST^MR||SalzeberAIRA^AphraAIRA^Taylor^^^^L|HowardAIRA^LorenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1247 Gezicht Ln^^Custer^MI^49405^USA^P||^PRN^PH^^^231^3629383|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SalzeberAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1247 Gezicht Ln^^Custer^MI^49405^USA^P|^PRN^PH^^^231^3629383ORC|RE||BJ21Y31285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ21Y31285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515-001-00^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515-001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15H31293^^^AIRA-TEST^MR||NelsonAIRA^AdonaAIRA^Phuong^^^^L|CorrinAIRA^AlonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1938 Rietjerksteradeel Pl^^Northwest^MI^48504^USA^P||^PRN^PH^^^810^7407856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NelsonAIRA^CorrinAIRA^^^^^L|MTH^Mother^HL70063|1938 Rietjerksteradeel Pl^^Northwest^MI^48504^USA^P|^PRN^PH^^^810^7407856ORC|RE||BT15H31293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15H31293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515-001-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G42F31301^^^AIRA-TEST^MR||MultnomahAIRA^AbigailAIRA^Afina^^^^L|ReynoldsAIRA^SonakshiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1395 Rlagtwedde Ave^^Dimondale^MI^48821^USA^P||^PRN^PH^^^517^6627309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MultnomahAIRA^ReynoldsAIRA^^^^^L|MTH^Mother^HL70063|1395 Rlagtwedde Ave^^Dimondale^MI^48821^USA^P|^PRN^PH^^^517^6627309ORC|RE||BG42F31301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG42F31301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515-002-01^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515000100|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G66E31309^^^AIRA-TEST^MR||AdamsAIRA^QuinnAIRA^Mackenzie^^^^L|San FranciscoAIRA^AndromacheAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1982 Oaag en Braassem Pl^^South Boardman^MI^49680^USA^P||^PRN^PH^^^231^8167769|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^San FranciscoAIRA^^^^^L|MTH^Mother^HL70063|1982 Oaag en Braassem Pl^^South Boardman^MI^49680^USA^P|^PRN^PH^^^231^8167769ORC|RE||BG66E31309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG66E31309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515000100^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515000101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y35T31314^^^AIRA-TEST^MR||OaklandAIRA^FernandaAIRA^Tracy^^^^L|AldridgeAIRA^CalixteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1565 Wageningen Cir^^Samaria^MI^48177^USA^P||^PRN^PH^^^734^7301171|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OaklandAIRA^AldridgeAIRA^^^^^L|MTH^Mother^HL70063|1565 Wageningen Cir^^Samaria^MI^48177^USA^P|^PRN^PH^^^734^7301171ORC|RE||BY35T31314.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY35T31314.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515000101^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42515000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A70H31325^^^AIRA-TEST^MR||RiversideAIRA^ChristalAIRA^Evelina^^^^L|La SalleAIRA^KieleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1118 Ouenen Pl^^Westland^MI^48186^USA^P||^PRN^PH^^^734^4011767|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RiversideAIRA^La SalleAIRA^^^^^L|MTH^Mother^HL70063|1118 Ouenen Pl^^Westland^MI^48186^USA^P|^PRN^PH^^^734^4011767ORC|RE||BA70H31325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA70H31325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42515000201^IXIARO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-012-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U77E31333^^^AIRA-TEST^MR||HighlandAIRA^KarlyAIRA^Joann^^^^L|McClungAIRA^RiddhiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1251 Bon en Breugel Cir^^Amway Corp^MI^49357^USA^P||^PRN^PH^^^616^9452585|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HighlandAIRA^McClungAIRA^^^^^L|MTH^Mother^HL70063|1251 Bon en Breugel Cir^^Amway Corp^MI^49357^USA^P|^PRN^PH^^^616^9452585ORC|RE||BU77E31333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU77E31333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-012-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z65U31341^^^AIRA-TEST^MR||OmssundAIRA^AlkinaAIRA^Myra^^^^L|MontgomeryAIRA^YemenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1981 Bchouwen-Duiveland St^^Covert^MI^49043^USA^P||^PRN^PH^^^269^8288351|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OmssundAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1981 Bchouwen-Duiveland St^^Covert^MI^49043^USA^P|^PRN^PH^^^269^8288351ORC|RE||BZ65U31341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ65U31341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-012-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-013-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T96U31349^^^AIRA-TEST^MR||PolkAIRA^SafakAIRA^Sade^^^^L|La PazAIRA^EdmeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1327 Rest Cir^^Tawas City^MI^48763^USA^P||^PRN^PH^^^989^5926739|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^La PazAIRA^^^^^L|MTH^Mother^HL70063|1327 Rest Cir^^Tawas City^MI^48763^USA^P|^PRN^PH^^^989^5926739ORC|RE||BT96U31349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT96U31349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-013-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D88N31354^^^AIRA-TEST^MR||BreathittAIRA^EtsuAIRA^Kalie^^^^L|MontgomeryAIRA^DeborahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1893 Wantumadiel Ln^^Canton^MI^48184^USA^P||^PRN^PH^^^734^6850707|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BreathittAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1893 Wantumadiel Ln^^Canton^MI^48184^USA^P|^PRN^PH^^^734^6850707ORC|RE||BD88N31354.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD88N31354.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-013-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-014-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N16Q31365^^^AIRA-TEST^MR||GuadalupeAIRA^NasrinAIRA^Crispina^^^^L|McPhersonAIRA^JoannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1895 Me Ronde Venen St^^Ada^MI^49355^USA^P||^PRN^PH^^^616^2791623|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuadalupeAIRA^McPhersonAIRA^^^^^L|MTH^Mother^HL70063|1895 Me Ronde Venen St^^Ada^MI^49355^USA^P|^PRN^PH^^^616^2791623ORC|RE||BN16Q31365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN16Q31365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-014-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-014-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W12W31373^^^AIRA-TEST^MR||PetersonAIRA^RhiannonAIRA^Cecia^^^^L|HancockAIRA^MikkiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1123 Dergelijke Ave^^Rockland^MI^49960^USA^P||^PRN^PH^^^906^6750871|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PetersonAIRA^HancockAIRA^^^^^L|MTH^Mother^HL70063|1123 Dergelijke Ave^^Rockland^MI^49960^USA^P|^PRN^PH^^^906^6750871ORC|RE||BW12W31373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW12W31373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-014-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-015-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I37R31381^^^AIRA-TEST^MR||CarrollAIRA^TopazAIRA^Ghera^^^^L|JeffersonAIRA^NinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1394 Onderdeel Cir^^Detroit^MI^48218^USA^P||^PRN^PH^^^313^5199405|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1394 Onderdeel Cir^^Detroit^MI^48218^USA^P|^PRN^PH^^^313^5199405ORC|RE||BI37R31381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI37R31381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-015-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-015-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M67D31389^^^AIRA-TEST^MR||WoodAIRA^VanoraAIRA^Briony^^^^L|ManisteeAIRA^AlissonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1063 Sapelle Ln^^Armada^MI^48005^USA^P||^PRN^PH^^^586^7989806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1063 Sapelle Ln^^Armada^MI^48005^USA^P|^PRN^PH^^^586^7989806ORC|RE||BM67D31389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM67D31389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-015-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-016-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S80V31394^^^AIRA-TEST^MR||AlexandersonAIRA^NoelleAIRA^Devore^^^^L|DuvalAIRA^KaritaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1156 Bcht-Susteren Pl^^Peshawbestown^MI^49682^USA^P||^PRN^PH^^^231^5735326|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlexandersonAIRA^DuvalAIRA^^^^^L|MTH^Mother^HL70063|1156 Bcht-Susteren Pl^^Peshawbestown^MI^49682^USA^P|^PRN^PH^^^231^5735326ORC|RE||BS80V31394.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS80V31394.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-016-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-016-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K38Q31402^^^AIRA-TEST^MR||O'BrienAIRA^RudelleAIRA^Falguni^^^^L|OldhamAIRA^NevadaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1232 Vorst aan de Maas Ln^^Ridgeway^MI^49229^USA^P||^PRN^PH^^^517^2547846|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'BrienAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1232 Vorst aan de Maas Ln^^Ridgeway^MI^49229^USA^P|^PRN^PH^^^517^2547846ORC|RE||BK38Q31402.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK38Q31402.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-016-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-017-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A93N31413^^^AIRA-TEST^MR||GeaugaAIRA^SkylerAIRA^Addi^^^^L|WhitleyAIRA^DamianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1241 Mcheemda Ave^^Lake Orion^MI^48360^USA^P||^PRN^PH^^^248^2281433|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeaugaAIRA^WhitleyAIRA^^^^^L|MTH^Mother^HL70063|1241 Mcheemda Ave^^Lake Orion^MI^48360^USA^P|^PRN^PH^^^248^2281433ORC|RE||BA93N31413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA93N31413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-017-01^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-017-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T79A31421^^^AIRA-TEST^MR||OwenAIRA^StefaniaAIRA^Zalika^^^^L|OceanaAIRA^BrigitAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1258 Hijkerk Cir^^Reed City^MI^49677^USA^P||^PRN^PH^^^231^3071279|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwenAIRA^OceanaAIRA^^^^^L|MTH^Mother^HL70063|1258 Hijkerk Cir^^Reed City^MI^49677^USA^P|^PRN^PH^^^231^3071279ORC|RE||BT79A31421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT79A31421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-017-10^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-116-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L06I31429^^^AIRA-TEST^MR||BendAIRA^ParisaAIRA^Raisa^^^^L|GarzaAIRA^AmesAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1275 Rundert Pl^^Mendon^MI^49072^USA^P||^PRN^PH^^^269^2501899|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BendAIRA^GarzaAIRA^^^^^L|MTH^Mother^HL70063|1275 Rundert Pl^^Mendon^MI^49072^USA^P|^PRN^PH^^^269^2501899ORC|RE||BL06I31429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL06I31429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-116-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-117-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G12S31437^^^AIRA-TEST^MR||CameronAIRA^EvaAIRA^Maiya^^^^L|MercerAIRA^JulietteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1387 Ocharsterland Pl^^Ann Arbor^MI^48108^USA^P||^PRN^PH^^^734^8682615|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CameronAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1387 Ocharsterland Pl^^Ann Arbor^MI^48108^USA^P|^PRN^PH^^^734^8682615ORC|RE||BG12S31437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG12S31437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-117-01^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874-117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J46I31442^^^AIRA-TEST^MR||HernandezAIRA^KebiraAIRA^Bryna^^^^L|MarinAIRA^DelbinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1393 Branendonck St^^Goodison^MI^48306^USA^P||^PRN^PH^^^248^8995003|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HernandezAIRA^MarinAIRA^^^^^L|MTH^Mother^HL70063|1393 Branendonck St^^Goodison^MI^48306^USA^P|^PRN^PH^^^248^8995003ORC|RE||BJ46I31442.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ46I31442.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874-117-10^FLUBLOK, QUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B57M31453^^^AIRA-TEST^MR||ClintonAIRA^CassiaAIRA^Charlie^^^^L|RiverAIRA^CataloniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1090 Aeere Ave^^East Grand Ra^MI^49506^USA^P||^PRN^PH^^^616^6378206|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^RiverAIRA^^^^^L|MTH^Mother^HL70063|1090 Aeere Ave^^East Grand Ra^MI^49506^USA^P|^PRN^PH^^^616^6378206ORC|RE||BB57M31453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB57M31453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001201^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C44S31461^^^AIRA-TEST^MR||CoconinoAIRA^IrelandAIRA^Zulema^^^^L|GreenAIRA^ErinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1611 Gebruiken Ln^^Leslie^MI^49251^USA^P||^PRN^PH^^^517^3518228|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoconinoAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1611 Gebruiken Ln^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^3518228ORC|RE||BC44S31461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC44S31461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001210^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H28K31469^^^AIRA-TEST^MR||ReevesAIRA^KadijaAIRA^Sheela^^^^L|LeeAIRA^AlaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1282 Oenkum Ln^^Fowlerville^MI^48836^USA^P||^PRN^PH^^^517^7827702|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReevesAIRA^LeeAIRA^^^^^L|MTH^Mother^HL70063|1282 Oenkum Ln^^Fowlerville^MI^48836^USA^P|^PRN^PH^^^517^7827702ORC|RE||BH28K31469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH28K31469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001301^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y35W31477^^^AIRA-TEST^MR||ButteAIRA^MoselleAIRA^Justine^^^^L|BenewahAIRA^ThanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1161 Oosten Ave^^Farmington Hills^MI^48336^USA^P||^PRN^PH^^^248^2994694|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButteAIRA^BenewahAIRA^^^^^L|MTH^Mother^HL70063|1161 Oosten Ave^^Farmington Hills^MI^48336^USA^P|^PRN^PH^^^248^2994694ORC|RE||BY35W31477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY35W31477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001310^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K38J31482^^^AIRA-TEST^MR||WrightAIRA^MadronaAIRA^Willa^^^^L|BrazoriaAIRA^CalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1499 Oidden-Drenthe St^^Lima Township^MI^48118^USA^P||^PRN^PH^^^734^6816155|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WrightAIRA^BrazoriaAIRA^^^^^L|MTH^Mother^HL70063|1499 Oidden-Drenthe St^^Lima Township^MI^48118^USA^P|^PRN^PH^^^734^6816155ORC|RE||BK38J31482.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK38J31482.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001401^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B73X31490^^^AIRA-TEST^MR||MerrickAIRA^DayleAIRA^Anna^^^^L|WarrenAIRA^HarleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1730 Pemert-Bakel Pl^^Bridgewater^MI^48115^USA^P||^PRN^PH^^^734^2478515|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MerrickAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1730 Pemert-Bakel Pl^^Bridgewater^MI^48115^USA^P|^PRN^PH^^^734^2478515ORC|RE||BB73X31490.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB73X31490.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001410^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H30Z31501^^^AIRA-TEST^MR||FranklinAIRA^ArmaniAIRA^Leoma^^^^L|ChristensenAIRA^QuintessaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1007 Wuth Pl^^Huntington Woods^MI^48070^USA^P||^PRN^PH^^^248^4194337|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^ChristensenAIRA^^^^^L|MTH^Mother^HL70063|1007 Wuth Pl^^Huntington Woods^MI^48070^USA^P|^PRN^PH^^^248^4194337ORC|RE||BH30Z31501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH30Z31501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001501^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z49B31509^^^AIRA-TEST^MR||ClayAIRA^BrielleAIRA^Ellamay^^^^L|AinslieAIRA^KristinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1651 Mronckhorst Ave^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^4398130|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClayAIRA^AinslieAIRA^^^^^L|MTH^Mother^HL70063|1651 Mronckhorst Ave^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^4398130ORC|RE||BZ49B31509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ49B31509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001510^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z71N31517^^^AIRA-TEST^MR||MarshAIRA^Ann-MargretAIRA^Umeko^^^^L|CheboyganAIRA^ChelsiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1620 Mteenwijkerland St^^Harbor Springs^MI^49740^USA^P||^PRN^PH^^^616^2661016|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarshAIRA^CheboyganAIRA^^^^^L|MTH^Mother^HL70063|1620 Mteenwijkerland St^^Harbor Springs^MI^49740^USA^P|^PRN^PH^^^616^2661016ORC|RE||BZ71N31517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ71N31517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001601^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H05V31522^^^AIRA-TEST^MR||BorthroydAIRA^EllemaAIRA^Katren^^^^L|AroostookAIRA^FleurAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1152 Oor Ave^^Pompeii^MI^48874^USA^P||^PRN^PH^^^989^8045507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BorthroydAIRA^AroostookAIRA^^^^^L|MTH^Mother^HL70063|1152 Oor Ave^^Pompeii^MI^48874^USA^P|^PRN^PH^^^989^8045507ORC|RE||BH05V31522.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH05V31522.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001610^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N90D31530^^^AIRA-TEST^MR||DixonAIRA^EmmylouAIRA^Hanne^^^^L|GarrardAIRA^KaelynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1410 Venterwolde St^^Little Lake^MI^49833^USA^P||^PRN^PH^^^906^4369734|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DixonAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1410 Venterwolde St^^Little Lake^MI^49833^USA^P|^PRN^PH^^^906^4369734ORC|RE||BN90D31530.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN90D31530.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001701^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874001710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D16C31538^^^AIRA-TEST^MR||LampasasAIRA^RangiAIRA^Borgny^^^^L|SuthernsAIRA^CadenceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1022 Kardenberg Ave^^Sharon^MI^48158^USA^P||^PRN^PH^^^734^5001590|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LampasasAIRA^SuthernsAIRA^^^^^L|MTH^Mother^HL70063|1022 Kardenberg Ave^^Sharon^MI^48158^USA^P|^PRN^PH^^^734^5001590ORC|RE||BD16C31538.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD16C31538.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874001710^Flublok^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874011601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C50I31549^^^AIRA-TEST^MR||Santa CruzAIRA^BedaAIRA^Noella^^^^L|HughesAIRA^KlavdiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1806 Binsum St^^Lyndon Township^MI^48118^USA^P||^PRN^PH^^^734^4619522|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa CruzAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1806 Binsum St^^Lyndon Township^MI^48118^USA^P|^PRN^PH^^^734^4619522ORC|RE||BC50I31549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC50I31549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874011601^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874011701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L49Q31557^^^AIRA-TEST^MR||FlemingAIRA^ChelsaAIRA^Goldie^^^^L|FinnAIRA^NaysaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1405 Deerenveen Pl^^Camp Grayling^MI^49739^USA^P||^PRN^PH^^^989^3863519|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FlemingAIRA^FinnAIRA^^^^^L|MTH^Mother^HL70063|1405 Deerenveen Pl^^Camp Grayling^MI^49739^USA^P|^PRN^PH^^^989^3863519ORC|RE||BL49Q31557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL49Q31557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874011701^Flublok, quadrIvalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-42874011710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W08Y31565^^^AIRA-TEST^MR||LokkenAIRA^SimoniAIRA^Kirsten^^^^L|AdamsAIRA^NerissaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1619 Kinterswijk St^^Reading^MI^49274^USA^P||^PRN^PH^^^517^7044579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LokkenAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1619 Kinterswijk St^^Reading^MI^49274^USA^P|^PRN^PH^^^517^7044579ORC|RE||BW08Y31565.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW08Y31565.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||42874011710^FLUBLOK, QUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G64V31570^^^AIRA-TEST^MR||AdsgaardAIRA^SariahAIRA^Alima^^^^L|ClayAIRA^WilonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1493 He Wolden Ln^^GR^MI^49505^USA^P||^PRN^PH^^^616^5990807|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdsgaardAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1493 He Wolden Ln^^GR^MI^49505^USA^P|^PRN^PH^^^616^5990807ORC|RE||BG64V31570.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG64V31570.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-002-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-002-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W05Q31581^^^AIRA-TEST^MR||MorganAIRA^RicardaAIRA^Kanya^^^^L|ValleyAIRA^HelenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1008 Kiel Pl^^Augusta Township^MI^48160^USA^P||^PRN^PH^^^734^9379504|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1008 Kiel Pl^^Augusta Township^MI^48160^USA^P|^PRN^PH^^^734^9379504ORC|RE||BW05Q31581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW05Q31581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-002-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-003-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U93L31589^^^AIRA-TEST^MR||LundgrenAIRA^GiliAIRA^Syria^^^^L|CarrollAIRA^PetronelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1952 Dchijndel Ln^^Duncan^MI^48131^USA^P||^PRN^PH^^^734^2725249|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LundgrenAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1952 Dchijndel Ln^^Duncan^MI^48131^USA^P|^PRN^PH^^^734^2725249ORC|RE||BU93L31589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU93L31589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-003-01^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528-003-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25H31597^^^AIRA-TEST^MR||LubbockAIRA^OrdeliaAIRA^Ava^^^^L|HallAIRA^ArielAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1713 Zpe St^^Hubbell^MI^49934^USA^P||^PRN^PH^^^906^7681816|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LubbockAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1713 Zpe St^^Hubbell^MI^49934^USA^P|^PRN^PH^^^906^7681816ORC|RE||BZ25H31597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25H31597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528-003-05^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T42X31605^^^AIRA-TEST^MR||FayetteAIRA^ElodiaAIRA^Agate^^^^L|HoltAIRA^AudoraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1738 Huenen Pl^^Sharon Hollow^MI^48158^USA^P||^PRN^PH^^^734^5032904|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FayetteAIRA^HoltAIRA^^^^^L|MTH^Mother^HL70063|1738 Huenen Pl^^Sharon Hollow^MI^48158^USA^P|^PRN^PH^^^734^5032904ORC|RE||BT42X31605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT42X31605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528000201^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528000205|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O01I31613^^^AIRA-TEST^MR||SpokaneAIRA^RubyAIRA^Sabiha^^^^L|HaagenAIRA^MinetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1519 Rde Ave^^Ann Arbor^MI^48109^USA^P||^PRN^PH^^^734^7058572|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SpokaneAIRA^HaagenAIRA^^^^^L|MTH^Mother^HL70063|1519 Rde Ave^^Ann Arbor^MI^48109^USA^P|^PRN^PH^^^734^7058572ORC|RE||BO01I31613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO01I31613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528000205^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528000301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L26M31621^^^AIRA-TEST^MR||SewardAIRA^ClaraAIRA^Breda^^^^L|RobertsAIRA^MillyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1185 Meudal St^^Davison^MI^48423^USA^P||^PRN^PH^^^810^5995042|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SewardAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1185 Meudal St^^Davison^MI^48423^USA^P|^PRN^PH^^^810^5995042ORC|RE||BL26M31621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL26M31621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528000301^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-43528000305|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15F31626^^^AIRA-TEST^MR||GrantAIRA^LysanderAIRA^Dania^^^^L|LeonAIRA^CoraliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1885 Sedemblik Ave^^Ravenna^MI^49451^USA^P||^PRN^PH^^^231^4288966|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^LeonAIRA^^^^^L|MTH^Mother^HL70063|1885 Sedemblik Ave^^Ravenna^MI^49451^USA^P|^PRN^PH^^^231^4288966ORC|RE||BT15F31626.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15F31626.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||43528000305^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-114-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z18U31637^^^AIRA-TEST^MR||PocahontasAIRA^NordicaAIRA^Skylar^^^^L|MerrickAIRA^MahalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1469 Cladel Ave^^Loretto^MI^49852^USA^P||^PRN^PH^^^906^3083254|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PocahontasAIRA^MerrickAIRA^^^^^L|MTH^Mother^HL70063|1469 Cladel Ave^^Loretto^MI^49852^USA^P|^PRN^PH^^^906^3083254ORC|RE||BZ18U31637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ18U31637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028-114-01^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J08M31645^^^AIRA-TEST^MR||KnowlesAIRA^SaidahAIRA^Talya^^^^L|DeuelAIRA^WylieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1692 Stof Cir^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^3642789|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnowlesAIRA^DeuelAIRA^^^^^L|MTH^Mother^HL70063|1692 Stof Cir^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^3642789ORC|RE||BJ08M31645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ08M31645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028-114-02^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-114-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y72H31653^^^AIRA-TEST^MR||RockcastleAIRA^AbileneAIRA^Ariana^^^^L|WallerAIRA^KaylenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1195 Berkelland Ave^^Mount Pleasant^MI^48858^USA^P||^PRN^PH^^^989^6007566|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RockcastleAIRA^WallerAIRA^^^^^L|MTH^Mother^HL70063|1195 Berkelland Ave^^Mount Pleasant^MI^48858^USA^P|^PRN^PH^^^989^6007566ORC|RE||BY72H31653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY72H31653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028-114-11^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-208-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G89E31661^^^AIRA-TEST^MR||AdairAIRA^LeilahAIRA^Saida^^^^L|PhelpsAIRA^GianinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1196 Quotient Cir^^Alanson^MI^49706^USA^P||^PRN^PH^^^616^9427015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1196 Quotient Cir^^Alanson^MI^49706^USA^P|^PRN^PH^^^616^9427015ORC|RE||BG89E31661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG89E31661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028-208-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-218-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X87S31666^^^AIRA-TEST^MR||KananenAIRA^ChruseAIRA^Julianna^^^^L|LamarAIRA^BellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1920 Vutten Cir^^Macomb Township^MI^48044^USA^P||^PRN^PH^^^586^8423170|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KananenAIRA^LamarAIRA^^^^^L|MTH^Mother^HL70063|1920 Vutten Cir^^Macomb Township^MI^48044^USA^P|^PRN^PH^^^586^8423170ORC|RE||BX87S31666.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX87S31666.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028-218-11^Meningococcal (Groups A) CRM197 Oligosaccharide Co^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028-219-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I04Q31677^^^AIRA-TEST^MR||CassAIRA^CelestynAIRA^Carol^^^^L|StephensAIRA^PansyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1665 Leerenveen Cir^^L' Anse^MI^49946^USA^P||^PRN^PH^^^906^6346457|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1665 Leerenveen Cir^^L' Anse^MI^49946^USA^P|^PRN^PH^^^906^6346457ORC|RE||BI04Q31677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI04Q31677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028-219-11^Meningococcal (Groups C, Y, W-135) CRM197 Oligosac^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028011401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q48Q31685^^^AIRA-TEST^MR||ColumbiaAIRA^ShivaniAIRA^Mersadize^^^^L|TaylorAIRA^CadeeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1375 Hudwest Fryslan Pl^^Raisinvl Township^MI^48161^USA^P||^PRN^PH^^^734^8536604|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColumbiaAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1375 Hudwest Fryslan Pl^^Raisinvl Township^MI^48161^USA^P|^PRN^PH^^^734^8536604ORC|RE||BQ48Q31685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ48Q31685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028011401^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028011402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V49R31693^^^AIRA-TEST^MR||RinggoldAIRA^HeliAIRA^Philadelphia^^^^L|LakeAIRA^CharlieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1313 Heldere Ave^^Farmingtn Hls^MI^48334^USA^P||^PRN^PH^^^248^2268775|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RinggoldAIRA^LakeAIRA^^^^^L|MTH^Mother^HL70063|1313 Heldere Ave^^Farmingtn Hls^MI^48334^USA^P|^PRN^PH^^^248^2268775ORC|RE||BV49R31693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV49R31693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028011402^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028011411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U85K31701^^^AIRA-TEST^MR||NemahaAIRA^AdoraAIRA^Ettie^^^^L|MadisonAIRA^Mary-JaneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1114 Onze Ln^^Saugatuck^MI^49453^USA^P||^PRN^PH^^^269^7952259|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NemahaAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1114 Onze Ln^^Saugatuck^MI^49453^USA^P|^PRN^PH^^^269^7952259ORC|RE||BU85K31701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU85K31701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028011411^Bexsero^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028020801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H02M31706^^^AIRA-TEST^MR||San MateoAIRA^NorahAIRA^Arilda^^^^L|MagoffinAIRA^GalinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1125 Bittard-Geleen St^^Canadian Lake^MI^49346^USA^P||^PRN^PH^^^231^2725398|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San MateoAIRA^MagoffinAIRA^^^^^L|MTH^Mother^HL70063|1125 Bittard-Geleen St^^Canadian Lake^MI^49346^USA^P|^PRN^PH^^^231^2725398ORC|RE||BH02M31706.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH02M31706.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028020801^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028021811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R38K31717^^^AIRA-TEST^MR||TulareAIRA^MadisynAIRA^Betrys^^^^L|ThomasAIRA^MeckenzieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1788 Dolenwaard Pl^^Detroit^MI^48202^USA^P||^PRN^PH^^^313^9561877|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TulareAIRA^ThomasAIRA^^^^^L|MTH^Mother^HL70063|1788 Dolenwaard Pl^^Detroit^MI^48202^USA^P|^PRN^PH^^^313^9561877ORC|RE||BR38K31717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR38K31717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028021811^Meningococcal (Groups A) CRM197 Oligosaccharide Co^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-46028021911|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A01A31725^^^AIRA-TEST^MR||Buena VistaAIRA^LaverneAIRA^Anusree^^^^L|LawrenceAIRA^RobinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1426 Kolonie St^^Glendora^MI^49107^USA^P||^PRN^PH^^^269^2865811|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Buena VistaAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1426 Kolonie St^^Glendora^MI^49107^USA^P|^PRN^PH^^^269^2865811ORC|RE||BA01A31725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA01A31725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||46028021911^Meningococcal (Groups C, Y, W-135) CRM197 Oligosac^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-010-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E00G31733^^^AIRA-TEST^MR||VictoriaAIRA^AdimaAIRA^Nasrin^^^^L|ErikssonAIRA^PangariAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1799 Kok Cir^^National Mine^MI^49865^USA^P||^PRN^PH^^^906^5907147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VictoriaAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1799 Kok Cir^^National Mine^MI^49865^USA^P|^PRN^PH^^^906^5907147ORC|RE||BE00G31733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE00G31733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-010-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-010-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X51R31741^^^AIRA-TEST^MR||SpoonerAIRA^DelcineAIRA^Mackenzie^^^^L|DeschutesAIRA^LindyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1516 Partij Ln^^Deerton^MI^49822^USA^P||^PRN^PH^^^906^9206463|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SpoonerAIRA^DeschutesAIRA^^^^^L|MTH^Mother^HL70063|1516 Partij Ln^^Deerton^MI^49822^USA^P|^PRN^PH^^^906^9206463ORC|RE||BX51R31741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX51R31741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-010-25^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-010-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y94E31746^^^AIRA-TEST^MR||SkagAIRA^ZerlindaAIRA^Melvina^^^^L|SaginawAIRA^NonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1723 Rsten Cir^^Powers^MI^49874^USA^P||^PRN^PH^^^906^2858550|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkagAIRA^SaginawAIRA^^^^^L|MTH^Mother^HL70063|1723 Rsten Cir^^Powers^MI^49874^USA^P|^PRN^PH^^^906^2858550ORC|RE||BY94E31746.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY94E31746.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-010-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-011-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z72M31756^^^AIRA-TEST^MR||WarrenAIRA^SarahiAIRA^Samta^^^^L|MahoningAIRA^TimotheaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1546 Heeze-Leende Cir^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^4869579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WarrenAIRA^MahoningAIRA^^^^^L|MTH^Mother^HL70063|1546 Heeze-Leende Cir^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^4869579ORC|RE||BZ72M31756.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ72M31756.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-011-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-011-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N20P31765^^^AIRA-TEST^MR||PenistonAIRA^DulcieAIRA^Meryl^^^^L|NewaygoAIRA^BettieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1483 Begin Ln^^Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^3313600|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PenistonAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1483 Begin Ln^^Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^3313600ORC|RE||BN20P31765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN20P31765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-011-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-012-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U03B31773^^^AIRA-TEST^MR||NapaAIRA^AzulAIRA^Zagir^^^^L|HarrisonAIRA^CressidaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1914 Hissewaard Cir^^Berrien Sprgs^MI^49103^USA^P||^PRN^PH^^^269^7262356|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NapaAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1914 Hissewaard Cir^^Berrien Sprgs^MI^49103^USA^P|^PRN^PH^^^269^7262356ORC|RE||BU03B31773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU03B31773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-012-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-012-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S92N31781^^^AIRA-TEST^MR||GilliamAIRA^JocosaAIRA^Mychau^^^^L|McCleanAIRA^KakraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1745 Roekel Cir^^Pontiac^MI^48340^USA^P||^PRN^PH^^^248^5588439|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GilliamAIRA^McCleanAIRA^^^^^L|MTH^Mother^HL70063|1745 Roekel Cir^^Pontiac^MI^48340^USA^P|^PRN^PH^^^248^5588439ORC|RE||BS92N31781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS92N31781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-012-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-013-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O80S31786^^^AIRA-TEST^MR||WatersAIRA^AliciaAIRA^Cadence^^^^L|BedfordAIRA^EricaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1481 Beendam Ave^^West Bloomfield^MI^48323^USA^P||^PRN^PH^^^248^3656709|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WatersAIRA^BedfordAIRA^^^^^L|MTH^Mother^HL70063|1481 Beendam Ave^^West Bloomfield^MI^48323^USA^P|^PRN^PH^^^248^3656709ORC|RE||BO80S31786.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO80S31786.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-013-10^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-013-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P34V31797^^^AIRA-TEST^MR||JacksonAIRA^NonaAIRA^Aurelia^^^^L|Santa ClaraAIRA^LanaiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1495 Zedum Ln^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^3802871|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^Santa ClaraAIRA^^^^^L|MTH^Mother^HL70063|1495 Zedum Ln^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^3802871ORC|RE||BP34V31797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP34V31797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-013-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-013-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V30J31805^^^AIRA-TEST^MR||CusterAIRA^MarlissAIRA^Leda^^^^L|HooperAIRA^AdeleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1140 Baag en Braassem St^^Ottawa Lake^MI^49267^USA^P||^PRN^PH^^^734^2389444|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusterAIRA^HooperAIRA^^^^^L|MTH^Mother^HL70063|1140 Baag en Braassem St^^Ottawa Lake^MI^49267^USA^P|^PRN^PH^^^734^2389444ORC|RE||BV30J31805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV30J31805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-013-58^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-013-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I43F31813^^^AIRA-TEST^MR||MontcalmAIRA^ClementineAIRA^Jocelynn^^^^L|LoweAIRA^NancyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1046 Eeldermalsen St^^Grand Rapids^MI^49599^USA^P||^PRN^PH^^^616^7352097|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontcalmAIRA^LoweAIRA^^^^^L|MTH^Mother^HL70063|1046 Eeldermalsen St^^Grand Rapids^MI^49599^USA^P|^PRN^PH^^^616^7352097ORC|RE||BI43F31813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI43F31813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-013-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-014-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F37F31821^^^AIRA-TEST^MR||CaribouAIRA^EmanuelaAIRA^Cayla^^^^L|RaumaAIRA^RatiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1471 Vampen Pl^^Leslie^MI^49251^USA^P||^PRN^PH^^^517^2819280|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaribouAIRA^RaumaAIRA^^^^^L|MTH^Mother^HL70063|1471 Vampen Pl^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^2819280ORC|RE||BF37F31821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF37F31821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-014-50^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-014-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L46N31826^^^AIRA-TEST^MR||SusasAIRA^TeklaAIRA^Evadine^^^^L|PocahontasAIRA^RiddhiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1132 Kith Cir^^Benzonia^MI^49616^USA^P||^PRN^PH^^^231^9555644|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SusasAIRA^PocahontasAIRA^^^^^L|MTH^Mother^HL70063|1132 Kith Cir^^Benzonia^MI^49616^USA^P|^PRN^PH^^^231^9555644ORC|RE||BL46N31826.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL46N31826.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-014-88^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-111-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q01C31837^^^AIRA-TEST^MR||WilliamsAIRA^AnikaAIRA^Janthina^^^^L|Walla WallaAIRA^AdalgisaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1809 Koggenland Cir^^Reese^MI^48757^USA^P||^PRN^PH^^^989^6607851|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsAIRA^Walla WallaAIRA^^^^^L|MTH^Mother^HL70063|1809 Koggenland Cir^^Reese^MI^48757^USA^P|^PRN^PH^^^989^6607851ORC|RE||BQ01C31837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ01C31837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-111-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-112-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K80L31845^^^AIRA-TEST^MR||UnionAIRA^VerenaAIRA^Quiterie^^^^L|UnionAIRA^MetisAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1826 Tegengesteld St^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^4891192|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1826 Tegengesteld St^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^4891192ORC|RE||BK80L31845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK80L31845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-112-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-113-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y19X31853^^^AIRA-TEST^MR||FremmingAIRA^LissaAIRA^Sibley^^^^L|ClintonAIRA^SayokoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1847 Feventer St^^Harrison Township^MI^48045^USA^P||^PRN^PH^^^586^5897426|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremmingAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1847 Feventer St^^Harrison Township^MI^48045^USA^P|^PRN^PH^^^586^5897426ORC|RE||BY19X31853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY19X31853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-113-00^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-113-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J42V31861^^^AIRA-TEST^MR||BurkeAIRA^LucettaAIRA^Kajal^^^^L|BullittAIRA^YoginiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1103 Zorger-Odoorn Cir^^Lenox^MI^48050^USA^P||^PRN^PH^^^586^2171338|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^BullittAIRA^^^^^L|MTH^Mother^HL70063|1103 Zorger-Odoorn Cir^^Lenox^MI^48050^USA^P|^PRN^PH^^^586^2171338ORC|RE||BJ42V31861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ42V31861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-113-25^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-215-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B70F31866^^^AIRA-TEST^MR||San DiegoAIRA^SeraphinaAIRA^Solange^^^^L|LewisAIRA^GloraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1125 Wetenschap St^^Flint^MI^48501^USA^P||^PRN^PH^^^810^2881307|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San DiegoAIRA^LewisAIRA^^^^^L|MTH^Mother^HL70063|1125 Wetenschap St^^Flint^MI^48501^USA^P|^PRN^PH^^^810^2881307ORC|RE||BB70F31866.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB70F31866.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-215-10^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-215-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D97V31877^^^AIRA-TEST^MR||WhitleyAIRA^MaritaAIRA^Paige^^^^L|JulinAIRA^BiddyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1426 Noevorden Cir^^Highland^MI^48356^USA^P||^PRN^PH^^^248^6630015|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitleyAIRA^JulinAIRA^^^^^L|MTH^Mother^HL70063|1426 Noevorden Cir^^Highland^MI^48356^USA^P|^PRN^PH^^^248^6630015ORC|RE||BD97V31877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD97V31877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-215-15^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-215-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U85C31885^^^AIRA-TEST^MR||KernAIRA^AnAIRA^Neeharika^^^^L|CroweAIRA^MatangiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1532 Delfzijl Ave^^Marysville^MI^48040^USA^P||^PRN^PH^^^810^6197552|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KernAIRA^CroweAIRA^^^^^L|MTH^Mother^HL70063|1532 Delfzijl Ave^^Marysville^MI^48040^USA^P|^PRN^PH^^^810^6197552ORC|RE||BU85C31885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU85C31885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-215-58^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-215-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A37C31893^^^AIRA-TEST^MR||JonesAIRA^TapiAIRA^Hannah^^^^L|KingAIRA^MareldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1817 Deerhugowaard St^^Eastpointe^MI^48021^USA^P||^PRN^PH^^^586^4532336|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JonesAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1817 Deerhugowaard St^^Eastpointe^MI^48021^USA^P|^PRN^PH^^^586^4532336ORC|RE||BA37C31893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA37C31893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-215-88^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-225-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z03H31901^^^AIRA-TEST^MR||HarrisAIRA^NadiaAIRA^Leoda^^^^L|ClarkAIRA^ElkeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1545 Klaar Pl^^Gwinn^MI^49841^USA^P||^PRN^PH^^^906^8614901|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1545 Klaar Pl^^Gwinn^MI^49841^USA^P|^PRN^PH^^^906^8614901ORC|RE||BZ03H31901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ03H31901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-225-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-225-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K26I31906^^^AIRA-TEST^MR||SeminoleAIRA^SyeiraAIRA^Tara^^^^L|GustafsonAIRA^PalomaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1666 Zoeree-Overflakkee Pl^^Grand Rapids^MI^49548^USA^P||^PRN^PH^^^616^9724936|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SeminoleAIRA^GustafsonAIRA^^^^^L|MTH^Mother^HL70063|1666 Zoeree-Overflakkee Pl^^Grand Rapids^MI^49548^USA^P|^PRN^PH^^^616^9724936ORC|RE||BK26I31906.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK26I31906.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-225-58^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-248-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A17G31917^^^AIRA-TEST^MR||FoxAIRA^WasimaAIRA^Lynette^^^^L|CalhounAIRA^GanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1945 Eardenberg Ave^^Hancock^MI^49930^USA^P||^PRN^PH^^^906^9237609|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FoxAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1945 Eardenberg Ave^^Hancock^MI^49930^USA^P|^PRN^PH^^^906^9237609ORC|RE||BA17G31917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA17G31917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-248-58^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-250-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J88A31925^^^AIRA-TEST^MR||SpieccAIRA^AzariaAIRA^Heidy^^^^L|HutchinsonAIRA^CharlotAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1804 Olissingen Cir^^De Tour Vlle^MI^49725^USA^P||^PRN^PH^^^906^9414989|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SpieccAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1804 Olissingen Cir^^De Tour Vlle^MI^49725^USA^P|^PRN^PH^^^906^9414989ORC|RE||BJ88A31925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ88A31925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-250-51^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-278-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L20V31933^^^AIRA-TEST^MR||ClarkAIRA^YeseniaAIRA^Persis^^^^L|HowardAIRA^SelenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1304 Ouder St^^Comstock Park^MI^49321^USA^P||^PRN^PH^^^616^9125481|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1304 Ouder St^^Comstock Park^MI^49321^USA^P|^PRN^PH^^^616^9125481ORC|RE||BL20V31933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL20V31933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-278-10^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-286-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H37S31941^^^AIRA-TEST^MR||McIntoshAIRA^AbigailAIRA^Savitri^^^^L|OsceolaAIRA^MarleneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1621 Ten Boer Pl^^Gagetown^MI^48735^USA^P||^PRN^PH^^^989^5997976|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McIntoshAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1621 Ten Boer Pl^^Gagetown^MI^48735^USA^P|^PRN^PH^^^989^5997976ORC|RE||BH37S31941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH37S31941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-286-01^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-286-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O59Y31946^^^AIRA-TEST^MR||JeffersonAIRA^GwynAIRA^Flanna^^^^L|TerrellAIRA^TakakoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1816 Gittard-Geleen St^^Cadmus^MI^49221^USA^P||^PRN^PH^^^517^8325733|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^TerrellAIRA^^^^^L|MTH^Mother^HL70063|1816 Gittard-Geleen St^^Cadmus^MI^49221^USA^P|^PRN^PH^^^517^8325733ORC|RE||BO59Y31946.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO59Y31946.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-286-05^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-286-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R51R31957^^^AIRA-TEST^MR||JepsenAIRA^TomikoAIRA^Bhayana^^^^L|ImperialAIRA^LeilahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1607 Foogezand-Sappemeer Ave^^Muskegon^MI^49441^USA^P||^PRN^PH^^^231^4748884|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JepsenAIRA^ImperialAIRA^^^^^L|MTH^Mother^HL70063|1607 Foogezand-Sappemeer Ave^^Muskegon^MI^49441^USA^P|^PRN^PH^^^231^4748884ORC|RE||BR51R31957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR51R31957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-286-10^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-286-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y90D31965^^^AIRA-TEST^MR||FranklinAIRA^IdehAIRA^Fredrica^^^^L|AppanooseAIRA^EmanuelaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1262 Nldebroek St^^York Township^MI^48160^USA^P||^PRN^PH^^^734^9684971|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^AppanooseAIRA^^^^^L|MTH^Mother^HL70063|1262 Nldebroek St^^York Township^MI^48160^USA^P|^PRN^PH^^^734^9684971ORC|RE||BY90D31965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY90D31965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-286-58^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-291-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V51N31973^^^AIRA-TEST^MR||WilliamsAIRA^MaddieAIRA^Pippa^^^^L|WallinAIRA^NyxAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1809 Sorendijk Pl^^Clarkston^MI^48348^USA^P||^PRN^PH^^^248^3069072|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsAIRA^WallinAIRA^^^^^L|MTH^Mother^HL70063|1809 Sorendijk Pl^^Clarkston^MI^48348^USA^P|^PRN^PH^^^248^3069072ORC|RE||BV51N31973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV51N31973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-291-10^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-291-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I17D31981^^^AIRA-TEST^MR||IsdalAIRA^ApollineAIRA^Calista^^^^L|KalamazooAIRA^AlalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1445 Souten Ln^^Cornell^MI^49818^USA^P||^PRN^PH^^^906^8920274|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IsdalAIRA^KalamazooAIRA^^^^^L|MTH^Mother^HL70063|1445 Souten Ln^^Cornell^MI^49818^USA^P|^PRN^PH^^^906^8920274ORC|RE||BI17D31981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI17D31981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-291-83^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-298-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E62I31986^^^AIRA-TEST^MR||BerrienAIRA^KaiaAIRA^Kimberly^^^^L|FloydAIRA^MagenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1581 Sanderd Cir^^Hardwood^MI^49807^USA^P||^PRN^PH^^^906^4829277|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BerrienAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1581 Sanderd Cir^^Hardwood^MI^49807^USA^P|^PRN^PH^^^906^4829277ORC|RE||BE62I31986.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE62I31986.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-298-10^TRIPEDIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-386-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H17Q31997^^^AIRA-TEST^MR||StantonAIRA^AlariceAIRA^Karen^^^^L|SpoonerAIRA^JaquelineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1718 Aiddelburg Ln^^Detroit^MI^48269^USA^P||^PRN^PH^^^313^2279881|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StantonAIRA^SpoonerAIRA^^^^^L|MTH^Mother^HL70063|1718 Aiddelburg Ln^^Detroit^MI^48269^USA^P|^PRN^PH^^^313^2279881ORC|RE||BH17Q31997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH17Q31997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-386-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-387-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K10F32005^^^AIRA-TEST^MR||WayneAIRA^AinaAIRA^Kit^^^^L|BrowneAIRA^MallanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1592 Meusel-De Mierden Ave^^McBrides^MI^48852^USA^P||^PRN^PH^^^989^7623949|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^BrowneAIRA^^^^^L|MTH^Mother^HL70063|1592 Meusel-De Mierden Ave^^McBrides^MI^48852^USA^P|^PRN^PH^^^989^7623949ORC|RE||BK10F32005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK10F32005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-387-65^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-388-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G06Y32013^^^AIRA-TEST^MR||LovingAIRA^ReneeAIRA^Laquetta^^^^L|WagonerAIRA^SirishaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1579 Kerschelling Cir^^Berkley^MI^48072^USA^P||^PRN^PH^^^248^9713990|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LovingAIRA^WagonerAIRA^^^^^L|MTH^Mother^HL70063|1579 Kerschelling Cir^^Berkley^MI^48072^USA^P|^PRN^PH^^^248^9713990ORC|RE||BG06Y32013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG06Y32013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-388-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-389-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S91I32021^^^AIRA-TEST^MR||ClintonAIRA^AnabelleAIRA^Arlette^^^^L|PerryAIRA^BriannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1479 Reertruidenberg Pl^^Albion^MI^49224^USA^P||^PRN^PH^^^517^9084014|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1479 Reertruidenberg Pl^^Albion^MI^49224^USA^P|^PRN^PH^^^517^9084014ORC|RE||BS91I32021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS91I32021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-389-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-390-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V50I32026^^^AIRA-TEST^MR||NapaAIRA^UjjwalaAIRA^Alvira^^^^L|StarkAIRA^ManonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1117 Oeek St^^Mattawan^MI^49071^USA^P||^PRN^PH^^^269^7392463|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NapaAIRA^StarkAIRA^^^^^L|MTH^Mother^HL70063|1117 Oeek St^^Mattawan^MI^49071^USA^P|^PRN^PH^^^269^7392463ORC|RE||BV50I32026.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV50I32026.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-390-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-391-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C13Q32037^^^AIRA-TEST^MR||ParkAIRA^HestiaAIRA^Aideen^^^^L|Cerro GordoAIRA^BetsyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1108 Buijk Ln^^Rollin^MI^49247^USA^P||^PRN^PH^^^517^4951104|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParkAIRA^Cerro GordoAIRA^^^^^L|MTH^Mother^HL70063|1108 Buijk Ln^^Rollin^MI^49247^USA^P|^PRN^PH^^^517^4951104ORC|RE||BC13Q32037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC13Q32037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-391-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-392-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K63Q32045^^^AIRA-TEST^MR||Roger MillsAIRA^ViennaAIRA^Vilhelmina^^^^L|JasperAIRA^BriallenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1706 Lijssen Ln^^Grandville^MI^49418^USA^P||^PRN^PH^^^616^6927918|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Roger MillsAIRA^JasperAIRA^^^^^L|MTH^Mother^HL70063|1706 Lijssen Ln^^Grandville^MI^49418^USA^P|^PRN^PH^^^616^6927918ORC|RE||BK63Q32045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK63Q32045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-392-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-392-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K67I32053^^^AIRA-TEST^MR||JohnsonAIRA^MirembaAIRA^Adishree^^^^L|JacksonAIRA^EuphemiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1790 Salkenswaard Ln^^Gregory^MI^48137^USA^P||^PRN^PH^^^734^6602496|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1790 Salkenswaard Ln^^Gregory^MI^48137^USA^P|^PRN^PH^^^734^6602496ORC|RE||BK67I32053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK67I32053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-392-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-393-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J24R32061^^^AIRA-TEST^MR||KentAIRA^ParvatiAIRA^Fuensanta^^^^L|LarssenAIRA^EmmettAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1813 Wulpen-Wittem Cir^^Saint Helen^MI^48656^USA^P||^PRN^PH^^^989^6812579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentAIRA^LarssenAIRA^^^^^L|MTH^Mother^HL70063|1813 Wulpen-Wittem Cir^^Saint Helen^MI^48656^USA^P|^PRN^PH^^^989^6812579ORC|RE||BJ24R32061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ24R32061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-393-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-393-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H22N32066^^^AIRA-TEST^MR||HardinAIRA^AlbertaAIRA^Falguni^^^^L|LynchAIRA^AtifaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1824 Succes Ave^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^7077994|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HardinAIRA^LynchAIRA^^^^^L|MTH^Mother^HL70063|1824 Succes Ave^^Belleville^MI^48112^USA^P|^PRN^PH^^^734^7077994ORC|RE||BH22N32066.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH22N32066.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-393-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-394-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X82T32077^^^AIRA-TEST^MR||SullivanAIRA^MangenaAIRA^Elissa^^^^L|FurnasAIRA^FaricaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1578 Valsmeer St^^Gerber Products Inc^MI^49413^USA^P||^PRN^PH^^^231^4303982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SullivanAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1578 Valsmeer St^^Gerber Products Inc^MI^49413^USA^P|^PRN^PH^^^231^4303982ORC|RE||BX82T32077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX82T32077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-394-15^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-394-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M80W32085^^^AIRA-TEST^MR||Box ButteAIRA^CarnelianAIRA^Zhalore^^^^L|IdahoAIRA^DebraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1506 Pond Ln^^Johannesburg^MI^49751^USA^P||^PRN^PH^^^989^2020069|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Box ButteAIRA^IdahoAIRA^^^^^L|MTH^Mother^HL70063|1506 Pond Ln^^Johannesburg^MI^49751^USA^P|^PRN^PH^^^989^2020069ORC|RE||BM80W32085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM80W32085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-394-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-395-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L66S32093^^^AIRA-TEST^MR||MurrayAIRA^KenyaAIRA^Shoshanah^^^^L|McKinnonAIRA^HirokoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1477 Ve Fryske Marren St^^Freedom Township^MI^48118^USA^P||^PRN^PH^^^734^2751394|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurrayAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1477 Ve Fryske Marren St^^Freedom Township^MI^48118^USA^P|^PRN^PH^^^734^2751394ORC|RE||BL66S32093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL66S32093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-395-65^FLUZONE HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-395-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K56B32101^^^AIRA-TEST^MR||WilliamsonAIRA^BrunellaAIRA^Alyssa^^^^L|CameronAIRA^MabelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1799 Doordenveld Ave^^Stevensville^MI^49127^USA^P||^PRN^PH^^^269^5832513|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsonAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1799 Doordenveld Ave^^Stevensville^MI^49127^USA^P|^PRN^PH^^^269^5832513ORC|RE||BK56B32101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK56B32101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-395-88^Fluzone HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-396-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L66I32106^^^AIRA-TEST^MR||PayneAIRA^TamasineAIRA^Madison^^^^L|Van WertAIRA^AlcinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1703 Heghel Ln^^Milford Township^MI^48380^USA^P||^PRN^PH^^^248^3675612|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PayneAIRA^Van WertAIRA^^^^^L|MTH^Mother^HL70063|1703 Heghel Ln^^Milford Township^MI^48380^USA^P|^PRN^PH^^^248^3675612ORC|RE||BL66I32106.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL66I32106.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-396-15^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-396-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q21E32117^^^AIRA-TEST^MR||LucasAIRA^KeyannaAIRA^Cerelia^^^^L|BoyleAIRA^BrooklynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1915 Pynaarlo Ln^^Bitely^MI^49309^USA^P||^PRN^PH^^^231^4316644|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^BoyleAIRA^^^^^L|MTH^Mother^HL70063|1915 Pynaarlo Ln^^Bitely^MI^49309^USA^P|^PRN^PH^^^231^4316644ORC|RE||BQ21E32117.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ21E32117.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-396-78^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-397-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S01P32125^^^AIRA-TEST^MR||SchleicherAIRA^AbijahAIRA^Armani^^^^L|FultonAIRA^AkiliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1645 Crummen Pl^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^3296503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SchleicherAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1645 Crummen Pl^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^3296503ORC|RE||BS01P32125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS01P32125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-397-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-397-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J77G32133^^^AIRA-TEST^MR||KingAIRA^AikoAIRA^Smridhi^^^^L|McKinnonAIRA^NancyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1118 Glphen aan den Rijn Ln^^Gladstone^MI^49837^USA^P||^PRN^PH^^^906^6257464|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KingAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1118 Glphen aan den Rijn Ln^^Gladstone^MI^49837^USA^P|^PRN^PH^^^906^6257464ORC|RE||BJ77G32133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ77G32133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-397-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-399-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E61W32141^^^AIRA-TEST^MR||HarrisonAIRA^NagihanAIRA^Shahira^^^^L|DelawareAIRA^MorgenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1230 Waterland Pl^^Woodland^MI^48897^USA^P||^PRN^PH^^^269^9160892|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1230 Waterland Pl^^Woodland^MI^48897^USA^P|^PRN^PH^^^269^9160892ORC|RE||BE61W32141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE61W32141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-399-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-399-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C62G32146^^^AIRA-TEST^MR||LorainAIRA^AnnaAIRA^Eurwen^^^^L|MuskingumAIRA^ZuzaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1033 Tirschot Ln^^Cass City^MI^48726^USA^P||^PRN^PH^^^989^3699254|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LorainAIRA^MuskingumAIRA^^^^^L|MTH^Mother^HL70063|1033 Tirschot Ln^^Cass City^MI^48726^USA^P|^PRN^PH^^^989^3699254ORC|RE||BC62G32146.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC62G32146.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-399-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z38R32157^^^AIRA-TEST^MR||MurrayAIRA^AutumnAIRA^Pooja^^^^L|O'NeillAIRA^ArdathAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1988 Aieuwkoop Ln^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^4443955|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurrayAIRA^O'NeillAIRA^^^^^L|MTH^Mother^HL70063|1988 Aieuwkoop Ln^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^4443955ORC|RE||BZ38R32157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ38R32157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-05^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S77A32165^^^AIRA-TEST^MR||BrazoriaAIRA^SapnaAIRA^Meadow^^^^L|WorthAIRA^RosAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1823 Doekel Pl^^Saint Clair Township^MI^48079^USA^P||^PRN^PH^^^810^7433065|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrazoriaAIRA^WorthAIRA^^^^^L|MTH^Mother^HL70063|1823 Doekel Pl^^Saint Clair Township^MI^48079^USA^P|^PRN^PH^^^810^7433065ORC|RE||BS77A32165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS77A32165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-10^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B35M32173^^^AIRA-TEST^MR||GreeneAIRA^BeatriceAIRA^Lisa^^^^L|HarrisonAIRA^LorelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1365 Geiderland Ln^^Karlin^MI^49643^USA^P||^PRN^PH^^^231^2264000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeneAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1365 Geiderland Ln^^Karlin^MI^49643^USA^P|^PRN^PH^^^231^2264000ORC|RE||BB35M32173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB35M32173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-15^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K98K32181^^^AIRA-TEST^MR||MahoneyAIRA^TenzinAIRA^Devnet^^^^L|LinnAIRA^CybilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1938 Aevenaar Pl^^Detroit^MI^48236^USA^P||^PRN^PH^^^313^3044937|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahoneyAIRA^LinnAIRA^^^^^L|MTH^Mother^HL70063|1938 Aevenaar Pl^^Detroit^MI^48236^USA^P|^PRN^PH^^^313^3044937ORC|RE||BK98K32181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK98K32181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-20^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H25W32186^^^AIRA-TEST^MR||CarrollAIRA^KatherineAIRA^Elodia^^^^L|San BernardinoAIRA^AvelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1095 Earen Ln^^Traverse City^MI^49696^USA^P||^PRN^PH^^^231^3200864|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^San BernardinoAIRA^^^^^L|MTH^Mother^HL70063|1095 Earen Ln^^Traverse City^MI^49696^USA^P|^PRN^PH^^^231^3200864ORC|RE||BH25W32186.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH25W32186.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-58^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E05F32197^^^AIRA-TEST^MR||CheyenneAIRA^AncikaAIRA^Elaina^^^^L|WoodsAIRA^DespinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1627 Rellendoorn Ave^^Springfld Township^MI^48350^USA^P||^PRN^PH^^^248^9329482|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CheyenneAIRA^WoodsAIRA^^^^^L|MTH^Mother^HL70063|1627 Rellendoorn Ave^^Springfld Township^MI^48350^USA^P|^PRN^PH^^^248^9329482ORC|RE||BE05F32197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE05F32197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-88^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-400-89|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T14Q32205^^^AIRA-TEST^MR||KinneyAIRA^EddaAIRA^Jaelynn^^^^L|LubbockAIRA^MalkaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1464 Hladel Ln^^GR^MI^49514^USA^P||^PRN^PH^^^616^5427419|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KinneyAIRA^LubbockAIRA^^^^^L|MTH^Mother^HL70063|1464 Hladel Ln^^GR^MI^49514^USA^P|^PRN^PH^^^616^5427419ORC|RE||BT14Q32205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT14Q32205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-400-89^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-401-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E55A32213^^^AIRA-TEST^MR||HickmanAIRA^CrystalAIRA^Morgandy^^^^L|SmithAIRA^YolandaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1104 Neiderland Ln^^Redford^MI^48240^USA^P||^PRN^PH^^^313^5920812|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HickmanAIRA^SmithAIRA^^^^^L|MTH^Mother^HL70063|1104 Neiderland Ln^^Redford^MI^48240^USA^P|^PRN^PH^^^313^5920812ORC|RE||BE55A32213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE55A32213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-401-65^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-401-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H58R32221^^^AIRA-TEST^MR||RichardsonAIRA^DericaAIRA^Krupa^^^^L|Pend OreilleAIRA^ManhattanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1293 Be Wolden Cir^^Cascade Township^MI^49506^USA^P||^PRN^PH^^^616^8174347|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RichardsonAIRA^Pend OreilleAIRA^^^^^L|MTH^Mother^HL70063|1293 Be Wolden Cir^^Cascade Township^MI^49506^USA^P|^PRN^PH^^^616^8174347ORC|RE||BH58R32221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH58R32221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-401-88^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-403-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H64P32226^^^AIRA-TEST^MR||AuglaizeAIRA^ArielAIRA^Eva^^^^L|JohnssonAIRA^MansiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1277 Dost Gelre Ln^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^2059178|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AuglaizeAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1277 Dost Gelre Ln^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^2059178ORC|RE||BH64P32226.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH64P32226.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-403-65^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-403-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T45D32237^^^AIRA-TEST^MR||DubuqueAIRA^IngerAIRA^Madonna^^^^L|WashingtonAIRA^GabrielleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1644 Vteenbergen Ln^^Morrice^MI^48857^USA^P||^PRN^PH^^^517^3682250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DubuqueAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1644 Vteenbergen Ln^^Morrice^MI^48857^USA^P|^PRN^PH^^^517^3682250ORC|RE||BT45D32237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT45D32237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-403-88^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-413-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R15Z32245^^^AIRA-TEST^MR||AlexanderAIRA^SheridanAIRA^Amena^^^^L|KjerulfAIRA^MurphyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1509 Aanmelden Ave^^Moorestown^MI^49651^USA^P||^PRN^PH^^^231^9471190|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlexanderAIRA^KjerulfAIRA^^^^^L|MTH^Mother^HL70063|1509 Aanmelden Ave^^Moorestown^MI^49651^USA^P|^PRN^PH^^^231^9471190ORC|RE||BR15Z32245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR15Z32245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-413-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-413-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E85W32253^^^AIRA-TEST^MR||LoveAIRA^IslaAIRA^Dietlinde^^^^L|MontourAIRA^AlexinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1613 Wrijven Ln^^Comerica Incorporated^MI^48275^USA^P||^PRN^PH^^^313^6176845|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoveAIRA^MontourAIRA^^^^^L|MTH^Mother^HL70063|1613 Wrijven Ln^^Comerica Incorporated^MI^48275^USA^P|^PRN^PH^^^313^6176845ORC|RE||BE85W32253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE85W32253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-413-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-413-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L33P32261^^^AIRA-TEST^MR||PotterAIRA^JermayneAIRA^Grace^^^^L|PowellAIRA^KaterinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1147 Caarlemmermeer St^^Detroit^MI^48266^USA^P||^PRN^PH^^^313^7811998|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PotterAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1147 Caarlemmermeer St^^Detroit^MI^48266^USA^P|^PRN^PH^^^313^7811998ORC|RE||BL33P32261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL33P32261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-413-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-413-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K46A32266^^^AIRA-TEST^MR||BonnerAIRA^HeatherAIRA^Alaysia^^^^L|MariposaAIRA^ShaunnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1697 Sint Anthonis Ave^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^2525441|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BonnerAIRA^MariposaAIRA^^^^^L|MTH^Mother^HL70063|1697 Sint Anthonis Ave^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^2525441ORC|RE||BK46A32266.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK46A32266.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-413-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-414-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A46W32277^^^AIRA-TEST^MR||HoodAIRA^KarlyAIRA^Tania^^^^L|MontourAIRA^FuscienneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1952 Tint Anthonis Pl^^Onaway^MI^49765^USA^P||^PRN^PH^^^989^6557582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoodAIRA^MontourAIRA^^^^^L|MTH^Mother^HL70063|1952 Tint Anthonis Pl^^Onaway^MI^49765^USA^P|^PRN^PH^^^989^6557582ORC|RE||BA46W32277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA46W32277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-414-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-414-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A10U32285^^^AIRA-TEST^MR||GrantAIRA^NirvanaAIRA^Beth^^^^L|WestportAIRA^OrendaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1896 Iteenwijkerland Cir^^Independence^MI^48346^USA^P||^PRN^PH^^^248^4601731|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^WestportAIRA^^^^^L|MTH^Mother^HL70063|1896 Iteenwijkerland Cir^^Independence^MI^48346^USA^P|^PRN^PH^^^248^4601731ORC|RE||BA10U32285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA10U32285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-414-50^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-414-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J45R32293^^^AIRA-TEST^MR||DawsonAIRA^SusiAIRA^Haleigh^^^^L|LivingstonAIRA^LonikieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1577 Soeree-Overflakkee Cir^^Romeo^MI^48065^USA^P||^PRN^PH^^^586^4424048|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DawsonAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1577 Soeree-Overflakkee Cir^^Romeo^MI^48065^USA^P|^PRN^PH^^^586^4424048ORC|RE||BJ45R32293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ45R32293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-414-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-414-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W13A32301^^^AIRA-TEST^MR||NuckollsAIRA^AnataAIRA^Khalida^^^^L|PageAIRA^OonaghAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1813 Wollumerland en Nieuwkruisland St^^Highland Township^MI^48356^USA^P||^PRN^PH^^^248^9351013|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NuckollsAIRA^PageAIRA^^^^^L|MTH^Mother^HL70063|1813 Wollumerland en Nieuwkruisland St^^Highland Township^MI^48356^USA^P|^PRN^PH^^^248^9351013ORC|RE||BW13A32301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW13A32301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-414-88^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-415-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C30U32306^^^AIRA-TEST^MR||GilespieAIRA^DillianAIRA^Shri^^^^L|LatimerAIRA^MollieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1251 Dluis Pl^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^5057075|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GilespieAIRA^LatimerAIRA^^^^^L|MTH^Mother^HL70063|1251 Dluis Pl^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^5057075ORC|RE||BC30U32306.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC30U32306.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-415-10^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-415-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F57A32314^^^AIRA-TEST^MR||Pend OreilleAIRA^NiciaAIRA^Isabella^^^^L|NicholasAIRA^ZenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1590 Best St^^Grand Rapids^MI^49534^USA^P||^PRN^PH^^^616^4456405|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Pend OreilleAIRA^NicholasAIRA^^^^^L|MTH^Mother^HL70063|1590 Best St^^Grand Rapids^MI^49534^USA^P|^PRN^PH^^^616^4456405ORC|RE||BF57A32314.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF57A32314.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-415-58^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-415-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D63A32325^^^AIRA-TEST^MR||RowanAIRA^SivAIRA^Endora^^^^L|BreathittAIRA^ElinoreAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1016 Baalte St^^Saint Heights^MI^48311^USA^P||^PRN^PH^^^586^9373613|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RowanAIRA^BreathittAIRA^^^^^L|MTH^Mother^HL70063|1016 Baalte St^^Saint Heights^MI^48311^USA^P|^PRN^PH^^^586^9373613ORC|RE||BD63A32325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD63A32325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-415-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-416-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F30L32333^^^AIRA-TEST^MR||OrangeAIRA^AlimaAIRA^Ghislain^^^^L|HumboldtAIRA^ShaunaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1924 Cranendonck Ave^^Bloomfield Township^MI^48301^USA^P||^PRN^PH^^^248^7652845|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OrangeAIRA^HumboldtAIRA^^^^^L|MTH^Mother^HL70063|1924 Cranendonck Ave^^Bloomfield Township^MI^48301^USA^P|^PRN^PH^^^248^7652845ORC|RE||BF30L32333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF30L32333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-416-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-416-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N29L32341^^^AIRA-TEST^MR||WexfordAIRA^DoeAIRA^Kiska^^^^L|MasonAIRA^OrielAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1835 Eoensdrecht Pl^^Levering^MI^49755^USA^P||^PRN^PH^^^616^4107919|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WexfordAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1835 Eoensdrecht Pl^^Levering^MI^49755^USA^P|^PRN^PH^^^616^4107919ORC|RE||BN29L32341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN29L32341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-416-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-416-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A70B32349^^^AIRA-TEST^MR||LoweAIRA^OlindaAIRA^Cara^^^^L|PenobscotAIRA^LorrettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1673 Vreugde St^^Sylvan Township^MI^48118^USA^P||^PRN^PH^^^734^9742914|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoweAIRA^PenobscotAIRA^^^^^L|MTH^Mother^HL70063|1673 Vreugde St^^Sylvan Township^MI^48118^USA^P|^PRN^PH^^^734^9742914ORC|RE||BA70B32349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA70B32349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-416-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-416-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G26J32357^^^AIRA-TEST^MR||CannavinAIRA^BristolAIRA^Catherine^^^^L|GarfieldAIRA^KarliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1016 Vreemd Ave^^Remus^MI^49340^USA^P||^PRN^PH^^^989^2461578|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CannavinAIRA^GarfieldAIRA^^^^^L|MTH^Mother^HL70063|1016 Vreemd Ave^^Remus^MI^49340^USA^P|^PRN^PH^^^989^2461578ORC|RE||BG26J32357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG26J32357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-416-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-417-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y63I32362^^^AIRA-TEST^MR||CusterAIRA^NadiaAIRA^Eileen^^^^L|SimpsonAIRA^WapekaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1339 Wcheemda Ln^^Hopkins^MI^49328^USA^P||^PRN^PH^^^269^4358579|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusterAIRA^SimpsonAIRA^^^^^L|MTH^Mother^HL70063|1339 Wcheemda Ln^^Hopkins^MI^49328^USA^P|^PRN^PH^^^269^4358579ORC|RE||BY63I32362.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY63I32362.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-417-10^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-417-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L34J32373^^^AIRA-TEST^MR||MagriAIRA^BlazeAIRA^Violeta^^^^L|ImperialAIRA^MaricelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1947 Beeuwarden Cir^^DTE Energy Brm^MI^48269^USA^P||^PRN^PH^^^313^2036639|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagriAIRA^ImperialAIRA^^^^^L|MTH^Mother^HL70063|1947 Beeuwarden Cir^^DTE Energy Brm^MI^48269^USA^P|^PRN^PH^^^313^2036639ORC|RE||BL34J32373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL34J32373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-417-50^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-417-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H05K32381^^^AIRA-TEST^MR||LoupAIRA^FondaAIRA^Marcie^^^^L|StephensAIRA^AlexaviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1183 Delft Pl^^Morenci^MI^49256^USA^P||^PRN^PH^^^517^4705506|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoupAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1183 Delft Pl^^Morenci^MI^49256^USA^P|^PRN^PH^^^517^4705506ORC|RE||BH05K32381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH05K32381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-417-58^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-417-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K36F32389^^^AIRA-TEST^MR||FranklinAIRA^JaioneAIRA^Schuyler^^^^L|SpencerAIRA^AbirAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1861 Woerdijk St^^Scio Township^MI^48103^USA^P||^PRN^PH^^^734^8446131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^SpencerAIRA^^^^^L|MTH^Mother^HL70063|1861 Woerdijk St^^Scio Township^MI^48103^USA^P|^PRN^PH^^^734^8446131ORC|RE||BK36F32389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK36F32389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-417-88^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G38E32397^^^AIRA-TEST^MR||MonroeAIRA^IvoryAIRA^Padmini^^^^L|BerksAIRA^ThomasinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1944 Zus Ave^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^5926195|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MonroeAIRA^BerksAIRA^^^^^L|MTH^Mother^HL70063|1944 Zus Ave^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^5926195ORC|RE||BG38E32397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG38E32397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-418-10^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-418-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T60B32402^^^AIRA-TEST^MR||FultonAIRA^MichaelaAIRA^Carmen^^^^L|KentAIRA^MetaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1100 Bmsterdam St^^Utica^MI^48315^USA^P||^PRN^PH^^^586^2148908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FultonAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1100 Bmsterdam St^^Utica^MI^48315^USA^P|^PRN^PH^^^586^2148908ORC|RE||BT60B32402.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT60B32402.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-418-50^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-418-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J31V32413^^^AIRA-TEST^MR||LakeAIRA^AlexandraAIRA^Urbana^^^^L|OfvermarkAIRA^AnnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1580 Garen Ave^^Burt^MI^48417^USA^P||^PRN^PH^^^989^2316552|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^OfvermarkAIRA^^^^^L|MTH^Mother^HL70063|1580 Garen Ave^^Burt^MI^48417^USA^P|^PRN^PH^^^989^2316552ORC|RE||BJ31V32413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ31V32413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-418-58^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-418-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S79U32421^^^AIRA-TEST^MR||ThorsenAIRA^DysisAIRA^Kamballa^^^^L|RockAIRA^FlosAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1778 Weylingen Pl^^Leland^MI^49654^USA^P||^PRN^PH^^^231^5401470|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThorsenAIRA^RockAIRA^^^^^L|MTH^Mother^HL70063|1778 Weylingen Pl^^Leland^MI^49654^USA^P|^PRN^PH^^^231^5401470ORC|RE||BS79U32421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS79U32421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-418-88^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-487-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B49A32429^^^AIRA-TEST^MR||SullivanAIRA^SonnenscheinAIRA^Aleksandra^^^^L|HarrisonAIRA^OkalaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1468 Zucphen Pl^^Onaway^MI^49765^USA^P||^PRN^PH^^^989^9277417|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SullivanAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1468 Zucphen Pl^^Onaway^MI^49765^USA^P|^PRN^PH^^^989^9277417ORC|RE||BB49A32429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB49A32429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-487-58^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-488-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N79C32437^^^AIRA-TEST^MR||PikeAIRA^AnchoretAIRA^Addisyn^^^^L|BlaineAIRA^DaniellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1531 Dlphen aan den Rijn Cir^^Troy^MI^48098^USA^P||^PRN^PH^^^248^6275612|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1531 Dlphen aan den Rijn Cir^^Troy^MI^48098^USA^P|^PRN^PH^^^248^6275612ORC|RE||BN79C32437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN79C32437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-488-78^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-489-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y59J32445^^^AIRA-TEST^MR||McQuadeAIRA^KalikaAIRA^Kalama^^^^L|RileyAIRA^YlwaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1725 Aronckhorst St^^Freeland^MI^48623^USA^P||^PRN^PH^^^989^7635876|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McQuadeAIRA^RileyAIRA^^^^^L|MTH^Mother^HL70063|1725 Aronckhorst St^^Freeland^MI^48623^USA^P|^PRN^PH^^^989^7635876ORC|RE||BY59J32445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY59J32445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-489-01^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-489-91|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P51D32453^^^AIRA-TEST^MR||CummingsAIRA^EdenAIRA^Jenna^^^^L|CliveAIRA^KatelinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1885 Eoes Ln^^Selfridge^MI^48045^USA^P||^PRN^PH^^^586^6336754|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CummingsAIRA^CliveAIRA^^^^^L|MTH^Mother^HL70063|1885 Eoes Ln^^Selfridge^MI^48045^USA^P|^PRN^PH^^^586^6336754ORC|RE||BP51D32453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP51D32453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-489-91^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-510-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I40W32458^^^AIRA-TEST^MR||NeorinAIRA^AbinaAIRA^Talwyn^^^^L|GraysonAIRA^MinkaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1112 Bang Pl^^Lathrup Village^MI^48076^USA^P||^PRN^PH^^^248^8691984|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NeorinAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1112 Bang Pl^^Lathrup Village^MI^48076^USA^P|^PRN^PH^^^248^8691984ORC|RE||BI40W32458.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI40W32458.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-510-05^PENTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-513-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J97T32469^^^AIRA-TEST^MR||BaylorAIRA^MinetteAIRA^Isla^^^^L|LyastromAIRA^DejaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1450 Eerg en Dal St^^Dansville^MI^48819^USA^P||^PRN^PH^^^517^5799982|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BaylorAIRA^LyastromAIRA^^^^^L|MTH^Mother^HL70063|1450 Eerg en Dal St^^Dansville^MI^48819^USA^P|^PRN^PH^^^517^5799982ORC|RE||BJ97T32469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ97T32469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-513-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-513-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X43L32477^^^AIRA-TEST^MR||WheelerAIRA^RishbhaAIRA^Shyanne^^^^L|DanuelsonAIRA^OlcayAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1207 Hoorn Cir^^Harrison^MI^48625^USA^P||^PRN^PH^^^989^5986363|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^DanuelsonAIRA^^^^^L|MTH^Mother^HL70063|1207 Hoorn Cir^^Harrison^MI^48625^USA^P|^PRN^PH^^^989^5986363ORC|RE||BX43L32477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX43L32477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-513-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-514-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y51K32485^^^AIRA-TEST^MR||AtokaAIRA^ChowAIRA^Fern^^^^L|WhatcomAIRA^KamilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1430 Widderkerk Pl^^Ada^MI^49357^USA^P||^PRN^PH^^^616^8340999|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtokaAIRA^WhatcomAIRA^^^^^L|MTH^Mother^HL70063|1430 Widderkerk Pl^^Ada^MI^49357^USA^P|^PRN^PH^^^616^8340999ORC|RE||BY51K32485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY51K32485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-514-00^Fluzone Quadrivalent, Peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-514-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J76S32493^^^AIRA-TEST^MR||BreckinridgeAIRA^KavitaAIRA^Kerzi^^^^L|GelfryAIRA^ShrijaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1823 Laag en Braassem St^^Waterford Township^MI^48328^USA^P||^PRN^PH^^^248^9224679|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BreckinridgeAIRA^GelfryAIRA^^^^^L|MTH^Mother^HL70063|1823 Laag en Braassem St^^Waterford Township^MI^48328^USA^P|^PRN^PH^^^248^9224679ORC|RE||BJ76S32493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ76S32493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-514-25^Fluzone Quadrivalent, peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-516-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M30T32498^^^AIRA-TEST^MR||BowieAIRA^TonyaAIRA^Sindy^^^^L|BrownAIRA^DuanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1885 Thuis Cir^^Farmingtn Hls^MI^48331^USA^P||^PRN^PH^^^248^5084566|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BowieAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1885 Thuis Cir^^Farmingtn Hls^MI^48331^USA^P|^PRN^PH^^^248^5084566ORC|RE||BM30T32498.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM30T32498.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-516-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-516-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N87A32509^^^AIRA-TEST^MR||DodgeAIRA^SophiaAIRA^Nan^^^^L|TexasAIRA^BeverlyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1606 Will en Sint Hubert Pl^^Topinabee^MI^49791^USA^P||^PRN^PH^^^231^7014523|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DodgeAIRA^TexasAIRA^^^^^L|MTH^Mother^HL70063|1606 Will en Sint Hubert Pl^^Topinabee^MI^49791^USA^P|^PRN^PH^^^231^7014523ORC|RE||BN87A32509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN87A32509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-516-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-517-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X90V32517^^^AIRA-TEST^MR||JacksonAIRA^AlekaAIRA^Gwendolen^^^^L|KootenaiAIRA^MedinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1980 Haag en Braassem Ln^^Gilford^MI^48736^USA^P||^PRN^PH^^^989^3765450|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^KootenaiAIRA^^^^^L|MTH^Mother^HL70063|1980 Haag en Braassem Ln^^Gilford^MI^48736^USA^P|^PRN^PH^^^989^3765450ORC|RE||BX90V32517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX90V32517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-517-00^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-517-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W67Q32525^^^AIRA-TEST^MR||ClarkAIRA^MargaretAIRA^Amadi^^^^L|IsdalAIRA^HoratiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1121 Hoggenland Cir^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^8250430|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^IsdalAIRA^^^^^L|MTH^Mother^HL70063|1121 Hoggenland Cir^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^8250430ORC|RE||BW67Q32525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW67Q32525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-517-25^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-518-00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K40Z32533^^^AIRA-TEST^MR||CraneAIRA^BreannaAIRA^Pepita^^^^L|MasonAIRA^IlukaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1199 Oiessenlanden Ln^^Farmington^MI^48335^USA^P||^PRN^PH^^^248^5014005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CraneAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1199 Oiessenlanden Ln^^Farmington^MI^48335^USA^P|^PRN^PH^^^248^5014005ORC|RE||BK40Z32533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK40Z32533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-518-00^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-518-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A38E32538^^^AIRA-TEST^MR||LaceyAIRA^TrilochanaAIRA^Vivien^^^^L|LieAIRA^LavaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1296 Zastricum Ave^^GR^MI^49546^USA^P||^PRN^PH^^^616^7786425|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaceyAIRA^LieAIRA^^^^^L|MTH^Mother^HL70063|1296 Zastricum Ave^^GR^MI^49546^USA^P|^PRN^PH^^^616^7786425ORC|RE||BA38E32538.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA38E32538.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-518-25^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-545-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K07C32549^^^AIRA-TEST^MR||UptonAIRA^MarthaAIRA^Vanda^^^^L|KnottAIRA^GalienaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1703 Keeze-Leende St^^Rochester^MI^48309^USA^P||^PRN^PH^^^248^9305688|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UptonAIRA^KnottAIRA^^^^^L|MTH^Mother^HL70063|1703 Keeze-Leende St^^Rochester^MI^48309^USA^P|^PRN^PH^^^248^9305688ORC|RE||BK07C32549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK07C32549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-545-03^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-545-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O40C32557^^^AIRA-TEST^MR||CoshoctonAIRA^PallasAIRA^Euphemia^^^^L|PerryAIRA^NatalyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1392 Voppersum Pl^^Brighton Township^MI^48114^USA^P||^PRN^PH^^^810^6323324|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoshoctonAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1392 Voppersum Pl^^Brighton Township^MI^48114^USA^P|^PRN^PH^^^810^6323324ORC|RE||BO40C32557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO40C32557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-545-05^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-545-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I30V32565^^^AIRA-TEST^MR||FranklinAIRA^JoraAIRA^Mickie^^^^L|KearneyAIRA^RosalieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1774 Nrootegast Cir^^Total Petroleum^MI^48802^USA^P||^PRN^PH^^^989^3200348|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^KearneyAIRA^^^^^L|MTH^Mother^HL70063|1774 Nrootegast Cir^^Total Petroleum^MI^48802^USA^P|^PRN^PH^^^989^3200348ORC|RE||BI30V32565.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI30V32565.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-545-15^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-547-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N79M32573^^^AIRA-TEST^MR||JanttiAIRA^JewellAIRA^Zara^^^^L|FayetteAIRA^GymeaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1440 Gmmen Ln^^Iron River^MI^49935^USA^P||^PRN^PH^^^906^3713064|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JanttiAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1440 Gmmen Ln^^Iron River^MI^49935^USA^P|^PRN^PH^^^906^3713064ORC|RE||BN79M32573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN79M32573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-547-58^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-560-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R79U32578^^^AIRA-TEST^MR||LewisAIRA^AlloraAIRA^Hollye^^^^L|WilssonAIRA^CosetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1037 Nardenberg St^^Hamilton^MI^49419^USA^P||^PRN^PH^^^269^7306690|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LewisAIRA^WilssonAIRA^^^^^L|MTH^Mother^HL70063|1037 Nardenberg St^^Hamilton^MI^49419^USA^P|^PRN^PH^^^269^7306690ORC|RE||BR79U32578.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR79U32578.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-560-05^DTAP-IPV^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-562-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V38W32589^^^AIRA-TEST^MR||DawesAIRA^GypsyAIRA^Eugenia^^^^L|ClevelandAIRA^NadaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1973 Gardinxveld-Giessendam Pl^^GR^MI^49501^USA^P||^PRN^PH^^^616^5863402|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DawesAIRA^ClevelandAIRA^^^^^L|MTH^Mother^HL70063|1973 Gardinxveld-Giessendam Pl^^GR^MI^49501^USA^P|^PRN^PH^^^616^5863402ORC|RE||BV38W32589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV38W32589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-562-10^Quadracel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-562-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K85T32597^^^AIRA-TEST^MR||San SabaAIRA^LidiaAIRA^Lyndey^^^^L|Keya PahaAIRA^HadyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1031 Springen St^^Flushing^MI^48433^USA^P||^PRN^PH^^^810^7246220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San SabaAIRA^Keya PahaAIRA^^^^^L|MTH^Mother^HL70063|1031 Springen St^^Flushing^MI^48433^USA^P|^PRN^PH^^^810^7246220ORC|RE||BK85T32597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK85T32597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-562-58^QUADRACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-589-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J15K32605^^^AIRA-TEST^MR||CastroAIRA^CallanAIRA^Liza^^^^L|BurlesonAIRA^TahiraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1781 Balburg St^^Berrien Center^MI^49102^USA^P||^PRN^PH^^^269^2330420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CastroAIRA^BurlesonAIRA^^^^^L|MTH^Mother^HL70063|1781 Balburg St^^Berrien Center^MI^49102^USA^P|^PRN^PH^^^269^2330420ORC|RE||BJ15K32605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ15K32605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-589-05^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-589-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y76A32613^^^AIRA-TEST^MR||BurkeAIRA^RueAIRA^Kazanna^^^^L|BeckhamAIRA^EstherAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1205 Medeklinker Ave^^Grosse Pointe Woods^MI^48230^USA^P||^PRN^PH^^^313^4372445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1205 Medeklinker Ave^^Grosse Pointe Woods^MI^48230^USA^P|^PRN^PH^^^313^4372445ORC|RE||BY76A32613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY76A32613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-589-58^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-621-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z81E32618^^^AIRA-TEST^MR||HeffernanAIRA^BellonaAIRA^Tehya^^^^L|DightAIRA^AtlantaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1683 Guiven Pl^^Kalamazoo^MI^49019^USA^P||^PRN^PH^^^269^7812583|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^DightAIRA^^^^^L|MTH^Mother^HL70063|1683 Guiven Pl^^Kalamazoo^MI^49019^USA^P|^PRN^PH^^^269^7812583ORC|RE||BZ81E32618.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ81E32618.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-621-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-621-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F38N32629^^^AIRA-TEST^MR||FagenAIRA^TalullaAIRA^Idola^^^^L|ThiemerAIRA^CarmineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1409 Tith St^^Grand Rapids^MI^49599^USA^P||^PRN^PH^^^616^5288644|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FagenAIRA^ThiemerAIRA^^^^^L|MTH^Mother^HL70063|1409 Tith St^^Grand Rapids^MI^49599^USA^P|^PRN^PH^^^616^5288644ORC|RE||BF38N32629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF38N32629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-621-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-625-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C77D32637^^^AIRA-TEST^MR||SnowAIRA^GauriAIRA^Binty^^^^L|DauphinAIRA^AlysonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1197 Winsum Ln^^Three Oaks^MI^49128^USA^P||^PRN^PH^^^269^5920316|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SnowAIRA^DauphinAIRA^^^^^L|MTH^Mother^HL70063|1197 Winsum Ln^^Three Oaks^MI^49128^USA^P|^PRN^PH^^^269^5920316ORC|RE||BC77D32637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC77D32637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-625-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-625-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B64Q32645^^^AIRA-TEST^MR||CaldwellAIRA^RybaAIRA^Papillon^^^^L|Cerro GordoAIRA^SavinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1594 Dengelo Cir^^Novi Township^MI^48375^USA^P||^PRN^PH^^^248^4990766|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaldwellAIRA^Cerro GordoAIRA^^^^^L|MTH^Mother^HL70063|1594 Dengelo Cir^^Novi Township^MI^48375^USA^P|^PRN^PH^^^248^4990766ORC|RE||BB64Q32645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB64Q32645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-625-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-627-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V43J32653^^^AIRA-TEST^MR||ChippewaAIRA^JosephineAIRA^Julie^^^^L|MackeyAIRA^AlalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1244 Vwenterand St^^Melvindale^MI^48122^USA^P||^PRN^PH^^^313^2706893|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChippewaAIRA^MackeyAIRA^^^^^L|MTH^Mother^HL70063|1244 Vwenterand St^^Melvindale^MI^48122^USA^P|^PRN^PH^^^313^2706893ORC|RE||BV43J32653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV43J32653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-627-15^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-627-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I70H32658^^^AIRA-TEST^MR||UptonAIRA^AideenAIRA^Deborah^^^^L|OneidaAIRA^FaineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1462 Vrave Ln^^Michigan Center^MI^49254^USA^P||^PRN^PH^^^517^8583184|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UptonAIRA^OneidaAIRA^^^^^L|MTH^Mother^HL70063|1462 Vrave Ln^^Michigan Center^MI^49254^USA^P|^PRN^PH^^^517^8583184ORC|RE||BI70H32658.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI70H32658.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-627-78^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-629-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G29F32669^^^AIRA-TEST^MR||FloydAIRA^TottieAIRA^Corazon^^^^L|LakeAIRA^AmityAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1346 Selmond Pl^^Parchment^MI^49004^USA^P||^PRN^PH^^^269^4311522|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^LakeAIRA^^^^^L|MTH^Mother^HL70063|1346 Selmond Pl^^Parchment^MI^49004^USA^P|^PRN^PH^^^269^4311522ORC|RE||BG29F32669.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG29F32669.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-629-15^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-629-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A04X32677^^^AIRA-TEST^MR||BoydAIRA^SofiaAIRA^Gizane^^^^L|DawesAIRA^VanessaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1829 Cirkel Ln^^Turner^MI^48765^USA^P||^PRN^PH^^^989^5869624|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BoydAIRA^DawesAIRA^^^^^L|MTH^Mother^HL70063|1829 Cirkel Ln^^Turner^MI^48765^USA^P|^PRN^PH^^^989^5869624ORC|RE||BA04X32677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA04X32677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-629-78^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-640-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V94V32685^^^AIRA-TEST^MR||HenryAIRA^MagenaAIRA^Jana^^^^L|CraigAIRA^IlenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1708 Diessenlanden Pl^^Flint^MI^48550^USA^P||^PRN^PH^^^810^2981296|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HenryAIRA^CraigAIRA^^^^^L|MTH^Mother^HL70063|1708 Diessenlanden Pl^^Flint^MI^48550^USA^P|^PRN^PH^^^810^2981296ORC|RE||BV94V32685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV94V32685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-640-15^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-650-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O62C32693^^^AIRA-TEST^MR||FloydAIRA^FilberthaAIRA^Lorelei^^^^L|SiskiyouAIRA^NirvanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1631 Brak Cir^^East Grand Rapids^MI^49506^USA^P||^PRN^PH^^^616^5127206|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^SiskiyouAIRA^^^^^L|MTH^Mother^HL70063|1631 Brak Cir^^East Grand Rapids^MI^49506^USA^P|^PRN^PH^^^616^5127206ORC|RE||BO62C32693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO62C32693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-650-10^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-650-25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U48K32698^^^AIRA-TEST^MR||Cerro GordoAIRA^AtlantaAIRA^Lindon^^^^L|FranklinAIRA^AkutiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1347 Dexel Ave^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^4168657|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Cerro GordoAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1347 Dexel Ave^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^4168657ORC|RE||BU48K32698.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU48K32698.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-650-25^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-650-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O07H32706^^^AIRA-TEST^MR||AlgerAIRA^YamunaAIRA^Joslyn^^^^L|CarrollAIRA^MalloryAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1104 Mtichtse Vecht Pl^^Huntington Woods^MI^48070^USA^P||^PRN^PH^^^248^8604973|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlgerAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1104 Mtichtse Vecht Pl^^Huntington Woods^MI^48070^USA^P|^PRN^PH^^^248^8604973ORC|RE||BO07H32706.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO07H32706.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-650-50^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-650-70|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O94P32717^^^AIRA-TEST^MR||SkagitAIRA^SteffieAIRA^Kristabel^^^^L|KananenAIRA^BrettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1065 Hedum Ln^^Oden^MI^49764^USA^P||^PRN^PH^^^616^7192086|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkagitAIRA^KananenAIRA^^^^^L|MTH^Mother^HL70063|1065 Hedum Ln^^Oden^MI^49764^USA^P|^PRN^PH^^^616^7192086ORC|RE||BO94P32717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO94P32717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-650-70^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-650-90|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I94I32725^^^AIRA-TEST^MR||McCarthyAIRA^JobeyAIRA^Charlotte^^^^L|AshlandAIRA^AiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1637 Noch St^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^6553477|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCarthyAIRA^AshlandAIRA^^^^^L|MTH^Mother^HL70063|1637 Noch St^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^6553477ORC|RE||BI94I32725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI94I32725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-650-90^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-703-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N06D32733^^^AIRA-TEST^MR||SulitAIRA^FayeAIRA^Lanikai^^^^L|PhillipsAIRA^SabineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1335 Koorst Ave^^Armada^MI^48005^USA^P||^PRN^PH^^^586^7077480|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SulitAIRA^PhillipsAIRA^^^^^L|MTH^Mother^HL70063|1335 Koorst Ave^^Armada^MI^48005^USA^P|^PRN^PH^^^586^7077480ORC|RE||BN06D32733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN06D32733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-703-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-705-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K05I32741^^^AIRA-TEST^MR||LoupAIRA^NoraAIRA^Jacoba^^^^L|GraysonAIRA^MagdaleneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1081 Oaag en Braassem St^^Westland^MI^48186^USA^P||^PRN^PH^^^734^8240686|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoupAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1081 Oaag en Braassem St^^Westland^MI^48186^USA^P|^PRN^PH^^^734^8240686ORC|RE||BK05I32741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK05I32741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-705-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-707-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K99L32746^^^AIRA-TEST^MR||KimbleAIRA^JennyAIRA^Mandara^^^^L|McFernanAIRA^SurupaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1947 Melodie Cir^^Dearborn^MI^48121^USA^P||^PRN^PH^^^313^2196347|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KimbleAIRA^McFernanAIRA^^^^^L|MTH^Mother^HL70063|1947 Melodie Cir^^Dearborn^MI^48121^USA^P|^PRN^PH^^^313^2196347ORC|RE||BK99L32746.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK99L32746.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-707-48^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-707-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R64R32757^^^AIRA-TEST^MR||ShackelfordAIRA^MalilaAIRA^Floriane^^^^L|SmithAIRA^ColumbiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1503 Beerde Pl^^Detroit^MI^48231^USA^P||^PRN^PH^^^313^3020138|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShackelfordAIRA^SmithAIRA^^^^^L|MTH^Mother^HL70063|1503 Beerde Pl^^Detroit^MI^48231^USA^P|^PRN^PH^^^313^3020138ORC|RE||BR64R32757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR64R32757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-707-55^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-708-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C75Y32765^^^AIRA-TEST^MR||ManningAIRA^GalaAIRA^Levana^^^^L|WintermanAIRA^ZonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1348 Naanstad Cir^^Saint Joseph^MI^49085^USA^P||^PRN^PH^^^269^7625541|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ManningAIRA^WintermanAIRA^^^^^L|MTH^Mother^HL70063|1348 Naanstad Cir^^Saint Joseph^MI^49085^USA^P|^PRN^PH^^^269^7625541ORC|RE||BC75Y32765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC75Y32765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-708-40^Fluzone Intradermal Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-708-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U78A32773^^^AIRA-TEST^MR||MarionAIRA^JanineAIRA^Samara^^^^L|JohnstonAIRA^NamazziAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1976 Zes Pl^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^3929722|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^JohnstonAIRA^^^^^L|MTH^Mother^HL70063|1976 Zes Pl^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^3929722ORC|RE||BU78A32773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU78A32773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-708-48^FLUZONE INTRADERMAL QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-709-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K48X32781^^^AIRA-TEST^MR||MasonAIRA^HanaAIRA^Jacoba^^^^L|LivingstonAIRA^NeeharikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1310 Kteenwijkerland Ave^^Gm Truck and Bus^MI^48553^USA^P||^PRN^PH^^^810^8421296|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1310 Kteenwijkerland Ave^^Gm Truck and Bus^MI^48553^USA^P|^PRN^PH^^^810^8421296ORC|RE||BK48X32781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK48X32781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-709-48^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-709-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I96L32786^^^AIRA-TEST^MR||ReaganAIRA^AcanthaAIRA^Arielle^^^^L|McCarthyAIRA^JocastaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1337 Pijnacker-Nootdorp St^^Skanee^MI^49962^USA^P||^PRN^PH^^^906^6436481|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReaganAIRA^McCarthyAIRA^^^^^L|MTH^Mother^HL70063|1337 Pijnacker-Nootdorp St^^Skanee^MI^49962^USA^P|^PRN^PH^^^906^6436481ORC|RE||BI96L32786.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI96L32786.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-709-55^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-710-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X95A32797^^^AIRA-TEST^MR||SnohomishAIRA^BedeliaAIRA^Jocasta^^^^L|OlsonAIRA^IoneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1846 Aeudal Ave^^Eastlake^MI^49626^USA^P||^PRN^PH^^^231^7375956|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SnohomishAIRA^OlsonAIRA^^^^^L|MTH^Mother^HL70063|1846 Aeudal Ave^^Eastlake^MI^49626^USA^P|^PRN^PH^^^231^7375956ORC|RE||BX95A32797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX95A32797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-710-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-710-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O49V32805^^^AIRA-TEST^MR||PikeAIRA^KristelAIRA^Ava^^^^L|WinnebagoAIRA^MarilynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1943 Harneveld Cir^^Huntington Woods^MI^48070^USA^P||^PRN^PH^^^248^9692461|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^WinnebagoAIRA^^^^^L|MTH^Mother^HL70063|1943 Harneveld Cir^^Huntington Woods^MI^48070^USA^P|^PRN^PH^^^248^9692461ORC|RE||BO49V32805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO49V32805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-710-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-712-40|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N10Q32813^^^AIRA-TEST^MR||BaragaAIRA^KarissaAIRA^Gabby^^^^L|ErieAIRA^TaniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1677 Hergen Cir^^Port Austin^MI^48467^USA^P||^PRN^PH^^^989^9671631|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BaragaAIRA^ErieAIRA^^^^^L|MTH^Mother^HL70063|1677 Hergen Cir^^Port Austin^MI^48467^USA^P|^PRN^PH^^^989^9671631ORC|RE||BN10Q32813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN10Q32813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-712-40^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-712-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G19N32821^^^AIRA-TEST^MR||MurphyAIRA^AntionetteAIRA^Wilhelmina^^^^L|HardinAIRA^IngeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1499 Het Pl^^Rives Junction^MI^49277^USA^P||^PRN^PH^^^517^8253847|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurphyAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1499 Het Pl^^Rives Junction^MI^49277^USA^P|^PRN^PH^^^517^8253847ORC|RE||BG19N32821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG19N32821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-712-48^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-718-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D38A32826^^^AIRA-TEST^MR||MohaveAIRA^ClaraAIRA^Rhoswen^^^^L|BlackAIRA^AkritiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1973 Ras St^^Kincheloe^MI^49786^USA^P||^PRN^PH^^^906^8124961|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MohaveAIRA^BlackAIRA^^^^^L|MTH^Mother^HL70063|1973 Ras St^^Kincheloe^MI^49786^USA^P|^PRN^PH^^^906^8124961ORC|RE||BD38A32826.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD38A32826.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-718-10^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-718-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I56N32837^^^AIRA-TEST^MR||CaribouAIRA^WasemeAIRA^Danica^^^^L|JacksonAIRA^MersadizeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1582 Zeven Cir^^Ferndale^MI^48220^USA^P||^PRN^PH^^^248^9879445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaribouAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1582 Zeven Cir^^Ferndale^MI^48220^USA^P|^PRN^PH^^^248^9879445ORC|RE||BI56N32837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI56N32837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-718-88^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-790-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U56T32845^^^AIRA-TEST^MR||McKeanAIRA^BrisaAIRA^Hallie^^^^L|ClintonAIRA^JocosaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1539 Wantumadiel Ave^^Ann Arbor^MI^48107^USA^P||^PRN^PH^^^734^3047441|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKeanAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1539 Wantumadiel Ave^^Ann Arbor^MI^48107^USA^P|^PRN^PH^^^734^3047441ORC|RE||BU56T32845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU56T32845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-790-20^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-790-38|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K88C32853^^^AIRA-TEST^MR||ArenacAIRA^NaomiAIRA^Elie^^^^L|LuceAIRA^GrierAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1806 Meudal Cir^^Maybee^MI^48159^USA^P||^PRN^PH^^^734^4263259|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArenacAIRA^LuceAIRA^^^^^L|MTH^Mother^HL70063|1806 Meudal Cir^^Maybee^MI^48159^USA^P|^PRN^PH^^^734^4263259ORC|RE||BK88C32853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK88C32853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-790-38^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-790-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G38R32861^^^AIRA-TEST^MR||CrawfordAIRA^DamianaAIRA^Lujuana^^^^L|MontgomeryAIRA^RajaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1626 Banderd St^^Lenox Township^MI^48048^USA^P||^PRN^PH^^^586^5870891|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1626 Banderd St^^Lenox Township^MI^48048^USA^P|^PRN^PH^^^586^5870891ORC|RE||BG38R32861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG38R32861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-790-51^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-790-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E25A32866^^^AIRA-TEST^MR||WilbargerAIRA^GalateaAIRA^Brit^^^^L|PocahontasAIRA^PiperAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1129 Oinschoten Ave^^Midland^MI^48670^USA^P||^PRN^PH^^^989^9842445|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilbargerAIRA^PocahontasAIRA^^^^^L|MTH^Mother^HL70063|1129 Oinschoten Ave^^Midland^MI^48670^USA^P|^PRN^PH^^^989^9842445ORC|RE||BE25A32866.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE25A32866.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-790-88^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-800-83|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F43T32877^^^AIRA-TEST^MR||PawneeAIRA^TeresaAIRA^Ahuva^^^^L|FloydAIRA^BansariAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1936 Straat Pl^^Andrews University^MI^49104^USA^P||^PRN^PH^^^269^2594024|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PawneeAIRA^FloydAIRA^^^^^L|MTH^Mother^HL70063|1936 Straat Pl^^Andrews University^MI^49104^USA^P|^PRN^PH^^^269^2594024ORC|RE||BF43T32877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF43T32877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-800-83^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-820-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C20S32885^^^AIRA-TEST^MR||NordbyAIRA^KristaAIRA^Ardine^^^^L|BrownAIRA^MorenwynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1235 Kuren Cir^^Southfield^MI^48086^USA^P||^PRN^PH^^^248^5496172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NordbyAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1235 Kuren Cir^^Southfield^MI^48086^USA^P|^PRN^PH^^^248^5496172ORC|RE||BC20S32885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC20S32885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-820-10^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-860-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T08Q32893^^^AIRA-TEST^MR||HowathAIRA^AmelindaAIRA^Olga^^^^L|ComancheAIRA^EleoraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1948 Blmelo St^^Hastings^MI^49058^USA^P||^PRN^PH^^^269^8475765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowathAIRA^ComancheAIRA^^^^^L|MTH^Mother^HL70063|1948 Blmelo St^^Hastings^MI^49058^USA^P|^PRN^PH^^^269^8475765ORC|RE||BT08Q32893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT08Q32893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-860-10^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-860-55|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G82F32901^^^AIRA-TEST^MR||CoshoctonAIRA^AbijahAIRA^Kaede^^^^L|HillsdaleAIRA^MarianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1569 Vis Cir^^Walkerville^MI^49459^USA^P||^PRN^PH^^^231^4940582|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoshoctonAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1569 Vis Cir^^Walkerville^MI^49459^USA^P|^PRN^PH^^^231^4940582ORC|RE||BG82F32901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG82F32901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-860-55^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-860-78|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F91U32906^^^AIRA-TEST^MR||WrightAIRA^AkaishaAIRA^Cala^^^^L|RockcastleAIRA^JadwigaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1960 Aoorst St^^Eastport^MI^49627^USA^P||^PRN^PH^^^231^8880136|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WrightAIRA^RockcastleAIRA^^^^^L|MTH^Mother^HL70063|1960 Aoorst St^^Eastport^MI^49627^USA^P|^PRN^PH^^^231^8880136ORC|RE||BF91U32906.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF91U32906.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-860-78^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-860-88|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y42F32914^^^AIRA-TEST^MR||LatahAIRA^RaquelleAIRA^Gelsey^^^^L|KimballAIRA^AilishAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1543 Oangedijk Pl^^Kimball Township^MI^48074^USA^P||^PRN^PH^^^810^8894618|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LatahAIRA^KimballAIRA^^^^^L|MTH^Mother^HL70063|1543 Oangedijk Pl^^Kimball Township^MI^48074^USA^P|^PRN^PH^^^810^8894618ORC|RE||BY42F32914.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY42F32914.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-860-88^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-913-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K13V32925^^^AIRA-TEST^MR||StephensAIRA^AraceliAIRA^Dysthe^^^^L|WahkiakumAIRA^TarynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1390 Noststellingwerf Pl^^Temperance^MI^48182^USA^P||^PRN^PH^^^734^5309371|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StephensAIRA^WahkiakumAIRA^^^^^L|MTH^Mother^HL70063|1390 Noststellingwerf Pl^^Temperance^MI^48182^USA^P|^PRN^PH^^^734^5309371ORC|RE||BK13V32925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK13V32925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-913-01^STAMARIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-915-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F42L32933^^^AIRA-TEST^MR||SaginawAIRA^EsmereldaAIRA^Colletta^^^^L|YorkAIRA^TarajiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1211 Dlphen aan den Rijn Pl^^Belmont^MI^49306^USA^P||^PRN^PH^^^616^2967499|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SaginawAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1211 Dlphen aan den Rijn Pl^^Belmont^MI^49306^USA^P|^PRN^PH^^^616^2967499ORC|RE||BF42L32933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF42L32933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-915-01^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-915-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O29B32941^^^AIRA-TEST^MR||HamiltonAIRA^LaniAIRA^Joyanne^^^^L|OsceolaAIRA^AbiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1705 Gaan Ln^^Fennville^MI^49408^USA^P||^PRN^PH^^^269^6115191|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1705 Gaan Ln^^Fennville^MI^49408^USA^P|^PRN^PH^^^269^6115191ORC|RE||BO29B32941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO29B32941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-915-05^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-915-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V48Y32949^^^AIRA-TEST^MR||GilliamAIRA^SydneeAIRA^Surupa^^^^L|BlaineAIRA^KaleighAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1510 Varlingen Cir^^Bloomfield Township^MI^48302^USA^P||^PRN^PH^^^248^4905178|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GilliamAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1510 Varlingen Cir^^Bloomfield Township^MI^48302^USA^P|^PRN^PH^^^248^4905178ORC|RE||BV48Y32949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV48Y32949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-915-58^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281-915-68|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q56C32957^^^AIRA-TEST^MR||ViergesAIRA^LaurindaAIRA^Erma^^^^L|NewportAIRA^NeciAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1305 Sa en Hunze Cir^^Detroit^MI^48220^USA^P||^PRN^PH^^^248^9232186|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ViergesAIRA^NewportAIRA^^^^^L|MTH^Mother^HL70063|1305 Sa en Hunze Cir^^Detroit^MI^48220^USA^P|^PRN^PH^^^248^9232186ORC|RE||BQ56C32957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ56C32957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281-915-68^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L25H32962^^^AIRA-TEST^MR||OfvermarkAIRA^ErmineAIRA^Annie^^^^L|WebsterAIRA^ChizuAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1923 Beiderland Ln^^Pontiac^MI^48340^USA^P||^PRN^PH^^^248^4945301|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OfvermarkAIRA^WebsterAIRA^^^^^L|MTH^Mother^HL70063|1923 Beiderland Ln^^Pontiac^MI^48340^USA^P|^PRN^PH^^^248^4945301ORC|RE||BL25H32962.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL25H32962.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001010^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001025|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N33Q32973^^^AIRA-TEST^MR||TobinAIRA^OfiliaAIRA^Daisy^^^^L|AlgerAIRA^CereliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1835 Wollands Kroon Pl^^Selfridge Air National Guard^MI^48045^USA^P||^PRN^PH^^^586^2753648|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TobinAIRA^AlgerAIRA^^^^^L|MTH^Mother^HL70063|1835 Wollands Kroon Pl^^Selfridge Air National Guard^MI^48045^USA^P|^PRN^PH^^^586^2753648ORC|RE||BN33Q32973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN33Q32973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001025^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001050|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T10X32981^^^AIRA-TEST^MR||MartinAIRA^ArletteAIRA^Linnea^^^^L|Santa ClaraAIRA^JaydaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1328 Lergeijk Pl^^Bham^MI^48012^USA^P||^PRN^PH^^^248^4596079|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MartinAIRA^Santa ClaraAIRA^^^^^L|MTH^Mother^HL70063|1328 Lergeijk Pl^^Bham^MI^48012^USA^P|^PRN^PH^^^248^4596079ORC|RE||BT10X32981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT10X32981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001050^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H08Z32989^^^AIRA-TEST^MR||MahaskaAIRA^SharniAIRA^Raphaela^^^^L|PendletonAIRA^AinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1994 Pijnacker-Nootdorp Pl^^Detroit^MI^48211^USA^P||^PRN^PH^^^313^6155542|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahaskaAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1994 Pijnacker-Nootdorp Pl^^Detroit^MI^48211^USA^P|^PRN^PH^^^313^6155542ORC|RE||BH08Z32989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH08Z32989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001110^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001150|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R62U32997^^^AIRA-TEST^MR||GartenlaubAIRA^NaomiAIRA^Nydia^^^^L|StonewallAIRA^FirakiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1384 Bekela St^^Grindstone City^MI^48467^USA^P||^PRN^PH^^^989^2473077|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GartenlaubAIRA^StonewallAIRA^^^^^L|MTH^Mother^HL70063|1384 Bekela St^^Grindstone City^MI^48467^USA^P|^PRN^PH^^^989^2473077ORC|RE||BR62U32997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR62U32997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001150^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F20D33002^^^AIRA-TEST^MR||LovingAIRA^IsolaAIRA^Efterpi^^^^L|GrahamAIRA^AlikeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1971 Wergen op Zoom St^^Nazareth^MI^49074^USA^P||^PRN^PH^^^269^5911683|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LovingAIRA^GrahamAIRA^^^^^L|MTH^Mother^HL70063|1971 Wergen op Zoom St^^Nazareth^MI^49074^USA^P|^PRN^PH^^^269^5911683ORC|RE||BF20D33002.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF20D33002.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001210^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001250|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T79L33013^^^AIRA-TEST^MR||SagadahocAIRA^MerisAIRA^Joyanne^^^^L|HoggAIRA^HavanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1265 Staphorst St^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^2060628|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SagadahocAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1265 Staphorst St^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^2060628ORC|RE||BT79L33013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT79L33013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001250^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B43F33021^^^AIRA-TEST^MR||LatimerAIRA^KristelAIRA^Arran^^^^L|GreeneAIRA^BenedictaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1581 Hlphen aan den Rijn Ave^^Eastmanville^MI^49404^USA^P||^PRN^PH^^^616^9671760|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LatimerAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1581 Hlphen aan den Rijn Ave^^Eastmanville^MI^49404^USA^P|^PRN^PH^^^616^9671760ORC|RE||BB43F33021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB43F33021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001310^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001350|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G49L33029^^^AIRA-TEST^MR||ArthurAIRA^DelcineAIRA^Christel^^^^L|GreerAIRA^ChaitalyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1640 Zaag Ave^^Lakeland^MI^48143^USA^P||^PRN^PH^^^810^5374473|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArthurAIRA^GreerAIRA^^^^^L|MTH^Mother^HL70063|1640 Zaag Ave^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^5374473ORC|RE||BG49L33029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG49L33029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001350^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001358|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I35F33037^^^AIRA-TEST^MR||ColoradoAIRA^SachiAIRA^Voleta^^^^L|DeschutesAIRA^PetaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1903 Eaaksbergen Ave^^Pompeii^MI^48874^USA^P||^PRN^PH^^^989^6856419|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColoradoAIRA^DeschutesAIRA^^^^^L|MTH^Mother^HL70063|1903 Eaaksbergen Ave^^Pompeii^MI^48874^USA^P|^PRN^PH^^^989^6856419ORC|RE||BI35F33037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI35F33037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001358^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D48A33042^^^AIRA-TEST^MR||SnohomishAIRA^AriciaAIRA^Lykaios^^^^L|DouglasAIRA^QuobaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1956 Bon en Breugel St^^Grand Ledge^MI^48837^USA^P||^PRN^PH^^^517^7741318|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SnohomishAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1956 Bon en Breugel St^^Grand Ledge^MI^48837^USA^P|^PRN^PH^^^517^7741318ORC|RE||BD48A33042.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD48A33042.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001388^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001450|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50M33053^^^AIRA-TEST^MR||CornelinsonAIRA^LillianAIRA^Mignon^^^^L|HougenAIRA^FondaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1866 Joststellingwerf St^^Watersmeet^MI^49969^USA^P||^PRN^PH^^^906^9237400|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CornelinsonAIRA^HougenAIRA^^^^^L|MTH^Mother^HL70063|1866 Joststellingwerf St^^Watersmeet^MI^49969^USA^P|^PRN^PH^^^906^9237400ORC|RE||BH50M33053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50M33053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001450^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281001488|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B12G33061^^^AIRA-TEST^MR||UnionAIRA^LuiseAIRA^Ishita^^^^L|O'DonnellAIRA^HettyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1419 Noeree-Overflakkee St^^Saginaw^MI^48605^USA^P||^PRN^PH^^^989^6124535|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^O'DonnellAIRA^^^^^L|MTH^Mother^HL70063|1419 Noeree-Overflakkee St^^Saginaw^MI^48605^USA^P|^PRN^PH^^^989^6124535ORC|RE||BB12G33061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB12G33061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281001488^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281011125|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A66K33069^^^AIRA-TEST^MR||HoltAIRA^ErikaAIRA^Meenakshi^^^^L|SciotoAIRA^NevaehAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1128 Reldermalsen Ave^^Brownstwn Township^MI^48174^USA^P||^PRN^PH^^^734^6182974|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoltAIRA^SciotoAIRA^^^^^L|MTH^Mother^HL70063|1128 Reldermalsen Ave^^Brownstwn Township^MI^48174^USA^P|^PRN^PH^^^734^6182974ORC|RE||BA66K33069.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA66K33069.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281011125^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281011225|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V41C33077^^^AIRA-TEST^MR||Walla WallaAIRA^EmaAIRA^Kelda^^^^L|McPhersonAIRA^KajolAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1474 Gratis Ave^^Grand Rapids^MI^49560^USA^P||^PRN^PH^^^616^9491418|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Walla WallaAIRA^McPhersonAIRA^^^^^L|MTH^Mother^HL70063|1474 Gratis Ave^^Grand Rapids^MI^49560^USA^P|^PRN^PH^^^616^9491418ORC|RE||BV41C33077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV41C33077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281011225^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281011300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G48A33082^^^AIRA-TEST^MR||MorrinAIRA^AnupamaAIRA^Coreen^^^^L|HarlanAIRA^EbertaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1935 Derg en Dal Cir^^Smyrna^MI^48887^USA^P||^PRN^PH^^^616^9280411|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrinAIRA^HarlanAIRA^^^^^L|MTH^Mother^HL70063|1935 Derg en Dal Cir^^Smyrna^MI^48887^USA^P|^PRN^PH^^^616^9280411ORC|RE||BG48A33082.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG48A33082.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281011300^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281011325|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J17N33093^^^AIRA-TEST^MR||MarshallAIRA^KathrynAIRA^Lisbeth^^^^L|PikeAIRA^KairosAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1578 Hwartewaterland Pl^^Honor^MI^49640^USA^P||^PRN^PH^^^231^4924233|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarshallAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1578 Hwartewaterland Pl^^Honor^MI^49640^USA^P|^PRN^PH^^^231^4924233ORC|RE||BJ17N33093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ17N33093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281011325^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281021510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X86E33101^^^AIRA-TEST^MR||WalcottAIRA^RupertaAIRA^Belinda^^^^L|ClayAIRA^GebrieleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1926 Hemert-Bakel St^^Palo^MI^48870^USA^P||^PRN^PH^^^989^6894206|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WalcottAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1926 Hemert-Bakel St^^Palo^MI^48870^USA^P|^PRN^PH^^^989^6894206ORC|RE||BX86E33101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX86E33101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281021510^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281021515|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I29C33109^^^AIRA-TEST^MR||HampsonAIRA^ArmadaAIRA^Graeae^^^^L|WrightAIRA^TatyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1753 Mudwest-Fryslan Pl^^Cedar River^MI^49887^USA^P||^PRN^PH^^^906^8052973|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HampsonAIRA^WrightAIRA^^^^^L|MTH^Mother^HL70063|1753 Mudwest-Fryslan Pl^^Cedar River^MI^49887^USA^P|^PRN^PH^^^906^8052973ORC|RE||BI29C33109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI29C33109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281021515^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281021558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I37K33117^^^AIRA-TEST^MR||HuronAIRA^AnkeAIRA^Moyna^^^^L|AuglaizeAIRA^TegwenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1157 Nooise Meren Ln^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^5273497|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuronAIRA^AuglaizeAIRA^^^^^L|MTH^Mother^HL70063|1157 Nooise Meren Ln^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^5273497ORC|RE||BI37K33117.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI37K33117.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281021558^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281021588|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L73A33122^^^AIRA-TEST^MR||WilliamsAIRA^DulcineaAIRA^Cara^^^^L|FremontAIRA^AileenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1185 Roirle Ln^^Saint Clair Shores^MI^48081^USA^P||^PRN^PH^^^586^9895136|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsAIRA^FremontAIRA^^^^^L|MTH^Mother^HL70063|1185 Roirle Ln^^Saint Clair Shores^MI^48081^USA^P|^PRN^PH^^^586^9895136ORC|RE||BL73A33122.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL73A33122.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281021588^TENIVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281022510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K96V33133^^^AIRA-TEST^MR||StevensAIRA^IvyAIRA^Dacio^^^^L|ChelanAIRA^NurayAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1284 Sterven Pl^^Hghtn Lk Heights^MI^48630^USA^P||^PRN^PH^^^989^7496194|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StevensAIRA^ChelanAIRA^^^^^L|MTH^Mother^HL70063|1284 Sterven Pl^^Hghtn Lk Heights^MI^48630^USA^P|^PRN^PH^^^989^7496194ORC|RE||BK96V33133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK96V33133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281022510^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281022558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V65O33141^^^AIRA-TEST^MR||ColemanAIRA^SkylaAIRA^Adah^^^^L|FremstadAIRA^HaimiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1222 Wreda Ave^^Madison Heights^MI^48071^USA^P||^PRN^PH^^^248^3240908|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColemanAIRA^FremstadAIRA^^^^^L|MTH^Mother^HL70063|1222 Wreda Ave^^Madison Heights^MI^48071^USA^P|^PRN^PH^^^248^3240908ORC|RE||BV65O33141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV65O33141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281022558^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281024858|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C59J33149^^^AIRA-TEST^MR||OwsleyAIRA^NathaniaAIRA^Nicole^^^^L|SalzeberAIRA^RoannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1864 Passen Ave^^Schaffer^MI^49807^USA^P||^PRN^PH^^^906^8628354|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwsleyAIRA^SalzeberAIRA^^^^^L|MTH^Mother^HL70063|1864 Passen Ave^^Schaffer^MI^49807^USA^P|^PRN^PH^^^906^8628354ORC|RE||BC59J33149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC59J33149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281024858^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281025051|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P14G33157^^^AIRA-TEST^MR||VenturaAIRA^RaimyAIRA^Karli^^^^L|OldhamAIRA^OrchidAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1320 Dorst aan de Maas Ave^^Walled Lake^MI^48390^USA^P||^PRN^PH^^^248^5915528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VenturaAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1320 Dorst aan de Maas Ave^^Walled Lake^MI^48390^USA^P|^PRN^PH^^^248^5915528ORC|RE||BP14G33157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP14G33157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281025051^IMOVAX RABIES^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281027810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q07C33165^^^AIRA-TEST^MR||WyomingAIRA^PangariAIRA^Ashlynn^^^^L|OfvermarkAIRA^ShannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1669 Moes Pl^^Stockbridge^MI^49285^USA^P||^PRN^PH^^^517^7440970|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WyomingAIRA^OfvermarkAIRA^^^^^L|MTH^Mother^HL70063|1669 Moes Pl^^Stockbridge^MI^49285^USA^P|^PRN^PH^^^517^7440970ORC|RE||BQ07C33165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ07C33165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281027810^DIPHTHERIA AND TETANUS TOXOIDS ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281028601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I32M33173^^^AIRA-TEST^MR||AllenAIRA^HelenaAIRA^Ellen^^^^L|MarinAIRA^CameoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1816 Bdam-Volendam St^^Barlow Branch^MI^49696^USA^P||^PRN^PH^^^231^5130898|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^MarinAIRA^^^^^L|MTH^Mother^HL70063|1816 Bdam-Volendam St^^Barlow Branch^MI^49696^USA^P|^PRN^PH^^^231^5130898ORC|RE||BI32M33173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI32M33173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281028601^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281028605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E08Q33178^^^AIRA-TEST^MR||ToaleAIRA^SkylarAIRA^Waltraud^^^^L|SacramentoAIRA^MinelliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1521 Rergeijk Cir^^Southfield^MI^48076^USA^P||^PRN^PH^^^248^3323429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ToaleAIRA^SacramentoAIRA^^^^^L|MTH^Mother^HL70063|1521 Rergeijk Cir^^Southfield^MI^48076^USA^P|^PRN^PH^^^248^3323429ORC|RE||BE08Q33178.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE08Q33178.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281028605^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281028610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q98S33189^^^AIRA-TEST^MR||FlemingAIRA^BeulahAIRA^Abrianna^^^^L|BrownfieldAIRA^NaimahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1790 Pose Cir^^Belding^MI^48809^USA^P||^PRN^PH^^^616^6267405|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FlemingAIRA^BrownfieldAIRA^^^^^L|MTH^Mother^HL70063|1790 Pose Cir^^Belding^MI^48809^USA^P|^PRN^PH^^^616^6267405ORC|RE||BQ98S33189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ98S33189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281028610^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281028658|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J73O33197^^^AIRA-TEST^MR||CochranAIRA^MuzafferAIRA^Reva^^^^L|MontourAIRA^SitembileAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1980 Butten Ave^^Commerce^MI^48390^USA^P||^PRN^PH^^^248^2133434|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CochranAIRA^MontourAIRA^^^^^L|MTH^Mother^HL70063|1980 Butten Ave^^Commerce^MI^48390^USA^P|^PRN^PH^^^248^2133434ORC|RE||BJ73O33197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ73O33197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281028658^DAPTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281029110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I26D33205^^^AIRA-TEST^MR||MercerAIRA^SerafinaAIRA^Anusree^^^^L|MontereyAIRA^PayalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1104 Voirle Pl^^Ripley^MI^49930^USA^P||^PRN^PH^^^906^2727163|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercerAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1104 Voirle Pl^^Ripley^MI^49930^USA^P|^PRN^PH^^^906^2727163ORC|RE||BI26D33205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI26D33205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281029110^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281029183|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G88L33213^^^AIRA-TEST^MR||CharlevoixAIRA^IngaborgAIRA^Lynelle^^^^L|OlssonAIRA^MadilynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1099 Cwartewaterland St^^Romulus^MI^48174^USA^P||^PRN^PH^^^734^6300780|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CharlevoixAIRA^OlssonAIRA^^^^^L|MTH^Mother^HL70063|1099 Cwartewaterland St^^Romulus^MI^48174^USA^P|^PRN^PH^^^734^6300780ORC|RE||BG88L33213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG88L33213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281029183^DECAVAC^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281029810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W00U33218^^^AIRA-TEST^MR||GarfieldAIRA^AneiraAIRA^Eirena^^^^L|LoveAIRA^EndaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1961 Zorne Pl^^Grawn^MI^49637^USA^P||^PRN^PH^^^231^5810526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarfieldAIRA^LoveAIRA^^^^^L|MTH^Mother^HL70063|1961 Zorne Pl^^Grawn^MI^49637^USA^P|^PRN^PH^^^231^5810526ORC|RE||BW00U33218.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW00U33218.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281029810^TRIPEDIA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281038615|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P49T33229^^^AIRA-TEST^MR||DodgeAIRA^LealaAIRA^Zuza^^^^L|McLeanAIRA^GaeaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1952 Eaaksbergen Cir^^Chesterfield^MI^48051^USA^P||^PRN^PH^^^586^3105281|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DodgeAIRA^McLeanAIRA^^^^^L|MTH^Mother^HL70063|1952 Eaaksbergen Cir^^Chesterfield^MI^48051^USA^P|^PRN^PH^^^586^3105281ORC|RE||BP49T33229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP49T33229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281038615^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281038765|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V58J33237^^^AIRA-TEST^MR||WhitmanAIRA^YseultAIRA^Quella^^^^L|CambriaAIRA^DianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1646 Dellendoorn Cir^^Comerica^MI^48267^USA^P||^PRN^PH^^^313^4975442|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitmanAIRA^CambriaAIRA^^^^^L|MTH^Mother^HL70063|1646 Dellendoorn Cir^^Comerica^MI^48267^USA^P|^PRN^PH^^^313^4975442ORC|RE||BV58J33237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV58J33237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281038765^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281038815|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y42K33245^^^AIRA-TEST^MR||MitchellAIRA^PivariAIRA^Gabriela^^^^L|SabineAIRA^CarmineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1583 Echijndel Ave^^Hermansville^MI^49847^USA^P||^PRN^PH^^^906^4281402|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MitchellAIRA^SabineAIRA^^^^^L|MTH^Mother^HL70063|1583 Echijndel Ave^^Hermansville^MI^49847^USA^P|^PRN^PH^^^906^4281402ORC|RE||BY42K33245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY42K33245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281038815^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281038965|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P01P33253^^^AIRA-TEST^MR||SeminoleAIRA^CybeleAIRA^Brandy^^^^L|San DiegoAIRA^StacyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1541 Vertegenwoordigen Pl^^Grosse Pointe Woods^MI^48236^USA^P||^PRN^PH^^^313^9472612|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SeminoleAIRA^San DiegoAIRA^^^^^L|MTH^Mother^HL70063|1541 Vertegenwoordigen Pl^^Grosse Pointe Woods^MI^48236^USA^P|^PRN^PH^^^313^9472612ORC|RE||BP01P33253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP01P33253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281038965^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039015|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O34H33258^^^AIRA-TEST^MR||TetlowAIRA^HeidyAIRA^Kyla^^^^L|WallerAIRA^VolanteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1278 Heeuwarden Pl^^Lansing^MI^48930^USA^P||^PRN^PH^^^517^3919102|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TetlowAIRA^WallerAIRA^^^^^L|MTH^Mother^HL70063|1278 Heeuwarden Pl^^Lansing^MI^48930^USA^P|^PRN^PH^^^517^3919102ORC|RE||BO34H33258.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO34H33258.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039015^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J14Y33269^^^AIRA-TEST^MR||Hood RiverAIRA^AmeliaAIRA^Loveday^^^^L|WhitakerAIRA^AnkareedaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1874 Wontfoort Ave^^Wyoming^MI^49548^USA^P||^PRN^PH^^^616^7103033|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Hood RiverAIRA^WhitakerAIRA^^^^^L|MTH^Mother^HL70063|1874 Wontfoort Ave^^Wyoming^MI^49548^USA^P|^PRN^PH^^^616^7103033ORC|RE||BJ14Y33269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ14Y33269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039165^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039215|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F58O33277^^^AIRA-TEST^MR||RobertsAIRA^KennaAIRA^Tina^^^^L|BurlesonAIRA^AldabellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1078 Fernheze Ln^^Boyne City^MI^49712^USA^P||^PRN^PH^^^231^8956345|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobertsAIRA^BurlesonAIRA^^^^^L|MTH^Mother^HL70063|1078 Fernheze Ln^^Boyne City^MI^49712^USA^P|^PRN^PH^^^231^8956345ORC|RE||BF58O33277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF58O33277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039215^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039278|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P09V33285^^^AIRA-TEST^MR||San SabaAIRA^PenelopeAIRA^Adela^^^^L|MarionAIRA^JanelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1066 Oeder-Betuwe Ave^^Jenison^MI^49428^USA^P||^PRN^PH^^^616^3422705|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San SabaAIRA^MarionAIRA^^^^^L|MTH^Mother^HL70063|1066 Oeder-Betuwe Ave^^Jenison^MI^49428^USA^P|^PRN^PH^^^616^3422705ORC|RE||BP09V33285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP09V33285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039278^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039365|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R48N33293^^^AIRA-TEST^MR||WayneAIRA^AlizaAIRA^Lilly^^^^L|CedarAIRA^CaryAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1406 Rlphen-Chaam St^^Capac^MI^48014^USA^P||^PRN^PH^^^810^5188966|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^CedarAIRA^^^^^L|MTH^Mother^HL70063|1406 Rlphen-Chaam St^^Capac^MI^48014^USA^P|^PRN^PH^^^810^5188966ORC|RE||BR48N33293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR48N33293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039365^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O42E33298^^^AIRA-TEST^MR||AtascosaAIRA^RaphaelaAIRA^Padmini^^^^L|PawneeAIRA^TegwenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1986 Minder St^^Cedar^MI^49621^USA^P||^PRN^PH^^^231^7452161|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtascosaAIRA^PawneeAIRA^^^^^L|MTH^Mother^HL70063|1986 Minder St^^Cedar^MI^49621^USA^P|^PRN^PH^^^231^7452161ORC|RE||BO42E33298.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO42E33298.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039388^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039415|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z18M33309^^^AIRA-TEST^MR||GillespieAIRA^BakanaAIRA^Harley^^^^L|VenturaAIRA^BlondelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1279 Mranekeradeel Ln^^Warren^MI^48088^USA^P||^PRN^PH^^^586^7910252|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GillespieAIRA^VenturaAIRA^^^^^L|MTH^Mother^HL70063|1279 Mranekeradeel Ln^^Warren^MI^48088^USA^P|^PRN^PH^^^586^7910252ORC|RE||BZ18M33309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ18M33309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039415^Fluzone^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039478|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J35I33317^^^AIRA-TEST^MR||ClarkAIRA^BronaAIRA^Reena^^^^L|WoodburyAIRA^YangchenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1141 Luijk Ln^^Byron Township^MI^49315^USA^P||^PRN^PH^^^616^2910626|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkAIRA^WoodburyAIRA^^^^^L|MTH^Mother^HL70063|1141 Luijk Ln^^Byron Township^MI^49315^USA^P|^PRN^PH^^^616^2910626ORC|RE||BJ35I33317.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ35I33317.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039478^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039565|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N98O33325^^^AIRA-TEST^MR||KjerulfAIRA^DarrelleAIRA^Kirsten^^^^L|MissaukeeAIRA^IsobelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1100 Pangedijk Cir^^Ida^MI^48140^USA^P||^PRN^PH^^^734^8764069|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KjerulfAIRA^MissaukeeAIRA^^^^^L|MTH^Mother^HL70063|1100 Pangedijk Cir^^Ida^MI^48140^USA^P|^PRN^PH^^^734^8764069ORC|RE||BN98O33325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98O33325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039565^FLUZONE HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039588|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S29W33333^^^AIRA-TEST^MR||StarkAIRA^BernadineAIRA^Tadako^^^^L|TiogaAIRA^LavaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1709 Senlo Ave^^Brethren^MI^49619^USA^P||^PRN^PH^^^231^8185510|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StarkAIRA^TiogaAIRA^^^^^L|MTH^Mother^HL70063|1709 Senlo Ave^^Brethren^MI^49619^USA^P|^PRN^PH^^^231^8185510ORC|RE||BS29W33333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS29W33333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039588^Fluzone HD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039615|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D06O33338^^^AIRA-TEST^MR||Santa CruzAIRA^VidoniaAIRA^Charity^^^^L|CreekAIRA^PhoenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1988 Genlo Cir^^Interlochen^MI^49643^USA^P||^PRN^PH^^^231^6378776|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa CruzAIRA^CreekAIRA^^^^^L|MTH^Mother^HL70063|1988 Genlo Cir^^Interlochen^MI^49643^USA^P|^PRN^PH^^^231^6378776ORC|RE||BD06O33338.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD06O33338.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039615^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039678|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O38C33349^^^AIRA-TEST^MR||LawrenceAIRA^MyraAIRA^Imogene^^^^L|GratiotAIRA^SmitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1625 Naren Ave^^Pearl Beach^MI^48001^USA^P||^PRN^PH^^^810^9053919|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LawrenceAIRA^GratiotAIRA^^^^^L|MTH^Mother^HL70063|1625 Naren Ave^^Pearl Beach^MI^48001^USA^P|^PRN^PH^^^810^9053919ORC|RE||BO38C33349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO38C33349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039678^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039765|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S81P33357^^^AIRA-TEST^MR||KitsapAIRA^XyliaAIRA^Allison^^^^L|StrubleAIRA^KristalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1739 Nestland St^^Omena^MI^49674^USA^P||^PRN^PH^^^231^8610279|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KitsapAIRA^StrubleAIRA^^^^^L|MTH^Mother^HL70063|1739 Nestland St^^Omena^MI^49674^USA^P|^PRN^PH^^^231^8610279ORC|RE||BS81P33357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS81P33357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039765^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039788|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K12S33365^^^AIRA-TEST^MR||DaviessAIRA^VenetiaAIRA^Felipa^^^^L|BrowneAIRA^MajondraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1875 Fe Fryske Marren Ln^^Milford Township^MI^48381^USA^P||^PRN^PH^^^248^2623725|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DaviessAIRA^BrowneAIRA^^^^^L|MTH^Mother^HL70063|1875 Fe Fryske Marren Ln^^Milford Township^MI^48381^USA^P|^PRN^PH^^^248^2623725ORC|RE||BK12S33365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK12S33365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039788^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039965|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E31K33373^^^AIRA-TEST^MR||RinggoldAIRA^LinnetAIRA^Alina^^^^L|ClearwaterAIRA^KoraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1154 Koerden St^^Us Army Tank-Auto Command^MI^48397^USA^P||^PRN^PH^^^586^5905281|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RinggoldAIRA^ClearwaterAIRA^^^^^L|MTH^Mother^HL70063|1154 Koerden St^^Us Army Tank-Auto Command^MI^48397^USA^P|^PRN^PH^^^586^5905281ORC|RE||BE31K33373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE31K33373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039965^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281039988|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G78N33381^^^AIRA-TEST^MR||GrantAIRA^MaiaAIRA^Jessie^^^^L|MissaukeeAIRA^MildredAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1852 Suijk St^^Pontiac^MI^48342^USA^P||^PRN^PH^^^248^5111590|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^MissaukeeAIRA^^^^^L|MTH^Mother^HL70063|1852 Suijk St^^Pontiac^MI^48342^USA^P|^PRN^PH^^^248^5111590ORC|RE||BG78N33381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG78N33381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281039988^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S10V33389^^^AIRA-TEST^MR||StephensAIRA^ViolentaAIRA^Mohana^^^^L|LoveAIRA^DevikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1445 Guiven St^^Port Sanilac^MI^48469^USA^P||^PRN^PH^^^810^2105912|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StephensAIRA^LoveAIRA^^^^^L|MTH^Mother^HL70063|1445 Guiven St^^Port Sanilac^MI^48469^USA^P|^PRN^PH^^^810^2105912ORC|RE||BS10V33389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS10V33389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040005^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O66R33394^^^AIRA-TEST^MR||WayrynenAIRA^DahliaAIRA^Briar^^^^L|DallamAIRA^RomyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1668 Gijnacker-Nootdorp Ave^^Washington Township^MI^48095^USA^P||^PRN^PH^^^586^6903339|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayrynenAIRA^DallamAIRA^^^^^L|MTH^Mother^HL70063|1668 Gijnacker-Nootdorp Ave^^Washington Township^MI^48095^USA^P|^PRN^PH^^^586^6903339ORC|RE||BO66R33394.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO66R33394.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040010^ADACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040015|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O40G33405^^^AIRA-TEST^MR||BernstrainAIRA^ZeldaAIRA^Mridul^^^^L|CopelandAIRA^VickiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1722 Oden St^^Holt^MI^48842^USA^P||^PRN^PH^^^517^4565992|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BernstrainAIRA^CopelandAIRA^^^^^L|MTH^Mother^HL70063|1722 Oden St^^Holt^MI^48842^USA^P|^PRN^PH^^^517^4565992ORC|RE||BO40G33405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO40G33405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040015^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040020|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F33X33413^^^AIRA-TEST^MR||ClintonAIRA^EbonyAIRA^Minnie^^^^L|PowellAIRA^KatrineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1329 Relmond Pl^^Jerome^MI^49249^USA^P||^PRN^PH^^^517^8585332|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1329 Relmond Pl^^Jerome^MI^49249^USA^P|^PRN^PH^^^517^8585332ORC|RE||BF33X33413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF33X33413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040020^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040058|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H11R33421^^^AIRA-TEST^MR||GreenAIRA^Tineka JawanaAIRA^Avril^^^^L|PendletonAIRA^GeneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1295 Sneeuw Ave^^Watervliet^MI^49098^USA^P||^PRN^PH^^^269^4802771|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreenAIRA^PendletonAIRA^^^^^L|MTH^Mother^HL70063|1295 Sneeuw Ave^^Watervliet^MI^49098^USA^P|^PRN^PH^^^269^4802771ORC|RE||BH11R33421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH11R33421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040058^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A55F33429^^^AIRA-TEST^MR||ChristensonAIRA^JenicaAIRA^Myra^^^^L|ComalAIRA^AkilaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1146 Kranendonck Ln^^L' Anse^MI^49946^USA^P||^PRN^PH^^^906^2571690|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChristensonAIRA^ComalAIRA^^^^^L|MTH^Mother^HL70063|1146 Kranendonck Ln^^L' Anse^MI^49946^USA^P|^PRN^PH^^^906^2571690ORC|RE||BA55F33429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA55F33429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040088^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040089|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W04Y33437^^^AIRA-TEST^MR||SpoonerAIRA^BajiAIRA^Aponi^^^^L|DodgeAIRA^AileenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1077 Meppel Cir^^Saginaw^MI^48606^USA^P||^PRN^PH^^^989^5773093|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SpoonerAIRA^DodgeAIRA^^^^^L|MTH^Mother^HL70063|1077 Meppel Cir^^Saginaw^MI^48606^USA^P|^PRN^PH^^^989^5773093ORC|RE||BW04Y33437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW04Y33437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040089^Adacel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C98Z33445^^^AIRA-TEST^MR||PayneAIRA^PegAIRA^Melanctha^^^^L|PowellAIRA^BrennaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1730 Oalsmeer Ln^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^6710905|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PayneAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1730 Oalsmeer Ln^^Cannonsburg^MI^49317^USA^P|^PRN^PH^^^616^6710905ORC|RE||BC98Z33445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC98Z33445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040165^Fluzone High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040188|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M68D33450^^^AIRA-TEST^MR||ColumbiaAIRA^MakikoAIRA^Cadence^^^^L|DanuelsonAIRA^BethshayaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1343 Deder-Betuwe Ave^^Southfield^MI^48033^USA^P||^PRN^PH^^^248^4401095|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColumbiaAIRA^DanuelsonAIRA^^^^^L|MTH^Mother^HL70063|1343 Deder-Betuwe Ave^^Southfield^MI^48033^USA^P|^PRN^PH^^^248^4401095ORC|RE||BM68D33450.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM68D33450.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040188^Fluzone, High Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040365|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H42Y33461^^^AIRA-TEST^MR||RainsAIRA^CauveryAIRA^Saryu^^^^L|ValleyAIRA^LeilaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1303 Kastricum Cir^^Harrison Township^MI^48045^USA^P||^PRN^PH^^^586^2488715|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RainsAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1303 Kastricum Cir^^Harrison Township^MI^48045^USA^P|^PRN^PH^^^586^2488715ORC|RE||BH42Y33461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH42Y33461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040365^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281040388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G87R33469^^^AIRA-TEST^MR||LeonAIRA^AparajitaAIRA^Maizah^^^^L|AdamsAIRA^SachaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1664 Lijfheerenlanden St^^Beechwood^MI^49935^USA^P||^PRN^PH^^^906^4645143|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeonAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1664 Lijfheerenlanden St^^Beechwood^MI^49935^USA^P|^PRN^PH^^^906^4645143ORC|RE||BG87R33469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG87R33469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281040388^FLUZONE High-Dose^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O14N33477^^^AIRA-TEST^MR||MenardAIRA^AnezkaAIRA^Rajni^^^^L|ProtheroeAIRA^KylieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1929 Kersel Pl^^Gm Vehicle Development Center^MI^48557^USA^P||^PRN^PH^^^810^8119010|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenardAIRA^ProtheroeAIRA^^^^^L|MTH^Mother^HL70063|1929 Kersel Pl^^Gm Vehicle Development Center^MI^48557^USA^P|^PRN^PH^^^810^8119010ORC|RE||BO14N33477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO14N33477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041310^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041350|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W28T33485^^^AIRA-TEST^MR||FrontierAIRA^JasminAIRA^Ashling^^^^L|IronAIRA^OctaviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1004 Littard-Geleen Ln^^Kalamazoo^MI^49007^USA^P||^PRN^PH^^^269^9642037|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FrontierAIRA^IronAIRA^^^^^L|MTH^Mother^HL70063|1004 Littard-Geleen Ln^^Kalamazoo^MI^49007^USA^P|^PRN^PH^^^269^9642037ORC|RE||BW28T33485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW28T33485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041350^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041358|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H15H33490^^^AIRA-TEST^MR||SalineAIRA^OrnellaAIRA^Brie^^^^L|ClarkAIRA^KaitlynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1896 Nalfsen Ln^^Bois Blanc Island^MI^49775^USA^P||^PRN^PH^^^231^3942890|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SalineAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1896 Nalfsen Ln^^Bois Blanc Island^MI^49775^USA^P|^PRN^PH^^^231^3942890ORC|RE||BH15H33490.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH15H33490.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041358^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041388|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V85S33501^^^AIRA-TEST^MR||MadisonAIRA^BrierAIRA^Stephany^^^^L|DeltaAIRA^FrancescaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1842 Aingewaard Cir^^Eagle River^MI^49950^USA^P||^PRN^PH^^^906^6755540|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^DeltaAIRA^^^^^L|MTH^Mother^HL70063|1842 Aingewaard Cir^^Eagle River^MI^49950^USA^P|^PRN^PH^^^906^6755540ORC|RE||BV85S33501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV85S33501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041388^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P78P33509^^^AIRA-TEST^MR||O'BrianAIRA^JenellAIRA^Cornelian^^^^L|FlemingAIRA^AlannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1702 Rmallingerland Cir^^Waterford^MI^48329^USA^P||^PRN^PH^^^248^2039278|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'BrianAIRA^FlemingAIRA^^^^^L|MTH^Mother^HL70063|1702 Rmallingerland Cir^^Waterford^MI^48329^USA^P|^PRN^PH^^^248^2039278ORC|RE||BP78P33509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP78P33509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041410^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041450|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C21K33517^^^AIRA-TEST^MR||DunnAIRA^DeirdreAIRA^Visala^^^^L|DouglasAIRA^ElizabethAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1645 Benterwolde Ln^^Palmer^MI^49871^USA^P||^PRN^PH^^^906^8403042|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DunnAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1645 Benterwolde Ln^^Palmer^MI^49871^USA^P|^PRN^PH^^^906^8403042ORC|RE||BC21K33517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC21K33517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041450^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041458|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D74E33525^^^AIRA-TEST^MR||SmithAIRA^DestineeAIRA^Doneen^^^^L|ComalAIRA^DylanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1442 Koerden Ln^^Hoxeyville^MI^49601^USA^P||^PRN^PH^^^231^2447056|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SmithAIRA^ComalAIRA^^^^^L|MTH^Mother^HL70063|1442 Koerden Ln^^Hoxeyville^MI^49601^USA^P|^PRN^PH^^^231^2447056ORC|RE||BD74E33525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD74E33525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041458^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041488|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G13O33530^^^AIRA-TEST^MR||HardinAIRA^YuriAIRA^Carina^^^^L|BlairAIRA^JaneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1582 Zon Pl^^Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^4050239|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HardinAIRA^BlairAIRA^^^^^L|MTH^Mother^HL70063|1582 Zon Pl^^Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^4050239ORC|RE||BG13O33530.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG13O33530.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041488^Fluzone Quadrivalent PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W20X33541^^^AIRA-TEST^MR||BonnevilleAIRA^ChizuAIRA^Taryn^^^^L|BarrettAIRA^OrianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1672 Hteenbergen Pl^^Athens^MI^49011^USA^P||^PRN^PH^^^269^2158228|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BonnevilleAIRA^BarrettAIRA^^^^^L|MTH^Mother^HL70063|1672 Hteenbergen Pl^^Athens^MI^49011^USA^P|^PRN^PH^^^269^2158228ORC|RE||BW20X33541.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW20X33541.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041510^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K95Y33549^^^AIRA-TEST^MR||WayneAIRA^KelilaAIRA^Roma^^^^L|CrawfordAIRA^EkaterinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1903 Straight Ave^^L Anse^MI^49946^USA^P||^PRN^PH^^^906^5854627|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1903 Straight Ave^^L Anse^MI^49946^USA^P|^PRN^PH^^^906^5854627ORC|RE||BK95Y33549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK95Y33549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041558^FLUZONE QUADRIVALENT PF^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041588|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J43Q33557^^^AIRA-TEST^MR||McClainAIRA^AlexaAIRA^Tess^^^^L|BuckshornAIRA^MeganAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1312 Bwartewaterland Ln^^Rives Jct^MI^49277^USA^P||^PRN^PH^^^517^5002980|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McClainAIRA^BuckshornAIRA^^^^^L|MTH^Mother^HL70063|1312 Bwartewaterland Ln^^Rives Jct^MI^49277^USA^P|^PRN^PH^^^517^5002980ORC|RE||BJ43Q33557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ43Q33557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041588^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G69E33565^^^AIRA-TEST^MR||ButlerAIRA^AretinaAIRA^Shannah^^^^L|Del NorteAIRA^CarlottaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1259 Dank Ave^^Wayne^MI^48184^USA^P||^PRN^PH^^^734^7861157|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^Del NorteAIRA^^^^^L|MTH^Mother^HL70063|1259 Dank Ave^^Wayne^MI^48184^USA^P|^PRN^PH^^^734^7861157ORC|RE||BG69E33565.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG69E33565.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041610^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041650|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y73C33570^^^AIRA-TEST^MR||MorganAIRA^NatashaAIRA^Prashanti^^^^L|RileyAIRA^SabihaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1641 Steenwijkerland St^^GR^MI^49504^USA^P||^PRN^PH^^^616^5439525|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^RileyAIRA^^^^^L|MTH^Mother^HL70063|1641 Steenwijkerland St^^GR^MI^49504^USA^P|^PRN^PH^^^616^5439525ORC|RE||BY73C33570.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY73C33570.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041650^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041658|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J28Y33578^^^AIRA-TEST^MR||CalhounAIRA^AneyaAIRA^Trudy^^^^L|SponlandAIRA^AndrayaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1004 Gemert-Bakel Ave^^Kawkawlin^MI^48631^USA^P||^PRN^PH^^^989^5207877|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CalhounAIRA^SponlandAIRA^^^^^L|MTH^Mother^HL70063|1004 Gemert-Bakel Ave^^Kawkawlin^MI^48631^USA^P|^PRN^PH^^^989^5207877ORC|RE||BJ28Y33578.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ28Y33578.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041658^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041688|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K94V33589^^^AIRA-TEST^MR||ComanoAIRA^ManuelaAIRA^Esperance^^^^L|Roger MillsAIRA^SahanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1088 Zchagen Cir^^GR^MI^49503^USA^P||^PRN^PH^^^616^4522899|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComanoAIRA^Roger MillsAIRA^^^^^L|MTH^Mother^HL70063|1088 Zchagen Cir^^GR^MI^49503^USA^P|^PRN^PH^^^616^4522899ORC|RE||BK94V33589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK94V33589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041688^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H74N33597^^^AIRA-TEST^MR||MooreAIRA^MarleneAIRA^Kaliska^^^^L|JohnstonAIRA^MarieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1119 Bissewaard Ave^^Centreville^MI^49032^USA^P||^PRN^PH^^^269^5932791|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MooreAIRA^JohnstonAIRA^^^^^L|MTH^Mother^HL70063|1119 Bissewaard Ave^^Centreville^MI^49032^USA^P|^PRN^PH^^^269^5932791ORC|RE||BH74N33597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH74N33597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041710^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041750|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K15J33605^^^AIRA-TEST^MR||ShastaAIRA^PurvaAIRA^Adoncia^^^^L|CoosAIRA^KatrinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1871 Gebruiken St^^Good Hart^MI^49737^USA^P||^PRN^PH^^^616^2350029|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShastaAIRA^CoosAIRA^^^^^L|MTH^Mother^HL70063|1871 Gebruiken St^^Good Hart^MI^49737^USA^P|^PRN^PH^^^616^2350029ORC|RE||BK15J33605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK15J33605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041750^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041758|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K88Z33613^^^AIRA-TEST^MR||Pend OreilleAIRA^KinetaAIRA^Peni^^^^L|KartwoldAIRA^MalenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1270 Oppervlak Pl^^Northfield Township^MI^48189^USA^P||^PRN^PH^^^734^3789187|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Pend OreilleAIRA^KartwoldAIRA^^^^^L|MTH^Mother^HL70063|1270 Oppervlak Pl^^Northfield Township^MI^48189^USA^P|^PRN^PH^^^734^3789187ORC|RE||BK88Z33613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK88Z33613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041758^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041788|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E82I33621^^^AIRA-TEST^MR||GuernseyAIRA^RasikaAIRA^Teagan^^^^L|RoscommonAIRA^MikaylaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1750 Aeiderdorp St^^Lansing^MI^48950^USA^P||^PRN^PH^^^517^5157669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuernseyAIRA^RoscommonAIRA^^^^^L|MTH^Mother^HL70063|1750 Aeiderdorp St^^Lansing^MI^48950^USA^P|^PRN^PH^^^517^5157669ORC|RE||BE82I33621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE82I33621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041788^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E54X33626^^^AIRA-TEST^MR||DanielsonAIRA^BrieAIRA^Lucy^^^^L|WilliamsAIRA^MelliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1967 Everbetuwe Ln^^Watton^MI^49970^USA^P||^PRN^PH^^^906^6828858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DanielsonAIRA^WilliamsAIRA^^^^^L|MTH^Mother^HL70063|1967 Everbetuwe Ln^^Watton^MI^49970^USA^P|^PRN^PH^^^906^6828858ORC|RE||BE54X33626.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE54X33626.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041810^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041850|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G13H33637^^^AIRA-TEST^MR||EricksonAIRA^LilliAIRA^Vida^^^^L|SiouxAIRA^AlthedaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1293 Nontferland Pl^^Camp Grayling^MI^49739^USA^P||^PRN^PH^^^989^7367369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EricksonAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1293 Nontferland Pl^^Camp Grayling^MI^49739^USA^P|^PRN^PH^^^989^7367369ORC|RE||BG13H33637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG13H33637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041850^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041858|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K17O33645^^^AIRA-TEST^MR||JohnssonAIRA^LimberAIRA^Dixie^^^^L|SmithAIRA^PascaleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1373 Guiven Cir^^Ameritech^MI^48663^USA^P||^PRN^PH^^^989^5503773|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnssonAIRA^SmithAIRA^^^^^L|MTH^Mother^HL70063|1373 Guiven Cir^^Ameritech^MI^48663^USA^P|^PRN^PH^^^989^5503773ORC|RE||BK17O33645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK17O33645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041858^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281041888|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R45A33653^^^AIRA-TEST^MR||ManningAIRA^UnnatiAIRA^Kayla^^^^L|DillAIRA^SnigdhaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1321 Alphen aan den Rijn Ln^^Farwell^MI^48622^USA^P||^PRN^PH^^^989^2944799|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ManningAIRA^DillAIRA^^^^^L|MTH^Mother^HL70063|1321 Alphen aan den Rijn Ln^^Farwell^MI^48622^USA^P|^PRN^PH^^^989^2944799ORC|RE||BR45A33653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR45A33653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281041888^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281048758|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T89M33661^^^AIRA-TEST^MR||DimmitAIRA^MelancthaAIRA^Primrose^^^^L|CanadianAIRA^VelvetAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1169 Vijf Pl^^Athens^MI^49011^USA^P||^PRN^PH^^^269^4169279|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DimmitAIRA^CanadianAIRA^^^^^L|MTH^Mother^HL70063|1169 Vijf Pl^^Athens^MI^49011^USA^P|^PRN^PH^^^269^4169279ORC|RE||BT89M33661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT89M33661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281048758^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281048878|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P09C33666^^^AIRA-TEST^MR||QuinlaAIRA^ClareAIRA^Estrella^^^^L|ShermanAIRA^EskarneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1085 Le Marne St^^Carsonville^MI^48419^USA^P||^PRN^PH^^^810^3850629|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|QuinlaAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1085 Le Marne St^^Carsonville^MI^48419^USA^P|^PRN^PH^^^810^3850629ORC|RE||BP09C33666.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP09C33666.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281048878^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281048901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R96R33677^^^AIRA-TEST^MR||BrewsterAIRA^MildredAIRA^Philippa^^^^L|GladwinAIRA^RoshanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1856 Rlphen aan den Rijn Ave^^Gaylord^MI^49735^USA^P||^PRN^PH^^^989^3120526|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrewsterAIRA^GladwinAIRA^^^^^L|MTH^Mother^HL70063|1856 Rlphen aan den Rijn Ave^^Gaylord^MI^49735^USA^P|^PRN^PH^^^989^3120526ORC|RE||BR96R33677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR96R33677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281048901^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281048991|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A51S33685^^^AIRA-TEST^MR||BeaverAIRA^MersadizeAIRA^Valisa^^^^L|FayetteAIRA^ArielAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1225 Ba en Hunze St^^Rockwood^MI^48173^USA^P||^PRN^PH^^^734^7608387|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1225 Ba en Hunze St^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^7608387ORC|RE||BA51S33685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA51S33685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281048991^MENOMUNE - A/C/Y/W-135 COMBINED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z13P33693^^^AIRA-TEST^MR||KeanyAIRA^ZiselAIRA^Jocasta^^^^L|WintermanAIRA^VasantiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1179 Sijnwaarden Ln^^Portage^MI^49002^USA^P||^PRN^PH^^^269^9886769|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KeanyAIRA^WintermanAIRA^^^^^L|MTH^Mother^HL70063|1179 Sijnwaarden Ln^^Portage^MI^49002^USA^P|^PRN^PH^^^269^9886769ORC|RE||BZ13P33693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ13P33693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051005^PENTACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P43T33701^^^AIRA-TEST^MR||SacramentoAIRA^AmaniAIRA^Tillie^^^^L|MaderaAIRA^MarinkaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1118 Rodegraven-Reeuwijk Ave^^Camp Grayling^MI^49739^USA^P||^PRN^PH^^^989^7581312|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SacramentoAIRA^MaderaAIRA^^^^^L|MTH^Mother^HL70063|1118 Rodegraven-Reeuwijk Ave^^Camp Grayling^MI^49739^USA^P|^PRN^PH^^^989^7581312ORC|RE||BP43T33701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP43T33701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051300^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051325|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P17W33706^^^AIRA-TEST^MR||GelfryAIRA^SerildaAIRA^Klavdia^^^^L|GrantAIRA^RaeleneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1034 Lopen Ave^^Midland^MI^48686^USA^P||^PRN^PH^^^989^8512473|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GelfryAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1034 Lopen Ave^^Midland^MI^48686^USA^P|^PRN^PH^^^989^8512473ORC|RE||BP17W33706.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP17W33706.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051325^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051400|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q58B33717^^^AIRA-TEST^MR||AnningAIRA^PreranaAIRA^Crystal^^^^L|BowieAIRA^NamiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1775 Moekel Ave^^Ontonagon^MI^49953^USA^P||^PRN^PH^^^906^2932798|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AnningAIRA^BowieAIRA^^^^^L|MTH^Mother^HL70063|1775 Moekel Ave^^Ontonagon^MI^49953^USA^P|^PRN^PH^^^906^2932798ORC|RE||BQ58B33717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ58B33717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051400^Fluzone Quadrivalent, Peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051425|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X96R33725^^^AIRA-TEST^MR||JacksonAIRA^RubyAIRA^Kaer^^^^L|WyandotAIRA^NathalieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1224 Heerijnen Ave^^Lansing^MI^48980^USA^P||^PRN^PH^^^517^7062618|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^WyandotAIRA^^^^^L|MTH^Mother^HL70063|1224 Heerijnen Ave^^Lansing^MI^48980^USA^P|^PRN^PH^^^517^7062618ORC|RE||BX96R33725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX96R33725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051425^Fluzone Quadrivalent, peds^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051600|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B76B33733^^^AIRA-TEST^MR||WinnebagoAIRA^BethanyAIRA^Orsa^^^^L|BrooksAIRA^StephanieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1288 Altijd Ln^^Dearborn^MI^48121^USA^P||^PRN^PH^^^313^9570298|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WinnebagoAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1288 Altijd Ln^^Dearborn^MI^48121^USA^P|^PRN^PH^^^313^9570298ORC|RE||BB76B33733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB76B33733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051600^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051625|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K99O33741^^^AIRA-TEST^MR||CumingAIRA^CallistoAIRA^Jigisha^^^^L|FremstadAIRA^MaryamAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1032 Vatwijk St^^Escanaba^MI^49829^USA^P||^PRN^PH^^^906^7811000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CumingAIRA^FremstadAIRA^^^^^L|MTH^Mother^HL70063|1032 Vatwijk St^^Escanaba^MI^49829^USA^P|^PRN^PH^^^906^7811000ORC|RE||BK99O33741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK99O33741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051625^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A13T33746^^^AIRA-TEST^MR||GladwinAIRA^BethanyAIRA^Barbie^^^^L|DillAIRA^CybillAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1966 Buijk Ln^^Belding^MI^48887^USA^P||^PRN^PH^^^616^3802468|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GladwinAIRA^DillAIRA^^^^^L|MTH^Mother^HL70063|1966 Buijk Ln^^Belding^MI^48887^USA^P|^PRN^PH^^^616^3802468ORC|RE||BA13T33746.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA13T33746.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051700^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051725|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H86M33757^^^AIRA-TEST^MR||CavilAIRA^JadaAIRA^Toni^^^^L|Santa ClaraAIRA^OzoraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1485 Hergeijk Pl^^Meskegon^MI^49442^USA^P||^PRN^PH^^^231^5279640|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CavilAIRA^Santa ClaraAIRA^^^^^L|MTH^Mother^HL70063|1485 Hergeijk Pl^^Meskegon^MI^49442^USA^P|^PRN^PH^^^231^5279640ORC|RE||BH86M33757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH86M33757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051725^Fluzone Quadrivalent, pediatric^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051800|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C13P33765^^^AIRA-TEST^MR||VenangoAIRA^GalenaAIRA^Meggie^^^^L|JacksonAIRA^BananAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1570 Halderberge Ave^^Sault Sainte Marie^MI^49783^USA^P||^PRN^PH^^^906^9390615|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VenangoAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1570 Halderberge Ave^^Sault Sainte Marie^MI^49783^USA^P|^PRN^PH^^^906^9390615ORC|RE||BC13P33765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC13P33765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051800^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281051825|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V58Z33773^^^AIRA-TEST^MR||SagadahocAIRA^SumatiAIRA^Keeley^^^^L|YamhillAIRA^PaniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1001 Aijkerk Pl^^Williamston^MI^48895^USA^P||^PRN^PH^^^517^8070413|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SagadahocAIRA^YamhillAIRA^^^^^L|MTH^Mother^HL70063|1001 Aijkerk Pl^^Williamston^MI^48895^USA^P|^PRN^PH^^^517^8070413ORC|RE||BV58Z33773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV58Z33773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281051825^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281054503|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R72A33781^^^AIRA-TEST^MR||JauppiAIRA^RohiniAIRA^Tizane^^^^L|PlumasAIRA^GeraldineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1208 Wudwest-Fryslan Pl^^Meskegon^MI^49440^USA^P||^PRN^PH^^^231^7402794|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JauppiAIRA^PlumasAIRA^^^^^L|MTH^Mother^HL70063|1208 Wudwest-Fryslan Pl^^Meskegon^MI^49440^USA^P|^PRN^PH^^^231^7402794ORC|RE||BR72A33781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR72A33781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281054503^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281054505|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W90K33786^^^AIRA-TEST^MR||RobertsAIRA^OrvokkiAIRA^Pierette^^^^L|DouglasAIRA^HyldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1580 Haals Cir^^Ellsworth^MI^49729^USA^P||^PRN^PH^^^231^8138213|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobertsAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1580 Haals Cir^^Ellsworth^MI^49729^USA^P|^PRN^PH^^^231^8138213ORC|RE||BW90K33786.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW90K33786.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281054505^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281054515|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U92B33797^^^AIRA-TEST^MR||BoydAIRA^PoojaAIRA^Atlanta^^^^L|MitchellAIRA^DaniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1111 Dpmeer Pl^^Eastpointe^MI^48021^USA^P||^PRN^PH^^^586^5173653|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BoydAIRA^MitchellAIRA^^^^^L|MTH^Mother^HL70063|1111 Dpmeer Pl^^Eastpointe^MI^48021^USA^P|^PRN^PH^^^586^5173653ORC|RE||BU92B33797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU92B33797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281054515^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281054758|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N94G33805^^^AIRA-TEST^MR||BagleyAIRA^SavinaAIRA^Maris^^^^L|SummresgillAIRA^ElfredaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1783 Dnderbanken Cir^^GR^MI^49512^USA^P||^PRN^PH^^^616^7878661|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BagleyAIRA^SummresgillAIRA^^^^^L|MTH^Mother^HL70063|1783 Dnderbanken Cir^^GR^MI^49512^USA^P|^PRN^PH^^^616^7878661ORC|RE||BN94G33805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN94G33805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281054758^ACTHIB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281056005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z56Y33813^^^AIRA-TEST^MR||CoryellAIRA^NanonAIRA^Hoshi^^^^L|TobinAIRA^BethanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1880 Eladel Ave^^Riverdale^MI^48877^USA^P||^PRN^PH^^^989^7520394|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoryellAIRA^TobinAIRA^^^^^L|MTH^Mother^HL70063|1880 Eladel Ave^^Riverdale^MI^48877^USA^P|^PRN^PH^^^989^7520394ORC|RE||BZ56Y33813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ56Y33813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281056005^DTAP-IPV^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281056210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F54R33821^^^AIRA-TEST^MR||CusackAIRA^JenellAIRA^Akanksha^^^^L|PatariAIRA^RoselynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1346 Asten Ln^^Ypsilanti^MI^48197^USA^P||^PRN^PH^^^734^9713482|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusackAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1346 Asten Ln^^Ypsilanti^MI^48197^USA^P|^PRN^PH^^^734^9713482ORC|RE||BF54R33821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF54R33821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281056210^Quadracel^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281056258|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O07R33826^^^AIRA-TEST^MR||YoloAIRA^GebrieleAIRA^Devika^^^^L|AlleghenyAIRA^FalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1162 Wde Cir^^Maple City^MI^49664^USA^P||^PRN^PH^^^231^3911987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoloAIRA^AlleghenyAIRA^^^^^L|MTH^Mother^HL70063|1162 Wde Cir^^Maple City^MI^49664^USA^P|^PRN^PH^^^231^3911987ORC|RE||BO07R33826.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO07R33826.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281056258^QUADRACEL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281058905|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E08G33837^^^AIRA-TEST^MR||HayesAIRA^JaffaAIRA^Hagar^^^^L|ArmstrongAIRA^DevoraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1939 Oedemblik Ave^^China^MI^48054^USA^P||^PRN^PH^^^810^5669260|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HayesAIRA^ArmstrongAIRA^^^^^L|MTH^Mother^HL70063|1939 Oedemblik Ave^^China^MI^48054^USA^P|^PRN^PH^^^810^5669260ORC|RE||BE08G33837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE08G33837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281058905^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281058958|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P04X33845^^^AIRA-TEST^MR||KjerulfAIRA^AlissaAIRA^Annora^^^^L|MorrinAIRA^ChanceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1775 Werschelling St^^Litchfield^MI^49252^USA^P||^PRN^PH^^^517^4330909|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KjerulfAIRA^MorrinAIRA^^^^^L|MTH^Mother^HL70063|1775 Werschelling St^^Litchfield^MI^49252^USA^P|^PRN^PH^^^517^4330909ORC|RE||BP04X33845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP04X33845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281058958^Menactra^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K81S33853^^^AIRA-TEST^MR||DakotaAIRA^NapeaAIRA^Kolora^^^^L|KlamathAIRA^QueenieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1607 Berneuzen Cir^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^2716476|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DakotaAIRA^KlamathAIRA^^^^^L|MTH^Mother^HL70063|1607 Berneuzen Cir^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^2716476ORC|RE||BK81S33853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK81S33853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062115^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062178|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F25J33861^^^AIRA-TEST^MR||HillsdaleAIRA^DeepikaAIRA^Chaylen^^^^L|McCrackenAIRA^AmadiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1116 Zronckhorst St^^Brighton Township^MI^48116^USA^P||^PRN^PH^^^810^8238674|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillsdaleAIRA^McCrackenAIRA^^^^^L|MTH^Mother^HL70063|1116 Zronckhorst St^^Brighton Township^MI^48116^USA^P|^PRN^PH^^^810^8238674ORC|RE||BF25J33861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF25J33861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062178^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062515|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I12R33866^^^AIRA-TEST^MR||PiscataquisAIRA^SharmisthaAIRA^Marielle^^^^L|La SalleAIRA^CarysAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1102 Slip St^^Minden City^MI^48456^USA^P||^PRN^PH^^^989^4708713|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PiscataquisAIRA^La SalleAIRA^^^^^L|MTH^Mother^HL70063|1102 Slip St^^Minden City^MI^48456^USA^P|^PRN^PH^^^989^4708713ORC|RE||BI12R33866.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI12R33866.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062515^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062578|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C58G33877^^^AIRA-TEST^MR||ZavalaAIRA^SupritiAIRA^Gytha^^^^L|PeskenAIRA^BerdineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1497 Dldebroek St^^Pontiac^MI^48343^USA^P||^PRN^PH^^^248^3267472|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ZavalaAIRA^PeskenAIRA^^^^^L|MTH^Mother^HL70063|1497 Dldebroek St^^Pontiac^MI^48343^USA^P|^PRN^PH^^^248^3267472ORC|RE||BC58G33877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC58G33877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062578^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062715|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S17J33885^^^AIRA-TEST^MR||UnionAIRA^ReineAIRA^Gypsy^^^^L|TaylorAIRA^RozaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1329 Oromstrijen Pl^^Brampton^MI^49837^USA^P||^PRN^PH^^^906^2510910|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1329 Oromstrijen Pl^^Brampton^MI^49837^USA^P|^PRN^PH^^^906^2510910ORC|RE||BS17J33885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS17J33885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062715^Fluzone quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062778|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J32C33893^^^AIRA-TEST^MR||CrawfordAIRA^SimbaAIRA^Miracle^^^^L|HenryAIRA^RyannAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1234 Simpelveld Ave^^Otisville^MI^48463^USA^P||^PRN^PH^^^810^4412826|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^HenryAIRA^^^^^L|MTH^Mother^HL70063|1234 Simpelveld Ave^^Otisville^MI^48463^USA^P|^PRN^PH^^^810^4412826ORC|RE||BJ32C33893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ32C33893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062778^Fluzone Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062915|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W46G33901^^^AIRA-TEST^MR||TylerAIRA^SanciaAIRA^Bree^^^^L|WayrynenAIRA^KymAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1837 Bereiken Ln^^Orion^MI^48360^USA^P||^PRN^PH^^^248^2873890|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TylerAIRA^WayrynenAIRA^^^^^L|MTH^Mother^HL70063|1837 Bereiken Ln^^Orion^MI^48360^USA^P|^PRN^PH^^^248^2873890ORC|RE||BW46G33901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW46G33901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062915^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281062978|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L38K33906^^^AIRA-TEST^MR||KearneyAIRA^PtolemaAIRA^Wanetta^^^^L|MackinacAIRA^EdreaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1585 Beeze-Leende Ln^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^4273792|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KearneyAIRA^MackinacAIRA^^^^^L|MTH^Mother^HL70063|1585 Beeze-Leende Ln^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^4273792ORC|RE||BL38K33906.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL38K33906.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281062978^FLUZONE QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281064015|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W64I33917^^^AIRA-TEST^MR||BuckshornAIRA^ImogeneAIRA^Noelani^^^^L|BaylorAIRA^BronwynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1232 Pistool Ave^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^2545375|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BuckshornAIRA^BaylorAIRA^^^^^L|MTH^Mother^HL70063|1232 Pistool Ave^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^2545375ORC|RE||BW64I33917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW64I33917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281064015^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281065010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H27M33925^^^AIRA-TEST^MR||IversenAIRA^OnidaAIRA^Athalia^^^^L|WayneAIRA^LoreAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1963 Aontfoort Ave^^Onekama^MI^49675^USA^P||^PRN^PH^^^231^2614940|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IversenAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1963 Aontfoort Ave^^Onekama^MI^49675^USA^P|^PRN^PH^^^231^2614940ORC|RE||BH27M33925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH27M33925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281065010^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281065025|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I68I33933^^^AIRA-TEST^MR||HeffernanAIRA^SilvestraAIRA^Harmony^^^^L|EdwardsAIRA^SukutaiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1127 Hpsterland Ln^^Concord^MI^49237^USA^P||^PRN^PH^^^517^9028611|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^EdwardsAIRA^^^^^L|MTH^Mother^HL70063|1127 Hpsterland Ln^^Concord^MI^49237^USA^P|^PRN^PH^^^517^9028611ORC|RE||BI68I33933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI68I33933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281065025^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281065050|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F58B33941^^^AIRA-TEST^MR||FisherAIRA^LouellaAIRA^Jeno^^^^L|HusseyAIRA^SheilaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1773 Voelen Cir^^Waterford Township^MI^48328^USA^P||^PRN^PH^^^248^3208765|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FisherAIRA^HusseyAIRA^^^^^L|MTH^Mother^HL70063|1773 Voelen Cir^^Waterford Township^MI^48328^USA^P|^PRN^PH^^^248^3208765ORC|RE||BF58B33941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF58B33941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281065050^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281065070|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C94Y33949^^^AIRA-TEST^MR||ByrneAIRA^WaltraudAIRA^Mira^^^^L|JulinAIRA^VenusAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1866 Teert Pl^^Pleasant Rdg^MI^48069^USA^P||^PRN^PH^^^248^5987147|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ByrneAIRA^JulinAIRA^^^^^L|MTH^Mother^HL70063|1866 Teert Pl^^Pleasant Rdg^MI^48069^USA^P|^PRN^PH^^^248^5987147ORC|RE||BC94Y33949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC94Y33949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281065070^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281065090|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E97G33957^^^AIRA-TEST^MR||SandstromAIRA^MerielAIRA^Darri^^^^L|LoganAIRA^RadellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1543 Wude IJsselstreek Ln^^Waldron^MI^49288^USA^P||^PRN^PH^^^517^7181561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SandstromAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1543 Wude IJsselstreek Ln^^Waldron^MI^49288^USA^P|^PRN^PH^^^517^7181561ORC|RE||BE97G33957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE97G33957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281065090^INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070355|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K26T33962^^^AIRA-TEST^MR||NacogdochesAIRA^YnezAIRA^Delta^^^^L|LoweAIRA^BernadetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1442 Bekela Pl^^Forest Lake^MI^49862^USA^P||^PRN^PH^^^906^2765417|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NacogdochesAIRA^LoweAIRA^^^^^L|MTH^Mother^HL70063|1442 Bekela Pl^^Forest Lake^MI^49862^USA^P|^PRN^PH^^^906^2765417ORC|RE||BK26T33962.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK26T33962.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070355^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070555|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R50Y33973^^^AIRA-TEST^MR||BurkeAIRA^RhodantheAIRA^Yareli^^^^L|WheelerAIRA^ShobhanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1488 Akkoord Cir^^Breedsville^MI^49027^USA^P||^PRN^PH^^^269^5015466|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1488 Akkoord Cir^^Breedsville^MI^49027^USA^P|^PRN^PH^^^269^5015466ORC|RE||BR50Y33973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR50Y33973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070555^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070748|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I54H33981^^^AIRA-TEST^MR||ClearwaterAIRA^MakaniAIRA^Jasmine^^^^L|MeaghanAIRA^KarliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1961 Sapelle St^^Chippewa Lake^MI^49320^USA^P||^PRN^PH^^^231^6868083|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClearwaterAIRA^MeaghanAIRA^^^^^L|MTH^Mother^HL70063|1961 Sapelle St^^Chippewa Lake^MI^49320^USA^P|^PRN^PH^^^231^6868083ORC|RE||BI54H33981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI54H33981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070748^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070755|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F66N33989^^^AIRA-TEST^MR||KeithAIRA^JaydaAIRA^Charleen^^^^L|LaneAIRA^TahirahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1253 Heerhugowaard Ln^^Lake Isabella^MI^48893^USA^P||^PRN^PH^^^989^8431255|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KeithAIRA^LaneAIRA^^^^^L|MTH^Mother^HL70063|1253 Heerhugowaard Ln^^Lake Isabella^MI^48893^USA^P|^PRN^PH^^^989^8431255ORC|RE||BF66N33989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF66N33989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070755^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070840|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F28B33997^^^AIRA-TEST^MR||LoganAIRA^KazannaAIRA^Marny^^^^L|FrontierAIRA^EmogeneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1463 Cijk bij Duurstede St^^Belding^MI^48887^USA^P||^PRN^PH^^^616^3877600|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoganAIRA^FrontierAIRA^^^^^L|MTH^Mother^HL70063|1463 Cijk bij Duurstede St^^Belding^MI^48887^USA^P|^PRN^PH^^^616^3877600ORC|RE||BF28B33997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF28B33997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070840^Fluzone Intradermal Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070848|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H11D34002^^^AIRA-TEST^MR||KnoxAIRA^WakandaAIRA^Ailish^^^^L|AdairAIRA^IsolaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1544 Oppingedam Pl^^North Street^MI^48049^USA^P||^PRN^PH^^^810^2699559|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^AdairAIRA^^^^^L|MTH^Mother^HL70063|1544 Oppingedam Pl^^North Street^MI^48049^USA^P|^PRN^PH^^^810^2699559ORC|RE||BH11D34002.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH11D34002.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070848^FLUZONE INTRADERMAL QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070948|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O88P34013^^^AIRA-TEST^MR||ShelbyAIRA^AgnesAIRA^Savina^^^^L|PatariAIRA^HarmonyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1474 Oromstrijen Ave^^Raisinvl Township^MI^48161^USA^P||^PRN^PH^^^734^7455156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^PatariAIRA^^^^^L|MTH^Mother^HL70063|1474 Oromstrijen Ave^^Raisinvl Township^MI^48161^USA^P|^PRN^PH^^^734^7455156ORC|RE||BO88P34013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO88P34013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070948^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281070955|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J71I34021^^^AIRA-TEST^MR||HoeyAIRA^OphrahAIRA^Cindylou^^^^L|BarrenAIRA^BlossomAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1975 Kestland St^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^6210537|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoeyAIRA^BarrenAIRA^^^^^L|MTH^Mother^HL70063|1975 Kestland St^^Lincoln Park^MI^48146^USA^P|^PRN^PH^^^313^6210537ORC|RE||BJ71I34021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ71I34021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281070955^FLUZONE Intradermal^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281071040|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E62S34029^^^AIRA-TEST^MR||IowaAIRA^ConcepcionAIRA^Sabina^^^^L|KearneyAIRA^CrystalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1926 Eittard-Geleen St^^Warren^MI^48090^USA^P||^PRN^PH^^^586^4792035|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IowaAIRA^KearneyAIRA^^^^^L|MTH^Mother^HL70063|1926 Eittard-Geleen St^^Warren^MI^48090^USA^P|^PRN^PH^^^586^4792035ORC|RE||BE62S34029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE62S34029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281071040^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281071048|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S20N34037^^^AIRA-TEST^MR||ClearwaterAIRA^DiamantaAIRA^Kiden^^^^L|LincolnAIRA^KerstinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1252 Vest Maas en Waal Pl^^Hanover^MI^49241^USA^P||^PRN^PH^^^517^7969819|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClearwaterAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1252 Vest Maas en Waal Pl^^Hanover^MI^49241^USA^P|^PRN^PH^^^517^7969819ORC|RE||BS20N34037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS20N34037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281071048^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281071240|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q98O34042^^^AIRA-TEST^MR||LickingAIRA^RosalindAIRA^Zera^^^^L|HallAIRA^SirounAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1182 Zingewaard St^^South Boardman^MI^49680^USA^P||^PRN^PH^^^231^8967451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LickingAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1182 Zingewaard St^^South Boardman^MI^49680^USA^P|^PRN^PH^^^231^8967451ORC|RE||BQ98O34042.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ98O34042.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281071240^fluzone ID quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281071248|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L49W34053^^^AIRA-TEST^MR||BranchAIRA^HalieyAIRA^Tobie^^^^L|HutchinsonAIRA^AneiraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1925 Bught Ln^^Milford^MI^48381^USA^P||^PRN^PH^^^248^7909620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BranchAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1925 Bught Ln^^Milford^MI^48381^USA^P|^PRN^PH^^^248^7909620ORC|RE||BL49W34053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL49W34053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281071248^Fluzone Intradermal quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281071810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D28N34061^^^AIRA-TEST^MR||MickelAIRA^SarikaAIRA^Tansy^^^^L|InghamAIRA^CarysAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1016 Bulst Pl^^Chippewa Temp Correction Fac^MI^49785^USA^P||^PRN^PH^^^906^7952309|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MickelAIRA^InghamAIRA^^^^^L|MTH^Mother^HL70063|1016 Bulst Pl^^Chippewa Temp Correction Fac^MI^49785^USA^P|^PRN^PH^^^906^7952309ORC|RE||BD28N34061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD28N34061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281071810^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281071888|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N72P34069^^^AIRA-TEST^MR||WayneAIRA^JasmineAIRA^Amaya^^^^L|ErikssonAIRA^NanetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1763 Dundert Pl^^Manton^MI^49663^USA^P||^PRN^PH^^^231^2110078|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1763 Dundert Pl^^Manton^MI^49663^USA^P|^PRN^PH^^^231^2110078ORC|RE||BN72P34069.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN72P34069.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281071888^Flublok Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281079020|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F27S34077^^^AIRA-TEST^MR||ClintonAIRA^SanciaAIRA^Nevaeh^^^^L|McEntegartAIRA^LowanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1583 Dijkerk Cir^^Michigan Bulb Co^MI^49550^USA^P||^PRN^PH^^^616^4153227|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^McEntegartAIRA^^^^^L|MTH^Mother^HL70063|1583 Dijkerk Cir^^Michigan Bulb Co^MI^49550^USA^P|^PRN^PH^^^616^4153227ORC|RE||BF27S34077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF27S34077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281079020^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281079038|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U47W34082^^^AIRA-TEST^MR||JohnsonAIRA^LaniAIRA^Undine^^^^L|MorreyAIRA^HeidiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1474 Pestland Ave^^Flint^MI^48506^USA^P||^PRN^PH^^^810^7619217|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^MorreyAIRA^^^^^L|MTH^Mother^HL70063|1474 Pestland Ave^^Flint^MI^48506^USA^P|^PRN^PH^^^810^7619217ORC|RE||BU47W34082.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU47W34082.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281079038^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281079051|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L50V34093^^^AIRA-TEST^MR||BeecherAIRA^ParveenAIRA^Akshita^^^^L|BrownAIRA^LitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1623 Ochouwen-Duiveland St^^Macomb^MI^48042^USA^P||^PRN^PH^^^586^3473354|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeecherAIRA^BrownAIRA^^^^^L|MTH^Mother^HL70063|1623 Ochouwen-Duiveland St^^Macomb^MI^48042^USA^P|^PRN^PH^^^586^3473354ORC|RE||BL50V34093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL50V34093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281079051^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281079088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O97O34101^^^AIRA-TEST^MR||FultonAIRA^AnvitaAIRA^Daba^^^^L|CrawfordAIRA^ShivaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1948 Rij Ave^^Port Huron^MI^48060^USA^P||^PRN^PH^^^810^5218795|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FultonAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1948 Rij Ave^^Port Huron^MI^48060^USA^P|^PRN^PH^^^810^5218795ORC|RE||BO97O34101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO97O34101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281079088^Typhim Vi^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281080083|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O15N34109^^^AIRA-TEST^MR||JohnsonAIRA^AyannaAIRA^Valencia^^^^L|GosperAIRA^VedetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1994 Seeuwarderadeel Cir^^Owendale^MI^48754^USA^P||^PRN^PH^^^989^4736666|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnsonAIRA^GosperAIRA^^^^^L|MTH^Mother^HL70063|1994 Seeuwarderadeel Cir^^Owendale^MI^48754^USA^P|^PRN^PH^^^989^4736666ORC|RE||BO15N34109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO15N34109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281080083^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281082010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K25W34117^^^AIRA-TEST^MR||McMullenAIRA^BeverlyAIRA^Daffodil^^^^L|PrebleAIRA^InasAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1273 Kestland Ln^^Maple City^MI^49664^USA^P||^PRN^PH^^^231^6585341|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McMullenAIRA^PrebleAIRA^^^^^L|MTH^Mother^HL70063|1273 Kestland Ln^^Maple City^MI^49664^USA^P|^PRN^PH^^^231^6585341ORC|RE||BK25W34117.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK25W34117.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281082010^TETANUS TOXOID ADSORBED^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281086010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W69L34122^^^AIRA-TEST^MR||LaRueAIRA^CeanaAIRA^Karel^^^^L|KiernanAIRA^MalavikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1462 Plaats Pl^^Rock^MI^49880^USA^P||^PRN^PH^^^906^4224875|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaRueAIRA^KiernanAIRA^^^^^L|MTH^Mother^HL70063|1462 Plaats Pl^^Rock^MI^49880^USA^P|^PRN^PH^^^906^4224875ORC|RE||BW69L34122.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW69L34122.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281086010^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281086055|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V31F34133^^^AIRA-TEST^MR||LemhiAIRA^AveraAIRA^Majella^^^^L|JohnsonAIRA^MargueriteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1941 Coerendaal Ave^^Otter Lake^MI^48464^USA^P||^PRN^PH^^^810^3931252|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LemhiAIRA^JohnsonAIRA^^^^^L|MTH^Mother^HL70063|1941 Coerendaal Ave^^Otter Lake^MI^48464^USA^P|^PRN^PH^^^810^3931252ORC|RE||BV31F34133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV31F34133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281086055^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281086078|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R33C34141^^^AIRA-TEST^MR||KnoxAIRA^PrimaveraAIRA^Vala^^^^L|EllisAIRA^EvelynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1703 Aedemblik Cir^^Ridgeway^MI^49229^USA^P||^PRN^PH^^^517^8215382|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^EllisAIRA^^^^^L|MTH^Mother^HL70063|1703 Aedemblik Cir^^Ridgeway^MI^49229^USA^P|^PRN^PH^^^517^8215382ORC|RE||BR33C34141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR33C34141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281086078^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281086088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L32X34149^^^AIRA-TEST^MR||GoodingAIRA^KeiraAIRA^Cindylou^^^^L|KitsapAIRA^HuldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1610 Bsten Cir^^Bank of America^MI^48279^USA^P||^PRN^PH^^^313^4964899|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GoodingAIRA^KitsapAIRA^^^^^L|MTH^Mother^HL70063|1610 Bsten Cir^^Bank of America^MI^48279^USA^P|^PRN^PH^^^313^4964899ORC|RE||BL32X34149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL32X34149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281086088^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281091301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U67T34157^^^AIRA-TEST^MR||WayneAIRA^GabrielleAIRA^Thetis^^^^L|GageAIRA^LisabetAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1374 Boirle Ln^^Douglas^MI^49406^USA^P||^PRN^PH^^^269^6388090|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^GageAIRA^^^^^L|MTH^Mother^HL70063|1374 Boirle Ln^^Douglas^MI^49406^USA^P|^PRN^PH^^^269^6388090ORC|RE||BU67T34157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU67T34157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281091301^STAMARIL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281091501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y60S34162^^^AIRA-TEST^MR||HumboldtAIRA^JulyaAIRA^Melba^^^^L|HopkinsAIRA^JillieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1753 Dorst aan de Maas St^^Farmingtn Hls^MI^48333^USA^P||^PRN^PH^^^248^4983994|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HumboldtAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1753 Dorst aan de Maas St^^Farmingtn Hls^MI^48333^USA^P|^PRN^PH^^^248^4983994ORC|RE||BY60S34162.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY60S34162.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281091501^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281091505|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G53M34173^^^AIRA-TEST^MR||MasonAIRA^ShoshanaAIRA^Obelia^^^^L|DawsonAIRA^PythiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1539 Gost Gelre Ln^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^7828983|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1539 Gost Gelre Ln^^Bloomfield Hills^MI^48304^USA^P|^PRN^PH^^^248^7828983ORC|RE||BG53M34173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG53M34173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281091505^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281091558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q09M34181^^^AIRA-TEST^MR||HansonAIRA^SalmaAIRA^Miranda^^^^L|DelawareAIRA^NoniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1793 Rudwest-Fryslan Cir^^Howell^MI^48844^USA^P||^PRN^PH^^^517^7985709|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HansonAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1793 Rudwest-Fryslan Cir^^Howell^MI^48844^USA^P|^PRN^PH^^^517^7985709ORC|RE||BQ09M34181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ09M34181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281091558^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-49281091568|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G60I34189^^^AIRA-TEST^MR||NewportAIRA^AshritaAIRA^Diamond^^^^L|ChristianAIRA^ShayleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1724 Kergen op Zoom St^^Van Buren Township^MI^48111^USA^P||^PRN^PH^^^734^9572273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewportAIRA^ChristianAIRA^^^^^L|MTH^Mother^HL70063|1724 Kergen op Zoom St^^Van Buren Township^MI^48111^USA^P|^PRN^PH^^^734^9572273ORC|RE||BG60I34189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG60I34189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||49281091568^YF-VAX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-1693-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y24V34197^^^AIRA-TEST^MR||GreeleyAIRA^BhayanaAIRA^Blaze^^^^L|RogersAIRA^My-DuyenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1087 Weten Pl^^Mi Department of Revenue^MI^48922^USA^P||^PRN^PH^^^517^3573548|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeleyAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1087 Weten Pl^^Mi Department of Revenue^MI^48922^USA^P|^PRN^PH^^^517^3573548ORC|RE||BY24V34197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY24V34197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-1693-0^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-1693-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J99F34205^^^AIRA-TEST^MR||PetersenAIRA^MindyAIRA^Trishna^^^^L|DeschutesAIRA^AutumnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1342 Llphen-Chaam Cir^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^4242801|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PetersenAIRA^DeschutesAIRA^^^^^L|MTH^Mother^HL70063|1342 Llphen-Chaam Cir^^Corunna^MI^48817^USA^P|^PRN^PH^^^989^4242801ORC|RE||BJ99F34205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ99F34205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-1693-9^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-2883-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S24L34213^^^AIRA-TEST^MR||TerrellAIRA^ArminaAIRA^Jordyn^^^^L|LaRueAIRA^MaleahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1192 Dier St^^Pontiac^MI^48343^USA^P||^PRN^PH^^^248^5796910|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TerrellAIRA^LaRueAIRA^^^^^L|MTH^Mother^HL70063|1192 Dier St^^Pontiac^MI^48343^USA^P|^PRN^PH^^^248^5796910ORC|RE||BS24L34213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS24L34213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-2883-0^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-2883-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C30H34218^^^AIRA-TEST^MR||TuscarawasAIRA^TajsaAIRA^Mura^^^^L|KlamathAIRA^ShardaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1629 Poensdrecht Cir^^Alba^MI^49611^USA^P||^PRN^PH^^^231^4301749|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuscarawasAIRA^KlamathAIRA^^^^^L|MTH^Mother^HL70063|1629 Poensdrecht Cir^^Alba^MI^49611^USA^P|^PRN^PH^^^231^4301749ORC|RE||BC30H34218.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC30H34218.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-2883-9^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-3096-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O04Y34229^^^AIRA-TEST^MR||FayetteAIRA^GitanjaliAIRA^Vesta^^^^L|BrewsterAIRA^OliviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1378 Bill en Sint Hubert Ln^^Shepherd^MI^48883^USA^P||^PRN^PH^^^989^9436720|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FayetteAIRA^BrewsterAIRA^^^^^L|MTH^Mother^HL70063|1378 Bill en Sint Hubert Ln^^Shepherd^MI^48883^USA^P|^PRN^PH^^^989^9436720ORC|RE||BO04Y34229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO04Y34229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-3096-0^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-3469-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T07V34237^^^AIRA-TEST^MR||CooperAIRA^YehudiAIRA^Elephteria^^^^L|NelsonAIRA^NyssaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1612 Mluis Pl^^Monroe^MI^48110^USA^P||^PRN^PH^^^734^3353620|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CooperAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1612 Mluis Pl^^Monroe^MI^48110^USA^P|^PRN^PH^^^734^3353620ORC|RE||BT07V34237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT07V34237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-3469-0^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090-3469-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J91D34245^^^AIRA-TEST^MR||VictoriaAIRA^SaralaAIRA^Hanna^^^^L|MajorAIRA^PennieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1699 Blmelo Ave^^Salem^MI^48175^USA^P||^PRN^PH^^^810^6790155|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VictoriaAIRA^MajorAIRA^^^^^L|MTH^Mother^HL70063|1699 Blmelo Ave^^Salem^MI^48175^USA^P|^PRN^PH^^^810^6790155ORC|RE||BJ91D34245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ91D34245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090-3469-9^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090169300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I66N34253^^^AIRA-TEST^MR||KimballAIRA^OrlanthaAIRA^Maya^^^^L|GarrardAIRA^LucianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1384 Post St^^Harrison Township^MI^48045^USA^P||^PRN^PH^^^586^7491926|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KimballAIRA^GarrardAIRA^^^^^L|MTH^Mother^HL70063|1384 Post St^^Harrison Township^MI^48045^USA^P|^PRN^PH^^^586^7491926ORC|RE||BI66N34253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI66N34253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090169300^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090169309|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J51G34258^^^AIRA-TEST^MR||BeaverAIRA^AriahAIRA^Gracie^^^^L|ButlerAIRA^UlfhildrAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1618 Hilvarenbeek Pl^^Detroit^MI^48217^USA^P||^PRN^PH^^^313^2855401|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1618 Hilvarenbeek Pl^^Detroit^MI^48217^USA^P|^PRN^PH^^^313^2855401ORC|RE||BJ51G34258.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ51G34258.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090169309^IPOL^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090288300|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I66F34269^^^AIRA-TEST^MR||TylerAIRA^DanielleAIRA^Bohdana^^^^L|MerrickAIRA^SultanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1236 Maar Pl^^Oak Park^MI^48237^USA^P||^PRN^PH^^^248^9830227|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TylerAIRA^MerrickAIRA^^^^^L|MTH^Mother^HL70063|1236 Maar Pl^^Oak Park^MI^48237^USA^P|^PRN^PH^^^248^9830227ORC|RE||BI66F34269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI66F34269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090288300^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090288309|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T43O34277^^^AIRA-TEST^MR||SimmingsenAIRA^IleneAIRA^Shayla^^^^L|UptonAIRA^PradeeptaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1582 Srimpen aan den IJssel Ave^^Waldron^MI^49288^USA^P||^PRN^PH^^^517^6663304|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimmingsenAIRA^UptonAIRA^^^^^L|MTH^Mother^HL70063|1582 Srimpen aan den IJssel Ave^^Waldron^MI^49288^USA^P|^PRN^PH^^^517^6663304ORC|RE||BT43O34277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT43O34277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090288309^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090309600|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O08N34285^^^AIRA-TEST^MR||PerryAIRA^AqueneAIRA^Jimena^^^^L|ChristensenAIRA^PerlinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1985 Woppersum Ln^^Clarkston^MI^48348^USA^P||^PRN^PH^^^248^5485018|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^ChristensenAIRA^^^^^L|MTH^Mother^HL70063|1985 Woppersum Ln^^Clarkston^MI^48348^USA^P|^PRN^PH^^^248^5485018ORC|RE||BO08N34285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO08N34285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090309600^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090346900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D25H34293^^^AIRA-TEST^MR||MetcalfeAIRA^AmesAIRA^Genji^^^^L|ValleyAIRA^GundaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1157 Veek Cir^^Vicksburg^MI^49097^USA^P||^PRN^PH^^^269^3438331|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MetcalfeAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1157 Veek Cir^^Vicksburg^MI^49097^USA^P|^PRN^PH^^^269^3438331ORC|RE||BD25H34293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD25H34293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090346900^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-50090346909|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N00A34301^^^AIRA-TEST^MR||HaskellAIRA^IsabelAIRA^Phoebe^^^^L|ColumbianaAIRA^KaileyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1578 Quotient Cir^^Williamsville^MI^48137^USA^P||^PRN^PH^^^734^7435127|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaskellAIRA^ColumbianaAIRA^^^^^L|MTH^Mother^HL70063|1578 Quotient Cir^^Williamsville^MI^48137^USA^P|^PRN^PH^^^734^7435127ORC|RE||BN00A34301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN00A34301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||50090346909^HEPLISAV-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285-138-50|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F94Q34309^^^AIRA-TEST^MR||CruzAIRA^MenuhaAIRA^Sage^^^^L|TaylorAIRA^ZiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1851 Rnschede Ln^^Plymouth^MI^48170^USA^P||^PRN^PH^^^734^4865289|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CruzAIRA^TaylorAIRA^^^^^L|MTH^Mother^HL70063|1851 Rnschede Ln^^Plymouth^MI^48170^USA^P|^PRN^PH^^^734^4865289ORC|RE||BF94Q34309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF94Q34309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285-138-50^Adenovirus Type 4 and Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285-174-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M32C34314^^^AIRA-TEST^MR||IronAIRA^TarynAIRA^Camelai^^^^L|KeithAIRA^EdenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1084 Berschelling Ln^^Utica^MI^48318^USA^P||^PRN^PH^^^586^4167073|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IronAIRA^KeithAIRA^^^^^L|MTH^Mother^HL70063|1084 Berschelling Ln^^Utica^MI^48318^USA^P|^PRN^PH^^^586^4167073ORC|RE||BM32C34314.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM32C34314.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285-174-02^Adenovirus Type 4 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285-175-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F64R34325^^^AIRA-TEST^MR||HardinAIRA^BessyAIRA^Dietlinde^^^^L|PikeAIRA^DariaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1821 Gochem Ln^^Merriweather^MI^49947^USA^P||^PRN^PH^^^906^6154887|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HardinAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1821 Gochem Ln^^Merriweather^MI^49947^USA^P|^PRN^PH^^^906^6154887ORC|RE||BF64R34325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF64R34325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285-175-02^Adenovirus Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285013850|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N09R34333^^^AIRA-TEST^MR||YoloAIRA^TriciaAIRA^Twyla^^^^L|LancasterAIRA^EwaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1235 Gidden-Delfland Ln^^Capac^MI^48014^USA^P||^PRN^PH^^^810^9359328|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YoloAIRA^LancasterAIRA^^^^^L|MTH^Mother^HL70063|1235 Gidden-Delfland Ln^^Capac^MI^48014^USA^P|^PRN^PH^^^810^9359328ORC|RE||BN09R34333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN09R34333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285013850^Adenovirus Type 4 and Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285017402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H34X34341^^^AIRA-TEST^MR||ThornleyAIRA^NanonAIRA^Hayley^^^^L|HindsAIRA^LeonardaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1754 Lorsele Cir^^Palms^MI^48465^USA^P||^PRN^PH^^^989^7859287|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThornleyAIRA^HindsAIRA^^^^^L|MTH^Mother^HL70063|1754 Lorsele Cir^^Palms^MI^48465^USA^P|^PRN^PH^^^989^7859287ORC|RE||BH34X34341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH34X34341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285017402^Adenovirus Type 4 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-51285017502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V92J34349^^^AIRA-TEST^MR||CrawfordAIRA^JanelleAIRA^Sushanti^^^^L|NordbyAIRA^WilmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1099 Boven St^^Waterford^MI^48330^USA^P||^PRN^PH^^^248^6666116|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^NordbyAIRA^^^^^L|MTH^Mother^HL70063|1099 Boven St^^Waterford^MI^48330^USA^P|^PRN^PH^^^248^6666116ORC|RE||BV92J34349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV92J34349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||51285017502^Adenovirus Type 7 Vaccine, Live, Oral^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-0734-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A07F34354^^^AIRA-TEST^MR||McKiernanAIRA^TryneAIRA^Madhu^^^^L|JonesAIRA^AnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1455 Mtrijen Pl^^Breedsville^MI^49027^USA^P||^PRN^PH^^^269^3018832|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKiernanAIRA^JonesAIRA^^^^^L|MTH^Mother^HL70063|1455 Mtrijen Pl^^Breedsville^MI^49027^USA^P|^PRN^PH^^^269^3018832ORC|RE||BA07F34354.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA07F34354.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-0734-0^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-0980-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B98E34365^^^AIRA-TEST^MR||SabineAIRA^BelvaAIRA^Valeska^^^^L|PresidioAIRA^DanikaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1492 Hit Ln^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^6375095|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SabineAIRA^PresidioAIRA^^^^^L|MTH^Mother^HL70063|1492 Hit Ln^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^6375095ORC|RE||BB98E34365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB98E34365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-0980-0^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-2219-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H14Q34373^^^AIRA-TEST^MR||ShelbyAIRA^NiveditaAIRA^Loveday^^^^L|OldhamAIRA^ScarlettAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1141 Ganderd Ave^^Saint Ignace^MI^49781^USA^P||^PRN^PH^^^906^9118623|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShelbyAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1141 Ganderd Ave^^Saint Ignace^MI^49781^USA^P|^PRN^PH^^^906^9118623ORC|RE||BH14Q34373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH14Q34373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-2219-0^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-2219-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15Q34381^^^AIRA-TEST^MR||StephensAIRA^YonaAIRA^Uriana^^^^L|HaskellAIRA^GalayAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1235 Lucphen Ave^^Saint Clr Shores^MI^48081^USA^P||^PRN^PH^^^586^9896638|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StephensAIRA^HaskellAIRA^^^^^L|MTH^Mother^HL70063|1235 Lucphen Ave^^Saint Clr Shores^MI^48081^USA^P|^PRN^PH^^^586^9896638ORC|RE||BT15Q34381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15Q34381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-2219-1^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-3339-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L22O34389^^^AIRA-TEST^MR||McKiernanAIRA^TallulahAIRA^Dulcinea^^^^L|VenangoAIRA^ShanataAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1907 Miss Pl^^Detroit^MI^48265^USA^P||^PRN^PH^^^313^7276735|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKiernanAIRA^VenangoAIRA^^^^^L|MTH^Mother^HL70063|1907 Miss Pl^^Detroit^MI^48265^USA^P|^PRN^PH^^^313^7276735ORC|RE||BL22O34389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL22O34389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-3339-1^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-3339-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B27O34397^^^AIRA-TEST^MR||MorrisAIRA^HermelindaAIRA^Saryu^^^^L|LorainAIRA^SuparnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1566 Menigte Cir^^Kingsford Retail^MI^49801^USA^P||^PRN^PH^^^906^8512491|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrisAIRA^LorainAIRA^^^^^L|MTH^Mother^HL70063|1566 Menigte Cir^^Kingsford Retail^MI^49801^USA^P|^PRN^PH^^^906^8512491ORC|RE||BB27O34397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB27O34397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-3339-9^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-4320-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N12R34405^^^AIRA-TEST^MR||DixonAIRA^KaylaAIRA^Ankareeda^^^^L|TehamaAIRA^PratikshaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1851 Le Ronde Venen Ln^^Lake Isabella^MI^48893^USA^P||^PRN^PH^^^989^7393546|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DixonAIRA^TehamaAIRA^^^^^L|MTH^Mother^HL70063|1851 Le Ronde Venen Ln^^Lake Isabella^MI^48893^USA^P|^PRN^PH^^^989^7393546ORC|RE||BN12R34405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN12R34405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-4320-0^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-4320-9|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S51K34410^^^AIRA-TEST^MR||LancasterAIRA^ZinniaAIRA^Journey^^^^L|LokkenAIRA^KimberlyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1490 Uoerendaal St^^Marshall^MI^49068^USA^P||^PRN^PH^^^269^6596933|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LancasterAIRA^LokkenAIRA^^^^^L|MTH^Mother^HL70063|1490 Uoerendaal St^^Marshall^MI^49068^USA^P|^PRN^PH^^^269^6596933ORC|RE||BS51K34410.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS51K34410.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-4320-9^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-6177-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U05F34421^^^AIRA-TEST^MR||MagriAIRA^VaruniAIRA^Paisley^^^^L|AllenAIRA^OrchidAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1403 Nergen op Zoom Ln^^Chippewa Lake^MI^49320^USA^P||^PRN^PH^^^231^4464483|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagriAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1403 Nergen op Zoom Ln^^Chippewa Lake^MI^49320^USA^P|^PRN^PH^^^231^4464483ORC|RE||BU05F34421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU05F34421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-6177-0^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868-6180-0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S88Y34429^^^AIRA-TEST^MR||BeaverAIRA^BathildeAIRA^Ireland^^^^L|MartinAIRA^IllonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1501 Rlissingen Pl^^Sterling Heights^MI^48311^USA^P||^PRN^PH^^^586^9522173|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BeaverAIRA^MartinAIRA^^^^^L|MTH^Mother^HL70063|1501 Rlissingen Pl^^Sterling Heights^MI^48311^USA^P|^PRN^PH^^^586^9522173ORC|RE||BS88Y34429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS88Y34429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868-6180-0^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868073400|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N47Y34437^^^AIRA-TEST^MR||RobinsonAIRA^MatildaAIRA^Tama^^^^L|DalyAIRA^AyitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1656 Ba en Hunze Cir^^Montgomery^MI^49255^USA^P||^PRN^PH^^^517^2171712|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobinsonAIRA^DalyAIRA^^^^^L|MTH^Mother^HL70063|1656 Ba en Hunze Cir^^Montgomery^MI^49255^USA^P|^PRN^PH^^^517^2171712ORC|RE||BN47Y34437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN47Y34437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868073400^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868098000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W05J34445^^^AIRA-TEST^MR||TulsaAIRA^CourtneyAIRA^Pepita^^^^L|HardemanAIRA^JinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1183 Hirschot St^^Marysville^MI^48040^USA^P||^PRN^PH^^^810^6043308|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TulsaAIRA^HardemanAIRA^^^^^L|MTH^Mother^HL70063|1183 Hirschot St^^Marysville^MI^48040^USA^P|^PRN^PH^^^810^6043308ORC|RE||BW05J34445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW05J34445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868098000^M-M-R II^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868221900|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P58H34453^^^AIRA-TEST^MR||BlaineAIRA^CassiaAIRA^Dawn^^^^L|SandersAIRA^ArgentaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1373 Pinnenmaas St^^Fort Gratiot Township^MI^48059^USA^P||^PRN^PH^^^810^6593605|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlaineAIRA^SandersAIRA^^^^^L|MTH^Mother^HL70063|1373 Pinnenmaas St^^Fort Gratiot Township^MI^48059^USA^P|^PRN^PH^^^810^6593605ORC|RE||BP58H34453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP58H34453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868221900^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868221901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02Y34461^^^AIRA-TEST^MR||MacombAIRA^LedahAIRA^Zaria^^^^L|OchiltreeAIRA^AlianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1079 Ooststellingwerf Cir^^Shelby^MI^49455^USA^P||^PRN^PH^^^231^8550024|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MacombAIRA^OchiltreeAIRA^^^^^L|MTH^Mother^HL70063|1079 Ooststellingwerf Cir^^Shelby^MI^49455^USA^P|^PRN^PH^^^231^8550024ORC|RE||BD02Y34461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02Y34461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868221901^RECOMBIVAX HB^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868333901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q09D34466^^^AIRA-TEST^MR||AtascosaAIRA^CorlissAIRA^Viridis^^^^L|PowerAIRA^ShantelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1960 Sarneveld Pl^^Pierport^MI^49614^USA^P||^PRN^PH^^^231^5978391|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AtascosaAIRA^PowerAIRA^^^^^L|MTH^Mother^HL70063|1960 Sarneveld Pl^^Pierport^MI^49614^USA^P|^PRN^PH^^^231^5978391ORC|RE||BQ09D34466.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ09D34466.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868333901^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868333909|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D26C34477^^^AIRA-TEST^MR||IowaAIRA^KonstanzeAIRA^Molly^^^^L|Del NorteAIRA^OdettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1839 Elst-Wijhe Ln^^Saint James^MI^49782^USA^P||^PRN^PH^^^906^4386862|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IowaAIRA^Del NorteAIRA^^^^^L|MTH^Mother^HL70063|1839 Elst-Wijhe Ln^^Saint James^MI^49782^USA^P|^PRN^PH^^^906^4386862ORC|RE||BD26C34477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD26C34477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868333909^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868432000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O28U34485^^^AIRA-TEST^MR||LubbockAIRA^LolaksiAIRA^Jigisha^^^^L|CalhounAIRA^CybilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1193 Ptrechtse Heuvelrug Ave^^Elk Rapids^MI^49629^USA^P||^PRN^PH^^^231^7493020|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LubbockAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1193 Ptrechtse Heuvelrug Ave^^Elk Rapids^MI^49629^USA^P|^PRN^PH^^^231^7493020ORC|RE||BO28U34485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO28U34485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868432000^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868432009|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K40O34493^^^AIRA-TEST^MR||MagoffinAIRA^NatalieAIRA^Carnation^^^^L|TulsaAIRA^AlateaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1641 Klimmen St^^Dearborn^MI^48120^USA^P||^PRN^PH^^^313^5079492|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagoffinAIRA^TulsaAIRA^^^^^L|MTH^Mother^HL70063|1641 Klimmen St^^Dearborn^MI^48120^USA^P|^PRN^PH^^^313^5079492ORC|RE||BK40O34493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK40O34493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868432009^PNEUMOVAX 23^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868617700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I86A34501^^^AIRA-TEST^MR||WhitleyAIRA^NoriAIRA^Julie^^^^L|ButlerAIRA^IrinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1388 Ptaphorst Pl^^Kenockee^MI^48006^USA^P||^PRN^PH^^^810^3201517|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitleyAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1388 Ptaphorst Pl^^Kenockee^MI^48006^USA^P|^PRN^PH^^^810^3201517ORC|RE||BI86A34501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI86A34501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868617700^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-54868618000|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y16W34506^^^AIRA-TEST^MR||GratiotAIRA^HarmonyAIRA^Belina^^^^L|JosephineAIRA^AudlinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1911 Laten vallen Cir^^Canton Township^MI^48188^USA^P||^PRN^PH^^^734^5188717|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GratiotAIRA^JosephineAIRA^^^^^L|MTH^Mother^HL70063|1911 Laten vallen Cir^^Canton Township^MI^48188^USA^P|^PRN^PH^^^734^5188717ORC|RE||BY16W34506.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY16W34506.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||54868618000^FLUZONE^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-55045-3841-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M51F34517^^^AIRA-TEST^MR||MonaghanAIRA^YvonneAIRA^Evette^^^^L|FrontierAIRA^AlavdaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1424 Beiloo St^^West Bloomfield^MI^48324^USA^P||^PRN^PH^^^248^3737370|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MonaghanAIRA^FrontierAIRA^^^^^L|MTH^Mother^HL70063|1424 Beiloo St^^West Bloomfield^MI^48324^USA^P|^PRN^PH^^^248^3737370ORC|RE||BM51F34517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM51F34517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||55045-3841-1^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-55045384101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M98L34525^^^AIRA-TEST^MR||Santa BarbaraAIRA^JemmaAIRA^Marelda^^^^L|WayneAIRA^DelveneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1406 Larneveld Cir^^Reese^MI^48757^USA^P||^PRN^PH^^^989^7424203|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa BarbaraAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1406 Larneveld Cir^^Reese^MI^48757^USA^P|^PRN^PH^^^989^7424203ORC|RE||BM98L34525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM98L34525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||55045384101^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-801-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X07Z34533^^^AIRA-TEST^MR||GalliaAIRA^CrystalAIRA^Edda^^^^L|EnnisAIRA^GenjiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1227 Heurne Ln^^Detroit^MI^48205^USA^P||^PRN^PH^^^313^9184523|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GalliaAIRA^EnnisAIRA^^^^^L|MTH^Mother^HL70063|1227 Heurne Ln^^Detroit^MI^48205^USA^P|^PRN^PH^^^313^9184523ORC|RE||BX07Z34533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX07Z34533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-801-11^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-802-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C19V34541^^^AIRA-TEST^MR||HarrisonAIRA^ShakuntalaAIRA^Kora^^^^L|Pend OreilleAIRA^BakarneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1157 Kamer Ave^^Three Oaks^MI^49128^USA^P||^PRN^PH^^^269^7603214|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^Pend OreilleAIRA^^^^^L|MTH^Mother^HL70063|1157 Kamer Ave^^Three Oaks^MI^49128^USA^P|^PRN^PH^^^269^7603214ORC|RE||BC19V34541.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC19V34541.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-802-02^AS03 Adjuvant^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-804-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R64M34549^^^AIRA-TEST^MR||LoganAIRA^PauletteAIRA^Francisca^^^^L|HuntAIRA^AmityAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1072 Geleid Cir^^Harsens Island^MI^48028^USA^P||^PRN^PH^^^810^5906366|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoganAIRA^HuntAIRA^^^^^L|MTH^Mother^HL70063|1072 Geleid Cir^^Harsens Island^MI^48028^USA^P|^PRN^PH^^^810^5906366ORC|RE||BR64M34549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR64M34549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-804-01^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-806-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F12D34557^^^AIRA-TEST^MR||OfvermarkAIRA^JunAIRA^Marielle^^^^L|SchuylkillAIRA^EdenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1789 Lwenterand Ave^^Newberry^MI^49868^USA^P||^PRN^PH^^^906^2506456|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OfvermarkAIRA^SchuylkillAIRA^^^^^L|MTH^Mother^HL70063|1789 Lwenterand Ave^^Newberry^MI^49868^USA^P|^PRN^PH^^^906^2506456ORC|RE||BF12D34557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF12D34557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-806-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-806-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M59E34562^^^AIRA-TEST^MR||TuscolaAIRA^EktaAIRA^Adelaide^^^^L|SykesAIRA^PreciousAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1183 Geere Ln^^Amasa^MI^49903^USA^P||^PRN^PH^^^906^5417381|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuscolaAIRA^SykesAIRA^^^^^L|MTH^Mother^HL70063|1183 Geere Ln^^Amasa^MI^49903^USA^P|^PRN^PH^^^906^5417381ORC|RE||BM59E34562.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM59E34562.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-806-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-808-15|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q56Z34573^^^AIRA-TEST^MR||TerrellAIRA^YoginiAIRA^Dianthe^^^^L|WilbargerAIRA^AhuvaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1189 Apeldoorn Ln^^Brampton^MI^49837^USA^P||^PRN^PH^^^906^7543182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TerrellAIRA^WilbargerAIRA^^^^^L|MTH^Mother^HL70063|1189 Apeldoorn Ln^^Brampton^MI^49837^USA^P|^PRN^PH^^^906^7543182ORC|RE||BQ56Z34573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ56Z34573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-808-15^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-809-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F77F34581^^^AIRA-TEST^MR||CarterAIRA^IsleenAIRA^Cala^^^^L|SulitAIRA^AislinnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1179 Speciaal Cir^^Sylvan Beach^MI^49463^USA^P||^PRN^PH^^^231^6014734|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarterAIRA^SulitAIRA^^^^^L|MTH^Mother^HL70063|1179 Speciaal Cir^^Sylvan Beach^MI^49463^USA^P|^PRN^PH^^^231^6014734ORC|RE||BF77F34581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF77F34581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-809-01^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-809-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W47V34589^^^AIRA-TEST^MR||LilleyAIRA^LolaAIRA^Adriano^^^^L|MaricopaAIRA^KamballaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1373 Me Wolden Ln^^Bath^MI^48808^USA^P||^PRN^PH^^^517^6677935|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LilleyAIRA^MaricopaAIRA^^^^^L|MTH^Mother^HL70063|1373 Me Wolden Ln^^Bath^MI^48808^USA^P|^PRN^PH^^^517^6677935ORC|RE||BW47V34589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW47V34589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-809-05^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-810-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B87K34597^^^AIRA-TEST^MR||OtsegoAIRA^PreciousAIRA^Enda^^^^L|MontourAIRA^SrutiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1525 Gehouden Ln^^Richmond^MI^48062^USA^P||^PRN^PH^^^586^5365591|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OtsegoAIRA^MontourAIRA^^^^^L|MTH^Mother^HL70063|1525 Gehouden Ln^^Richmond^MI^48062^USA^P|^PRN^PH^^^586^5365591ORC|RE||BB87K34597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB87K34597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-810-01^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-810-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T58G34602^^^AIRA-TEST^MR||WhitleyAIRA^JadeAIRA^Roselyn^^^^L|MarlinAIRA^LiliannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1575 Rechts Ln^^North Lakeport^MI^48059^USA^P||^PRN^PH^^^810^4168159|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitleyAIRA^MarlinAIRA^^^^^L|MTH^Mother^HL70063|1575 Rechts Ln^^North Lakeport^MI^48059^USA^P|^PRN^PH^^^810^4168159ORC|RE||BT58G34602.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT58G34602.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-810-11^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-810-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L82P34613^^^AIRA-TEST^MR||ParasariAIRA^AnonaAIRA^Sylvia^^^^L|Los AngelesAIRA^FayeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1260 Oudewater Cir^^GR^MI^49546^USA^P||^PRN^PH^^^616^8012780|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParasariAIRA^Los AngelesAIRA^^^^^L|MTH^Mother^HL70063|1260 Oudewater Cir^^GR^MI^49546^USA^P|^PRN^PH^^^616^8012780ORC|RE||BL82P34613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL82P34613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-810-43^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-810-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W99O34621^^^AIRA-TEST^MR||ChickasawAIRA^FairleeAIRA^Habiba^^^^L|WrigleyAIRA^JonieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1524 Lwolle Cir^^Clio^MI^48420^USA^P||^PRN^PH^^^810^8367651|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChickasawAIRA^WrigleyAIRA^^^^^L|MTH^Mother^HL70063|1524 Lwolle Cir^^Clio^MI^48420^USA^P|^PRN^PH^^^810^8367651ORC|RE||BW99O34621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW99O34621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-810-52^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-811-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T23F34629^^^AIRA-TEST^MR||LenbergAIRA^SummerAIRA^Cadrian^^^^L|KnoxAIRA^NirgunaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1575 Moet Pl^^Fremont^MI^49413^USA^P||^PRN^PH^^^231^8923455|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LenbergAIRA^KnoxAIRA^^^^^L|MTH^Mother^HL70063|1575 Moet Pl^^Fremont^MI^49413^USA^P|^PRN^PH^^^231^8923455ORC|RE||BT23F34629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT23F34629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-811-41^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-811-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q02W34637^^^AIRA-TEST^MR||GraysAIRA^CaronAIRA^Sonya^^^^L|ShermanAIRA^WinifredAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1343 Sissewaard Ave^^Casco^MI^48064^USA^P||^PRN^PH^^^810^3180728|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GraysAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1343 Sissewaard Ave^^Casco^MI^48064^USA^P|^PRN^PH^^^810^3180728ORC|RE||BQ02W34637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ02W34637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-811-43^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-811-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S61L34642^^^AIRA-TEST^MR||HighlandAIRA^MenuhaAIRA^Skylar^^^^L|MilamAIRA^MatangiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1683 Moderne Ln^^Saint Clair Shrs^MI^48080^USA^P||^PRN^PH^^^586^2846105|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HighlandAIRA^MilamAIRA^^^^^L|MTH^Mother^HL70063|1683 Moderne Ln^^Saint Clair Shrs^MI^48080^USA^P|^PRN^PH^^^586^2846105ORC|RE||BS61L34642.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS61L34642.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-811-51^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-811-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L20D34653^^^AIRA-TEST^MR||DalyAIRA^AriahAIRA^Harley^^^^L|CarbonAIRA^AkinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1025 Serschelling Ave^^Attica^MI^48412^USA^P||^PRN^PH^^^810^7878239|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DalyAIRA^CarbonAIRA^^^^^L|MTH^Mother^HL70063|1025 Serschelling Ave^^Attica^MI^48412^USA^P|^PRN^PH^^^810^7878239ORC|RE||BL20D34653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL20D34653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-811-52^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-812-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T38F34661^^^AIRA-TEST^MR||GunnersonAIRA^FridaAIRA^Maureen^^^^L|ClayAIRA^ClareAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1906 Vollumerland en Nieuwkruisland Ln^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^4330831|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GunnersonAIRA^ClayAIRA^^^^^L|MTH^Mother^HL70063|1906 Vollumerland en Nieuwkruisland Ln^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^4330831ORC|RE||BT38F34661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT38F34661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-812-01^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-812-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E34E34669^^^AIRA-TEST^MR||SeminoleAIRA^AneyaAIRA^Abbey^^^^L|NorthumberlandAIRA^KaerAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1312 Elburg St^^Fennville^MI^49408^USA^P||^PRN^PH^^^269^5293669|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SeminoleAIRA^NorthumberlandAIRA^^^^^L|MTH^Mother^HL70063|1312 Elburg St^^Fennville^MI^49408^USA^P|^PRN^PH^^^269^5293669ORC|RE||BE34E34669.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE34E34669.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-812-11^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-812-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L74T34677^^^AIRA-TEST^MR||BurkeAIRA^MahuruAIRA^Iluka^^^^L|AlconaAIRA^PhoenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1289 Rindhoven Ln^^Prudenville^MI^48651^USA^P||^PRN^PH^^^989^8015687|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^AlconaAIRA^^^^^L|MTH^Mother^HL70063|1289 Rindhoven Ln^^Prudenville^MI^48651^USA^P|^PRN^PH^^^989^8015687ORC|RE||BL74T34677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL74T34677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-812-43^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-812-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D21R34685^^^AIRA-TEST^MR||LincolnAIRA^SibelAIRA^Orelia^^^^L|CumberlandAIRA^CallanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1060 Neerenveen St^^Marshall^MI^49069^USA^P||^PRN^PH^^^269^8141902|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LincolnAIRA^CumberlandAIRA^^^^^L|MTH^Mother^HL70063|1060 Neerenveen St^^Marshall^MI^49069^USA^P|^PRN^PH^^^269^8141902ORC|RE||BD21R34685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD21R34685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-812-52^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G13P34690^^^AIRA-TEST^MR||TravisAIRA^TorieAIRA^Renata^^^^L|SierraAIRA^GardeniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1398 Papier St^^Clay Township^MI^48001^USA^P||^PRN^PH^^^810^7432399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TravisAIRA^SierraAIRA^^^^^L|MTH^Mother^HL70063|1398 Papier St^^Clay Township^MI^48001^USA^P|^PRN^PH^^^810^7432399ORC|RE||BG13P34690.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG13P34690.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-01^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L09P34701^^^AIRA-TEST^MR||JacksonAIRA^DonnaAIRA^Yetta^^^^L|EglandAIRA^CardiniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1903 Saasdonk Cir^^Brownstown^MI^48173^USA^P||^PRN^PH^^^734^2344871|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^EglandAIRA^^^^^L|MTH^Mother^HL70063|1903 Saasdonk Cir^^Brownstown^MI^48173^USA^P|^PRN^PH^^^734^2344871ORC|RE||BL09P34701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL09P34701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-05^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M40H34709^^^AIRA-TEST^MR||OwenAIRA^RylanAIRA^Neria^^^^L|HowathAIRA^GretaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1666 Vogel Ln^^Independence Township^MI^48348^USA^P||^PRN^PH^^^248^5449911|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwenAIRA^HowathAIRA^^^^^L|MTH^Mother^HL70063|1666 Vogel Ln^^Independence Township^MI^48348^USA^P|^PRN^PH^^^248^5449911ORC|RE||BM40H34709.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM40H34709.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-11^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G16L34717^^^AIRA-TEST^MR||LorainAIRA^CharisseAIRA^Selena^^^^L|DeltaAIRA^TeaganAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1328 Aaanstad Ln^^Troy^MI^48098^USA^P||^PRN^PH^^^248^9950238|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LorainAIRA^DeltaAIRA^^^^^L|MTH^Mother^HL70063|1328 Aaanstad Ln^^Troy^MI^48098^USA^P|^PRN^PH^^^248^9950238ORC|RE||BG16L34717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG16L34717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-34^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S07V34725^^^AIRA-TEST^MR||ParasariAIRA^MahinaAIRA^Kaili^^^^L|DodgeAIRA^CapriceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1743 Raag en Braassem Cir^^Southfield Township^MI^48025^USA^P||^PRN^PH^^^248^2321616|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParasariAIRA^DodgeAIRA^^^^^L|MTH^Mother^HL70063|1743 Raag en Braassem Cir^^Southfield Township^MI^48025^USA^P|^PRN^PH^^^248^2321616ORC|RE||BS07V34725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS07V34725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-41^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O76M34733^^^AIRA-TEST^MR||HumboldtAIRA^AjayAIRA^Kathy^^^^L|RockwallAIRA^NualaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1303 Bekela Ln^^GR^MI^49509^USA^P||^PRN^PH^^^616^6546773|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HumboldtAIRA^RockwallAIRA^^^^^L|MTH^Mother^HL70063|1303 Bekela Ln^^GR^MI^49509^USA^P|^PRN^PH^^^616^6546773ORC|RE||BO76M34733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO76M34733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-43^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-46|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I88G34741^^^AIRA-TEST^MR||PimaAIRA^IndiraAIRA^Elfreda^^^^L|GrundyAIRA^AllungaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1232 Talkenburg aan de Geul Cir^^Vulcan^MI^49892^USA^P||^PRN^PH^^^906^5792585|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PimaAIRA^GrundyAIRA^^^^^L|MTH^Mother^HL70063|1232 Talkenburg aan de Geul Cir^^Vulcan^MI^49892^USA^P|^PRN^PH^^^906^5792585ORC|RE||BI88G34741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI88G34741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-46^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-48|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X58M34746^^^AIRA-TEST^MR||OlssonAIRA^DidoAIRA^Laxmi^^^^L|WhitleyAIRA^KyraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1730 Heldrop St^^Grosse Ile^MI^48138^USA^P||^PRN^PH^^^734^5559840|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OlssonAIRA^WhitleyAIRA^^^^^L|MTH^Mother^HL70063|1730 Heldrop St^^Grosse Ile^MI^48138^USA^P|^PRN^PH^^^734^5559840ORC|RE||BX58M34746.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX58M34746.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-48^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-815-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O12X34757^^^AIRA-TEST^MR||MasonAIRA^CharityAIRA^Alena^^^^L|PawneeAIRA^NairneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1887 Ernhem Ave^^Cassopolis^MI^49031^USA^P||^PRN^PH^^^269^4289942|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^PawneeAIRA^^^^^L|MTH^Mother^HL70063|1887 Ernhem Ave^^Cassopolis^MI^49031^USA^P|^PRN^PH^^^269^4289942ORC|RE||BO12X34757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO12X34757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-815-52^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-816-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L71E34765^^^AIRA-TEST^MR||SimpsonAIRA^SofiaAIRA^Mykala^^^^L|CampAIRA^MariamAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1584 Ttrecht Ave^^Crystal Falls^MI^49920^USA^P||^PRN^PH^^^906^3274308|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimpsonAIRA^CampAIRA^^^^^L|MTH^Mother^HL70063|1584 Ttrecht Ave^^Crystal Falls^MI^49920^USA^P|^PRN^PH^^^906^3274308ORC|RE||BL71E34765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL71E34765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-816-01^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-816-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C84Z34773^^^AIRA-TEST^MR||PerryAIRA^GayatriAIRA^Gelsey^^^^L|Van WertAIRA^GabiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1441 Nastricum Pl^^New Lothrop^MI^48460^USA^P||^PRN^PH^^^810^4227227|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^Van WertAIRA^^^^^L|MTH^Mother^HL70063|1441 Nastricum Pl^^New Lothrop^MI^48460^USA^P|^PRN^PH^^^810^4227227ORC|RE||BC84Z34773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC84Z34773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-816-05^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-818-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y35Y34781^^^AIRA-TEST^MR||HellicoskiAIRA^DabriaAIRA^Sherrie^^^^L|FurnasAIRA^GudduAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1984 Zoorn Ave^^Grosse Pointe Woods^MI^48230^USA^P||^PRN^PH^^^313^4034429|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HellicoskiAIRA^FurnasAIRA^^^^^L|MTH^Mother^HL70063|1984 Zoorn Ave^^Grosse Pointe Woods^MI^48230^USA^P|^PRN^PH^^^313^4034429ORC|RE||BY35Y34781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY35Y34781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-818-11^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-819-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D75W34786^^^AIRA-TEST^MR||MedinaAIRA^GwendolenAIRA^Enora^^^^L|ButlerAIRA^JakaylaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1066 Dluis St^^Lansing^MI^48980^USA^P||^PRN^PH^^^517^3955827|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MedinaAIRA^ButlerAIRA^^^^^L|MTH^Mother^HL70063|1066 Dluis St^^Lansing^MI^48980^USA^P|^PRN^PH^^^517^3955827ORC|RE||BD75W34786.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD75W34786.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-819-12^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-820-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X79X34797^^^AIRA-TEST^MR||StevensAIRA^DeniseAIRA^Rumiko^^^^L|AndersonAIRA^LailahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1586 Sronckhorst St^^Elk Rapids^MI^49629^USA^P||^PRN^PH^^^231^4030683|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StevensAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1586 Sronckhorst St^^Elk Rapids^MI^49629^USA^P|^PRN^PH^^^231^4030683ORC|RE||BX79X34797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX79X34797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-820-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-820-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R54Y34805^^^AIRA-TEST^MR||Los AngelesAIRA^CarmenAIRA^Faylinn^^^^L|KentAIRA^MersadizeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1057 Eeghel Ave^^Lansing^MI^48913^USA^P||^PRN^PH^^^517^2753854|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Los AngelesAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1057 Eeghel Ave^^Lansing^MI^48913^USA^P|^PRN^PH^^^517^2753854ORC|RE||BR54Y34805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR54Y34805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-820-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-820-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E89G34813^^^AIRA-TEST^MR||CartonAIRA^AubreeAIRA^Cecily^^^^L|LeknesAIRA^LillianAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1110 Dteenwijkerland Ave^^Grand Haven^MI^49417^USA^P||^PRN^PH^^^616^6387964|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CartonAIRA^LeknesAIRA^^^^^L|MTH^Mother^HL70063|1110 Dteenwijkerland Ave^^Grand Haven^MI^49417^USA^P|^PRN^PH^^^616^6387964ORC|RE||BE89G34813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE89G34813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-820-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-820-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G91D34821^^^AIRA-TEST^MR||AdamsAIRA^DonnaAIRA^Zigana^^^^L|TownAIRA^SitaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1170 Wantumadiel St^^Roscommon^MI^48653^USA^P||^PRN^PH^^^989^3150702|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^TownAIRA^^^^^L|MTH^Mother^HL70063|1170 Wantumadiel St^^Roscommon^MI^48653^USA^P|^PRN^PH^^^989^3150702ORC|RE||BG91D34821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG91D34821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-820-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-821-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L14F34829^^^AIRA-TEST^MR||NevadaAIRA^TrixyAIRA^Violet^^^^L|Santa CruzAIRA^KaulaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1438 Sranendonck Pl^^Hubbard Lake^MI^49747^USA^P||^PRN^PH^^^989^6378435|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NevadaAIRA^Santa CruzAIRA^^^^^L|MTH^Mother^HL70063|1438 Sranendonck Pl^^Hubbard Lake^MI^49747^USA^P|^PRN^PH^^^989^6378435ORC|RE||BL14F34829.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL14F34829.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-821-01^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-821-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I58C34837^^^AIRA-TEST^MR||AndrewsAIRA^KanikaAIRA^Meena^^^^L|AndersonAIRA^FloyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1894 Tlagtwedde Ln^^Livonia^MI^48152^USA^P||^PRN^PH^^^734^5546747|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndrewsAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1894 Tlagtwedde Ln^^Livonia^MI^48152^USA^P|^PRN^PH^^^734^5546747ORC|RE||BI58C34837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI58C34837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-821-05^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-821-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N10G34842^^^AIRA-TEST^MR||O'NeillAIRA^AngelinaAIRA^Netanya^^^^L|GranholmAIRA^AdelindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1035 Rlbrandswaard Pl^^Constantine^MI^49042^USA^P||^PRN^PH^^^269^4817420|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'NeillAIRA^GranholmAIRA^^^^^L|MTH^Mother^HL70063|1035 Rlbrandswaard Pl^^Constantine^MI^49042^USA^P|^PRN^PH^^^269^4817420ORC|RE||BN10G34842.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN10G34842.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-821-11^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-821-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q33F34853^^^AIRA-TEST^MR||PushmatahaAIRA^MoriaAIRA^Gwendolyn^^^^L|FultonAIRA^AlexiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1381 Dest Maas en Waal Pl^^Union^MI^49130^USA^P||^PRN^PH^^^269^9968667|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PushmatahaAIRA^FultonAIRA^^^^^L|MTH^Mother^HL70063|1381 Dest Maas en Waal Pl^^Union^MI^49130^USA^P|^PRN^PH^^^269^9968667ORC|RE||BQ33F34853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ33F34853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-821-34^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-821-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G70N34861^^^AIRA-TEST^MR||NeorinAIRA^HadassahAIRA^Andraya^^^^L|JacksonAIRA^SkyeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1659 Trein Cir^^State of Michigan^MI^48913^USA^P||^PRN^PH^^^517^3396159|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NeorinAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1659 Trein Cir^^State of Michigan^MI^48913^USA^P|^PRN^PH^^^517^3396159ORC|RE||BG70N34861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG70N34861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-821-43^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-821-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N52N34869^^^AIRA-TEST^MR||ProtheroeAIRA^ZakiaAIRA^Abella^^^^L|GreeneAIRA^KarleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1470 Gudwest-Fryslan Ave^^Zondervan Corp^MI^49530^USA^P||^PRN^PH^^^616^7637313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ProtheroeAIRA^GreeneAIRA^^^^^L|MTH^Mother^HL70063|1470 Gudwest-Fryslan Ave^^Zondervan Corp^MI^49530^USA^P|^PRN^PH^^^616^7637313ORC|RE||BN52N34869.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN52N34869.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-821-52^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-823-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R03M34877^^^AIRA-TEST^MR||MuskogeeAIRA^AmiyahAIRA^Luciana^^^^L|GrayAIRA^LizzieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1712 Woensdrecht Ln^^Washingtn Township^MI^48095^USA^P||^PRN^PH^^^586^7041598|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MuskogeeAIRA^GrayAIRA^^^^^L|MTH^Mother^HL70063|1712 Woensdrecht Ln^^Washingtn Township^MI^48095^USA^P|^PRN^PH^^^586^7041598ORC|RE||BR03M34877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR03M34877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-823-11^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-825-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B59N34885^^^AIRA-TEST^MR||JohnAIRA^RoselleAIRA^Narmada^^^^L|JeffersonAIRA^JoannAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1623 Zuiden Cir^^North Star^MI^48862^USA^P||^PRN^PH^^^989^3364947|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1623 Zuiden Cir^^North Star^MI^48862^USA^P|^PRN^PH^^^989^3364947ORC|RE||BB59N34885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB59N34885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-825-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-825-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I12W34893^^^AIRA-TEST^MR||AllenAIRA^CleomenesAIRA^Medina^^^^L|RinggoldAIRA^BriellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1297 Piel Pl^^Fenton^MI^48430^USA^P||^PRN^PH^^^810^8409671|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^RinggoldAIRA^^^^^L|MTH^Mother^HL70063|1297 Piel Pl^^Fenton^MI^48430^USA^P|^PRN^PH^^^810^8409671ORC|RE||BI12W34893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI12W34893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-825-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-825-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M80W34898^^^AIRA-TEST^MR||LebanonAIRA^EdenAIRA^Aria^^^^L|IndianaAIRA^CaitlynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1264 Dulpen-Wittem St^^Lakeside^MI^49116^USA^P||^PRN^PH^^^269^6316821|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LebanonAIRA^IndianaAIRA^^^^^L|MTH^Mother^HL70063|1264 Dulpen-Wittem St^^Lakeside^MI^49116^USA^P|^PRN^PH^^^269^6316821ORC|RE||BM80W34898.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM80W34898.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-825-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-825-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J70Z34909^^^AIRA-TEST^MR||MadisonAIRA^SawyerAIRA^Lalita^^^^L|GreenAIRA^KaydenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1818 Boerderij Ave^^Lake Orion^MI^48360^USA^P||^PRN^PH^^^248^9682049|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MadisonAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1818 Boerderij Ave^^Lake Orion^MI^48360^USA^P|^PRN^PH^^^248^9682049ORC|RE||BJ70Z34909.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ70Z34909.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-825-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-826-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U18Z34917^^^AIRA-TEST^MR||CherokeeAIRA^PameeAIRA^Haya^^^^L|PrestonAIRA^SharleneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1208 Soirle Cir^^Maple City^MI^49664^USA^P||^PRN^PH^^^231^5436658|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CherokeeAIRA^PrestonAIRA^^^^^L|MTH^Mother^HL70063|1208 Soirle Cir^^Maple City^MI^49664^USA^P|^PRN^PH^^^231^5436658ORC|RE||BU18Z34917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU18Z34917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-826-01^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-826-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S76W34925^^^AIRA-TEST^MR||ArcherAIRA^ZiazanAIRA^Rosita^^^^L|SchleicherAIRA^RhonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1568 Dtein Ln^^Tawas City^MI^48764^USA^P||^PRN^PH^^^989^4562038|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArcherAIRA^SchleicherAIRA^^^^^L|MTH^Mother^HL70063|1568 Dtein Ln^^Tawas City^MI^48764^USA^P|^PRN^PH^^^989^4562038ORC|RE||BS76W34925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS76W34925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-826-05^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-826-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P67K34933^^^AIRA-TEST^MR||IarrestadAIRA^SienaAIRA^Ambika^^^^L|NelsonAIRA^ShaylaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1640 Noch Cir^^Prudenville^MI^48651^USA^P||^PRN^PH^^^989^8080557|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IarrestadAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1640 Noch Cir^^Prudenville^MI^48651^USA^P|^PRN^PH^^^989^8080557ORC|RE||BP67K34933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP67K34933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-826-11^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-826-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B65T34941^^^AIRA-TEST^MR||SeminoleAIRA^AniyaAIRA^Carin^^^^L|LivingstonAIRA^RitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1222 Soord-Beveland Pl^^Clinton Township^MI^48035^USA^P||^PRN^PH^^^586^2474994|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SeminoleAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1222 Soord-Beveland Pl^^Clinton Township^MI^48035^USA^P|^PRN^PH^^^586^2474994ORC|RE||BB65T34941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB65T34941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-826-34^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-826-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H58P34946^^^AIRA-TEST^MR||PintoAIRA^IolantheAIRA^Olena^^^^L|WallerAIRA^AdieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1374 Hucphen St^^Chippewa Lake^MI^49320^USA^P||^PRN^PH^^^231^7919934|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PintoAIRA^WallerAIRA^^^^^L|MTH^Mother^HL70063|1374 Hucphen St^^Chippewa Lake^MI^49320^USA^P|^PRN^PH^^^231^7919934ORC|RE||BH58P34946.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH58P34946.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-826-43^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-826-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E77Q34957^^^AIRA-TEST^MR||GanesAIRA^DorisAIRA^Kirilee^^^^L|PintoAIRA^OrindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1598 Vestigen Cir^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^3256318|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanesAIRA^PintoAIRA^^^^^L|MTH^Mother^HL70063|1598 Vestigen Cir^^Hesperia^MI^49421^USA^P|^PRN^PH^^^231^3256318ORC|RE||BE77Q34957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE77Q34957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-826-52^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-828-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P60A34965^^^AIRA-TEST^MR||HolmesAIRA^BarbAIRA^Danika^^^^L|UmatillaAIRA^RamonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1632 Weder-Betuwe Ln^^DTE^MI^48260^USA^P||^PRN^PH^^^313^4472376|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolmesAIRA^UmatillaAIRA^^^^^L|MTH^Mother^HL70063|1632 Weder-Betuwe Ln^^DTE^MI^48260^USA^P|^PRN^PH^^^313^4472376ORC|RE||BP60A34965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP60A34965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-828-01^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-828-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y16X34973^^^AIRA-TEST^MR||UnionAIRA^OrsaAIRA^Rosalind^^^^L|LyonAIRA^RohanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1098 Zeker St^^Owendale^MI^48754^USA^P||^PRN^PH^^^989^2265264|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1098 Zeker St^^Owendale^MI^48754^USA^P|^PRN^PH^^^989^2265264ORC|RE||BY16X34973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY16X34973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-828-03^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-830-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M63O34981^^^AIRA-TEST^MR||AslsenAIRA^CaralynAIRA^Neoma^^^^L|MooreAIRA^TarynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1668 Gaarbeek Ln^^Detroit^MI^48272^USA^P||^PRN^PH^^^313^2019130|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AslsenAIRA^MooreAIRA^^^^^L|MTH^Mother^HL70063|1668 Gaarbeek Ln^^Detroit^MI^48272^USA^P|^PRN^PH^^^313^2019130ORC|RE||BM63O34981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM63O34981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-830-05^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-830-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H01Q34989^^^AIRA-TEST^MR||DeweyAIRA^GiuseppinaAIRA^Mairead^^^^L|FranklinAIRA^LaylahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1377 Zmersfoort Cir^^Flint^MI^48557^USA^P||^PRN^PH^^^810^4137282|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeweyAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1377 Zmersfoort Cir^^Flint^MI^48557^USA^P|^PRN^PH^^^810^4137282ORC|RE||BH01Q34989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH01Q34989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-830-34^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-830-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X90Y34997^^^AIRA-TEST^MR||AroostookAIRA^ElunedAIRA^Keira^^^^L|MillsAIRA^AdelinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1159 Mattem St^^Strongs^MI^49790^USA^P||^PRN^PH^^^906^5583041|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AroostookAIRA^MillsAIRA^^^^^L|MTH^Mother^HL70063|1159 Mattem St^^Strongs^MI^49790^USA^P|^PRN^PH^^^906^5583041ORC|RE||BX90Y34997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX90Y34997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-830-43^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-830-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y17S35002^^^AIRA-TEST^MR||MorrillAIRA^IsabelAIRA^Jolanta^^^^L|LarsonAIRA^RebekahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1854 Doeree-Overflakkee St^^Carson City^MI^48811^USA^P||^PRN^PH^^^989^8471374|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrillAIRA^LarsonAIRA^^^^^L|MTH^Mother^HL70063|1854 Doeree-Overflakkee St^^Carson City^MI^48811^USA^P|^PRN^PH^^^989^8471374ORC|RE||BY17S35002.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY17S35002.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-830-52^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V72C35010^^^AIRA-TEST^MR||WashitaAIRA^KhalidahAIRA^Bronwen^^^^L|McGannAIRA^DextraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1498 Nekela Ave^^Homer^MI^49245^USA^P||^PRN^PH^^^517^7425564|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashitaAIRA^McGannAIRA^^^^^L|MTH^Mother^HL70063|1498 Nekela Ave^^Homer^MI^49245^USA^P|^PRN^PH^^^517^7425564ORC|RE||BV72C35010.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV72C35010.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-01^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F12A35021^^^AIRA-TEST^MR||MorganAIRA^NellekeAIRA^Lyndsey^^^^L|BarrenAIRA^WilonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1081 Westland St^^Battle Creek^MI^49037^USA^P||^PRN^PH^^^269^2435726|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^BarrenAIRA^^^^^L|MTH^Mother^HL70063|1081 Westland St^^Battle Creek^MI^49037^USA^P|^PRN^PH^^^269^2435726ORC|RE||BF12A35021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF12A35021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-05^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H62U35029^^^AIRA-TEST^MR||BurlesonAIRA^AlamedaAIRA^Enid^^^^L|IronAIRA^SigourneyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1671 Kiezen Ln^^Wayne^MI^48184^USA^P||^PRN^PH^^^734^5732257|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurlesonAIRA^IronAIRA^^^^^L|MTH^Mother^HL70063|1671 Kiezen Ln^^Wayne^MI^48184^USA^P|^PRN^PH^^^734^5732257ORC|RE||BH62U35029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH62U35029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-11^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-34|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N49V35037^^^AIRA-TEST^MR||PikeAIRA^BlancheAIRA^Arva^^^^L|BurtAIRA^EsmeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1470 Ken Boer Pl^^Elk Rapids^MI^49629^USA^P||^PRN^PH^^^231^2792887|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^BurtAIRA^^^^^L|MTH^Mother^HL70063|1470 Ken Boer Pl^^Elk Rapids^MI^49629^USA^P|^PRN^PH^^^231^2792887ORC|RE||BN49V35037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN49V35037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-34^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X40W35045^^^AIRA-TEST^MR||GraysonAIRA^ManjuAIRA^Mardi^^^^L|PurolaAIRA^JulesAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1265 Mapendrecht Pl^^Clinton Township^MI^48038^USA^P||^PRN^PH^^^586^2284638|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GraysonAIRA^PurolaAIRA^^^^^L|MTH^Mother^HL70063|1265 Mapendrecht Pl^^Clinton Township^MI^48038^USA^P|^PRN^PH^^^586^2284638ORC|RE||BX40W35045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX40W35045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-41^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-43|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q95T35053^^^AIRA-TEST^MR||TrinityAIRA^KaleaAIRA^Cynara^^^^L|ConnorAIRA^MeggieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1618 Nerkendam Ln^^Mosherville^MI^49258^USA^P||^PRN^PH^^^517^3967976|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TrinityAIRA^ConnorAIRA^^^^^L|MTH^Mother^HL70063|1618 Nerkendam Ln^^Mosherville^MI^49258^USA^P|^PRN^PH^^^517^3967976ORC|RE||BQ95T35053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ95T35053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-43^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-51|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W54V35058^^^AIRA-TEST^MR||RiversideAIRA^CadeeAIRA^Phillida^^^^L|AndersonAIRA^ZahraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1680 Nunspeet Ave^^Saint Clair Shrs^MI^48081^USA^P||^PRN^PH^^^586^4121940|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RiversideAIRA^AndersonAIRA^^^^^L|MTH^Mother^HL70063|1680 Nunspeet Ave^^Saint Clair Shrs^MI^48081^USA^P|^PRN^PH^^^586^4121940ORC|RE||BW54V35058.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW54V35058.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-51^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-842-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V49S35069^^^AIRA-TEST^MR||SwiftAIRA^NiamhAIRA^Swarupa^^^^L|BradyAIRA^CarmenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1347 Doetermeer St^^Traunik^MI^49891^USA^P||^PRN^PH^^^906^6205734|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SwiftAIRA^BradyAIRA^^^^^L|MTH^Mother^HL70063|1347 Doetermeer St^^Traunik^MI^49891^USA^P|^PRN^PH^^^906^6205734ORC|RE||BV49S35069.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV49S35069.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-842-52^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-851-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I99M35077^^^AIRA-TEST^MR||EglandAIRA^MignonAIRA^Navdeep^^^^L|ComalAIRA^AsteraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1368 Vinkelland Ave^^GR^MI^49505^USA^P||^PRN^PH^^^616^9449267|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EglandAIRA^ComalAIRA^^^^^L|MTH^Mother^HL70063|1368 Vinkelland Ave^^GR^MI^49505^USA^P|^PRN^PH^^^616^9449267ORC|RE||BI99M35077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI99M35077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-851-01^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-854-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J90R35085^^^AIRA-TEST^MR||LaRueAIRA^VeraAIRA^Romy^^^^L|TexasAIRA^SidonieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1725 Tude IJsselstreek St^^Eckerman^MI^49790^USA^P||^PRN^PH^^^906^3332807|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LaRueAIRA^TexasAIRA^^^^^L|MTH^Mother^HL70063|1725 Tude IJsselstreek St^^Eckerman^MI^49790^USA^P|^PRN^PH^^^906^3332807ORC|RE||BJ90R35085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ90R35085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-854-52^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-879-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A63F35093^^^AIRA-TEST^MR||LincolnAIRA^DerrythAIRA^Thara^^^^L|SomersetAIRA^BohdanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1643 Yudwest-Fryslan Cir^^Jackson^MI^49202^USA^P||^PRN^PH^^^517^2457597|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LincolnAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1643 Yudwest-Fryslan Cir^^Jackson^MI^49202^USA^P|^PRN^PH^^^517^2457597ORC|RE||BA63F35093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA63F35093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-879-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-879-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T30I35101^^^AIRA-TEST^MR||AlleghenyAIRA^BeldaAIRA^Haliey^^^^L|PontotocAIRA^ArellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1505 Lorst aan de Maas Cir^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^3249858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlleghenyAIRA^PontotocAIRA^^^^^L|MTH^Mother^HL70063|1505 Lorst aan de Maas Cir^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^3249858ORC|RE||BT30I35101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT30I35101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-879-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-880-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M51P35109^^^AIRA-TEST^MR||BranchAIRA^HokuAIRA^Karel^^^^L|San DiegoAIRA^IldikoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1152 Walburg Ave^^Douglas^MI^49406^USA^P||^PRN^PH^^^269^7267002|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BranchAIRA^San DiegoAIRA^^^^^L|MTH^Mother^HL70063|1152 Walburg Ave^^Douglas^MI^49406^USA^P|^PRN^PH^^^269^7267002ORC|RE||BM51P35109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM51P35109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-880-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-880-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E45N35114^^^AIRA-TEST^MR||WaldoAIRA^KachineAIRA^Marigold^^^^L|OakAIRA^LarkAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1781 Klaar St^^Muskegon^MI^49442^USA^P||^PRN^PH^^^231^3943904|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WaldoAIRA^OakAIRA^^^^^L|MTH^Mother^HL70063|1781 Klaar St^^Muskegon^MI^49442^USA^P|^PRN^PH^^^231^3943904ORC|RE||BE45N35114.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE45N35114.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-880-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-881-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C91R35125^^^AIRA-TEST^MR||WascoAIRA^VasudharaAIRA^Della^^^^L|JeffersonAIRA^AnnabelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1260 Glphen-Chaam Ln^^Eben Jct^MI^49825^USA^P||^PRN^PH^^^906^5478000|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WascoAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1260 Glphen-Chaam Ln^^Eben Jct^MI^49825^USA^P|^PRN^PH^^^906^5478000ORC|RE||BC91R35125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC91R35125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-881-41^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-881-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K79L35133^^^AIRA-TEST^MR||CassAIRA^CaraAIRA^Ronda^^^^L|ChickasawAIRA^AyitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1497 Gesterveld Ave^^Novi^MI^48375^USA^P||^PRN^PH^^^248^5806468|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^ChickasawAIRA^^^^^L|MTH^Mother^HL70063|1497 Gesterveld Ave^^Novi^MI^48375^USA^P|^PRN^PH^^^248^5806468ORC|RE||BK79L35133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK79L35133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-881-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-883-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y01X35141^^^AIRA-TEST^MR||AsotinAIRA^KaruahAIRA^Abiona^^^^L|GregoryAIRA^ConncettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1691 Lnschede Ln^^Trenary^MI^49891^USA^P||^PRN^PH^^^906^3432356|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AsotinAIRA^GregoryAIRA^^^^^L|MTH^Mother^HL70063|1691 Lnschede Ln^^Trenary^MI^49891^USA^P|^PRN^PH^^^906^3432356ORC|RE||BY01X35141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY01X35141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-883-41^Fluarix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-883-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O86V35149^^^AIRA-TEST^MR||GartenlaubAIRA^PeggyAIRA^Shelton^^^^L|WerstadAIRA^FaeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1377 Hubbergen Ave^^Detroit^MI^48207^USA^P||^PRN^PH^^^313^3230604|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GartenlaubAIRA^WerstadAIRA^^^^^L|MTH^Mother^HL70063|1377 Hubbergen Ave^^Detroit^MI^48207^USA^P|^PRN^PH^^^313^3230604ORC|RE||BO86V35149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO86V35149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-883-52^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-898-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C55V35157^^^AIRA-TEST^MR||O'ConnellAIRA^HirokoAIRA^Anusia^^^^L|JonesAIRA^TrinityAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1075 Klblasserdam Pl^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^4807536|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'ConnellAIRA^JonesAIRA^^^^^L|MTH^Mother^HL70063|1075 Klblasserdam Pl^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^4807536ORC|RE||BC55V35157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC55V35157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-898-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-898-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I51W35162^^^AIRA-TEST^MR||DauphinAIRA^QuestaAIRA^Charity^^^^L|AmadorAIRA^NealaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1030 Venster Cir^^Ray Township^MI^48096^USA^P||^PRN^PH^^^586^5627724|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DauphinAIRA^AmadorAIRA^^^^^L|MTH^Mother^HL70063|1030 Venster Cir^^Ray Township^MI^48096^USA^P|^PRN^PH^^^586^5627724ORC|RE||BI51W35162.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI51W35162.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-898-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-900-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V46U35173^^^AIRA-TEST^MR||CallahanAIRA^UsagiAIRA^Miki^^^^L|CalhounAIRA^RitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1964 Roststellingwerf Cir^^Dorr^MI^49323^USA^P||^PRN^PH^^^616^3719412|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CallahanAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1964 Roststellingwerf Cir^^Dorr^MI^49323^USA^P|^PRN^PH^^^616^3719412ORC|RE||BV46U35173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV46U35173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-900-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-900-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X04A35181^^^AIRA-TEST^MR||PendletonAIRA^MelbaAIRA^Raelynn^^^^L|WolfeAIRA^SafiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1595 Beiderland Ln^^Lowell^MI^49331^USA^P||^PRN^PH^^^616^9400729|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PendletonAIRA^WolfeAIRA^^^^^L|MTH^Mother^HL70063|1595 Beiderland Ln^^Lowell^MI^49331^USA^P|^PRN^PH^^^616^9400729ORC|RE||BX04A35181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX04A35181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-900-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-901-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C67P35189^^^AIRA-TEST^MR||IoniaAIRA^RosineAIRA^Alarice^^^^L|PintoAIRA^PrioskaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1831 Kolonie Ln^^Auburn Hills^MI^48326^USA^P||^PRN^PH^^^248^9215843|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IoniaAIRA^PintoAIRA^^^^^L|MTH^Mother^HL70063|1831 Kolonie Ln^^Auburn Hills^MI^48326^USA^P|^PRN^PH^^^248^9215843ORC|RE||BC67P35189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC67P35189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-901-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-901-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X78Q35197^^^AIRA-TEST^MR||ClintonAIRA^AllieAIRA^Zia^^^^L|AdamsAIRA^LilacAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1728 Farderwijk Ln^^Columbus Township^MI^48063^USA^P||^PRN^PH^^^810^4226446|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1728 Farderwijk Ln^^Columbus Township^MI^48063^USA^P|^PRN^PH^^^810^4226446ORC|RE||BX78Q35197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX78Q35197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-901-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-903-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P51P35205^^^AIRA-TEST^MR||LuceAIRA^JoannAIRA^Babette^^^^L|JulinAIRA^SumitraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1412 Nolenwaard Cir^^Allen Park^MI^48101^USA^P||^PRN^PH^^^313^7574580|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LuceAIRA^JulinAIRA^^^^^L|MTH^Mother^HL70063|1412 Nolenwaard Cir^^Allen Park^MI^48101^USA^P|^PRN^PH^^^313^7574580ORC|RE||BP51P35205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP51P35205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-903-41^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-903-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94Z35213^^^AIRA-TEST^MR||PrebleAIRA^FuensantaAIRA^Ceana^^^^L|SaundersAIRA^AkilinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1430 Gint-Michielsgestel Ave^^Willis^MI^48191^USA^P||^PRN^PH^^^734^4295650|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PrebleAIRA^SaundersAIRA^^^^^L|MTH^Mother^HL70063|1430 Gint-Michielsgestel Ave^^Willis^MI^48191^USA^P|^PRN^PH^^^734^4295650ORC|RE||BG94Z35213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94Z35213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-903-52^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-905-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C65T35218^^^AIRA-TEST^MR||RockcastleAIRA^JewelAIRA^Keelin^^^^L|NelsenAIRA^BarbAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1625 Eet Pl^^Kentwood^MI^49506^USA^P||^PRN^PH^^^616^2595836|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RockcastleAIRA^NelsenAIRA^^^^^L|MTH^Mother^HL70063|1625 Eet Pl^^Kentwood^MI^49506^USA^P|^PRN^PH^^^616^2595836ORC|RE||BC65T35218.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC65T35218.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-905-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-905-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W16Y35229^^^AIRA-TEST^MR||McKeanAIRA^MarieAIRA^Taryn^^^^L|MarinAIRA^SheenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1693 Mapelle Cir^^Hartford^MI^49057^USA^P||^PRN^PH^^^269^7847858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKeanAIRA^MarinAIRA^^^^^L|MTH^Mother^HL70063|1693 Mapelle Cir^^Hartford^MI^49057^USA^P|^PRN^PH^^^269^7847858ORC|RE||BW16Y35229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW16Y35229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-905-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-907-41|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B82S35237^^^AIRA-TEST^MR||GreeneAIRA^DanielaAIRA^Sawsan^^^^L|NordstromAIRA^LoganAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1752 Saaksbergen Ln^^Chassell^MI^49916^USA^P||^PRN^PH^^^906^9774458|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeneAIRA^NordstromAIRA^^^^^L|MTH^Mother^HL70063|1752 Saaksbergen Ln^^Chassell^MI^49916^USA^P|^PRN^PH^^^906^9774458ORC|RE||BB82S35237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB82S35237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-907-41^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-907-52|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I05Q35245^^^AIRA-TEST^MR||PayneAIRA^HonnaAIRA^Elita^^^^L|HampsonAIRA^ZeniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1018 Eeuningen Pl^^Filion^MI^48432^USA^P||^PRN^PH^^^989^4607535|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PayneAIRA^HampsonAIRA^^^^^L|MTH^Mother^HL70063|1018 Eeuningen Pl^^Filion^MI^48432^USA^P|^PRN^PH^^^989^4607535ORC|RE||BI05Q35245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI05Q35245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-907-52^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-955-09|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L53V35253^^^AIRA-TEST^MR||FreestoneAIRA^NellekeAIRA^Takara^^^^L|GagleAIRA^SamanthaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1384 Leudal Cir^^Essexville^MI^48732^USA^P||^PRN^PH^^^989^4419840|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FreestoneAIRA^GagleAIRA^^^^^L|MTH^Mother^HL70063|1384 Leudal Cir^^Essexville^MI^48732^USA^P|^PRN^PH^^^989^4419840ORC|RE||BL53V35253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL53V35253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-955-09^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-958-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I00T35261^^^AIRA-TEST^MR||MagriAIRA^AdelynAIRA^Aviva^^^^L|LawrenceAIRA^LibertyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1754 Kint-Oedenrode Pl^^Trenary^MI^49891^USA^P||^PRN^PH^^^906^3628927|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagriAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1754 Kint-Oedenrode Pl^^Trenary^MI^49891^USA^P|^PRN^PH^^^906^3628927ORC|RE||BI00T35261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI00T35261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-958-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-959-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N28Z35269^^^AIRA-TEST^MR||ArthurAIRA^KeeleyAIRA^Kellsie^^^^L|HarrisonAIRA^AldabellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1777 Geven Pl^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^7787409|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArthurAIRA^HarrisonAIRA^^^^^L|MTH^Mother^HL70063|1777 Geven Pl^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^7787409ORC|RE||BN28Z35269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN28Z35269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-959-01^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-964-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H45K35274^^^AIRA-TEST^MR||ClintonAIRA^FalguniAIRA^Gunnhild^^^^L|EnnisAIRA^ChelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1980 Deststellingwerf Cir^^Allendale^MI^49401^USA^P||^PRN^PH^^^616^6786909|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^EnnisAIRA^^^^^L|MTH^Mother^HL70063|1980 Deststellingwerf Cir^^Allendale^MI^49401^USA^P|^PRN^PH^^^616^6786909ORC|RE||BH45K35274.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH45K35274.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-964-12^RABAVERT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-966-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F12M35285^^^AIRA-TEST^MR||WayneAIRA^MariashaAIRA^Ana^^^^L|TulareAIRA^KamilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1591 Haanstad Ln^^Rockford^MI^49351^USA^P||^PRN^PH^^^616^4523005|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WayneAIRA^TulareAIRA^^^^^L|MTH^Mother^HL70063|1591 Haanstad Ln^^Rockford^MI^49351^USA^P|^PRN^PH^^^616^4523005ORC|RE||BF12M35285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF12M35285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-966-01^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-966-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W92S35293^^^AIRA-TEST^MR||JepsenAIRA^AmandlaAIRA^Vicki^^^^L|DouglasAIRA^VikritiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1877 Wtadskanaal St^^Leroy^MI^49655^USA^P||^PRN^PH^^^231^5617273|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JepsenAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1877 Wtadskanaal St^^Leroy^MI^49655^USA^P|^PRN^PH^^^231^5617273ORC|RE||BW92S35293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW92S35293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-966-12^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-976-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B73L35301^^^AIRA-TEST^MR||KernAIRA^AdilaAIRA^Madeleine^^^^L|MooreAIRA^CarynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1542 Eoosendaal Pl^^Bancroft^MI^48414^USA^P||^PRN^PH^^^989^9995973|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KernAIRA^MooreAIRA^^^^^L|MTH^Mother^HL70063|1542 Eoosendaal Pl^^Bancroft^MI^48414^USA^P|^PRN^PH^^^989^9995973ORC|RE||BB73L35301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB73L35301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-976-02^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-976-06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F65H35309^^^AIRA-TEST^MR||HamiltonAIRA^ShantayAIRA^Ila^^^^L|MahoningAIRA^KynleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1457 Sardenberg St^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^8057578|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^MahoningAIRA^^^^^L|MTH^Mother^HL70063|1457 Sardenberg St^^Battle Creek^MI^49015^USA^P|^PRN^PH^^^269^8057578ORC|RE||BF65H35309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF65H35309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-976-06^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160-976-20|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K41U35317^^^AIRA-TEST^MR||JacksonAIRA^VesperAIRA^Merlyn^^^^L|ClintonAIRA^CandidaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1988 Noeree-Overflakkee Cir^^Vernon^MI^48476^USA^P||^PRN^PH^^^989^5903229|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1988 Noeree-Overflakkee Cir^^Vernon^MI^48476^USA^P|^PRN^PH^^^989^5903229ORC|RE||BK41U35317.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK41U35317.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160-976-20^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K88X35322^^^AIRA-TEST^MR||WallerAIRA^TourmalineAIRA^Yazmin^^^^L|BernstrainAIRA^RoselaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1514 Levenaar Cir^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^4306780|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WallerAIRA^BernstrainAIRA^^^^^L|MTH^Mother^HL70063|1514 Levenaar Cir^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^4306780ORC|RE||BK88X35322.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK88X35322.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080111^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080202|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T15B35333^^^AIRA-TEST^MR||BellAIRA^CapriAIRA^Vasanta^^^^L|CusterAIRA^HaleighaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1542 Voor St^^Ira Township^MI^48023^USA^P||^PRN^PH^^^810^8595046|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BellAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1542 Voor St^^Ira Township^MI^48023^USA^P|^PRN^PH^^^810^8595046ORC|RE||BT15B35333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT15B35333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080202^AS03 Adjuvant^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L30S35341^^^AIRA-TEST^MR||WardleAIRA^EmmanuelleAIRA^Addilyn^^^^L|Saint ClairAIRA^MaliahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1657 Goeree-Overflakkee Cir^^Saint Clair Shrs^MI^48081^USA^P||^PRN^PH^^^586^5831725|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WardleAIRA^Saint ClairAIRA^^^^^L|MTH^Mother^HL70063|1657 Goeree-Overflakkee Cir^^Saint Clair Shrs^MI^48081^USA^P|^PRN^PH^^^586^5831725ORC|RE||BL30S35341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL30S35341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080401^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z44Y35349^^^AIRA-TEST^MR||BastropAIRA^JoyceAIRA^Ardis^^^^L|DavisAIRA^LizaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1888 Rinnenmaas St^^Port Hope^MI^48468^USA^P||^PRN^PH^^^989^2000912|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BastropAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1888 Rinnenmaas St^^Port Hope^MI^48468^USA^P|^PRN^PH^^^989^2000912ORC|RE||BZ44Y35349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ44Y35349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080601^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U61K35357^^^AIRA-TEST^MR||KlamathAIRA^MiriamAIRA^Rena^^^^L|HindsAIRA^ManuelaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1804 Lang Pl^^Brownstown^MI^48173^USA^P||^PRN^PH^^^734^9989468|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlamathAIRA^HindsAIRA^^^^^L|MTH^Mother^HL70063|1804 Lang Pl^^Brownstown^MI^48173^USA^P|^PRN^PH^^^734^9989468ORC|RE||BU61K35357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU61K35357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080605^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080815|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P71F35362^^^AIRA-TEST^MR||HumboldtAIRA^InnocentiaAIRA^Aditi^^^^L|WashingtonAIRA^MaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1702 Feerhugowaard St^^Grayling^MI^49738^USA^P||^PRN^PH^^^989^8197156|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HumboldtAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1702 Feerhugowaard St^^Grayling^MI^49738^USA^P|^PRN^PH^^^989^8197156ORC|RE||BP71F35362.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP71F35362.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080815^INFLUENZA (H5N1), adjuvanted^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z01L35373^^^AIRA-TEST^MR||BurnetAIRA^JordanaAIRA^Celina^^^^L|ChippewaAIRA^WilfredaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1693 Veerde Cir^^Lake Orion^MI^48359^USA^P||^PRN^PH^^^248^5559680|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurnetAIRA^ChippewaAIRA^^^^^L|MTH^Mother^HL70063|1693 Veerde Cir^^Lake Orion^MI^48359^USA^P|^PRN^PH^^^248^5559680ORC|RE||BZ01L35373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ01L35373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080901^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160080905|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H41L35381^^^AIRA-TEST^MR||RuskAIRA^AmadeaAIRA^Calla^^^^L|CharlevoixAIRA^ZaniyahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1599 Luid St^^Bloomfield Hills^MI^48303^USA^P||^PRN^PH^^^248^9245817|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RuskAIRA^CharlevoixAIRA^^^^^L|MTH^Mother^HL70063|1599 Luid St^^Bloomfield Hills^MI^48303^USA^P|^PRN^PH^^^248^9245817ORC|RE||BH41L35381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH41L35381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160080905^MENHIBRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V22S35389^^^AIRA-TEST^MR||Contra CostaAIRA^GlennaAIRA^Kyleigh^^^^L|SpokaneAIRA^CaelynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1912 Mill en Sint Hubert Pl^^Crooked Lake^MI^48116^USA^P||^PRN^PH^^^810^4702507|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Contra CostaAIRA^SpokaneAIRA^^^^^L|MTH^Mother^HL70063|1912 Mill en Sint Hubert Pl^^Crooked Lake^MI^48116^USA^P|^PRN^PH^^^810^4702507ORC|RE||BV22S35389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV22S35389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081001^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A56B35397^^^AIRA-TEST^MR||Van BurenAIRA^LidiaAIRA^Carlota^^^^L|CraneAIRA^YeneneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1893 Zierden Pl^^Farmington^MI^48331^USA^P||^PRN^PH^^^248^6027060|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Van BurenAIRA^CraneAIRA^^^^^L|MTH^Mother^HL70063|1893 Zierden Pl^^Farmington^MI^48331^USA^P|^PRN^PH^^^248^6027060ORC|RE||BA56B35397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA56B35397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081011^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081043|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A79U35405^^^AIRA-TEST^MR||McIntoshAIRA^DaliaAIRA^Aquamarine^^^^L|NowataAIRA^AmbarAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1429 Zoogeveen Pl^^Gould City^MI^49838^USA^P||^PRN^PH^^^906^7896676|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McIntoshAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1429 Zoogeveen Pl^^Gould City^MI^49838^USA^P|^PRN^PH^^^906^7896676ORC|RE||BA79U35405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA79U35405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081043^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N88V35413^^^AIRA-TEST^MR||GrantAIRA^NetanyaAIRA^Lodema^^^^L|TetlowAIRA^DeniseAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1390 Aldebroek Ln^^Farmington Hills^MI^48334^USA^P||^PRN^PH^^^248^3603562|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^TetlowAIRA^^^^^L|MTH^Mother^HL70063|1390 Aldebroek Ln^^Farmington Hills^MI^48334^USA^P|^PRN^PH^^^248^3603562ORC|RE||BN88V35413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN88V35413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081052^INFANRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M95E35418^^^AIRA-TEST^MR||GarfieldAIRA^RachelAIRA^Satoko^^^^L|JohnssonAIRA^PerditaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1452 Speciaal Pl^^Ironwood^MI^49938^USA^P||^PRN^PH^^^906^7427897|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarfieldAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1452 Speciaal Pl^^Ironwood^MI^49938^USA^P|^PRN^PH^^^906^7427897ORC|RE||BM95E35418.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM95E35418.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081141^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081143|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J70E35429^^^AIRA-TEST^MR||AshlandAIRA^JadwigaAIRA^Jaimie^^^^L|ChesterAIRA^JayaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1488 Geest Ave^^Saint Ignace^MI^49781^USA^P||^PRN^PH^^^906^2198025|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AshlandAIRA^ChesterAIRA^^^^^L|MTH^Mother^HL70063|1488 Geest Ave^^Saint Ignace^MI^49781^USA^P|^PRN^PH^^^906^2198025ORC|RE||BJ70E35429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ70E35429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081143^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081151|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T24R35437^^^AIRA-TEST^MR||GuernseyAIRA^MignonetteAIRA^Tusti^^^^L|SandstromAIRA^DellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1669 Relmond Ln^^Fremont^MI^49412^USA^P||^PRN^PH^^^231^9788978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuernseyAIRA^SandstromAIRA^^^^^L|MTH^Mother^HL70063|1669 Relmond Ln^^Fremont^MI^49412^USA^P|^PRN^PH^^^231^9788978ORC|RE||BT24R35437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT24R35437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081151^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U17G35445^^^AIRA-TEST^MR||JohnstonAIRA^MignonAIRA^Laylah^^^^L|AransasAIRA^SydneeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1263 Poosendaal St^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^6426353|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnstonAIRA^AransasAIRA^^^^^L|MTH^Mother^HL70063|1263 Poosendaal St^^Lincoln Park^MI^48146^USA^P|^PRN^PH^^^313^6426353ORC|RE||BU17G35445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU17G35445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081152^PEDIARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A40T35453^^^AIRA-TEST^MR||CalhounAIRA^NathaliaAIRA^Floriane^^^^L|PedersenAIRA^SkylaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1537 Hijchen Cir^^Ripley^MI^49930^USA^P||^PRN^PH^^^906^3734625|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CalhounAIRA^PedersenAIRA^^^^^L|MTH^Mother^HL70063|1537 Hijchen Cir^^Ripley^MI^49930^USA^P|^PRN^PH^^^906^3734625ORC|RE||BA40T35453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA40T35453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081201^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C77D35461^^^AIRA-TEST^MR||SulitAIRA^KeishaAIRA^Idona^^^^L|RichlandAIRA^PhylissAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1212 Oenray Ln^^Benzonia^MI^49616^USA^P||^PRN^PH^^^231^2253150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SulitAIRA^RichlandAIRA^^^^^L|MTH^Mother^HL70063|1212 Oenray Ln^^Benzonia^MI^49616^USA^P|^PRN^PH^^^231^2253150ORC|RE||BC77D35461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC77D35461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081211^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081243|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q60M35469^^^AIRA-TEST^MR||WinneshiekAIRA^UrianaAIRA^Blake^^^^L|PottawattamieAIRA^XuxaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1289 Baasgouw Ln^^Montgomery^MI^49255^USA^P||^PRN^PH^^^517^7150179|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WinneshiekAIRA^PottawattamieAIRA^^^^^L|MTH^Mother^HL70063|1289 Baasgouw Ln^^Montgomery^MI^49255^USA^P|^PRN^PH^^^517^7150179ORC|RE||BQ60M35469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ60M35469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081243^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A24D35474^^^AIRA-TEST^MR||WashingtonAIRA^ViolaAIRA^Nadda^^^^L|BinghamAIRA^AraceliAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1928 Sulpen-Wittem Ave^^Lake City^MI^49651^USA^P||^PRN^PH^^^231^9307140|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^BinghamAIRA^^^^^L|MTH^Mother^HL70063|1928 Sulpen-Wittem Ave^^Lake City^MI^49651^USA^P|^PRN^PH^^^231^9307140ORC|RE||BA24D35474.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA24D35474.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081252^KINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D02D35485^^^AIRA-TEST^MR||AndrewsAIRA^EudocieAIRA^Eve^^^^L|LackawannaAIRA^LilyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1888 Oundert Cir^^Belleville^MI^48111^USA^P||^PRN^PH^^^734^7231440|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndrewsAIRA^LackawannaAIRA^^^^^L|MTH^Mother^HL70063|1888 Oundert Cir^^Belleville^MI^48111^USA^P|^PRN^PH^^^734^7231440ORC|RE||BD02D35485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD02D35485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081501^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081505|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F98I35493^^^AIRA-TEST^MR||ConnorAIRA^CelandineAIRA^Sandya^^^^L|GillespieAIRA^AbbyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1611 Door Ave^^Brighton^MI^48116^USA^P||^PRN^PH^^^810^9626072|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ConnorAIRA^GillespieAIRA^^^^^L|MTH^Mother^HL70063|1611 Door Ave^^Brighton^MI^48116^USA^P|^PRN^PH^^^810^9626072ORC|RE||BF98I35493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF98I35493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081505^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H12S35501^^^AIRA-TEST^MR||FairfieldAIRA^FeliciaAIRA^Bansari^^^^L|BerrienAIRA^SidoniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1146 Arimpenerwaard Ln^^Orion Township^MI^48360^USA^P||^PRN^PH^^^248^4896098|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FairfieldAIRA^BerrienAIRA^^^^^L|MTH^Mother^HL70063|1146 Arimpenerwaard Ln^^Orion Township^MI^48360^USA^P|^PRN^PH^^^248^4896098ORC|RE||BH12S35501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH12S35501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081511^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081534|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y58L35509^^^AIRA-TEST^MR||ZavalaAIRA^ZambdaAIRA^Victoria^^^^L|ErikssonAIRA^BrygidaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1280 Vermenigvuldigen Pl^^Kentwood^MI^49518^USA^P||^PRN^PH^^^616^5177508|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ZavalaAIRA^ErikssonAIRA^^^^^L|MTH^Mother^HL70063|1280 Vermenigvuldigen Pl^^Kentwood^MI^49518^USA^P|^PRN^PH^^^616^5177508ORC|RE||BY58L35509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY58L35509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081534^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U41B35517^^^AIRA-TEST^MR||FanninAIRA^NolaAIRA^Elvina^^^^L|ClintonAIRA^DahliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1883 Spell Ln^^Royal Oak Township^MI^48220^USA^P||^PRN^PH^^^248^7922379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FanninAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1883 Spell Ln^^Royal Oak Township^MI^48220^USA^P|^PRN^PH^^^248^7922379ORC|RE||BU41B35517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU41B35517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081541^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081543|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P65P35522^^^AIRA-TEST^MR||LokkenAIRA^MeghanaAIRA^Mutsuko^^^^L|OttawaAIRA^SuprabhaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1253 Vaasdriel Ave^^Cascade^MI^49546^USA^P||^PRN^PH^^^616^6572197|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LokkenAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1253 Vaasdriel Ave^^Cascade^MI^49546^USA^P|^PRN^PH^^^616^6572197ORC|RE||BP65P35522.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP65P35522.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081543^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081546|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N34D35533^^^AIRA-TEST^MR||GunnersonAIRA^DaniellaAIRA^Goneril^^^^L|BellAIRA^EvangelineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1298 Sarneveld St^^Ida^MI^48140^USA^P||^PRN^PH^^^734^2599057|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GunnersonAIRA^BellAIRA^^^^^L|MTH^Mother^HL70063|1298 Sarneveld St^^Ida^MI^48140^USA^P|^PRN^PH^^^734^2599057ORC|RE||BN34D35533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN34D35533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081546^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081548|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G84Q35541^^^AIRA-TEST^MR||AnderssonAIRA^VasumatiAIRA^Thais^^^^L|GossAIRA^ZabrinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1132 Positie Ave^^Oscoda^MI^48750^USA^P||^PRN^PH^^^989^9147664|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AnderssonAIRA^GossAIRA^^^^^L|MTH^Mother^HL70063|1132 Positie Ave^^Oscoda^MI^48750^USA^P|^PRN^PH^^^989^9147664ORC|RE||BG84Q35541.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG84Q35541.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081548^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081552|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D56M35549^^^AIRA-TEST^MR||AmmensAIRA^AlingaAIRA^Fairuza^^^^L|McIntoshAIRA^EldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1381 Gebruiken St^^Dryden^MI^48428^USA^P||^PRN^PH^^^810^4276481|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AmmensAIRA^McIntoshAIRA^^^^^L|MTH^Mother^HL70063|1381 Gebruiken St^^Dryden^MI^48428^USA^P|^PRN^PH^^^810^4276481ORC|RE||BD56M35549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD56M35549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081552^TWINRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D11S35557^^^AIRA-TEST^MR||GonzalesAIRA^LowennaAIRA^Nashwa^^^^L|WashitaAIRA^BlytheAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1186 Deusden St^^Jonesville^MI^49250^USA^P||^PRN^PH^^^517^7877225|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GonzalesAIRA^WashitaAIRA^^^^^L|MTH^Mother^HL70063|1186 Deusden St^^Jonesville^MI^49250^USA^P|^PRN^PH^^^517^7877225ORC|RE||BD11S35557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD11S35557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081601^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L21O35565^^^AIRA-TEST^MR||ErieAIRA^DonellaAIRA^Panya^^^^L|HardemanAIRA^AvaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1962 Soldaat Cir^^De Witt^MI^48820^USA^P||^PRN^PH^^^517^8132353|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErieAIRA^HardemanAIRA^^^^^L|MTH^Mother^HL70063|1962 Soldaat Cir^^De Witt^MI^48820^USA^P|^PRN^PH^^^517^8132353ORC|RE||BL21O35565.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL21O35565.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081605^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X69K35573^^^AIRA-TEST^MR||JeffersonAIRA^TooraAIRA^Sawsan^^^^L|HoreAIRA^LyraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1149 Ve Ronde Venen Ln^^Shelby Township^MI^48316^USA^P||^PRN^PH^^^586^9002789|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JeffersonAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1149 Ve Ronde Venen Ln^^Shelby Township^MI^48316^USA^P|^PRN^PH^^^586^9002789ORC|RE||BX69K35573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX69K35573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081811^HIBERIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160081912|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D96S35578^^^AIRA-TEST^MR||AurumAIRA^PortiaAIRA^Aluma^^^^L|TrinityAIRA^CaronAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1389 Ge Bilt Cir^^Ann Arbor^MI^48113^USA^P||^PRN^PH^^^734^5359778|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AurumAIRA^TrinityAIRA^^^^^L|MTH^Mother^HL70063|1389 Ge Bilt Cir^^Ann Arbor^MI^48113^USA^P|^PRN^PH^^^734^5359778ORC|RE||BD96S35578.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD96S35578.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160081912^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H59M35589^^^AIRA-TEST^MR||LakeAIRA^JodiAIRA^Shyanne^^^^L|MadisonAIRA^BethanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1106 Hchagen Pl^^Fostoria^MI^48435^USA^P||^PRN^PH^^^989^9448528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1106 Hchagen Pl^^Fostoria^MI^48435^USA^P|^PRN^PH^^^989^9448528ORC|RE||BH59M35589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH59M35589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082001^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W12C35597^^^AIRA-TEST^MR||MaloneAIRA^ElysiaAIRA^Araminta^^^^L|GladwinAIRA^ZannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1719 Hemert-Bakel Ave^^Higgins Lake^MI^48627^USA^P||^PRN^PH^^^989^8921171|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MaloneAIRA^GladwinAIRA^^^^^L|MTH^Mother^HL70063|1719 Hemert-Bakel Ave^^Higgins Lake^MI^48627^USA^P|^PRN^PH^^^989^8921171ORC|RE||BW12C35597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW12C35597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082011^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082043|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M23D35605^^^AIRA-TEST^MR||HoeyAIRA^LucindaAIRA^Avasa^^^^L|LyastromAIRA^TeklaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1072 Omvatten Ln^^Genoa Township^MI^48116^USA^P||^PRN^PH^^^810^2834124|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoeyAIRA^LyastromAIRA^^^^^L|MTH^Mother^HL70063|1072 Omvatten Ln^^Genoa Township^MI^48116^USA^P|^PRN^PH^^^810^2834124ORC|RE||BM23D35605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM23D35605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082043^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X03J35613^^^AIRA-TEST^MR||MorrisAIRA^AphroditeAIRA^Phebe^^^^L|KalkaskaAIRA^BlindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1806 Vaals Cir^^Wyoming^MI^49508^USA^P||^PRN^PH^^^616^3187304|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrisAIRA^KalkaskaAIRA^^^^^L|MTH^Mother^HL70063|1806 Vaals Cir^^Wyoming^MI^49508^USA^P|^PRN^PH^^^616^3187304ORC|RE||BX03J35613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX03J35613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082052^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U24Z35621^^^AIRA-TEST^MR||WoodsAIRA^KimoraAIRA^Amiah^^^^L|MontgomeryAIRA^DamianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1926 Viel Cir^^Farmington Hills^MI^48333^USA^P||^PRN^PH^^^248^2390118|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodsAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1926 Viel Cir^^Farmington Hills^MI^48333^USA^P|^PRN^PH^^^248^2390118ORC|RE||BU24Z35621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU24Z35621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082101^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A34S35629^^^AIRA-TEST^MR||JohnstonAIRA^RavenAIRA^Kendra^^^^L|HardemanAIRA^XuxaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1004 Bulst Pl^^Grand Ledge^MI^48837^USA^P||^PRN^PH^^^517^5059124|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnstonAIRA^HardemanAIRA^^^^^L|MTH^Mother^HL70063|1004 Bulst Pl^^Grand Ledge^MI^48837^USA^P|^PRN^PH^^^517^5059124ORC|RE||BA34S35629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA34S35629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082105^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B14I35634^^^AIRA-TEST^MR||Santa CruzAIRA^BetrysAIRA^Carensa^^^^L|SaloAIRA^LeolaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1878 Kteenwijkerland St^^Jerome^MI^49249^USA^P||^PRN^PH^^^517^7642953|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Santa CruzAIRA^SaloAIRA^^^^^L|MTH^Mother^HL70063|1878 Kteenwijkerland St^^Jerome^MI^49249^USA^P|^PRN^PH^^^517^7642953ORC|RE||BB14I35634.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB14I35634.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082111^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082134|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V17B35645^^^AIRA-TEST^MR||FayetteAIRA^RanjitaAIRA^Altheda^^^^L|GrantAIRA^ShereeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1212 Blad Ave^^Waterford^MI^48330^USA^P||^PRN^PH^^^248^9356775|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FayetteAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1212 Blad Ave^^Waterford^MI^48330^USA^P|^PRN^PH^^^248^9356775ORC|RE||BV17B35645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV17B35645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082134^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082143|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B42K35653^^^AIRA-TEST^MR||BentonAIRA^VaraneseAIRA^Gelasia^^^^L|SilsethAIRA^NiveditaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1308 Beurne Pl^^Sherwood^MI^49089^USA^P||^PRN^PH^^^517^7190806|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BentonAIRA^SilsethAIRA^^^^^L|MTH^Mother^HL70063|1308 Beurne Pl^^Sherwood^MI^49089^USA^P|^PRN^PH^^^517^7190806ORC|RE||BB42K35653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB42K35653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082143^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M92Z35661^^^AIRA-TEST^MR||DixonAIRA^AvalonAIRA^Tapi^^^^L|ThomasAIRA^UrianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1933 Ben Helder Ave^^Henderson^MI^48841^USA^P||^PRN^PH^^^989^7318139|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DixonAIRA^ThomasAIRA^^^^^L|MTH^Mother^HL70063|1933 Ben Helder Ave^^Henderson^MI^48841^USA^P|^PRN^PH^^^989^7318139ORC|RE||BM92Z35661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM92Z35661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082152^ENGERIX-B^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X68N35669^^^AIRA-TEST^MR||PiscataquisAIRA^NirgunaAIRA^Steffie^^^^L|WallinAIRA^DarbyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1176 Grond Cir^^Rives Jct^MI^49277^USA^P||^PRN^PH^^^517^4623520|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PiscataquisAIRA^WallinAIRA^^^^^L|MTH^Mother^HL70063|1176 Grond Cir^^Rives Jct^MI^49277^USA^P|^PRN^PH^^^517^4623520ORC|RE||BX68N35669.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX68N35669.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082311^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C60K35677^^^AIRA-TEST^MR||DickinsonAIRA^QuintinaAIRA^Tonie^^^^L|PikeAIRA^GiuliettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1667 Lerkelland St^^Delray^MI^48217^USA^P||^PRN^PH^^^313^6964342|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DickinsonAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1667 Lerkelland St^^Delray^MI^48217^USA^P|^PRN^PH^^^313^6964342ORC|RE||BC60K35677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC60K35677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082501^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082511|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O91X35685^^^AIRA-TEST^MR||RodriguezAIRA^NitiAIRA^Adolfina^^^^L|SandersAIRA^ElizabethAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1547 Vijkerk Ave^^Allen Park^MI^48101^USA^P||^PRN^PH^^^313^8370527|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RodriguezAIRA^SandersAIRA^^^^^L|MTH^Mother^HL70063|1547 Vijkerk Ave^^Allen Park^MI^48101^USA^P|^PRN^PH^^^313^8370527ORC|RE||BO91X35685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO91X35685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082511^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082543|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V32Y35690^^^AIRA-TEST^MR||PetersenAIRA^AbirAIRA^Orea^^^^L|CampbellAIRA^AddieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1172 Bank Ave^^Twining^MI^48766^USA^P||^PRN^PH^^^989^7405341|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PetersenAIRA^CampbellAIRA^^^^^L|MTH^Mother^HL70063|1172 Bank Ave^^Twining^MI^48766^USA^P|^PRN^PH^^^989^7405341ORC|RE||BV32Y35690.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV32Y35690.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082543^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082552|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R37B35701^^^AIRA-TEST^MR||KnoxAIRA^JunAIRA^Minerva^^^^L|RobinsonAIRA^MaryAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1123 Coat Ave^^Mackinaw City^MI^49701^USA^P||^PRN^PH^^^231^5439688|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^RobinsonAIRA^^^^^L|MTH^Mother^HL70063|1123 Coat Ave^^Mackinaw City^MI^49701^USA^P|^PRN^PH^^^231^5439688ORC|RE||BR37B35701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR37B35701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082552^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y03G35709^^^AIRA-TEST^MR||WexfordAIRA^YoginiAIRA^Feodora^^^^L|PerryAIRA^RabiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1534 Heemskerk Pl^^Harsens Island^MI^48028^USA^P||^PRN^PH^^^810^5364752|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WexfordAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1534 Heemskerk Pl^^Harsens Island^MI^48028^USA^P|^PRN^PH^^^810^5364752ORC|RE||BY03G35709.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY03G35709.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082601^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082605|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q52Z35717^^^AIRA-TEST^MR||SharplesAIRA^PhyllisAIRA^Edwina^^^^L|VenturaAIRA^FuscienneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1020 Exacte Pl^^Redford^MI^48240^USA^P||^PRN^PH^^^313^5727560|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SharplesAIRA^VenturaAIRA^^^^^L|MTH^Mother^HL70063|1020 Exacte Pl^^Redford^MI^48240^USA^P|^PRN^PH^^^313^5727560ORC|RE||BQ52Z35717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ52Z35717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082605^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A19G35725^^^AIRA-TEST^MR||ClintonAIRA^NerinAIRA^Kumud^^^^L|MadisonAIRA^RimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1225 Nijnacker-Nootdorp Ave^^Grand Rapids^MI^49516^USA^P||^PRN^PH^^^616^6868202|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1225 Nijnacker-Nootdorp Ave^^Grand Rapids^MI^49516^USA^P|^PRN^PH^^^616^6868202ORC|RE||BA19G35725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA19G35725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082611^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082634|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X76S35733^^^AIRA-TEST^MR||McGannAIRA^CardiniaAIRA^Shalini^^^^L|CulbersonAIRA^TooraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1578 Eoordoostpolder Ave^^Novi^MI^48375^USA^P||^PRN^PH^^^248^5803373|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McGannAIRA^CulbersonAIRA^^^^^L|MTH^Mother^HL70063|1578 Eoordoostpolder Ave^^Novi^MI^48375^USA^P|^PRN^PH^^^248^5803373ORC|RE||BX76S35733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX76S35733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082634^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082643|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y56Z35741^^^AIRA-TEST^MR||BentonAIRA^LeeaAIRA^Lynnea^^^^L|HolingsonAIRA^MarthaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1613 Tegen Pl^^Omer^MI^48749^USA^P||^PRN^PH^^^989^9287461|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BentonAIRA^HolingsonAIRA^^^^^L|MTH^Mother^HL70063|1613 Tegen Pl^^Omer^MI^48749^USA^P|^PRN^PH^^^989^9287461ORC|RE||BY56Z35741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY56Z35741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082643^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082652|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G80Y35746^^^AIRA-TEST^MR||SiskiyouAIRA^XimenaAIRA^Lynn^^^^L|AdamsAIRA^BritanyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1610 Pint Anthonis Ave^^Milan Township^MI^48160^USA^P||^PRN^PH^^^734^6837532|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SiskiyouAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1610 Pint Anthonis Ave^^Milan Township^MI^48160^USA^P|^PRN^PH^^^734^6837532ORC|RE||BG80Y35746.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG80Y35746.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082652^HAVRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K19G35757^^^AIRA-TEST^MR||MorrosAIRA^AdeliciaAIRA^Shalini^^^^L|GrantAIRA^LeilaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1174 Dldebroek Cir^^Greenville^MI^48838^USA^P||^PRN^PH^^^231^4441961|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrosAIRA^GrantAIRA^^^^^L|MTH^Mother^HL70063|1174 Dldebroek Cir^^Greenville^MI^48838^USA^P|^PRN^PH^^^231^4441961ORC|RE||BK19G35757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK19G35757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082801^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160082803|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X40M35765^^^AIRA-TEST^MR||HopkinsAIRA^GalateaAIRA^Lysette^^^^L|LancasterAIRA^MarjorieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1687 Nam Ave^^Midland^MI^48640^USA^P||^PRN^PH^^^989^2359652|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HopkinsAIRA^LancasterAIRA^^^^^L|MTH^Mother^HL70063|1687 Nam Ave^^Midland^MI^48640^USA^P|^PRN^PH^^^989^2359652ORC|RE||BX40M35765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX40M35765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160082803^Shingrix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160083005|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F55R35773^^^AIRA-TEST^MR||MercerAIRA^BetseyAIRA^Afina^^^^L|PauldingAIRA^EucleaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1911 Mude IJsselstreek Ave^^Iron Mountain^MI^49801^USA^P||^PRN^PH^^^906^2742183|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MercerAIRA^PauldingAIRA^^^^^L|MTH^Mother^HL70063|1911 Mude IJsselstreek Ave^^Iron Mountain^MI^49801^USA^P|^PRN^PH^^^906^2742183ORC|RE||BF55R35773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF55R35773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160083005^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160083034|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K26L35781^^^AIRA-TEST^MR||MilamAIRA^HeddaAIRA^Ilsa^^^^L|PowellAIRA^AlineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1645 Sissewaard St^^Midland^MI^48667^USA^P||^PRN^PH^^^989^7265190|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MilamAIRA^PowellAIRA^^^^^L|MTH^Mother^HL70063|1645 Sissewaard St^^Midland^MI^48667^USA^P|^PRN^PH^^^989^7265190ORC|RE||BK26L35781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK26L35781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160083034^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160083043|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E78V35789^^^AIRA-TEST^MR||WallowaAIRA^YasminAIRA^Wihtburth^^^^L|ClearwaterAIRA^LethaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1664 Dans Ave^^Irons^MI^49644^USA^P||^PRN^PH^^^231^6973808|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WallowaAIRA^ClearwaterAIRA^^^^^L|MTH^Mother^HL70063|1664 Dans Ave^^Irons^MI^49644^USA^P|^PRN^PH^^^231^6973808ORC|RE||BE78V35789.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE78V35789.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160083043^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160083052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z25F35794^^^AIRA-TEST^MR||TamaAIRA^SvetlanaAIRA^Rosa^^^^L|NelsonAIRA^MedilionAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1702 Haanstad Cir^^Bay View^MI^49770^USA^P||^PRN^PH^^^231^6966934|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TamaAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1702 Haanstad Cir^^Bay View^MI^49770^USA^P|^PRN^PH^^^231^6966934ORC|RE||BZ25F35794.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ25F35794.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160083052^CERVARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A33A35805^^^AIRA-TEST^MR||CallowayAIRA^GloriaAIRA^Yumi^^^^L|HaleAIRA^BrigitAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1665 Coat Ave^^Stevensville^MI^49127^USA^P||^PRN^PH^^^269^8670384|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CallowayAIRA^HaleAIRA^^^^^L|MTH^Mother^HL70063|1665 Coat Ave^^Stevensville^MI^49127^USA^P|^PRN^PH^^^269^8670384ORC|RE||BA33A35805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA33A35805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084201^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084205|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W58G35813^^^AIRA-TEST^MR||RockAIRA^PeonyAIRA^Sapphira^^^^L|HamiltonAIRA^CloverAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1692 Dorger-Odoorn Ave^^Kentwood^MI^49548^USA^P||^PRN^PH^^^616^6687379|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RockAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1692 Dorger-Odoorn Ave^^Kentwood^MI^49548^USA^P|^PRN^PH^^^616^6687379ORC|RE||BW58G35813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW58G35813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084205^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N98N35821^^^AIRA-TEST^MR||SullivanAIRA^EdwinaAIRA^Mahdi^^^^L|BaileyAIRA^KarenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1784 Rheden Ln^^Washington Township^MI^48095^USA^P||^PRN^PH^^^586^4238832|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SullivanAIRA^BaileyAIRA^^^^^L|MTH^Mother^HL70063|1784 Rheden Ln^^Washington Township^MI^48095^USA^P|^PRN^PH^^^586^4238832ORC|RE||BN98N35821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN98N35821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084211^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084234|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L54T35829^^^AIRA-TEST^MR||NemahaAIRA^MaddyAIRA^Maisie^^^^L|LandbergAIRA^DolkarAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1263 Keere Ave^^Detroit^MI^48216^USA^P||^PRN^PH^^^313^3614485|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NemahaAIRA^LandbergAIRA^^^^^L|MTH^Mother^HL70063|1263 Keere Ave^^Detroit^MI^48216^USA^P|^PRN^PH^^^313^3614485ORC|RE||BL54T35829.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL54T35829.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084234^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084241|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U41O35837^^^AIRA-TEST^MR||MidlandAIRA^JohannaAIRA^Jasmine^^^^L|WallowaAIRA^NellieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1891 Overwegen St^^Lake Ann^MI^49650^USA^P||^PRN^PH^^^231^2832196|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MidlandAIRA^WallowaAIRA^^^^^L|MTH^Mother^HL70063|1891 Overwegen St^^Lake Ann^MI^49650^USA^P|^PRN^PH^^^231^2832196ORC|RE||BU41O35837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU41O35837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084241^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084243|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X38N35845^^^AIRA-TEST^MR||Van ZandtAIRA^LinneaAIRA^Reman^^^^L|Black HawkAIRA^AddiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1587 Lolenwaard St^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^4055428|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Van ZandtAIRA^Black HawkAIRA^^^^^L|MTH^Mother^HL70063|1587 Lolenwaard St^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^4055428ORC|RE||BX38N35845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX38N35845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084243^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084251|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V91B35850^^^AIRA-TEST^MR||MohaveAIRA^KirimaAIRA^Oralia^^^^L|MidlandAIRA^JulissaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1178 Schoen Cir^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^4953313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MohaveAIRA^MidlandAIRA^^^^^L|MTH^Mother^HL70063|1178 Schoen Cir^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^4953313ORC|RE||BV91B35850.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV91B35850.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084251^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160084252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B97C35861^^^AIRA-TEST^MR||ArmstrongAIRA^CasondraAIRA^Dannell^^^^L|JeffersonAIRA^KayleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1789 Me Fryske Marren Cir^^Kentwood Brch^MI^49528^USA^P||^PRN^PH^^^616^9138728|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArmstrongAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1789 Me Fryske Marren Cir^^Kentwood Brch^MI^49528^USA^P|^PRN^PH^^^616^9138728ORC|RE||BB97C35861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB97C35861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160084252^BOOSTRIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160085101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G63O35869^^^AIRA-TEST^MR||CarrollAIRA^EricaAIRA^Therese^^^^L|CartonAIRA^SamtaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1690 Baalte Cir^^Argyle^MI^48410^USA^P||^PRN^PH^^^989^4517599|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^CartonAIRA^^^^^L|MTH^Mother^HL70063|1690 Baalte Cir^^Argyle^MI^48410^USA^P|^PRN^PH^^^989^4517599ORC|RE||BG63O35869.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG63O35869.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160085101^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160085452|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E05Q35877^^^AIRA-TEST^MR||Scotts BluffAIRA^KameaAIRA^Mab^^^^L|CameronAIRA^SiobhanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1041 Plek Ave^^Rochester Hls^MI^48307^USA^P||^PRN^PH^^^248^6915980|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Scotts BluffAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1041 Plek Ave^^Rochester Hls^MI^48307^USA^P|^PRN^PH^^^248^6915980ORC|RE||BE05Q35877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE05Q35877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160085452^ROTARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160087941|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M63A35885^^^AIRA-TEST^MR||HolingsonAIRA^RasnaAIRA^Brittany^^^^L|AroostookAIRA^YogitaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1653 Mdam-Volendam Pl^^Quinnesec^MI^49876^USA^P||^PRN^PH^^^906^4385621|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolingsonAIRA^AroostookAIRA^^^^^L|MTH^Mother^HL70063|1653 Mdam-Volendam Pl^^Quinnesec^MI^49876^USA^P|^PRN^PH^^^906^4385621ORC|RE||BM63A35885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM63A35885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160087941^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160087952|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O95A35893^^^AIRA-TEST^MR||HockleyAIRA^HineAIRA^Doreen^^^^L|JohnAIRA^BerwynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1632 Nidden-Delfland Pl^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^5108451|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HockleyAIRA^JohnAIRA^^^^^L|MTH^Mother^HL70063|1632 Nidden-Delfland Pl^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^5108451ORC|RE||BO95A35893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO95A35893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160087952^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160088041|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L19R35901^^^AIRA-TEST^MR||LindAIRA^MoyaAIRA^Pierina^^^^L|BrazosAIRA^JetAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1228 Wietjerksteradeel Ave^^Berrien Sprgs^MI^49104^USA^P||^PRN^PH^^^269^9071710|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LindAIRA^BrazosAIRA^^^^^L|MTH^Mother^HL70063|1228 Wietjerksteradeel Ave^^Berrien Sprgs^MI^49104^USA^P|^PRN^PH^^^269^9071710ORC|RE||BL19R35901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL19R35901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160088041^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160088052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I09R35906^^^AIRA-TEST^MR||CrosbieAIRA^DymphnaAIRA^Sile^^^^L|EnnisAIRA^CaronAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1478 Wekela Ave^^Commerce^MI^48382^USA^P||^PRN^PH^^^248^4329856|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrosbieAIRA^EnnisAIRA^^^^^L|MTH^Mother^HL70063|1478 Wekela Ave^^Commerce^MI^48382^USA^P|^PRN^PH^^^248^4329856ORC|RE||BI09R35906.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI09R35906.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160088052^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160088141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D07F35917^^^AIRA-TEST^MR||OhioAIRA^AndreaAIRA^Carmen^^^^L|OkmulgeeAIRA^AudreyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1473 Darneveld Pl^^Jenison^MI^49428^USA^P||^PRN^PH^^^616^7246941|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OhioAIRA^OkmulgeeAIRA^^^^^L|MTH^Mother^HL70063|1473 Darneveld Pl^^Jenison^MI^49428^USA^P|^PRN^PH^^^616^7246941ORC|RE||BD07F35917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD07F35917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160088141^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160088152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E00D35925^^^AIRA-TEST^MR||HillsdaleAIRA^JosslynAIRA^Adelyn^^^^L|SomersetAIRA^AdelindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1908 Joststellingwerf St^^Midland^MI^48642^USA^P||^PRN^PH^^^989^3335593|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillsdaleAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1908 Joststellingwerf St^^Midland^MI^48642^USA^P|^PRN^PH^^^989^3335593ORC|RE||BE00D35925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE00D35925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160088152^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160088341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X44S35933^^^AIRA-TEST^MR||HallAIRA^GiacintaAIRA^Buffy^^^^L|MontagueAIRA^ReganAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1618 Moermond Pl^^Sanford^MI^48657^USA^P||^PRN^PH^^^989^5440403|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HallAIRA^MontagueAIRA^^^^^L|MTH^Mother^HL70063|1618 Moermond Pl^^Sanford^MI^48657^USA^P|^PRN^PH^^^989^5440403ORC|RE||BX44S35933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX44S35933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160088341^Fluarix^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160088352|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C56N35941^^^AIRA-TEST^MR||SimpsonAIRA^KenyaAIRA^Kelsie^^^^L|MurrayAIRA^BirgetAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1121 Gutten Ln^^Point Aux Pin^MI^49775^USA^P||^PRN^PH^^^231^5272842|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimpsonAIRA^MurrayAIRA^^^^^L|MTH^Mother^HL70063|1121 Gutten Ln^^Point Aux Pin^MI^49775^USA^P|^PRN^PH^^^231^5272842ORC|RE||BC56N35941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC56N35941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160088352^FLUARIX^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160089841|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T09I35949^^^AIRA-TEST^MR||CambriaAIRA^SelaAIRA^Chimalis^^^^L|OmssundAIRA^VeledaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1153 Pruten Ave^^Troy^MI^48007^USA^P||^PRN^PH^^^248^7894158|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CambriaAIRA^OmssundAIRA^^^^^L|MTH^Mother^HL70063|1153 Pruten Ave^^Troy^MI^48007^USA^P|^PRN^PH^^^248^7894158ORC|RE||BT09I35949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT09I35949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160089841^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160089852|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z83J35954^^^AIRA-TEST^MR||PerryAIRA^AlumitAIRA^Elaine^^^^L|NorthamptonAIRA^AshleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1901 Aaadhoeke Ln^^Sault Sainte Marie^MI^49783^USA^P||^PRN^PH^^^906^5642485|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^NorthamptonAIRA^^^^^L|MTH^Mother^HL70063|1901 Aaadhoeke Ln^^Sault Sainte Marie^MI^49783^USA^P|^PRN^PH^^^906^5642485ORC|RE||BZ83J35954.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ83J35954.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160089852^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090041|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M90B35965^^^AIRA-TEST^MR||DeuelAIRA^SubhangiAIRA^Desma^^^^L|ClintonAIRA^LeiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1928 Eeel en Maas Ave^^Hillman^MI^49746^USA^P||^PRN^PH^^^989^6956858|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeuelAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1928 Eeel en Maas Ave^^Hillman^MI^49746^USA^P|^PRN^PH^^^989^6956858ORC|RE||BM90B35965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM90B35965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090041^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090052|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B77B35973^^^AIRA-TEST^MR||LoganAIRA^GerardaAIRA^Blinn^^^^L|CowleAIRA^HonourAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1240 Maastricht Cir^^Huron Township^MI^48164^USA^P||^PRN^PH^^^734^3394973|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoganAIRA^CowleAIRA^^^^^L|MTH^Mother^HL70063|1240 Maastricht Cir^^Huron Township^MI^48164^USA^P|^PRN^PH^^^734^3394973ORC|RE||BB77B35973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB77B35973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090052^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y58X35981^^^AIRA-TEST^MR||CochiseAIRA^IndiaAIRA^Ardath^^^^L|Mc VeetyAIRA^TerraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1767 Aaasdriel Pl^^Barton City^MI^48705^USA^P||^PRN^PH^^^989^8061560|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CochiseAIRA^Mc VeetyAIRA^^^^^L|MTH^Mother^HL70063|1767 Aaasdriel Pl^^Barton City^MI^48705^USA^P|^PRN^PH^^^989^8061560ORC|RE||BY58X35981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY58X35981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090141^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090152|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X13G35989^^^AIRA-TEST^MR||GillespieAIRA^AineAIRA^Ritsuko^^^^L|WrigleyAIRA^OlianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1686 Beetje Pl^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^4400076|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GillespieAIRA^WrigleyAIRA^^^^^L|MTH^Mother^HL70063|1686 Beetje Pl^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^4400076ORC|RE||BX13G35989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX13G35989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090152^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090341|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D76R35997^^^AIRA-TEST^MR||BolgenAIRA^SonikaAIRA^Daksha^^^^L|CameronAIRA^SeonaidAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1991 Selfzijl Cir^^Capac^MI^48014^USA^P||^PRN^PH^^^810^9348117|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BolgenAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1991 Selfzijl Cir^^Capac^MI^48014^USA^P|^PRN^PH^^^810^9348117ORC|RE||BD76R35997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD76R35997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090341^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090352|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G78V36005^^^AIRA-TEST^MR||HemphillAIRA^WinAIRA^Marie^^^^L|MonroeAIRA^TalullaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1669 Kinderen Pl^^Sand Lake^MI^49343^USA^P||^PRN^PH^^^616^7861333|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HemphillAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1669 Kinderen Pl^^Sand Lake^MI^49343^USA^P|^PRN^PH^^^616^7861333ORC|RE||BG78V36005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG78V36005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090352^FLUARIX QUADRIVALENT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090541|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U10L36010^^^AIRA-TEST^MR||ChoctawAIRA^ClarabelleAIRA^Destiny^^^^L|BrooksAIRA^MerpatiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1300 Eluis Pl^^Bloomfield^MI^48301^USA^P||^PRN^PH^^^248^3096511|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChoctawAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1300 Eluis Pl^^Bloomfield^MI^48301^USA^P|^PRN^PH^^^248^3096511ORC|RE||BU10L36010.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU10L36010.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090541^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090552|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J42L36021^^^AIRA-TEST^MR||CassAIRA^AliceAIRA^Marguerite^^^^L|FiggensAIRA^CharuAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1887 Pistool Pl^^Lenox^MI^48048^USA^P||^PRN^PH^^^586^3743771|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^FiggensAIRA^^^^^L|MTH^Mother^HL70063|1887 Pistool Pl^^Lenox^MI^48048^USA^P|^PRN^PH^^^586^3743771ORC|RE||BJ42L36021.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ42L36021.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090552^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090741|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B53W36029^^^AIRA-TEST^MR||LatahAIRA^OnennAIRA^Saraid^^^^L|LindstromAIRA^ReneeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1247 Eardenberg Pl^^Vernon^MI^48476^USA^P||^PRN^PH^^^989^6792837|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LatahAIRA^LindstromAIRA^^^^^L|MTH^Mother^HL70063|1247 Eardenberg Pl^^Vernon^MI^48476^USA^P|^PRN^PH^^^989^6792837ORC|RE||BB53W36029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB53W36029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090741^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160090752|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T82M36037^^^AIRA-TEST^MR||EriksonAIRA^MadalynAIRA^Julianne^^^^L|WheelerAIRA^Zsa-ZsaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1168 Uenterwolde Pl^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^9263740|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EriksonAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1168 Uenterwolde Pl^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^9263740ORC|RE||BT82M36037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT82M36037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160090752^Fluarix Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160095509|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S08G36045^^^AIRA-TEST^MR||CochiseAIRA^ArabelleAIRA^Lauren^^^^L|TravisAIRA^FloyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1849 Stadskanaal Ave^^Casco^MI^48064^USA^P||^PRN^PH^^^810^9701148|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CochiseAIRA^TravisAIRA^^^^^L|MTH^Mother^HL70063|1849 Stadskanaal Ave^^Casco^MI^48064^USA^P|^PRN^PH^^^810^9701148ORC|RE||BS08G36045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS08G36045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160095509^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160095801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E41W36053^^^AIRA-TEST^MR||PasoAIRA^QuorraAIRA^Reena^^^^L|LivingstonAIRA^MaineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1441 Woerden Ave^^Roos^MI^48756^USA^P||^PRN^PH^^^989^2722240|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PasoAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1441 Woerden Ave^^Roos^MI^48756^USA^P|^PRN^PH^^^989^2722240ORC|RE||BE41W36053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE41W36053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160095801^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160095901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E70X36061^^^AIRA-TEST^MR||OkanoganAIRA^CrescentAIRA^Thanh^^^^L|KayAIRA^ShannonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1559 Dlphen-Chaam Ln^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^5800532|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OkanoganAIRA^KayAIRA^^^^^L|MTH^Mother^HL70063|1559 Dlphen-Chaam Ln^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^5800532ORC|RE||BE70X36061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE70X36061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160095901^Menveo^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160096412|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z07G36066^^^AIRA-TEST^MR||ErikssonAIRA^CristinAIRA^Rory^^^^L|CarrollAIRA^TrinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1983 Ealburg Ln^^Hope^MI^48628^USA^P||^PRN^PH^^^989^5755790|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErikssonAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1983 Ealburg Ln^^Hope^MI^48628^USA^P|^PRN^PH^^^989^5755790ORC|RE||BZ07G36066.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ07G36066.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160096412^RABAVERT^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160096601|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M33W36077^^^AIRA-TEST^MR||Van WertAIRA^FletaAIRA^Sharnie^^^^L|SiouxAIRA^ThetisAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1757 Ktichtse Vecht Cir^^Grand Rapids^MI^49588^USA^P||^PRN^PH^^^616^5386313|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Van WertAIRA^SiouxAIRA^^^^^L|MTH^Mother^HL70063|1757 Ktichtse Vecht Cir^^Grand Rapids^MI^49588^USA^P|^PRN^PH^^^616^5386313ORC|RE||BM33W36077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM33W36077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160096601^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160096612|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J22Q36085^^^AIRA-TEST^MR||SalterAIRA^SalimahAIRA^Corowa^^^^L|EliasonAIRA^LaurindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1065 Drachten St^^Livonia^MI^48150^USA^P||^PRN^PH^^^734^9186220|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SalterAIRA^EliasonAIRA^^^^^L|MTH^Mother^HL70063|1065 Drachten St^^Livonia^MI^48150^USA^P|^PRN^PH^^^734^9186220ORC|RE||BJ22Q36085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ22Q36085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160096612^Rabavert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160097602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R93S36093^^^AIRA-TEST^MR||Le FloreAIRA^AnonaAIRA^Olathe^^^^L|LaurelAIRA^CirceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1736 Schoonheid Ave^^Ithaca^MI^48847^USA^P||^PRN^PH^^^989^4094275|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Le FloreAIRA^LaurelAIRA^^^^^L|MTH^Mother^HL70063|1736 Schoonheid Ave^^Ithaca^MI^48847^USA^P|^PRN^PH^^^989^4094275ORC|RE||BR93S36093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR93S36093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160097602^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160097606|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X18O36101^^^AIRA-TEST^MR||AsotinAIRA^ButtercupAIRA^Wendy^^^^L|NowataAIRA^KleaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1353 Horne Pl^^Hersey^MI^49639^USA^P||^PRN^PH^^^231^9595959|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AsotinAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1353 Horne Pl^^Hersey^MI^49639^USA^P|^PRN^PH^^^231^9595959ORC|RE||BX18O36101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX18O36101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160097606^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-58160097620|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C24J36109^^^AIRA-TEST^MR||HaskellAIRA^FaynaAIRA^Heater^^^^L|CrawfordAIRA^SidonieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1223 Mond Pl^^Midland^MI^48641^USA^P||^PRN^PH^^^989^2342452|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaskellAIRA^CrawfordAIRA^^^^^L|MTH^Mother^HL70063|1223 Mond Pl^^Midland^MI^48641^USA^P|^PRN^PH^^^989^2342452ORC|RE||BC24J36109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC24J36109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||58160097620^BEXSERO^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62195-051-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D75N36114^^^AIRA-TEST^MR||CassAIRA^ShardaAIRA^Semra^^^^L|ManisteeAIRA^KristineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1307 Stein Cir^^Vassar^MI^48768^USA^P||^PRN^PH^^^989^6181462|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1307 Stein Cir^^Vassar^MI^48768^USA^P|^PRN^PH^^^989^6181462ORC|RE||BD75N36114.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD75N36114.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62195-051-01^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62195-051-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I03D36125^^^AIRA-TEST^MR||OlssonAIRA^GiannaAIRA^Nayoko^^^^L|TexasAIRA^AvelineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1216 Weere St^^Little Lake^MI^49833^USA^P||^PRN^PH^^^906^9993336|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OlssonAIRA^TexasAIRA^^^^^L|MTH^Mother^HL70063|1216 Weere St^^Little Lake^MI^49833^USA^P|^PRN^PH^^^906^9993336ORC|RE||BI03D36125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI03D36125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62195-051-10^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62195005101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F83I36133^^^AIRA-TEST^MR||ThomasAIRA^TarynAIRA^Majella^^^^L|CusterAIRA^ZeanesAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1931 Hlburg St^^Alger^MI^48610^USA^P||^PRN^PH^^^989^9965825|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThomasAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1931 Hlburg St^^Alger^MI^48610^USA^P|^PRN^PH^^^989^9965825ORC|RE||BF83I36133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF83I36133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62195005101^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62195005110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K78V36141^^^AIRA-TEST^MR||BlaineAIRA^SushmitaAIRA^Veda^^^^L|HardinAIRA^TottyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1518 We Wolden Ln^^Walloon Lake^MI^49796^USA^P||^PRN^PH^^^231^4873072|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlaineAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1518 We Wolden Ln^^Walloon Lake^MI^49796^USA^P|^PRN^PH^^^231^4873072ORC|RE||BK78V36141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK78V36141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62195005110^Ixiaro^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I54Y36149^^^AIRA-TEST^MR||ButlerAIRA^ChyouAIRA^Alarice^^^^L|CusterAIRA^RyleeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1649 Be Ronde Venen Ln^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^9779485|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1649 Be Ronde Venen Ln^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^9779485ORC|RE||BI54Y36149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI54Y36149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577-613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z72G36157^^^AIRA-TEST^MR||LycomingAIRA^MadelineAIRA^Anemone^^^^L|Van BurenAIRA^RosalieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1778 Vlees Ln^^Farmington^MI^48332^USA^P||^PRN^PH^^^248^6151172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LycomingAIRA^Van BurenAIRA^^^^^L|MTH^Mother^HL70063|1778 Vlees Ln^^Farmington^MI^48332^USA^P|^PRN^PH^^^248^6151172ORC|RE||BZ72G36157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ72G36157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577-613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T46M36165^^^AIRA-TEST^MR||KootenaiAIRA^ArtemisAIRA^Clare^^^^L|KlickitatAIRA^DaffodilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1352 Kuiken Pl^^Lake Station^MI^48632^USA^P||^PRN^PH^^^989^5126802|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KootenaiAIRA^KlickitatAIRA^^^^^L|MTH^Mother^HL70063|1352 Kuiken Pl^^Lake Station^MI^48632^USA^P|^PRN^PH^^^989^5126802ORC|RE||BT46M36165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT46M36165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577-614-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577-614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N67Z36170^^^AIRA-TEST^MR||UptonAIRA^VandaAIRA^Elrica^^^^L|DixonAIRA^AdysonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1121 Groeide Cir^^Norton Shores^MI^49441^USA^P||^PRN^PH^^^231^8067399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UptonAIRA^DixonAIRA^^^^^L|MTH^Mother^HL70063|1121 Groeide Cir^^Norton Shores^MI^49441^USA^P|^PRN^PH^^^231^8067399ORC|RE||BN67Z36170.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN67Z36170.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577-614-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577061301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G52E36181^^^AIRA-TEST^MR||AdaAIRA^LidiaAIRA^Yoshiko^^^^L|PikeAIRA^AdinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1925 Slagtwedde Pl^^Farmington^MI^48334^USA^P||^PRN^PH^^^248^4668882|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdaAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1925 Slagtwedde Pl^^Farmington^MI^48334^USA^P|^PRN^PH^^^248^4668882ORC|RE||BG52E36181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG52E36181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577061301^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577061311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H06T36189^^^AIRA-TEST^MR||CopelandAIRA^ShareeAIRA^Miriam^^^^L|HoltAIRA^HeaterAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1672 Goed St^^Detroit^MI^48225^USA^P||^PRN^PH^^^313^4468278|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CopelandAIRA^HoltAIRA^^^^^L|MTH^Mother^HL70063|1672 Goed St^^Detroit^MI^48225^USA^P|^PRN^PH^^^313^4468278ORC|RE||BH06T36189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH06T36189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577061311^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577061401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z61P36197^^^AIRA-TEST^MR||ScottAIRA^BarbaraAIRA^Elsa^^^^L|GunnersonAIRA^TeaganAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1458 Hilze en Rijen Pl^^Lake City^MI^49651^USA^P||^PRN^PH^^^231^5345997|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ScottAIRA^GunnersonAIRA^^^^^L|MTH^Mother^HL70063|1458 Hilze en Rijen Pl^^Lake City^MI^49651^USA^P|^PRN^PH^^^231^5345997ORC|RE||BZ61P36197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ61P36197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577061401^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-62577061411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K52W36205^^^AIRA-TEST^MR||HowardAIRA^ValerieAIRA^Kesare^^^^L|LibertyAIRA^AureliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1306 Best Ave^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^5803713|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowardAIRA^LibertyAIRA^^^^^L|MTH^Mother^HL70063|1306 Best Ave^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^5803713ORC|RE||BK52W36205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK52W36205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||62577061411^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63361-245-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L32Z36213^^^AIRA-TEST^MR||ParasariAIRA^JacquelineAIRA^Tegwen^^^^L|AlleghenyAIRA^AspenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1374 Nooit Ln^^Unadilla^MI^48137^USA^P||^PRN^PH^^^734^4209648|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParasariAIRA^AlleghenyAIRA^^^^^L|MTH^Mother^HL70063|1374 Nooit Ln^^Unadilla^MI^48137^USA^P|^PRN^PH^^^734^4209648ORC|RE||BL32Z36213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL32Z36213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63361-245-10^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63361-245-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z47C36221^^^AIRA-TEST^MR||OldhamAIRA^YasmineAIRA^Thistle^^^^L|WheelerAIRA^Joo-EunAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1677 Lellingwedde Pl^^Leland^MI^49654^USA^P||^PRN^PH^^^231^2890133|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OldhamAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1677 Lellingwedde Pl^^Leland^MI^49654^USA^P|^PRN^PH^^^231^2890133ORC|RE||BZ47C36221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ47C36221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63361-245-58^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63361024510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H33L36226^^^AIRA-TEST^MR||ReevesAIRA^LareyneAIRA^Zoe^^^^L|StephensAIRA^FriedaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1887 Sliedrecht Ave^^Waterford Township^MI^48327^USA^P||^PRN^PH^^^248^5237162|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReevesAIRA^StephensAIRA^^^^^L|MTH^Mother^HL70063|1887 Sliedrecht Ave^^Waterford Township^MI^48327^USA^P|^PRN^PH^^^248^5237162ORC|RE||BH33L36226.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH33L36226.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63361024510^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63361024558|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E69F36237^^^AIRA-TEST^MR||PinalAIRA^MagnoliaAIRA^Khalidah^^^^L|DelawareAIRA^WalidaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1947 Kmallingerland Cir^^Clarkston^MI^48347^USA^P||^PRN^PH^^^248^4705696|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PinalAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1947 Kmallingerland Cir^^Clarkston^MI^48347^USA^P|^PRN^PH^^^248^4705696ORC|RE||BE69F36237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE69F36237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63361024558^VAXELIS^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-501-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I26P36245^^^AIRA-TEST^MR||McLeanAIRA^LisetteAIRA^Nancy^^^^L|ProvidenceAIRA^PersiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1028 Nuth Pl^^Mi Department of Revenue^MI^48922^USA^P||^PRN^PH^^^517^2268355|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McLeanAIRA^ProvidenceAIRA^^^^^L|MTH^Mother^HL70063|1028 Nuth Pl^^Mi Department of Revenue^MI^48922^USA^P|^PRN^PH^^^517^2268355ORC|RE||BI26P36245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI26P36245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-501-01^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-501-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z82F36253^^^AIRA-TEST^MR||DillAIRA^YevonAIRA^Caresse^^^^L|McKinnonAIRA^MamikoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1814 Rindhoven Pl^^Oakland^MI^48363^USA^P||^PRN^PH^^^248^6265436|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DillAIRA^McKinnonAIRA^^^^^L|MTH^Mother^HL70063|1814 Rindhoven Pl^^Oakland^MI^48363^USA^P|^PRN^PH^^^248^6265436ORC|RE||BZ82F36253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ82F36253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-501-02^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-511-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J15R36261^^^AIRA-TEST^MR||BurkeAIRA^DohnaAIRA^Monica^^^^L|GogebicAIRA^TheraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1531 Irimpenerwaard Ln^^Commerce Township^MI^48390^USA^P||^PRN^PH^^^248^4367834|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^GogebicAIRA^^^^^L|MTH^Mother^HL70063|1531 Irimpenerwaard Ln^^Commerce Township^MI^48390^USA^P|^PRN^PH^^^248^4367834ORC|RE||BJ15R36261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ15R36261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-511-11^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-612-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R13C36266^^^AIRA-TEST^MR||UnionAIRA^ColletteAIRA^Tiegan^^^^L|HardinAIRA^MeghaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1394 Kijnacker-Nootdorp Ln^^Sault S Marie^MI^49783^USA^P||^PRN^PH^^^906^5269802|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UnionAIRA^HardinAIRA^^^^^L|MTH^Mother^HL70063|1394 Kijnacker-Nootdorp Ln^^Sault S Marie^MI^49783^USA^P|^PRN^PH^^^906^5269802ORC|RE||BR13C36266.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR13C36266.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-612-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-612-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C49Y36277^^^AIRA-TEST^MR||SchoolcraftAIRA^YumakoAIRA^Litsa^^^^L|LawrenceAIRA^JemimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1020 Aollumerland en Nieuwkruisland Ave^^Merriweather^MI^49947^USA^P||^PRN^PH^^^906^6140762|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SchoolcraftAIRA^LawrenceAIRA^^^^^L|MTH^Mother^HL70063|1020 Aollumerland en Nieuwkruisland Ave^^Merriweather^MI^49947^USA^P|^PRN^PH^^^906^6140762ORC|RE||BC49Y36277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC49Y36277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-612-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-613-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H75C36285^^^AIRA-TEST^MR||CokeAIRA^LynnetteAIRA^Alana^^^^L|MontgomeryAIRA^BrynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1088 Rudewater Cir^^Parma^MI^49269^USA^P||^PRN^PH^^^517^9131852|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CokeAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1088 Rudewater Cir^^Parma^MI^49269^USA^P|^PRN^PH^^^517^9131852ORC|RE||BH75C36285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH75C36285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-613-01^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851-613-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O42G36293^^^AIRA-TEST^MR||RandallAIRA^RebelAIRA^Tully^^^^L|BoyleAIRA^ClaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1293 Oarneveld Ave^^Marne^MI^49435^USA^P||^PRN^PH^^^616^9701305|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RandallAIRA^BoyleAIRA^^^^^L|MTH^Mother^HL70063|1293 Oarneveld Ave^^Marne^MI^49435^USA^P|^PRN^PH^^^616^9701305ORC|RE||BO42G36293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO42G36293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851-613-11^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851050101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P31U36301^^^AIRA-TEST^MR||MarionAIRA^DavidaAIRA^Esperance^^^^L|SalzeberAIRA^JoanneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1526 Dienen St^^Clyde Township^MI^48049^USA^P||^PRN^PH^^^810^5373034|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^SalzeberAIRA^^^^^L|MTH^Mother^HL70063|1526 Dienen St^^Clyde Township^MI^48049^USA^P|^PRN^PH^^^810^5373034ORC|RE||BP31U36301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP31U36301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851050101^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851050102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X46L36309^^^AIRA-TEST^MR||PikeAIRA^OlyaAIRA^Chrissy^^^^L|BerntsenAIRA^YusraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1822 Vrouwen Pl^^Farmingtn Hls^MI^48336^USA^P||^PRN^PH^^^248^6294814|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PikeAIRA^BerntsenAIRA^^^^^L|MTH^Mother^HL70063|1822 Vrouwen Pl^^Farmingtn Hls^MI^48336^USA^P|^PRN^PH^^^248^6294814ORC|RE||BX46L36309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX46L36309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851050102^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851051111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V89I36314^^^AIRA-TEST^MR||MathiesenAIRA^VeronicaAIRA^Dirran^^^^L|UmatillaAIRA^MagenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1695 Kerkrade St^^South Rockwood^MI^48179^USA^P||^PRN^PH^^^734^9274613|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MathiesenAIRA^UmatillaAIRA^^^^^L|MTH^Mother^HL70063|1695 Kerkrade St^^South Rockwood^MI^48179^USA^P|^PRN^PH^^^734^9274613ORC|RE||BV89I36314.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV89I36314.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851051111^RabAvert^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851061201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K54U36325^^^AIRA-TEST^MR||KrogAIRA^YindiAIRA^Rhoswen^^^^L|BlaineAIRA^AlouettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1223 Kaaren Ln^^Dover^MI^48130^USA^P||^PRN^PH^^^734^5135798|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KrogAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1223 Kaaren Ln^^Dover^MI^48130^USA^P|^PRN^PH^^^734^5135798ORC|RE||BK54U36325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK54U36325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851061201^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851061211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K43T36333^^^AIRA-TEST^MR||SantiagoAIRA^MekiaAIRA^Azra^^^^L|WarrenAIRA^LiviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1032 Kemsmond Pl^^Burt^MI^48417^USA^P||^PRN^PH^^^989^6564696|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SantiagoAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1032 Kemsmond Pl^^Burt^MI^48417^USA^P|^PRN^PH^^^989^6564696ORC|RE||BK43T36333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK43T36333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851061211^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851061301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D48T36341^^^AIRA-TEST^MR||NemahaAIRA^MaryamAIRA^Charla^^^^L|GreenAIRA^KadeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1287 Hon en Breugel Pl^^Daggett^MI^49821^USA^P||^PRN^PH^^^906^9155093|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NemahaAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1287 Hon en Breugel Pl^^Daggett^MI^49821^USA^P|^PRN^PH^^^906^9155093ORC|RE||BD48T36341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD48T36341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851061301^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-63851061311|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U29F36349^^^AIRA-TEST^MR||NevadaAIRA^ParnellaAIRA^Hilzarie^^^^L|JakobsenAIRA^SkyeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1325 Echouwen-Duiveland St^^Westland^MI^48186^USA^P||^PRN^PH^^^734^9528307|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NevadaAIRA^JakobsenAIRA^^^^^L|MTH^Mother^HL70063|1325 Echouwen-Duiveland St^^Westland^MI^48186^USA^P|^PRN^PH^^^734^9528307ORC|RE||BU29F36349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU29F36349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||63851061311^Flucelvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-64678-211-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F57K36357^^^AIRA-TEST^MR||WilliamsonAIRA^IngridAIRA^Elysa^^^^L|KildahlAIRA^PrashantiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1243 Nesterveld Pl^^Cone^MI^48160^USA^P||^PRN^PH^^^734^8776987|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilliamsonAIRA^KildahlAIRA^^^^^L|MTH^Mother^HL70063|1243 Nesterveld Pl^^Cone^MI^48160^USA^P|^PRN^PH^^^734^8776987ORC|RE||BF57K36357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF57K36357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||64678-211-01^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-64678-211-05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S93L36365^^^AIRA-TEST^MR||DundyAIRA^PatsyAIRA^Panya^^^^L|GardenAIRA^EkalaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1022 Zoeterwoude Cir^^Manchester^MI^48158^USA^P||^PRN^PH^^^734^9896607|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DundyAIRA^GardenAIRA^^^^^L|MTH^Mother^HL70063|1022 Zoeterwoude Cir^^Manchester^MI^48158^USA^P|^PRN^PH^^^734^9896607ORC|RE||BS93L36365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS93L36365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||64678-211-05^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-64678021101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M18J36370^^^AIRA-TEST^MR||CartonAIRA^HineAIRA^Godiva^^^^L|AudubonAIRA^KristinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1640 Eet Pl^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^2880969|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CartonAIRA^AudubonAIRA^^^^^L|MTH^Mother^HL70063|1640 Eet Pl^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^2880969ORC|RE||BM18J36370.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM18J36370.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||64678021101^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-64678021105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G14O36381^^^AIRA-TEST^MR||LucasAIRA^DaralisAIRA^Cybele^^^^L|ValleyAIRA^AndreanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1924 Mtrechtse Heuvelrug Cir^^Howell^MI^48843^USA^P||^PRN^PH^^^517^8436814|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^ValleyAIRA^^^^^L|MTH^Mother^HL70063|1924 Mtrechtse Heuvelrug Cir^^Howell^MI^48843^USA^P|^PRN^PH^^^517^8436814ORC|RE||BG14O36381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG14O36381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||64678021105^BioThrax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-107-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q47A36389^^^AIRA-TEST^MR||ComancheAIRA^MichelleAIRA^Durga^^^^L|EllisAIRA^LonikieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1002 Heder-Betuwe Cir^^Jackson^MI^49202^USA^P||^PRN^PH^^^517^4076957|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComancheAIRA^EllisAIRA^^^^^L|MTH^Mother^HL70063|1002 Heder-Betuwe Cir^^Jackson^MI^49202^USA^P|^PRN^PH^^^517^4076957ORC|RE||BQ47A36389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ47A36389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-107-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-108-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L72D36397^^^AIRA-TEST^MR||MinidokaAIRA^RobbinAIRA^Aemilia^^^^L|LindstromAIRA^KevinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1707 Zuurstof Ln^^Whitehall^MI^49463^USA^P||^PRN^PH^^^231^3341172|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MinidokaAIRA^LindstromAIRA^^^^^L|MTH^Mother^HL70063|1707 Zuurstof Ln^^Whitehall^MI^49463^USA^P|^PRN^PH^^^231^3341172ORC|RE||BL72D36397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL72D36397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-108-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-108-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V03O36405^^^AIRA-TEST^MR||LuzerneAIRA^WakandaAIRA^Apirka^^^^L|LucasAIRA^JadynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1659 Goed St^^Detroit^MI^48279^USA^P||^PRN^PH^^^313^2255503|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LuzerneAIRA^LucasAIRA^^^^^L|MTH^Mother^HL70063|1659 Goed St^^Detroit^MI^48279^USA^P|^PRN^PH^^^313^2255503ORC|RE||BV03O36405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV03O36405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-108-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-109-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V66K36413^^^AIRA-TEST^MR||ClarkeAIRA^EucleaAIRA^Nalani^^^^L|KananenAIRA^ImmacolataAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1064 Soord-Beveland St^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^7628831|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarkeAIRA^KananenAIRA^^^^^L|MTH^Mother^HL70063|1064 Soord-Beveland St^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^7628831ORC|RE||BV66K36413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV66K36413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-109-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-109-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z48R36421^^^AIRA-TEST^MR||OkfuskeeAIRA^HalcyoneAIRA^Delila^^^^L|FayetteAIRA^SiddhiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1578 Nwartewaterland Ave^^GR^MI^49548^USA^P||^PRN^PH^^^616^6180574|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OkfuskeeAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1578 Nwartewaterland Ave^^GR^MI^49548^USA^P|^PRN^PH^^^616^6180574ORC|RE||BZ48R36421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ48R36421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-109-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-110-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R61E36426^^^AIRA-TEST^MR||NordholmAIRA^AnzuAIRA^Bhayana^^^^L|GanesAIRA^MadilynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1454 Wiel Pl^^Twining^MI^48766^USA^P||^PRN^PH^^^989^2194478|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NordholmAIRA^GanesAIRA^^^^^L|MTH^Mother^HL70063|1454 Wiel Pl^^Twining^MI^48766^USA^P|^PRN^PH^^^989^2194478ORC|RE||BR61E36426.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR61E36426.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-110-01^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-110-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G66I36437^^^AIRA-TEST^MR||CoconinoAIRA^MalcaAIRA^Zakia^^^^L|KeweenawAIRA^CeanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1029 Heimerswaal Ln^^Curtis^MI^49820^USA^P||^PRN^PH^^^906^5089519|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoconinoAIRA^KeweenawAIRA^^^^^L|MTH^Mother^HL70063|1029 Heimerswaal Ln^^Curtis^MI^49820^USA^P|^PRN^PH^^^906^5089519ORC|RE||BG66I36437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG66I36437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-110-10^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M00N36445^^^AIRA-TEST^MR||Red WillowAIRA^AdahAIRA^Kitu^^^^L|PetersAIRA^LyndeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1615 Hmersfoort Ln^^Oden^MI^49764^USA^P||^PRN^PH^^^616^4491468|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Red WillowAIRA^PetersAIRA^^^^^L|MTH^Mother^HL70063|1615 Hmersfoort Ln^^Oden^MI^49764^USA^P|^PRN^PH^^^616^4491468ORC|RE||BM00N36445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM00N36445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-200-01^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S80V36453^^^AIRA-TEST^MR||RoachAIRA^GryffynAIRA^Dalia^^^^L|MathiesenAIRA^ParvaniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1172 Niddelburg Ave^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^9972144|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RoachAIRA^MathiesenAIRA^^^^^L|MTH^Mother^HL70063|1172 Niddelburg Ave^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^9972144ORC|RE||BS80V36453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS80V36453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-200-10^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-300-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V18I36461^^^AIRA-TEST^MR||San BenitoAIRA^EllenAIRA^Elzira^^^^L|Hood RiverAIRA^UmekoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1625 Twintig Ln^^Au Gres^MI^48703^USA^P||^PRN^PH^^^989^2842179|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San BenitoAIRA^Hood RiverAIRA^^^^^L|MTH^Mother^HL70063|1625 Twintig Ln^^Au Gres^MI^48703^USA^P|^PRN^PH^^^989^2842179ORC|RE||BV18I36461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV18I36461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-300-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-300-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I98R36469^^^AIRA-TEST^MR||KaneAIRA^ZionAIRA^Cory^^^^L|AdsgaardAIRA^LanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1773 Scht-Susteren St^^Harbor Springs^MI^49740^USA^P||^PRN^PH^^^616^4019566|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KaneAIRA^AdsgaardAIRA^^^^^L|MTH^Mother^HL70063|1773 Scht-Susteren St^^Harbor Springs^MI^49740^USA^P|^PRN^PH^^^616^4019566ORC|RE||BI98R36469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI98R36469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-300-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-301-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A52T36477^^^AIRA-TEST^MR||NordstromAIRA^EmaliaAIRA^Yasu^^^^L|LyonAIRA^RoseAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1491 Oeimerswaal Ln^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^9614725|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NordstromAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1491 Oeimerswaal Ln^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^9614725ORC|RE||BA52T36477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA52T36477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-301-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U96W36482^^^AIRA-TEST^MR||SheridanAIRA^EvaniaAIRA^Iluka^^^^L|MacombAIRA^MaciAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1871 Klap Ln^^Centennial Heights^MI^49913^USA^P||^PRN^PH^^^906^7810231|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SheridanAIRA^MacombAIRA^^^^^L|MTH^Mother^HL70063|1871 Klap Ln^^Centennial Heights^MI^49913^USA^P|^PRN^PH^^^906^7810231ORC|RE||BU96W36482.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU96W36482.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-301-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-302-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U53R36493^^^AIRA-TEST^MR||NewberryAIRA^ElaineAIRA^Brenna^^^^L|OkmulgeeAIRA^ReneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1588 Hlagtwedde St^^Wallace^MI^49893^USA^P||^PRN^PH^^^906^9285590|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NewberryAIRA^OkmulgeeAIRA^^^^^L|MTH^Mother^HL70063|1588 Hlagtwedde St^^Wallace^MI^49893^USA^P|^PRN^PH^^^906^9285590ORC|RE||BU53R36493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU53R36493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-302-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-302-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T58E36501^^^AIRA-TEST^MR||PrestonAIRA^AmyAIRA^Anezka^^^^L|TrinityAIRA^MiriamAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1927 Terug Ave^^Webster^MI^48130^USA^P||^PRN^PH^^^734^4530911|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PrestonAIRA^TrinityAIRA^^^^^L|MTH^Mother^HL70063|1927 Terug Ave^^Webster^MI^48130^USA^P|^PRN^PH^^^734^4530911ORC|RE||BT58E36501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT58E36501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-302-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-303-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B48M36509^^^AIRA-TEST^MR||PolkAIRA^SashiAIRA^Carine^^^^L|LoupAIRA^VolanteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1557 Vreemd St^^Fort Gratiot Township^MI^48059^USA^P||^PRN^PH^^^810^5471199|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^LoupAIRA^^^^^L|MTH^Mother^HL70063|1557 Vreemd St^^Fort Gratiot Township^MI^48059^USA^P|^PRN^PH^^^810^5471199ORC|RE||BB48M36509.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB48M36509.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-303-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-303-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N06E36517^^^AIRA-TEST^MR||KolarAIRA^AddysonAIRA^Meredith^^^^L|ToaleAIRA^SwetaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1335 Bruin Ave^^Birch Run^MI^48415^USA^P||^PRN^PH^^^989^4647359|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KolarAIRA^ToaleAIRA^^^^^L|MTH^Mother^HL70063|1335 Bruin Ave^^Birch Run^MI^48415^USA^P|^PRN^PH^^^989^4647359ORC|RE||BN06E36517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN06E36517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-303-10^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-304-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M30I36525^^^AIRA-TEST^MR||AdamsAIRA^OrnellaAIRA^Dae^^^^L|CreekAIRA^ThomasaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1475 Nindhoven Pl^^Lansing^MI^48917^USA^P||^PRN^PH^^^517^7248009|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^CreekAIRA^^^^^L|MTH^Mother^HL70063|1475 Nindhoven Pl^^Lansing^MI^48917^USA^P|^PRN^PH^^^517^7248009ORC|RE||BM30I36525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM30I36525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-304-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-304-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O31T36533^^^AIRA-TEST^MR||HuntingdonAIRA^JaylynnAIRA^Begonia^^^^L|NavarroAIRA^ElizabethAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1339 Wollumerland en Nieuwkruisland Pl^^Toivola^MI^49965^USA^P||^PRN^PH^^^906^8381988|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuntingdonAIRA^NavarroAIRA^^^^^L|MTH^Mother^HL70063|1339 Wollumerland en Nieuwkruisland Pl^^Toivola^MI^49965^USA^P|^PRN^PH^^^906^8381988ORC|RE||BO31T36533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO31T36533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-304-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-305-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X80Y36538^^^AIRA-TEST^MR||ErieAIRA^AlumaAIRA^Julianna^^^^L|LyonAIRA^ManiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1370 Grave Pl^^Jackson National Life Ins Co^MI^48951^USA^P||^PRN^PH^^^517^7471917|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErieAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1370 Grave Pl^^Jackson National Life Ins Co^MI^48951^USA^P|^PRN^PH^^^517^7471917ORC|RE||BX80Y36538.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX80Y36538.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-305-01^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019-305-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I60F36549^^^AIRA-TEST^MR||SalzeberAIRA^DidrikaAIRA^Cassiel^^^^L|OsceolaAIRA^KirstieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1764 Uude IJsselstreek St^^Freedom Township^MI^48118^USA^P||^PRN^PH^^^734^6726327|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SalzeberAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1764 Uude IJsselstreek St^^Freedom Township^MI^48118^USA^P|^PRN^PH^^^734^6726327ORC|RE||BI60F36549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI60F36549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019-305-10^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019010701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U24M36557^^^AIRA-TEST^MR||SylteAIRA^DevoraAIRA^Paulina^^^^L|IversenAIRA^ClareAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1567 Woggenland Cir^^Chesterfield Township^MI^48051^USA^P||^PRN^PH^^^586^9084272|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SylteAIRA^IversenAIRA^^^^^L|MTH^Mother^HL70063|1567 Woggenland Cir^^Chesterfield Township^MI^48051^USA^P|^PRN^PH^^^586^9084272ORC|RE||BU24M36557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU24M36557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019010701^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019010801|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L70W36565^^^AIRA-TEST^MR||AlleganAIRA^RowenaAIRA^Amber^^^^L|PayetteAIRA^ThuridAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1820 Pijnacker-Nootdorp Ave^^Farmington Hills^MI^48334^USA^P||^PRN^PH^^^248^7870207|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlleganAIRA^PayetteAIRA^^^^^L|MTH^Mother^HL70063|1820 Pijnacker-Nootdorp Ave^^Farmington Hills^MI^48334^USA^P|^PRN^PH^^^248^7870207ORC|RE||BL70W36565.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL70W36565.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019010801^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019010810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V99T36573^^^AIRA-TEST^MR||HolmfAIRA^SherryAIRA^Charisse^^^^L|ComancheAIRA^DanniellAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1778 Zieuwkoop St^^Mesick^MI^49668^USA^P||^PRN^PH^^^231^9093849|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolmfAIRA^ComancheAIRA^^^^^L|MTH^Mother^HL70063|1778 Zieuwkoop St^^Mesick^MI^49668^USA^P|^PRN^PH^^^231^9093849ORC|RE||BV99T36573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV99T36573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019010810^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019010901|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z60Y36581^^^AIRA-TEST^MR||MenomineeAIRA^CarissaAIRA^Moriah^^^^L|EigumAIRA^MaeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1932 Coensdrecht Ave^^Southfield^MI^48075^USA^P||^PRN^PH^^^248^6914975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenomineeAIRA^EigumAIRA^^^^^L|MTH^Mother^HL70063|1932 Coensdrecht Ave^^Southfield^MI^48075^USA^P|^PRN^PH^^^248^6914975ORC|RE||BZ60Y36581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ60Y36581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019010901^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019010910|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z21B36586^^^AIRA-TEST^MR||KarlssonAIRA^ElkeAIRA^Lala^^^^L|AlconaAIRA^IretaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1856 Eersel St^^Marquette^MI^49855^USA^P||^PRN^PH^^^906^6661670|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KarlssonAIRA^AlconaAIRA^^^^^L|MTH^Mother^HL70063|1856 Eersel St^^Marquette^MI^49855^USA^P|^PRN^PH^^^906^6661670ORC|RE||BZ21B36586.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ21B36586.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019010910^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019011001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W10H36597^^^AIRA-TEST^MR||ThiemerAIRA^LuvenaAIRA^Fabiana^^^^L|ThornleyAIRA^MildredAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1374 Dronten Ave^^Sebewaing^MI^48759^USA^P||^PRN^PH^^^989^4145648|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ThiemerAIRA^ThornleyAIRA^^^^^L|MTH^Mother^HL70063|1374 Dronten Ave^^Sebewaing^MI^48759^USA^P|^PRN^PH^^^989^4145648ORC|RE||BW10H36597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW10H36597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019011001^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019011010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G43B36605^^^AIRA-TEST^MR||KenedyAIRA^GudduAIRA^Maitane^^^^L|YoungAIRA^MorgenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1784 Oefening Pl^^Grosse Pointe Park^MI^48224^USA^P||^PRN^PH^^^313^9952501|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KenedyAIRA^YoungAIRA^^^^^L|MTH^Mother^HL70063|1784 Oefening Pl^^Grosse Pointe Park^MI^48224^USA^P|^PRN^PH^^^313^9952501ORC|RE||BG43B36605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG43B36605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019011010^FluMist^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019020001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D03Y36613^^^AIRA-TEST^MR||GanesAIRA^EunaAIRA^Narelle^^^^L|HopkinsAIRA^CelineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1914 Scheemda Cir^^North Muskegon^MI^49445^USA^P||^PRN^PH^^^231^2220682|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanesAIRA^HopkinsAIRA^^^^^L|MTH^Mother^HL70063|1914 Scheemda Cir^^North Muskegon^MI^49445^USA^P|^PRN^PH^^^231^2220682ORC|RE||BD03Y36613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD03Y36613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019020001^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019020010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G33Z36621^^^AIRA-TEST^MR||O'ConnellAIRA^VivianaAIRA^Flora^^^^L|PikeAIRA^LanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1873 Gppingedam Ave^^Ralph^MI^49877^USA^P||^PRN^PH^^^906^7132327|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'ConnellAIRA^PikeAIRA^^^^^L|MTH^Mother^HL70063|1873 Gppingedam Ave^^Ralph^MI^49877^USA^P|^PRN^PH^^^906^7132327ORC|RE||BG33Z36621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG33Z36621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019020010^Influenza A H1N1 2009 Monovalent Vaccine Live Intr^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W78X36629^^^AIRA-TEST^MR||MarionAIRA^AletheaAIRA^Ruchira^^^^L|BonnevilleAIRA^SachaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1880 Tollands Kroon St^^Hamburg^MI^48189^USA^P||^PRN^PH^^^734^9483827|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarionAIRA^BonnevilleAIRA^^^^^L|MTH^Mother^HL70063|1880 Tollands Kroon St^^Hamburg^MI^48189^USA^P|^PRN^PH^^^734^9483827ORC|RE||BW78X36629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW78X36629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030001^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G90M36637^^^AIRA-TEST^MR||WoodsAIRA^CrispinaAIRA^Petra^^^^L|HughesAIRA^ErasmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1339 Aoevorden Ln^^Moscow^MI^49257^USA^P||^PRN^PH^^^517^8788356|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodsAIRA^HughesAIRA^^^^^L|MTH^Mother^HL70063|1339 Aoevorden Ln^^Moscow^MI^49257^USA^P|^PRN^PH^^^517^8788356ORC|RE||BG90M36637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG90M36637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030010^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K80G36642^^^AIRA-TEST^MR||LouisaAIRA^RitsukoAIRA^Alena^^^^L|RoscommonAIRA^AlexAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1153 Gaarle-Nassau Cir^^Olivet^MI^49076^USA^P||^PRN^PH^^^269^3865280|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LouisaAIRA^RoscommonAIRA^^^^^L|MTH^Mother^HL70063|1153 Gaarle-Nassau Cir^^Olivet^MI^49076^USA^P|^PRN^PH^^^269^3865280ORC|RE||BK80G36642.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK80G36642.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030101^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q47E36653^^^AIRA-TEST^MR||LieAIRA^LailieAIRA^Lilac^^^^L|CollingsworthAIRA^MindaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1420 Oeudal Ln^^Comstock Park^MI^49321^USA^P||^PRN^PH^^^616^8613534|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LieAIRA^CollingsworthAIRA^^^^^L|MTH^Mother^HL70063|1420 Oeudal Ln^^Comstock Park^MI^49321^USA^P|^PRN^PH^^^616^8613534ORC|RE||BQ47E36653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ47E36653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030110^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X02A36661^^^AIRA-TEST^MR||CornelinsonAIRA^MakennaAIRA^Carling^^^^L|HawkeAIRA^ZakiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1370 Bunschoten Ave^^Cross Village^MI^49723^USA^P||^PRN^PH^^^616^3913502|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CornelinsonAIRA^HawkeAIRA^^^^^L|MTH^Mother^HL70063|1370 Bunschoten Ave^^Cross Village^MI^49723^USA^P|^PRN^PH^^^616^3913502ORC|RE||BX02A36661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX02A36661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030201^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E84G36669^^^AIRA-TEST^MR||SantiagoAIRA^JosieAIRA^Damini^^^^L|CusterAIRA^SubhadraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1093 Goudrichem Pl^^Barlow Branch^MI^49686^USA^P||^PRN^PH^^^231^4421411|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SantiagoAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1093 Goudrichem Pl^^Barlow Branch^MI^49686^USA^P|^PRN^PH^^^231^4421411ORC|RE||BE84G36669.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE84G36669.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030210^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P04L36677^^^AIRA-TEST^MR||WestmorelandAIRA^EllaAIRA^Melody^^^^L|FranklinAIRA^LataAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1167 Tubbergen Cir^^Oxford^MI^48371^USA^P||^PRN^PH^^^248^2220755|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WestmorelandAIRA^FranklinAIRA^^^^^L|MTH^Mother^HL70063|1167 Tubbergen Cir^^Oxford^MI^48371^USA^P|^PRN^PH^^^248^2220755ORC|RE||BP04L36677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP04L36677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030301^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V18H36685^^^AIRA-TEST^MR||HickmanAIRA^AinsleyAIRA^Mindel^^^^L|TravisAIRA^StinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1936 Kerneuzen Cir^^Flint^MI^48502^USA^P||^PRN^PH^^^810^3859981|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HickmanAIRA^TravisAIRA^^^^^L|MTH^Mother^HL70063|1936 Kerneuzen Cir^^Flint^MI^48502^USA^P|^PRN^PH^^^810^3859981ORC|RE||BV18H36685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV18H36685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030310^Flumist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E49X36690^^^AIRA-TEST^MR||SharplesAIRA^JanetteAIRA^Jordana^^^^L|EnaAIRA^NerinAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1714 Henkum Cir^^Stockbridge^MI^49285^USA^P||^PRN^PH^^^517^2896399|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SharplesAIRA^EnaAIRA^^^^^L|MTH^Mother^HL70063|1714 Henkum Cir^^Stockbridge^MI^49285^USA^P|^PRN^PH^^^517^2896399ORC|RE||BE49X36690.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE49X36690.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030401^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y79M36701^^^AIRA-TEST^MR||WheelerAIRA^MariAIRA^Hana^^^^L|CheboyganAIRA^SabineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1025 Ben Pl^^Flint^MI^48531^USA^P||^PRN^PH^^^810^9616634|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^CheboyganAIRA^^^^^L|MTH^Mother^HL70063|1025 Ben Pl^^Flint^MI^48531^USA^P|^PRN^PH^^^810^9616634ORC|RE||BY79M36701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY79M36701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030410^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030501|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C57D36709^^^AIRA-TEST^MR||LakeAIRA^PollyannaAIRA^Grette^^^^L|HowathAIRA^CeanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1199 Hlburg Cir^^Wequetonsing^MI^49740^USA^P||^PRN^PH^^^616^3296287|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^HowathAIRA^^^^^L|MTH^Mother^HL70063|1199 Hlburg Cir^^Wequetonsing^MI^49740^USA^P|^PRN^PH^^^616^3296287ORC|RE||BC57D36709.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC57D36709.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030501^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66019030510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P90F36717^^^AIRA-TEST^MR||GeaugaAIRA^AaliyahAIRA^Isobel^^^^L|RichardsonAIRA^LaeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1272 Meiderland Ave^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^6997391|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeaugaAIRA^RichardsonAIRA^^^^^L|MTH^Mother^HL70063|1272 Meiderland Ave^^New Buffalo^MI^49117^USA^P|^PRN^PH^^^269^6997391ORC|RE||BP90F36717.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP90F36717.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66019030510^FluMist Quadrivalent^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S05P36725^^^AIRA-TEST^MR||DeWittAIRA^RositaAIRA^Annice^^^^L|SwindellsAIRA^SalimahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1434 Mosser Pl^^Bloomfield Township^MI^48303^USA^P||^PRN^PH^^^248^9900441|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeWittAIRA^SwindellsAIRA^^^^^L|MTH^Mother^HL70063|1434 Mosser Pl^^Bloomfield Township^MI^48303^USA^P|^PRN^PH^^^248^9900441ORC|RE||BS05P36725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS05P36725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-000-01^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-000-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M23K36733^^^AIRA-TEST^MR||ClarksonAIRA^PemaAIRA^Dayana^^^^L|ErieAIRA^RaineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1798 Soevorden Cir^^Bham^MI^48009^USA^P||^PRN^PH^^^248^5280889|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClarksonAIRA^ErieAIRA^^^^^L|MTH^Mother^HL70063|1798 Soevorden Cir^^Bham^MI^48009^USA^P|^PRN^PH^^^248^5280889ORC|RE||BM23K36733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM23K36733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-000-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-112-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W46G36738^^^AIRA-TEST^MR||ComancheAIRA^TirionAIRA^Giorgetta^^^^L|ClermontAIRA^LavenderAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1377 Nedum Ln^^Pompeii^MI^48874^USA^P||^PRN^PH^^^989^2202666|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComancheAIRA^ClermontAIRA^^^^^L|MTH^Mother^HL70063|1377 Nedum Ln^^Pompeii^MI^48874^USA^P|^PRN^PH^^^989^2202666ORC|RE||BW46G36738.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW46G36738.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-112-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-112-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N07Q36749^^^AIRA-TEST^MR||KolarAIRA^FarikaAIRA^Penelope^^^^L|SundeAIRA^QuintessaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1582 Kaasdriel Ave^^Traverse City^MI^49685^USA^P||^PRN^PH^^^231^6722028|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KolarAIRA^SundeAIRA^^^^^L|MTH^Mother^HL70063|1582 Kaasdriel Ave^^Traverse City^MI^49685^USA^P|^PRN^PH^^^231^6722028ORC|RE||BN07Q36749.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN07Q36749.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-112-10^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-113-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F17L36757^^^AIRA-TEST^MR||HumboldtAIRA^NedivaAIRA^Hedea^^^^L|CopelandAIRA^MellissaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1886 Auenen Pl^^Omer^MI^48749^USA^P||^PRN^PH^^^989^2392146|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HumboldtAIRA^CopelandAIRA^^^^^L|MTH^Mother^HL70063|1886 Auenen Pl^^Omer^MI^48749^USA^P|^PRN^PH^^^989^2392146ORC|RE||BF17L36757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF17L36757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-113-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-113-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q56U36765^^^AIRA-TEST^MR||PatricioAIRA^HelenAIRA^Kaiya^^^^L|BrooksAIRA^TasmineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1841 Deist St^^Hillman^MI^49746^USA^P||^PRN^PH^^^989^2330321|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PatricioAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1841 Deist St^^Hillman^MI^49746^USA^P|^PRN^PH^^^989^2330321ORC|RE||BQ56U36765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ56U36765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-113-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-114-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q41V36773^^^AIRA-TEST^MR||CambriaAIRA^GotzoneAIRA^Achen^^^^L|SarpyAIRA^ArielAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1621 Kde St^^Mancelona^MI^49659^USA^P||^PRN^PH^^^231^6982177|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CambriaAIRA^SarpyAIRA^^^^^L|MTH^Mother^HL70063|1621 Kde St^^Mancelona^MI^49659^USA^P|^PRN^PH^^^231^6982177ORC|RE||BQ41V36773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ41V36773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-114-02^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-114-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N27U36781^^^AIRA-TEST^MR||SomersetAIRA^AmandlaAIRA^Storm^^^^L|HowardAIRA^CamelliaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1471 Doogeveen St^^Bad Axe^MI^48413^USA^P||^PRN^PH^^^989^4199342|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SomersetAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1471 Doogeveen St^^Bad Axe^MI^48413^USA^P|^PRN^PH^^^989^4199342ORC|RE||BN27U36781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN27U36781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-114-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-115-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H50Z36789^^^AIRA-TEST^MR||McQuadeAIRA^TammieAIRA^Poppy^^^^L|SullivanAIRA^XimenaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1229 Schilderen Pl^^Pleasant Rdg^MI^48069^USA^P||^PRN^PH^^^248^5468574|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McQuadeAIRA^SullivanAIRA^^^^^L|MTH^Mother^HL70063|1229 Schilderen Pl^^Pleasant Rdg^MI^48069^USA^P|^PRN^PH^^^248^5468574ORC|RE||BH50Z36789.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH50Z36789.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-115-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-115-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A97T36794^^^AIRA-TEST^MR||HeffernanAIRA^HadleyAIRA^Theresia^^^^L|WashingtonAIRA^IlsaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1184 Verwachten Ave^^L Anse^MI^49946^USA^P||^PRN^PH^^^906^8852943|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1184 Verwachten Ave^^L Anse^MI^49946^USA^P|^PRN^PH^^^906^8852943ORC|RE||BA97T36794.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA97T36794.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-115-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-116-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z54Z36805^^^AIRA-TEST^MR||ShoshoneAIRA^TimandraAIRA^Rebel^^^^L|ChesterAIRA^SteffieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1260 Vint-Oedenrode Pl^^Superior Township^MI^48105^USA^P||^PRN^PH^^^734^9127182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShoshoneAIRA^ChesterAIRA^^^^^L|MTH^Mother^HL70063|1260 Vint-Oedenrode Pl^^Superior Township^MI^48105^USA^P|^PRN^PH^^^734^9127182ORC|RE||BZ54Z36805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ54Z36805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-116-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-116-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O84U36813^^^AIRA-TEST^MR||FloydAIRA^BlakeAIRA^Brittany^^^^L|McErlaneAIRA^BeccalynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1006 Deemstede St^^Monroe^MI^48162^USA^P||^PRN^PH^^^734^2497794|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^McErlaneAIRA^^^^^L|MTH^Mother^HL70063|1006 Deemstede St^^Monroe^MI^48162^USA^P|^PRN^PH^^^734^2497794ORC|RE||BO84U36813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO84U36813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-116-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-116-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E21J36821^^^AIRA-TEST^MR||MasonAIRA^RenataAIRA^Lorrae^^^^L|ShelbyAIRA^RimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1813 Deek Cir^^Grand Rapids^MI^49544^USA^P||^PRN^PH^^^616^7257464|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1813 Deek Cir^^Grand Rapids^MI^49544^USA^P|^PRN^PH^^^616^7257464ORC|RE||BE21J36821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE21J36821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-116-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-116-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E46E36829^^^AIRA-TEST^MR||CavilAIRA^CatherineAIRA^Devika^^^^L|RiverAIRA^PaviAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1157 Weten St^^Clifford^MI^48727^USA^P||^PRN^PH^^^989^2537520|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CavilAIRA^RiverAIRA^^^^^L|MTH^Mother^HL70063|1157 Weten St^^Clifford^MI^48727^USA^P|^PRN^PH^^^989^2537520ORC|RE||BE46E36829.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE46E36829.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-116-12^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-117-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W70F36837^^^AIRA-TEST^MR||LohmannAIRA^VivienAIRA^Charlee^^^^L|RobertsonAIRA^ShysieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1963 Dus Cir^^White Pigeon^MI^49099^USA^P||^PRN^PH^^^269^8961883|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LohmannAIRA^RobertsonAIRA^^^^^L|MTH^Mother^HL70063|1963 Dus Cir^^White Pigeon^MI^49099^USA^P|^PRN^PH^^^269^8961883ORC|RE||BW70F36837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW70F36837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-117-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-117-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R50N36845^^^AIRA-TEST^MR||LamarAIRA^ChristianAIRA^Kamaria^^^^L|RobertsAIRA^YaffahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1216 Valkenburg aan de Geul Cir^^Calumet^MI^49942^USA^P||^PRN^PH^^^906^2204662|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LamarAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1216 Valkenburg aan de Geul Cir^^Calumet^MI^49942^USA^P|^PRN^PH^^^906^2204662ORC|RE||BR50N36845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR50N36845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-117-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-117-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B70K36850^^^AIRA-TEST^MR||CameronAIRA^KayleenAIRA^Jessie^^^^L|JohnssonAIRA^KensingtonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1193 Weemster Pl^^Wyoming^MI^49548^USA^P||^PRN^PH^^^616^3607131|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CameronAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1193 Weemster Pl^^Wyoming^MI^49548^USA^P|^PRN^PH^^^616^3607131ORC|RE||BB70K36850.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB70K36850.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-117-11^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-117-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94N36858^^^AIRA-TEST^MR||WebbAIRA^InnocentiaAIRA^Corey^^^^L|ThurstonAIRA^AmyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1109 Haalte St^^Webberville^MI^48892^USA^P||^PRN^PH^^^517^7667714|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WebbAIRA^ThurstonAIRA^^^^^L|MTH^Mother^HL70063|1109 Haalte St^^Webberville^MI^48892^USA^P|^PRN^PH^^^517^7667714ORC|RE||BG94N36858.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94N36858.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-117-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-118-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G81F36869^^^AIRA-TEST^MR||DanuelsonAIRA^OlyaAIRA^Bly^^^^L|SkagitAIRA^AnnabelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1463 Pluis Ave^^Mears^MI^49436^USA^P||^PRN^PH^^^231^5906073|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DanuelsonAIRA^SkagitAIRA^^^^^L|MTH^Mother^HL70063|1463 Pluis Ave^^Mears^MI^49436^USA^P|^PRN^PH^^^231^5906073ORC|RE||BG81F36869.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG81F36869.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-118-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-118-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C74T36877^^^AIRA-TEST^MR||SalzeberAIRA^LaxmiAIRA^Bryher^^^^L|KeweenawAIRA^MarieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1058 Balderberge St^^Saginaw^MI^48608^USA^P||^PRN^PH^^^989^9874611|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SalzeberAIRA^KeweenawAIRA^^^^^L|MTH^Mother^HL70063|1058 Balderberge St^^Saginaw^MI^48608^USA^P|^PRN^PH^^^989^9874611ORC|RE||BC74T36877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC74T36877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-118-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-118-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V42X36885^^^AIRA-TEST^MR||SandersAIRA^AdaminaAIRA^Dulce^^^^L|ColoradoAIRA^AlannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1817 Lchouwen-Duiveland Cir^^Ashley^MI^48806^USA^P||^PRN^PH^^^989^4008369|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SandersAIRA^ColoradoAIRA^^^^^L|MTH^Mother^HL70063|1817 Lchouwen-Duiveland Cir^^Ashley^MI^48806^USA^P|^PRN^PH^^^989^4008369ORC|RE||BV42X36885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV42X36885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-118-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-118-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y29G36893^^^AIRA-TEST^MR||MagoffinAIRA^ValentinaAIRA^Leena^^^^L|KingAIRA^SeraphinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1620 Testvoorne Cir^^Flint^MI^48554^USA^P||^PRN^PH^^^810^3008723|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MagoffinAIRA^KingAIRA^^^^^L|MTH^Mother^HL70063|1620 Testvoorne Cir^^Flint^MI^48554^USA^P|^PRN^PH^^^810^3008723ORC|RE||BY29G36893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY29G36893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-118-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R59T36901^^^AIRA-TEST^MR||RossAIRA^GalinaAIRA^Luba^^^^L|KennebecAIRA^BettyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1826 West Maas en Waal Pl^^Sylvan Beach^MI^49463^USA^P||^PRN^PH^^^231^7924537|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RossAIRA^KennebecAIRA^^^^^L|MTH^Mother^HL70063|1826 West Maas en Waal Pl^^Sylvan Beach^MI^49463^USA^P|^PRN^PH^^^231^7924537ORC|RE||BR59T36901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR59T36901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-200-02^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521-200-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K31K36906^^^AIRA-TEST^MR||LawrenceAIRA^DeepaliAIRA^Hippolyta^^^^L|GarvinAIRA^SavanahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1178 Rint Anthonis Cir^^Flint^MI^48502^USA^P||^PRN^PH^^^810^4332723|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LawrenceAIRA^GarvinAIRA^^^^^L|MTH^Mother^HL70063|1178 Rint Anthonis Cir^^Flint^MI^48502^USA^P|^PRN^PH^^^810^4332723ORC|RE||BK31K36906.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK31K36906.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521-200-10^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521000001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I37R36917^^^AIRA-TEST^MR||EmmetAIRA^BeataAIRA^Vanessa^^^^L|KentAIRA^ChristmasAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1666 Roggenland Ave^^Smiths Creek^MI^48074^USA^P||^PRN^PH^^^810^3286316|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EmmetAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1666 Roggenland Ave^^Smiths Creek^MI^48074^USA^P|^PRN^PH^^^810^3286316ORC|RE||BI37R36917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI37R36917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521000001^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521000011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B74P36925^^^AIRA-TEST^MR||SaloAIRA^IsisAIRA^Caydence^^^^L|WashingtonAIRA^MoonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1944 Beurne St^^Richland^MI^49083^USA^P||^PRN^PH^^^269^5025266|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SaloAIRA^WashingtonAIRA^^^^^L|MTH^Mother^HL70063|1944 Beurne St^^Richland^MI^49083^USA^P|^PRN^PH^^^269^5025266ORC|RE||BB74P36925.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB74P36925.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521000011^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011202|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S47G36933^^^AIRA-TEST^MR||ShortAIRA^EbrelAIRA^Philadelphia^^^^L|DawsonAIRA^GiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1311 Boes Ave^^Mid Michigan Reg Med Center^MI^48670^USA^P||^PRN^PH^^^989^2125452|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShortAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1311 Boes Ave^^Mid Michigan Reg Med Center^MI^48670^USA^P|^PRN^PH^^^989^2125452ORC|RE||BS47G36933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS47G36933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011202^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L18D36941^^^AIRA-TEST^MR||HolingsonAIRA^TeriAIRA^Hadria^^^^L|McIntoshAIRA^ChitraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1136 Derde Pl^^Harbor Springs^MI^49737^USA^P||^PRN^PH^^^616^6166475|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolingsonAIRA^McIntoshAIRA^^^^^L|MTH^Mother^HL70063|1136 Derde Pl^^Harbor Springs^MI^49737^USA^P|^PRN^PH^^^616^6166475ORC|RE||BL18D36941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL18D36941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011210^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011302|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E03H36949^^^AIRA-TEST^MR||HoughtonAIRA^LeodaAIRA^Jordane^^^^L|ClintonAIRA^EverildAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1837 Oosterhout Ln^^Gm Vehicle Development Center^MI^48557^USA^P||^PRN^PH^^^810^3464804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoughtonAIRA^ClintonAIRA^^^^^L|MTH^Mother^HL70063|1837 Oosterhout Ln^^Gm Vehicle Development Center^MI^48557^USA^P|^PRN^PH^^^810^3464804ORC|RE||BE03H36949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE03H36949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011302^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E64Q36957^^^AIRA-TEST^MR||SimpsonAIRA^BajiAIRA^Kendra^^^^L|CherokeeAIRA^ChantelAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1868 Iverbetuwe Cir^^Berrien Sprgs^MI^49104^USA^P||^PRN^PH^^^269^9790270|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimpsonAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1868 Iverbetuwe Cir^^Berrien Sprgs^MI^49104^USA^P|^PRN^PH^^^269^9790270ORC|RE||BE64Q36957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE64Q36957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011310^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011402|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O47J36962^^^AIRA-TEST^MR||TrinityAIRA^RebeccaAIRA^Rhoda^^^^L|NowataAIRA^MelisandeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1677 Eluis Ln^^Springport^MI^49284^USA^P||^PRN^PH^^^517^8298651|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TrinityAIRA^NowataAIRA^^^^^L|MTH^Mother^HL70063|1677 Eluis Ln^^Springport^MI^49284^USA^P|^PRN^PH^^^517^8298651ORC|RE||BO47J36962.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO47J36962.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011402^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011410|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q13Y36973^^^AIRA-TEST^MR||GladwinAIRA^BillieAIRA^Kamna^^^^L|RobertsAIRA^OndineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1488 Eoosendaal St^^Chesterfield^MI^48047^USA^P||^PRN^PH^^^586^7055818|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GladwinAIRA^RobertsAIRA^^^^^L|MTH^Mother^HL70063|1488 Eoosendaal St^^Chesterfield^MI^48047^USA^P|^PRN^PH^^^586^7055818ORC|RE||BQ13Y36973.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ13Y36973.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011410^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011502|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S80F36981^^^AIRA-TEST^MR||KellyAIRA^ChlorisAIRA^Sheela^^^^L|RainsAIRA^AnneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1193 Passeren St^^Rapid City^MI^49676^USA^P||^PRN^PH^^^231^9735207|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KellyAIRA^RainsAIRA^^^^^L|MTH^Mother^HL70063|1193 Passeren St^^Rapid City^MI^49676^USA^P|^PRN^PH^^^231^9735207ORC|RE||BS80F36981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS80F36981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011502^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011510|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F84N36989^^^AIRA-TEST^MR||MorganAIRA^AnaniAIRA^Patty^^^^L|EdmundsAIRA^DyanaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1053 Gomeren Ave^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^2680460|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorganAIRA^EdmundsAIRA^^^^^L|MTH^Mother^HL70063|1053 Gomeren Ave^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^2680460ORC|RE||BF84N36989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF84N36989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011510^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011602|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J23N36997^^^AIRA-TEST^MR||KaufmanAIRA^PersisAIRA^Vanja^^^^L|SharplesAIRA^NessanAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1805 Larneveld Ln^^Washingtn Township^MI^48095^USA^P||^PRN^PH^^^586^9883875|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KaufmanAIRA^SharplesAIRA^^^^^L|MTH^Mother^HL70063|1805 Larneveld Ln^^Washingtn Township^MI^48095^USA^P|^PRN^PH^^^586^9883875ORC|RE||BJ23N36997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ23N36997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011602^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011610|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W33A37005^^^AIRA-TEST^MR||HickmanAIRA^AnsticeAIRA^Juno^^^^L|RogersAIRA^BetrysAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1757 Uemsmond Cir^^Pleasant Lake^MI^49272^USA^P||^PRN^PH^^^517^9819210|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HickmanAIRA^RogersAIRA^^^^^L|MTH^Mother^HL70063|1757 Uemsmond Cir^^Pleasant Lake^MI^49272^USA^P|^PRN^PH^^^517^9819210ORC|RE||BW33A37005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW33A37005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011610^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011611|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A06Y37013^^^AIRA-TEST^MR||AndrewsAIRA^RexanaAIRA^Taylor^^^^L|KalkaskaAIRA^AylwenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1919 Zlphen aan den Rijn Ave^^Onondaga^MI^49264^USA^P||^PRN^PH^^^517^5799867|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndrewsAIRA^KalkaskaAIRA^^^^^L|MTH^Mother^HL70063|1919 Zlphen aan den Rijn Ave^^Onondaga^MI^49264^USA^P|^PRN^PH^^^517^5799867ORC|RE||BA06Y37013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA06Y37013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011611^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011612|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K39L37018^^^AIRA-TEST^MR||BannerAIRA^LeomaAIRA^Lesh^^^^L|SpokaneAIRA^SharmisthaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1589 Vynaarlo Ave^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^7698899|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BannerAIRA^SpokaneAIRA^^^^^L|MTH^Mother^HL70063|1589 Vynaarlo Ave^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^7698899ORC|RE||BK39L37018.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK39L37018.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011612^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I77E37029^^^AIRA-TEST^MR||PedersenAIRA^LinnetAIRA^Tulasi^^^^L|GosperAIRA^BereniceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1897 Htrecht St^^Detroit^MI^48235^USA^P||^PRN^PH^^^313^4505382|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PedersenAIRA^GosperAIRA^^^^^L|MTH^Mother^HL70063|1897 Htrecht St^^Detroit^MI^48235^USA^P|^PRN^PH^^^313^4505382ORC|RE||BI77E37029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI77E37029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011702^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J19E37037^^^AIRA-TEST^MR||GreerAIRA^WynfledAIRA^Maryann^^^^L|AlexanderAIRA^ZaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1667 Eeel en Maas Pl^^GR^MI^49504^USA^P||^PRN^PH^^^616^3122092|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreerAIRA^AlexanderAIRA^^^^^L|MTH^Mother^HL70063|1667 Eeel en Maas Pl^^GR^MI^49504^USA^P|^PRN^PH^^^616^3122092ORC|RE||BJ19E37037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ19E37037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011710^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011711|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G82I37045^^^AIRA-TEST^MR||AlleganAIRA^ShasmeckaAIRA^Purvaja^^^^L|MadisonAIRA^ZillahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1252 Zaad Ln^^Galesburg^MI^49053^USA^P||^PRN^PH^^^269^9524804|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlleganAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1252 Zaad Ln^^Galesburg^MI^49053^USA^P|^PRN^PH^^^269^9524804ORC|RE||BG82I37045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG82I37045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011711^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011712|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y61C37053^^^AIRA-TEST^MR||JacksonAIRA^JerardaAIRA^Nyx^^^^L|JohnAIRA^MelissaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1577 Einsum St^^Flint^MI^48502^USA^P||^PRN^PH^^^810^4982678|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^JohnAIRA^^^^^L|MTH^Mother^HL70063|1577 Einsum St^^Flint^MI^48502^USA^P|^PRN^PH^^^810^4982678ORC|RE||BY61C37053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY61C37053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011712^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011802|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B18I37061^^^AIRA-TEST^MR||MasonAIRA^PalomaAIRA^Joanne^^^^L|CassiaAIRA^KenwynAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1020 Neumen Ln^^Erie^MI^48133^USA^P||^PRN^PH^^^734^4259467|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^CassiaAIRA^^^^^L|MTH^Mother^HL70063|1020 Neumen Ln^^Erie^MI^48133^USA^P|^PRN^PH^^^734^4259467ORC|RE||BB18I37061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB18I37061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011802^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C59G37069^^^AIRA-TEST^MR||FayetteAIRA^KatyAIRA^Phyliss^^^^L|JepsenAIRA^PadminiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1673 Taadhoeke Pl^^Buchanan^MI^49107^USA^P||^PRN^PH^^^269^7771691|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FayetteAIRA^JepsenAIRA^^^^^L|MTH^Mother^HL70063|1673 Taadhoeke Pl^^Buchanan^MI^49107^USA^P|^PRN^PH^^^269^7771691ORC|RE||BC59G37069.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC59G37069.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011810^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M28C37074^^^AIRA-TEST^MR||MasonAIRA^GauriAIRA^Yasmin^^^^L|MendocinoAIRA^TimotheaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1963 Vloemendaal Ave^^Kentwood^MI^49548^USA^P||^PRN^PH^^^616^2837884|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^MendocinoAIRA^^^^^L|MTH^Mother^HL70063|1963 Vloemendaal Ave^^Kentwood^MI^49548^USA^P|^PRN^PH^^^616^2837884ORC|RE||BM28C37074.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM28C37074.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011811^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521011812|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I06H37085^^^AIRA-TEST^MR||LewisAIRA^MusettaAIRA^Florizel^^^^L|JeffersonAIRA^ArohaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1261 Hinkelland Cir^^Kalamazoo^MI^49004^USA^P||^PRN^PH^^^269^9734112|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LewisAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1261 Hinkelland Cir^^Kalamazoo^MI^49004^USA^P|^PRN^PH^^^269^9734112ORC|RE||BI06H37085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI06H37085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521011812^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521020002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V36Z37093^^^AIRA-TEST^MR||ShawAIRA^AwstaAIRA^Imani^^^^L|CalhounAIRA^LoriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1152 Scht-Susteren Ln^^Hudsonville^MI^49426^USA^P||^PRN^PH^^^616^3569991|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShawAIRA^CalhounAIRA^^^^^L|MTH^Mother^HL70063|1152 Scht-Susteren Ln^^Hudsonville^MI^49426^USA^P|^PRN^PH^^^616^3569991ORC|RE||BV36Z37093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV36Z37093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521020002^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-66521020010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S66C37101^^^AIRA-TEST^MR||LeeAIRA^AiyanaAIRA^Tomiko^^^^L|OntonagonAIRA^SevillaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1738 Moet St^^Tower^MI^49792^USA^P||^PRN^PH^^^989^6517551|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeeAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1738 Moet St^^Tower^MI^49792^USA^P|^PRN^PH^^^989^6517551ORC|RE||BS66C37101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS66C37101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||66521020010^Influenza A (H1N1) 2009 Monovalent Vaccine^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-69401-000-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K16X37109^^^AIRA-TEST^MR||ErikssonAIRA^ParnitaAIRA^Olena^^^^L|MontgomeryAIRA^QuintinaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1929 Horst aan de Maas Pl^^Trenton^MI^48183^USA^P||^PRN^PH^^^734^9683329|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErikssonAIRA^MontgomeryAIRA^^^^^L|MTH^Mother^HL70063|1929 Horst aan de Maas Pl^^Trenton^MI^48183^USA^P|^PRN^PH^^^734^9683329ORC|RE||BK16X37109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK16X37109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||69401-000-01^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-69401-000-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y67X37117^^^AIRA-TEST^MR||O'BrienAIRA^AbrilAIRA^Marielle^^^^L|ClatsopAIRA^RachnaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1525 Euren Ln^^GR^MI^49514^USA^P||^PRN^PH^^^616^4288270|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'BrienAIRA^ClatsopAIRA^^^^^L|MTH^Mother^HL70063|1525 Euren Ln^^GR^MI^49514^USA^P|^PRN^PH^^^616^4288270ORC|RE||BY67X37117.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY67X37117.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||69401-000-02^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-69401000001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G63P37125^^^AIRA-TEST^MR||PottawatomieAIRA^AlinaAIRA^Sirisha^^^^L|EnnisAIRA^FilberthaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1716 Diessenlanden Cir^^Bloomfield^MI^48301^USA^P||^PRN^PH^^^248^8810852|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PottawatomieAIRA^EnnisAIRA^^^^^L|MTH^Mother^HL70063|1716 Diessenlanden Cir^^Bloomfield^MI^48301^USA^P|^PRN^PH^^^248^8810852ORC|RE||BG63P37125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG63P37125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||69401000001^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-69401000002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z89H37130^^^AIRA-TEST^MR||OrangeAIRA^NikitaAIRA^Zee^^^^L|San JoaquinAIRA^GlynisAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1171 Maastricht Ave^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^3603578|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OrangeAIRA^San JoaquinAIRA^^^^^L|MTH^Mother^HL70063|1171 Maastricht Ave^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^3603578ORC|RE||BZ89H37130.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ89H37130.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||69401000002^Vivotif^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460-001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V93E37141^^^AIRA-TEST^MR||WoodAIRA^ShaylaAIRA^Renata^^^^L|KnightAIRA^DaleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1034 Mldebroek Ave^^Concord^MI^49237^USA^P||^PRN^PH^^^517^7625501|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoodAIRA^KnightAIRA^^^^^L|MTH^Mother^HL70063|1034 Mldebroek Ave^^Concord^MI^49237^USA^P|^PRN^PH^^^517^7625501ORC|RE||BV93E37141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV93E37141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460-001-01^Vaxchora^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V86E37149^^^AIRA-TEST^MR||JuniataAIRA^BirgitAIRA^Marketta^^^^L|DecaturAIRA^NicolaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1510 Castricum Pl^^Selfridge Angb^MI^48045^USA^P||^PRN^PH^^^586^5888477|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JuniataAIRA^DecaturAIRA^^^^^L|MTH^Mother^HL70063|1510 Castricum Pl^^Selfridge Angb^MI^48045^USA^P|^PRN^PH^^^586^5888477ORC|RE||BV86E37149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV86E37149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460-002-01^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460-002-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B38J37157^^^AIRA-TEST^MR||BordenAIRA^VevinaAIRA^Hedy^^^^L|DonleyAIRA^NatsukoAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1539 Lijssen Ln^^Michigan Bulb Co^MI^49550^USA^P||^PRN^PH^^^616^6890816|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BordenAIRA^DonleyAIRA^^^^^L|MTH^Mother^HL70063|1539 Lijssen Ln^^Michigan Bulb Co^MI^49550^USA^P|^PRN^PH^^^616^6890816ORC|RE||BB38J37157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB38J37157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460-002-02^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460000101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R55K37165^^^AIRA-TEST^MR||CusterAIRA^KatrinaAIRA^Ashley^^^^L|NelsonAIRA^SadeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1727 Beide Ln^^Commerce^MI^48382^USA^P||^PRN^PH^^^248^7580550|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusterAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1727 Beide Ln^^Commerce^MI^48382^USA^P|^PRN^PH^^^248^7580550ORC|RE||BR55K37165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR55K37165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460000101^Vaxchora^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C56P37173^^^AIRA-TEST^MR||Black HawkAIRA^IllonaAIRA^Riya^^^^L|HaskellAIRA^PerriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1731 Mooise Meren Ave^^Mayville^MI^48744^USA^P||^PRN^PH^^^989^9706754|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Black HawkAIRA^HaskellAIRA^^^^^L|MTH^Mother^HL70063|1731 Mooise Meren Ave^^Mayville^MI^48744^USA^P|^PRN^PH^^^989^9706754ORC|RE||BC56P37173.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC56P37173.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460000201^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70460000202|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G90S37181^^^AIRA-TEST^MR||NemahaAIRA^GlendaAIRA^Fiona^^^^L|LoveAIRA^PrudenceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1203 Ke Marne St^^Decatur^MI^49045^USA^P||^PRN^PH^^^269^7653952|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NemahaAIRA^LoveAIRA^^^^^L|MTH^Mother^HL70063|1203 Ke Marne St^^Decatur^MI^49045^USA^P|^PRN^PH^^^269^7653952ORC|RE||BG90S37181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG90S37181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70460000202^VAXCHORA^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-001-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K71H37186^^^AIRA-TEST^MR||BinghamAIRA^AqueneAIRA^Wapeka^^^^L|KentAIRA^ZelmaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1395 Breed Ave^^Muskegon^MI^49443^USA^P||^PRN^PH^^^231^3146148|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BinghamAIRA^KentAIRA^^^^^L|MTH^Mother^HL70063|1395 Breed Ave^^Muskegon^MI^49443^USA^P|^PRN^PH^^^231^3146148ORC|RE||BK71H37186.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK71H37186.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-001-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-001-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N19Y37197^^^AIRA-TEST^MR||DickinsonAIRA^ElephteriaAIRA^Ember^^^^L|SalzeberAIRA^ZofeyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1366 Destland St^^Pontiac^MI^48342^USA^P||^PRN^PH^^^248^3635121|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DickinsonAIRA^SalzeberAIRA^^^^^L|MTH^Mother^HL70063|1366 Destland St^^Pontiac^MI^48342^USA^P|^PRN^PH^^^248^3635121ORC|RE||BN19Y37197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN19Y37197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-001-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-002-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P07G37205^^^AIRA-TEST^MR||WilssonAIRA^RonaldaAIRA^Malak^^^^L|TillmanAIRA^SharonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1247 Gissewaard St^^Loch Alpine^MI^48103^USA^P||^PRN^PH^^^734^2299853|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilssonAIRA^TillmanAIRA^^^^^L|MTH^Mother^HL70063|1247 Gissewaard St^^Loch Alpine^MI^48103^USA^P|^PRN^PH^^^734^2299853ORC|RE||BP07G37205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP07G37205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-002-01^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-002-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C07Q37213^^^AIRA-TEST^MR||HeffernanAIRA^PreranaAIRA^Leoda^^^^L|LamarAIRA^AmethystAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1256 Mestland Ave^^Battle Creek^MI^49016^USA^P||^PRN^PH^^^269^3916867|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^LamarAIRA^^^^^L|MTH^Mother^HL70063|1256 Mestland Ave^^Battle Creek^MI^49016^USA^P|^PRN^PH^^^269^3916867ORC|RE||BC07Q37213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC07Q37213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-002-11^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-018-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D40O37221^^^AIRA-TEST^MR||ShiawasseeAIRA^SampritiAIRA^Chane^^^^L|ShelbyAIRA^VedetteAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1268 Hint-Michielsgestel Ln^^Sears^MI^49679^USA^P||^PRN^PH^^^231^6682245|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShiawasseeAIRA^ShelbyAIRA^^^^^L|MTH^Mother^HL70063|1268 Hint-Michielsgestel Ln^^Sears^MI^49679^USA^P|^PRN^PH^^^231^6682245ORC|RE||BD40O37221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD40O37221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-018-03^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-018-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q08N37229^^^AIRA-TEST^MR||JacksonAIRA^CaraAIRA^Guida^^^^L|MonroeAIRA^NawalAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1150 Deist Ave^^Fenwick^MI^48834^USA^P||^PRN^PH^^^989^3679716|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1150 Deist Ave^^Fenwick^MI^48834^USA^P|^PRN^PH^^^989^3679716ORC|RE||BQ08N37229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ08N37229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-018-04^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-119-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J31M37237^^^AIRA-TEST^MR||Walla WallaAIRA^ZelenkaAIRA^Taleen^^^^L|GuadalupeAIRA^MikkiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1318 Re Fryske Marren St^^Detroit^MI^48234^USA^P||^PRN^PH^^^313^7512639|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Walla WallaAIRA^GuadalupeAIRA^^^^^L|MTH^Mother^HL70063|1318 Re Fryske Marren St^^Detroit^MI^48234^USA^P|^PRN^PH^^^313^7512639ORC|RE||BJ31M37237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ31M37237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-119-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-119-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q70Y37242^^^AIRA-TEST^MR||Presque IsleAIRA^PaulinaAIRA^Colenso^^^^L|ClarkAIRA^ParthiviAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1318 Lucht Ave^^Grosse Pointe^MI^48224^USA^P||^PRN^PH^^^313^8275934|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Presque IsleAIRA^ClarkAIRA^^^^^L|MTH^Mother^HL70063|1318 Lucht Ave^^Grosse Pointe^MI^48224^USA^P|^PRN^PH^^^313^8275934ORC|RE||BQ70Y37242.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ70Y37242.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-119-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-119-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J34O37253^^^AIRA-TEST^MR||HusseyAIRA^AdelphaAIRA^Bruna^^^^L|CroweAIRA^KendraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1335 Rsten St^^Fulton^MI^49052^USA^P||^PRN^PH^^^269^4519684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HusseyAIRA^CroweAIRA^^^^^L|MTH^Mother^HL70063|1335 Rsten St^^Fulton^MI^49052^USA^P|^PRN^PH^^^269^4519684ORC|RE||BJ34O37253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ34O37253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-119-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-119-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I00V37261^^^AIRA-TEST^MR||McCrackenAIRA^VerenaAIRA^Kohia^^^^L|JacksonAIRA^FlorenceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1291 Oaadhoeke Cir^^North Port^MI^49670^USA^P||^PRN^PH^^^231^7427665|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McCrackenAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1291 Oaadhoeke Cir^^North Port^MI^49670^USA^P|^PRN^PH^^^231^7427665ORC|RE||BI00V37261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI00V37261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-119-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-120-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S87O37269^^^AIRA-TEST^MR||KootenaiAIRA^LizAIRA^Nona^^^^L|SomersetAIRA^LavenderAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1258 Zellingwedde Cir^^Coral^MI^49322^USA^P||^PRN^PH^^^231^8322257|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KootenaiAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1258 Zellingwedde Cir^^Coral^MI^49322^USA^P|^PRN^PH^^^231^8322257ORC|RE||BS87O37269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS87O37269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-120-02^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-120-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L86N37277^^^AIRA-TEST^MR||ShackelfordAIRA^SonnenscheinAIRA^Marigold^^^^L|MontmorencyMuskegonAIRA^PerditaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1010 Bpe Cir^^Kalamazoo^MI^49006^USA^P||^PRN^PH^^^269^7972684|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShackelfordAIRA^MontmorencyMuskegonAIRA^^^^^L|MTH^Mother^HL70063|1010 Bpe Cir^^Kalamazoo^MI^49006^USA^P|^PRN^PH^^^269^7972684ORC|RE||BL86N37277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL86N37277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-120-10^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-120-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S62O37285^^^AIRA-TEST^MR||PendletonAIRA^CallieAIRA^Lotus^^^^L|WayneAIRA^SiriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1579 Lokaliseren Ln^^Pompeii^MI^48874^USA^P||^PRN^PH^^^989^2757936|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PendletonAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1579 Lokaliseren Ln^^Pompeii^MI^48874^USA^P|^PRN^PH^^^989^2757936ORC|RE||BS62O37285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS62O37285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-120-11^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-120-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z11M37293^^^AIRA-TEST^MR||CedarAIRA^OnurAIRA^Jesal^^^^L|DanuelsonAIRA^WapekaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1384 Proningen Ave^^Georgetown Township^MI^49428^USA^P||^PRN^PH^^^616^4327232|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CedarAIRA^DanuelsonAIRA^^^^^L|MTH^Mother^HL70063|1384 Proningen Ave^^Georgetown Township^MI^49428^USA^P|^PRN^PH^^^616^4327232ORC|RE||BZ11M37293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ11M37293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-120-12^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-200-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O45N37298^^^AIRA-TEST^MR||ClearfieldAIRA^AylaAIRA^Hidi^^^^L|CallowayAIRA^KerenAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1362 Appel Ln^^Standale^MI^49534^USA^P||^PRN^PH^^^616^9813069|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClearfieldAIRA^CallowayAIRA^^^^^L|MTH^Mother^HL70063|1362 Appel Ln^^Standale^MI^49534^USA^P|^PRN^PH^^^616^9813069ORC|RE||BO45N37298.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO45N37298.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-200-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-200-02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P34J37309^^^AIRA-TEST^MR||AlfalfaAIRA^JerushaAIRA^Genevieve^^^^L|ManisteeAIRA^AdolphaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1379 Omallingerland Cir^^Somerset Center^MI^49282^USA^P||^PRN^PH^^^517^5558150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlfalfaAIRA^ManisteeAIRA^^^^^L|MTH^Mother^HL70063|1379 Omallingerland Cir^^Somerset Center^MI^49282^USA^P|^PRN^PH^^^517^5558150ORC|RE||BP34J37309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP34J37309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-200-02^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-200-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X85H37317^^^AIRA-TEST^MR||CarrollAIRA^ShoshannahAIRA^Pearl^^^^L|PhelpsAIRA^MyriamAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1846 Upeldoorn St^^Copper City^MI^49917^USA^P||^PRN^PH^^^906^9514844|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarrollAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1846 Upeldoorn St^^Copper City^MI^49917^USA^P|^PRN^PH^^^906^9514844ORC|RE||BX85H37317.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX85H37317.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-200-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-200-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E63F37325^^^AIRA-TEST^MR||RiverAIRA^LyndeyAIRA^Honey^^^^L|ConnorAIRA^EdolieAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1303 Kenray Ln^^Mount Morris^MI^48458^USA^P||^PRN^PH^^^810^8601432|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RiverAIRA^ConnorAIRA^^^^^L|MTH^Mother^HL70063|1303 Kenray Ln^^Mount Morris^MI^48458^USA^P|^PRN^PH^^^810^8601432ORC|RE||BE63F37325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE63F37325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-200-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-201-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O80F37333^^^AIRA-TEST^MR||GuthrieAIRA^IsraAIRA^Florizel^^^^L|VargasAIRA^ThomasaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1236 Mteenwijkerland Pl^^Lima Township^MI^48118^USA^P||^PRN^PH^^^734^8974549|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuthrieAIRA^VargasAIRA^^^^^L|MTH^Mother^HL70063|1236 Mteenwijkerland Pl^^Lima Township^MI^48118^USA^P|^PRN^PH^^^734^8974549ORC|RE||BO80F37333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO80F37333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-201-01^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-201-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I84V37341^^^AIRA-TEST^MR||LoganAIRA^DooriyaAIRA^Lilly^^^^L|Red WillowAIRA^NekaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1815 Lerkelland Cir^^Britton^MI^49229^USA^P||^PRN^PH^^^517^2939751|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoganAIRA^Red WillowAIRA^^^^^L|MTH^Mother^HL70063|1815 Lerkelland Cir^^Britton^MI^49229^USA^P|^PRN^PH^^^517^2939751ORC|RE||BI84V37341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI84V37341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-201-11^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-301-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A23H37349^^^AIRA-TEST^MR||HamiltonAIRA^AdonaAIRA^Raina^^^^L|OrangeAIRA^ZenithAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1255 Huidige St^^Burlington^MI^49029^USA^P||^PRN^PH^^^517^3641993|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HamiltonAIRA^OrangeAIRA^^^^^L|MTH^Mother^HL70063|1255 Huidige St^^Burlington^MI^49029^USA^P|^PRN^PH^^^517^3641993ORC|RE||BA23H37349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA23H37349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-301-10^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-301-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C46H37354^^^AIRA-TEST^MR||PhelpsAIRA^IndaliaiAIRA^Atlanta^^^^L|FanninAIRA^KristineAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1685 Barum Cir^^Rochester Hills^MI^48309^USA^P||^PRN^PH^^^248^9553394|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PhelpsAIRA^FanninAIRA^^^^^L|MTH^Mother^HL70063|1685 Barum Cir^^Rochester Hills^MI^48309^USA^P|^PRN^PH^^^248^9553394ORC|RE||BC46H37354.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC46H37354.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-301-12^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-318-03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K78W37365^^^AIRA-TEST^MR||MeadeAIRA^KomalAIRA^Anona^^^^L|BlaineAIRA^MaximeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1971 Dithoorn St^^Meskegon^MI^49440^USA^P||^PRN^PH^^^231^9206119|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MeadeAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1971 Dithoorn St^^Meskegon^MI^49440^USA^P|^PRN^PH^^^231^9206119ORC|RE||BK78W37365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK78W37365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-318-03^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-318-04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O91X37373^^^AIRA-TEST^MR||San JoaquinAIRA^FelipaAIRA^Rata^^^^L|RockAIRA^JudyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1707 Dynaarlo Ave^^Brownstown Township^MI^48183^USA^P||^PRN^PH^^^734^2502915|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|San JoaquinAIRA^RockAIRA^^^^^L|MTH^Mother^HL70063|1707 Dynaarlo Ave^^Brownstown Township^MI^48183^USA^P|^PRN^PH^^^734^2502915ORC|RE||BO91X37373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO91X37373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-318-04^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-418-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I37S37381^^^AIRA-TEST^MR||LivingstonAIRA^OdeaAIRA^Vida^^^^L|GeaugaAIRA^TehyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1866 Wersel Pl^^Leonard^MI^48367^USA^P||^PRN^PH^^^248^9511857|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LivingstonAIRA^GeaugaAIRA^^^^^L|MTH^Mother^HL70063|1866 Wersel Pl^^Leonard^MI^48367^USA^P|^PRN^PH^^^248^9511857ORC|RE||BI37S37381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI37S37381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-418-10^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-418-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D54C37389^^^AIRA-TEST^MR||MilamAIRA^PasangAIRA^Safia^^^^L|RomsvigAIRA^LynseyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1704 Banderd Pl^^Grosse Pointe Farms^MI^48230^USA^P||^PRN^PH^^^313^3903432|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MilamAIRA^RomsvigAIRA^^^^^L|MTH^Mother^HL70063|1704 Banderd Pl^^Grosse Pointe Farms^MI^48230^USA^P|^PRN^PH^^^313^3903432ORC|RE||BD54C37389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD54C37389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-418-11^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-614-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G93V37397^^^AIRA-TEST^MR||MissaukeeAIRA^BlazeAIRA^Renata^^^^L|GilliamAIRA^RonaldaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1798 Roggenland Pl^^Ludington^MI^49431^USA^P||^PRN^PH^^^231^3553724|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MissaukeeAIRA^GilliamAIRA^^^^^L|MTH^Mother^HL70063|1798 Roggenland Pl^^Ludington^MI^49431^USA^P|^PRN^PH^^^231^3553724ORC|RE||BG93V37397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG93V37397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-614-01^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461-614-11|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y69N37405^^^AIRA-TEST^MR||VenturaAIRA^GedalaAIRA^Zena^^^^L|CherokeeAIRA^KalistaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1718 Als Ave^^Tustin^MI^49688^USA^P||^PRN^PH^^^231^9626048|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VenturaAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1718 Als Ave^^Tustin^MI^49688^USA^P|^PRN^PH^^^231^9626048ORC|RE||BY69N37405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY69N37405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461-614-11^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461000101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q58H37410^^^AIRA-TEST^MR||DallasAIRA^CheriAIRA^Sparrow^^^^L|LubbockAIRA^SericaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1909 Tijchen Pl^^Millington^MI^48746^USA^P||^PRN^PH^^^989^8278791|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DallasAIRA^LubbockAIRA^^^^^L|MTH^Mother^HL70063|1909 Tijchen Pl^^Millington^MI^48746^USA^P|^PRN^PH^^^989^8278791ORC|RE||BQ58H37410.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ58H37410.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461000101^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461000111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F93W37421^^^AIRA-TEST^MR||MasonAIRA^HinaAIRA^Marilee^^^^L|YoakumAIRA^KaylynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1253 Wemert-Bakel Ln^^Mason^MI^48854^USA^P||^PRN^PH^^^517^3223546|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MasonAIRA^YoakumAIRA^^^^^L|MTH^Mother^HL70063|1253 Wemert-Bakel Ln^^Mason^MI^48854^USA^P|^PRN^PH^^^517^3223546ORC|RE||BF93W37421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF93W37421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461000111^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461000201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S09M37429^^^AIRA-TEST^MR||PatricioAIRA^CadenceAIRA^Dimity^^^^L|OkfuskeeAIRA^MarcyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1900 Vochem Ln^^Fostoria^MI^48435^USA^P||^PRN^PH^^^989^4705450|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PatricioAIRA^OkfuskeeAIRA^^^^^L|MTH^Mother^HL70063|1900 Vochem Ln^^Fostoria^MI^48435^USA^P|^PRN^PH^^^989^4705450ORC|RE||BS09M37429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS09M37429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461000201^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461000211|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O55D37437^^^AIRA-TEST^MR||FultonAIRA^DeanneAIRA^Afina^^^^L|PetersAIRA^KhloeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1073 Tietjerksteradeel Pl^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^5849855|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FultonAIRA^PetersAIRA^^^^^L|MTH^Mother^HL70063|1073 Tietjerksteradeel Pl^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^5849855ORC|RE||BO55D37437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO55D37437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461000211^Fluad^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461001803|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X03D37445^^^AIRA-TEST^MR||CassAIRA^JulianneAIRA^Debby^^^^L|PoweshiekAIRA^JuliannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1208 Bisterwijk Ave^^Farmingtn Hls^MI^48336^USA^P||^PRN^PH^^^248^4673150|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^PoweshiekAIRA^^^^^L|MTH^Mother^HL70063|1208 Bisterwijk Ave^^Farmingtn Hls^MI^48336^USA^P|^PRN^PH^^^248^4673150ORC|RE||BX03D37445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX03D37445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461001803^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461001804|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z24A37453^^^AIRA-TEST^MR||ChristensonAIRA^AllissonAIRA^Naretha^^^^L|KimballAIRA^ManasiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1036 Farderwijk Cir^^Boyne Falls^MI^49713^USA^P||^PRN^PH^^^231^6526528|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ChristensonAIRA^KimballAIRA^^^^^L|MTH^Mother^HL70063|1036 Farderwijk Cir^^Boyne Falls^MI^49713^USA^P|^PRN^PH^^^231^6526528ORC|RE||BZ24A37453.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ24A37453.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461001804^FLUAD^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461011902|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J65I37458^^^AIRA-TEST^MR||HowathAIRA^EmerAIRA^Elise^^^^L|ClarksonAIRA^SaidahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1784 Hpe Ln^^Rock^MI^49880^USA^P||^PRN^PH^^^906^7646938|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowathAIRA^ClarksonAIRA^^^^^L|MTH^Mother^HL70063|1784 Hpe Ln^^Rock^MI^49880^USA^P|^PRN^PH^^^906^7646938ORC|RE||BJ65I37458.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ65I37458.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461011902^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461011910|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q59T37469^^^AIRA-TEST^MR||CamasAIRA^CambriaAIRA^Precious^^^^L|BlackAIRA^AlexAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1465 Ocharsterland Pl^^Scottville^MI^49454^USA^P||^PRN^PH^^^231^4308928|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CamasAIRA^BlackAIRA^^^^^L|MTH^Mother^HL70063|1465 Ocharsterland Pl^^Scottville^MI^49454^USA^P|^PRN^PH^^^231^4308928ORC|RE||BQ59T37469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ59T37469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461011910^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461011911|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E91H37477^^^AIRA-TEST^MR||WashingtonAIRA^KalypsoAIRA^Tristessa^^^^L|GogebicAIRA^AasiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1529 Laadhoeke Ave^^Ann Arbor^MI^48104^USA^P||^PRN^PH^^^734^7720105|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^GogebicAIRA^^^^^L|MTH^Mother^HL70063|1529 Laadhoeke Ave^^Ann Arbor^MI^48104^USA^P|^PRN^PH^^^734^7720105ORC|RE||BE91H37477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE91H37477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461011911^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461011912|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F81S37485^^^AIRA-TEST^MR||KitsapAIRA^SuksmaAIRA^Sophia^^^^L|BayAIRA^JadeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1183 Eemert-Bakel St^^Macomb Township^MI^48042^USA^P||^PRN^PH^^^586^4302984|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KitsapAIRA^BayAIRA^^^^^L|MTH^Mother^HL70063|1183 Eemert-Bakel St^^Macomb Township^MI^48042^USA^P|^PRN^PH^^^586^4302984ORC|RE||BF81S37485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF81S37485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461011912^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461012002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y79F37493^^^AIRA-TEST^MR||HaskellAIRA^MeinwenAIRA^Isoke^^^^L|ModocAIRA^LienAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1729 Herkelland Ave^^State of Michigan^MI^48913^USA^P||^PRN^PH^^^517^5933978|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaskellAIRA^ModocAIRA^^^^^L|MTH^Mother^HL70063|1729 Herkelland Ave^^State of Michigan^MI^48913^USA^P|^PRN^PH^^^517^5933978ORC|RE||BY79F37493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY79F37493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461012002^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461012010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W25E37501^^^AIRA-TEST^MR||WilsonAIRA^HermelindaAIRA^Hayden^^^^L|MonaghanAIRA^JoleneAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1954 Wden St^^Reed City^MI^49677^USA^P||^PRN^PH^^^231^6211210|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WilsonAIRA^MonaghanAIRA^^^^^L|MTH^Mother^HL70063|1954 Wden St^^Reed City^MI^49677^USA^P|^PRN^PH^^^231^6211210ORC|RE||BW25E37501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW25E37501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461012010^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461012011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L51G37506^^^AIRA-TEST^MR||AldridgeAIRA^MarinaAIRA^Kendall^^^^L|SwindellsAIRA^TullyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1560 Toppersum St^^Hudson Mills^MI^48130^USA^P||^PRN^PH^^^734^5783279|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AldridgeAIRA^SwindellsAIRA^^^^^L|MTH^Mother^HL70063|1560 Toppersum St^^Hudson Mills^MI^48130^USA^P|^PRN^PH^^^734^5783279ORC|RE||BL51G37506.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL51G37506.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461012011^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461012012|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z67B37517^^^AIRA-TEST^MR||SivertsenAIRA^MarkettaAIRA^Emelia^^^^L|JonsonAIRA^KalilaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1481 Baaksbergen Ln^^Pittsfield Township^MI^48104^USA^P||^PRN^PH^^^734^7332796|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SivertsenAIRA^JonsonAIRA^^^^^L|MTH^Mother^HL70063|1481 Baaksbergen Ln^^Pittsfield Township^MI^48104^USA^P|^PRN^PH^^^734^7332796ORC|RE||BZ67B37517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ67B37517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461012012^Fluvirin^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461020001|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P80N37525^^^AIRA-TEST^MR||IdahoAIRA^CassandraAIRA^Kathryn^^^^L|KendallAIRA^RevelationAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1371 Rersel Pl^^Roulo^MI^48111^USA^P||^PRN^PH^^^734^6334438|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IdahoAIRA^KendallAIRA^^^^^L|MTH^Mother^HL70063|1371 Rersel Pl^^Roulo^MI^48111^USA^P|^PRN^PH^^^734^6334438ORC|RE||BP80N37525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP80N37525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461020001^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461020002|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T93F37533^^^AIRA-TEST^MR||LakeAIRA^VidyaAIRA^Lorretta^^^^L|DuncanAIRA^OliviaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1017 Duder-Amstel Pl^^Rochester Hls^MI^48306^USA^P||^PRN^PH^^^248^5004351|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^DuncanAIRA^^^^^L|MTH^Mother^HL70063|1017 Duder-Amstel Pl^^Rochester Hls^MI^48306^USA^P|^PRN^PH^^^248^5004351ORC|RE||BT93F37533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT93F37533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461020002^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461020011|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K93Y37541^^^AIRA-TEST^MR||PerryAIRA^AissaAIRA^Rosheen^^^^L|HallAIRA^MuniraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1874 Tpe Ln^^Northville^MI^48168^USA^P||^PRN^PH^^^248^5736449|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PerryAIRA^HallAIRA^^^^^L|MTH^Mother^HL70063|1874 Tpe Ln^^Northville^MI^48168^USA^P|^PRN^PH^^^248^5736449ORC|RE||BK93Y37541.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK93Y37541.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461020011^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461020012|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X52Z37549^^^AIRA-TEST^MR||AndersonAIRA^ParnitaAIRA^Manju^^^^L|WeilAIRA^KatyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1391 Laarn Cir^^Woodland Park^MI^49309^USA^P||^PRN^PH^^^231^3837732|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndersonAIRA^WeilAIRA^^^^^L|MTH^Mother^HL70063|1391 Laarn Cir^^Woodland Park^MI^49309^USA^P|^PRN^PH^^^231^3837732ORC|RE||BX52Z37549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX52Z37549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461020012^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461020101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W54N37557^^^AIRA-TEST^MR||MissaukeeAIRA^NordicaAIRA^Panyin^^^^L|ChopeAIRA^PearlyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1262 Cwartewaterland St^^Grand Rapids^MI^49548^USA^P||^PRN^PH^^^616^7611932|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MissaukeeAIRA^ChopeAIRA^^^^^L|MTH^Mother^HL70063|1262 Cwartewaterland St^^Grand Rapids^MI^49548^USA^P|^PRN^PH^^^616^7611932ORC|RE||BW54N37557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW54N37557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461020101^Flucelvax Quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461020111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I88B37562^^^AIRA-TEST^MR||RonningAIRA^PaulineAIRA^Ola^^^^L|MacombAIRA^AlohiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1738 Hinkelland Ln^^West Olive^MI^49460^USA^P||^PRN^PH^^^616^9523996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RonningAIRA^MacombAIRA^^^^^L|MTH^Mother^HL70063|1738 Hinkelland Ln^^West Olive^MI^49460^USA^P|^PRN^PH^^^616^9523996ORC|RE||BI88B37562.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI88B37562.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461020111^Flucelvax, quadrivalent, preservative free^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461030110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M10J37573^^^AIRA-TEST^MR||AlfalfaAIRA^NehaAIRA^Maren^^^^L|MontmorencyMuskegonAIRA^AdrianaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1141 Hampen Cir^^Mount Clemens^MI^48046^USA^P||^PRN^PH^^^586^7366897|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AlfalfaAIRA^MontmorencyMuskegonAIRA^^^^^L|MTH^Mother^HL70063|1141 Hampen Cir^^Mount Clemens^MI^48046^USA^P|^PRN^PH^^^586^7366897ORC|RE||BM10J37573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM10J37573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461030110^Flucelvax, quadrivalent, preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461030112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H60J37581^^^AIRA-TEST^MR||BonnerAIRA^VardaAIRA^Endora^^^^L|MagoffinAIRA^AzlandAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1355 Seere St^^Troy^MI^48007^USA^P||^PRN^PH^^^248^2657990|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BonnerAIRA^MagoffinAIRA^^^^^L|MTH^Mother^HL70063|1355 Seere St^^Troy^MI^48007^USA^P|^PRN^PH^^^248^2657990ORC|RE||BH60J37581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH60J37581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461030112^Flucelvax, quad, with preservative^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461031803|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O84J37589^^^AIRA-TEST^MR||WardleAIRA^DarleneAIRA^Seirian^^^^L|HutchinsonAIRA^SaumyaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1519 Pongeradeel Cir^^Rockford^MI^49341^USA^P||^PRN^PH^^^616^2188623|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WardleAIRA^HutchinsonAIRA^^^^^L|MTH^Mother^HL70063|1519 Pongeradeel Cir^^Rockford^MI^49341^USA^P|^PRN^PH^^^616^2188623ORC|RE||BO84J37589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO84J37589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461031803^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461031804|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J04W37597^^^AIRA-TEST^MR||AdairAIRA^UnniAIRA^Girija^^^^L|Twin FallsAIRA^DiellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1288 Duizend Ave^^Marenisco^MI^49947^USA^P||^PRN^PH^^^906^9607023|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^Twin FallsAIRA^^^^^L|MTH^Mother^HL70063|1288 Duizend Ave^^Marenisco^MI^49947^USA^P|^PRN^PH^^^906^9607023ORC|RE||BJ04W37597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ04W37597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461031804^FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461041810|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y88E37605^^^AIRA-TEST^MR||SiskiyouAIRA^KaelynAIRA^Cybele^^^^L|ProvidenceAIRA^UttaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1939 Boermond St^^Trufant^MI^49347^USA^P||^PRN^PH^^^231^7891676|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SiskiyouAIRA^ProvidenceAIRA^^^^^L|MTH^Mother^HL70063|1939 Boermond St^^Trufant^MI^49347^USA^P|^PRN^PH^^^231^7891676ORC|RE||BY88E37605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY88E37605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461041810^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461041811|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F07S37613^^^AIRA-TEST^MR||KernAIRA^RajaniAIRA^Bessy^^^^L|HaughtonAIRA^EleniAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1072 Kldebroek Ln^^Dewitt^MI^48820^USA^P||^PRN^PH^^^517^7876408|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KernAIRA^HaughtonAIRA^^^^^L|MTH^Mother^HL70063|1072 Kldebroek Ln^^Dewitt^MI^48820^USA^P|^PRN^PH^^^517^7876408ORC|RE||BF07S37613.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF07S37613.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461041811^FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461061401|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y74T37618^^^AIRA-TEST^MR||BelmontAIRA^KaleaAIRA^Latonia^^^^L|LincolnAIRA^ItiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1677 Buidhorn St^^Brownstown Township^MI^48134^USA^P||^PRN^PH^^^734^5426290|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BelmontAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1677 Buidhorn St^^Brownstown Township^MI^48134^USA^P|^PRN^PH^^^734^5426290ORC|RE||BY74T37618.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY74T37618.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461061401^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-70461061411|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A09A37629^^^AIRA-TEST^MR||GreenupAIRA^RosalbaAIRA^Keyla^^^^L|BryanAIRA^UnnatiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1473 Poest Ave^^Hulbert^MI^49748^USA^P||^PRN^PH^^^906^3913268|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreenupAIRA^BryanAIRA^^^^^L|MTH^Mother^HL70063|1473 Poest Ave^^Hulbert^MI^49748^USA^P|^PRN^PH^^^906^3913268ORC|RE||BA09A37629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA09A37629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||70461061411^FluceIvax^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-470-10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P59K37637^^^AIRA-TEST^MR||KlebergAIRA^MaximeAIRA^Kaylin^^^^L|CusterAIRA^GonerilAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1621 Aeventer Cir^^GR^MI^49525^USA^P||^PRN^PH^^^616^4724696|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlebergAIRA^CusterAIRA^^^^^L|MTH^Mother^HL70063|1621 Aeventer Cir^^GR^MI^49525^USA^P|^PRN^PH^^^616^4724696ORC|RE||BP59K37637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP59K37637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420-470-10^Physicians EZ Use Flu Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-471-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T25S37645^^^AIRA-TEST^MR||DelawareAIRA^AmaraAIRA^Kaylen^^^^L|Contra CostaAIRA^HazelleAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1780 Algemeen Ave^^Ridgeway^MI^49229^USA^P||^PRN^PH^^^517^5282915|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DelawareAIRA^Contra CostaAIRA^^^^^L|MTH^Mother^HL70063|1780 Algemeen Ave^^Ridgeway^MI^49229^USA^P|^PRN^PH^^^517^5282915ORC|RE||BT25S37645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT25S37645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420-471-01^Medical Provider Single Use EZ Flu Shot Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-482-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T77V37653^^^AIRA-TEST^MR||NicholasAIRA^OliviaAIRA^Haylie^^^^L|LoganAIRA^SherAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1802 Eerste St^^Alden^MI^49612^USA^P||^PRN^PH^^^231^2849438|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NicholasAIRA^LoganAIRA^^^^^L|MTH^Mother^HL70063|1802 Eerste St^^Alden^MI^49612^USA^P|^PRN^PH^^^231^2849438ORC|RE||BT77V37653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT77V37653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420-482-01^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420-483-01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q78E37661^^^AIRA-TEST^MR||ParasariAIRA^PoojaAIRA^Lillian^^^^L|SacAIRA^TivonaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1485 Gardenberg Cir^^Detroit^MI^48217^USA^P||^PRN^PH^^^313^3353146|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParasariAIRA^SacAIRA^^^^^L|MTH^Mother^HL70063|1485 Gardenberg Cir^^Detroit^MI^48217^USA^P|^PRN^PH^^^313^3353146ORC|RE||BQ78E37661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ78E37661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420-483-01^Medical Provider Single Use EZ Flu Shot 2013-2014^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420047010|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F67M37666^^^AIRA-TEST^MR||WheelerAIRA^AngelicaAIRA^Hema^^^^L|ShermanAIRA^HathorAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1382 Veendam Ave^^Saint Clair^MI^48079^USA^P||^PRN^PH^^^810^5228071|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WheelerAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1382 Veendam Ave^^Saint Clair^MI^48079^USA^P|^PRN^PH^^^810^5228071ORC|RE||BF67M37666.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF67M37666.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420047010^Physicians EZ Use Flu Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420047101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z82L37677^^^AIRA-TEST^MR||HarrisonAIRA^ZiselAIRA^Usha^^^^L|OntonagonAIRA^PeytonAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1560 Herg en Dal Cir^^Grass Lake^MI^49240^USA^P||^PRN^PH^^^517^6555048|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^OntonagonAIRA^^^^^L|MTH^Mother^HL70063|1560 Herg en Dal Cir^^Grass Lake^MI^49240^USA^P|^PRN^PH^^^517^6555048ORC|RE||BZ82L37677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ82L37677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420047101^Medical Provider Single Use EZ Flu Shot Kit^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420048201|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y27N37685^^^AIRA-TEST^MR||CottonAIRA^EdnaAIRA^Julianne^^^^L|OldhamAIRA^ChanceAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1623 Celmond Ln^^Lakewood Club^MI^49457^USA^P||^PRN^PH^^^231^5619321|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CottonAIRA^OldhamAIRA^^^^^L|MTH^Mother^HL70063|1623 Celmond Ln^^Lakewood Club^MI^49457^USA^P|^PRN^PH^^^231^5619321ORC|RE||BY27N37685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY27N37685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420048201^FLUVIRIN^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-NDC-76420048301|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G93L37693^^^AIRA-TEST^MR||TobiassenAIRA^LoriAIRA^Fayme^^^^L|GreenAIRA^MarianAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1430 Beerhugowaard Ave^^Reading^MI^49274^USA^P||^PRN^PH^^^517^3205561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TobiassenAIRA^GreenAIRA^^^^^L|MTH^Mother^HL70063|1430 Beerhugowaard Ave^^Reading^MI^49274^USA^P|^PRN^PH^^^517^3205561ORC|RE||BG93L37693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG93L37693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||76420048301^Medical Provider Single Use EZ Flu Shot 2013-2014^NDC|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-MIA04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I84A37701^^^AIRA-TEST^MR||HallAIRA^RajniAIRA^Lae^^^^L|ThornleyAIRA^AshamedAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1662 Periode St^^Port Huron^MI^48061^USA^P||^PRN^PH^^^810^8678885|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HallAIRA^ThornleyAIRA^^^^^L|MTH^Mother^HL70063|1662 Periode St^^Port Huron^MI^48061^USA^P|^PRN^PH^^^810^8678885ORC|RE||BI84A37701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI84A37701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA04^Public vaccine - MI-VRP (Michigan Vaccine Replacement Program)^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-MIA05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B71R37709^^^AIRA-TEST^MR||VictoriaAIRA^LimberAIRA^Cairine^^^^L|AllamakeeAIRA^AgateAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1792 Met St^^Topinabee^MI^49791^USA^P||^PRN^PH^^^231^3959053|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|VictoriaAIRA^AllamakeeAIRA^^^^^L|MTH^Mother^HL70063|1792 Met St^^Topinabee^MI^49791^USA^P|^PRN^PH^^^231^3959053ORC|RE||BB71R37709.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB71R37709.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA05^Medicare (parts A, B and D)^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-MIA08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F72J37714^^^AIRA-TEST^MR||HowardAIRA^ArelyAIRA^Gae^^^^L|CherokeeAIRA^MarkettaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1877 Treda Ave^^Walker^MI^49544^USA^P||^PRN^PH^^^616^9405601|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowardAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1877 Treda Ave^^Walker^MI^49544^USA^P|^PRN^PH^^^616^9405601ORC|RE||BF72J37714.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF72J37714.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA08^Private Stock Vaccine -Other Public Purchase^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-MIA10|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C29I37722^^^AIRA-TEST^MR||GarfieldAIRA^BharatiAIRA^Jezebel^^^^L|MonroeAIRA^AdrienneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1983 Nodegraven-Reeuwijk St^^Custer^MI^49405^USA^P||^PRN^PH^^^231^4094108|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GarfieldAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1983 Nodegraven-Reeuwijk St^^Custer^MI^49405^USA^P|^PRN^PH^^^231^4094108ORC|RE||BC29I37722.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC29I37722.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA10^All Hazard eligible -Public Purchase^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-MIA14|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q91T37733^^^AIRA-TEST^MR||WhitleyAIRA^MoinaAIRA^Dusty^^^^L|ForestAIRA^PhilomelaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1367 Gwenterand Ave^^Caledonia^MI^49316^USA^P||^PRN^PH^^^616^6563117|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitleyAIRA^ForestAIRA^^^^^L|MTH^Mother^HL70063|1367 Gwenterand Ave^^Caledonia^MI^49316^USA^P|^PRN^PH^^^616^6563117ORC|RE||BQ91T37733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ91T37733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|MIA14^Medicaid-Non VFC^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-OR01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N42L37741^^^AIRA-TEST^MR||SiouxAIRA^RebelAIRA^Orseline^^^^L|LapeerAIRA^AmiahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1395 Slip Pl^^Jeddo^MI^48032^USA^P||^PRN^PH^^^810^2640805|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SiouxAIRA^LapeerAIRA^^^^^L|MTH^Mother^HL70063|1395 Slip Pl^^Jeddo^MI^48032^USA^P|^PRN^PH^^^810^2640805ORC|RE||BN42L37741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN42L37741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|OR01^S - Special Projects^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V00|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W38X37749^^^AIRA-TEST^MR||NobleAIRA^WinsomeAIRA^Cinderella^^^^L|WoldAIRA^EmmylouAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1512 Keemster St^^Bellevue^MI^49021^USA^P||^PRN^PH^^^269^8918166|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NobleAIRA^WoldAIRA^^^^^L|MTH^Mother^HL70063|1512 Keemster St^^Bellevue^MI^49021^USA^P|^PRN^PH^^^269^8918166ORC|RE||BW38X37749.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW38X37749.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V00^VFC eligibility unknown^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W48O37757^^^AIRA-TEST^MR||LancasterAIRA^RosaAIRA^Gisselle^^^^L|SamuelsonAIRA^XenobiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1988 Gat Ln^^Flint^MI^48554^USA^P||^PRN^PH^^^810^8813633|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LancasterAIRA^SamuelsonAIRA^^^^^L|MTH^Mother^HL70063|1988 Gat Ln^^Flint^MI^48554^USA^P|^PRN^PH^^^810^8813633ORC|RE||BW48O37757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW48O37757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T76N37765^^^AIRA-TEST^MR||Los AngelesAIRA^DanielleAIRA^Shahira^^^^L|LycomingAIRA^MayaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1329 Bpe Ln^^Mc Bain^MI^49657^USA^P||^PRN^PH^^^231^2996445|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Los AngelesAIRA^LycomingAIRA^^^^^L|MTH^Mother^HL70063|1329 Bpe Ln^^Mc Bain^MI^49657^USA^P|^PRN^PH^^^231^2996445ORC|RE||BT76N37765.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT76N37765.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible-Medicaid/Medicaid managed care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z55A37770^^^AIRA-TEST^MR||BellAIRA^NiobeAIRA^Bronwen^^^^L|ChopeAIRA^MarciaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1544 Heder-Betuwe St^^Lachine^MI^49753^USA^P||^PRN^PH^^^989^7188442|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BellAIRA^ChopeAIRA^^^^^L|MTH^Mother^HL70063|1544 Heder-Betuwe St^^Lachine^MI^49753^USA^P|^PRN^PH^^^989^7188442ORC|RE||BZ55A37770.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ55A37770.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible-Uninsured^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F26H37781^^^AIRA-TEST^MR||BuchananAIRA^AleksandraAIRA^Ila^^^^L|BerreenAIRA^GretchenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1303 Deghel Ln^^Lansing^MI^48909^USA^P||^PRN^PH^^^517^9051309|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BuchananAIRA^BerreenAIRA^^^^^L|MTH^Mother^HL70063|1303 Deghel Ln^^Lansing^MI^48909^USA^P|^PRN^PH^^^517^9051309ORC|RE||BF26H37781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF26H37781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible- American Indian/Alaskan Native^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D56L37789^^^AIRA-TEST^MR||TkrenAIRA^SammaAIRA^Madalynn^^^^L|OkanoganAIRA^BrigitAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1573 Geen Pl^^Lansing^MI^48917^USA^P||^PRN^PH^^^517^2647281|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TkrenAIRA^OkanoganAIRA^^^^^L|MTH^Mother^HL70063|1573 Geen Pl^^Lansing^MI^48917^USA^P|^PRN^PH^^^517^2647281ORC|RE||BD56L37789.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD56L37789.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible-Federally Qualified Health Center Patient^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N68W37797^^^AIRA-TEST^MR||SeminoleAIRA^AideenAIRA^Bara^^^^L|AlexandersonAIRA^SofieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1535 Uaarle-Nassau Ln^^Mackinac City^MI^49701^USA^P||^PRN^PH^^^231^3862574|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SeminoleAIRA^AlexandersonAIRA^^^^^L|MTH^Mother^HL70063|1535 Uaarle-Nassau Ln^^Mackinac City^MI^49701^USA^P|^PRN^PH^^^231^3862574ORC|RE||BN68W37797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN68W37797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V06^VFC eligible- State specific eligibility (e.g. S-CHIP plan)^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M51U37805^^^AIRA-TEST^MR||FloydAIRA^MalinaAIRA^Jamilah^^^^L|MontmorencyMuskegonAIRA^RosemaryAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1101 Loeree-Overflakkee Pl^^Portage^MI^49024^USA^P||^PRN^PH^^^269^4470079|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^MontmorencyMuskegonAIRA^^^^^L|MTH^Mother^HL70063|1101 Loeree-Overflakkee Pl^^Portage^MI^49024^USA^P|^PRN^PH^^^269^4470079ORC|RE||BM51U37805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM51U37805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V07^VFC eligibility- Local-specific eligibility^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V08|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A49I37813^^^AIRA-TEST^MR||DentonAIRA^MasaAIRA^Shridevi^^^^L|DentonAIRA^ThyrrniAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1737 Fractie St^^Sterling Heights^MI^48310^USA^P||^PRN^PH^^^586^9530065|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DentonAIRA^DentonAIRA^^^^^L|MTH^Mother^HL70063|1737 Fractie St^^Sterling Heights^MI^48310^USA^P|^PRN^PH^^^586^9530065ORC|RE||BA49I37813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA49I37813.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V08^Not VFC eligible-Under-insured^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V22|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P97T37818^^^AIRA-TEST^MR||BlaineAIRA^SydneeAIRA^Diya^^^^L|GartenlaubAIRA^KassidyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1723 Wundert Cir^^Petersburg^MI^49270^USA^P||^PRN^PH^^^734^8307605|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlaineAIRA^GartenlaubAIRA^^^^^L|MTH^Mother^HL70063|1723 Wundert Cir^^Petersburg^MI^49270^USA^P|^PRN^PH^^^734^8307605ORC|RE||BP97T37818.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP97T37818.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V22^CHIP^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V23|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J16S37829^^^AIRA-TEST^MR||LawrenceAIRA^KierstenAIRA^Araminta^^^^L|CowlitzAIRA^MiraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1350 Voedsel Ave^^Sears^MI^49679^USA^P||^PRN^PH^^^231^5853302|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LawrenceAIRA^CowlitzAIRA^^^^^L|MTH^Mother^HL70063|1350 Voedsel Ave^^Sears^MI^49679^USA^P|^PRN^PH^^^231^5853302ORC|RE||BJ16S37829.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ16S37829.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V23^317^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V24|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U40X37837^^^AIRA-TEST^MR||HuntingdonAIRA^NylahAIRA^Aminta^^^^L|MagriAIRA^SuzieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1266 Alkmaar Cir^^Rosebush^MI^48878^USA^P||^PRN^PH^^^989^8623217|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuntingdonAIRA^MagriAIRA^^^^^L|MTH^Mother^HL70063|1266 Alkmaar Cir^^Rosebush^MI^48878^USA^P|^PRN^PH^^^989^8623217ORC|RE||BU40X37837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU40X37837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V24^Medicare^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-VFC-V25|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X83K37845^^^AIRA-TEST^MR||GeneseeAIRA^JarkaAIRA^Miranda^^^^L|MercerAIRA^LarissaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1654 Broer St^^Wakefield^MI^49968^USA^P||^PRN^PH^^^906^7513081|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GeneseeAIRA^MercerAIRA^^^^^L|MTH^Mother^HL70063|1654 Broer St^^Wakefield^MI^49968^USA^P|^PRN^PH^^^906^7513081ORC|RE||BX83K37845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX83K37845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V25^Sate program eligibility^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-B|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D60W37853^^^AIRA-TEST^MR||JasperAIRA^NaliniAIRA^Meckenzie^^^^L|GageAIRA^WillaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1957 Selecteren Ln^^North Muskegon^MI^49445^USA^B||^PRN^PH^^^231^7419924|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JasperAIRA^GageAIRA^^^^^L|MTH^Mother^HL70063|1957 Selecteren Ln^^North Muskegon^MI^49445^USA^P|^PRN^PH^^^231^7419924ORC|RE||BD60W37853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD60W37853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-BA|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F76P37861^^^AIRA-TEST^MR||JohnAIRA^GwendolynAIRA^Dyan^^^^L|IsabellaAIRA^BegaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1634 Perg en Dal Ln^^Lansing^MI^48912^USA^BA||^PRN^PH^^^517^9198041|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JohnAIRA^IsabellaAIRA^^^^^L|MTH^Mother^HL70063|1634 Perg en Dal Ln^^Lansing^MI^48912^USA^P|^PRN^PH^^^517^9198041ORC|RE||BF76P37861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF76P37861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-BDL|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C87D37869^^^AIRA-TEST^MR||PierceAIRA^NeridaAIRA^Quincy^^^^L|UnionAIRA^DanikaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1430 Excite Ln^^Milford^MI^48381^USA^BDL||^PRN^PH^^^248^2579982|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PierceAIRA^UnionAIRA^^^^^L|MTH^Mother^HL70063|1430 Excite Ln^^Milford^MI^48381^USA^P|^PRN^PH^^^248^2579982ORC|RE||BC87D37869.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC87D37869.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-BR|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W52B37874^^^AIRA-TEST^MR||AntelopeAIRA^MedinaAIRA^Brygida^^^^L|Buena VistaAIRA^FloramariaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1913 Dergeijk Ave^^Bridgeport^MI^48722^USA^BR||^PRN^PH^^^989^2078260|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AntelopeAIRA^Buena VistaAIRA^^^^^L|MTH^Mother^HL70063|1913 Dergeijk Ave^^Bridgeport^MI^48722^USA^P|^PRN^PH^^^989^2078260ORC|RE||BW52B37874.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW52B37874.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-C|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M43L37885^^^AIRA-TEST^MR||RunnelsAIRA^ManiAIRA^Iman^^^^L|GrendalAIRA^VinayaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1839 Waarom Ln^^Saint Clair^MI^48079^USA^C||^PRN^PH^^^810^2242416|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RunnelsAIRA^GrendalAIRA^^^^^L|MTH^Mother^HL70063|1839 Waarom Ln^^Saint Clair^MI^48079^USA^P|^PRN^PH^^^810^2242416ORC|RE||BM43L37885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM43L37885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-F|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L92G37893^^^AIRA-TEST^MR||EdmundsAIRA^LaurynAIRA^Quinn^^^^L|LetcherAIRA^MichelineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1012 Zuijk Ln^^Kendall^MI^49062^USA^F||^PRN^PH^^^269^4008503|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EdmundsAIRA^LetcherAIRA^^^^^L|MTH^Mother^HL70063|1012 Zuijk Ln^^Kendall^MI^49062^USA^P|^PRN^PH^^^269^4008503ORC|RE||BL92G37893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL92G37893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-H|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y62F37901^^^AIRA-TEST^MR||CanadianAIRA^NestaAIRA^Willow^^^^L|SykesAIRA^DabaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1578 Hoog Pl^^Franklin^MI^48025^USA^H||^PRN^PH^^^248^4915302|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CanadianAIRA^SykesAIRA^^^^^L|MTH^Mother^HL70063|1578 Hoog Pl^^Franklin^MI^48025^USA^P|^PRN^PH^^^248^4915302ORC|RE||BY62F37901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY62F37901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-L|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D58C37909^^^AIRA-TEST^MR||BlaineAIRA^AsenkaAIRA^Kyra^^^^L|KarlssonAIRA^FloramariaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1761 Nollumerland en Nieuwkruisland Pl^^Marlette^MI^48453^USA^L||^PRN^PH^^^989^5534228|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlaineAIRA^KarlssonAIRA^^^^^L|MTH^Mother^HL70063|1761 Nollumerland en Nieuwkruisland Pl^^Marlette^MI^48453^USA^P|^PRN^PH^^^989^5534228ORC|RE||BD58C37909.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD58C37909.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-M|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A36A37917^^^AIRA-TEST^MR||ClintonAIRA^ValgerdrAIRA^Rhonwen^^^^L|BlaineAIRA^NaidaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1843 Lernheze Ln^^Gm Truck and Bus^MI^48553^USA^M||^PRN^PH^^^810^4738332|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^BlaineAIRA^^^^^L|MTH^Mother^HL70063|1843 Lernheze Ln^^Gm Truck and Bus^MI^48553^USA^P|^PRN^PH^^^810^4738332ORC|RE||BA36A37917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA36A37917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-N|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S28M37922^^^AIRA-TEST^MR||BrowneAIRA^TessaAIRA^Belinda^^^^L|SwindellsAIRA^TemiraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1887 Aen Boer St^^Bellevue^MI^49021^USA^N||^PRN^PH^^^269^4037298|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrowneAIRA^SwindellsAIRA^^^^^L|MTH^Mother^HL70063|1887 Aen Boer St^^Bellevue^MI^49021^USA^P|^PRN^PH^^^269^4037298ORC|RE||BS28M37922.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS28M37922.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-O|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D17F37933^^^AIRA-TEST^MR||OttawaAIRA^KesiAIRA^Findabhair^^^^L|NevadaAIRA^GaliAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1133 Kijdemeren Ave^^Fulton^MI^49052^USA^O||^PRN^PH^^^269^8220304|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OttawaAIRA^NevadaAIRA^^^^^L|MTH^Mother^HL70063|1133 Kijdemeren Ave^^Fulton^MI^49052^USA^P|^PRN^PH^^^269^8220304ORC|RE||BD17F37933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD17F37933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-P|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B45E37941^^^AIRA-TEST^MR||LorainAIRA^NeveahAIRA^Jumoke^^^^L|OchiltreeAIRA^ClorindaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1878 Kelft Cir^^Copper Harbor^MI^49918^USA^P||^PRN^PH^^^906^9974731|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LorainAIRA^OchiltreeAIRA^^^^^L|MTH^Mother^HL70063|1878 Kelft Cir^^Copper Harbor^MI^49918^USA^P|^PRN^PH^^^906^9974731ORC|RE||BB45E37941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB45E37941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-ADR-TYPE1-RH|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W78Q37949^^^AIRA-TEST^MR||HillsdaleAIRA^WaratahAIRA^Alice^^^^L|McErlaneAIRA^IsabellaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1313 Lorsele St^^Bridgman^MI^49106^USA^RH||^PRN^PH^^^269^4761819|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HillsdaleAIRA^McErlaneAIRA^^^^^L|MTH^Mother^HL70063|1313 Lorsele St^^Bridgman^MI^49106^USA^P|^PRN^PH^^^269^4761819ORC|RE||BW78Q37949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW78Q37949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90281|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X62T37957^^^AIRA-TEST^MR||LakeAIRA^AddisynAIRA^Kalila^^^^L|BakerAIRA^EudociaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1414 Oeek St^^GR^MI^49510^USA^P||^PRN^PH^^^616^3918861|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^BakerAIRA^^^^^L|MTH^Mother^HL70063|1414 Oeek St^^GR^MI^49510^USA^P|^PRN^PH^^^616^3918861ORC|RE||BX62T37957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90281^IG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX62T37957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90283|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O61R37965^^^AIRA-TEST^MR||El DoradoAIRA^ZaraAIRA^Marabel^^^^L|AdamsAIRA^ToriAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1766 Groningen St^^Kalamazoo^MI^49002^USA^P||^PRN^PH^^^269^2080025|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|El DoradoAIRA^AdamsAIRA^^^^^L|MTH^Mother^HL70063|1766 Groningen St^^Kalamazoo^MI^49002^USA^P|^PRN^PH^^^269^2080025ORC|RE||BO61R37965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90283^IGIV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO61R37965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90287|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X05Q37970^^^AIRA-TEST^MR||TuolumneAIRA^DestaAIRA^Romaine^^^^L|LemhiAIRA^DayleAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1766 Schinnen Pl^^Posen^MI^49776^USA^P||^PRN^PH^^^989^8638051|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TuolumneAIRA^LemhiAIRA^^^^^L|MTH^Mother^HL70063|1766 Schinnen Pl^^Posen^MI^49776^USA^P|^PRN^PH^^^989^8638051ORC|RE||BX05Q37970.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90287^botulinum antitoxin^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX05Q37970.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90291|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X53L37981^^^AIRA-TEST^MR||LatahAIRA^TainnAIRA^Jamari^^^^L|GilaAIRA^RupaliAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1744 Auidhorn Cir^^Frankenmuth^MI^48787^USA^P||^PRN^PH^^^989^4294547|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LatahAIRA^GilaAIRA^^^^^L|MTH^Mother^HL70063|1744 Auidhorn Cir^^Frankenmuth^MI^48787^USA^P|^PRN^PH^^^989^4294547ORC|RE||BX53L37981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90291^CMVIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX53L37981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90296|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O18D37989^^^AIRA-TEST^MR||ReillyAIRA^FloriaAIRA^Jennifer^^^^L|KeithAIRA^DashaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1812 Gebruikelijke Pl^^Harrisville^MI^48740^USA^P||^PRN^PH^^^989^9156223|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ReillyAIRA^KeithAIRA^^^^^L|MTH^Mother^HL70063|1812 Gebruikelijke Pl^^Harrisville^MI^48740^USA^P|^PRN^PH^^^989^9156223ORC|RE||BO18D37989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90296^diphtheria antitoxin^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO18D37989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90371|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L69D37997^^^AIRA-TEST^MR||ButlerAIRA^FleurAIRA^Diamond^^^^L|SonomaAIRA^BethanyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1371 Tollands Kroon St^^Kalamazoo^MI^49024^USA^P||^PRN^PH^^^269^7015543|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^SonomaAIRA^^^^^L|MTH^Mother^HL70063|1371 Tollands Kroon St^^Kalamazoo^MI^49024^USA^P|^PRN^PH^^^269^7015543ORC|RE||BL69D37997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90371^HBIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL69D37997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90375|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C87D38005^^^AIRA-TEST^MR||GrantAIRA^SloaneAIRA^Shammara^^^^L|GreeleyAIRA^RosalbaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1299 Wave Cir^^Christian Reformed Church^MI^49560^USA^P||^PRN^PH^^^616^6742047|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrantAIRA^GreeleyAIRA^^^^^L|MTH^Mother^HL70063|1299 Wave Cir^^Christian Reformed Church^MI^49560^USA^P|^PRN^PH^^^616^6742047ORC|RE||BC87D38005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90375^RIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC87D38005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90376|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V82S38013^^^AIRA-TEST^MR||CaddoAIRA^LatoyaAIRA^Saryu^^^^L|KalamazooAIRA^HindaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1080 Wollumerland Ave^^Howell^MI^48863^USA^P||^PRN^PH^^^517^6666981|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaddoAIRA^KalamazooAIRA^^^^^L|MTH^Mother^HL70063|1080 Wollumerland Ave^^Howell^MI^48863^USA^P|^PRN^PH^^^517^6666981ORC|RE||BV82S38013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90376^RIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV82S38013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90378|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P18S38018^^^AIRA-TEST^MR||HancockAIRA^RyokoAIRA^Cameo^^^^L|AllenAIRA^ZiliaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1625 Bittard-Geleen Pl^^Grosse Pointe^MI^48224^USA^P||^PRN^PH^^^313^3900602|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HancockAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1625 Bittard-Geleen Pl^^Grosse Pointe^MI^48224^USA^P|^PRN^PH^^^313^3900602ORC|RE||BP18S38018.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90378^RSV-MAb^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP18S38018.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90379|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S68K38029^^^AIRA-TEST^MR||OwyheeAIRA^RobinAIRA^Sandi^^^^L|La SalleAIRA^DelaneyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1461 Mellendoorn Cir^^Utica^MI^48316^USA^P||^PRN^PH^^^586^5000016|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OwyheeAIRA^La SalleAIRA^^^^^L|MTH^Mother^HL70063|1461 Mellendoorn Cir^^Utica^MI^48316^USA^P|^PRN^PH^^^586^5000016ORC|RE||BS68K38029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90379^RSV-IGIV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS68K38029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90389|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y14X38037^^^AIRA-TEST^MR||BlairAIRA^GudaAIRA^Maresa^^^^L|LincolnAIRA^CeriseAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1636 Auren Ln^^Parchment^MI^49004^USA^P||^PRN^PH^^^269^6001578|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlairAIRA^LincolnAIRA^^^^^L|MTH^Mother^HL70063|1636 Auren Ln^^Parchment^MI^49004^USA^P|^PRN^PH^^^269^6001578ORC|RE||BY14X38037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90389^TIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY14X38037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90393|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P41Y38045^^^AIRA-TEST^MR||RyanAIRA^AliciaAIRA^Mariasha^^^^L|GratiotAIRA^KylaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1721 Oidden-Drenthe Pl^^Bloomfield Township^MI^48301^USA^P||^PRN^PH^^^248^5243596|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RyanAIRA^GratiotAIRA^^^^^L|MTH^Mother^HL70063|1721 Oidden-Drenthe Pl^^Bloomfield Township^MI^48301^USA^P|^PRN^PH^^^248^5243596ORC|RE||BP41Y38045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90393^vaccinia immune globulin^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP41Y38045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90396|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R10G38053^^^AIRA-TEST^MR||MorrellAIRA^HedeaAIRA^Ireland^^^^L|CassAIRA^SabrinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1944 Tevenaar Cir^^Farmingtn Hls^MI^48333^USA^P||^PRN^PH^^^248^4975567|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MorrellAIRA^CassAIRA^^^^^L|MTH^Mother^HL70063|1944 Tevenaar Cir^^Farmingtn Hls^MI^48333^USA^P|^PRN^PH^^^248^4975567ORC|RE||BR10G38053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90396^VZIG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR10G38053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90470|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z11X38061^^^AIRA-TEST^MR||BaylorAIRA^LeticiaAIRA^Klara^^^^L|AllottAIRA^TheresaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1257 Honderd Cir^^Flint^MI^48503^USA^P||^PRN^PH^^^810^7129478|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BaylorAIRA^AllottAIRA^^^^^L|MTH^Mother^HL70063|1257 Honderd Cir^^Flint^MI^48503^USA^P|^PRN^PH^^^810^7129478ORC|RE||BZ11X38061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90470^Novel Influenza-H1N1-09, all formulations^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ11X38061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90476|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E14S38066^^^AIRA-TEST^MR||SciotoAIRA^YeneneAIRA^Beta^^^^L|ChristianAIRA^VerbenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1123 Zollumerland Ln^^Waterford^MI^48327^USA^P||^PRN^PH^^^248^5331611|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SciotoAIRA^ChristianAIRA^^^^^L|MTH^Mother^HL70063|1123 Zollumerland Ln^^Waterford^MI^48327^USA^P|^PRN^PH^^^248^5331611ORC|RE||BE14S38066.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90476^adenovirus, type 4^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE14S38066.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90477|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V52R38077^^^AIRA-TEST^MR||UlsethAIRA^LaurelAIRA^Elisa^^^^L|MurphyAIRA^ReneeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1242 Sijsden-Margraten St^^Duck Lake^MI^49284^USA^P||^PRN^PH^^^517^5621135|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|UlsethAIRA^MurphyAIRA^^^^^L|MTH^Mother^HL70063|1242 Sijsden-Margraten St^^Duck Lake^MI^49284^USA^P|^PRN^PH^^^517^5621135ORC|RE||BV52R38077.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90477^adenovirus, type 7^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV52R38077.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90581|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X70H38085^^^AIRA-TEST^MR||HancockAIRA^OfrahAIRA^Shannah^^^^L|PhelpsAIRA^TiffanyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1096 Broer Pl^^Quinnesec^MI^49876^USA^P||^PRN^PH^^^906^4289996|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HancockAIRA^PhelpsAIRA^^^^^L|MTH^Mother^HL70063|1096 Broer Pl^^Quinnesec^MI^49876^USA^P|^PRN^PH^^^906^4289996ORC|RE||BX70H38085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90581^anthrax^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX70H38085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90585|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q35N38093^^^AIRA-TEST^MR||KaufmanAIRA^BrynleeAIRA^Laney^^^^L|Van ZandtAIRA^FarikaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1254 Zingewaard Pl^^Essexville^MI^48732^USA^P||^PRN^PH^^^989^3603750|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KaufmanAIRA^Van ZandtAIRA^^^^^L|MTH^Mother^HL70063|1254 Zingewaard Pl^^Essexville^MI^48732^USA^P|^PRN^PH^^^989^3603750ORC|RE||BQ35N38093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90585^BCG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ35N38093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90620|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M89L38101^^^AIRA-TEST^MR||ColumbiaAIRA^AbijahAIRA^Pamela^^^^L|CrosbieAIRA^SyeiraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1039 Glans Cir^^Kalkaska^MI^49646^USA^P||^PRN^PH^^^231^5225693|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColumbiaAIRA^CrosbieAIRA^^^^^L|MTH^Mother^HL70063|1039 Glans Cir^^Kalkaska^MI^49646^USA^P|^PRN^PH^^^231^5225693ORC|RE||BM89L38101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90620^Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B, 2 dose schedule, for intramuscular^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM89L38101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90621|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S23Z38109^^^AIRA-TEST^MR||StonewallAIRA^LanayaAIRA^Marcy^^^^L|GosperAIRA^JourneyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1583 Wmmen Pl^^Bruce Crossing^MI^49912^USA^P||^PRN^PH^^^906^8396556|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StonewallAIRA^GosperAIRA^^^^^L|MTH^Mother^HL70063|1583 Wmmen Pl^^Bruce Crossing^MI^49912^USA^P|^PRN^PH^^^906^8396556ORC|RE||BS23Z38109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90621^Meningococcal recombinant lipoprotein vaccine, serogroup B, 3 dose schedule, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS23Z38109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90625|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D52A38114^^^AIRA-TEST^MR||McKiernanAIRA^HeidiAIRA^Parveen^^^^L|DawsonAIRA^CuylerAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1683 Natie Ln^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^9797102|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|McKiernanAIRA^DawsonAIRA^^^^^L|MTH^Mother^HL70063|1683 Natie Ln^^Saginaw^MI^48609^USA^P|^PRN^PH^^^989^9797102ORC|RE||BD52A38114.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90625^Cholera vaccine live, adult dosage, 1 dose schedule, for oral use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD52A38114.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90630|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J51P38125^^^AIRA-TEST^MR||YumaAIRA^PyrenaAIRA^Kelda^^^^L|StarrAIRA^ArmynelAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1365 Andere St^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^7156486|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YumaAIRA^StarrAIRA^^^^^L|MTH^Mother^HL70063|1365 Andere St^^Ash Township^MI^48117^USA^P|^PRN^PH^^^734^7156486ORC|RE||BJ51P38125.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90630^Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ51P38125.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90632|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B96W38133^^^AIRA-TEST^MR||AnderssonAIRA^YayoiAIRA^Valeda^^^^L|DouglasAIRA^PaziaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1325 Bevenaar Pl^^Secretary of State^MI^48918^USA^P||^PRN^PH^^^517^5632104|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AnderssonAIRA^DouglasAIRA^^^^^L|MTH^Mother^HL70063|1325 Bevenaar Pl^^Secretary of State^MI^48918^USA^P|^PRN^PH^^^517^5632104ORC|RE||BB96W38133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90632^Hep A, adult^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB96W38133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90633|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z65R38141^^^AIRA-TEST^MR||LakeAIRA^ManjuAIRA^Dae^^^^L|MonroeAIRA^EfterpiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1416 Ea en Hunze St^^Detroit^MI^48220^USA^P||^PRN^PH^^^248^9471262|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^MonroeAIRA^^^^^L|MTH^Mother^HL70063|1416 Ea en Hunze St^^Detroit^MI^48220^USA^P|^PRN^PH^^^248^9471262ORC|RE||BZ65R38141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90633^Hep A, ped/adol, 2 dose^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ65R38141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90634|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z21I38149^^^AIRA-TEST^MR||PayneAIRA^KyraAIRA^Kaylynn^^^^L|TemplemanAIRA^AnnabelAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1603 Oloemendaal St^^Ann Arbor^MI^48107^USA^P||^PRN^PH^^^734^2153196|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PayneAIRA^TemplemanAIRA^^^^^L|MTH^Mother^HL70063|1603 Oloemendaal St^^Ann Arbor^MI^48107^USA^P|^PRN^PH^^^734^2153196ORC|RE||BZ21I38149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90634^Hep A, ped/adol, 3 dose^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ21I38149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90636|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H48D38157^^^AIRA-TEST^MR||GonzalesAIRA^ChrysillaAIRA^Orseline^^^^L|WagonerAIRA^OdessaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1684 Lidden-Drenthe Pl^^Sylvan Beach^MI^49461^USA^P||^PRN^PH^^^231^2268214|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GonzalesAIRA^WagonerAIRA^^^^^L|MTH^Mother^HL70063|1684 Lidden-Drenthe Pl^^Sylvan Beach^MI^49461^USA^P|^PRN^PH^^^231^2268214ORC|RE||BH48D38157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90636^Hep A-Hep B^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH48D38157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90644|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F81R38162^^^AIRA-TEST^MR||Del NorteAIRA^AzizaAIRA^Snofrid^^^^L|CochranAIRA^MckinleyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1560 Gemeenschappelijke St^^Howell^MI^48844^USA^P||^PRN^PH^^^517^4854272|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Del NorteAIRA^CochranAIRA^^^^^L|MTH^Mother^HL70063|1560 Gemeenschappelijke St^^Howell^MI^48844^USA^P|^PRN^PH^^^517^4854272ORC|RE||BF81R38162.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90644^Meningococcal C/Y-HIB PRP^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF81R38162.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90645|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D51T38170^^^AIRA-TEST^MR||LuzerneAIRA^DeeAIRA^Harmony^^^^L|OklahomaAIRA^AdaliaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1103 Rindhoven Ave^^East Kingsford^MI^49801^USA^P||^PRN^PH^^^906^5603012|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LuzerneAIRA^OklahomaAIRA^^^^^L|MTH^Mother^HL70063|1103 Rindhoven Ave^^East Kingsford^MI^49801^USA^P|^PRN^PH^^^906^5603012ORC|RE||BD51T38170.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90645^Hib (HbOC)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD51T38170.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90646|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V36B38181^^^AIRA-TEST^MR||TaylorAIRA^KalaAIRA^Ivory^^^^L|MononAIRA^KristieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1391 Aeventer St^^Shelby Township^MI^48317^USA^P||^PRN^PH^^^586^8455130|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TaylorAIRA^MononAIRA^^^^^L|MTH^Mother^HL70063|1391 Aeventer St^^Shelby Township^MI^48317^USA^P|^PRN^PH^^^586^8455130ORC|RE||BV36B38181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90646^Hib (PRP-D)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV36B38181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90647|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E36K38189^^^AIRA-TEST^MR||WotherspoonAIRA^AspasiaAIRA^Milan^^^^L|LorainAIRA^GiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1231 Sanderd St^^Midland^MI^48640^USA^P||^PRN^PH^^^989^8781968|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WotherspoonAIRA^LorainAIRA^^^^^L|MTH^Mother^HL70063|1231 Sanderd St^^Midland^MI^48640^USA^P|^PRN^PH^^^989^8781968ORC|RE||BE36K38189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90647^Hib (PRP-OMP)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE36K38189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90648|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H87X38197^^^AIRA-TEST^MR||KnottAIRA^KarlyAIRA^Janice^^^^L|DeltaAIRA^MariolaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1436 Aalsmeer Cir^^Mosherville^MI^49258^USA^P||^PRN^PH^^^517^4044026|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnottAIRA^DeltaAIRA^^^^^L|MTH^Mother^HL70063|1436 Aalsmeer Cir^^Mosherville^MI^49258^USA^P|^PRN^PH^^^517^4044026ORC|RE||BH87X38197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90648^Hib (PRP-T)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH87X38197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90649|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V00B38205^^^AIRA-TEST^MR||CottonAIRA^WasemeAIRA^Cyprien^^^^L|WebbAIRA^LucettaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1559 Randerd Ave^^Gulliver^MI^49840^USA^P||^PRN^PH^^^906^2778647|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CottonAIRA^WebbAIRA^^^^^L|MTH^Mother^HL70063|1559 Randerd Ave^^Gulliver^MI^49840^USA^P|^PRN^PH^^^906^2778647ORC|RE||BV00B38205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90649^HPV, quadrivalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV00B38205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90650|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U86M38210^^^AIRA-TEST^MR||GanesAIRA^AlianaAIRA^Achit^^^^L|DallasAIRA^LottyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1803 Aerkelland Ln^^Gm Truck and Bus^MI^48551^USA^P||^PRN^PH^^^810^6569020|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GanesAIRA^DallasAIRA^^^^^L|MTH^Mother^HL70063|1803 Aerkelland Ln^^Gm Truck and Bus^MI^48551^USA^P|^PRN^PH^^^810^6569020ORC|RE||BU86M38210.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90650^HPV, bivalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU86M38210.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90651|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B86Q38221^^^AIRA-TEST^MR||DeuelAIRA^EttaAIRA^Amata^^^^L|NewaygoAIRA^PaigeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1732 Laalte Pl^^Melvindale^MI^48122^USA^P||^PRN^PH^^^313^4515394|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DeuelAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1732 Laalte Pl^^Melvindale^MI^48122^USA^P|^PRN^PH^^^313^4515394ORC|RE||BB86Q38221.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90651^Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB86Q38221.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90653|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V16T38229^^^AIRA-TEST^MR||SenecaAIRA^MagdalenAIRA^Lilia^^^^L|EigumAIRA^FloraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1079 Haastricht Cir^^Traunik^MI^49891^USA^P||^PRN^PH^^^906^5139351|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SenecaAIRA^EigumAIRA^^^^^L|MTH^Mother^HL70063|1079 Haastricht Cir^^Traunik^MI^49891^USA^P|^PRN^PH^^^906^5139351ORC|RE||BV16T38229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90653^Influenza virus vaccine, inactivated, subunit, adjuvanted for IM us^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV16T38229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90654|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P35W38237^^^AIRA-TEST^MR||AurumAIRA^SaritaAIRA^Simone^^^^L|WilsonAIRA^ErikaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1051 Roerden Ln^^Iron Mountain^MI^49802^USA^P||^PRN^PH^^^906^8875730|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AurumAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1051 Roerden Ln^^Iron Mountain^MI^49802^USA^P|^PRN^PH^^^906^8875730ORC|RE||BP35W38237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90654^Influenza, seasonal, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP35W38237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90655|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A23W38245^^^AIRA-TEST^MR||SundeAIRA^LychorindaAIRA^Euclea^^^^L|CarrollAIRA^TurquoiseAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1887 Ma en Hunze Cir^^Detroit^MI^48211^USA^P||^PRN^PH^^^313^5950924|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SundeAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1887 Ma en Hunze Cir^^Detroit^MI^48211^USA^P|^PRN^PH^^^313^5950924ORC|RE||BA23W38245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90655^Influenza, seasonal, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA23W38245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90656|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z21V38253^^^AIRA-TEST^MR||SundeAIRA^MaggieAIRA^Rianna^^^^L|OwenAIRA^MiracleAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1925 Neemskerk St^^Muskegon Heights^MI^49444^USA^P||^PRN^PH^^^231^7269826|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SundeAIRA^OwenAIRA^^^^^L|MTH^Mother^HL70063|1925 Neemskerk St^^Muskegon Heights^MI^49444^USA^P|^PRN^PH^^^231^7269826ORC|RE||BZ21V38253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90656^Influenza, seasonal, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ21V38253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90657|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V63F38258^^^AIRA-TEST^MR||SkagAIRA^KristinaAIRA^Ava^^^^L|CannavinAIRA^DulceAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1477 Pmallingerland Ln^^Tustin^MI^49688^USA^P||^PRN^PH^^^231^8523918|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SkagAIRA^CannavinAIRA^^^^^L|MTH^Mother^HL70063|1477 Pmallingerland Ln^^Tustin^MI^49688^USA^P|^PRN^PH^^^231^8523918ORC|RE||BV63F38258.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90657^Influenza, seasonal, injectable^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV63F38258.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90658|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C55R38269^^^AIRA-TEST^MR||Los AngelesAIRA^MalatiAIRA^Sheree^^^^L|LickingAIRA^MarikaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1516 Sleutel Ave^^Pontiac^MI^48340^USA^P||^PRN^PH^^^248^9864245|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Los AngelesAIRA^LickingAIRA^^^^^L|MTH^Mother^HL70063|1516 Sleutel Ave^^Pontiac^MI^48340^USA^P|^PRN^PH^^^248^9864245ORC|RE||BC55R38269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90658^Influenza, seasonal, injectable^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC55R38269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90659|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V64I38277^^^AIRA-TEST^MR||RoscommonAIRA^AylaAIRA^Delvene^^^^L|LeelanauAIRA^DelfinaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1797 Boorst Pl^^Coleman^MI^48618^USA^P||^PRN^PH^^^989^5028315|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RoscommonAIRA^LeelanauAIRA^^^^^L|MTH^Mother^HL70063|1797 Boorst Pl^^Coleman^MI^48618^USA^P|^PRN^PH^^^989^5028315ORC|RE||BV64I38277.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90659^influenza, whole^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV64I38277.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90660|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U36W38285^^^AIRA-TEST^MR||HellicoskiAIRA^MaddisonAIRA^Swati^^^^L|ParkAIRA^AnataAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1112 Wrijven Pl^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^4680836|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HellicoskiAIRA^ParkAIRA^^^^^L|MTH^Mother^HL70063|1112 Wrijven Pl^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^4680836ORC|RE||BU36W38285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90660^influenza, live, intranasal^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU36W38285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90661|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z05X38293^^^AIRA-TEST^MR||LawrenceAIRA^LujuanaAIRA^Ragini^^^^L|GalliaAIRA^RaginiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1677 Ging Ave^^Warren^MI^48090^USA^P||^PRN^PH^^^586^7857603|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LawrenceAIRA^GalliaAIRA^^^^^L|MTH^Mother^HL70063|1677 Ging Ave^^Warren^MI^48090^USA^P|^PRN^PH^^^586^7857603ORC|RE||BZ05X38293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90661^Influenza, injectable, MDCK, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ05X38293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90662|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W56W38301^^^AIRA-TEST^MR||LakeAIRA^KazannaAIRA^Ester^^^^L|ManningAIRA^YasmeenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1092 Aelfzijl Cir^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^7624084|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LakeAIRA^ManningAIRA^^^^^L|MTH^Mother^HL70063|1092 Aelfzijl Cir^^Ash Township^MI^48117^USA^P|^PRN^PH^^^734^7624084ORC|RE||BW56W38301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90662^Influenza, high dose seasonal^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW56W38301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90663|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N94R38306^^^AIRA-TEST^MR||PetersonAIRA^BronAIRA^Niradhara^^^^L|MariposaAIRA^JohannaAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1996 Dexel St^^Scio Township^MI^48103^USA^P||^PRN^PH^^^734^4928060|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PetersonAIRA^MariposaAIRA^^^^^L|MTH^Mother^HL70063|1996 Dexel St^^Scio Township^MI^48103^USA^P|^PRN^PH^^^734^4928060ORC|RE||BN94R38306.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90663^Novel Influenza-H1N1-09, all formulations^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN94R38306.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90664|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L23Y38317^^^AIRA-TEST^MR||GrahamAIRA^OctaviaAIRA^Melanie^^^^L|O'DonnellAIRA^LondynAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1911 Slecht Ave^^Mount Pleasant^MI^48859^USA^P||^PRN^PH^^^989^2858407|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrahamAIRA^O'DonnellAIRA^^^^^L|MTH^Mother^HL70063|1911 Slecht Ave^^Mount Pleasant^MI^48859^USA^P|^PRN^PH^^^989^2858407ORC|RE||BL23Y38317.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90664^Novel Influenza-H1N1-09, nasal^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL23Y38317.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90665|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R55C38325^^^AIRA-TEST^MR||RobertsAIRA^HokuAIRA^Sanjna^^^^L|WheelerAIRA^GracieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1250 Pad Ln^^Millersburg^MI^49759^USA^P||^PRN^PH^^^989^9477119|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobertsAIRA^WheelerAIRA^^^^^L|MTH^Mother^HL70063|1250 Pad Ln^^Millersburg^MI^49759^USA^P|^PRN^PH^^^989^9477119ORC|RE||BR55C38325.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90665^Lyme disease^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR55C38325.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90666|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M13U38333^^^AIRA-TEST^MR||Box ButteAIRA^ClaraAIRA^Ardelle^^^^L|CoshoctonAIRA^LeslieAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1045 Hit Ave^^Limestone^MI^49816^USA^P||^PRN^PH^^^906^8394962|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|Box ButteAIRA^CoshoctonAIRA^^^^^L|MTH^Mother^HL70063|1045 Hit Ave^^Limestone^MI^49816^USA^P|^PRN^PH^^^906^8394962ORC|RE||BM13U38333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90666^Novel influenza-H1N1-09, preservative-free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM13U38333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90668|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y17V38341^^^AIRA-TEST^MR||PolkAIRA^NikkiAIRA^Marianna^^^^L|CarrollAIRA^TealAIRA^^^^^M|20100430|F||2106-3^White^CDCREC|1886 Boorst Cir^^Grandville^MI^49468^USA^P||^PRN^PH^^^616^9046926|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1886 Boorst Cir^^Grandville^MI^49468^USA^P|^PRN^PH^^^616^9046926ORC|RE||BY17V38341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100630||90668^Novel influenza-H1N1-09^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY17V38341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100830||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100830||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90669|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O01N38349^^^AIRA-TEST^MR||DanielsonAIRA^FlaviaAIRA^Kerry^^^^L|LivingstonAIRA^DakshaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1313 Eirschot Pl^^Rose City^MI^48654^USA^P||^PRN^PH^^^989^7925302|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DanielsonAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1313 Eirschot Pl^^Rose City^MI^48654^USA^P|^PRN^PH^^^989^7925302ORC|RE||BO01N38349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90669^pneumococcal conjugate PCV 7^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO01N38349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90670|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q32X38354^^^AIRA-TEST^MR||ClintonAIRA^AlaniAIRA^Delwyn^^^^L|PortageAIRA^CyreneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1488 Kaanstad Ln^^Ludington^MI^49431^USA^P||^PRN^PH^^^231^6556311|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ClintonAIRA^PortageAIRA^^^^^L|MTH^Mother^HL70063|1488 Kaanstad Ln^^Ludington^MI^49431^USA^P|^PRN^PH^^^231^6556311ORC|RE||BQ32X38354.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90670^Pneumococcal conjugate PCV 13^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ32X38354.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90672|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P87K38365^^^AIRA-TEST^MR||GilliamAIRA^SarmisthaAIRA^Neeharika^^^^L|WestmorelandAIRA^AwstaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1934 Wldebroek Ln^^South Haven^MI^49090^USA^P||^PRN^PH^^^269^8091466|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GilliamAIRA^WestmorelandAIRA^^^^^L|MTH^Mother^HL70063|1934 Wldebroek Ln^^South Haven^MI^49090^USA^P|^PRN^PH^^^269^8091466ORC|RE||BP87K38365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90672^Influenza virus vaccine, quadrivalent, live, for intranasal use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP87K38365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90673|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F98F38373^^^AIRA-TEST^MR||PlacerAIRA^RichelleAIRA^Atara^^^^L|AllenAIRA^FelicityAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1537 Ee Marne Ave^^Waterford Township^MI^48329^USA^P||^PRN^PH^^^248^9752952|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlacerAIRA^AllenAIRA^^^^^L|MTH^Mother^HL70063|1537 Ee Marne Ave^^Waterford Township^MI^48329^USA^P|^PRN^PH^^^248^9752952ORC|RE||BF98F38373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90673^Influenza, recombinant, injectable, preservative free^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF98F38373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90674|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C21L38381^^^AIRA-TEST^MR||NordholmAIRA^AgnetaAIRA^Silvana^^^^L|JeffersonAIRA^IannaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1264 Hoensdrecht Ln^^Lapeer^MI^48446^USA^P||^PRN^PH^^^810^7814481|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|NordholmAIRA^JeffersonAIRA^^^^^L|MTH^Mother^HL70063|1264 Hoensdrecht Ln^^Lapeer^MI^48446^USA^P|^PRN^PH^^^810^7814481ORC|RE||BC21L38381.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90674^Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC21L38381.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90675|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G58E38389^^^AIRA-TEST^MR||BradyAIRA^JumokeAIRA^Ahava^^^^L|BurnetAIRA^AshritaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1580 Nangedijk Cir^^Watersmeet^MI^49969^USA^P||^PRN^PH^^^906^6505421|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BradyAIRA^BurnetAIRA^^^^^L|MTH^Mother^HL70063|1580 Nangedijk Cir^^Watersmeet^MI^49969^USA^P|^PRN^PH^^^906^6505421ORC|RE||BG58E38389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90675^rabies, intramuscular injection^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG58E38389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90676|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y95U38397^^^AIRA-TEST^MR||HoltAIRA^MyrtleAIRA^Rihanna^^^^L|HamiltonAIRA^MelisendaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1713 Hochem St^^Goodrich^MI^48438^USA^P||^PRN^PH^^^810^9742632|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HoltAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1713 Hochem St^^Goodrich^MI^48438^USA^P|^PRN^PH^^^810^9742632ORC|RE||BY95U38397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90676^rabies, intradermal injection^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY95U38397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90680|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N47S38402^^^AIRA-TEST^MR||YorkAIRA^ShaniyaAIRA^Sierra^^^^L|CherokeeAIRA^YaniraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1167 Miss Cir^^Detroit^MI^48224^USA^P||^PRN^PH^^^313^7939002|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YorkAIRA^CherokeeAIRA^^^^^L|MTH^Mother^HL70063|1167 Miss Cir^^Detroit^MI^48224^USA^P|^PRN^PH^^^313^7939002ORC|RE||BN47S38402.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90680^rotavirus, pentavalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN47S38402.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90681|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B52W38413^^^AIRA-TEST^MR||ButlerAIRA^JaylynAIRA^Celandine^^^^L|Keya PahaAIRA^ErasmaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1088 Huidplas Cir^^GR^MI^49505^USA^P||^PRN^PH^^^616^2281872|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^Keya PahaAIRA^^^^^L|MTH^Mother^HL70063|1088 Huidplas Cir^^GR^MI^49505^USA^P|^PRN^PH^^^616^2281872ORC|RE||BB52W38413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90681^rotavirus, monovalent^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB52W38413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90682|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P69Y38421^^^AIRA-TEST^MR||KnowlesAIRA^EdreaAIRA^Lisabet^^^^L|JacksonAIRA^VeronaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1807 Bederweert Ave^^Detroit^MI^48201^USA^P||^PRN^PH^^^313^8688752|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnowlesAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1807 Bederweert Ave^^Detroit^MI^48201^USA^P|^PRN^PH^^^313^8688752ORC|RE||BP69Y38421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90682^Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP69Y38421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90685|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I80T38429^^^AIRA-TEST^MR||GreggAIRA^MollieAIRA^Teresa^^^^L|MasonAIRA^LakotaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1643 Bemsmond Ave^^Carney^MI^49812^USA^P||^PRN^PH^^^906^8702521|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreggAIRA^MasonAIRA^^^^^L|MTH^Mother^HL70063|1643 Bemsmond Ave^^Carney^MI^49812^USA^P|^PRN^PH^^^906^8702521ORC|RE||BI80T38429.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90685^Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular us^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI80T38429.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90686|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F90Y38437^^^AIRA-TEST^MR||WallinAIRA^MadisonAIRA^Hope^^^^L|DanielsonAIRA^GiorgiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1931 Tranendonck Ave^^Garden^MI^49835^USA^P||^PRN^PH^^^906^2001997|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WallinAIRA^DanielsonAIRA^^^^^L|MTH^Mother^HL70063|1931 Tranendonck Ave^^Garden^MI^49835^USA^P|^PRN^PH^^^906^2001997ORC|RE||BF90Y38437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90686^Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals 3 years of age and older, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF90Y38437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90687|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G06P38445^^^AIRA-TEST^MR||HindsAIRA^AiAIRA^Queenie^^^^L|WilsonAIRA^ToralAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1582 Dlagtwedde Ave^^Dearborn Heights^MI^48125^USA^P||^PRN^PH^^^313^7604781|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HindsAIRA^WilsonAIRA^^^^^L|MTH^Mother^HL70063|1582 Dlagtwedde Ave^^Dearborn Heights^MI^48125^USA^P|^PRN^PH^^^313^7604781ORC|RE||BG06P38445.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90687^Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG06P38445.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90688|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D00D38450^^^AIRA-TEST^MR||LegresleyAIRA^RiannonAIRA^Julie^^^^L|HamiltonAIRA^MathildaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1219 Llissingen Cir^^Stambaugh^MI^49964^USA^P||^PRN^PH^^^906^9371411|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LegresleyAIRA^HamiltonAIRA^^^^^L|MTH^Mother^HL70063|1219 Llissingen Cir^^Stambaugh^MI^49964^USA^P|^PRN^PH^^^906^9371411ORC|RE||BD00D38450.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90688^Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD00D38450.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90689|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E67X38461^^^AIRA-TEST^MR||MissaukeeAIRA^DemelzaAIRA^Else^^^^L|EastlandAIRA^HanyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1411 Oeusden Cir^^Ludington^MI^49431^USA^P||^PRN^PH^^^231^5638245|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MissaukeeAIRA^EastlandAIRA^^^^^L|MTH^Mother^HL70063|1411 Oeusden Cir^^Ludington^MI^49431^USA^P|^PRN^PH^^^231^5638245ORC|RE||BE67X38461.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90689^Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE67X38461.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90690|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U31V38469^^^AIRA-TEST^MR||MarshallAIRA^SavanahAIRA^Dacia^^^^L|TillamookAIRA^SemineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1052 Wollumerland St^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^2336768|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MarshallAIRA^TillamookAIRA^^^^^L|MTH^Mother^HL70063|1052 Wollumerland St^^Belleville^MI^48112^USA^P|^PRN^PH^^^734^2336768ORC|RE||BU31V38469.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90690^typhoid, oral^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU31V38469.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90691|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F38B38477^^^AIRA-TEST^MR||JacksonAIRA^HagarAIRA^Ninon^^^^L|YorkAIRA^ColleenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1291 Senlo St^^Manistee^MI^49660^USA^P||^PRN^PH^^^231^2078554|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JacksonAIRA^YorkAIRA^^^^^L|MTH^Mother^HL70063|1291 Senlo St^^Manistee^MI^49660^USA^P|^PRN^PH^^^231^2078554ORC|RE||BF38B38477.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90691^typhoid, ViCPs^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF38B38477.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90692|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C62R38485^^^AIRA-TEST^MR||AdairAIRA^MarleneAIRA^Drisana^^^^L|DelawareAIRA^GillianAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1531 Keerhugowaard Ln^^North Street^MI^48049^USA^P||^PRN^PH^^^810^5609110|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^DelawareAIRA^^^^^L|MTH^Mother^HL70063|1531 Keerhugowaard Ln^^North Street^MI^48049^USA^P|^PRN^PH^^^810^5609110ORC|RE||BC62R38485.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90692^typhoid, parenteral^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC62R38485.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90693|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U48J38493^^^AIRA-TEST^MR||HougenAIRA^NathaniaAIRA^Lysandra^^^^L|PedersenAIRA^MedinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1625 Sudwest-Fryslan Ave^^Detroit^MI^48238^USA^P||^PRN^PH^^^313^8574529|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HougenAIRA^PedersenAIRA^^^^^L|MTH^Mother^HL70063|1625 Sudwest-Fryslan Ave^^Detroit^MI^48238^USA^P|^PRN^PH^^^313^8574529ORC|RE||BU48J38493.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90693^typhoid, parenteral, AKD (U.S. military)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU48J38493.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90696|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M08P38501^^^AIRA-TEST^MR||CastroAIRA^PendaAIRA^Thara^^^^L|TetonAIRA^MerleAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1793 Nieuwkoop Ln^^Caspian^MI^49915^USA^P||^PRN^PH^^^906^6788055|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CastroAIRA^TetonAIRA^^^^^L|MTH^Mother^HL70063|1793 Nieuwkoop Ln^^Caspian^MI^49915^USA^P|^PRN^PH^^^906^6788055ORC|RE||BM08P38501.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90696^DTaP-IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM08P38501.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90697|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O51N38506^^^AIRA-TEST^MR||TkrenAIRA^GinAIRA^Rach^^^^L|BuffaloAIRA^DinahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1054 Katoen Cir^^Chrysler Corporation^MI^48288^USA^P||^PRN^PH^^^313^4722516|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TkrenAIRA^BuffaloAIRA^^^^^L|MTH^Mother^HL70063|1054 Katoen Cir^^Chrysler Corporation^MI^48288^USA^P|^PRN^PH^^^313^4722516ORC|RE||BO51N38506.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90697^Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO51N38506.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90698|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P14D38517^^^AIRA-TEST^MR||GratiotAIRA^CarrieAIRA^Jamilah^^^^L|BoydAIRA^EchoAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1605 Dennep Ave^^Plainwell^MI^49080^USA^P||^PRN^PH^^^269^4254434|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GratiotAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1605 Dennep Ave^^Plainwell^MI^49080^USA^P|^PRN^PH^^^269^4254434ORC|RE||BP14D38517.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90698^DTaP-Hib-IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP14D38517.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90700|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R55U38525^^^AIRA-TEST^MR||KalamazooAIRA^AviceAIRA^Philana^^^^L|MercedAIRA^AshamedAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1699 Mennep Cir^^Kentwood^MI^49512^USA^P||^PRN^PH^^^616^8433282|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KalamazooAIRA^MercedAIRA^^^^^L|MTH^Mother^HL70063|1699 Mennep Cir^^Kentwood^MI^49512^USA^P|^PRN^PH^^^616^8433282ORC|RE||BR55U38525.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90700^DTaP, 5 pertussis antigens^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR55U38525.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90701|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z85G38533^^^AIRA-TEST^MR||ColumbiaAIRA^YachneAIRA^Eve^^^^L|FanninAIRA^MelbaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1868 Vverbetuwe Pl^^Total Petroleum^MI^48802^USA^P||^PRN^PH^^^989^6642898|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ColumbiaAIRA^FanninAIRA^^^^^L|MTH^Mother^HL70063|1868 Vverbetuwe Pl^^Total Petroleum^MI^48802^USA^P|^PRN^PH^^^989^6642898ORC|RE||BZ85G38533.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90701^DTP^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ85G38533.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90702|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G02Z38541^^^AIRA-TEST^MR||GreeneAIRA^KaylaAIRA^Narmada^^^^L|BoydAIRA^OlgaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1595 Square Ave^^Warren^MI^48093^USA^P||^PRN^PH^^^586^7165554|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeneAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1595 Square Ave^^Warren^MI^48093^USA^P|^PRN^PH^^^586^7165554ORC|RE||BG02Z38541.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90702^DT (pediatric)^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG02Z38541.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90703|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S38H38549^^^AIRA-TEST^MR||WalkerAIRA^MaineAIRA^Rosevear^^^^L|HoeyAIRA^OwenaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1954 Hendrik-Ido-Ambacht Ave^^Napoleon^MI^49261^USA^P||^PRN^PH^^^517^9138845|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WalkerAIRA^HoeyAIRA^^^^^L|MTH^Mother^HL70063|1954 Hendrik-Ido-Ambacht Ave^^Napoleon^MI^49261^USA^P|^PRN^PH^^^517^9138845ORC|RE||BS38H38549.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90703^tetanus toxoid, adsorbed^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS38H38549.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90704|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S35M38557^^^AIRA-TEST^MR||MontereyAIRA^YasmineAIRA^Jimena^^^^L|PerryAIRA^AbigailAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1607 Symbool Cir^^Clarklake^MI^49234^USA^P||^PRN^PH^^^517^3162942|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MontereyAIRA^PerryAIRA^^^^^L|MTH^Mother^HL70063|1607 Symbool Cir^^Clarklake^MI^49234^USA^P|^PRN^PH^^^517^3162942ORC|RE||BS35M38557.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90704^mumps^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS35M38557.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90705|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K18V38562^^^AIRA-TEST^MR||CaldwellAIRA^BrigitAIRA^Safak^^^^L|HendersonAIRA^AieshaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1267 Vint Anthonis St^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^2833827|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CaldwellAIRA^HendersonAIRA^^^^^L|MTH^Mother^HL70063|1267 Vint Anthonis St^^Fairview^MI^48621^USA^P|^PRN^PH^^^989^2833827ORC|RE||BK18V38562.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90705^measles^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK18V38562.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90706|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O92W38573^^^AIRA-TEST^MR||La PazAIRA^PippaAIRA^Maysa^^^^L|FayetteAIRA^MarlyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1861 Neerijnen Ave^^Oden^MI^49764^USA^P||^PRN^PH^^^616^2803289|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|La PazAIRA^FayetteAIRA^^^^^L|MTH^Mother^HL70063|1861 Neerijnen Ave^^Oden^MI^49764^USA^P|^PRN^PH^^^616^2803289ORC|RE||BO92W38573.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90706^rubella^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO92W38573.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90707|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y33G38581^^^AIRA-TEST^MR||HaysAIRA^SharmanAIRA^Komal^^^^L|CarsonAIRA^RukminiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1110 Duijk Cir^^Grand Rapids^MI^49512^USA^P||^PRN^PH^^^616^6622749|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaysAIRA^CarsonAIRA^^^^^L|MTH^Mother^HL70063|1110 Duijk Cir^^Grand Rapids^MI^49512^USA^P|^PRN^PH^^^616^6622749ORC|RE||BY33G38581.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90707^MMR^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY33G38581.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90708|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W49U38589^^^AIRA-TEST^MR||HaughtonAIRA^CorlissAIRA^Ema^^^^L|ShermanAIRA^NishthaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1526 Zernheze Ave^^Cooks^MI^49817^USA^P||^PRN^PH^^^906^6200402|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HaughtonAIRA^ShermanAIRA^^^^^L|MTH^Mother^HL70063|1526 Zernheze Ave^^Cooks^MI^49817^USA^P|^PRN^PH^^^906^6200402ORC|RE||BW49U38589.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90708^M/R^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW49U38589.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90710|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E91E38597^^^AIRA-TEST^MR||CusackAIRA^TatumAIRA^Avah^^^^L|LenbergAIRA^ClareAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1824 Aeiderdorp Ln^^Gm Service Parts Operations^MI^48554^USA^P||^PRN^PH^^^810^5339125|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CusackAIRA^LenbergAIRA^^^^^L|MTH^Mother^HL70063|1824 Aeiderdorp Ln^^Gm Service Parts Operations^MI^48554^USA^P|^PRN^PH^^^810^5339125ORC|RE||BE91E38597.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90710^MMRV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE91E38597.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90712|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X75D38605^^^AIRA-TEST^MR||CastroAIRA^IlsaAIRA^Arlynda^^^^L|PierceAIRA^LuciaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1804 Verkopen St^^Kimball^MI^48074^USA^P||^PRN^PH^^^810^7137109|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CastroAIRA^PierceAIRA^^^^^L|MTH^Mother^HL70063|1804 Verkopen St^^Kimball^MI^48074^USA^P|^PRN^PH^^^810^7137109ORC|RE||BX75D38605.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90712^OPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX75D38605.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90713|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R35W38610^^^AIRA-TEST^MR||SimpsonAIRA^SukutaiAIRA^Ziahon^^^^L|LouisaAIRA^AneiraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1577 Oeststellingwerf Ave^^Mulliken^MI^48861^USA^P||^PRN^PH^^^517^5003350|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SimpsonAIRA^LouisaAIRA^^^^^L|MTH^Mother^HL70063|1577 Oeststellingwerf Ave^^Mulliken^MI^48861^USA^P|^PRN^PH^^^517^5003350ORC|RE||BR35W38610.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90713^IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR35W38610.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90714|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S39G38621^^^AIRA-TEST^MR||ArmstrongAIRA^KanthaAIRA^Milena^^^^L|HoeyAIRA^SophiaAIRA^^^^^M|20040831|F||2106-3^White^CDCREC|1671 Deere Cir^^Filer City^MI^49634^USA^P||^PRN^PH^^^231^6236438|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArmstrongAIRA^HoeyAIRA^^^^^L|MTH^Mother^HL70063|1671 Deere Cir^^Filer City^MI^49634^USA^P|^PRN^PH^^^231^6236438ORC|RE||BS39G38621.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20041031||90714^typhoid, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS39G38621.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20041231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20041231||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90715|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R32V38629^^^AIRA-TEST^MR||AshtabulaAIRA^GularaAIRA^Alumit^^^^L|MacombAIRA^HerthaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1482 Budwest-Fryslan Cir^^Armada Township^MI^48005^USA^P||^PRN^PH^^^586^5127614|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AshtabulaAIRA^MacombAIRA^^^^^L|MTH^Mother^HL70063|1482 Budwest-Fryslan Cir^^Armada Township^MI^48005^USA^P|^PRN^PH^^^586^5127614ORC|RE||BR32V38629.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90715^Tdap^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR32V38629.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90716|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I66X38637^^^AIRA-TEST^MR||ShermanAIRA^ZiazanAIRA^Gwendolyn^^^^L|CameronAIRA^AlmaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1924 Ueiderland Pl^^Clinton Township^MI^48035^USA^P||^PRN^PH^^^586^3256481|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ShermanAIRA^CameronAIRA^^^^^L|MTH^Mother^HL70063|1924 Ueiderland Pl^^Clinton Township^MI^48035^USA^P|^PRN^PH^^^586^3256481ORC|RE||BI66X38637.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90716^varicella^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI66X38637.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90717|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B82C38645^^^AIRA-TEST^MR||JofrayAIRA^TieganAIRA^Dara^^^^L|NormanAIRA^MackenzieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1406 Snelheid Ave^^Otsego^MI^49078^USA^P||^PRN^PH^^^269^9861747|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JofrayAIRA^NormanAIRA^^^^^L|MTH^Mother^HL70063|1406 Snelheid Ave^^Otsego^MI^49078^USA^P|^PRN^PH^^^269^9861747ORC|RE||BB82C38645.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90717^yellow fever^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB82C38645.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90718|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A53Q38653^^^AIRA-TEST^MR||BurkeAIRA^SraddhaAIRA^Mariola^^^^L|WellsAIRA^JudithAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1487 Re Marne Pl^^Oxford^MI^48371^USA^P||^PRN^PH^^^248^9619001|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BurkeAIRA^WellsAIRA^^^^^L|MTH^Mother^HL70063|1487 Re Marne Pl^^Oxford^MI^48371^USA^P|^PRN^PH^^^248^9619001ORC|RE||BA53Q38653.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90718^Td (adult), adsorbed^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA53Q38653.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90720|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P10M38661^^^AIRA-TEST^MR||KlamathAIRA^YthaAIRA^Idonia^^^^L|RowanAIRA^HerthaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1418 Aoerdalen Cir^^Hamilton^MI^49419^USA^P||^PRN^PH^^^269^4213087|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KlamathAIRA^RowanAIRA^^^^^L|MTH^Mother^HL70063|1418 Aoerdalen Cir^^Hamilton^MI^49419^USA^P|^PRN^PH^^^269^4213087ORC|RE||BP10M38661.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90720^DTP-Hib^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP10M38661.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90721|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I66K38666^^^AIRA-TEST^MR||AdairAIRA^TanuAIRA^Lisa^^^^L|ColumbiaAIRA^VenetiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1295 Trimpenerwaard Ln^^Barryton^MI^49305^USA^P||^PRN^PH^^^989^3220831|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdairAIRA^ColumbiaAIRA^^^^^L|MTH^Mother^HL70063|1295 Trimpenerwaard Ln^^Barryton^MI^49305^USA^P|^PRN^PH^^^989^3220831ORC|RE||BI66K38666.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90721^DTaP-Hib^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI66K38666.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90723|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P36D38677^^^AIRA-TEST^MR||CalhounAIRA^IshitaAIRA^Tean^^^^L|KeokukAIRA^MalayaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1951 Cijsden-Margraten Pl^^Jackson^MI^49204^USA^P||^PRN^PH^^^517^9268749|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CalhounAIRA^KeokukAIRA^^^^^L|MTH^Mother^HL70063|1951 Cijsden-Margraten Pl^^Jackson^MI^49204^USA^P|^PRN^PH^^^517^9268749ORC|RE||BP36D38677.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90723^DTaP-Hep B-IPV^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP36D38677.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90724|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A49V38685^^^AIRA-TEST^MR||TulareAIRA^OzoraAIRA^Grace^^^^L|MetcalfeAIRA^AdelindaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1243 Dluis Pl^^Hardwood^MI^49807^USA^P||^PRN^PH^^^906^3205249|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TulareAIRA^MetcalfeAIRA^^^^^L|MTH^Mother^HL70063|1243 Dluis Pl^^Hardwood^MI^49807^USA^P|^PRN^PH^^^906^3205249ORC|RE||BA49V38685.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90724^influenza, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA49V38685.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90725|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B48R38693^^^AIRA-TEST^MR||BrooksAIRA^JaylaAIRA^Lhamu^^^^L|GalvestonAIRA^MariannaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1675 Finsum St^^Hudsonville^MI^49426^USA^P||^PRN^PH^^^616^4114218|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BrooksAIRA^GalvestonAIRA^^^^^L|MTH^Mother^HL70063|1675 Finsum St^^Hudsonville^MI^49426^USA^P|^PRN^PH^^^616^4114218ORC|RE||BB48R38693.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90725^cholera^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB48R38693.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90726|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z53S38701^^^AIRA-TEST^MR||CarterAIRA^ThaliaAIRA^Catriona^^^^L|HoggAIRA^PatriciaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1961 Muren Cir^^Saint Clair Shrs^MI^48081^USA^P||^PRN^PH^^^586^3094281|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarterAIRA^HoggAIRA^^^^^L|MTH^Mother^HL70063|1961 Muren Cir^^Saint Clair Shrs^MI^48081^USA^P|^PRN^PH^^^586^3094281ORC|RE||BZ53S38701.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90726^rabies, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ53S38701.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90727|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P10T38709^^^AIRA-TEST^MR||GreenupAIRA^XyliaAIRA^Millie^^^^L|GlennAIRA^DelphineAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1806 Aissewaard Ln^^Grand Rapids^MI^49516^USA^P||^PRN^PH^^^616^8254421|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreenupAIRA^GlennAIRA^^^^^L|MTH^Mother^HL70063|1806 Aissewaard Ln^^Grand Rapids^MI^49516^USA^P|^PRN^PH^^^616^8254421ORC|RE||BP10T38709.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90727^plague^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP10T38709.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90728|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F56P38714^^^AIRA-TEST^MR||LoupAIRA^YurikoAIRA^Guida^^^^L|LivingstonAIRA^DabaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1906 Woerdijk St^^Independence Township^MI^48348^USA^P||^PRN^PH^^^248^6410712|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LoupAIRA^LivingstonAIRA^^^^^L|MTH^Mother^HL70063|1906 Woerdijk St^^Independence Township^MI^48348^USA^P|^PRN^PH^^^248^6410712ORC|RE||BF56P38714.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90728^BCG^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF56P38714.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90730|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y96W38725^^^AIRA-TEST^MR||MerrickAIRA^NatalyAIRA^Tineka Jawana^^^^L|LindstromAIRA^LinnetAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1113 Klkmaar Ln^^Marshall^MI^49069^USA^P||^PRN^PH^^^269^8018065|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MerrickAIRA^LindstromAIRA^^^^^L|MTH^Mother^HL70063|1113 Klkmaar Ln^^Marshall^MI^49069^USA^P|^PRN^PH^^^269^8018065ORC|RE||BY96W38725.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90730^Hep A, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY96W38725.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90731|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N80V38733^^^AIRA-TEST^MR||AntrimAIRA^HelkiAIRA^Alatea^^^^L|DavisAIRA^ArvaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1969 Oijnacker-Nootdorp Cir^^Anchorville^MI^48004^USA^P||^PRN^PH^^^810^9084364|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AntrimAIRA^DavisAIRA^^^^^L|MTH^Mother^HL70063|1969 Oijnacker-Nootdorp Cir^^Anchorville^MI^48004^USA^P|^PRN^PH^^^810^9084364ORC|RE||BN80V38733.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90731^Hep B, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN80V38733.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90732|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J07M38741^^^AIRA-TEST^MR||AndersonAIRA^IoAIRA^Amalie^^^^L|HarperAIRA^PetaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1461 Plotseling Ln^^Grandville^MI^49418^USA^P||^PRN^PH^^^616^4640887|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AndersonAIRA^HarperAIRA^^^^^L|MTH^Mother^HL70063|1461 Plotseling Ln^^Grandville^MI^49418^USA^P|^PRN^PH^^^616^4640887ORC|RE||BJ07M38741.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90732^pneumococcal polysaccharide PPV23^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ07M38741.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90733|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J27O38749^^^AIRA-TEST^MR||GreeneAIRA^FaustineAIRA^Jazlynn^^^^L|IrvingAIRA^NgaioAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1006 Tidden-Delfland Cir^^Lakeview^MI^48850^USA^P||^PRN^PH^^^989^5494910|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeneAIRA^IrvingAIRA^^^^^L|MTH^Mother^HL70063|1006 Tidden-Delfland Cir^^Lakeview^MI^48850^USA^P|^PRN^PH^^^989^5494910ORC|RE||BJ27O38749.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90733^meningococcal MPSV4^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ27O38749.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90734|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M69H38757^^^AIRA-TEST^MR||AppanooseAIRA^AlishaAIRA^Nettie^^^^L|HumboldtAIRA^GauriAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1514 Keghel St^^La Salle^MI^48145^USA^P||^PRN^PH^^^734^9850129|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AppanooseAIRA^HumboldtAIRA^^^^^L|MTH^Mother^HL70063|1514 Keghel St^^La Salle^MI^48145^USA^P|^PRN^PH^^^734^9850129ORC|RE||BM69H38757.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90734^meningococcal MCV4P^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM69H38757.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90735|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D38G38762^^^AIRA-TEST^MR||HeffernanAIRA^ImaAIRA^Jillie^^^^L|BakerAIRA^RileyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1944 Festerveld Pl^^Ferrysburg^MI^49409^USA^P||^PRN^PH^^^616^8515915|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HeffernanAIRA^BakerAIRA^^^^^L|MTH^Mother^HL70063|1944 Festerveld Pl^^Ferrysburg^MI^49409^USA^P|^PRN^PH^^^616^8515915ORC|RE||BD38G38762.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90735^Japanese encephalitis SC^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD38G38762.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90736|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R97I38773^^^AIRA-TEST^MR||PlacerAIRA^LeticiaAIRA^Amari^^^^L|GraysonAIRA^AquaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1542 Zedemblik St^^Hamburg^MI^48189^USA^P||^PRN^PH^^^734^6753362|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PlacerAIRA^GraysonAIRA^^^^^L|MTH^Mother^HL70063|1542 Zedemblik St^^Hamburg^MI^48189^USA^P|^PRN^PH^^^734^6753362ORC|RE||BR97I38773.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90736^zoster^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR97I38773.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90737|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E82R38781^^^AIRA-TEST^MR||FremontAIRA^PaulaAIRA^Nagihan^^^^L|GreenlandAIRA^MaidaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1630 Jmmen St^^Adrian^MI^49221^USA^P||^PRN^PH^^^517^5682104|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FremontAIRA^GreenlandAIRA^^^^^L|MTH^Mother^HL70063|1630 Jmmen St^^Adrian^MI^49221^USA^P|^PRN^PH^^^517^5682104ORC|RE||BE82R38781.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90737^Hib, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE82R38781.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90738|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L76S38789^^^AIRA-TEST^MR||WoldAIRA^OlvaAIRA^Isabel^^^^L|SylteAIRA^KagamiAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1344 Spe Ave^^Flint^MI^48550^USA^P||^PRN^PH^^^810^2033018|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WoldAIRA^SylteAIRA^^^^^L|MTH^Mother^HL70063|1344 Spe Ave^^Flint^MI^48550^USA^P|^PRN^PH^^^810^2033018ORC|RE||BL76S38789.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90738^Japanese Encephalitis IM^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL76S38789.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90739|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J43O38797^^^AIRA-TEST^MR||PhiladelphiaAIRA^ChristmasAIRA^Milli^^^^L|AudubonAIRA^RyanAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1890 Littard-Geleen Pl^^Detroit^MI^48211^USA^P||^PRN^PH^^^313^7486670|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PhiladelphiaAIRA^AudubonAIRA^^^^^L|MTH^Mother^HL70063|1890 Littard-Geleen Pl^^Detroit^MI^48211^USA^P|^PRN^PH^^^313^7486670ORC|RE||BJ43O38797.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90739^Hepatitis B, adult dosage (2 dose schedule), for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ43O38797.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90740|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W70L38805^^^AIRA-TEST^MR||KnoxAIRA^DomingaAIRA^Vinata^^^^L|WalshAIRA^CharleenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1641 Ouidhorn Cir^^Rawsonville^MI^48197^USA^P||^PRN^PH^^^734^9242847|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KnoxAIRA^WalshAIRA^^^^^L|MTH^Mother^HL70063|1641 Ouidhorn Cir^^Rawsonville^MI^48197^USA^P|^PRN^PH^^^734^9242847ORC|RE||BW70L38805.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90740^Hep B, dialysis^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW70L38805.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90741|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E78Z38810^^^AIRA-TEST^MR||KinneyAIRA^ThomasaAIRA^Alpha^^^^L|FreestoneAIRA^CeridwenAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1723 Binterswijk Ln^^Warren^MI^48397^USA^P||^PRN^PH^^^586^8411948|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KinneyAIRA^FreestoneAIRA^^^^^L|MTH^Mother^HL70063|1723 Binterswijk Ln^^Warren^MI^48397^USA^P|^PRN^PH^^^586^8411948ORC|RE||BE78Z38810.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90741^IG, unspecified formulation^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE78Z38810.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90743|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z35C38821^^^AIRA-TEST^MR||WhartonAIRA^FredericaAIRA^Adele^^^^L|WarrenAIRA^ClaudiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1961 Srechterland Ln^^Erie^MI^48133^USA^P||^PRN^PH^^^734^6853387|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhartonAIRA^WarrenAIRA^^^^^L|MTH^Mother^HL70063|1961 Srechterland Ln^^Erie^MI^48133^USA^P|^PRN^PH^^^734^6853387ORC|RE||BZ35C38821.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90743^Hep B, adult^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BZ35C38821.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90744|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L33X38829^^^AIRA-TEST^MR||PasoAIRA^RajaAIRA^Buffy^^^^L|SomersetAIRA^MaiyaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1724 Brengen Pl^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^6999816|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PasoAIRA^SomersetAIRA^^^^^L|MTH^Mother^HL70063|1724 Brengen Pl^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^6999816ORC|RE||BL33X38829.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90744^Hep B, adolescent or pediatric^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL33X38829.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90745|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H24S38837^^^AIRA-TEST^MR||YakimaAIRA^LilahAIRA^Mesha^^^^L|WhitleyAIRA^BredaAIRA^^^^^M|20101116|F||2106-3^White^CDCREC|1420 Verbranden Cir^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^2133917|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|YakimaAIRA^WhitleyAIRA^^^^^L|MTH^Mother^HL70063|1420 Verbranden Cir^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^2133917ORC|RE||BH24S38837.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20110116||90745^Hep B, adolescent/high risk infant^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH24S38837.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20110316||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20110316||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90746|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T16A38845^^^AIRA-TEST^MR||CrawfordAIRA^NailahAIRA^Galen^^^^L|WinneshiekAIRA^CascadiaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1128 View Pl^^Shelby Township^MI^48316^USA^P||^PRN^PH^^^586^9726905|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CrawfordAIRA^WinneshiekAIRA^^^^^L|MTH^Mother^HL70063|1128 View Pl^^Shelby Township^MI^48316^USA^P|^PRN^PH^^^586^9726905ORC|RE||BT16A38845.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90746^Hep B, adult^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT16A38845.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90747|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H66R38853^^^AIRA-TEST^MR||ParasariAIRA^MargeAIRA^Cheri^^^^L|SpieccAIRA^ToakaseAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1955 Bmsterdam Pl^^Dixboro^MI^48105^USA^P||^PRN^PH^^^734^9184682|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ParasariAIRA^SpieccAIRA^^^^^L|MTH^Mother^HL70063|1955 Bmsterdam Pl^^Dixboro^MI^48105^USA^P|^PRN^PH^^^734^9184682ORC|RE||BH66R38853.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90747^Hep B, dialysis^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH66R38853.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90748|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q40A38861^^^AIRA-TEST^MR||BexarAIRA^AngeniAIRA^Winifred^^^^L|MarrietteAIRA^MarileeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1804 Elke Ave^^Detroit^MI^48211^USA^P||^PRN^PH^^^313^8182975|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BexarAIRA^MarrietteAIRA^^^^^L|MTH^Mother^HL70063|1804 Elke Ave^^Detroit^MI^48211^USA^P|^PRN^PH^^^313^8182975ORC|RE||BQ40A38861.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90748^Hib-Hep B^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ40A38861.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90750|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O59B38866^^^AIRA-TEST^MR||GreeneAIRA^BristolAIRA^Skyler^^^^L|RaumaAIRA^TrudeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1143 Mongeradeel Cir^^Howard City^MI^49329^USA^P||^PRN^PH^^^231^2212050|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GreeneAIRA^RaumaAIRA^^^^^L|MTH^Mother^HL70063|1143 Mongeradeel Cir^^Howard City^MI^49329^USA^P|^PRN^PH^^^231^2212050ORC|RE||BO59B38866.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90750^Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO59B38866.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CPT-90756|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V72N38877^^^AIRA-TEST^MR||PolkAIRA^NadezdaAIRA^Hilda^^^^L|YuurAIRA^AdrianaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1776 Rongeradeel St^^Howell^MI^48855^USA^P||^PRN^PH^^^517^9345230|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|PolkAIRA^YuurAIRA^^^^^L|MTH^Mother^HL70063|1776 Rongeradeel St^^Howell^MI^48855^USA^P|^PRN^PH^^^517^9345230ORC|RE||BV72N38877.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||90756^Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use^CPT|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV72N38877.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-117|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V31J38885^^^AIRA-TEST^MR||GrahamAIRA^CynthiaAIRA^Sitembile^^^^L|TkrenAIRA^MatildaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1747 Benterwolde St^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^7690874|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GrahamAIRA^TkrenAIRA^^^^^L|MTH^Mother^HL70063|1747 Benterwolde St^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^7690874ORC|RE||BV31J38885.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||117^VZIG (IND)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV31J38885.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-12|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U53N38893^^^AIRA-TEST^MR||WashingtonAIRA^NatividadAIRA^Hayfa^^^^L|LyonAIRA^HengAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1119 He Bilt Ln^^Ira Township^MI^48023^USA^P||^PRN^PH^^^810^8340672|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^LyonAIRA^^^^^L|MTH^Mother^HL70063|1119 He Bilt Ln^^Ira Township^MI^48023^USA^P|^PRN^PH^^^810^8340672ORC|RE||BU53N38893.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||12^diphtheria antitoxin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU53N38893.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-123|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C55B38901^^^AIRA-TEST^MR||IndianaAIRA^ValerieAIRA^Philomena^^^^L|MitchellAIRA^IsraAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1732 Warum Cir^^Gr Blanc^MI^48439^USA^P||^PRN^PH^^^810^5723095|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IndianaAIRA^MitchellAIRA^^^^^L|MTH^Mother^HL70063|1732 Warum Cir^^Gr Blanc^MI^48439^USA^P|^PRN^PH^^^810^5723095ORC|RE||BC55B38901.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||123^influenza, H5N1-1203^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BC55B38901.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-13|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T41P38909^^^AIRA-TEST^MR||MenardAIRA^KikiAIRA^Mahdi^^^^L|JohnssonAIRA^ManishaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1093 Zoevorden Ln^^Traunik^MI^49891^USA^P||^PRN^PH^^^906^6369495|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MenardAIRA^JohnssonAIRA^^^^^L|MTH^Mother^HL70063|1093 Zoevorden Ln^^Traunik^MI^49891^USA^P|^PRN^PH^^^906^6369495ORC|RE||BT41P38909.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||13^TIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BT41P38909.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-145|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H77J38917^^^AIRA-TEST^MR||MultnomahAIRA^AlizeAIRA^Algerine^^^^L|WhatcomAIRA^ConcordiaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1521 Aochem Pl^^Independence^MI^48346^USA^P||^PRN^PH^^^248^4841141|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MultnomahAIRA^WhatcomAIRA^^^^^L|MTH^Mother^HL70063|1521 Aochem Pl^^Independence^MI^48346^USA^P|^PRN^PH^^^248^4841141ORC|RE||BH77J38917.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||145^RSV-Mab (new)^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH77J38917.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-146|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J74C38922^^^AIRA-TEST^MR||KossuthAIRA^AlessandraAIRA^Immacolata^^^^L|FarrellAIRA^MidoriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1618 Jen Helder Ln^^Shelby Township^MI^48317^USA^P||^PRN^PH^^^586^6042099|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KossuthAIRA^FarrellAIRA^^^^^L|MTH^Mother^HL70063|1618 Jen Helder Ln^^Shelby Township^MI^48317^USA^P|^PRN^PH^^^586^6042099ORC|RE||BJ74C38922.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||146^DTaP,IPV,Hib,HepB^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ74C38922.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-154|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E12P38933^^^AIRA-TEST^MR||TurvoAIRA^ArizaAIRA^Patia^^^^L|UptonAIRA^BeauAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1279 Milburg Ln^^Farmington Hls^MI^48333^USA^P||^PRN^PH^^^248^9945928|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TurvoAIRA^UptonAIRA^^^^^L|MTH^Mother^HL70063|1279 Milburg Ln^^Farmington Hls^MI^48333^USA^P|^PRN^PH^^^248^9945928ORC|RE||BE12P38933.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||154^Hepatitis A immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE12P38933.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-156|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K01R38941^^^AIRA-TEST^MR||CarlisleAIRA^StellaAIRA^Sanjula^^^^L|SantiagoAIRA^TrixyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1932 Kapitein Ave^^Detroit^MI^48201^USA^P||^PRN^PH^^^313^4394036|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CarlisleAIRA^SantiagoAIRA^^^^^L|MTH^Mother^HL70063|1932 Kapitein Ave^^Detroit^MI^48201^USA^P|^PRN^PH^^^313^4394036ORC|RE||BK01R38941.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||156^Rho(D)-IG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK01R38941.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-157|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X99I38949^^^AIRA-TEST^MR||LeknesAIRA^IlenaAIRA^Zoie^^^^L|Nez PerceAIRA^ShobiAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1365 Dalfsen St^^Oxford^MI^48370^USA^P||^PRN^PH^^^248^8830654|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LeknesAIRA^Nez PerceAIRA^^^^^L|MTH^Mother^HL70063|1365 Dalfsen St^^Oxford^MI^48370^USA^P|^PRN^PH^^^248^8830654ORC|RE||BX99I38949.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||157^Rho(D) -IG IM^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX99I38949.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-159|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X04Z38957^^^AIRA-TEST^MR||CoalAIRA^JadeAIRA^Cadence^^^^L|CarrollAIRA^NerhimAIRA^^^^^M|20120704|F||2106-3^White^CDCREC|1598 Hergen Pl^^Brockway Township^MI^48097^USA^P||^PRN^PH^^^810^6241893|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoalAIRA^CarrollAIRA^^^^^L|MTH^Mother^HL70063|1598 Hergen Pl^^Brockway Township^MI^48097^USA^P|^PRN^PH^^^810^6241893ORC|RE||BX04Z38957.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20130704||159^Rho(D) Unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX04Z38957.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20130904||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20130904||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-23|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X12T38965^^^AIRA-TEST^MR||O'BrienAIRA^JennyAIRA^Chaya^^^^L|VanceAIRA^BodilAIRA^^^^^M|20180116|F||2106-3^White^CDCREC|1611 Massenaar Ave^^Ontonagon^MI^49953^USA^P||^PRN^PH^^^906^5498276|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|O'BrienAIRA^VanceAIRA^^^^^L|MTH^Mother^HL70063|1611 Massenaar Ave^^Ontonagon^MI^49953^USA^P|^PRN^PH^^^906^5498276ORC|RE||BX12T38965.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20180316||23^plague^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX12T38965.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20180516||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20180516||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-27|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U85G38970^^^AIRA-TEST^MR||GuernseyAIRA^FainaAIRA^Dido^^^^L|RoseAIRA^NavdeepAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1553 Besparen Cir^^Middleton^MI^48856^USA^P||^PRN^PH^^^989^8551996|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GuernseyAIRA^RoseAIRA^^^^^L|MTH^Mother^HL70063|1553 Besparen Cir^^Middleton^MI^48856^USA^P|^PRN^PH^^^989^8551996ORC|RE||BU85G38970.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||27^botulinum antitoxin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU85G38970.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-29|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P02Q38981^^^AIRA-TEST^MR||ArmstrongAIRA^EmaAIRA^Corinna^^^^L|SciotoAIRA^AnabellaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1419 Studie Ln^^Battle Creek^MI^49016^USA^P||^PRN^PH^^^269^7735572|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ArmstrongAIRA^SciotoAIRA^^^^^L|MTH^Mother^HL70063|1419 Studie Ln^^Battle Creek^MI^49016^USA^P|^PRN^PH^^^269^7735572ORC|RE||BP02Q38981.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||29^CMVIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP02Q38981.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-30|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G92C38989^^^AIRA-TEST^MR||WashingtonAIRA^ThoraAIRA^Elisabeth^^^^L|JacksonAIRA^CaseyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1844 Domeren Cir^^Royal Oak^MI^48073^USA^P||^PRN^PH^^^248^4200307|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1844 Domeren Cir^^Royal Oak^MI^48073^USA^P|^PRN^PH^^^248^4200307ORC|RE||BG92C38989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||30^HBIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG92C38989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-36|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q27O38997^^^AIRA-TEST^MR||TrinityAIRA^RaquelleAIRA^Vaishali^^^^L|KrogAIRA^CarlyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1096 Auren Cir^^Raisinvl Township^MI^48161^USA^P||^PRN^PH^^^734^4635476|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TrinityAIRA^KrogAIRA^^^^^L|MTH^Mother^HL70063|1096 Auren Cir^^Raisinvl Township^MI^48161^USA^P|^PRN^PH^^^734^4635476ORC|RE||BQ27O38997.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||36^VZIG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ27O38997.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-56|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D20E39005^^^AIRA-TEST^MR||LucasAIRA^VerenaAIRA^Uma^^^^L|AlbrechtsonAIRA^MansiAIRA^^^^^M|19690831|F||2106-3^White^CDCREC|1795 Lomeren Ln^^Wellston^MI^49689^USA^P||^PRN^PH^^^231^8494975|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LucasAIRA^AlbrechtsonAIRA^^^^^L|MTH^Mother^HL70063|1795 Lomeren Ln^^Wellston^MI^49689^USA^P|^PRN^PH^^^231^8494975ORC|RE||BD20E39005.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19691031||56^dengue fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD20E39005.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19691231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19691231||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-57|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V46T39013^^^AIRA-TEST^MR||BlackAIRA^LillieAIRA^Usagi^^^^L|Los AngelesAIRA^SumaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1159 Btein St^^Amway Corp^MI^49355^USA^P||^PRN^PH^^^616^3537308|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BlackAIRA^Los AngelesAIRA^^^^^L|MTH^Mother^HL70063|1159 Btein St^^Amway Corp^MI^49355^USA^P|^PRN^PH^^^616^3537308ORC|RE||BV46T39013.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||57^hantavirus^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV46T39013.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-58|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L50R39018^^^AIRA-TEST^MR||RobinsonAIRA^SumeyAIRA^Gryffyn^^^^L|SkagitAIRA^BerniaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1179 Ialten Cir^^Dixboro^MI^48105^USA^P||^PRN^PH^^^734^8122696|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|RobinsonAIRA^SkagitAIRA^^^^^L|MTH^Mother^HL70063|1179 Ialten Cir^^Dixboro^MI^48105^USA^P|^PRN^PH^^^734^8122696ORC|RE||BL50R39018.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||58^Hep C^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BL50R39018.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-59|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H70G39029^^^AIRA-TEST^MR||ComanoAIRA^AlishaAIRA^Leah^^^^L|ThrockmortonAIRA^BrittanyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1990 Ass St^^Grand Rapids^MI^49505^USA^P||^PRN^PH^^^616^6087488|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ComanoAIRA^ThrockmortonAIRA^^^^^L|MTH^Mother^HL70063|1990 Ass St^^Grand Rapids^MI^49505^USA^P|^PRN^PH^^^616^6087488ORC|RE||BH70G39029.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||59^Hep E^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BH70G39029.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-60|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J92H39037^^^AIRA-TEST^MR||CallowayAIRA^IslaAIRA^Rochelle^^^^L|VistanstAIRA^GretelAIRA^^^^^M|19690831|F||2106-3^White^CDCREC|1891 Dwenterand Cir^^Lansing^MI^48930^USA^P||^PRN^PH^^^517^9251874|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CallowayAIRA^VistanstAIRA^^^^^L|MTH^Mother^HL70063|1891 Dwenterand Cir^^Lansing^MI^48930^USA^P|^PRN^PH^^^517^9251874ORC|RE||BJ92H39037.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19691031||60^herpes simplex 2^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ92H39037.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19691231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19691231||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-61|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R33Z39045^^^AIRA-TEST^MR||HarrisonAIRA^KarishmaAIRA^Hue^^^^L|ChopeAIRA^LuvenaAIRA^^^^^M|19690831|F||2106-3^White^CDCREC|1968 Kollands Kroon Pl^^Deerfield^MI^49238^USA^P||^PRN^PH^^^517^3445047|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HarrisonAIRA^ChopeAIRA^^^^^L|MTH^Mother^HL70063|1968 Kollands Kroon Pl^^Deerfield^MI^49238^USA^P|^PRN^PH^^^517^3445047ORC|RE||BR33Z39045.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|19691031||61^HIV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR33Z39045.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|19691231||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|19691231||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-63|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B25S39053^^^AIRA-TEST^MR||CulpAIRA^DarayAIRA^Lisbeth^^^^L|JacksonAIRA^TaimaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1565 Wint Anthonis Ln^^Glennie^MI^48737^USA^P||^PRN^PH^^^989^6889834|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CulpAIRA^JacksonAIRA^^^^^L|MTH^Mother^HL70063|1565 Wint Anthonis Ln^^Glennie^MI^48737^USA^P|^PRN^PH^^^989^6889834ORC|RE||BB25S39053.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||63^Junin virus^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB25S39053.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-64|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P13B39061^^^AIRA-TEST^MR||OsageAIRA^AdrianoAIRA^Isla^^^^L|ClareAIRA^EsmeAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1056 Ferwerderadeel Ave^^Greenland^MI^49929^USA^P||^PRN^PH^^^906^7924834|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OsageAIRA^ClareAIRA^^^^^L|MTH^Mother^HL70063|1056 Ferwerderadeel Ave^^Greenland^MI^49929^USA^P|^PRN^PH^^^906^7924834ORC|RE||BP13B39061.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||64^leishmaniasis^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP13B39061.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-65|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R92F39069^^^AIRA-TEST^MR||GradyAIRA^EmberAIRA^Niral^^^^L|MontereyAIRA^BaraAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1107 Tudwest-Fryslan Ave^^Mayville^MI^48744^USA^P||^PRN^PH^^^989^9324287|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|GradyAIRA^MontereyAIRA^^^^^L|MTH^Mother^HL70063|1107 Tudwest-Fryslan Ave^^Mayville^MI^48744^USA^P|^PRN^PH^^^989^9324287ORC|RE||BR92F39069.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||65^leprosy^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR92F39069.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-67|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P98Z39074^^^AIRA-TEST^MR||WashingtonAIRA^DextraAIRA^Baako^^^^L|Bear LakeAIRA^EffyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1318 Zynaarlo Pl^^Brownstown^MI^48173^USA^P||^PRN^PH^^^734^5974637|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^Bear LakeAIRA^^^^^L|MTH^Mother^HL70063|1318 Zynaarlo Pl^^Brownstown^MI^48173^USA^P|^PRN^PH^^^734^5974637ORC|RE||BP98Z39074.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||67^malaria^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP98Z39074.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-68|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D92A39085^^^AIRA-TEST^MR||LovingAIRA^AncillaAIRA^Umeko^^^^L|OrangeAIRA^TessAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1632 KJsselstein Ave^^Moscow^MI^49257^USA^P||^PRN^PH^^^517^4071182|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|LovingAIRA^OrangeAIRA^^^^^L|MTH^Mother^HL70063|1632 KJsselstein Ave^^Moscow^MI^49257^USA^P|^PRN^PH^^^517^4071182ORC|RE||BD92A39085.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||68^melanoma^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD92A39085.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-70|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y04O39093^^^AIRA-TEST^MR||BagleyAIRA^KalareAIRA^Bailey^^^^L|SuthernsAIRA^TerriAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1091 Rantumadiel Ln^^Macomb Township^MI^48042^USA^P||^PRN^PH^^^586^5938626|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BagleyAIRA^SuthernsAIRA^^^^^L|MTH^Mother^HL70063|1091 Rantumadiel Ln^^Macomb Township^MI^48042^USA^P|^PRN^PH^^^586^5938626ORC|RE||BY04O39093.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||70^Q fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY04O39093.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-71|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P46S39101^^^AIRA-TEST^MR||ButlerAIRA^MiahAIRA^Zeitia^^^^L|PawneeAIRA^OphrahAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1614 Vooral Cir^^Wyoming^MI^49503^USA^P||^PRN^PH^^^616^3881137|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^PawneeAIRA^^^^^L|MTH^Mother^HL70063|1614 Vooral Cir^^Wyoming^MI^49503^USA^P|^PRN^PH^^^616^3881137ORC|RE||BP46S39101.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||71^RSV-IGIV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP46S39101.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-72|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D78G39109^^^AIRA-TEST^MR||CassAIRA^MercedesAIRA^Brysen^^^^L|WoodAIRA^RosettaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1298 Tijfheerenlanden Ave^^Harbor Beach^MI^48441^USA^P||^PRN^PH^^^989^2229124|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CassAIRA^WoodAIRA^^^^^L|MTH^Mother^HL70063|1298 Tijfheerenlanden Ave^^Harbor Beach^MI^48441^USA^P|^PRN^PH^^^989^2229124ORC|RE||BD78G39109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||72^rheumatic fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD78G39109.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-73|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R01N39117^^^AIRA-TEST^MR||FrioAIRA^RomaineAIRA^Tatya^^^^L|PayetteAIRA^RolandaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1217 Grote St^^Spalding^MI^49886^USA^P||^PRN^PH^^^906^2627457|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FrioAIRA^PayetteAIRA^^^^^L|MTH^Mother^HL70063|1217 Grote St^^Spalding^MI^49886^USA^P|^PRN^PH^^^906^2627457ORC|RE||BR01N39117.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||73^Rift Valley fever^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR01N39117.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-79|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I23C39122^^^AIRA-TEST^MR||MurrayAIRA^AysegalAIRA^Mirabel^^^^L|McDonaldAIRA^SibleyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1783 Oormerland Cir^^Livonia^MI^48153^USA^P||^PRN^PH^^^734^3476873|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurrayAIRA^McDonaldAIRA^^^^^L|MTH^Mother^HL70063|1783 Oormerland Cir^^Livonia^MI^48153^USA^P|^PRN^PH^^^734^3476873ORC|RE||BI23C39122.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||79^vaccinia immune globulin^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI23C39122.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-86|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I53D39133^^^AIRA-TEST^MR||MaloneAIRA^ElisaAIRA^Merrill^^^^L|ComalAIRA^MarlyAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1426 Uarlingen Ln^^Big Rapids^MI^49307^USA^P||^PRN^PH^^^231^4420155|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MaloneAIRA^ComalAIRA^^^^^L|MTH^Mother^HL70063|1426 Uarlingen Ln^^Big Rapids^MI^49307^USA^P|^PRN^PH^^^231^4420155ORC|RE||BI53D39133.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||86^IG^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI53D39133.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-87|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M33J39141^^^AIRA-TEST^MR||OntonagonAIRA^PankitaAIRA^Bernadette^^^^L|PowerAIRA^DelannaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1328 Vooral Ln^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^7877865|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OntonagonAIRA^PowerAIRA^^^^^L|MTH^Mother^HL70063|1328 Vooral Ln^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^7877865ORC|RE||BM33J39141.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||87^IGIV^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BM33J39141.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-93|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G94S39149^^^AIRA-TEST^MR||KeanyAIRA^BronnenAIRA^Myndee^^^^L|NewaygoAIRA^GracelynnAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1463 Iuren Ln^^Farmington Hls^MI^48334^USA^P||^PRN^PH^^^248^5146758|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KeanyAIRA^NewaygoAIRA^^^^^L|MTH^Mother^HL70063|1463 Iuren Ln^^Farmington Hls^MI^48334^USA^P|^PRN^PH^^^248^5146758ORC|RE||BG94S39149.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||93^RSV-MAb^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG94S39149.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-95|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D71T39157^^^AIRA-TEST^MR||MayesAIRA^RobertaAIRA^Rayma^^^^L|HayesAIRA^SakinahAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1344 Hronckhorst Ave^^Kinross^MI^49752^USA^P||^PRN^PH^^^906^3101548|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MayesAIRA^HayesAIRA^^^^^L|MTH^Mother^HL70063|1344 Hronckhorst Ave^^Kinross^MI^49752^USA^P|^PRN^PH^^^906^3101548ORC|RE||BD71T39157.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||95^TST-OT tine test^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BD71T39157.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-96|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B53S39165^^^AIRA-TEST^MR||ViergesAIRA^CarrylAIRA^Elie^^^^L|GreggAIRA^MekiaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1779 Zisterwijk Ave^^Manistee^MI^49660^USA^P||^PRN^PH^^^231^9677462|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ViergesAIRA^GreggAIRA^^^^^L|MTH^Mother^HL70063|1779 Zisterwijk Ave^^Manistee^MI^49660^USA^P|^PRN^PH^^^231^9677462ORC|RE||BB53S39165.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||96^TST-PPD intradermal^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BB53S39165.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-97|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N58X39170^^^AIRA-TEST^MR||IarrestadAIRA^JamilahAIRA^Esperanza^^^^L|ManningAIRA^TayceAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1114 Glphen-Chaam Ln^^Orion Township^MI^48359^USA^P||^PRN^PH^^^248^4359587|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|IarrestadAIRA^ManningAIRA^^^^^L|MTH^Mother^HL70063|1114 Glphen-Chaam Ln^^Orion Township^MI^48359^USA^P|^PRN^PH^^^248^4359587ORC|RE||BN58X39170.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||97^TST-PPD tine test^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN58X39170.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-98|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E13U39181^^^AIRA-TEST^MR||AdamsAIRA^ZenithAIRA^Ahuva^^^^L|WayneAIRA^JocundaAIRA^^^^^M|20100529|F||2106-3^White^CDCREC|1776 Zuidplas Cir^^Wheeler^MI^48662^USA^P||^PRN^PH^^^989^8138561|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AdamsAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1776 Zuidplas Cir^^Wheeler^MI^48662^USA^P|^PRN^PH^^^989^8138561ORC|RE||BE13U39181.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100729||98^TST, unspecified formulation^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE13U39181.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100929||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100929||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-99|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V97K39189^^^AIRA-TEST^MR||WhitakerAIRA^CatalinaAIRA^Nayeli^^^^L|San FranciscoAIRA^NickiAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1320 Lutphen Pl^^Portage^MI^49081^USA^P||^PRN^PH^^^269^7800843|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WhitakerAIRA^San FranciscoAIRA^^^^^L|MTH^Mother^HL70063|1320 Lutphen Pl^^Portage^MI^49081^USA^P|^PRN^PH^^^269^7800843ORC|RE||BV97K39189.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||99^RESERVED - do not use^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BV97K39189.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-998|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R35C39197^^^AIRA-TEST^MR||HuntingdonAIRA^ZeanesAIRA^Merisa^^^^L|ScottAIRA^ClorindaAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1546 Hotterdam Cir^^Pigeon^MI^48755^USA^P||^PRN^PH^^^989^4857875|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HuntingdonAIRA^ScottAIRA^^^^^L|MTH^Mother^HL70063|1546 Hotterdam Cir^^Pigeon^MI^48755^USA^P|^PRN^PH^^^989^4857875ORC|RE||BR35C39197.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||998^no vaccine administered^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR35C39197.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|eNR-CV-CVX-999|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N86F39205^^^AIRA-TEST^MR||WashitaAIRA^SolosoloAIRA^Damiana^^^^L|BoydAIRA^KyokoAIRA^^^^^M|20100127|F||2106-3^White^CDCREC|1318 Vergeijk Pl^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^7224250|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashitaAIRA^BoydAIRA^^^^^L|MTH^Mother^HL70063|1318 Vergeijk Pl^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^7224250ORC|RE||BN86F39205.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20100327||999^unknown^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN86F39205.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20100527||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20100527||||||FMSH|^~\&|||||20200307140619-0400||VXU^V04^VXU_V04|TWF-DE.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U11Q39537^^^AIRA-TEST^MR||CassAIRA^MarisaAIRA^Marinna^^^^L|HuntingdonAIRA^SwarupaAIRA^^^^^M|20160106|F||2106-3^White^CDCREC|1093 Zoggenland Ln^^Harrisville^MI^48740^USA^P||^PRN^PH^^^989^3235573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307NK1|1|CassAIRA^HuntingdonAIRA^^^^^L|MTH^Mother^HL70063|1093 Zoggenland Ln^^Harrisville^MI^48740^USA^P|^PRN^PH^^^989^3235573ORC|RE||BU11Q39537.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200106||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AMSH|^~\&|||||20200307140619-0400||VXU^V04^VXU_V04|TWF-DE.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U11Q39537^^^AIRA-TEST^MR||CassAIRA^MarisaAIRA^Marinna^^^^L|HuntingdonAIRA^SwarupaAIRA^^^^^M|20160106|F||2106-3^White^CDCREC|1093 Zoggenland Ln^^Harrisville^MI^48740^USA^P||^PRN^PH^^^989^3235573|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200307|20200307NK1|1|CassAIRA^HuntingdonAIRA^^^^^L|MTH^Mother^HL70063|1093 Zoggenland Ln^^Harrisville^MI^48740^USA^P|^PRN^PH^^^989^3235573ORC|RE||BU11Q39537.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200106||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AMSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M54X159.F9^^^AIRA-TEST^MR||ElliottAIRA^SteffieAIRA^Libby^^^^L|OrangeAIRA^MadelynnAIRA^^^^^M|20210309|F||2106-3^White^CDCREC|1641 Leeze-Leende Ln^^River Rouge^MI^48218^USA^P||^PRN^PH^^^313^9612384|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ElliottAIRA^MadelynnAIRA^^^^^L|MTH^Mother^HL70063|1641 Leeze-Leende Ln^^River Rouge^MI^48218^USA^P|^PRN^PH^^^313^9612384|ORC|RE||D26X20401.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0116|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||O60W161.Fe^^^AIRA-TEST^MR||SimpsonAIRA^AngeniAIRA^Luna^^^^L|AntelopeAIRA^SamicahAIRA^^^^^M|20210309|F||2028-9^Asian^CDCREC|1428 Reusel-De Mierden Pl^^Washingtn Township^MI^48094^USA^P||^PRN^PH^^^586^6231533|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SimpsonAIRA^SamicahAIRA^^^^^L|MTH^Mother^HL70063|1428 Reusel-De Mierden Pl^^Washingtn Township^MI^48094^USA^P|^PRN^PH^^^586^6231533|ORC|RE||B08N20408.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0117|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J33O163.Fj^^^AIRA-TEST^MR||JungstroinAIRA^SlevinAIRA^F^^^^L|MonroeAIRA^ToinetteAIRA^^^^^M|DOB|M||2106-3^White^CDCREC|1451 Oengelo St^^Woodhaven^MI^48183^USA^P||^PRN^PH^^^734^7163816|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|Van WertAIRA^ToinetteAIRA^^^^^L|MTH^Mother^HL70063|1451 Oengelo St^^Woodhaven^MI^48183^USA^P|^PRN^PH^^^734^7163816|ORC|RE||P89V20415.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0118|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||V24C165.Fn^^^AIRA-TEST^MR||HoughtonAIRA^HesterAIRA^Zhalore^^^^L|EstillAIRA^XenobiaAIRA^^^^^M||F||2106-3^White^CDCREC|1706 Zalkenswaard Cir^^Bloomingdale^MI^49026^USA^P||^PRN^PH^^^269^4913477|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HoughtonAIRA^XenobiaAIRA^^^^^L|MTH^Mother^HL70063|1706 Zalkenswaard Cir^^Bloomingdale^MI^49026^USA^P|^PRN^PH^^^269^4913477|ORC|RE||M56Z20421.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0120|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G53V169.Fw^^^AIRA-TEST^MR||MarionAIRA^MumtazAIRA^Walker^^^^L|SwisherAIRA^TokikoAIRA^^^^^M|18950115|M||2106-3^White^CDCREC|1158 Hlagtwedde St^^Brownstown Township^MI^48164^USA^P||^PRN^PH^^^734^2704005|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SwisherAIRA^TokikoAIRA^^^^^L|MTH^Mother^HL70063|1158 Hlagtwedde St^^Brownstown Township^MI^48164^USA^P|^PRN^PH^^^734^2704005|ORC|RE||B01O20426.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0129|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U46E197.GD^^^AIRA-TEST^MR||MorrisAIRA^AlisaAIRA^Agneta^^^^L|BradyAIRA^AphroditeAIRA^^^^^M|20160313|F||2054-5^Black or African-American^CDCREC|1426 Bos St^^Flint^MI^48507^USA^P||^PRN^PH^^^810^4561839|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||19500101|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|DickinsonAIRA^AphroditeAIRA^^^^^L|MTH^Mother^HL70063|1426 Bos St^^Flint^MI^48507^USA^P|^PRN^PH^^^810^4561839|ORC|RE||Z83Q20431.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0130|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D35Z199.GI^^^AIRA-TEST^MR||FranklinAIRA^LaraAIRA^Jin^^^^L|SterlingAIRA^AshleeAIRA^^^^^M|20160322|F||2106-3^White^CDCREC|1254 Wssen Ave^^Watton^MI^49970^USA^P||^PRN^PH^^^906^4588152|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20210309|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|FranklinAIRA^AshleeAIRA^^^^^L|MTH^Mother^HL70063|1254 Wssen Ave^^Watton^MI^49970^USA^P|^PRN^PH^^^906^4588152|ORC|RE||N13V20438.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0131|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X40U201.GN^^^AIRA-TEST^MR||HarrisAIRA^MasaAIRA^Novyanna^^^^L|HamiltonAIRA^UlvaAIRA^^^^^M|20160305|F||1002-5^American Indian or Alaska Native^CDCREC|1069 Etten-Leur Pl^^Grand Blanc^MI^48439^USA^P||^PRN^PH^^^810^8787512|||||||||2135-2^Hispanic or Latino^CDCREC|||||||Y|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HarrisAIRA^UlvaAIRA^^^^^L|MTH^Mother^HL70063|1069 Etten-Leur Pl^^Grand Blanc^MI^48439^USA^P|^PRN^PH^^^810^8787512|ORC|RE||E03E20445.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0133|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||F53L205.GX^^^AIRA-TEST^MR||SuthernsAIRA^ZosimaAIRA^Verona^^^^L|MaderaAIRA^MorvenAIRA^^^^^M|20160229|F||2106-3^White^CDCREC|1514 Ueesp Pl^^Onsted^MI^49265^USA^P||^PRN^PH^^^517^9585619|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20200309|N|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SuthernsAIRA^MorvenAIRA^^^^^L|MTH^Mother^HL70063|1514 Ueesp Pl^^Onsted^MI^49265^USA^P|^PRN^PH^^^517^9585619|ORC|RE||M90O20451.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0139|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S74P217.Hs^^^AIRA-TEST^MR||SwiftAIRA^OberonAIRA^M^^^^L|PayetteAIRA^ParkerAIRA^^^^^M|20160309|M||2054-5^Black or African-American^CDCREC|1869 Haasdriel Ln^^Williamsburg^MI^49690^USA^P||^PRN^PH^^^231^7939772|||||||||105 E Market St^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|EdmonsonAIRA^ParkerAIRA^^^^^L|MTH^Mother^HL70063|1869 Haasdriel Ln^^Williamsburg^MI^49690^USA^P|^PRN^PH^^^231^7939772|ORC|RE||M13R20457.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0140|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H94H275.JF^^^AIRA-TEST^MR||ComancheAIRA^Apt #5^Golding^^^^L|CharlevoixAIRA^OhannaAIRA^^^^^M|20160306|M||2106-3^White^CDCREC|1662 Vermenigvuldigen Cir^^Farmington Hills^MI^48335^USA^P||^PRN^PH^^^248^8541232|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CarterAIRA^OhannaAIRA^^^^^L|MTH^Mother^HL70063|1662 Vermenigvuldigen Cir^^Farmington Hills^MI^48335^USA^P|^PRN^PH^^^248^8541232|ORC|RE||D57S20461.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0141|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||P48F277.JK^^^AIRA-TEST^MR||HarlanAIRA^^Raul^^^^L|LincolnAIRA^AdrienneAIRA^^^^^M|20160314|M||2106-3^White^CDCREC|1786 Werwerderadeel Ave^^Berlin Township^MI^48002^USA^P||^PRN^PH^^^810^4744490|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HarlanAIRA^AdrienneAIRA^^^^^L|MTH^Mother^HL70063|1786 Werwerderadeel Ave^^Berlin Township^MI^48002^USA^P|^PRN^PH^^^810^4744490|ORC|RE||V54U20467.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0146|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z52G225.HJ^^^AIRA-TEST^MR||NordstromAIRA^HardikAIRA^Xurxo^^^^L|WayneAIRA^AdoraAIRA^^^^^M|20160322|||2106-3^White^CDCREC|1487 Giekerkerhoek Ave^^Hiawatha Temp Correction Fac^MI^49786^USA^P||^PRN^PH^^^906^8530051|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|NordstromAIRA^AdoraAIRA^^^^^L|MTH^Mother^HL70063|1487 Giekerkerhoek Ave^^Hiawatha Temp Correction Fac^MI^49786^USA^P|^PRN^PH^^^906^8530051|ORC|RE||L09Z20473.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0147|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0147^^^AIRA-TEST^MR||NewportAIRA^KirstenAIRA^Ilisapesi^^^^L|BowieAIRA^MayrahAIRA^^^^^M|20160302|A||1002-5^American Indian or Alaska Native^CDCREC|1226 Loekel Cir^^Saginaw^MI^48602^USA^P||^PRN^PH^^^989^5535018|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|NewportAIRA^MayrahAIRA^^^^^L|MTH^Mother^HL70063|1226 Loekel Cir^^Saginaw^MI^48602^USA^P|^PRN^PH^^^989^5535018|ORC|RE||V42V20478.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0165|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W31G281.JV^^^AIRA-TEST^MR||Apt #5^DelilahAIRA^Mahdi^^^^L|LincolnAIRA^GiannaAIRA^^^^^M|20160229|F||2054-5^Black or African-American^CDCREC|1462 Land Ln^^Grand Rapids^MI^49508^USA^P||^PRN^PH^^^616^8621231|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MartinsonAIRA^GiannaAIRA^^^^^L|MTH^Mother^HL70063|1462 Land Ln^^Grand Rapids^MI^49508^USA^P|^PRN^PH^^^616^8621231|ORC|RE||M31E20483.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0166|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Q04A283.K0^^^AIRA-TEST^MR||^MarijanAIRA^Cullen^^^^L|HancockAIRA^KeikoAIRA^^^^^M|20160226|M||2028-9^Asian^CDCREC|1570 Moeten Pl^^Brownstown^MI^48174^USA^P||^PRN^PH^^^734^3768380|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|PerryAIRA^KeikoAIRA^^^^^L|MTH^Mother^HL70063|1570 Moeten Pl^^Brownstown^MI^48174^USA^P|^PRN^PH^^^734^3768380|ORC|RE||H91F20488.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0200|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J04J371.Nn^^^AIRA-TEST^MR||ErieAIRA^JosieAIRA^Stefanie^^^^L|WilliamsAIRA^JaimieAIRA^^^^^M|20160229|F||2054-5^Black or African-American^CDCREC|1358 Tmsterdam Cir^^Spruce^MI^48762^USA^P||^PRN^PH^^^989^2163668|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|Y|20160229|||A|20200309|20200309|NK1|1|WhatcomAIRA^JaimieAIRA^^^^^L|MTH^Mother^HL70063|1358 Tmsterdam Cir^^Spruce^MI^48762^USA^P|^PRN^PH^^^989^2163668|ORC|RE||R55V20495.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0220|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||^^^^||ClarkAIRA^LaniAIRA^Graham^^^^L|WashingtonAIRA^FilbertaAIRA^^^^^M|20160315|M||2106-3^White^CDCREC|1431 Derkelland St^^Grayling^MI^49739^USA^P||^PRN^PH^^^989^2897235|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MaverickAIRA^FilbertaAIRA^^^^^L|MTH^Mother^HL70063|1431 Derkelland St^^Grayling^MI^49739^USA^P|^PRN^PH^^^989^2897235|ORC|RE||B68W20501.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0244|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W67K473.Rp^^^AIRA-TEST^MR||BelmontAIRA^LaurenceAIRA^S^^^^L|HarlanAIRA^KaiaAIRA^^^^^M|20160305|M||2106-3^White^CDCREC|1512 Nenterwolde Cir^^Saginaw^MI^48607^USA^P||^PRN^PH^^^989^4109712|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|BelmontAIRA^KaiaAIRA^^^^^L|MTH^Mother^HL70063|1512 Nenterwolde Cir^^Saginaw^MI^48607^USA^P|^PRN^PH^^^989^4109712|ORC|RE||H82X20511.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082732-0600||VXU^V04^VXU_V04|dzl-DQMQE0247|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R20T481.RH^^^AIRA-TEST^MR||ChelanAIRA^DarienAIRA^Sheridon^^^^L|ParkesAIRA^PippaAIRA^^^^^M|20160318|M||2106-3^White^CDCREC|1130 Salkenburg aan de Geul St^^Troy^MI^48099^USA^P||^PRN^PH^^^248^2119252|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ChelanAIRA^PippaAIRA^^^^^L|MTH^Mother^HL70063|1130 Salkenburg aan de Geul St^^Troy^MI^48099^USA^P|^PRN^PH^^^248^2119252|ORC|RE||Q33U20519.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||PCV^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0252|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T94A495.Sd^^^AIRA-TEST^MR||FayetteAIRA^RosalineAIRA^^^^^L|OsbornAIRA^PrudenceAIRA^^^^^M|20160303|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1177 Rrimpenerwaard Pl^^Royal Oak^MI^48073^USA^P||^PRN^PH^^^248^2389772|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|FayetteAIRA^PrudenceAIRA^^^^^L|MTH^Mother^HL70063|1177 Rrimpenerwaard Pl^^Royal Oak^MI^48073^USA^P|^PRN^PH^^^248^2389772|ORC|RE||L40E20525.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20210309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0253|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X42O497.Sh^^^AIRA-TEST^MR||KeithAIRA^CostardAIRA^Jed^^^^L|SivertsenAIRA^ErmaAIRA^^^^^M|20160303|M||2028-9^Asian^CDCREC|1697 Oloemendaal Ave^^Dollar Bay^MI^49922^USA^P||^PRN^PH^^^906^6364369|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20160303|Y|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KeithAIRA^ErmaAIRA^^^^^L|MTH^Mother^HL70063|1697 Oloemendaal Ave^^Dollar Bay^MI^49922^USA^P|^PRN^PH^^^906^6364369|ORC|RE||Q78M20531.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0255|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B61W501.Sq^^^AIRA-TEST^MR||MadisonAIRA^TommyAIRA^Zeroun^^^^L|ChoctawAIRA^CornelianAIRA^^^^^M|20160306|M||1002-5^American Indian or Alaska Native^CDCREC|1094 Maasgouw St^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^8566943|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ChoctawAIRA^CornelianAIRA^^^^^L|MTH^Mother^HL70063|1094 Maasgouw St^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^8566943|ORC|RE||F63X20536.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|19700101||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0257|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W32P505.SA^^^AIRA-TEST^MR||ComancheAIRA^RandyAIRA^Azzan^^^^L|PittsburgAIRA^KieraAIRA^^^^^M|20160310|M||2106-3^White^CDCREC|1094 Doxtel St^^Houghton Lake Heights^MI^48630^USA^P||^PRN^PH^^^989^6252575|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ComancheAIRA^KieraAIRA^^^^^L|MTH^Mother^HL70063|1094 Doxtel St^^Houghton Lake Heights^MI^48630^USA^P|^PRN^PH^^^989^6252575|ORC|RE||A31P20542.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||01^DTP^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0260|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M88P511.SS^^^AIRA-TEST^MR||CanadianAIRA^ClayAIRA^C^^^^L|KennebecAIRA^NualaAIRA^^^^^M|20160320|M||2106-3^White^CDCREC|1401 Atrechtse Heuvelrug St^^Chrysler Corporation^MI^48288^USA^P||^PRN^PH^^^313^6829802|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|GalliaAIRA^NualaAIRA^^^^^L|MTH^Mother^HL70063|1401 Atrechtse Heuvelrug St^^Chrysler Corporation^MI^48288^USA^P|^PRN^PH^^^313^6829802|ORC|RE||R45T20547.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|MMR||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0261|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R28X513.SX^^^AIRA-TEST^MR||BrennanAIRA^GomerAIRA^E^^^^L|BergenAIRA^MarnyAIRA^^^^^M|20160304|M||2106-3^White^CDCREC|1798 Woorn Ave^^Sears^MI^49679^USA^P||^PRN^PH^^^231^5024345|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|BrennanAIRA^MarnyAIRA^^^^^L|MTH^Mother^HL70063|1798 Woorn Ave^^Sears^MI^49679^USA^P|^PRN^PH^^^231^5024345|ORC|RE||Y24W20551.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0289|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J69F577.Vw^^^AIRA-TEST^MR||SabineAIRA^GithaAIRA^Clotilda^^^^L|McCullochAIRA^ZoeyAIRA^^^^^M|20160325|F||2054-5^Black or African-American^CDCREC|1449 Bidderkerk Pl^^Mass City^MI^49948^USA^P||^PRN^PH^^^906^8666627|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SabineAIRA^ZoeyAIRA^^^^^L|MTH^Mother^HL70063|1449 Bidderkerk Pl^^Mass City^MI^49948^USA^P|^PRN^PH^^^906^8666627|ORC|RE||J43J20555.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||MMR|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0308|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S70D621.XE^^^AIRA-TEST^MR||JernneAIRA^MissyAIRA^Kimberley^^^^L|LindAIRA^EleanorAIRA^^^^^M|20160325|F||2106-3^White^CDCREC|1398 Oinsum St^^Dearborn^MI^48121^USA^P||^PRN^PH^^^313^5601736|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|LindAIRA^EleanorAIRA^^^^^L|MTH^Mother^HL70063|1398 Oinsum St^^Dearborn^MI^48121^USA^P|^PRN^PH^^^313^5601736|ORC|RE||G79I20558.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0310|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0310^^^AIRA-TEST^MR||Bear LakeAIRA^AlexaviaAIRA^Win^^^^L|WyomingAIRA^GalenAIRA^^^^^M|20160312|F||2106-3^White^CDCREC|1057 Thuis St^^Rochester Hills^MI^48307^USA^P||^PRN^PH^^^248^5631190|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WyomingAIRA^GalenAIRA^^^^^L|MTH^Mother^HL70063|1057 Thuis St^^Rochester Hills^MI^48307^USA^P|^PRN^PH^^^248^5631190|ORC|RE||J32X20562.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX^90744^HepB^C4|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0314|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G28E635.Yp^^^AIRA-TEST^MR||MartinAIRA^NarelleAIRA^A^^^^L|ElkAIRA^ThyrrniAIRA^^^^^M|20160307|F||2106-3^White^CDCREC|1785 Kchijndel St^^Atlanta^MI^49709^USA^P||^PRN^PH^^^989^6560978|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MartinAIRA^ThyrrniAIRA^^^^^L|MTH^Mother^HL70063|1785 Kchijndel St^^Atlanta^MI^49709^USA^P|^PRN^PH^^^989^6560978|ORC|RE||Y80N20567.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0332|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G93C691.11h^^^AIRA-TEST^MR||SenecaAIRA^MakenaAIRA^Cornelian^^^^L|PowellAIRA^MornaAIRA^^^^^M|20160308|F||1002-5^American Indian or Alaska Native^CDCREC|1904 Kerkrade St^^Keego Harbor^MI^48320^USA^P||^PRN^PH^^^248^5739874|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|PowellAIRA^MornaAIRA^^^^^L|MTH^Mother^HL70063|1904 Kerkrade St^^Keego Harbor^MI^48320^USA^P|^PRN^PH^^^248^5739874|ORC|RE||R43O20571.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0333|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0333^^^AIRA-TEST^MR||DickinsonAIRA^JaxsonAIRA^I^^^^L|KnoxAIRA^AlumaAIRA^^^^^M|20160318|M||2054-5^Black or African-American^CDCREC|1606 Tnschede Pl^^Cement City^MI^49233^USA^P||^PRN^PH^^^517^8720281|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|DickinsonAIRA^AlumaAIRA^^^^^L|MTH^Mother^HL70063|1606 Tnschede Pl^^Cement City^MI^49233^USA^P|^PRN^PH^^^517^8720281|ORC|RE||D50V20575.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||LA^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0359|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0359^^^AIRA-TEST^MR||MaricopaAIRA^MaggieAIRA^S^^^^L|SanduskyAIRA^CamilleAIRA^^^^^M|20160311|F||2106-3^White^CDCREC|1154 Zeggen Ave^^Lake Leelanau^MI^49653^USA^P||^PRN^PH^^^231^3692522|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MaricopaAIRA^CamilleAIRA^^^^^L|MTH^Mother^HL70063|1154 Zeggen Ave^^Lake Leelanau^MI^49653^USA^P|^PRN^PH^^^231^3692522|ORC|RE||R62W20579.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|00^Parental Decision||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0366|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H21Y803.16n^^^AIRA-TEST^MR||HoreAIRA^HaralAIRA^Krischnan^^^^L|RiversideAIRA^JobeyAIRA^^^^^M|20160310|M||2106-3^White^CDCREC|1552 Doetinchem Pl^^Ann Arbor^MI^48113^USA^P||^PRN^PH^^^734^8645182|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HoreAIRA^JobeyAIRA^^^^^L|MTH^Mother^HL70063|1552 Doetinchem Pl^^Ann Arbor^MI^48113^USA^P|^PRN^PH^^^734^8645182|ORC|RE||D13C20583.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|Harvey|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0467|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R47H655.Zy^^^AIRA-TEST^MR||BakerAIRA^FilipinaAIRA^Emogen^^^^L|BakerAIRA^OlgaAIRA^^^^^M|20160311|F||2106-3^White^CDCREC|1636 Baasdriel St^^Flint^MI^48531^USA^P||^PRN^PH^^^810^9730076|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KennebecAIRA^OlgaAIRA^^^^^L|MTH^Mother^HL70063|1636 Baasdriel St^^Flint^MI^48531^USA^P|^PRN^PH^^^810^9730076|ORC|RE||Y38V20587.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V00^VFC eligibility unknown^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0468|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B17L657.ZF^^^AIRA-TEST^MR||WaschingAIRA^AnarAIRA^P^^^^L|RaumaAIRA^SashenkaAIRA^^^^^M|20160307|F||2106-3^White^CDCREC|1505 Leurne Cir^^Bham^MI^48012^USA^P||^PRN^PH^^^248^5292504|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WaschingAIRA^SashenkaAIRA^^^^^L|MTH^Mother^HL70063|1505 Leurne Cir^^Bham^MI^48012^USA^P|^PRN^PH^^^248^5292504|ORC|RE||Q55C20591.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|^^||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0469|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C67P659.ZM^^^AIRA-TEST^MR||McErlaneAIRA^LilianAIRA^Yona^^^^L|ClaytonAIRA^AllissonAIRA^^^^^M|20160310|F||2106-3^White^CDCREC|1686 Na en Hunze Ave^^Moscow^MI^49257^USA^P||^PRN^PH^^^517^2425050|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ClaytonAIRA^AllissonAIRA^^^^^L|MTH^Mother^HL70063|1686 Na en Hunze Ave^^Moscow^MI^49257^USA^P|^PRN^PH^^^517^2425050|ORC|RE||D10W20595.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|ZZZ01^VFC Eligible^||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0491|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M25G471.Rl^^^AIRA-TEST^MR||HemphillAIRA^HeleneAIRA^M^^^^L|HarrisAIRA^CameoAIRA^^^^^M|20160321|F||2106-3^White^CDCREC|1961 Ke Marne Ave^^Alger^MI^48610^USA^P||^PRN^PH^^^989^6599036|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MetcalfeAIRA^CameoAIRA^^^^^L|MTH^Mother^HL70063|1961 Ke Marne Ave^^Alger^MI^48610^USA^P|^PRN^PH^^^989^6599036|ORC|RE||Q07A20599.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||01^DTP^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0493|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X66Y771.152^^^AIRA-TEST^MR||AnderssonAIRA^GythaAIRA^Anastasia^^^^L|PasoAIRA^JaninaAIRA^^^^^M|20160228|F||2106-3^White^CDCREC|1164 Seere Ln^^Fremont^MI^49413^USA^P||^PRN^PH^^^231^2484814|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|AnderssonAIRA^JaninaAIRA^^^^^L|MTH^Mother^HL70063|1164 Seere Ln^^Fremont^MI^49413^USA^P|^PRN^PH^^^231^2484814|ORC|RE||K52N20603.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||02^OPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||WAL^Wyeth^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0058|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C64I5.v1^^^AIRA-TEST^MR||HarrisonAIRA^RaphaelAIRA^Abhijit^^^^L|MarionAIRA^VioletAIRA^^^^^M|20160306|M||2106-3^White^CDCREC|1699 Oudewater Ave^^Lansing^MI^48918^USA^P||^PRN^PH^^^517^9462404|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HarrisonAIRA^VioletAIRA^^^^^L|MTH^Mother^HL70063|1699 Oudewater Ave^^ANYTOWN^MI^48918^USA^P|^PRN^PH^^^517^9462404|ORC|RE||G17K20607.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0064|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J61Y17.w7^^^AIRA-TEST^MR||KayAIRA^KarolinaAIRA^Poonam^^^^L|HarneyAIRA^LilianaAIRA^^^^^M|20160315|F||2028-9^Asian^CDCREC|1611 Otrijen Ln^^Saginaw^MI^48605^USA^P||^PRN^PH^^^989^7001611|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|PurolaAIRA^LilianaAIRA^^^^^L|MTH^Mother^HL70063|1611 Otrijen Ln^^Saginaw^MI^48605^SOMETHING^P|^PRN^PH^^^989^7001611|ORC|RE||Z37N20610.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0074|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z62I37.y7^^^AIRA-TEST^MR||LackawannaAIRA^RoisAIRA^Mattie^^^^L|LyonAIRA^FloyAIRA^^^^^M|20160311|F||2106-3^White^CDCREC|1754 Wynaarlo Pl^^Midland Hospital Center^MI^48670^USA^P||^PRN^PH^^^989^2105352|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SaginawAIRA^FloyAIRA^^^^^L|MTH^Mother^HL70063|1754 Wynaarlo Pl^^Midland Hospital Center^Mass^48670^USA^P|^PRN^PH^^^989^2105352|ORC|RE||Z53E20614.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0077|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X84L55.z2^^^AIRA-TEST^MR||MonoAIRA^VedangaAIRA^Vamana^^^^L|WintermanAIRA^DominicaAIRA^^^^^M|20160311|M||1002-5^American Indian or Alaska Native^CDCREC|1886 Raarle-Nassau Ln^^Burr Oak^MI^49030^USA^P||^PRN^PH^^^269^5255098|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MonoAIRA^DominicaAIRA^^^^^L|MTH^Mother^HL70063|1886 Raarle-Nassau Ln^^Burr Oak^MI^9o21o^USA^P|^PRN^PH^^^269^5255098|ORC|RE||R26S20619.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0079|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S25P59.zk^^^AIRA-TEST^MR||O NeillAIRA^HartwinAIRA^Niraj^^^^L|FreestoneAIRA^PreciousAIRA^^^^^M|20160316|M||2106-3^White^CDCREC|1310 Onze Ave^^Belleville^MI^48111^USA^P||^PRN^PH^^^734^2962427|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|^^^^^^L|MTH^Mother^HL70063|1310 Onze Ave^^Belleville^MI^48111^USA^P|^PRN^PH^^^734^2962427|ORC|RE||Y14X20623.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0080|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D98X61.zr^^^AIRA-TEST^MR||HindsAIRA^ZdenkaAIRA^R^^^^L|DaviessAIRA^RebeccaAIRA^^^^^M|20160320|F||2106-3^White^CDCREC|1675 Berg Ave^^Saint Clr Shores^MI^48082^USA^P||^PRN^PH^^^586^9887106|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HindsAIRA^^^^^^L|MTH^Mother^HL70063|1675 Berg Ave^^Saint Clr Shores^MI^48082^USA^P|^PRN^PH^^^586^9887106|ORC|RE||I08C20627.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082733-0600||VXU^V04^VXU_V04|dzl-DQMQE0081|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T90Z63.zy^^^AIRA-TEST^MR||WorthAIRA^BrooklynnAIRA^Malu^^^^L|TehamaAIRA^TryphenaAIRA^^^^^M|20160225|F||2106-3^White^CDCREC|1081 Weverwijk Ln^^Sault S Marie^MI^49785^USA^P||^PRN^PH^^^906^5624321|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|^TryphenaAIRA^^^^^L|MTH^Mother^HL70063|1081 Weverwijk Ln^^Sault S Marie^MI^49785^USA^P|^PRN^PH^^^906^5624321|ORC|RE||V21M20630.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0082|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D04T65.zE^^^AIRA-TEST^MR||CassAIRA^RussellAIRA^Gilmer^^^^L|ProvidenceAIRA^DristiAIRA^^^^^M|20160318|M||2131-1^Other Race^CDCREC|1539 Arimpenerwaard St^^Rockford^MI^49341^USA^P||^PRN^PH^^^616^8532773|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CassAIRA^DristiAIRA^^^^^L|MTH^Mother^HL70063|1539 Arimpenerwaard St^^Rockford^MI^49341^USA^P|^PRN^PH^^^^8532773|ORC|RE||J28V20634.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0083|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y92P67.zM^^^AIRA-TEST^MR||WayneAIRA^AckleyAIRA^Jesus^^^^L|BraceyAIRA^YdelAIRA^^^^^M|20160313|M||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1031 Westland Pl^^Commerce^MI^48390^USA^P||^PRN^PH^^^248^5989346|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|BraceyAIRA^YdelAIRA^^^^^L|MTH^Mother^HL70063|1031 Westland Pl^^Commerce^MI^48390^USA^P|^PRN^PH^^^APPLE GATE^5989346|ORC|RE||T41K20639.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0088|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C89F77.Ak^^^AIRA-TEST^MR||LinnAIRA^UtaAIRA^^^^^L|San JuanAIRA^AmazoniaAIRA^^^^^M|20160310|F||2054-5^Black or African-American^CDCREC|1584 Trein Pl^^Michigan Center^MI^49254^USA^P||^PRN^PH^^^517^9143641|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|LinnAIRA^AmazoniaAIRA^^^^^L|^^|1584 Trein Pl^^Michigan Center^MI^49254^USA^P|^PRN^PH^^^517^9143641|ORC|RE||I38T20643.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0090|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M29F83.AE^^^AIRA-TEST^MR||LyonAIRA^PhoenixAIRA^Zarek^^^^L|LyonAIRA^DeieneAIRA^^^^^M|20160229|M||2131-1^Other Race^CDCREC|1452 Noevorden Pl^^Kincheloe^MI^49784^USA^P||^PRN^PH^^^906^4225727|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CamasAIRA^DeieneAIRA^^^^^L|DS^Dog Sitter^HL70063|1452 Noevorden Pl^^Kincheloe^MI^49784^USA^P|^PRN^PH^^^906^4225727|ORC|RE||K53O20647.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0099|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W11G115.CT^^^AIRA-TEST^MR||DillAIRA^SpencerAIRA^Xavier^^^^L|AndersonAIRA^TrinityAIRA^^^^^M|20160311|M||2106-3^White^CDCREC|1374 Gilvarenbeek Pl^^Mount Clemens^MI^48043^US of A^P||^PRN^PH^^^586^8904513|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SamuelsonAIRA^TrinityAIRA^^^^^L|MTH^Mother^HL70063|1374 Gilvarenbeek Pl^^Mount Clemens^MI^48043^USA^P|^PRN^PH^^^586^8904513|ORC|RE||Y83F20650.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X09C153.EW^^^AIRA-TEST^MR||KyleAIRA^CelesteAIRA^Keturah^^^^L|NordbyAIRA^AvaAIRA^^^^^M|20160316|F||2054-5^Black or African-American^CDCREC|1591 Deist Cir^^Dearborn Heights^MI^50^USA^P||^PRN^PH^^^313^6041956|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KyleAIRA^AvaAIRA^^^^^L|MTH^Mother^HL70063|1591 Deist Cir^^Dearborn Heights^MI^48127^USA^P|^PRN^PH^^^313^6041956|ORC|RE||W91A20654.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0121|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||W66F171.FB^^^AIRA-TEST^MR||ArmstrongAIRA^VailAIRA^O^^^^L|AnningAIRA^MorgandyAIRA^^^^^M|20160320|M||2054-5^Black or African-American^CDCREC|1962 Lpmeer Pl^^Suttons Bay^MI^49682^USA^P||^PRN^PH^^^231^3044451|||||||||2186-5^not Hispanic or Latino^CDCREC||X|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ArmstrongAIRA^MorgandyAIRA^^^^^L|MTH^Mother^HL70063|1962 Lpmeer Pl^^Suttons Bay^MI^49682^USA^P|^PRN^PH^^^231^3044451|ORC|RE||L95W20659.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0123|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A54U175.FO^^^AIRA-TEST^MR||ElmoreAIRA^KatebAIRA^R^^^^L|PetersonAIRA^OlvaAIRA^^^^^M|20160311|M||2106-3^White^CDCREC|1020 Plannen Cir^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^8447130|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|Twin|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ElmoreAIRA^OlvaAIRA^^^^^L|MTH^Mother^HL70063|1020 Plannen Cir^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^8447130|ORC|RE||T37X20663.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0135|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L49O209.H6^^^AIRA-TEST^MR||ChickasawAIRA^StockleyAIRA^Esmond^^^^L|OwyheeAIRA^NuAIRA^^^^^M|20160304|M||1002-5^American Indian or Alaska Native^CDCREC|1201 Lied Ave^^Greenville^MI^48838^USA^P||^PRN^PH^^^231^5569407|||||||||H^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|FrontierAIRA^NuAIRA^^^^^L|MTH^Mother^HL70063|1201 Lied Ave^^Greenville^MI^48838^USA^P|^PRN^PH^^^231^5569407|ORC|RE||V66O20667.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0153|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||F53F243.Im^^^AIRA-TEST^MR||CulbersonAIRA^SnofridAIRA^^^^^L|MathiesenAIRA^MaureenAIRA^^^^^M|20160301|F||2106-3^White^CDCREC|1517 Rekenen Ave^^Hubbell^MI^49934^USA^P||^PRN^PH^^^906^2910670|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|Presque IsleAIRA^^^^^^L|MTH^Mother^HL70063|1517 Rekenen Ave^^Hubbell^MI^49934^USA^P|^PRN^PH^^^906^2910670|ORC|RE||R39A20671.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0154|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C99V245.Iq^^^AIRA-TEST^MR||GarvinAIRA^MarleyAIRA^K^^^^L|ShortAIRA^WanetaAIRA^^^^^M|20160310|M||2054-5^Black or African-American^CDCREC|1559 Nijdemeren St^^Plainwell^MI^49080^USA^P||^PRN^PH^^^269^9690166|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|^WanetaAIRA^^^^^L|MTH^Mother^HL70063|1559 Nijdemeren St^^Plainwell^MI^49080^USA^P|^PRN^PH^^^269^9690166|ORC|RE||A55J20675.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0155|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X72T239.Id^^^AIRA-TEST^MR||WebsterAIRA^PendaAIRA^S^^^^L|ButlerAIRA^EmmyAIRA^^^^^M|20160303|F||2106-3^White^CDCREC|1648 Mijn Cir^^Harrison^MI^48625^USA^P||^PRN^PH^^^989^8902363|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|^^^^^^L|MTH^Mother^HL70063|1648 Mijn Cir^^Harrison^MI^48625^USA^P|^PRN^PH^^^989^8902363|ORC|RE||S14X20678.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0157|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A57X247.Iv^^^AIRA-TEST^MR||LoganAIRA^TyeeAIRA^Kaushal^^^^L|HitchcockAIRA^JagratiAIRA^^^^^M|20160308|M||2106-3^White^CDCREC|1703 Longeradeel Pl^^Coloma^MI^49039^USA^P||^PRN^PH^^^269^9128023|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|LoganAIRA^JagratiAIRA^^^^^L|MTH^Mother^HL70063|1703 Longeradeel Pl^^Coloma^MI^49039^USA^P|^PRN^PH^^^269^9128023|ORC|RE||C37K20682.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0159|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y46Y251.ID^^^AIRA-TEST^MR||PacificAIRA^DagnyAIRA^Chloe^^^^L|McLeanAIRA^CharityAIRA^^^^^M|20160229|F||2054-5^Black or African-American^CDCREC|1351 Toxtel Ave^^Walhalla^MI^49458^USA^P||^PRN^PH^^^231^6917232|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|PacificAIRA^CharityAIRA^^^^^L|^Mother^HL70063|1351 Toxtel Ave^^Walhalla^MI^49458^USA^P|^PRN^PH^^^231^6917232|ORC|RE||B49N20687.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0164|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||N38N261.J3^^^AIRA-TEST^MR||ThorneAIRA^ShmuelAIRA^Stanbury^^^^L|PacificAIRA^ZolaAIRA^^^^^M|20160310|M||2131-1^Other Race^CDCREC|1463 Viel Ave^^GR^MI^49548^USA^P||^PRN^PH^^^616^3709840|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||MMR|20200309|20200309|NK1|1|PacificAIRA^ZolaAIRA^^^^^L|MTH^Mother^HL70063|1463 Viel Ave^^GR^MI^49548^USA^P|^PRN^PH^^^616^3709840|ORC|RE||T09H20691.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0174|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M74A299.KG^^^AIRA-TEST^MR||HayesAIRA^LydiaAIRA^Vedette^^^^L|UmatillaAIRA^SabellaAIRA^^^^^M|20160316|F||2106-3^White^CDCREC|1599 Melk Pl^^Rockwood^MI^48173^USA^P||8279950^PRN^PH^^^^8279950|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KrogAIRA^SabellaAIRA^^^^^L|MTH^Mother^HL70063|1599 Melk Pl^^Rockwood^MI^48173^USA^P|^PRN^PH^^^734^8279950|ORC|RE||C28D20695.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0175|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S95I301.KK^^^AIRA-TEST^MR||HumboldtAIRA^BethanAIRA^Z^^^^L|WashingtonAIRA^ShawnaAIRA^^^^^M|20160305|F||2106-3^White^CDCREC|1858 Aan Cir^^Nottawa^MI^49075^USA^P||104 E Market St^^Allegany^^^MI^04599|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WashingtonAIRA^ShawnaAIRA^^^^^L|MTH^Mother^HL70063|1858 Aan Cir^^Nottawa^MI^49075^USA^P|^PRN^PH^^^269^4561361|ORC|RE||G82J20698.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0198|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C60J367.Ne^^^AIRA-TEST^MR||KentAIRA^MiracleAIRA^^^^^L|RyanAIRA^MarjetaAIRA^^^^^M|20160305|F||2106-3^White^CDCREC|1408 Lellingwedde Cir^^New Era^MI^49446^USA^P||^PRN^PH^^^231^3645427|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|(555)555-1234||||A|20200309|20200309|NK1|1|KentAIRA^MarjetaAIRA^^^^^L|MTH^Mother^HL70063|1408 Lellingwedde Cir^^New Era^MI^49446^USA^P|^PRN^PH^^^231^3645427|ORC|RE||J77L20702.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0205|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||N37Z381.NP^^^AIRA-TEST^MR||CassAIRA^AbiAIRA^^^^^L|JeffersonAIRA^GitikaAIRA^^^^^M|20160315|M||2106-3^White^CDCREC|1972 Hijkerk Ave^^Camden^MI^49232^USA^P||^PRN^PH^^^517^2389638|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||(505)555-1234^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CassAIRA^GitikaAIRA^^^^^L|MTH^Mother^HL70063|1972 Hijkerk Ave^^Camden^MI^49232^USA^P|^PRN^PH^^^517^2389638|ORC|RE||K46L20707.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0206|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R88M383.NU^^^AIRA-TEST^MR||WrigleyAIRA^JaquesAIRA^A^^^^L|ClatsopAIRA^DeetaAIRA^^^^^M|20160311|M||I^Black or African-American^CDCREC|1900 Dchtkarspelen St^^Bailey^MI^49303^USA^P||^PRN^PH^^^231^9769150|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WalcottAIRA^DeetaAIRA^^^^^L|MTH^Mother^HL70063|1900 Dchtkarspelen St^^Bailey^MI^49303^USA^P|^PRN^PH^^^231^9769150|ORC|RE||B56K20711.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0210|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X47C391.Oc^^^AIRA-TEST^MR||WoodsAIRA^AhmedAIRA^Eudor^^^^L|ClayAIRA^LanayaAIRA^^^^^M|20160305|M||108 N Main St^White^CDCREC|1872 Mittenseradiel Ave^^Iron Mountain^MI^49831^USA^P||^PRN^PH^^^906^5709053|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ClayAIRA^LanayaAIRA^^^^^L|MTH^Mother^HL70063|1872 Mittenseradiel Ave^^Iron Mountain^MI^49831^USA^P|^PRN^PH^^^906^5709053|ORC|RE||G56Y20715.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0217|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S19M405.OK^^^AIRA-TEST^MR||PulaskiAIRA^PriyaAIRA^Ewa^^^^L|ErikssonAIRA^AbbeyAIRA^^^^^M|20160316|F||2028-9^Asian^CDCREC|1381 Kontferland Pl^^Thompson^MI^49854^USA^P||^PRN^PH^^^906^7167307|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||Immu-compromised|20200309|20200309|NK1|1|AndroscogginAIRA^AbbeyAIRA^^^^^L|MTH^Mother^HL70063|1381 Kontferland Pl^^Thompson^MI^49854^USA^P|^PRN^PH^^^906^7167307|ORC|RE||I64Z20719.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0218|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C30O407.OO^^^AIRA-TEST^MR~123456789^^^USA^SS||CarrollAIRA^FritziAIRA^Mary-Ellen^^^^L|FremstadAIRA^GabrielaAIRA^^^^^M|20160314|F||2106-3^White^CDCREC|1639 Menigte Ave^^Michigamme^MI^49861^USA^P||^PRN^PH^^^906^9613551|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CarrollAIRA^GabrielaAIRA^^^^^L|MTH^Mother^HL70063|1639 Menigte Ave^^Michigamme^MI^49861^USA^P|^PRN^PH^^^906^9613551|ORC|RE||P90T20722.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0236|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K59O455.QH^^^AIRA-TEST^MR||WayneAIRA^LondonAIRA^C^^^^L|Los AngelesAIRA^AtinAIRA^^^^^M|20160313|F||1002-5^American Indian or Alaska Native^CDCREC|1601 Diepe St^^Croton^MI^49337^USA^P||^PRN^PH^^^231^6019007|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MarionAIRA^AtinAIRA^^^^^L|MTH^Mother^HL70063|1601 Diepe St^^Croton^MI^49337^USA^P|^PRN^PH^^^231^6019007|ORC|RE||X53W20726.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|P|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0245|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z58K475.Ru^^^AIRA-TEST^MR||MasonAIRA^BillyAIRA^Sumati^^^^L|SnowAIRA^FabienneAIRA^^^^^M|20160312|M||2106-3^White^CDCREC|1842 Wchtkarspelen Cir^^Detroit^MI^48233^USA^P||^PRN^PH^^^313^5334825|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|BallardAIRA^FabienneAIRA^^^^^L|MTH^Mother^HL70063|1842 Wchtkarspelen Cir^^Detroit^MI^48233^USA^P|^PRN^PH^^^313^5334825|ORC|RE||A39M20731.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||45^Hep B, unspecified formulation^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0249|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G86J485.RQ^^^AIRA-TEST^MR||ClintonAIRA^JoabAIRA^Ingram^^^^L|YamhillAIRA^TayceAIRA^^^^^M|20160310|M||2131-1^Other Race^CDCREC|1426 Angst Ave^^Point Aux Pin^MI^49775^USA^P||^PRN^PH^^^231^3610251|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CambriaAIRA^TayceAIRA^^^^^L|MTH^Mother^HL70063|1426 Angst Ave^^Point Aux Pin^MI^49775^USA^P|^PRN^PH^^^231^3610251|ORC|RE||L10V20735.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||999^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082734-0600||VXU^V04^VXU_V04|dzl-DQMQE0251|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M31I493.S8^^^AIRA-TEST^MR||BastropAIRA^KalleAIRA^Alike^^^^L|JeffersonAIRA^JackieAIRA^^^^^M|20160324|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1467 Betalen Ave^^Flint^MI^48552^USA^P||^PRN^PH^^^810^3376103|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|AllenAIRA^JackieAIRA^^^^^L|MTH^Mother^HL70063|1467 Betalen Ave^^Flint^MI^48552^USA^P|^PRN^PH^^^810^3376103|ORC|RE||G73S20739.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP|20160324|MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0256|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U19F503.Sv^^^AIRA-TEST^MR||PortageAIRA^RoninAIRA^Telford^^^^L|LoganAIRA^TaniaAIRA^^^^^M|20011010|M||2054-5^Black or African-American^CDCREC|1397 Guidhorn Pl^^Rapid River^MI^49878^USA^P||^PRN^PH^^^906^9973938|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|PortageAIRA^TaniaAIRA^^^^^L|MTH^Mother^HL70063|1397 Guidhorn Pl^^Rapid River^MI^49878^USA^P|^PRN^PH^^^906^9973938|ORC|RE||N19M20743.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20100301||100^pneumococcal conjugate PCV 7^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0258|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A18N507.SI^^^AIRA-TEST^MR||CochranAIRA^DilysAIRA^Marylou^^^^L|HitchcockAIRA^BathshebaAIRA^^^^^M|20160309|F||2054-5^Black or African-American^CDCREC|1955 Pose Ave^^Traverse City^MI^49685^USA^P||^PRN^PH^^^231^2767874|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CochranAIRA^BathshebaAIRA^^^^^L|MTH^Mother^HL70063|1955 Pose Ave^^Traverse City^MI^49685^USA^P|^PRN^PH^^^231^2767874|ORC|RE||K96P20746.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||118^HPV, bivalent^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0273|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T69G545.Ud^^^AIRA-TEST^MR||EllisAIRA^HusseinAIRA^I^^^^L|BranchAIRA^PtolemaAIRA^^^^^M|20160308|M||1002-5^American Indian or Alaska Native^CDCREC|1435 Terwijl Ln^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^7953465|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WheelerAIRA^PtolemaAIRA^^^^^L|MTH^Mother^HL70063|1435 Terwijl Ln^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^7953465|ORC|RE||R57C20750.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|IN^Intranasal^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0278|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J52W555.UE^^^AIRA-TEST^MR||BreckinridgeAIRA^SonaAIRA^M^^^^L|NeorinAIRA^DavanAIRA^^^^^M|20160315|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1166 Outphen Pl^^Christmas^MI^49862^USA^P||^PRN^PH^^^906^7641390|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|BreckinridgeAIRA^DavanAIRA^^^^^L|MTH^Mother^HL70063|1166 Outphen Pl^^Christmas^MI^49862^USA^P|^PRN^PH^^^906^7641390|ORC|RE||X08L20755.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|MMR^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0284|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S82Q567.V8^^^AIRA-TEST^MR||IrvingAIRA^MoisesAIRA^Talorg^^^^L|MetcalfeAIRA^AmissaAIRA^^^^^M|20160311|M||2028-9^Asian^CDCREC|1670 Zetten Ave^^Hamburg^MI^48139^USA^P||^PRN^PH^^^810^2453724|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|IrvingAIRA^AmissaAIRA^^^^^L|MTH^Mother^HL70063|1670 Zetten Ave^^Hamburg^MI^48139^USA^P|^PRN^PH^^^810^2453724|ORC|RE||M01T20759.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|Jones Clinic^^|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0327|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S84C681.10O^^^AIRA-TEST^MR||CimarronAIRA^BurgessAIRA^J^^^^L|MuskingumAIRA^KristyAIRA^^^^^M|20160322|M||2106-3^White^CDCREC|1341 Loetinchem St^^National City^MI^48748^USA^P||^PRN^PH^^^989^7057574|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CimarronAIRA^KristyAIRA^^^^^L|MTH^Mother^HL70063|1341 Loetinchem St^^National City^MI^48748^USA^P|^PRN^PH^^^989^7057574|ORC|RE||M60W20763.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|999|||00^New immunization record^NIP001|||||||||||CP|A|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0329|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L41P685.10Y^^^AIRA-TEST^MR||MayesAIRA^RashneAIRA^Samudra^^^^L|FultonAIRA^AmoritaAIRA^^^^^M|20160313|M||2054-5^Black or African-American^CDCREC|1942 Most Gelre Ave^^Washington Township^MI^48094^USA^P||^PRN^PH^^^586^5743660|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|FultonAIRA^AmoritaAIRA^^^^^L|MTH^Mother^HL70063|1942 Most Gelre Ave^^Washington Township^MI^48094^USA^P|^PRN^PH^^^586^5743660|ORC|RE||W22Q20767.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||01^Historical information - source unspecified^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0336|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||R63K703.12o^^^AIRA-TEST^MR||VistanstAIRA^ManuAIRA^T^^^^L|HardemanAIRA^ManonAIRA^^^^^M|20160312|M||2106-3^White^CDCREC|1646 Listerwijk St^^Farmington^MI^48331^USA^P||^PRN^PH^^^248^8390108|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ChoctawAIRA^ManonAIRA^^^^^L|MTH^Mother^HL70063|1646 Listerwijk St^^Farmington^MI^48331^USA^P|^PRN^PH^^^248^8390108|ORC|RE||U21K20771.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC|Never|MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0338|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D13O707.12x^^^AIRA-TEST^MR||HardinAIRA^LeonardoAIRA^A^^^^L|MahoningAIRA^CharleighAIRA^^^^^M|20160309|M||2106-3^White^CDCREC|1729 Spel Ave^^Sault Sainte Marie^MI^49784^USA^P||^PRN^PH^^^906^7001118|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|FairfieldAIRA^CharleighAIRA^^^^^L|MTH^Mother^HL70063|1729 Spel Ave^^Sault Sainte Marie^MI^49784^USA^P|^PRN^PH^^^906^7001118|ORC|RE||H17P20775.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Lot||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0339|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G55Y709.12C^^^AIRA-TEST^MR||BraceyAIRA^UlfhildrAIRA^Yvette^^^^L|BlaineAIRA^CalaAIRA^^^^^M|20160320|F||2106-3^White^CDCREC|1812 Gevaar Ln^^GR^MI^49519^USA^P||^PRN^PH^^^616^6384708|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|AndrewsAIRA^CalaAIRA^^^^^L|MTH^Mother^HL70063|1812 Gevaar Ln^^GR^MI^49519^USA^P|^PRN^PH^^^616^6384708|ORC|RE||A81G20779.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0343|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||X17I719.12Z^^^AIRA-TEST^MR||BellAIRA^DunhamAIRA^Xenophon^^^^L|KyleAIRA^SkylaAIRA^^^^^M|20160224|M||2106-3^White^CDCREC|1382 Mldebroek Ave^^Warren^MI^48093^USA^P||^PRN^PH^^^586^6595969|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|BellAIRA^SkylaAIRA^^^^^L|MTH^Mother^HL70063|1382 Mldebroek Ave^^Warren^MI^48093^USA^P|^PRN^PH^^^586^6595969|ORC|RE||B20P20783.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR|||||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0344|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0344^^^AIRA-TEST^MR||PayetteAIRA^AmishaAIRA^C^^^^L|Hood RiverAIRA^SaravatiAIRA^^^^^M|20160308|F||2054-5^Black or African-American^CDCREC|1126 Goorst Cir^^Delton^MI^49046^USA^P||^PRN^PH^^^269^7875080|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|PayetteAIRA^SaravatiAIRA^^^^^L|MTH^Mother^HL70063|1126 Goorst Cir^^Delton^MI^49046^USA^P|^PRN^PH^^^269^7875080|ORC|RE||Y58R20787.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||ZZZ^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0370|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||I95P729.13n^^^AIRA-TEST^MR||VistanstAIRA^IbrahimAIRA^^^^^L|MasonAIRA^MitexiAIRA^^^^^M|20160304|M||2106-3^White^CDCREC|1033 Otichtse Vecht Ln^^Farmington^MI^48333^USA^P||^PRN^PH^^^248^9586773|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|VistanstAIRA^MitexiAIRA^^^^^L|MTH^Mother^HL70063|1033 Otichtse Vecht Ln^^Farmington^MI^48333^USA^P|^PRN^PH^^^248^9586773|ORC|20110506||Q21J20790.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0372|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U13D733.13A^^^AIRA-TEST^MR||LawrenceAIRA^KlaudiaAIRA^B^^^^L|MadisonAIRA^MatangiAIRA^^^^^M|20160304|F||2054-5^Black or African-American^CDCREC|1342 Dienen Cir^^Warren^MI^48397^USA^P||^PRN^PH^^^586^5496861|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KalamazooAIRA^MatangiAIRA^^^^^L|MTH^Mother^HL70063|1342 Dienen Cir^^Warren^MI^48397^USA^P|^PRN^PH^^^586^5496861|ORC|UR||X17F20794.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0393|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K86T413.P3^^^^MR||CoosAIRA^SangitaAIRA^Colleen^^^^L|MarionAIRA^MartaAIRA^^^^^M|20160315|F||2106-3^White^CDCREC|1422 Ofwel St^^Almont^MI^48003^USA^P||^PRN^PH^^^810^8658441|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ShoshoneAIRA^MartaAIRA^^^^^L|MTH^Mother^HL70063|1422 Ofwel St^^Almont^MI^48003^USA^P|^PRN^PH^^^810^8658441|ORC|RE||D23B20799.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0394|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G53V415.P7^^^AIRA-TEST^||WoodAIRA^ClodaghAIRA^Ayushmati^^^^L|MarshallAIRA^OzoraAIRA^^^^^M|20160314|F||2106-3^White^CDCREC|1074 Wteenbergen St^^Brunswick^MI^49425^USA^P||^PRN^PH^^^231^9061151|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WoodAIRA^OzoraAIRA^^^^^L|MTH^Mother^HL70063|1074 Wteenbergen St^^Brunswick^MI^49425^USA^P|^PRN^PH^^^231^9061151|ORC|RE||G56U20803.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0399|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T14T51.yP^^^AIRA-TEST^MR||GustafsonAIRA^MayAIRA^E^^^^L|LackawannaAIRA^SonnenscheinAIRA^^^^^M|20160309|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1982 Kookplaten Pl^^Northville Township^MI^48167^USA^P||^PRN^PH^^^248^7092084|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|EmmetAIRA^SonnenscheinAIRA^^^^^L|MTH^Mother^HL70063|1982 Kookplaten Pl^^Northville Township^MI^48167^USA^PRIMARY|^PRN^PH^^^248^7092084|ORC|RE||I91X20807.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0409|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||D63R295.Kw^^^AIRA-TEST^MR||LancasterAIRA^CalandraAIRA^J^^^^Samuel|OtoeAIRA^LinetteAIRA^^^^^M|20160305|F||2106-3^White^CDCREC|1074 Ne Wolden Cir^^Clio^MI^48420^USA^P||^PRN^PH^^^810^7250661|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|LancasterAIRA^LinetteAIRA^^^^^L|MTH^Mother^HL70063|1074 Ne Wolden Cir^^Clio^MI^48420^USA^P|^PRN^PH^^^810^7250661|ORC|RE||Q43S20811.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0450|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K82K543.U8^^^AIRA-TEST^MR||AldridgeAIRA^MackenzieAIRA^^^^^L|WilsonAIRA^CarolAIRA^^^^^M|20160303|M||2106-3^White^CDCREC|1480 Flochteren Cir^^Farmington^MI^48335^USA^P||^PRN^PH^^^248^7301350|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|AldridgeAIRA^CarolAIRA^^^^^L|MTH^Mother^HL70063|1480 Flochteren Cir^^Farmington^MI^48335^USA^P|^PRN^PH^^^248^7301350|ORC|RE||M77O20814.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|CM^milliliters^ISO+||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0451|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A10N141.Er^^^AIRA-TEST^MR||UnionAIRA^BellancaAIRA^M^^^^L|HoltAIRA^BriellaAIRA^^^^^M|20160312|F||2106-3^White^CDCREC|1839 Woorst Pl^^Grand Rapids^MI^49534^USA^||^PRN^PH^^^616^5916531|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|UnionAIRA^BriellaAIRA^^^^^L|MTH^Mother^HL70063|1839 Woorst Pl^^Grand Rapids^MI^49534^USA^P|^PRN^PH^^^616^5916531|ORC|RE||J68H20818.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0457|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H65R313.Lb^^^AIRA-TEST^MR||DodgeAIRA^EamnonnAIRA^Jatin^^^^L|SullivanAIRA^PollyannaAIRA^^^^^M|20160305|M||2106-3^White^CDCREC|1927 Luid Pl^^Buick Oldsmobile Cadillac^MI^48550^USA^P||(810)4482037^Apt B^PH^^^810^4482037|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|DodgeAIRA^PollyannaAIRA^^^^^L|MTH^Mother^HL70063|1927 Luid Pl^^Buick Oldsmobile Cadillac^MI^48550^USA^P|^PRN^PH^^^810^4482037|ORC|RE||N89O20823.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0462|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||I94N323.Ly^^^AIRA-TEST^MR||LatahAIRA^TaylarAIRA^Theodosia^^^^L|LarsenAIRA^EmersonAIRA^^^^^M|20160314|F||2106-3^White^CDCREC|1180 Goudrichem Ave^^Riley^MI^48041^USA^P||(810)5611609^PRN^BAD^^^810^5611609|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|LatahAIRA^EmersonAIRA^^^^^L|MTH^Mother^HL70063|1180 Goudrichem Ave^^Riley^MI^48041^USA^P|^PRN^PH^^^810^5611609|ORC|RE||K16L20827.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0473|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B74Q93.Be^^^AIRA-TEST^MR||MarionAIRA^JafarAIRA^^^^^L|BurnetAIRA^LakotaAIRA^^^^^M|20160308|M||2106-3^White^CDCREC|1426 Zeewolde Cir^^Royal Oak Township^MI^48220^USA^P||^PRN^PH^^^248^9882054|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|MarionAIRA^LakotaAIRA^^^^^L|MTH^Mother^HL70063|1426 Zeewolde Cir^^Royal Oak Township^MI^48220^USA^P|^PRN^PH^^^248^9882054|ORC|RE||V60S20831.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1||64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0474|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y98Y95.Bp^^^AIRA-TEST^MR||TillamookAIRA^AziAIRA^Y^^^^L|JeffersonAIRA^CristyAIRA^^^^^M|20160311|M||2106-3^White^CDCREC|1905 Blijven Pl^^Prattville^MI^49271^USA^P||^PRN^PH^^^517^7694461|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|TillamookAIRA^CristyAIRA^^^^^L|MTH^Mother^HL70063|1905 Blijven Pl^^Prattville^MI^49271^USA^P|^PRN^PH^^^517^7694461|ORC|RE||L64G20834.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CODED VALUE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0483|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||T04M487.RV^^^AIRA-TEST^MR||CamasAIRA^DeweyAIRA^A^^^^L|DightAIRA^NellieAIRA^^^^^M|20160305|M||2106-3^White^CDCREC|1997 Danderd Pl^^Harbor Point^MI^49740^USA^P||^PRN^PH^^^616^6111425|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|FultonAIRA^NellieAIRA^^^^^L|MTH^Mother^HL70063|1997 Danderd Pl^^Harbor Point^MI^49740^USA^P|^PRN^PH^^^616^6111425|ORC|RE||G05V20838.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0484|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y53J489.RZ^^^AIRA-TEST^MR||InghamAIRA^ShubhaAIRA^Kineta^^^^L|CallowayAIRA^NovaAIRA^^^^^M|20160227|F||2106-3^White^CDCREC|1841 Nerkendam St^^Holland^MI^49423^USA^P||^PRN^PH^^^616^5708536|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CallowayAIRA^NovaAIRA^^^^^L|MTH^Mother^HL70063|1841 Nerkendam St^^Holland^MI^49423^USA^P|^PRN^PH^^^616^5708536|ORC|RE||H72G20843.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX CODE|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0485|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||F89X81.Ay^^^AIRA-TEST^MR||BristolAIRA^ColtonAIRA^Sukarman^^^^L|SimmingsenAIRA^AnanAIRA^^^^^M|20160316|M||2028-9^Asian^CDCREC|1447 Zeven Ln^^Blissfield^MI^49228^USA^P||^PRN^PH^^^517^3906517|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SimmingsenAIRA^AnanAIRA^^^^^L|CHD^Child^HL70063|1447 Zeven Ln^^Blissfield^MI^49228^USA^P|^PRN^PH^^^517^3906517|ORC|RE||F36V20847.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082735-0600||VXU^V04^VXU_V04|dzl-DQMQE0490|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||P77J479.RD^^^AIRA-TEST^MR||OntonagonAIRA^HunterAIRA^^^^^L|WinnebagoAIRA^RiannonAIRA^^^^^M|20011010|M||2106-3^White^CDCREC|1202 Mellendoorn Pl^^Brownstown^MI^48164^USA^P||^PRN^PH^^^734^9913492|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WinnebagoAIRA^RiannonAIRA^^^^^L|MTH^Mother^HL70063|1202 Mellendoorn Pl^^Brownstown^MI^48164^USA^P|^PRN^PH^^^734^9913492|ORC|RE||A51T20851.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20100301||100^pneumococcal conjugate PCV 7^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0516|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||V38N297.KB^^^AIRA-TEST^MR||HoreAIRA^AtulyaAIRA^B^^^^A|BellAIRA^RoselleAIRA^^^^^M|20160315|M||2106-3^White^CDCREC|1671 Sterven Pl^^White Pine^MI^49971^USA^P||^PRN^PH^^^906^6393668|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HoreAIRA^RoselleAIRA^^^^^L|MTH^Mother^HL70063|1671 Sterven Pl^^White Pine^MI^49971^USA^P|^PRN^PH^^^906^6393668|ORC|RE||V53S20855.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0520|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C99N149.EN^^^AIRA-TEST^MR||ClarkAIRA^BryleighAIRA^Chelsea^^^^L|JeffersonAIRA^SharmisthaAIRA^^^^^M|20160305|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1369 Drukke Pl^^Perkins^MI^49872^USA^PRIMARY||^PRN^PH^^^906^2821317|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ClarkAIRA^SharmisthaAIRA^^^^^L|MTH^Mother^HL70063|1369 Drukke Pl^^Perkins^MI^49872^USA^P|^PRN^PH^^^906^2821317|ORC|RE||C87K20859.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0555|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L25W527.Tw^^^AIRA-TEST^MR||KearneyAIRA^KeiraAIRA^Liora^^^^L|BullittAIRA^AlannaAIRA^^^^^M|20160302|F||2106-3^White^CDCREC|1958 Hteenbergen Pl^^Springfield Township^MI^48350^USA^P||^PRN^PH^^^248^7289848|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KearneyAIRA^AlannaAIRA^^^^^L|MTH^Mother^HL70063|1958 Hteenbergen Pl^^Springfield Township^MI^48350^USA^P|^PRN^PH^^^248^7289848|ORC|RE||P80O20862.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|MMR|mL^mililiters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0060|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||L07Z9.vm^^^AIRA-TEST^MR||CameronAIRA^StaceyAIRA^Kairi^^^^L|MarshallAIRA^ElephteriaAIRA^^^^^M|20160302|F||2106-3^White^CDCREC|1231 Gss Cir^^Sterling Heights^MI^48313^USA^P||^PRN^PH^^^586^7021659|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|GonzalesAIRA^ElephteriaAIRA^^^^^L|MTH^Mother^HL70063|1231 Gss Cir^^Sterling Heights^MI^48313^US^P|^PRN^PH^^^586^7021659|ORC|RE||T73P20866.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0095|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Y43F107.Cn^^^AIRA-TEST^MR||WayneAIRA^PindanAIRA^S^^^^L|RainsAIRA^MichaelaAIRA^^^^^M|20160323|M||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1844 Pagina Ave^^Afton^MI^49705^US^P||^PRN^PH^^^231^3172968|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|WayneAIRA^MichaelaAIRA^^^^^L|MTH^Mother^HL70063|1844 Pagina Ave^^Afton^MI^49705^USA^P|^PRN^PH^^^231^3172968|ORC|RE||E68U20871.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0180|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||H31J331.LQ^^^AIRA-TEST^MR||LoveAIRA^ManderAIRA^H^^^^L|PurolaAIRA^BeryanAIRA^^^^^M|20160314|M||2106-3^White^CDCREC|1045 Lladel St^^Allenton^MI^48002^USA^P||^PRN^PH^^^810^9557514|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|LoveAIRA^BeryanAIRA^^^^^L|MTH^Mother^HL70063|1045 Lladel St^^Allenton^MI^48002^USA^P|^PRN^PH^^^810^9557514|ORC|RE||Z05Y20875.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0235|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||E89W453.QC^^^AIRA-TEST^MR||CarbonAIRA^LeilaAIRA^Orpah^^^^L|KlickitatAIRA^KakraAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1785 Lift Cir^^Charlevoix^MI^49720^USA^P||^PRN^PH^^^231^4506696|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CarbonAIRA^KakraAIRA^^^^^L|MTH^Mother^HL70063|1785 Lift Cir^^Charlevoix^MI^49720^USA^P|^PRN^PH^^^231^4506696|ORC|RE||P16T20879.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP||RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0248|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0248^^^AIRA-TEST^MR||AransasAIRA^KeanAIRA^Jorge^^^^L|CarrollAIRA^AissaAIRA^^^^^M|20160224|M||2028-9^Asian^CDCREC|1374 Kunspeet Pl^^Detroit^MI^48268^USA^P||^PRN^PH^^^313^3339434|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|AransasAIRA^AissaAIRA^^^^^L|MTH^Mother^HL70063|1374 Kunspeet Pl^^Detroit^MI^48268^USA^P|^PRN^PH^^^313^3339434|ORC|RE||Q81T20883.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||998^No Vaccine Administered^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0259|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||Z18Y509.SN^^^AIRA-TEST^MR||GageAIRA^SanjeevAIRA^Solomon^^^^L|TetlowAIRA^ShardaAIRA^^^^^M|20160309|M||1002-5^American Indian or Alaska Native^CDCREC|1381 Beurne Cir^^State Farm Ins^MI^49069^USA^P||^PRN^PH^^^269^8409008|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|GageAIRA^ShardaAIRA^^^^^L|MTH^Mother^HL70063|1381 Beurne Cir^^State Farm Ins^MI^49069^USA^P|^PRN^PH^^^269^8409008|ORC|RE||P48H20887.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||118^HPV, bivalent^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0271|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||V56M533.TL^^^AIRA-TEST^MR||McErlaneAIRA^AdalynnAIRA^^^^^L|HarrisonAIRA^AlessandraAIRA^^^^^M|20160306|F||2106-3^White^CDCREC|1887 Mlagtwedde Ave^^Kalamazoo^MI^49003^USA^P||^PRN^PH^^^269^2569374|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HarrisonAIRA^AlessandraAIRA^^^^^L|MTH^Mother^HL70063|1887 Mlagtwedde Ave^^Kalamazoo^MI^49003^USA^P|^PRN^PH^^^269^2569374|ORC|RE||Z53T20890.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|999|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0272|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||K21M541.U4^^^AIRA-TEST^MR||RaumaAIRA^SherlynAIRA^Martina^^^^L|ParkAIRA^CarleyAIRA^^^^^M|20160303|F||2131-1^Other Race^CDCREC|1491 Wolenwaard Pl^^Grandville^MI^49468^USA^P||^PRN^PH^^^616^6515014|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|RaumaAIRA^CarleyAIRA^^^^^L|MTH^Mother^HL70063|1491 Wolenwaard Pl^^Grandville^MI^49468^USA^P|^PRN^PH^^^616^6515014|ORC|RE||L15T20894.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0277|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U86Q553.UA^^^AIRA-TEST^MR||HoltAIRA^OttavioAIRA^Sunil^^^^L|CarrollAIRA^AnandaAIRA^^^^^M|20160320|M||2131-1^Other Race^CDCREC|1696 Beerenveen Cir^^Mosherville^MI^49258^USA^P||^PRN^PH^^^517^6044167|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HoltAIRA^AnandaAIRA^^^^^L|MTH^Mother^HL70063|1696 Beerenveen Cir^^Mosherville^MI^49258^USA^P|^PRN^PH^^^517^6044167|ORC|RE||B11U20899.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|A|RXR|^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0322|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||U25A671.10p^^^AIRA-TEST^MR||SanilacAIRA^HalifaxAIRA^Chandan^^^^L|RunnelsAIRA^AlestiAIRA^^^^^M|20160226|M||2028-9^Asian^CDCREC|1581 Slip Cir^^Watersmeet^MI^49969^USA^P||^PRN^PH^^^906^9970124|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|RogersAIRA^AlestiAIRA^^^^^L|MTH^Mother^HL70063|1581 Slip Cir^^Watersmeet^MI^49969^USA^P|^PRN^PH^^^906^9970124|ORC|RE||^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0325|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||UDQA0325^^^AIRA-TEST^MR||JanttiAIRA^DamarionAIRA^N^^^^L|NemahaAIRA^LiviAIRA^^^^^M|20160225|M||1002-5^American Indian or Alaska Native^CDCREC|1242 Gittard-Geleen Ln^^Milan Township^MI^48160^USA^P||^PRN^PH^^^734^4973869|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|NemahaAIRA^LiviAIRA^^^^^L|MTH^Mother^HL70063|1242 Gittard-Geleen Ln^^Milan Township^MI^48160^USA^P|^PRN^PH^^^734^4973869|ORC|RE||^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0340|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||S38F711.12G^^^AIRA-TEST^MR||GradyAIRA^PascalAIRA^^^^^L|McLennanAIRA^LarissaAIRA^^^^^M|20160310|M||2106-3^White^CDCREC|1714 Huth Cir^^Allegan^MI^49010^USA^P||^PRN^PH^^^269^6169887|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|GradyAIRA^LarissaAIRA^^^^^L|MTH^Mother^HL70063|1714 Huth Cir^^Allegan^MI^49010^USA^P|^PRN^PH^^^269^6169887|ORC|RE||L00Y20911.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||BA^Baxter^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0363|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||B60X797.168^^^AIRA-TEST^MR||El DoradoAIRA^ShaneAIRA^^^^^L|GranholmAIRA^BerangerAIRA^^^^^M|20160303|F||2076-8^Native Hawaiian or Other Pacific Islander^CDCREC|1089 Hemert-Bakel Ave^^Eaton Rapids^MI^48827^USA^P||^PRN^PH^^^517^9906815|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|GranholmAIRA^BerangerAIRA^^^^^L|MTH^Mother^HL70063|1089 Hemert-Bakel Ave^^Eaton Rapids^MI^48827^USA^P|^PRN^PH^^^517^9906815|ORC|RE||P95X20914.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||RE|A|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0371|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||J35C731.13s^^^AIRA-TEST^MR||McLeanAIRA^BlissAIRA^^^^^L|TravisAIRA^JoleneAIRA^^^^^M|20160318|F||2054-5^Black or African-American^CDCREC|1010 Haren St^^Centennial Heights^MI^49913^USA^P||^PRN^PH^^^906^9042267|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|CulbersonAIRA^JoleneAIRA^^^^^L|MTH^Mother^HL70063|1010 Haren St^^Centennial Heights^MI^49913^USA^P|^PRN^PH^^^906^9042267|ORC|||B59R20918.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0382|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C73P647.Z7^^^AIRA-TEST^MR||JohnAIRA^PetuniaAIRA^^^^^L|MontgomeryAIRA^AliciaAIRA^^^^^M|20160229|F||2054-5^Black or African-American^CDCREC|1888 Vost Gelre Ave^^Eagle^MI^48822^USA^P||^PRN^PH^^^517^9069239|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|JohnAIRA^AliciaAIRA^^^^^L|MTH^Mother^HL70063|1888 Vost Gelre Ave^^Eagle^MI^48822^USA^P|^PRN^PH^^^517^9069239|ORC|RE||^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0398|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||C89N49.yJ^^^AIRA-TEST^MR||UnionAIRA^StilesAIRA^S^^^^L|GrantAIRA^GemmaAIRA^^^^^M|20160310|M||2131-1^Other Race^CDCREC|1379 Vers Ave^^Bham^MI^48012^USA^P||^PRN^PH^^^248^9399970|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|UnionAIRA^GemmaAIRA^^^^^L|MTH^Mother^HL70063|1379 Vers Ave^^Bham^MI^48012^USA^|^PRN^PH^^^248^9399970|ORC|RE||R64M20927.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0408|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||A66K293.Ks^^^AIRA-TEST^MR||KananenAIRA^DivyeshAIRA^M^^^^|ChampaignAIRA^KadenceAIRA^^^^^M|20160325|M||2106-3^White^CDCREC|1949 Culst St^^Grand Rapids^MI^49502^USA^P||^PRN^PH^^^616^8608343|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|HendersonAIRA^KadenceAIRA^^^^^L|MTH^Mother^HL70063|1949 Culst St^^Grand Rapids^MI^49502^USA^P|^PRN^PH^^^616^8608343|ORC|RE||P81L20931.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0447|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||G48W535.TP^^^AIRA-TEST^MR||McMullenAIRA^SineadAIRA^Nandini^^^^L|McMullenAIRA^PanyinAIRA^^^^^M|20160307|F||2054-5^Black or African-American^CDCREC|1664 Dmersfoort Ave^^Barlow Branch^MI^49686^USA^P||^PRN^PH^^^231^9460534|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|KittitasAIRA^PanyinAIRA^^^^^L|MTH^Mother^HL70063|1664 Dmersfoort Ave^^Barlow Branch^MI^49686^USA^P|^PRN^PH^^^231^9460534|ORC|RE||S67J20935.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|1|dose^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0456|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||P88Z311.L7^^^AIRA-TEST^MR||SpieccAIRA^LeontesAIRA^H^^^^L|CentreAIRA^AfinaAIRA^^^^^M|20160315|M||2106-3^White^CDCREC|1265 Aingewaard Ln^^Lansing^MI^48922^USA^P||(517)2311107^^PH^^^517^2311107|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|ManisteeAIRA^AfinaAIRA^^^^^L|MTH^Mother^HL70063|1265 Aingewaard Ln^^Lansing^MI^48922^USA^P|^PRN^PH^^^517^2311107|ORC|RE||E24B20939.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200309082736-0600||VXU^V04^VXU_V04|dzl-DQMQE0554|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|PID|1||M75Z529.TB^^^AIRA-TEST^MR||IoniaAIRA^DellAIRA^Annabeth^^^^L|SomersetAIRA^ZariahAIRA^^^^^M|20160316|F||2106-3^White^CDCREC|1305 Geleden Cir^^Ironwood^MI^49938^USA^P||^PRN^PH^^^906^2627094|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200309|20200309|NK1|1|SomersetAIRA^ZariahAIRA^^^^^L|MTH^Mother^HL70063|1305 Geleden Cir^^Ironwood^MI^49938^USA^P|^PRN^PH^^^906^2627094|ORC|RE||D45J20943.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1^^^^PRN||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L^^^PRN|RXA|0|1|20200309||21^Varicella^CVX||mL^mililiters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX|||CP|A|RXR|C38299^^NCIT|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20200309|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200309||||||F|MSH|^~\&|||||20200308073733.994-0500||VXU^V04^VXU_V04|cPU-GM-1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R66Y19792^^^NIST-MPI-1^MR||MorrowAIRA^PiusAIRA^Pompey^^^^L|Santa CruzAIRA^^^^^^M|20191229|M||1002-5^American Indian or Alaska Native^CDCREC|1266 Lppingedam Ln^^Eureka^MI^48833^USA^P||^PRN^PH^^^989^4079630|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200308|||A|20191229|20200308NK1|1|MorrowAIRA^Santa CruzAIRA^Elizabeth^^^^L|MTH^Mother^HL70063|1266 Lppingedam Ln^^Eureka^MI^48833^USA^P|^PRN^PH^^^989^4079630NK1|2|MorrowAIRA^ApacheAIRA^William^^^^L|FTH^Father^HL70063|1266 Lppingedam Ln^^Eureka^MI^48833^USA^P|^PRN^CP^^^989^4079630ORC|RE|AR66Y19792.1^NIST-AA-IZ-2|BR66Y19792.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200308||49281-0560-05^Pentacel^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||526434|20200405|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300017211160720^Polio VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308OBX|5|CE|69764-9^Document Type^LN|4|253088698300006611150402^Haemophilus Influenzae type b VIS^cdcgs1vis||||||F|||20200308OBX|6|DT|29769-7^Date Vis Presented^LN|4|20200308||||||F|||20200308OBX|7|CE|69764-9^Document Type^LN|5|253088698300003511070517^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F|||20200308OBX|8|DT|29769-7^Date Vis Presented^LN|5|20200308||||||F|||20200308ORC|RE|AR66Y19792.2^NIST-AA-IZ-2|BR66Y19792.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4047-20^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||297961|20200531|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300019611150415^Rotavirus VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AR66Y19792.3^NIST-AA-IZ-2|BR66Y19792.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200308||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||353480|20200412|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300015811151105^Pneumococcal Conjugate (PCV13) VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE||BR66Y19792.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20191230||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BR66Y19792.5^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20200128||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200308084727.655-0500||VXU^V04^VXU_V04|cPU-GM-1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B21Y19799^^^NIST-MPI-1^MR||LewisAIRA^MegaraAIRA^^^^^L||19880228|F||2028-9^Asian^CDCREC|1620 Uaterland Cir^^Dewitt^MI^48820^USA^P||^PRN^PH^^^517^5419635~^NET^^Elise.Wong@isp.com|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200308|||A|19880228|20200308ORC|RE|AB21Y19799.1^NIST-AA-IZ-2|BB21Y19799.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200308||49281-0215-88^TENIVAC^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||315841|20200830|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300028811170411^Tetanus/Diphtheria (Td) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE||BB21Y19799.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20190627||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BB21Y19799.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRNRXA|0|1|20180728||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200308093847.808-0500||VXU^V04^VXU_V04|cPU-GM-1.3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N46A19806^^^NIST-MPI-1^MR||HoltAIRA^AtraylAIRA^Khalid^^^^L||20190215|M||2106-3^White^CDCREC|1621 Baalte St^^Munith^MI^49259^USA^P||^PRN^PH^^^517^3377521|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20200308|||A|20090215|20200308NK1|1|HoltAIRA^NicholasAIRA^Leonard^^^^L|FTH^Father^HL70063|1621 Baalte St^^Munith^MI^49259^USA^P|^PRN^PH^^^517^3377521ORC|RE|AN46A19806.1^NIST-AA-IZ-2|BN46A19806.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MDRXA|0|1|20200308||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208490|20201004|MSD^Merck and Co., Inc.^MVX|||CP|URXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|cPU-GM-2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V11Y19813^^^AIRA^MR||BathAIRA^LiliaAIRA^Corowa^^^^L|PayneAIRA^HarshaAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1028 Gollands Kroon Pl^^Coloma^MI^49038^USA^P||^PRN^PH^^^269^9483228|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|BathAIRA^PayneAIRA^Marion^^^^L|MTH^Mother^HL70063|1028 Gollands Kroon Pl^^Coloma^MI^49038^USA^P|^PRN^PH^^^269^9483228ORC|RE|AV11Y19813.1^AIRA|BV11Y19813.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRNRXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|cPU-GM-2.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B42R19820^^^AIRA^MR||CrawfordAIRA^AnabelleAIRA^Pia^^^^L|AndersenAIRA^RoselaniAIRA^^^^^M|20040226|F||2106-3^White^CDCREC|1962 Suidhorn Pl^^Chase Bank^MI^48277^USA^P||^PRN^PH^^^313^4962925|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|CrawfordAIRA^AndersenAIRA^Marion^^^^L|MTH^Mother^HL70063|1962 Suidhorn Pl^^Chase Bank^MI^48277^USA^P|^PRN^PH^^^313^4962925ORC|RE||BB42R19820.1^AIRARXA|0|1|20080308||03^MMR^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|cPU-GM-2.3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W46H19827^^^AIRA^MR||HowardAIRA^RohanaAIRA^Kamil^^^^L|JohnstonAIRA^GuenevereAIRA^^^^^M|20181126|F||2106-3^White^CDCREC|1820 Laag en Braassem St^^Roos^MI^48756^USA^P||^PRN^PH^^^989^6744440|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HowardAIRA^JohnstonAIRA^Marion^^^^L|MTH^Mother^HL70063|1820 Laag en Braassem St^^Roos^MI^48756^USA^P|^PRN^PH^^^989^6744440ORC|RE||BW46H19827.1^AIRARXA|0|1|20181126||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.2^AIRARXA|0|1|20190126||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.3^AIRARXA|0|1|20190126||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.4^AIRARXA|0|1|20190126||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.5^AIRARXA|0|1|20190126||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.6^AIRARXA|0|1|20190126||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.7^AIRARXA|0|1|20190126||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.8^AIRARXA|0|1|20190328||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.9^AIRARXA|0|1|20190328||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.10^AIRARXA|0|1|20190328||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.11^AIRARXA|0|1|20190328||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.12^AIRARXA|0|1|20190328||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.13^AIRARXA|0|1|20190528||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.14^AIRARXA|0|1|20190528||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.15^AIRARXA|0|1|20190528||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.16^AIRARXA|0|1|20190528||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BW46H19827.17^AIRARXA|0|1|20190528||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AW46H19827.18^AIRA|BW46H19827.18^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20201201|PMC^Sanofi^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AW46H19827.19^AIRA|BW46H19827.19^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20201201|PFR^Pfizer^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AW46H19827.20^AIRA|BW46H19827.20^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AW46H19827.21^AIRA|BW46H19827.21^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|cPU-GM-2.4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M75C19832^^^AIRA^MR||ParasariAIRA^BobbieAIRA^^^^^L||20160226|FORC|RE||BM75C19832.1^AIRARXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||AOBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||FOBX|2|CE|69764-9^Document Type^LN|2|253088698300013411100521^Measles Mumps Rubella Varicella VIS^cdcgs1vis||||||FOBX|3|DT|29769-7^Date Vis Presented^LN|2|20200308||||||FMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|cPU-GM-2.5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E68F19837^^^AIRA^MR||ClaytonAIRA^AdriannaAIRA^^^^^L||20160226|FORC|RE||BE68F19837.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AMSH|^~\&|||||20200308082215-0400||VXU^V04^VXU_V04|cZy-A.01.01|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M81F19944^^^MAA^MR||NanceAIRA^TheoraAIRA^Narmada^^^^L|BrooksAIRA^AlbertaAIRA^^^^^M|20180318|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|1985 Scherpenzeel Pl^^Washington Township^MI^48095^USA^L||^PRN^PH^^^586^6922495|||||||||2186-5^non Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200122|20200122NK1|1|NanceAIRA^BrooksAIRA^^^^^L|MTH^Mother^HL70063|1985 Scherpenzeel Pl^^Washington Township^MI^48095^USA^L|^PRN^PH^^^586^6922495ORC|RE||BM81F19944.1^NDA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||140^Influenza^CVX|0.25|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001|7832-1^Lemon^Mike^A^^^^^NIST-AA-1|^^^B31||||J6702KP|20200708|PMC^sanofi pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308082215-0500||VXU^V04^VXU_V04|cZy-A.01.02|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P21R19951^^^MAA^MR~184-25-4562^^^MAA^SS||LeeAIRA^BoydAIRA^^^^^L||19490203|M|||||^~^NET^^Eisig@hotmail.comORC|RE||BP21R19951.1^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20200308||115^Tdap^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^0||||Z79YG|20200708|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20200306|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|139^Td(adult) unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20130509||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308082215-0500||VXU^V04^VXU_V04|cZy-A.01.03|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z17T19956^^^MAA^MR||OklahomaAIRA^TrixyAIRA^^^^^L||20090508|FORC|RE||BZ17T19956.1^NDARXA|0|1|20181023||83^Hep A^CVX|999|||01^Historical information - source unspecified^NIP001MSH|^~\&|||||20200308082215-0500||VXU^V04^VXU_V04|cZy-A.01.04|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F41U19965^^^MAA^MR||JacksonAIRA^BirdieAIRA^^^^^L||20090420|FPD1||||||||||||N|20200308ORC|RE||BF41U19965.1^NDARXA|0|1|20181022||118^HPV^CVX|999|||01^Historical information - source unspecified^NIP001MSH|^~\&|||||20200308082215-0500||VXU^V04^VXU_V04|cZy-A.01.05|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F57S19972^^^MAA^MR||O'ConnellAIRA^GugliehnoAIRA^^^^^L||20180331|MORC|RE||BF57S19972.1^CDCRXA|0|1|20200308||03^MMR^CVX|999||||||||||||00^Parental Refusal^NIP002||REMSH|^~\&|||||20200308082215-0500||VXU^V04^VXU_V04|cZy-A.01.06|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F95K19979^^^NIST MPI^MR||JohnsonAIRA^MeadowAIRA^^^^^L||20090506|FORC|RE||BF95K19979.1^CDCRXA|0|1|20181023||998^No vaccine administered^CVX|999||||||||||||||NAOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||FMSH|^~\&|||||20200308082215-0500||VXU^V04^VXU_V04|cZy-A.01.07|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q96N19984^^^MAA^MR||EmmetAIRA^CullenAIRA^Dev^^^^L||20170313|MORC|RE||BQ96N19984.1^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20200308||140^Influenza^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||W1356FE|20200708|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RA^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200124|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|88^Influenza, unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FORC|RE||BQ96N19984.2^NDARXA|0|1|20180908||133^PCV 13^CVX|999|||01^Historical information - source unspecified^NIP001ORC|RE||BQ96N19984.3^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20200308||110^DTaP-Hep B-IPV^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||||||78HH34I|20200708|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LA^Left Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20200124|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|107^DTaP^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20070517||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FOBX|5|CE|30956-7^vaccine type^LN|3|89^Polio^CVX||||||FOBX|6|TS|29768-9^Date vaccine information statement published^LN|3|20111108||||||FOBX|7|TS|29769-7^Date vaccine information statement presented^LN|3|20200308||||||FOBX|8|CE|30956-7^vaccine type^LN|4|45^Hep B, unspecified formulation^CVX||||||FOBX|9|TS|29768-9^Date vaccine information statement published^LN|4|20120202||||||FOBX|10|TS|29769-7^Date vaccine information statement presented^LN|4|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|cZy-A0|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A61U19989^^^AIRA-TEST^MR||EllisAIRA^AliaAIRA^Sinead^^^^L|DurbinAIRA^JaelynnAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1844 Duidelijk Ave^^Norton Shores^MI^49441^USA^P||^PRN^PH^^^231^8945415|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|EllisAIRA^DurbinAIRA^^^^^L|MTH^Mother^HL70063|1844 Duidelijk Ave^^Norton Shores^MI^49441^USA^P|^PRN^PH^^^231^8945415ORC|RE||BA61U19989.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA61U19989.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308073733.994-0500||VXU^V04^VXU_V04|d44-L.IZ-AD-1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E63S20001^^^NIST-MPI-1^MR||DavisAIRA^DamonAIRA^Layton^^^^L|KentonAIRA^^^^^^M|20191229|M||1002-5^American Indian or Alaska Native^CDCREC|1325 Sulpen-Wittem Pl^^Foster City^MI^49834^USA^P||^PRN^PH^^^906^8329086|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200308|||A|20191229|20200308NK1|1|DavisAIRA^KentonAIRA^Elizabeth^^^^L|MTH^Mother^HL70063|1325 Sulpen-Wittem Pl^^Foster City^MI^49834^USA^P|^PRN^PH^^^906^8329086NK1|2|DavisAIRA^LivingstonAIRA^William^^^^L|FTH^Father^HL70063|1325 Sulpen-Wittem Pl^^Foster City^MI^49834^USA^P|^PRN^CP^^^906^8329086ORC|RE|AE63S20001.1^NIST-AA-IZ-2|BE63S20001.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||49281-0560-05^Pentacel^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||526434|20200405|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300017211160720^Polio VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308OBX|5|CE|69764-9^Document Type^LN|4|253088698300006611150402^Haemophilus Influenzae type b VIS^cdcgs1vis||||||F|||20200308OBX|6|DT|29769-7^Date Vis Presented^LN|4|20200308||||||F|||20200308OBX|7|CE|69764-9^Document Type^LN|5|253088698300003511070517^Diphtheria/Tetanus/Pertussis (DTaP) VIS^cdcgs1vis||||||F|||20200308OBX|8|DT|29769-7^Date Vis Presented^LN|5|20200308||||||F|||20200308ORC|RE|AE63S20001.2^NIST-AA-IZ-2|BE63S20001.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4047-20^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||297961|20200531|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300019611150415^Rotavirus VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AE63S20001.3^NIST-AA-IZ-2|BE63S20001.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||353480|20200412|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V04^VFC Eligible - American Indian/Alaska Native^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300015811151105^Pneumococcal Conjugate (PCV13) VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE||BE63S20001.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20191230||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BE63S20001.5^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200128||45^Hep B, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200308084727.655-0500||VXU^V04^VXU_V04|d44-L.IZ-AD-2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J26F20008^^^NIST-MPI-1^MR||KnottAIRA^PakunaAIRA^^^^^L||19880228|F||2028-9^Asian^CDCREC|1932 Veld Ln^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^8477045~^NET^^Elise.Wong@isp.com|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||02^Reminder/recall - any method^HL70215|N|20200308|||A|19880228|20200308ORC|RE|AJ26F20008.1^NIST-AA-IZ-2|BJ26F20008.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||49281-0215-88^TENIVAC^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||315841|20200830|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300028811170411^Tetanus/Diphtheria (Td) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE||BJ26F20008.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20190627||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AORC|RE||BJ26F20008.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20180728||88^influenza, unspecified formulation^CVX|999|||01^Historical Administration^NIP001|||||||||||CP|AMSH|^~\&|||||20200308093847.804-0500||VXU^V04^VXU_V04|d44-L.IZ-AD-3|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F56R20015^^^NIST-MPI-1^MR||ColoradoAIRA^TeanAIRA^Claire^^^^L|HammarAIRA^^^^^^M|20080904|F||2106-3^White^CDCREC|1262 Gat Ave^^Sandusky^MI^48471^USA^P||^PRN^PH^^^810^6625994|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||01^No reminder/recall^HL70215|Y|20200308|||A|20080904|20200308NK1|1|ColoradoAIRA^HammarAIRA^Michelle^^^^L|MTH^Mother^HL70063|1262 Gat Ave^^Sandusky^MI^48471^USA^P|^PRN^PH^^^810^6625994ORC|RE|AF56R20015.1^NIST-AA-IZ-2|BF56R20015.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4119-01^GARDASIL 9^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||795441|20200906|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V05^VFC Eligible - Underinsured^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300029511161202^HPV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308093847.804-0500||VXU^V04^VXU_V04|d44-L.IZ-AD-4|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z75Q20022^^^NIST-MPI-1^MR||McErlaineAIRA^RexanaAIRA^Angel^^^^L|PimaAIRA^^^^^^M|20080904|F||2106-3^White^CDCREC|1493 Aieuwkoop St^^Seney^MI^49883^USA^P||^PRN^PH^^^906^7507680|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||NPD1|||||||||||01^No reminder/recall^HL70215|Y|20200308|||A|20080904|20200308NK1|1|McErlaineAIRA^PimaAIRA^Michelle^^^^L|MTH^Mother^HL70063|1493 Aieuwkoop St^^Seney^MI^49883^USA^P|^PRN^PH^^^906^7507680ORC|RE|AZ75Q20022.1^NIST-AA-IZ-2|BZ75Q20022.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4119-01^GARDASIL 9^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||795441|20200906|MSD^Merck and Co., Inc.^MVX|||CP|DRXR|C28161^Intramuscular^NCIT|RD^Right Deltoid^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|VXC50^Public^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V05^VFC Eligible - Underinsured^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300029511161202^HPV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308093847.808-0500||VXU^V04^VXU_V04|d44-L.IZ-AD-5|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F14C20029^^^NIST-MPI-1^MR||LoganAIRA^AkivaAIRA^Rayan^^^^L||20190215|M||2106-3^White^CDCREC|1257 Eeder-Betuwe St^^White Pigeon^MI^49099^USA^P||^PRN^PH^^^269^2624303|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20200308|||A|20090215|20200308NK1|1|LoganAIRA^StoryAIRA^Leonard^^^^L|FTH^Father^HL70063|1257 Eeder-Betuwe St^^White Pigeon^MI^49099^USA^P|^PRN^PH^^^269^2624303ORC|RE|AF14C20029.1^NIST-AA-IZ-2|BF14C20029.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||58160-0806-01^HIBERIX^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||328734|20200607|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AF14C20029.2^NIST-AA-IZ-2|BF14C20029.2^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208940|20201004|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AF14C20029.3^NIST-AA-IZ-2|BF14C20029.3^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4681-01^M-M-R II^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||134301|20200712|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300012711120420^Measles/Mumps/Rubella VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE||BF14C20029.4^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|||||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200308093847.808-0500||VXU^V04^VXU_V04|d44-L.IZ-AD-6|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A31S20036^^^NIST-MPI-1^MR||MitchellAIRA^SaxonAIRA^Yeshaya^^^^L||20190215|M||2106-3^White^CDCREC|1484 Dteenwijkerland Ave^^Perry^MI^48872^USA^P||^PRN^PH^^^517^4741499|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||08^Reminder/recall - to provider^HL70215|N|20200308|||A|20090215|20200308NK1|1|MitchellAIRA^LeeAIRA^Leonard^^^^L|FTH^Father^HL70063|1484 Dteenwijkerland Ave^^Perry^MI^48872^USA^P|^PRN^PH^^^517^4741499ORC|RE|AA31S20036.1^NIST-AA-IZ-2|BA31S20036.1^NIST-AA-IZ-2|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362RXA|0|1|20200308||00006-4095-01^VAQTA^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1^L^^^PRN|^^^NIST-Clinic-1||||208490|20201004|MSD^Merck and Co., Inc.^MVX|||CP|URXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|TZK-P.1.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A56N39547^^^AIRA-TEST^MR||KentAIRA^AwusiAIRA^Ayla^^^^L|PecosAIRA^HokuAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1954 Laren Cir^^Detroit^MI^48215^USA^P||^PRN^PH^^^313^9611781|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KentAIRA^PecosAIRA^^^^^L|MTH^Mother^HL70063|1954 Laren Cir^^Detroit^MI^48215^USA^P|^PRN^PH^^^313^9611781ORC|RE||BA56N39547.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|TzS-Q15.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J80A39437^^^AIRA-TEST^MR||CartonAIRA^LeontineAIRA^An^^^^L|MetcalfeAIRA^TadakoAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1521 Beeze-Leende Pl^^Detroit^MI^48219^USA^P||^PRN^PH^^^313^5327755|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CartonAIRA^MetcalfeAIRA^^^^^L|MTH^Mother^HL70063|1521 Beeze-Leende Pl^^Detroit^MI^48219^USA^P|^PRN^PH^^^313^5327755ORC|RE||BJ80A39437.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ80A39437.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|TzS-Q15.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J82J39447^^^AIRA-TEST^MR||HowardAIRA^UtaAIRA^Evelyn^^^^L|AransasAIRA^AbriendaAIRA^^^^^M|20191107|F||2106-3^White^CDCREC|1614 Rernheze Cir^^Pontiac^MI^48340^USA^P||^PRN^PH^^^248^2558781|||||||||2186-5^not Hispanic or Latino^HL70005PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HowardAIRA^AransasAIRA^^^^^L|MTH^Mother^HL70063|1614 Rernheze Cir^^Pontiac^MI^48340^USA^P|^PRN^PH^^^248^2558781ORC|RE||BJ82J39447.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BJ82J39447.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.1.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Q98A39463^^^AIRA^MR||CavilAIRA^ClaiborneAIRA^Iliana^^^^L|PolkAIRA^JacquelineAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1476 Eenheid Ln^^Garden City^MI^48136^USA^P||^PRN^PH^^^734^3914560|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|CavilAIRA^PolkAIRA^Marion^^^^L|MTH^Mother^HL70063|1476 Eenheid Ln^^Garden City^MI^48136^USA^P|^PRN^PH^^^734^3914560ORC|RE|AQ98A39463.1^AIRA|BQ98A39463.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AQ98A39463.2^AIRA|BQ98A39463.2^AIRARXA|0|1|20190308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.2.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P44C39471^^^AIRA^MR||AroostookAIRA^AmalaAIRA^Abbie^^^^L|LeeAIRA^VivianAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1151 Molecuul St^^Ray Township^MI^48096^USA^P||^PRN^PH^^^586^2427565|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|AroostookAIRA^LeeAIRA^Marion^^^^L|MTH^Mother^HL70063|1151 Molecuul St^^Ray Township^MI^48096^USA^P|^PRN^PH^^^586^2427565ORC|RE|AP44C39471.1^AIRA|BP44C39471.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AP44C39471.2^AIRA|BP44C39471.2^AIRARXA|0|1|20190308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.3.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P35P39479^^^AIRA^MR||IversenAIRA^RionaAIRA^Roz^^^^L|McErlaneAIRA^GeraldineAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1361 Diemen Ln^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^4086985|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|IversenAIRA^McErlaneAIRA^Marion^^^^L|MTH^Mother^HL70063|1361 Diemen Ln^^Hamtramck^MI^48212^USA^P|^PRN^PH^^^313^4086985ORC|RE|AP35P39479.1^AIRA|BP35P39479.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AP35P39479.2^AIRA|BP35P39479.2^AIRARXA|0|1|20190308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.3.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G76S39486^^^AIRA^MR||GreeleyAIRA^MckinleyAIRA^Briony^^^^L|HuntAIRA^VitaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1174 Kapitein Cir^^Dexter Township^MI^48169^USA^P||^PRN^PH^^^734^7618102|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|GreeleyAIRA^HuntAIRA^Marion^^^^L|MTH^Mother^HL70063|1174 Kapitein Cir^^Dexter Township^MI^48169^USA^P|^PRN^PH^^^734^7618102ORC|RE|AG76S39486.1^AIRA|BG76S39486.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AG76S39486.2^AIRA|BG76S39486.2^AIRARXA|0|1|20190308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.5.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z91Z39503^^^AIRA^MR||LegresleyAIRA^ZeaAIRA^Acanit^^^^L|ChesterAIRA^MyleeAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1973 Galderberge Ln^^Flint^MI^48556^USA^P||^PRN^PH^^^810^8836225|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|1|||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|LegresleyAIRA^ChesterAIRA^Marion^^^^L|MTH^Mother^HL70063|1973 Galderberge Ln^^Flint^MI^48556^USA^P|^PRN^PH^^^810^8836225ORC|RE|AZ91Z39503.1^AIRA|BZ91Z39503.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AZ91Z39503.2^AIRA|BZ91Z39503.2^AIRARXA|0|1|20190308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.5.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L40V39508^^^AIRA^MR||LegresleyAIRA^ZeaAIRA^Bergen^^^^L|ChesterAIRA^MyleeAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1973 Galderberge Ln^^Flint^MI^48556^USA^P||^PRN^PH^^^810^8836225|||||||||2186-5^not Hispanic or Latino^CDCREC||Y|2|||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|LegresleyAIRA^ChesterAIRA^Marion^^^^L|MTH^Mother^HL70063|1973 Galderberge Ln^^Flint^MI^48556^USA^P|^PRN^PH^^^810^8836225ORC|RE|AZ91Z39503.1^AIRA|BZ91Z39503.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AZ91Z39503.2^AIRA|BZ91Z39503.2^AIRARXA|0|1|20190308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|TFG-QA.7.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N71D39521^^^AIRA^MR||WynneAIRA^QuintinaAIRA^Jael^^^^L|ChaseAIRA^KerenAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1494 Worger-Odoorn St^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^8138230|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|WynneAIRA^ChaseAIRA^Marion^^^^L|MTH^Mother^HL70063|1494 Worger-Odoorn St^^Corunna^MI^48817^USA^P|^PRN^PH^^^989^8138230ORC|RE||BN71D39521.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BN71D39521.2^AIRARXA|0|1|20170308||83^Hep A peds^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.1.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y42N20041^^^AIRA^MR||HalsallAIRA^CarolineAIRA^Luna^^^^L|San BenitoAIRA^MadonnaAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1944 Herkendam Cir^^Warren^MI^48091^USA^P||^PRN^PH^^^586^4449704|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HalsallAIRA^San BenitoAIRA^Marion^^^^L|MTH^Mother^HL70063|1944 Herkendam Cir^^Warren^MI^48091^USA^P|^PRN^PH^^^586^4449704ORC|RE|AY42N20041.1^AIRA|BY42N20041.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.1.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V79R20043^^^AIRA^MR||CollingsworthAIRA^VaisakhiAIRA^Alpha^^^^L|AlpenaAIRA^KatharineAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1684 Dijfheerenlanden Cir^^Branch^MI^49402^USA^P||^PRN^PH^^^231^8482859|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|CollingsworthAIRA^AlpenaAIRA^Marion^^^^L|MTH^Mother^HL70063|1684 Dijfheerenlanden Cir^^Branch^MI^49402^USA^P|^PRN^PH^^^231^8482859ORC|RE|AV79R20043.1^AIRA|BV79R20043.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C65U20053^^^AIRA^MR||MononAIRA^SangmuAIRA^^^^^L||20160226|FORC|RE||BC65U20053.1^AIRARXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||AOBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||FOBX|2|CE|69764-9^Document Type^LN|2|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||FOBX|3|DT|29769-7^Date Vis Presented^LN|2|20200308||||||FMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U00E20055^^^AIRA^MR||BorthroydAIRA^SuravindaAIRA^^^^^L||20160226|FORC|RE||BU00E20055.1^AIRARXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||AOBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||FOBX|2|CE|69764-9^Document Type^LN|2|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||FOBX|3|DT|29769-7^Date Vis Presented^LN|2|20200308||||||FMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||T51M20065^^^AIRA^MR||GillespieAIRA^ZoilaAIRA^^^^^L||20160226|FORC|RE||BT51M20065.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K17J20067^^^AIRA^MR||StarkAIRA^LynseyAIRA^^^^^L||20160226|FORC|RE||BK17J20067.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S92P20075^^^AIRA^MR||JonesAIRA^AmaniAIRA^^^^^L||20160226|FORC|RE||9999^AIRA|RXA|0|1|20200308||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V70J20077^^^AIRA^MR||TehamaAIRA^EasterAIRA^^^^^L||20160226|FORC|RE||9999^AIRA|RXA|0|1|20200308||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.4.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C49U20087^^^AIRA^MR||AntrimAIRA^ThirzaAIRA^^^^^L||20160226|FORC|RE||BC49U20087.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170308||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||FMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.4.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L84R20089^^^AIRA^MR||HowathAIRA^KateAIRA^^^^^L||20160226|FORC|RE||BL84R20089.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170308||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||FMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.5.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E38D20097^^^AIRA^MR||LundgrenAIRA^NarkeashaAIRA^^^^^L||20160226|FORC|RE||BE38D20097.1^AIRARXA|0|1|20170308||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170308||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.10.5.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L75V20099^^^AIRA^MR||RobertsAIRA^BorgnyAIRA^^^^^L||20160226|FORC|RE||BL75V20099.1^AIRARXA|0|1|20170308||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||AORC|RE||9999^AIRA|RXA|0|1|20170308||998^No Vaccine Administered^CVX|999|||||||||||||||AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.11.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I56R20107^^^AIRA^MR||NapaAIRA^MirembaAIRA^Geranium^^^^L|PresidioAIRA^ZotiaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1275 Rernheze Pl^^Nazareth^MI^49074^USA^P||^PRN^PH^^^269^7301518|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|NapaAIRA^PresidioAIRA^Marion^^^^L|MTH^Mother^HL70063|1275 Rernheze Pl^^Nazareth^MI^49074^USA^P|^PRN^PH^^^269^7301518ORC|RE|AI56R20107.1^AIRA|BI56R20107.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||PA|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.11.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M43K20109^^^AIRA^MR||ProvidenceAIRA^MarjorieAIRA^Selena^^^^L|NelsonAIRA^AlviraAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1967 Orootegast Ave^^East Lansing^MI^48825^USA^P||^PRN^PH^^^517^3571039|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ProvidenceAIRA^NelsonAIRA^Marion^^^^L|MTH^Mother^HL70063|1967 Orootegast Ave^^East Lansing^MI^48825^USA^P|^PRN^PH^^^517^3571039ORC|RE|AM43K20109.1^AIRA|BM43K20109.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||PA|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.11.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G29E20119^^^AIRA^MR||RichardsonAIRA^ValeriaAIRA^Casey^^^^L|WalkerAIRA^AliyaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1274 Liefde St^^Wyandotte^MI^48193^USA^P||^PRN^PH^^^734^4827976|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|RichardsonAIRA^WalkerAIRA^Marion^^^^L|MTH^Mother^HL70063|1274 Liefde St^^Wyandotte^MI^48193^USA^P|^PRN^PH^^^734^4827976ORC|RE|AG29E20119.1^AIRA|BG29E20119.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||PA|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.11.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I77A20121^^^AIRA^MR||YorkAIRA^SmritiAIRA^Saige^^^^L|OkmulgeeAIRA^ArdisAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1289 Schijndel Pl^^Emmett Township^MI^48022^USA^P||^PRN^PH^^^810^9397260|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|YorkAIRA^OkmulgeeAIRA^Marion^^^^L|MTH^Mother^HL70063|1289 Schijndel Pl^^Emmett Township^MI^48022^USA^P|^PRN^PH^^^810^9397260ORC|RE|AI77A20121.1^AIRA|BI77A20121.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||PA|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.12.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U01R20129^^^AIRA^MR||RussellAIRA^LisbetAIRA^Jordan^^^^L|PermanAIRA^FairleeAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1013 Rluis Ave^^Meskegon^MI^49445^USA^P||^PRN^PH^^^231^6588854|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|RussellAIRA^PermanAIRA^Marion^^^^L|MTH^Mother^HL70063|1013 Rluis Ave^^Meskegon^MI^49445^USA^P|^PRN^PH^^^231^6588854ORC|RE|AU01R20129.1^AIRA|BU01R20129.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.13.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D06Q20136^^^AIRA^MR||MontereyAIRA^FionolaAIRA^Salwa^^^^L|CarrollAIRA^OonaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1545 Werking St^^Total Petroleum^MI^48802^USA^P||^PRN^PH^^^989^8906613|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|MontereyAIRA^CarrollAIRA^Marion^^^^L|MTH^Mother^HL70063|1545 Werking St^^Total Petroleum^MI^48802^USA^P|^PRN^PH^^^989^8906613ORC|RE|AD06Q20136.1^AIRA|BD06Q20136.1^AIRARXA|0|1|20150225||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.13.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O52W20143^^^AIRA^MR||NewberryAIRA^NabelungAIRA^Achen^^^^L|CarrollAIRA^SuzanneAIRA^^^^^M||F||2106-3^White^CDCREC|1353 Aub St^^Clifford^MI^48727^USA^P||^PRN^PH^^^989^3859142|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|NewberryAIRA^CarrollAIRA^Marion^^^^L|MTH^Mother^HL70063|1353 Aub St^^Clifford^MI^48727^USA^P|^PRN^PH^^^989^3859142ORC|RE|AO52W20143.1^AIRA|BO52W20143.1^AIRARXA|0|1|20200308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.15.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||D85N20150^^^AIRA^MR||BolotadAIRA^EmilyAIRA^Sachi^^^^L|CallowayAIRA^QuintaAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1128 Herkelland Ln^^Riverside^MI^49084^USA^P||^PRN^PH^^^269^5048699|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|BolotadAIRA^CallowayAIRA^Marion^^^^L|MTH^Mother^HL70063|1128 Herkelland Ln^^Riverside^MI^49084^USA^P|^PRN^PH^^^269^5048699ORC|RE|AD85N20150.1^AIRA|BD85N20150.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AD85N20150.2^AIRA|BD85N20150.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AD85N20150.3^AIRA|BD85N20150.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-0860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.15.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I86D20152^^^AIRA^MR||AransasAIRA^SuzyAIRA^Roshan^^^^L|FayetteAIRA^DeianiraAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1455 Hoeree-Overflakkee St^^Barbeau^MI^49710^USA^P||^PRN^PH^^^906^5345945|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|AransasAIRA^FayetteAIRA^Marion^^^^L|MTH^Mother^HL70063|1455 Hoeree-Overflakkee St^^Barbeau^MI^49710^USA^P|^PRN^PH^^^906^5345945ORC|RE|AI86D20152.1^AIRA|BI86D20152.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AI86D20152.2^AIRA|BI86D20152.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AI86D20152.3^AIRA|BI86D20152.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-0860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.15.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I58Z20162^^^AIRA^MR||HillAIRA^MollyAIRA^Zosima^^^^L|HancockAIRA^WanikaAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1342 Eorst aan de Maas St^^Detroit^MI^48207^USA^P||^PRN^PH^^^313^3389988|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HillAIRA^HancockAIRA^Marion^^^^L|MTH^Mother^HL70063|1342 Eorst aan de Maas St^^Detroit^MI^48207^USA^P|^PRN^PH^^^313^3389988ORC|RE|AI58Z20162.1^AIRA|BI58Z20162.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AI58Z20162.2^AIRA|BI58Z20162.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AI58Z20162.3^AIRA|BI58Z20162.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-0860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.15.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A34M20164^^^AIRA^MR||WinneshiekAIRA^CharityAIRA^Kendall^^^^L|PasoAIRA^BeataAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1471 Pose Ave^^Frontier^MI^49239^USA^P||^PRN^PH^^^517^7718358|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|WinneshiekAIRA^PasoAIRA^Marion^^^^L|MTH^Mother^HL70063|1471 Pose Ave^^Frontier^MI^49239^USA^P|^PRN^PH^^^517^7718358ORC|RE|AA34M20164.1^AIRA|BA34M20164.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AA34M20164.2^AIRA|BA34M20164.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AA34M20164.3^AIRA|BA34M20164.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-0860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P43T20174^^^AIRA^MR||NacogdochesAIRA^AudlinAIRA^Jordane^^^^L|SkagAIRA^VernaAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1963 Fe Wolden Ave^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^4027520|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|NacogdochesAIRA^SkagAIRA^Marion^^^^L|MTH^Mother^HL70063|1963 Fe Wolden Ave^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^4027520ORC|RE|AP43T20174.1^AIRA|BP43T20174.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005197104^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AP43T20174.2^AIRA|BP43T20174.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006404741^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AP43T20174.3^AIRA|BP43T20174.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281086010^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A70U20176^^^AIRA^MR||ValleyAIRA^MalloryAIRA^Kolora^^^^L|Van ZandtAIRA^QamraAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1808 Ealfsen Cir^^Detroit^MI^48221^USA^P||^PRN^PH^^^313^4692197|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ValleyAIRA^Van ZandtAIRA^Marion^^^^L|MTH^Mother^HL70063|1808 Ealfsen Cir^^Detroit^MI^48221^USA^P|^PRN^PH^^^313^4692197ORC|RE|AA70U20176.1^AIRA|BA70U20176.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005197104^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AA70U20176.2^AIRA|BA70U20176.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006404741^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AA70U20176.3^AIRA|BA70U20176.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281086010^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I03J20186^^^AIRA^MR||ValleyAIRA^EsmeAIRA^Tracey^^^^L|ThorsenAIRA^HannaAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1674 Fe Wolden Ave^^Baroda^MI^49101^USA^P||^PRN^PH^^^269^4645971|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ValleyAIRA^ThorsenAIRA^Marion^^^^L|MTH^Mother^HL70063|1674 Fe Wolden Ave^^Baroda^MI^49101^USA^P|^PRN^PH^^^269^4645971ORC|RE|AI03J20186.1^AIRA|BI03J20186.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005197101^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AI03J20186.2^AIRA|BI03J20186.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006404701^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AI03J20186.3^AIRA|BI03J20186.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281086078^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E61H20188^^^AIRA^MR||HowathAIRA^MinAIRA^Fujita^^^^L|JeffersonAIRA^ElennaAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1820 Land Ave^^Sault Sainte Marie^MI^49786^USA^P||^PRN^PH^^^906^4195272|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HowathAIRA^JeffersonAIRA^Marion^^^^L|MTH^Mother^HL70063|1820 Land Ave^^Sault Sainte Marie^MI^49786^USA^P|^PRN^PH^^^906^4195272ORC|RE|AE61H20188.1^AIRA|BE61H20188.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00005197101^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AE61H20188.2^AIRA|BE61H20188.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||00006404701^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AE61H20188.3^AIRA|BE61H20188.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281086078^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||B44T20198^^^AIRA^MR||RoseAIRA^KordeliaAIRA^Zariah^^^^L|BorthroydAIRA^ToriAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1551 Keel en Maas St^^Independence Township^MI^48346^USA^P||^PRN^PH^^^248^4121121|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|RoseAIRA^BorthroydAIRA^Marion^^^^L|MTH^Mother^HL70063|1551 Keel en Maas St^^Independence Township^MI^48346^USA^P|^PRN^PH^^^248^4121121ORC|RE|AB44T20198.1^AIRA|BB44T20198.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AB44T20198.2^AIRA|BB44T20198.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AB44T20198.3^AIRA|BB44T20198.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R68L20200^^^AIRA^MR||MasonAIRA^FifiAIRA^Miranda^^^^L|CarbonAIRA^KaiAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1675 Oergen op Zoom Ave^^Kingston^MI^48741^USA^P||^PRN^PH^^^989^8377200|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|MasonAIRA^CarbonAIRA^Marion^^^^L|MTH^Mother^HL70063|1675 Oergen op Zoom Ave^^Kingston^MI^48741^USA^P|^PRN^PH^^^989^8377200ORC|RE|AR68L20200.1^AIRA|BR68L20200.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0005-1971-04^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AR68L20200.2^AIRA|BR68L20200.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0006-4047-41^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AR68L20200.3^AIRA|BR68L20200.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-860-10^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.4.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z73J20208^^^AIRA^MR||BooneAIRA^TadiAIRA^Toyo^^^^L|StantonAIRA^PaisleyAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1986 Oss Cir^^Ahmeek^MI^49901^USA^P||^PRN^PH^^^906^3354667|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|BooneAIRA^StantonAIRA^Marion^^^^L|MTH^Mother^HL70063|1986 Oss Cir^^Ahmeek^MI^49901^USA^P|^PRN^PH^^^906^3354667ORC|RE|AZ73J20208.1^AIRA|BZ73J20208.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AZ73J20208.2^AIRA|BZ73J20208.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AZ73J20208.3^AIRA|BZ73J20208.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|d6Y-SA.16.4.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E67U20210^^^AIRA^MR||FoxAIRA^MelvinaAIRA^Calandra^^^^L|BuffaloAIRA^WalburgaAIRA^^^^^M|20200107|F||2106-3^White^CDCREC|1216 Warmte St^^Croswell^MI^48422^USA^P||^PRN^PH^^^810^3956764|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|FoxAIRA^BuffaloAIRA^Marion^^^^L|MTH^Mother^HL70063|1216 Warmte St^^Croswell^MI^48422^USA^P|^PRN^PH^^^810^3956764ORC|RE|AE67U20210.1^AIRA|BE67U20210.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0005-1971-01^Prevnar 13^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||353480|20250104|PFR^Pfizer, Inc^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300015811151105^Pneumococcal Conjugate (PCV13) Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AE67U20210.2^AIRA|BE67U20210.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||0006-4047-01^RotaTeq^NDC|2.0|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||297961|20250222|MSD^Merck and Co., Inc.^MVX|||CP|ARXR|C38288^Oral^NCITOBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|1|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300019611180223^Rotavirus Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308ORC|RE|AE67U20210.3^AIRA|BE67U20210.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||49281-860-78^IPOL^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||526434|20241228|PMC^Sanofi Pasteur^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RT^Right Thigh^HL70163OBX|1|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|2|CE|69764-9^Document Type^LN|2|253088698300017211160720^Polio Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|3|DT|29769-7^Date Vis Presented^LN|2|20151130||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.2.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X98S20220^^^AIRA^MR||BarrenAIRA^LataAIRA^Floria^^^^L|MahoneyAIRA^MohiniAIRA^^^^^M|20040226|F||2106-3^White^CDCREC|1291 Sodegraven-Reeuwijk St^^Paw Paw^MI^49079^USA^P||^PRN^PH^^^269^6115321|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|BarrenAIRA^MahoneyAIRA^Marion^^^^L|MTH^Mother^HL70063|1291 Sodegraven-Reeuwijk St^^Paw Paw^MI^49079^USA^P|^PRN^PH^^^269^6115321ORC|RE||BX98S20220.1^AIRARXA|0|1|20080308||03^MMR^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.2.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A15X20222^^^AIRA^MR||LoganAIRA^AilishAIRA^Nikki^^^^L|NowataAIRA^EnyaAIRA^^^^^M|20040226|F||2106-3^White^CDCREC|1849 Mittard-Geleen Cir^^Beechwood^MI^49935^USA^P||^PRN^PH^^^906^6449387|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|LoganAIRA^NowataAIRA^Marion^^^^L|MTH^Mother^HL70063|1849 Mittard-Geleen Cir^^Beechwood^MI^49935^USA^P|^PRN^PH^^^906^6449387ORC|RE||BA15X20222.1^AIRARXA|0|1|20080308||03^MMR^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.3.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y12F20230^^^AIRA^MR||CallahanAIRA^BehiraAIRA^Maryann^^^^L|IsabellaAIRA^NasicheAIRA^^^^^M|20181126|F||2106-3^White^CDCREC|1107 Deert Ave^^Orion^MI^48360^USA^P||^PRN^PH^^^248^2178869|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|CallahanAIRA^IsabellaAIRA^Marion^^^^L|MTH^Mother^HL70063|1107 Deert Ave^^Orion^MI^48360^USA^P|^PRN^PH^^^248^2178869ORC|RE||BY12F20230.1^AIRARXA|0|1|20181126||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.2^AIRARXA|0|1|20190126||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.3^AIRARXA|0|1|20190126||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.4^AIRARXA|0|1|20190126||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.5^AIRARXA|0|1|20190126||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.6^AIRARXA|0|1|20190126||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.7^AIRARXA|0|1|20190126||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.8^AIRARXA|0|1|20190328||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.9^AIRARXA|0|1|20190328||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.10^AIRARXA|0|1|20190328||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.11^AIRARXA|0|1|20190328||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.12^AIRARXA|0|1|20190328||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.13^AIRARXA|0|1|20190528||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.14^AIRARXA|0|1|20190528||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.15^AIRARXA|0|1|20190528||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.16^AIRARXA|0|1|20190528||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BY12F20230.17^AIRARXA|0|1|20190528||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AY12F20230.18^AIRA|BY12F20230.18^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20201201|PMC^Sanofi^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AY12F20230.19^AIRA|BY12F20230.19^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20201201|PFR^Pfizer^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AY12F20230.20^AIRA|BY12F20230.20^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AY12F20230.21^AIRA|BY12F20230.21^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.3.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K90P20232^^^AIRA^MR||SchuylkillAIRA^VeraAIRA^Acadia^^^^L|MadisonAIRA^EstelleAIRA^^^^^M|20181126|F||2106-3^White^CDCREC|1406 Giekerkerhoek St^^Akron^MI^48701^USA^P||^PRN^PH^^^989^2114690|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|SchuylkillAIRA^MadisonAIRA^Marion^^^^L|MTH^Mother^HL70063|1406 Giekerkerhoek St^^Akron^MI^48701^USA^P|^PRN^PH^^^989^2114690ORC|RE||BK90P20232.1^AIRARXA|0|1|20181126||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.2^AIRARXA|0|1|20190126||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.3^AIRARXA|0|1|20190126||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.4^AIRARXA|0|1|20190126||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.5^AIRARXA|0|1|20190126||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.6^AIRARXA|0|1|20190126||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.7^AIRARXA|0|1|20190126||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.8^AIRARXA|0|1|20190328||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.9^AIRARXA|0|1|20190328||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.10^AIRARXA|0|1|20190328||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.11^AIRARXA|0|1|20190328||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.12^AIRARXA|0|1|20190328||10^IPV^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.13^AIRARXA|0|1|20190528||45^Hep B Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.14^AIRARXA|0|1|20190528||122^Rotavirus Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.15^AIRARXA|0|1|20190528||107^DTaP Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.16^AIRARXA|0|1|20190528||17^Hib Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE||BK90P20232.17^AIRARXA|0|1|20190528||152^PCV Unspecified Formulation^CVX|999|||01^Historical^NIP001|||||||||||CP|AORC|RE|AK90P20232.18^AIRA|BK90P20232.18^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||120^DTaP-Hib-IPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||983BG|20201201|PMC^Sanofi^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AK90P20232.19^AIRA|BK90P20232.19^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||133^PCV13^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A1345C|20201201|PFR^Pfizer^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300026411151105^Multi Pediatric Vaccines VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AK90P20232.20^AIRA|BK90P20232.20^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AK90P20232.21^AIRA|BK90P20232.21^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A peds^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||825AR23|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N17Y20240^^^AIRA^MR||ThurstonAIRA^EllieAIRA^Annika^^^^L|CamasAIRA^OctaviaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1218 Vden Cir^^Farmingtn Hls^MI^48335^USA^P||^PRN^PH^^^248^9728610|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ThurstonAIRA^CamasAIRA^Marion^^^^L|MTH^Mother^HL70063|1218 Vden Cir^^Farmingtn Hls^MI^48335^USA^P|^PRN^PH^^^248^9728610ORC|RE|AN17Y20240.1^AIRA|BN17Y20240.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H10R20242^^^AIRA^MR||DimmitAIRA^MiyokoAIRA^Africa^^^^L|CheyenneAIRA^PhoebeAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1979 Spel Pl^^Shelby Township^MI^48318^USA^P||^PRN^PH^^^586^3526045|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|DimmitAIRA^CheyenneAIRA^Marion^^^^L|MTH^Mother^HL70063|1979 Spel Pl^^Shelby Township^MI^48318^USA^P|^PRN^PH^^^586^3526045ORC|RE|AH10R20242.1^AIRA|BH10R20242.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N17Y20240^^^AIRA^MR||ThurstonAIRA^EllieAIRA^Annika^^^^L|CamasAIRA^OctaviaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1218 Vden Cir^^Farmingtn Hls^MI^48335^USA^P||^PRN^PH^^^248^9728610|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ThurstonAIRA^CamasAIRA^Marion^^^^L|MTH^Mother^HL70063|1218 Vden Cir^^Farmingtn Hls^MI^48335^USA^P|^PRN^PH^^^248^9728610ORC|RE|AN17Y20240.1^AIRA|BN17Y20240.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.1.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H10R20242^^^AIRA^MR||DimmitAIRA^MiyokoAIRA^Africa^^^^L|CheyenneAIRA^PhoebeAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1979 Spel Pl^^Shelby Township^MI^48318^USA^P||^PRN^PH^^^586^3526045|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|DimmitAIRA^CheyenneAIRA^Marion^^^^L|MTH^Mother^HL70063|1979 Spel Pl^^Shelby Township^MI^48318^USA^P|^PRN^PH^^^586^3526045ORC|RE|AH10R20242.1^AIRA|BH10R20242.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S95Y20259^^^AIRA^MR||HockleyAIRA^JulesAIRA^Shashi^^^^L|StephensAIRA^MyrnaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1098 Soorst Ln^^Howell^MI^48855^USA^P||^PRN^PH^^^517^2755744|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HockleyAIRA^StephensAIRA^Marion^^^^L|MTH^Mother^HL70063|1098 Soorst Ln^^Howell^MI^48855^USA^P|^PRN^PH^^^517^2755744ORC|RE|AS95Y20259.1^AIRA|BS95Y20259.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||08^HepB adolescent or pediatric^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis B Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L07H20261^^^AIRA^MR||AransasAIRA^CalthaAIRA^Kimora^^^^L|GraysonAIRA^VandanaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1409 Lranendonck Ave^^Trout Creek^MI^49967^USA^P||^PRN^PH^^^906^6739897|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|AransasAIRA^GraysonAIRA^Marion^^^^L|MTH^Mother^HL70063|1409 Lranendonck Ave^^Trout Creek^MI^49967^USA^P|^PRN^PH^^^906^6739897ORC|RE|AL07H20261.1^AIRA|BL07H20261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||08^HepB adolescent or pediatric^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis B Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.2.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S95Y20259^^^AIRA^MR||HockleyAIRA^JulesAIRA^Shashi^^^^L|StephensAIRA^MyrnaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1098 Soorst Ln^^Howell^MI^48855^USA^P||^PRN^PH^^^517^2755744|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HockleyAIRA^StephensAIRA^Marion^^^^L|MTH^Mother^HL70063|1098 Soorst Ln^^Howell^MI^48855^USA^P|^PRN^PH^^^517^2755744ORC|RE|AS95Y20259.1^AIRA|BS95Y20259.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201201|SKB^GlaxoSmithKline^MVX|||CP|U|RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.2.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L07H20261^^^AIRA^MR||AransasAIRA^CalthaAIRA^Kimora^^^^L|GraysonAIRA^VandanaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1409 Lranendonck Ave^^Trout Creek^MI^49967^USA^P||^PRN^PH^^^906^6739897|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|AransasAIRA^GraysonAIRA^Marion^^^^L|MTH^Mother^HL70063|1409 Lranendonck Ave^^Trout Creek^MI^49967^USA^P|^PRN^PH^^^906^6739897ORC|RE|AL07H20261.1^AIRA|BL07H20261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201201|SKB^GlaxoSmithKline^MVX|||CP|U|RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300005911190815^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I58G20280^^^AIRA^MR||AdamsAIRA^RaimyAIRA^Ronan^^^^L|LewisAIRA^KomalAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1234 Uoudrichem Ave^^Trout Creek^MI^49967^USA^P||^PRN^PH^^^906^3411118|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|AdamsAIRA^LewisAIRA^Marion^^^^L|MTH^Mother^HL70063|1234 Uoudrichem Ave^^Trout Creek^MI^49967^USA^P|^PRN^PH^^^906^3411118ORC|RE|AI58G20280.1^AIRA|BI58G20280.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W31Y20282^^^AIRA^MR||SiouxAIRA^PerlinaAIRA^Vanjan^^^^L|WalshAIRA^RulaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1078 Merwerderadeel Ave^^Bark River^MI^49807^USA^P||^PRN^PH^^^906^9220782|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|SiouxAIRA^WalshAIRA^Marion^^^^L|MTH^Mother^HL70063|1078 Merwerderadeel Ave^^Bark River^MI^49807^USA^P|^PRN^PH^^^906^9220782ORC|RE|AW31Y20282.1^AIRA|BW31Y20282.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.3.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I58G20280^^^AIRA^MR||AdamsAIRA^RaimyAIRA^Ronan^^^^L|LewisAIRA^KomalAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1234 Uoudrichem Ave^^Trout Creek^MI^49967^USA^P||^PRN^PH^^^906^3411118|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|AdamsAIRA^LewisAIRA^Marion^^^^L|MTH^Mother^HL70063|1234 Uoudrichem Ave^^Trout Creek^MI^49967^USA^P|^PRN^PH^^^906^3411118ORC|RE|AI58G20280.1^AIRA|O69B20292.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.4.3.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W31Y20282^^^AIRA^MR||SiouxAIRA^PerlinaAIRA^Vanjan^^^^L|WalshAIRA^RulaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1078 Merwerderadeel Ave^^Bark River^MI^49807^USA^P||^PRN^PH^^^906^9220782|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|SiouxAIRA^WalshAIRA^Marion^^^^L|MTH^Mother^HL70063|1078 Merwerderadeel Ave^^Bark River^MI^49807^USA^P|^PRN^PH^^^906^9220782ORC|RE|AW31Y20282.1^AIRA|W96O20293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200306||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|U|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.5.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K02O20299^^^AIRA^MR||ComancheAIRA^ZivaAIRA^Keandra^^^^L|San BernardinoAIRA^CrisiantAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1864 Spoedig St^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^9119438|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ComancheAIRA^San BernardinoAIRA^Marion^^^^L|MTH^Mother^HL70063|1864 Spoedig St^^Lake Linden^MI^49945^USA^P|^PRN^PH^^^906^9119438ORC|RE|AK02O20299.1^AIRA|BK02O20299.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AK02O20299.2^AIRA|BK02O20299.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.5.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R46S20301^^^AIRA^MR||PeskenAIRA^OraAIRA^Alessandra^^^^L|RonningAIRA^MarninaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1265 Keek Ave^^Lansing^MI^48915^USA^P||^PRN^PH^^^517^5444071|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|PeskenAIRA^RonningAIRA^Marion^^^^L|MTH^Mother^HL70063|1265 Keek Ave^^Lansing^MI^48915^USA^P|^PRN^PH^^^517^5444071ORC|RE|AR46S20301.1^AIRA|BR46S20301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308ORC|RE|AR46S20301.2^AIRA|BR46S20301.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||A35AS548E|20201201|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300004211160720^Hepatitis A Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.5.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K02O20299^^^AIRA^MR||ComancheAIRA^ZivaAIRA^Keandra^^^^L|San BernardinoAIRA^CrisiantAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1864 Spoedig St^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^9119438|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ComancheAIRA^San BernardinoAIRA^Marion^^^^L|MTH^Mother^HL70063|1864 Spoedig St^^Lake Linden^MI^49945^USA^P|^PRN^PH^^^906^9119438ORC|RE|AK02O20299.1^AIRA|BK02O20299.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|D|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.5.1.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R46S20301^^^AIRA^MR||PeskenAIRA^OraAIRA^Alessandra^^^^L|RonningAIRA^MarninaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1265 Keek Ave^^Lansing^MI^48915^USA^P||^PRN^PH^^^517^5444071|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|PeskenAIRA^RonningAIRA^Marion^^^^L|MTH^Mother^HL70063|1265 Keek Ave^^Lansing^MI^48915^USA^P|^PRN^PH^^^517^5444071ORC|RE|AR46S20301.1^AIRA|BR46S20301.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^AIRA^L^^^PRN||57422^RADON^NICHOLAS^JOHN^^^^^AIRA^L^^^PRN|||||444^Clinic Name^HL70362RXA|0|1|20200308||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|7824^Jackson^Lily^Suzanne^^^^^AIRA^L^^^PRN|^^^AIRA-Clinic-1||||Q3110HZ|20201201|MSD^Merck and Co^MVX|||CP|D|RXR|C38299^Subcutaneous^NCIT|LT^Left Thigh^HL70163OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20200308OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20200308|||VXC40^per immunization^CDCPHINVSOBX|3|CE|69764-9^Document Type^LN|3|253088698300013411190815^MMRV Vaccine VIS^cdcgs1vis||||||F|||20200308OBX|4|DT|29769-7^Date Vis Presented^LN|3|20200308||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.6.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W09S20316^^^AIRA^MR||CentreAIRA^JanaeAIRA^Charlene^^^^L|BucksAIRA^KarenaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1431 Plbrandswaard Pl^^Ypsilanti^MI^48198^USA^P||^PRN^PH^^^734^3918496|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|Y|20200308|||A|20200308|20200308NK1|1|CentreAIRA^BucksAIRA^Marion^^^^L|MTH^Mother^HL70063|1431 Plbrandswaard Pl^^Ypsilanti^MI^48198^USA^P|^PRN^PH^^^734^3918496ORC|RE|AW09S20316.1^AIRA|BW09S20316.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.6.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R68R20318^^^AIRA^MR||NuckollsAIRA^KanthaAIRA^Nova^^^^L|LoveAIRA^AudrinaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1168 Mengen Cir^^Northville^MI^48167^USA^P||^PRN^PH^^^248^5127297|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|Y|20200308|||A|20200308|20200308NK1|1|NuckollsAIRA^LoveAIRA^Marion^^^^L|MTH^Mother^HL70063|1168 Mengen Cir^^Northville^MI^48167^USA^P|^PRN^PH^^^248^5127297ORC|RE|AR68R20318.1^AIRA|BR68R20318.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.6.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R67A20324^^^AIRA^MR||FranklinAIRA^ArikaAIRA^Zuri^^^^L|GilaAIRA^LexiAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1041 Mcherpenzeel St^^Merrill^MI^48637^USA^P||^PRN^PH^^^989^2100936|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|FranklinAIRA^GilaAIRA^Marion^^^^L|MTH^Mother^HL70063|1041 Mcherpenzeel St^^Merrill^MI^48637^USA^P|^PRN^PH^^^989^2100936ORC|RE|AR67A20324.1^AIRA|BR67A20324.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.6.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J55B20326^^^AIRA^MR||PhelpsAIRA^AndreaAIRA^Niobe^^^^L|JeffersonAIRA^MikaylaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1894 Aoststellingwerf Pl^^Flint^MI^48552^USA^P||^PRN^PH^^^810^9550848|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|PhelpsAIRA^JeffersonAIRA^Marion^^^^L|MTH^Mother^HL70063|1894 Aoststellingwerf Pl^^Flint^MI^48552^USA^P|^PRN^PH^^^810^9550848ORC|RE|AJ55B20326.1^AIRA|BJ55B20326.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.7.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V01T20336^^^AIRA^MR||HardinAIRA^SadieAIRA^Belen^^^^L|FranklinAIRA^LeilahAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1913 Wouten St^^Lawton^MI^49065^USA^P||^PRN^PH^^^269^6489199|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|HardinAIRA^FranklinAIRA^Marion^^^^L|MTH^Mother^HL70063|1913 Wouten St^^Lawton^MI^49065^USA^P|^PRN^PH^^^269^6489199ORC|RE||9999^AIRA|RXA|0|1|20200308||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.7.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U76Y20338^^^AIRA^MR||ChelanAIRA^JocelynAIRA^Marley^^^^L|BedfordAIRA^MahdiAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1658 Sergeijk Pl^^Bham^MI^48009^USA^P||^PRN^PH^^^248^4007046|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ChelanAIRA^BedfordAIRA^Marion^^^^L|MTH^Mother^HL70063|1658 Sergeijk Pl^^Bham^MI^48009^USA^P|^PRN^PH^^^248^4007046ORC|RE||9999^AIRA|RXA|0|1|20200308||21^varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.8.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V35H20347^^^AIRA^MR||VintonAIRA^RiannaAIRA^Eartha^^^^L|CartonAIRA^AtarahAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1994 Loerdijk St^^Lambertville^MI^48144^USA^P||^PRN^PH^^^734^3432331|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|VintonAIRA^CartonAIRA^Marion^^^^L|MTH^Mother^HL70063|1994 Loerdijk St^^Lambertville^MI^48144^USA^P|^PRN^PH^^^734^3432331ORC|RE|AV35H20347.1^AIRA|BV35H20347.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.8.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Z62C20349^^^AIRA^MR||CraneAIRA^DieuwertjeAIRA^Barina^^^^L|DefianceAIRA^DruellaAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1930 Beschrijven Ave^^Highland^MI^48357^USA^P||^PRN^PH^^^248^9703377|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|CraneAIRA^DefianceAIRA^Marion^^^^L|MTH^Mother^HL70063|1930 Beschrijven Ave^^Highland^MI^48357^USA^P|^PRN^PH^^^248^9703377ORC|RE|AZ62C20349.1^AIRA|BZ62C20349.1^AIRARXA|0|1|20170308||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||||CP|AMSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.8.1.2|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V35H20347^^^AIRA^MR||VintonAIRA^RiannaAIRA^Eartha^^^^L|CartonAIRA^AtarahAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1994 Loerdijk St^^Lambertville^MI^48144^USA^P||^PRN^PH^^^734^3432331|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|VintonAIRA^CartonAIRA^Marion^^^^L|MTH^Mother^HL70063|1994 Loerdijk St^^Lambertville^MI^48144^USA^P|^PRN^PH^^^734^3432331ORC|RE||9999^AIRA|RXA|0|1|20170308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||F|||20170308|MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.8.1.2-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||V35H20347^^^AIRA^MR||VintonAIRA^RiannaAIRA^Eartha^^^^L|CartonAIRA^AtarahAIRA^^^^^M|20160226|F||2106-3^White^CDCREC|1994 Loerdijk St^^Lambertville^MI^48144^USA^P||^PRN^PH^^^734^3432331|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|VintonAIRA^CartonAIRA^Marion^^^^L|MTH^Mother^HL70063|1994 Loerdijk St^^Lambertville^MI^48144^USA^P|^PRN^PH^^^734^3432331ORC|RE||9999^AIRA|RXA|0|1|20170308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|31044-1^Reaction^LN|1|39579001^Anaphylaxis^SCT||||||F|||20170308|MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.9.1.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||J68X20369^^^AIRA^MR||WallerAIRA^AlisonAIRA^Ali^^^^L|EvansAIRA^TrishAIRA^^^^^M|19940225|F||2106-3^White^CDCREC|1575 Appel Ln^^Ortonville^MI^48462^USA^P||^PRN^PH^^^248^8877705|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|WallerAIRA^EvansAIRA^Marion^^^^L|MTH^Mother^HL70063|1575 Appel Ln^^Ortonville^MI^48462^USA^P|^PRN^PH^^^248^8877705ORC|RE||9999^AIRA|RXA|0|1|20200308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|30945-0^Vaccination contraindication^LN|1|77386006^Patient Currently Pregnant^SCT||||||F|||20200308OBX|2|DT|30946-8^Vaccination contraindication effective date^LN|1|20160605||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.9.1.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||M94G20371^^^AIRA^MR||DeuelAIRA^TheraAIRA^Sanaa^^^^L|CarterAIRA^RayelleAIRA^^^^^M|19940225|F||2106-3^White^CDCREC|1352 Eierden Ave^^Republic^MI^49879^USA^P||^PRN^PH^^^906^6506093|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|DeuelAIRA^CarterAIRA^Marion^^^^L|MTH^Mother^HL70063|1352 Eierden Ave^^Republic^MI^49879^USA^P|^PRN^PH^^^906^6506093ORC|RE||9999^AIRA|RXA|0|1|20200308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|30945-0^Vaccination contraindication^LN|1|77386006^Patient Currently Pregnant^SCT||||||F|||20200308OBX|2|DT|30946-8^Vaccination contraindication effective date^LN|1|20160605||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.9.2.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||H03L20380^^^AIRA^MR||ShiawasseeAIRA^JagratiAIRA^Magenta^^^^L|BullittAIRA^StarrAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1264 Aeeuwarden Pl^^Ann Arbor^MI^48108^USA^P||^PRN^PH^^^734^2788639|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|ShiawasseeAIRA^BullittAIRA^Marion^^^^L|MTH^Mother^HL70063|1264 Aeeuwarden Pl^^Ann Arbor^MI^48108^USA^P|^PRN^PH^^^734^2788639ORC|RE||9999^AIRA|RXA|0|1|20200308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.9.2.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G00J20382^^^AIRA^MR||SutterAIRA^SammiAIRA^Alazne^^^^L|LincolnAIRA^WilmaAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1974 Wet Cir^^Detroit^MI^48279^USA^P||^PRN^PH^^^313^4243880|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|SutterAIRA^LincolnAIRA^Marion^^^^L|MTH^Mother^HL70063|1974 Wet Cir^^Detroit^MI^48279^USA^P|^PRN^PH^^^313^4243880ORC|RE||9999^AIRA|RXA|0|1|20200308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^History of Varicella infection^SCT||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.9.3.1|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X89E20391^^^AIRA^MR||UnionAIRA^BriettaAIRA^Edlyn^^^^L|CooperAIRA^MadelineAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1534 Aastricum St^^Galesburg^MI^49053^USA^P||^PRN^PH^^^269^9276742|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|UnionAIRA^CooperAIRA^Marion^^^^L|MTH^Mother^HL70063|1534 Aastricum St^^Galesburg^MI^49053^USA^P|^PRN^PH^^^269^9276742ORC|RE||9999^AIRA|RXA|0|1|20200308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|75505-8^Disease with serological evidence of immunity^LN|1|271511000^Serology confirmed Hepatitis B^SCT||||||F|||20200308MSH|^~\&|||||20200308102500-0600||VXU^V04^VXU_V04|d6Y-SA.9.3.1-D|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R52G20393^^^AIRA^MR||MiamiAIRA^RanjanaAIRA^Tolena^^^^L|HancockAIRA^TadiAIRA^^^^^M|20190225|F||2106-3^White^CDCREC|1146 Pteenwijkerland Ln^^Spring Lake^MI^49456^USA^P||^PRN^PH^^^616^8441574|||||||||2186-5^not Hispanic or Latino^CDCREC||N||||||NPD1|||||||||||02^Reminder/Recall - any method^HL70215|N|20200308|||A|20200308|20200308NK1|1|MiamiAIRA^HancockAIRA^Marion^^^^L|MTH^Mother^HL70063|1146 Pteenwijkerland Ln^^Spring Lake^MI^49456^USA^P|^PRN^PH^^^616^8441574ORC|RE||9999^AIRA|RXA|0|1|20200308||998^No Vaccine Administered^CVX|999||||||||||||||NA|AOBX|1|CE|75505-8^Disease with serological evidence of immunity^LN|1|271511000^Serology confirmed Hepatitis B^SCT||||||F|||20200308MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.101|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U17B39213^^^AIRA-TEST^MR||ButlerAIRA^JeraldineAIRA^Fayna^^^^L|BeecherAIRA^JihanAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1767 Nansingerland Ln^^Kalamazoo^MI^49009^USA^P||^PRN^PH^^^269^4139541|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ButlerAIRA^BeecherAIRA^^^^^L|MTH^Mother^HL70063|1767 Nansingerland Ln^^Kalamazoo^MI^49009^USA^P|^PRN^PH^^^269^4139541ORC|RE||BU17B39213.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU17B39213.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.102|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||PID|1||Q78S39218^^^AIRA-TEST^MR||HayesAIRA^FriedaAIRA^Lavani^^^^L|ParkesAIRA^MarleyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1194 Schelp Ave^^Wyoming^MI^49519^USA^P||^PRN^PH^^^616^7459317|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HayesAIRA^ParkesAIRA^^^^^L|MTH^Mother^HL70063|1194 Schelp Ave^^Wyoming^MI^49519^USA^P|^PRN^PH^^^616^7459317ORC|RE||BQ78S39218.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BQ78S39218.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.103|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1|PID|1||G18J39229^^^AIRA-TEST^MR||FloydAIRA^KamballaAIRA^Enid^^^^L|HobellAIRA^AdrianaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1253 Marneveld Cir^^Bangor^MI^49013^USA^P||^PRN^PH^^^269^8280493|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^HobellAIRA^^^^^L|MTH^Mother^HL70063|1253 Marneveld Cir^^Bangor^MI^49013^USA^P|^PRN^PH^^^269^8280493ORC|RE||BG18J39229.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG18J39229.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.104|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N28U39237^^^0150213078758545063923627551051491551309522531961813775465660544151359463423961785519077061002329538304335083417576758883245593515366797956994553074861722186495615122557516057512303953281108735246094086930050554922031951679769^MR||SullivanAIRA^ArminaAIRA^Sevilla^^^^L|LyastromAIRA^SteshaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1475 Punt Ln^^Wellston^MI^49689^USA^P||^PRN^PH^^^231^4381933|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SullivanAIRA^LyastromAIRA^^^^^L|MTH^Mother^HL70063|1475 Punt Ln^^Wellston^MI^49689^USA^P|^PRN^PH^^^231^4381933ORC|RE||BN28U39237.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN28U39237.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.105|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||G58D39245^^^AIRA-TEST^PI||ErieAIRA^AgapeAIRA^Grania^^^^L|BullittAIRA^LibertyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1438 Winkelland Cir^^Monroe^MI^48161^USA^P||^PRN^PH^^^734^5184621|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|ErieAIRA^BullittAIRA^^^^^L|MTH^Mother^HL70063|1438 Winkelland Cir^^Monroe^MI^48161^USA^P|^PRN^PH^^^734^5184621ORC|RE||BG58D39245.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BG58D39245.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.106|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I95J39253^^^AIRA-TEST^MR||CameronAIRA^ZanetaAIRA^Adorabelle^^^^L|BoundaryAIRA^EmersynAIRA^^^^^M|20131003113759-0700|F||2106-3^White^CDCREC|1796 Gevenaar Ln^^Port Huron^MI^48061^USA^P||^PRN^PH^^^810^6708582|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CameronAIRA^BoundaryAIRA^^^^^L|MTH^Mother^HL70063|1796 Gevenaar Ln^^Port Huron^MI^48061^USA^P|^PRN^PH^^^810^6708582ORC|RE||BI95J39253.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI95J39253.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.107|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||X50E39261^^^AIRA-TEST^MR||OxfordAIRA^ConstanceAIRA^Whitney^^^^L|HoreAIRA^AnneAIRA^^^^^M|20160107|F||KLINGON^Klingon^CDCREC|1372 Worger-Odoorn Cir^^Flint^MI^48551^USA^P||^PRN^PH^^^810^7234703|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|OxfordAIRA^HoreAIRA^^^^^L|MTH^Mother^HL70063|1372 Worger-Odoorn Cir^^Flint^MI^48551^USA^P|^PRN^PH^^^810^7234703ORC|RE||BX50E39261.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BX50E39261.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.108|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||K30J39269^^^AIRA-TEST^MR||MurphyAIRA^VegaAIRA^Virginia^^^^L|FoxAIRA^MinaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1064 Weinig Ln^^Bellevue^MI^49021^USA^P||^PRN^PH^^^269^7090956|||||||||KLINGON^Klingon^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MurphyAIRA^FoxAIRA^^^^^L|MTH^Mother^HL70063|1064 Weinig Ln^^Bellevue^MI^49021^USA^P|^PRN^PH^^^269^7090956ORC|RE||BK30J39269.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BK30J39269.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.109|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P48U39274^^^AIRA-TEST^MR||HolmesAIRA^AlmedaAIRA^Mersadize^^^^L|OsceolaAIRA^ElectraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1025 Beginnen St^^Somerset^MI^49281^USA^P||^PRN^PH^^^517^5243230|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|HolmesAIRA^OsceolaAIRA^^^^^L|MTH^Mother^HL70063|1025 Beginnen St^^Somerset^MI^49281^USA^P|^PRN^PH^^^517^5243230ORC|RE||BP48U39274.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BP48U39274.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.110|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y24D39285^^^AIRA-TEST^MR||FloydAIRA^XuxaAIRA^Silvana^^^^L|MorreyAIRA^TrudeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1399 Totterdam Pl^^Alma^MI^48802^USA^P||^PRN^PH^^^989^3260834|||||||||2186-5^not Hispanic or Latino^CDCREC||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FloydAIRA^MorreyAIRA^^^^^L|MTH^Mother^HL70063|1399 Totterdam Pl^^Alma^MI^48802^USA^P|^PRN^PH^^^989^3260834ORC|RE||BY24D39285.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY24D39285.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.111|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||Y28G39293^^^AIRA-TEST^MR||MahaskaAIRA^PreetiAIRA^Dobrila^^^^L|KimbleAIRA^ShirleyAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1571 Daalre St^^Rochester Hills^MI^48308^USA^P||^PRN^PH^^^248^4308637|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MahaskaAIRA^KimbleAIRA^^^^^L|MTH^Mother^HL70063|1571 Daalre St^^Rochester Hills^MI^48308^USA^P|^PRN^PH^^^248^4308637ORC|RE||BY28G39293.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BY28G39293.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.112|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||C84W39301^^^AIRA-TEST^MR||FiggensAIRA^KeiAIRA^Sydnee^^^^L|MadisonAIRA^TakaraAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1444 Ode St^^Lansing State Journal^MI^48919^USA^P||^PRN^PH^^^517^3073309|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FiggensAIRA^MadisonAIRA^^^^^L|MTH^Mother^HL70063|1444 Ode St^^Lansing State Journal^MI^48919^USA^P|^PRN^PH^^^517^3073309MSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.113|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||R93H39309^^^AIRA-TEST^MR||SnyderAIRA^KeilanaAIRA^Natividad^^^^L|CroweAIRA^DesdemonaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1932 Bpeldoorn Cir^^Eben Jct^MI^49825^USA^P||^PRN^PH^^^906^8262699|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SnyderAIRA^CroweAIRA^^^^^L|MTH^Mother^HL70063|1932 Bpeldoorn Cir^^Eben Jct^MI^49825^USA^P|^PRN^PH^^^906^8262699ORC|RE||BR93H39309.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200309083012-0600||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BR93H39309.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.114|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||F93N39317^^^AIRA-TEST^MR||TansbergAIRA^MiyokoAIRA^Shubha^^^^L|ShortAIRA^PhilaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1970 Hisse St^^Clarklake^MI^49234^USA^P||^PRN^PH^^^517^4707841|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|TansbergAIRA^ShortAIRA^^^^^L|MTH^Mother^HL70063|1970 Hisse St^^Clarklake^MI^49234^USA^P|^PRN^PH^^^517^4707841ORC|RE||BF93N39317.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BF93N39317.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.115|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I92O39322^^^AIRA-TEST^MR||CreghanAIRA^PapillonAIRA^Sasha^^^^L|San DiegoAIRA^GeraniumAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1516 Seventer Ln^^GR^MI^49518^USA^P||^PRN^PH^^^616^6977596|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CreghanAIRA^San DiegoAIRA^^^^^L|MTH^Mother^HL70063|1516 Seventer Ln^^GR^MI^49518^USA^P|^PRN^PH^^^616^6977596ORC|RE||BI92O39322.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This \F\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI92O39322.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.116|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||I53I39333^^^AIRA-TEST^MR||CoshoctonAIRA^KelilaAIRA^Chitrangda^^^^L|ChoctawAIRA^SamikshaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1575 Rijkerk St^^Jackson National Life Ins Co^MI^48951^USA^P||^PRN^PH^^^517^6006136|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CoshoctonAIRA^ChoctawAIRA^^^^^L|MTH^Mother^HL70063|1575 Rijkerk St^^Jackson National Life Ins Co^MI^48951^USA^P|^PRN^PH^^^517^6006136ORC|RE||BI53I39333.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This \S\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BI53I39333.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.117|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S69D39341^^^AIRA-TEST^MR||MitchellAIRA^FairleeAIRA^Carnelian^^^^L|CarsonAIRA^KumariAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1399 Wchiedam Ave^^Alden^MI^49612^USA^P||^PRN^PH^^^231^8305758|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MitchellAIRA^CarsonAIRA^^^^^L|MTH^Mother^HL70063|1399 Wchiedam Ave^^Alden^MI^49612^USA^P|^PRN^PH^^^231^8305758ORC|RE||BS69D39341.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This \T\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BS69D39341.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.118|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||E40D39349^^^AIRA-TEST^MR||BullittAIRA^MarlonAIRA^Harsha^^^^L|KlamathAIRA^PenelopeAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1016 Ke Wolden Ln^^Roseville^MI^48066^USA^P||^PRN^PH^^^586^8554770|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|BullittAIRA^KlamathAIRA^^^^^L|MTH^Mother^HL70063|1016 Ke Wolden Ln^^Roseville^MI^48066^USA^P|^PRN^PH^^^586^8554770ORC|RE||BE40D39349.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This \R\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BE40D39349.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.119|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||W99X39357^^^AIRA-TEST^MR||SchoolcraftAIRA^KesareAIRA^Mellissa^^^^L|HillsdaleAIRA^BarbieAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1439 Varlingen Cir^^Huron Township^MI^48164^USA^P||^PRN^PH^^^734^2164374|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|SchoolcraftAIRA^HillsdaleAIRA^^^^^L|MTH^Mother^HL70063|1439 Varlingen Cir^^Huron Township^MI^48164^USA^P|^PRN^PH^^^734^2164374ORC|RE||BW99X39357.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This \E\ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BW99X39357.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.120|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||N12W39365^^^AIRA-TEST^MR||AllenAIRA^DestineeAIRA^Marlene^^^^L|HowardAIRA^RaelinAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1731 Ierneuzen St^^Sumpter Township^MI^48111^USA^P||^PRN^PH^^^734^9542777|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|AllenAIRA^HowardAIRA^^^^^L|MTH^Mother^HL70063|1731 Ierneuzen St^^Sumpter Township^MI^48111^USA^P|^PRN^PH^^^734^9542777ORC|RE||BN12W39365.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This \ That^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BN12W39365.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.121|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||U45R39373^^^AIRA-TEST^MR||MartinsonAIRA^MadeiraAIRA^Adele^^^^L|OgemawAIRA^ChimalisAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1934 Vwolle St^^Canton^MI^48187^USA^P||^PRN^PH^^^734^6872114|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|MartinsonAIRA^OgemawAIRA^^^^^L|MTH^Mother^HL70063|1934 Vwolle St^^Canton^MI^48187^USA^P|^PRN^PH^^^734^6872114ORC|RE||BU45R39373.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^This is a very long description for a vaccine, that normally you shouldn't expect to see, but since this field should not be read by the receiver it should be accepted, HL7 allows up to 199 chars.^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BU45R39373.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.122|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||P18Z39378^^^AIRA-TEST^MR||FranklinAIRA^KamaliAIRA^Mirabel^^^^L|Keya PahaAIRA^ZadaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1349 Deststellingwerf Cir^^Burtchville^MI^48059^USA^P||^PRN^PH^^^810^5714797|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|FranklinAIRA^Keya PahaAIRA^^^^^L|MTH^Mother^HL70063|1349 Deststellingwerf Cir^^Burtchville^MI^48059^USA^P|^PRN^PH^^^810^5714797ORC|RE||BP18Z39378.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001||||||||^This is a very long description for a manufac, that normally you shouldn't expect to see, but since this field should not be read by the receiver it should be accepted, HL7 allows up to 199 chars.|||CP|AORC|RE||BP18Z39378.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.123|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||S42Q39389^^^AIRA-TEST^MR||DomoAIRA^YelenaAIRA^Miki^^^^L|NelsonAIRA^ThaddeaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1323 Afhangen Pl^^South Lyon^MI^48178^USA^P||^PRN^PH^^^248^6174373|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|DomoAIRA^NelsonAIRA^^^^^L|MTH^Mother^HL70063|1323 Afhangen Pl^^South Lyon^MI^48178^USA^P|^PRN^PH^^^248^6174373ORC|RE||BS42Q39389.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001||||||||^Merk & Co|||CP|AORC|RE||BS42Q39389.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.124|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L79H39397^^^AIRA-TEST^MR||JernneAIRA^ZiselAIRA^Emanuel^^^^L|BeckhamAIRA^ZionaAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1559 Roststellingwerf Ave^^Canton^MI^48184^USA^P||^PRN^PH^^^734^7944751|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|JernneAIRA^BeckhamAIRA^^^^^L|MTH^Mother^HL70063|1559 Roststellingwerf Ave^^Canton^MI^48184^USA^P|^PRN^PH^^^734^7944751ORC|RE||BL79H39397.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|A||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||ORC|RE||BL79H39397.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.125|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||L52J39405^^^AIRA-TEST^MR||CliveAIRA^UrsellAIRA^Anthea^^^^L|RussellAIRA^InduAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1742 Sturen St^^Minden City^MI^48465^USA^P||^PRN^PH^^^989^8446148|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|CliveAIRA^RussellAIRA^^^^^L|MTH^Mother^HL70063|1742 Sturen St^^Minden City^MI^48465^USA^P|^PRN^PH^^^989^8446148ORC|RE||BL52J39405.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|A|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||1|ORC|RE||BL52J39405.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.126|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||O33T39413^^^AIRA-TEST^MR||WashingtonAIRA^CharlotteAIRA^Mirrin^^^^L|WayneAIRA^FarrahAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1391 Garneveld Pl^^Rawsonville^MI^48197^USA^P||^PRN^PH^^^734^8124154|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|WashingtonAIRA^WayneAIRA^^^^^L|MTH^Mother^HL70063|1391 Garneveld Pl^^Rawsonville^MI^48197^USA^P|^PRN^PH^^^734^8124154ORC|RE||BO33T39413.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BO33T39413.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.127|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A40Y39421^^^AIRA-TEST^MR||KimballAIRA^OlenaAIRA^Lene^^^^L|OttawaAIRA^ParveenAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1152 Lpeldoorn Ave^^Middleville^MI^49333^USA^P||^PRN^PH^^^269^5638220|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|KimballAIRA^OttawaAIRA^^^^^L|MTH^Mother^HL70063|1152 Lpeldoorn Ave^^Middleville^MI^49333^USA^P|^PRN^PH^^^269^5638220ORC|RE||BA40Y39421.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA40Y39421.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||FMSH|^~\&|||||20200308140619-0400||VXU^V04^VXU_V04|SUP-D.01.135|P|2.5.1|||ER|AL|||||Z22^CDCPHINVSPID|1||A82X39426^^^AIRA-TEST^MR||None^RadaAIRA^Orchid^^^^L|AdaAIRA^HermioneAIRA^^^^^M|20160107|F||2106-3^White^CDCREC|1230 Rierden Ln^^Carsonville^MI^48419^USA^P||^PRN^PH^^^810^5177666|||||||||2186-5^not Hispanic or Latino^CDCRECPD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20200308|20200308NK1|1|StanislausAIRA^AdaAIRA^^^^^L|MTH^Mother^HL70063|1230 Rierden Ln^^Carsonville^MI^48419^USA^P|^PRN^PH^^^810^5177666ORC|RE||BA82X39426.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1RXA|0|1|20200107||21^Varicella^CVX|999|||01^Historical information - source unspecified^NIP001|||||||||||CP|AORC|RE||BA82X39426.2^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^LRXA|0|1|20200308||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX|||CP|ARXR|C38299^Subcutaneous^NCIT|RA^^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20200308|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20200308||||||F